data_2kop_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kop _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.768 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.6 t . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 107.864 -1.161 . . . . 1.34 107.864 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.88 -42.72 48.47 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.363 1.065 . . . . 0.74 113.757 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -58.53 -23.79 59.04 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.173 0.511 . . . . 2.66 112.148 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -84.33 -45.14 13.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.272 -0.64 . . . . 2.73 109.272 175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.505 HG23 ' HA ' ' A' ' 73' ' ' THR . 79.8 mt -71.57 -65.44 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.03 0 CA-C-N 115.001 -0.999 . . . . 1.05 110.484 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.39 -48.81 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 C-N-CA 123.768 0.827 . . . . 1.05 112.614 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.68 77.64 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 123.327 0.392 . . . . 1.07 111.206 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -81.45 -40.5 11.03 Favored Glycine 0 N--CA 1.405 -3.424 0 C-N-CA 120.709 -0.758 . . . . 0.21 112.952 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.742 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -65.39 -38.09 88.94 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.161 0.984 . . . . 1.03 108.879 -176.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.549 ' HB1' HG21 ' A' ' 23' ' ' VAL . . . -61.82 -43.39 98.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.608 -0.724 . . . . 1.06 109.846 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.675 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.9 mt-10 -63.91 -35.74 81.65 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.754 0.659 . . . . 0.68 112.282 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.742 HD13 ' HA ' ' A' ' 11' ' ' LEU . 60.7 mt -62.25 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.621 -0.881 . . . . 1.16 108.621 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.3 t -68.34 -23.86 28.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 CA-C-O 121.591 0.71 . . . . 1.14 110.659 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.675 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -66.35 -46.18 77.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.235 -0.893 . . . . 0.36 109.096 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.75 -44.8 15.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.233 -0.894 . . . . 2.07 111.614 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.694 HG13 HG22 ' A' ' 46' ' ' VAL . 21.0 mm -59.57 -51.91 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.783 0.433 . . . . 1.31 110.793 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.524 ' HB2' HG11 ' A' ' 38' ' ' VAL . . . -108.33 -81.42 0.57 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.52 0.676 . . . . 1.18 110.631 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.45 55.7 0.01 OUTLIER Glycine 0 CA--C 1.484 -1.86 0 N-CA-C 110.322 -1.111 . . . . 0.43 110.322 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.648 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -97.82 160.79 27.68 Favored Pre-proline 0 C--N 1.278 -2.52 0 N-CA-C 107.976 -1.12 . . . . 1.06 107.976 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -93.24 143.57 2.1 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 122.523 2.148 . . . . 1.08 109.192 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.549 HG21 ' HB1' ' A' ' 12' ' ' ALA . 13.8 p -74.1 56.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 123.287 1.518 . . . . 1.28 112.802 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.51 -14.48 0.2 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.26 -1.336 . . . . 2.31 110.068 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.437 ' O ' ' HE3' ' A' ' 30' ' ' LYS . 1.6 t70 -87.61 -37.14 17.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.861 0.839 . . . . 1.59 109.172 -173.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.599 HG23 HD12 ' A' ' 36' ' ' LEU . 21.7 t -77.7 90.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.991 -1.114 . . . . 1.07 107.991 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -101.84 -96.29 0.28 Allowed 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.955 0.883 . . . . 2.11 109.014 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.418 ' HA ' HG11 ' A' ' 69' ' ' VAL . 95.4 mt -153.15 157.13 39.88 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 104.238 -2.505 . . . . 1.75 104.238 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' H ' ' CA ' ' A' ' 70' ' ' GLY . 30.5 t70 68.69 9.31 7.27 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.501 1.125 . . . . 0.72 110.657 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 68' ' ' THR . 46.6 mmtt -93.57 126.2 38.59 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-N 115.586 -0.734 . . . . 2.01 109.282 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.528 ' CB ' ' HB3' ' A' ' 34' ' ' ASP . 7.1 m -74.38 25.51 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 C-N-CA 126.501 1.92 . . . . 1.32 114.63 -171.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.735 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 70.2 m-85 41.84 -97.29 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.625 1.57 . . . . 0.71 113.746 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.55 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 10.2 t -57.58 -35.44 70.41 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 123.565 0.746 . . . . 1.36 111.141 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HB3' ' CB ' ' A' ' 31' ' ' SER . 19.3 t70 -83.67 -40.82 18.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.482 -0.326 . . . . 1.74 111.098 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.84 -54.45 3.96 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 118.683 -1.207 . . . . 1.29 110.821 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.599 HD12 HG23 ' A' ' 26' ' ' VAL . 17.3 mt -74.06 -38.37 63.97 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.457 -1.247 . . . . 1.11 111.405 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.6 t70 89.4 69.37 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.538 1.535 . . . . 1.12 109.605 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.55 ' H ' ' HA ' ' A' ' 33' ' ' THR . 15.0 t -111.68 155.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.927 -1.942 . . . . 1.21 106.57 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 43' ' ' MET . 12.2 m-20 -76.5 119.85 20.91 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.251 -0.648 . . . . 2.0 109.251 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.449 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 10.2 t -42.51 -50.71 5.25 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.584 1.153 . . . . 0.99 113.58 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.62 -29.54 70.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.46 0.648 . . . . 1.81 111.43 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.436 ' O ' HG21 ' A' ' 46' ' ' VAL . 21.7 m -84.43 -15.12 47.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.17 -0.468 . . . . 0.91 110.688 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.735 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -62.8 -35.01 78.49 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 123.429 0.692 . . . . 1.3 110.579 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.76 -42.62 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.138 -0.689 . . . . 1.07 109.138 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.99 -44.54 94.45 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.194 -0.669 . . . . 0.68 109.194 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.694 HG22 HG13 ' A' ' 18' ' ' ILE . 47.8 t -59.65 -29.03 41.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 114.998 -1.001 . . . . 1.31 111.244 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 1.011 HG21 HG11 ' A' ' 63' ' ' VAL . 40.4 t -77.78 -51.77 17.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.876 -0.787 . . . . 1.29 108.876 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.2 -21.57 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.429 -0.805 . . . . 1.1 109.272 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.22 -38.0 31.96 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.71 -56.36 16.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.337 -0.847 . . . . 1.05 110.253 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.297 0.6 OUTLIER -63.47 -36.7 84.62 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 114.379 1.251 . . . . 0.64 114.379 -176.328 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.73 -24.12 64.43 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.892 0.377 . . . . 2.07 111.486 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -88.26 -40.91 13.28 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.737 0.303 . . . . 3.11 110.554 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.456 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 8.5 m-85 -94.52 -2.1 52.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.81 113.032 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 81.77 7.18 1.07 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.3 1.04 . . . . 1.99 113.723 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 76' ' ' ILE . 11.5 p -89.73 178.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.328 -0.99 . . . . 1.14 108.328 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -133.45 130.51 38.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.241 -1.392 . . . . 2.7 107.241 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.44 HG12 ' HE2' ' A' ' 75' ' ' TYR . 61.9 mt -124.68 113.36 27.17 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.182 -0.673 . . . . 1.09 109.182 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HG23 ' A' ' 63' ' ' VAL . 73.3 Cg_endo -72.56 164.42 35.65 Favored 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 123.089 2.526 . . . . 0.4 110.518 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.9 -30.31 70.8 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.929 0.344 . . . . 1.98 111.929 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.51 -31.39 72.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.693 0.282 . . . . 2.06 111.094 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.609 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 15.2 m-20 -86.61 -28.21 23.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.034 0.383 . . . . 0.52 112.034 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 1.011 HG11 HG21 ' A' ' 47' ' ' VAL . 69.7 t -55.05 -48.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.415 -0.957 . . . . 1.12 108.415 173.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -80.65 -1.92 44.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.253 -0.885 . . . . 2.73 111.772 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.406 ' CB ' ' HA ' ' A' ' 62' ' ' ASP . 38.5 t30 -92.21 -29.47 16.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.597 -0.89 . . . . 1.92 108.597 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.874 HD13 ' HA ' ' A' ' 72' ' ' ALA . 25.6 mt -85.7 112.29 20.9 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.432 -1.322 . . . . 1.04 107.432 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.523 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -104.76 -21.99 13.27 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.705 -1.198 . . . . 2.98 110.966 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 30.6 p -127.79 169.85 13.4 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 108.804 -0.813 . . . . 1.03 108.804 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.656 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 1.6 p -73.88 -13.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.804 0.811 . . . . 1.91 110.419 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.432 ' CA ' ' H ' ' A' ' 29' ' ' ASP . . . -68.95 -47.28 55.61 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 108.772 -1.731 . . . . 0.33 108.772 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.523 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.6 m-20 -58.19 -56.36 23.1 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.014 -0.736 . . . . 1.39 109.014 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.874 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.65 -61.64 2.08 Favored 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 124.718 1.262 . . . . 1.04 111.926 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.505 ' HA ' HG23 ' A' ' 7' ' ' ILE . 31.6 m -57.92 -44.03 86.58 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 113.643 0.979 . . . . 1.07 113.643 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 0.6 OUTLIER -65.2 -33.3 75.69 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 122.905 0.482 . . . . 4.04 109.842 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.44 ' HE2' HG12 ' A' ' 58' ' ' ILE . 88.4 t80 -72.68 -52.72 14.12 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.422 -0.808 . . . . 0.9 110.023 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.714 ' HA ' HG22 ' A' ' 56' ' ' VAL . 70.7 mt -52.88 -66.26 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.698 0 C-N-CA 124.717 1.207 . . . . 1.12 111.519 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.768 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.4 tt -50.41 -49.08 55.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.596 1.558 . . . . 2.08 109.484 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.3 t70 -67.56 -23.42 65.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.424 -1.716 . . . . 0.64 111.575 -174.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -101.96 -12.88 17.86 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.868 -0.606 . . . . 1.59 112.448 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 68.0 mt-30 . . . . . 0 CA--C 1.464 -2.33 0 N-CA-C 107.1 -1.444 . . . . 1.09 107.1 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.432 -1.335 0 N-CA-C 109.362 -0.607 . . . . 1.34 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 73' ' ' THR . 1.0 OUTLIER -50.3 -46.4 55.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 125.615 1.566 . . . . 0.74 113.419 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.97 -23.59 63.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.58 0.585 . . . . 2.66 112.58 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -84.64 -32.2 23.79 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.821 -1.177 . . . . 2.73 107.821 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.496 HG21 ' HA ' ' A' ' 73' ' ' THR . 74.2 mt -79.88 -64.81 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.112 -0.949 . . . . 1.05 109.238 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -55.6 -42.59 69.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 112.626 0.602 . . . . 1.05 112.626 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -60.92 -40.07 91.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.57 -0.452 . . . . 1.07 110.691 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.69 -35.89 21.03 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 120.889 -0.672 . . . . 0.21 112.6 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.694 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -65.9 -39.75 90.9 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.508 -1.293 . . . . 1.03 107.508 -179.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.703 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.77 -49.84 67.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 123.926 0.766 . . . . 1.06 109.867 175.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.59 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 35.1 mt-10 -58.58 -42.68 88.59 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 124.223 0.952 . . . . 0.68 111.521 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.694 HD11 ' HA ' ' A' ' 11' ' ' LEU . 66.4 mt -59.4 -38.75 76.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.509 -0.769 . . . . 1.16 110.232 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 11' ' ' LEU . 61.9 t -71.83 -30.16 36.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.614 -0.721 . . . . 1.14 109.845 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.59 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.8 m120 -67.33 -42.65 83.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.102 -0.703 . . . . 0.36 109.102 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 37.1 mm-40 -70.68 -58.8 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.917 -1.038 . . . . 2.07 111.887 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.772 HG21 ' HB3' ' A' ' 42' ' ' SER . 28.0 mt -72.82 -39.36 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 112.619 0.6 . . . . 1.31 112.619 -174.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB2' HG11 ' A' ' 38' ' ' VAL . . . -106.27 -80.37 0.56 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.13 -0.628 . . . . 1.18 111.441 -178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.69 53.17 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.656 -0.783 . . . . 0.43 112.756 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.795 HG21 HG22 ' A' ' 26' ' ' VAL . 1.6 mp -98.02 155.22 37.27 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.612 -0.514 . . . . 1.06 109.612 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 24' ' ' GLU . 5.7 Cg_exo -88.76 40.14 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.017 2.478 . . . . 1.08 114.362 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.29 8.0 p 53.2 -18.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 117.383 2.364 . . . . 1.28 117.383 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 22' ' ' PRO . 12.9 pt-20 -103.58 -12.8 16.85 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.351 -0.843 . . . . 2.31 111.401 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.59 -29.87 46.34 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.923 -0.769 . . . . 1.59 108.923 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.795 HG22 HG21 ' A' ' 21' ' ' ILE . 41.8 t -73.23 95.05 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.557 -1.201 . . . . 1.07 108.136 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -130.62 149.51 52.25 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 103.751 -2.685 . . . . 2.11 103.751 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 mt -48.63 145.97 3.33 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 124.007 0.923 . . . . 1.75 109.862 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 80.05 10.37 1.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.539 1.149 . . . . 0.72 110.707 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.722 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 34.2 mmtp -99.9 124.28 45.05 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.675 -0.861 . . . . 2.01 108.675 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 15.2 m -81.46 38.01 0.48 Allowed 'General case' 0 C--N 1.249 -3.781 0 C-N-CA 126.058 1.743 . . . . 1.32 113.007 -173.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.664 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 88.4 m-85 36.42 -91.83 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.991 1.716 . . . . 0.71 114.524 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.9 t -53.72 -33.12 54.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.091 0.956 . . . . 1.36 112.27 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -94.04 -44.41 8.05 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.879 0.371 . . . . 1.74 111.484 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.722 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 6.7 m-20 -88.63 -33.55 17.59 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.784 1.031 . . . . 1.29 113.784 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.599 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.0 mt -98.7 -31.42 11.92 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.038 -0.356 . . . . 1.11 110.038 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 84.55 62.79 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.223 1.487 . . . . 1.12 108.975 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.659 HG11 ' HB2' ' A' ' 19' ' ' ALA . 26.7 t -109.39 124.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.701 -2.045 . . . . 1.21 107.71 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.45 122.66 15.15 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 121.064 -0.254 . . . . 2.0 111.212 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' MET . 26.8 t -37.21 -43.04 0.49 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.938 1.459 . . . . 0.99 114.938 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.2 mt -60.91 -46.26 91.35 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.944 0.878 . . . . 1.81 109.56 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.772 ' HB3' HG21 ' A' ' 18' ' ' ILE . 8.3 m -71.71 -29.3 64.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.511 -1.222 . . . . 0.91 110.501 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.648 ' HE3' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -53.16 -47.25 68.92 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 124.966 1.307 . . . . 1.3 112.798 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 48' ' ' VAL . 59.9 t -55.9 -45.6 79.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.013 0.82 . . . . 1.07 109.995 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -60.32 -44.1 95.78 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 109.34 -0.615 . . . . 0.68 109.34 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 42' ' ' SER . 94.6 t -58.82 -28.54 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.027 0.931 . . . . 1.31 111.677 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.847 HG22 HG11 ' A' ' 63' ' ' VAL . 32.1 t -79.72 -50.98 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 108.04 -1.096 . . . . 1.29 108.04 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 44' ' ' VAL . 49.0 t -59.35 -38.74 76.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.214 -1.357 . . . . 1.1 108.91 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -71.21 -35.04 71.39 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.42 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.75 11.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.267 -0.879 . . . . 1.05 109.339 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.279 0.0 OUTLIER -63.95 -34.07 77.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 113.721 1.008 . . . . 0.64 113.721 -176.95 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.49 -24.73 66.45 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.445 0.535 . . . . 2.07 112.445 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -88.85 -41.56 12.4 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.503 -0.479 . . . . 3.11 111.629 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.447 ' HZ ' ' N ' ' A' ' 11' ' ' LEU . 8.8 m-85 -88.87 -0.83 57.72 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 113.267 0.84 . . . . 0.81 113.267 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 80.2 -0.07 2.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.435 1.084 . . . . 1.99 112.837 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' A' ' 76' ' ' ILE . 7.6 p -84.75 177.45 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.389 -0.967 . . . . 1.14 108.389 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -137.11 131.76 33.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.934 -0.765 . . . . 2.7 108.934 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.563 HG12 ' HE2' ' A' ' 75' ' ' TYR . 54.0 mt -124.43 113.59 27.52 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.804 -0.635 . . . . 1.09 109.382 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.563 ' O ' HG22 ' A' ' 63' ' ' VAL . 36.5 Cg_endo -67.07 157.82 59.88 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 122.564 2.176 . . . . 0.4 109.917 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.81 -29.88 63.18 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.685 0.755 . . . . 1.98 109.359 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.91 -47.2 87.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.569 -1.196 . . . . 2.06 111.452 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 59.3 m-20 -83.12 -24.94 32.39 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 111.812 0.301 . . . . 0.52 111.812 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.847 HG11 HG22 ' A' ' 47' ' ' VAL . 67.2 t -52.53 -48.11 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.324 -0.991 . . . . 1.12 108.324 173.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -75.57 -2.39 28.94 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.153 0.797 . . . . 2.73 113.153 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.87 -25.92 14.46 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.002 0.429 . . . . 1.92 110.418 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.859 HD13 ' HA ' ' A' ' 72' ' ' ALA . 37.4 mt -79.72 119.51 22.74 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 106.017 -1.846 . . . . 1.04 106.017 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -110.37 -35.04 6.17 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.58 -0.848 . . . . 2.98 110.571 176.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 31.6 p -111.43 177.65 4.59 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 109.089 -0.708 . . . . 1.03 109.089 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.664 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -86.99 -13.03 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 N-CA-C 108.263 -1.014 . . . . 1.91 108.263 174.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.35 -35.95 59.81 Favored Glycine 0 C--O 1.216 -0.981 0 N-CA-C 108.385 -1.886 . . . . 0.33 108.385 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' CG ' ' HZ1' ' A' ' 67' ' ' LYS . 11.7 m-20 -66.74 -60.27 2.84 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.821 1.249 . . . . 1.39 109.501 173.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.859 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.75 -61.1 2.41 Favored 'General case' 0 CA--C 1.469 -2.164 0 CA-C-N 113.474 -1.694 . . . . 1.04 112.317 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.658 HG22 ' HG2' ' A' ' 4' ' ' GLN . 59.2 m -59.75 -34.34 72.83 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.914 -1.039 . . . . 1.07 113.324 -175.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -43.4 70.06 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 108.027 -1.101 . . . . 4.04 108.027 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.563 ' HE2' HG12 ' A' ' 58' ' ' ILE . 87.1 t80 -61.27 -50.86 71.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.856 -1.065 . . . . 0.9 109.611 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.712 ' HA ' HG21 ' A' ' 56' ' ' VAL . 76.7 mt -54.79 -65.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.037 -1.438 . . . . 1.12 110.634 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.13 -41.74 62.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.634 0.773 . . . . 2.08 109.939 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.34 -34.51 76.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.14 -0.936 . . . . 0.64 111.723 -175.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -95.71 -7.16 38.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 113.631 0.974 . . . . 1.59 113.631 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.476 HE21 HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.489 -1.397 0 N-CA-C 113.97 1.1 . . . . 1.09 113.97 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.456 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.0 t . . . . . 0 N--CA 1.437 -1.101 0 N-CA-C 111.083 0.031 . . . . 1.34 111.083 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.25 -37.06 45.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.945 1.298 . . . . 0.74 112.848 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -48.76 66.92 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.895 0.747 . . . . 2.66 110.854 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.35 -38.18 87.01 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.505 0.722 . . . . 2.73 109.907 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.504 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.7 mt -72.13 -66.79 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.028 0 CA-C-N 115.681 -0.691 . . . . 1.05 112.344 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.449 HG22 HD12 ' A' ' 28' ' ' LEU . 58.3 t -60.0 -41.12 85.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 112.377 0.51 . . . . 1.05 112.377 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.36 86.84 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.269 0.355 . . . . 1.07 110.54 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.62 -40.15 10.04 Favored Glycine 0 N--CA 1.414 -2.825 0 CA-C-N 115.815 -0.629 . . . . 0.21 113.584 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.26 -37.14 86.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.605 -0.887 . . . . 1.03 108.605 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -58.12 -49.23 77.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.893 -0.594 . . . . 1.06 109.418 175.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.707 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 49.7 mt-10 -60.23 -41.57 93.39 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 124.131 0.894 . . . . 0.68 112.244 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.67 HD11 ' HA ' ' A' ' 11' ' ' LEU . 69.1 mt -56.84 -42.15 77.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.618 -0.719 . . . . 1.16 109.887 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.631 HG12 ' HB ' ' A' ' 21' ' ' ILE . 98.4 t -70.16 -22.85 24.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.778 0.799 . . . . 1.14 110.879 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.707 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.9 m120 -76.34 -42.2 45.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.55 -1.278 . . . . 0.36 107.55 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -76.92 -39.76 49.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.551 -1.204 . . . . 2.07 112.252 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 HG23 ' A' ' 46' ' ' VAL . 20.7 mm -71.96 -53.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.895 0.379 . . . . 1.31 110.563 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.33 -74.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.374 -0.531 . . . . 1.18 111.26 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.55 44.77 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.353 -0.927 . . . . 0.43 112.221 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.816 HG21 HG21 ' A' ' 26' ' ' VAL . 1.5 mp -84.9 151.0 57.01 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.984 -0.747 . . . . 1.06 108.984 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 13.3 Cg_exo -83.27 29.24 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 124.277 3.318 . . . . 1.08 115.004 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p 54.1 7.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 C-N-CA 126.195 1.798 . . . . 1.28 114.351 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -107.95 -27.1 10.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.943 -0.473 . . . . 2.31 111.834 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' HB3' HD21 ' A' ' 36' ' ' LEU . 11.1 m-20 -83.17 -28.64 29.19 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 116.054 -0.521 . . . . 1.59 112.094 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 21' ' ' ILE . 22.1 t -78.37 87.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.118 -0.633 . . . . 1.07 110.399 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' HG13 ' A' ' 69' ' ' VAL . 96.5 mttt -125.6 168.84 13.15 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.473 -0.785 . . . . 2.11 109.422 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.449 HD12 HG22 ' A' ' 8' ' ' VAL . 5.5 mp -60.19 139.3 57.63 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.255 -0.43 . . . . 1.75 110.081 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 79.28 12.68 1.23 Allowed 'General case' 0 C--N 1.316 -0.855 0 O-C-N 125.044 1.465 . . . . 0.72 111.252 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.7 mmtt -99.47 124.75 44.91 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 109.301 -0.629 . . . . 2.01 109.301 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.5 m -78.9 34.42 0.23 Allowed 'General case' 0 C--N 1.254 -3.578 0 C-N-CA 126.356 1.862 . . . . 1.32 114.377 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.789 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 79.9 m-85 43.04 -93.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.499 1.519 . . . . 0.71 114.913 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -67.35 -24.37 65.71 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.993 -0.442 . . . . 1.36 111.98 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -89.45 -52.99 4.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.935 0.398 . . . . 1.74 110.952 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.55 -41.31 19.78 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 116.155 -0.475 . . . . 1.29 112.221 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 26' ' ' VAL . 16.1 mt -83.4 -76.32 0.29 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 119.097 -0.478 . . . . 1.11 110.525 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 34.2 t70 159.82 -16.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 O-C-N 124.411 1.069 . . . . 1.12 110.608 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 36' ' ' LEU . 3.0 t -47.13 135.37 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.037 1.335 . . . . 1.21 113.276 -171.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 43' ' ' MET . 11.3 t70 -59.49 112.8 1.91 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.516 -0.766 . . . . 2.0 111.805 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 17.3 t -40.82 -43.31 2.0 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 116.069 1.877 . . . . 0.99 116.069 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.22 -30.69 38.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.254 -1.378 . . . . 1.81 110.66 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 46' ' ' VAL . 20.1 m -76.14 -13.92 60.18 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.601 -0.727 . . . . 0.91 110.165 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.789 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.13 -36.09 76.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 123.44 0.696 . . . . 1.3 110.301 177.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.97 -44.68 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 123.959 0.787 . . . . 1.07 109.36 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.65 -43.09 94.03 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.181 -0.674 . . . . 0.68 109.181 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 18' ' ' ILE . 57.6 t -59.26 -24.98 29.15 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.015 -0.993 . . . . 1.31 111.455 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.968 HG23 HG11 ' A' ' 63' ' ' VAL . 42.3 t -80.18 -54.32 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 N-CA-C 106.933 -1.506 . . . . 1.29 106.933 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.2 t -53.85 -40.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.372 -1.74 . . . . 1.1 110.07 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.91 -37.08 64.76 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-O 121.233 0.54 . . . . 1.0 110.27 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.97 4.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.059 -0.973 . . . . 1.05 109.905 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.296 0.9 OUTLIER -62.8 -35.53 80.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 114.377 1.251 . . . . 0.64 114.377 -176.1 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.67 -30.46 71.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.356 0.502 . . . . 2.07 112.356 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -82.82 -36.72 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.777 -0.369 . . . . 3.11 110.979 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 7.7 m-85 -87.58 -19.43 27.83 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.766 1.024 . . . . 0.81 113.766 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.0 t70 103.76 -5.35 0.02 OUTLIER 'General case' 0 N--CA 1.532 3.641 0 O-C-N 125.29 1.619 . . . . 1.99 114.227 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 76' ' ' ILE . 8.1 p -87.17 172.96 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 O-C-N 121.141 -0.974 . . . . 1.14 109.513 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.838 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -126.6 118.79 25.54 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.208 -1.405 . . . . 2.7 107.208 174.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.591 HG12 ' HE2' ' A' ' 75' ' ' TYR . 57.5 mt -111.64 114.03 52.69 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 120.88 -0.328 . . . . 1.09 110.929 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' VAL . 83.2 Cg_endo -72.82 164.6 35.11 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.524 2.816 . . . . 0.4 110.913 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.45 -38.71 74.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.905 0.482 . . . . 1.98 111.058 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.556 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.0 m-20 -61.82 -34.71 76.42 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-N 115.816 -0.629 . . . . 2.06 111.592 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.56 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.0 m-20 -87.36 -23.98 24.4 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.659 -0.816 . . . . 0.52 113.177 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.968 HG11 HG23 ' A' ' 47' ' ' VAL . 79.4 t -55.96 -45.68 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.093 -1.077 . . . . 1.12 108.093 172.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 17.4 ptmt -74.78 -10.27 59.35 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.202 -0.908 . . . . 2.73 111.84 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -91.56 -13.52 31.87 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.264 0.554 . . . . 1.92 110.168 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' A' ' 72' ' ' ALA . 24.9 mt -95.96 109.54 21.9 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 107.101 -1.444 . . . . 1.04 107.101 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.54 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -105.72 -45.22 4.46 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.742 -1.206 . . . . 2.98 107.742 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 62.8 p -102.86 170.44 7.99 Favored 'General case' 0 N--CA 1.383 -3.808 0 CA-C-N 114.937 -1.028 . . . . 1.03 108.821 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -79.31 -12.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.464 -0.939 . . . . 1.91 108.464 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.66 -46.98 64.36 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 108.597 -1.801 . . . . 0.33 108.597 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.92 -52.42 65.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 109.026 -0.731 . . . . 1.39 109.026 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.845 ' HA ' HD12 ' A' ' 66' ' ' LEU . . . -52.25 -61.26 2.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 O-C-N 124.635 1.209 . . . . 1.04 111.365 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.491 ' HA ' HG21 ' A' ' 7' ' ' ILE . 52.5 m -55.7 -50.87 69.15 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 124.211 0.945 . . . . 1.07 113.471 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.548 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.5 mptm? -60.52 -34.14 73.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 123.3 0.64 . . . . 4.04 110.185 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.591 ' HE2' HG12 ' A' ' 58' ' ' ILE . 77.1 t80 -70.37 -55.89 8.0 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.771 -0.455 . . . . 0.9 109.771 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.591 ' HA ' HG12 ' A' ' 56' ' ' VAL . 63.8 mt -50.31 -66.44 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 124.662 1.185 . . . . 1.12 110.909 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.88 -54.32 36.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.781 1.232 . . . . 2.08 110.047 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 11.9 t70 -70.57 -24.4 62.77 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.542 -1.208 . . . . 0.64 112.02 -169.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.27 -4.87 48.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.416 0.895 . . . . 1.59 113.416 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.59 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 2.0 pt20 . . . . . 0 CA--C 1.473 -2.012 0 CA-C-O 122.391 1.091 . . . . 1.09 110.898 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.46 ' O ' HG13 ' A' ' 7' ' ' ILE . 2.5 t . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 119.114 -0.469 . . . . 1.34 109.93 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.405 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -48.32 -40.32 24.86 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.398 0.888 . . . . 0.74 113.398 -176.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.27 -33.74 65.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.046 0.841 . . . . 2.66 110.411 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -87.15 -37.74 17.07 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.403 -0.817 . . . . 2.73 109.837 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.639 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.1 mt -65.67 -65.75 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 116.392 -0.367 . . . . 1.05 111.711 -172.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.682 HG22 HD13 ' A' ' 28' ' ' LEU . 59.1 t -56.91 -42.31 78.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 122.126 0.17 . . . . 1.05 111.394 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -38.74 78.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.813 0.696 . . . . 1.07 111.278 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.66 -38.45 10.63 Favored Glycine 0 N--CA 1.419 -2.47 0 CA-C-N 116.183 -0.462 . . . . 0.21 113.117 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.716 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -63.97 -40.48 96.49 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.978 -0.749 . . . . 1.03 108.978 -178.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.639 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.34 -50.77 64.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.127 0.892 . . . . 1.06 109.685 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.602 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 55.6 mt-10 -61.54 -38.91 89.14 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 124.0 0.813 . . . . 0.68 111.927 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.716 HD13 ' HA ' ' A' ' 11' ' ' LEU . 66.7 mt -59.85 -45.01 95.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.843 -0.617 . . . . 1.16 109.548 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 11' ' ' LEU . 62.0 t -67.6 -24.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-O 121.747 0.784 . . . . 1.14 110.131 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.602 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.9 m120 -72.09 -38.49 69.37 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.281 -0.872 . . . . 0.36 109.322 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -82.13 -48.87 10.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.659 -0.7 . . . . 2.07 111.349 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.624 HG23 ' HB3' ' A' ' 42' ' ' SER . 33.4 mm -62.77 -53.14 50.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.902 -0.59 . . . . 1.31 110.545 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -104.5 -78.27 0.57 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.421 -0.585 . . . . 1.18 109.421 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.27 45.96 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 120.747 -0.74 . . . . 0.43 112.031 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' HG11 ' A' ' 15' ' ' VAL . 1.5 mp -80.69 152.47 72.42 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 109.037 -0.727 . . . . 1.06 109.037 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.8 Cg_exo -84.83 23.34 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.104 2.536 . . . . 1.08 115.089 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.8 p 58.88 -9.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.69 1.996 . . . . 1.28 115.489 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.8 pt-20 -103.79 -7.02 20.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.365 0.602 . . . . 2.31 111.176 -174.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -99.66 -16.49 18.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.775 0.798 . . . . 1.59 110.676 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' A' ' 12' ' ' ALA . 12.8 t -78.11 86.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 114.385 -1.28 . . . . 1.07 110.468 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.52 148.94 37.19 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.186 -1.042 . . . . 2.11 108.186 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.682 HD13 HG22 ' A' ' 8' ' ' VAL . 6.0 mp -59.89 140.27 56.78 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.578 -0.527 . . . . 1.75 109.578 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 87.26 7.21 0.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.545 1.538 . . . . 0.72 109.642 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -104.03 128.44 51.61 Favored 'General case' 0 CA--C 1.465 -2.316 0 CA-C-N 115.269 -0.878 . . . . 2.01 109.214 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.635 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 3.0 m -80.65 105.8 12.17 Favored 'General case' 1 C--N 1.238 -4.269 0 CA-C-N 114.188 -1.369 . . . . 1.32 108.316 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.749 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.4 m-85 -43.51 -55.26 4.33 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.596 0.758 . . . . 0.71 112.081 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 t -78.23 6.3 8.48 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 113.431 0.9 . . . . 1.36 113.431 -173.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -139.92 -62.18 0.52 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.318 -0.553 . . . . 1.74 110.037 -174.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.05 -44.91 75.3 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.096 -0.957 . . . . 1.29 110.146 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.618 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 16.9 mt -81.38 -44.6 17.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.137 -0.938 . . . . 1.11 109.279 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 93.84 65.32 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 126.632 1.973 . . . . 1.12 111.908 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.7 HG13 ' HE3' ' A' ' 43' ' ' MET . 48.8 t -96.04 149.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 113.485 -1.689 . . . . 1.21 107.587 171.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.405 ' O ' HD22 ' A' ' 41' ' ' LEU . 5.3 m-20 -73.96 17.82 0.16 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 115.99 1.848 . . . . 2.0 115.99 -174.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 43' ' ' MET . 28.7 t 68.0 -53.65 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.271 1.952 . . . . 0.99 116.271 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.405 HD22 ' O ' ' A' ' 39' ' ' ASP . 1.7 pt? -71.36 -34.15 70.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.257 1.027 . . . . 1.81 108.491 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.624 ' HB3' HG23 ' A' ' 18' ' ' ILE . 2.1 m -65.81 -22.84 66.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.968 -1.469 . . . . 0.91 110.045 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.7 ' HE3' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.99 -43.44 98.83 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 115.375 -0.829 . . . . 1.3 112.021 -176.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.35 -43.83 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 O-C-N 124.398 1.061 . . . . 1.07 110.034 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.41 -46.82 85.69 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.917 -0.771 . . . . 0.68 108.917 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 42' ' ' SER . 61.9 t -58.54 -27.0 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.731 -1.122 . . . . 1.31 111.484 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.99 HG22 HG13 ' A' ' 63' ' ' VAL . 44.5 t -80.15 -52.53 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 107.658 -1.238 . . . . 1.29 107.658 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.28 -44.51 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 124.728 1.268 . . . . 1.1 108.919 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.69 88.33 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 121.244 0.545 . . . . 1.0 110.811 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 -55.9 17.19 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.472 -0.785 . . . . 1.05 110.239 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.561 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.262 0.0 OUTLIER -62.81 -34.03 76.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.754 1.02 . . . . 0.64 113.754 -178.188 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -67.84 -28.66 67.75 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.77 0.285 . . . . 2.07 111.77 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -87.52 -38.16 16.27 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.775 0.321 . . . . 3.11 111.52 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.639 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 10.0 m-85 -94.46 -3.91 49.18 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.106 0.78 . . . . 0.81 113.106 -172.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 87.66 -2.5 0.55 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 125.16 1.384 . . . . 1.99 114.719 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.74 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 13.9 p -81.2 173.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.363 -0.935 . . . . 1.14 108.772 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 22.2 tptp -127.58 124.91 39.26 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 107.462 -1.31 . . . . 2.7 107.462 171.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.555 HG12 ' HE2' ' A' ' 75' ' ' TYR . 59.7 mt -114.43 113.21 45.71 Favored Pre-proline 0 N--CA 1.429 -1.496 0 C-N-CA 120.599 -0.441 . . . . 1.09 111.106 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.568 ' O ' HG23 ' A' ' 63' ' ' VAL . 30.9 Cg_endo -66.87 152.53 80.26 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 122.642 2.228 . . . . 0.4 109.845 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 3.9 p-10 -59.1 -27.87 65.98 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.307 0.379 . . . . 1.98 111.123 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.76 -46.04 87.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 2.06 110.379 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -74.76 -26.91 60.1 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 112.01 0.374 . . . . 0.52 112.01 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.99 HG13 HG22 ' A' ' 47' ' ' VAL . 86.8 t -55.57 -41.44 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.86 -1.163 . . . . 1.12 107.86 172.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 60' ' ' ASP . 57.8 mttp -73.94 -7.83 53.81 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.067 -0.97 . . . . 2.73 112.564 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.06 -24.47 15.32 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.233 0.539 . . . . 1.92 110.316 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.892 HD11 ' HA ' ' A' ' 72' ' ' ALA . 39.1 mt -85.48 118.44 25.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.889 -1.152 . . . . 1.04 107.889 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.54 ' HG2' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -112.17 -29.16 7.68 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.918 -1.113 . . . . 2.98 110.591 175.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 13.6 p -116.55 179.5 3.99 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 109.477 -0.564 . . . . 1.03 109.477 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.749 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -87.23 -12.89 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 122.062 0.934 . . . . 1.91 109.787 176.045 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.439 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -76.6 -30.99 55.56 Favored Glycine 0 C--O 1.207 -1.542 0 N-CA-C 108.305 -1.918 . . . . 0.33 108.305 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.27 -60.35 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.21 -0.995 . . . . 1.39 109.144 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.892 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -49.03 -60.95 2.34 Favored 'General case' 0 CA--C 1.479 -1.771 0 O-C-N 124.569 1.168 . . . . 1.04 112.361 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.45 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.3 m -57.45 -47.99 80.36 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.894 -1.048 . . . . 1.07 113.006 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 5.7 mptp? -55.83 -50.52 70.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 124.213 0.945 . . . . 4.04 109.815 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.555 ' HE2' HG12 ' A' ' 58' ' ' ILE . 82.8 t80 -56.23 -51.51 67.82 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.364 1.04 . . . . 0.9 111.43 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 69.8 mt -54.27 -65.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.424 -1.262 . . . . 1.12 110.432 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tt -54.33 -42.8 70.6 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.11 0.964 . . . . 2.08 109.589 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 36.9 t70 -62.4 -26.81 68.68 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.41 1.084 . . . . 0.64 111.561 -172.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -102.13 -8.04 21.72 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.836 1.05 . . . . 1.59 113.836 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.74 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 115.191 1.552 . . . . 1.09 115.191 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 7' ' ' ILE . 15.2 t . . . . . 0 C--O 1.219 -0.544 0 N-CA-C 111.162 0.06 . . . . 1.34 111.162 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.618 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -49.85 -46.97 51.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.157 0.983 . . . . 0.74 113.363 -178.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.64 -24.79 66.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.873 0.368 . . . . 2.66 111.624 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -87.7 -31.08 19.9 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.152 -0.684 . . . . 2.73 109.152 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.573 HG21 ' CE2' ' A' ' 54' ' ' PHE . 97.4 mt -74.39 -65.98 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.141 0 CA-C-N 116.145 -0.48 . . . . 1.05 110.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.49 -40.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 112.365 0.506 . . . . 1.05 112.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.91 98.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.37 -0.532 . . . . 1.07 110.632 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.48 -35.07 33.96 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 115.783 -0.644 . . . . 0.21 112.235 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.741 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -67.44 -39.37 85.4 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.16 -1.052 . . . . 1.03 108.16 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.616 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -55.36 -50.32 69.98 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.832 -0.803 . . . . 1.06 108.832 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.579 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 46.6 mt-10 -59.24 -42.48 91.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.113 0.883 . . . . 0.68 112.704 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.741 HD11 ' HA ' ' A' ' 11' ' ' LEU . 65.6 mt -56.07 -43.06 74.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.315 0.579 . . . . 1.16 109.923 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.726 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.8 t -68.86 -25.34 30.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.755 0.788 . . . . 1.14 110.168 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.579 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.6 m120 -74.07 -42.18 60.58 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.923 -1.139 . . . . 0.36 107.923 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.56 -47.95 51.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.311 -0.858 . . . . 2.07 111.445 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.4 mm -67.14 -53.16 35.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.896 -0.593 . . . . 1.31 111.317 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.73 -78.42 0.58 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.559 -0.456 . . . . 1.18 111.695 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.02 43.17 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.094 -1.051 . . . . 0.43 112.916 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.848 HG21 HG21 ' A' ' 26' ' ' VAL . 1.4 mp -79.41 151.25 74.75 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.033 -0.729 . . . . 1.06 109.033 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' GLU . 4.6 Cg_exo -89.74 37.5 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.613 2.876 . . . . 1.08 113.276 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 9.2 p 56.11 -22.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.982 2.113 . . . . 1.28 116.021 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' PRO . 29.8 mm-40 -88.73 -22.8 23.16 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.603 0.761 . . . . 2.31 111.873 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.582 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 6.6 t70 -74.57 -32.71 62.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.583 0.706 . . . . 1.59 110.494 -171.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.848 HG21 HG21 ' A' ' 21' ' ' ILE . 22.0 t -78.96 94.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.908 -1.042 . . . . 1.07 111.104 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -124.3 158.55 32.32 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.315 -0.995 . . . . 2.11 108.315 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 69' ' ' VAL . 90.6 mt -54.97 141.22 34.66 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 122.934 0.494 . . . . 1.75 110.288 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.54 ' H ' ' N ' ' A' ' 70' ' ' GLY . 27.1 t70 77.22 10.55 2.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.36 1.464 . . . . 0.72 111.009 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 69' ' ' VAL . 72.1 mmtt -100.36 129.06 46.29 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 115.374 -0.83 . . . . 2.01 109.226 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 30.6 t -74.85 119.89 19.65 Favored 'General case' 1 C--N 1.244 -4.011 0 CA-C-N 115.078 -0.965 . . . . 1.32 109.901 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.636 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 74.0 m-85 -51.49 -55.87 16.5 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 123.975 0.91 . . . . 0.71 111.892 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 3.5 p -66.47 -57.45 7.33 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 122.11 0.957 . . . . 1.36 111.942 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.498 ' HB2' ' OG ' ' A' ' 31' ' ' SER . 8.0 m-20 -82.64 -41.17 19.77 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 115.202 1.556 . . . . 1.74 115.202 -166.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.474 ' HB2' ' N ' ' A' ' 31' ' ' SER . 5.3 m-20 -91.66 -43.81 9.39 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.719 0.295 . . . . 1.29 111.113 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.699 HD13 HG22 ' A' ' 26' ' ' VAL . 17.8 mt -76.09 -90.11 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.758 -0.656 . . . . 1.11 110.418 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 38.9 t70 163.56 10.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.364 1.066 . . . . 1.12 109.047 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.484 HG21 HG11 ' A' ' 15' ' ' VAL . 12.4 t -77.57 119.14 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 108.764 -0.828 . . . . 1.21 108.764 -172.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.7 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 13.2 t70 -58.44 120.99 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 124.106 0.879 . . . . 2.0 111.456 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.8 t -41.78 -30.91 0.27 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 127.455 2.302 . . . . 0.99 116.128 175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.7 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 4.3 pp -86.32 -31.96 21.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 120.4 1.455 . . . . 1.81 111.023 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -80.15 -13.76 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.46 1.124 . . . . 0.91 109.401 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.658 ' HA ' ' HE2' ' A' ' 43' ' ' MET . 3.8 tpt -60.03 -36.09 76.51 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 127.334 2.253 . . . . 1.3 110.403 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 47' ' ' VAL . 58.1 t -66.68 -25.15 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 CA-C-N 115.213 -0.903 . . . . 1.07 110.943 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -77.02 -41.02 44.36 Favored 'General case' 0 C--O 1.215 -0.739 0 O-C-N 121.515 -0.741 . . . . 0.68 109.6 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 t -59.57 -25.83 32.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.177 -0.919 . . . . 1.31 111.66 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.725 HG11 HG12 ' A' ' 63' ' ' VAL . 10.7 p -81.48 -47.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 CA-C-O 122.201 1.0 . . . . 1.29 110.145 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.02 -39.5 85.9 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 CA-C-N 112.869 -1.969 . . . . 1.1 108.749 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 -32.04 72.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.004 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.79 -59.16 4.17 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.952 -1.022 . . . . 1.05 110.122 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.288 0.0 OUTLIER -62.44 -34.69 77.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 114.014 1.116 . . . . 0.64 114.014 -175.635 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.29 -41.82 80.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.449 0.642 . . . . 2.07 111.321 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -81.68 -41.14 21.79 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.259 -0.882 . . . . 3.11 110.812 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.573 ' CE2' HG21 ' A' ' 7' ' ' ILE . 10.4 m-85 -83.65 -44.38 14.6 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 117.735 -1.126 . . . . 0.81 113.454 -172.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 15.8 t70 155.91 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 124.616 1.198 . . . . 1.99 112.55 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.617 HG13 ' HA ' ' A' ' 76' ' ' ILE . 8.6 p -75.29 174.56 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.301 -0.863 . . . . 1.14 112.924 -164.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.3 127.04 52.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.207 -1.775 . . . . 2.7 106.207 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 ' HE2' ' A' ' 75' ' ' TYR . 59.8 mt -118.87 112.42 36.62 Favored Pre-proline 0 C--N 1.293 -1.871 0 C-N-CA 120.216 -0.594 . . . . 1.09 110.09 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.535 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.5 Cg_endo -69.27 155.95 66.05 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.361 2.707 . . . . 0.4 110.554 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.183 0.593 . . . . 1.98 112.128 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.7 m-20 -65.44 -54.24 31.28 Favored 'General case' 0 C--O 1.209 -1.044 0 O-C-N 123.22 0.325 . . . . 2.06 110.538 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.526 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 11.6 m-20 -66.92 -31.85 72.72 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.509 0.559 . . . . 0.52 112.509 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.725 HG12 HG11 ' A' ' 47' ' ' VAL . 41.3 t -50.22 -59.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.281 0.988 . . . . 1.12 109.015 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 14.6 ptmm? -72.61 -1.86 17.75 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.574 -0.739 . . . . 2.73 112.916 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.68 -18.17 21.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.733 0.777 . . . . 1.92 109.418 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.84 HD13 ' HA ' ' A' ' 72' ' ' ALA . 40.1 mt -84.9 116.09 23.14 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.579 -2.008 . . . . 1.04 105.579 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.655 ' HG2' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -111.68 -30.05 7.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 117.982 -1.487 . . . . 2.98 109.65 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.655 HG21 ' HG2' ' A' ' 67' ' ' LYS . 31.1 p -119.14 173.46 6.91 Favored 'General case' 0 N--CA 1.395 -3.204 0 N-CA-C 109.183 -0.673 . . . . 1.03 109.183 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 30' ' ' LYS . 23.7 t -72.01 -18.98 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 108.492 -0.929 . . . . 1.91 108.492 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.54 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -70.13 -40.96 71.36 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 110.142 -1.183 . . . . 0.33 110.142 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.554 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.2 m-20 -67.89 -55.04 14.35 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.547 -0.908 . . . . 1.39 108.547 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.84 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.46 -61.33 2.31 Favored 'General case' 0 CA--C 1.471 -2.058 0 O-C-N 124.875 1.359 . . . . 1.04 111.97 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.618 HG21 ' HG2' ' A' ' 4' ' ' GLN . 50.0 m -57.64 -51.19 70.51 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.591 -1.186 . . . . 1.07 112.682 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.4 OUTLIER -53.49 -49.53 67.3 Favored 'General case' 0 N--CA 1.422 -1.827 0 O-C-N 124.325 1.016 . . . . 4.04 109.601 177.241 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 87.1 t80 -56.96 -52.01 66.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.747 0.819 . . . . 0.9 111.208 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.617 ' HA ' HG13 ' A' ' 56' ' ' VAL . 69.9 mt -52.01 -65.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 124.812 1.32 . . . . 1.12 109.79 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.76 -45.01 70.48 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.144 1.378 . . . . 2.08 110.346 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.59 -30.32 71.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.916 -1.038 . . . . 0.64 111.105 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -100.32 -11.62 20.15 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 113.82 1.044 . . . . 1.59 113.82 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 14.8 mt-30 . . . . . 0 CA--C 1.476 -1.898 0 CA-C-O 122.798 1.285 . . . . 1.09 107.641 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.434 -1.27 0 CA-C-O 120.652 0.263 . . . . 1.34 111.231 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.587 ' HG2' HG22 ' A' ' 73' ' ' THR . 0.8 OUTLIER -51.85 -37.08 50.57 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.138 1.775 . . . . 0.74 112.423 177.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.4 -35.33 65.23 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 123.735 0.647 . . . . 2.66 111.869 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.48 -31.18 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.358 0.599 . . . . 2.73 109.504 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.608 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 80.4 mt -73.27 -66.44 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 115.775 -0.648 . . . . 1.05 109.985 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 28' ' ' LEU . 96.7 t -52.62 -38.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.067 0.765 . . . . 1.05 113.067 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.27 98.69 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.419 -0.512 . . . . 1.07 109.86 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.473 ' HA2' ' NH1' ' A' ' 53' ' ' ARG . . . -76.34 -39.93 29.8 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.366 -0.834 . . . . 0.21 112.313 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.742 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -67.04 -39.04 86.88 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 123.745 0.818 . . . . 1.03 109.377 -176.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -58.47 -43.68 89.0 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.687 -0.486 . . . . 1.06 109.687 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.556 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 44.4 mt-10 -61.31 -42.78 99.24 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.889 0.743 . . . . 0.68 111.46 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.742 HD13 ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -60.7 -40.76 85.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.342 0.591 . . . . 1.16 110.046 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.731 HG12 ' HB ' ' A' ' 21' ' ' ILE . 23.9 t -73.65 -22.61 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.472 0.654 . . . . 1.14 110.162 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -72.59 -54.04 10.25 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.205 -1.035 . . . . 0.36 108.205 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.14 -44.8 62.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.342 -1.299 . . . . 2.07 113.602 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 42' ' ' SER . 14.5 mt -76.27 -53.33 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.985 -0.686 . . . . 1.31 111.106 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.636 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -91.91 -80.14 0.36 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 1.18 110.809 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.93 40.04 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.16 0 C-N-CA 121.076 -0.583 . . . . 0.43 111.755 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.731 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -82.55 161.14 60.03 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 109.473 -0.566 . . . . 1.06 109.473 178.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.43 ' O ' HG21 ' A' ' 21' ' ' ILE . 6.0 Cg_endo -90.62 141.64 3.26 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.895 2.396 . . . . 1.08 108.415 171.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -72.61 45.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.086 0 N-CA-C 113.98 1.104 . . . . 1.28 113.98 -171.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.51 -20.96 0.43 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.31 1.044 . . . . 2.31 110.548 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.65 -36.44 65.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.122 -0.49 . . . . 1.59 112.105 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.594 HG22 HD12 ' A' ' 36' ' ' LEU . 41.1 t -75.91 93.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.998 -0.546 . . . . 1.07 109.582 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 69' ' ' VAL . 30.8 mmtp -133.17 168.55 18.32 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.821 -1.178 . . . . 2.11 107.821 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.471 HD22 ' HE2' ' A' ' 74' ' ' LYS . 6.3 mp -63.67 146.92 52.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.845 -0.798 . . . . 1.75 108.845 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 t70 78.3 8.39 2.28 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.702 1.251 . . . . 0.72 110.241 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 71.4 mmtt -106.08 125.57 51.16 Favored 'General case' 0 CA--C 1.473 -1.993 0 CA-C-N 115.709 -0.678 . . . . 2.01 109.679 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 4.2 m -81.85 108.78 15.65 Favored 'General case' 0 C--N 1.245 -3.96 0 CA-C-N 114.248 -1.342 . . . . 1.32 108.763 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.866 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.4 m-85 -37.27 -66.69 0.22 Allowed 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.547 1.539 . . . . 0.71 114.197 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 t -85.87 15.5 4.84 Favored 'General case' 0 C--N 1.275 -2.67 0 O-C-N 121.1 -1.0 . . . . 1.36 112.742 -174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.25 -65.72 0.64 Allowed 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.627 -0.671 . . . . 1.74 111.364 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.479 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 21.5 m-20 -68.94 -41.4 78.12 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.311 -0.858 . . . . 1.29 109.962 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.692 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 27.0 mt -79.38 -50.1 11.36 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.618 -0.719 . . . . 1.11 111.024 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 11.2 t70 94.5 68.89 0.0 OUTLIER 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.278 1.611 . . . . 1.12 110.557 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.636 HG11 ' HB1' ' A' ' 19' ' ' ALA . 40.5 t -105.81 162.69 4.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.277 -1.783 . . . . 1.21 110.156 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.25 3.6 5.55 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.49 1.116 . . . . 2.0 113.028 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.413 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.1 p 67.41 -47.58 0.49 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.328 1.851 . . . . 0.99 113.081 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.68 -49.15 77.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.997 0.919 . . . . 1.81 108.783 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.581 ' O ' HG21 ' A' ' 46' ' ' VAL . 2.2 m -63.75 -16.26 60.71 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.987 -1.461 . . . . 0.91 112.314 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.866 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -66.22 -34.48 78.11 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 123.406 0.682 . . . . 1.3 111.393 -176.351 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.59 -38.33 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 109.125 -0.694 . . . . 1.07 109.125 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.87 -44.94 91.58 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.943 -1.132 . . . . 0.68 107.943 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 42' ' ' SER . 97.8 t -57.25 -24.72 21.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.354 -1.294 . . . . 1.31 112.091 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.971 HG11 HG21 ' A' ' 63' ' ' VAL . 23.2 t -78.69 -53.66 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.957 -1.127 . . . . 1.29 107.957 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.73 -31.9 50.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.573 -1.194 . . . . 1.1 109.413 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB1' HG22 ' A' ' 14' ' ' ILE . . . -76.35 -32.01 58.41 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.158 0.504 . . . . 1.0 110.285 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.11 -62.86 1.22 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.486 -0.779 . . . . 1.05 109.973 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.264 0.0 OUTLIER -60.69 -37.23 80.95 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 114.411 1.263 . . . . 0.64 114.411 -174.594 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.87 -30.7 67.94 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.4 0.519 . . . . 2.07 112.4 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.473 ' NH1' ' HA2' ' A' ' 10' ' ' GLY . 64.0 ttt180 -88.05 -32.92 18.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.78 0.324 . . . . 3.11 110.96 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.608 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.6 m-85 -95.54 -1.9 49.63 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.066 0.765 . . . . 0.81 113.066 -171.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 79.75 -2.91 2.06 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.447 1.099 . . . . 1.99 113.328 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.556 ' CG1' HG21 ' A' ' 76' ' ' ILE . 10.0 p -83.92 178.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 N-CA-C 107.985 -1.117 . . . . 1.14 107.985 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HD2' ' OE2' ' A' ' 51' ' ' GLU . 21.3 tptm -136.27 130.76 33.51 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.197 -1.038 . . . . 2.7 108.197 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.509 HG12 ' HE2' ' A' ' 75' ' ' TYR . 37.2 mt -128.96 110.21 18.41 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 123.1 0.25 . . . . 1.09 110.612 -175.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.536 ' O ' HG23 ' A' ' 63' ' ' VAL . 70.1 Cg_endo -74.47 166.84 28.51 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.581 2.187 . . . . 0.4 109.811 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -59.93 -29.24 68.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.149 0.5 . . . . 1.98 110.124 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 25.6 t70 -62.81 -38.92 92.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.288 -0.869 . . . . 2.06 111.307 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.434 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 29.5 m-20 -87.14 -28.33 22.53 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.485 -0.486 . . . . 0.52 111.455 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.971 HG21 HG11 ' A' ' 47' ' ' VAL . 54.1 t -52.1 -46.71 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.16 -0.682 . . . . 1.12 109.16 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 45.7 pttt -70.9 -2.16 14.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.064 -0.971 . . . . 2.73 113.086 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 95.4 m-20 -96.06 -34.93 11.55 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.828 0.347 . . . . 1.92 110.399 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.731 HD11 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -76.32 112.68 13.06 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.913 -0.773 . . . . 1.04 108.913 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -33.52 7.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.551 0.691 . . . . 2.98 110.361 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.0 p -116.02 169.36 9.32 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.795 -1.187 . . . . 1.03 107.795 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.487 HG22 ' HG1' ' A' ' 73' ' ' THR . 0.5 OUTLIER -78.65 -13.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 119.831 -0.747 . . . . 1.91 109.293 175.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.14 -44.63 86.63 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.953 -1.659 . . . . 0.33 108.953 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.34 -48.99 71.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.498 -0.926 . . . . 1.39 108.498 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.731 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -57.26 -61.65 2.32 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 114.851 -1.068 . . . . 1.04 111.424 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.587 HG22 ' HG2' ' A' ' 4' ' ' GLN . 28.1 m -58.64 -39.67 81.2 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 113.997 1.11 . . . . 1.07 113.997 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.471 ' HE2' HD22 ' A' ' 28' ' ' LEU . 5.3 mptp? -60.91 -51.08 70.8 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.2 -1.037 . . . . 4.04 108.2 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.509 ' HE2' HG12 ' A' ' 58' ' ' ILE . 89.6 t80 -55.88 -49.13 74.23 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.29 0.994 . . . . 0.9 110.687 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.629 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 78.1 mt -57.67 -66.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.022 -0.99 . . . . 1.12 111.109 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -52.46 -47.1 66.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.532 1.533 . . . . 2.08 109.799 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 14.0 t70 -66.72 -28.17 68.21 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.238 -1.346 . . . . 0.64 110.931 -172.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -103.47 -2.4 26.92 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 113.403 0.89 . . . . 1.59 113.403 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 59.8 mt-30 . . . . . 0 CA--C 1.468 -2.201 0 N-CA-C 106.699 -1.593 . . . . 1.09 106.699 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.432 -1.372 0 CA-C-O 120.815 0.34 . . . . 1.34 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.455 ' HG2' HG23 ' A' ' 8' ' ' VAL . 6.1 tm0? -57.43 -35.04 69.58 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 125.679 1.591 . . . . 0.74 112.469 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.76 -24.36 67.67 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.632 0.583 . . . . 2.66 111.335 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 -44.02 11.46 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.854 -0.795 . . . . 2.73 108.854 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.582 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 79.3 mt -64.31 -64.99 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.72 0 CA-C-N 116.158 -0.474 . . . . 1.05 112.012 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.455 HG23 ' HG2' ' A' ' 4' ' ' GLN . 55.2 t -56.97 -39.26 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 112.026 0.38 . . . . 1.05 112.026 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.74 -36.49 84.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.231 0.539 . . . . 1.07 110.576 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.55 -40.87 8.67 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 115.779 -0.646 . . . . 0.21 112.92 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -64.84 -36.07 83.15 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.491 -0.929 . . . . 1.03 108.491 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.711 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.52 -51.67 67.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.771 -0.65 . . . . 1.06 109.39 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.638 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.6 mt-10 -58.12 -41.9 84.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 124.204 0.94 . . . . 0.68 112.499 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 11' ' ' LEU . 76.7 mt -58.11 -43.42 85.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.503 -0.771 . . . . 1.16 109.701 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.576 HG12 ' HB ' ' A' ' 21' ' ' ILE . 86.1 t -68.82 -23.89 28.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.872 0.844 . . . . 1.14 110.679 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.638 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.2 m120 -75.06 -42.62 56.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.335 -0.987 . . . . 0.36 108.335 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.31 -41.19 57.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.845 -1.07 . . . . 2.07 111.636 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.709 HG13 HG21 ' A' ' 46' ' ' VAL . 30.8 mm -70.45 -53.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 116.701 -0.227 . . . . 1.31 111.007 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' HG12 ' A' ' 38' ' ' VAL . . . -106.31 -82.45 0.54 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.013 0.435 . . . . 1.18 110.607 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.34 43.96 0.02 OUTLIER Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.561 -0.828 . . . . 0.43 112.419 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.641 HG21 HG22 ' A' ' 26' ' ' VAL . 1.6 mp -80.52 151.06 71.33 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.859 -0.423 . . . . 1.06 109.859 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.9 Cg_exo -86.17 33.3 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.155 2.57 . . . . 1.08 114.056 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.265 9.8 p 56.61 -20.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 C-N-CA 127.052 2.141 . . . . 1.28 116.433 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' PRO . 11.4 pt-20 -95.51 -13.94 24.08 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.554 -0.716 . . . . 2.31 112.54 -174.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 29.8 t0 -84.45 -28.2 26.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.728 0.775 . . . . 1.59 110.023 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.711 HG21 ' HA ' ' A' ' 12' ' ' ALA . 25.5 t -73.6 93.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.577 -1.192 . . . . 1.07 109.072 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.479 ' O ' HG11 ' A' ' 69' ' ' VAL . 33.3 mmtp -131.09 151.88 50.97 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 106.954 -1.498 . . . . 2.11 106.954 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.7 mt -50.09 143.53 8.07 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.763 0.665 . . . . 1.75 109.531 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 82.8 4.81 0.97 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.9 1.28 . . . . 0.72 111.129 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -103.6 132.83 49.5 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 108.936 -0.764 . . . . 2.01 108.936 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 57.9 m -86.53 116.96 25.0 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 124.047 0.842 . . . . 1.32 109.666 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.717 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 94.6 m-85 -45.65 -67.46 0.28 Allowed 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 125.17 1.388 . . . . 0.71 114.178 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 t -71.79 -25.85 62.19 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.685 -1.259 . . . . 1.36 111.843 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 7.3 m-20 -87.62 -64.18 1.19 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.406 0.622 . . . . 1.74 110.972 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 31' ' ' SER . 4.5 m-20 -74.29 -57.6 3.84 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 115.282 -0.872 . . . . 1.29 110.439 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.65 HD11 HG23 ' A' ' 26' ' ' VAL . 16.8 mt -68.17 -38.24 81.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.015 -0.993 . . . . 1.11 111.122 -172.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 30.2 t70 82.84 64.98 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.459 1.6 . . . . 1.12 109.558 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 19' ' ' ALA . 21.8 t -108.78 159.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 112.463 -2.153 . . . . 1.21 106.548 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.63 120.23 19.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.361 -0.977 . . . . 2.0 108.361 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.425 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 5.0 p -49.11 -38.15 23.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.078 0.951 . . . . 0.99 112.306 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.406 HD13 ' N ' ' A' ' 42' ' ' SER . 3.9 pp -70.63 -28.42 64.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.16 0.43 . . . . 1.81 112.16 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 46' ' ' VAL . 50.0 m -82.04 -15.7 52.72 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.425 0.631 . . . . 0.91 110.266 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.657 ' O ' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -58.92 -37.35 76.48 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-N 115.445 -0.798 . . . . 1.3 111.715 -179.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.29 -45.72 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 124.087 0.867 . . . . 1.07 109.421 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.31 -49.79 74.99 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 108.615 -0.883 . . . . 0.68 108.615 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.709 HG21 HG13 ' A' ' 18' ' ' ILE . 54.2 t -57.34 -29.98 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.971 1.308 . . . . 1.31 111.672 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.843 HG23 HG13 ' A' ' 63' ' ' VAL . 38.3 t -76.96 -49.68 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.336 0 N-CA-C 108.294 -1.002 . . . . 1.29 108.294 -176.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.27 -35.5 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-N 114.692 -1.14 . . . . 1.1 108.777 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.29 76.25 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.538 0.685 . . . . 1.0 109.915 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.71 -58.35 7.77 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 114.932 -1.031 . . . . 1.05 109.843 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.627 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.257 0.0 OUTLIER -61.15 -37.03 81.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.056 1.132 . . . . 0.64 114.056 -177.375 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.69 -37.58 76.39 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.296 0.373 . . . . 2.07 111.401 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -84.73 -37.84 20.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.052 0.389 . . . . 3.11 112.052 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.582 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.0 m-85 -92.68 -11.03 35.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.352 1.242 . . . . 0.81 114.352 -170.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 87.51 4.22 0.33 Allowed 'General case' 0 N--CA 1.519 2.995 0 N-CA-C 114.448 1.277 . . . . 1.99 114.448 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.1 p -84.12 175.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.183 -1.414 . . . . 1.14 107.183 175.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 20.5 tptp -131.75 122.35 25.7 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.887 -1.894 . . . . 2.7 105.887 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.568 HG13 ' HB3' ' A' ' 51' ' ' GLU . 52.4 mt -113.72 107.05 53.25 Favored Pre-proline 0 C--N 1.291 -1.969 0 C-N-CA 119.754 -0.778 . . . . 1.09 110.618 -174.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.553 ' O ' HG23 ' A' ' 63' ' ' VAL . 36.3 Cg_endo -64.8 152.38 82.3 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 C-N-CA 122.948 2.432 . . . . 0.4 109.739 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.2 -33.57 53.34 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.561 0.744 . . . . 1.98 111.153 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 21.5 t70 -62.43 -43.51 98.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.546 -0.752 . . . . 2.06 111.679 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.437 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 40.9 m-20 -86.46 -21.83 26.82 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.403 0.52 . . . . 0.52 112.403 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.843 HG13 HG23 ' A' ' 47' ' ' VAL . 51.1 t -53.68 -50.43 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.246 -1.02 . . . . 1.12 108.246 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.1 pttp -79.55 -1.47 37.96 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.523 -1.217 . . . . 2.73 111.332 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.25 -18.84 24.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.295 -1.002 . . . . 1.92 108.295 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.838 HD13 ' HA ' ' A' ' 72' ' ' ALA . 27.6 mt -90.38 117.82 29.39 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 106.783 -1.562 . . . . 1.04 106.783 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HZ1' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -104.82 -37.63 6.96 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.695 -0.802 . . . . 2.98 110.769 175.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 41.1 p -109.73 178.87 4.29 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 109.486 -0.561 . . . . 1.03 109.486 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.717 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -85.08 -13.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.365 -0.976 . . . . 1.91 108.365 173.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -67.5 -49.07 53.52 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 107.165 -2.374 . . . . 0.33 107.165 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' CG ' ' HZ1' ' A' ' 67' ' ' LYS . 8.6 m-20 -56.43 -57.09 13.81 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 124.95 1.3 . . . . 1.39 110.411 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.838 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.34 -60.99 2.56 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.442 1.089 . . . . 1.04 111.667 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.406 ' HA ' HG21 ' A' ' 7' ' ' ILE . 34.4 m -60.39 -45.33 93.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 113.26 0.837 . . . . 1.07 113.26 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.502 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.6 mptm? -63.52 -22.72 67.05 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 122.651 0.38 . . . . 4.04 110.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -82.2 -52.92 6.49 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 116.041 -0.527 . . . . 0.9 109.599 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.722 ' HA ' HG21 ' A' ' 56' ' ' VAL . 71.6 mt -52.74 -66.93 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 C-N-CA 124.827 1.251 . . . . 1.12 111.351 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 HD22 ' C ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -52.95 -39.91 63.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.552 1.541 . . . . 2.08 111.9 -177.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 6.1 t70 -72.69 -26.29 61.56 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 113.261 -1.791 . . . . 0.64 111.481 -175.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -103.08 -8.59 20.42 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.994 0.739 . . . . 1.59 112.994 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 60.7 mt-30 . . . . . 0 CA--C 1.476 -1.88 0 CA-C-O 123.104 1.43 . . . . 1.09 108.225 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 15.1 t . . . . . 0 N--CA 1.423 -1.803 0 N-CA-C 109.869 -0.419 . . . . 1.34 109.869 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.566 ' HA ' HD13 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -47.71 -39.92 18.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.163 1.385 . . . . 0.74 113.238 174.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -59.2 -22.56 61.2 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.519 0.933 . . . . 2.66 113.519 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 3' ' ' THR . 29.9 tt0 -79.15 -39.82 32.5 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.806 -0.812 . . . . 2.73 108.806 174.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.634 ' CD1' ' HB2' ' A' ' 77' ' ' LEU . 63.9 mt -76.7 -66.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.643 -1.162 . . . . 1.05 111.526 -169.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 28' ' ' LEU . 48.1 t -56.51 -47.08 82.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 111.554 0.205 . . . . 1.05 111.554 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.35 -36.2 66.04 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.75 0.656 . . . . 1.07 112.212 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.4 -43.87 6.79 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 120.907 -0.663 . . . . 0.21 112.21 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.505 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -61.09 -39.9 91.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 124.402 1.081 . . . . 1.03 109.216 -177.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.679 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -56.31 -48.2 77.17 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 115.897 -0.592 . . . . 1.06 109.905 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.694 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 97.3 mt-10 -63.59 -34.09 77.04 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.983 0.802 . . . . 0.68 112.278 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.505 HD11 ' HA ' ' A' ' 11' ' ' LEU . 58.9 mt -68.26 -38.8 80.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.829 -0.623 . . . . 1.16 109.495 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 11' ' ' LEU . 59.7 t -72.26 -23.6 21.61 Favored 'Isoleucine or valine' 0 C--O 1.253 1.279 0 CA-C-O 121.427 0.632 . . . . 1.14 110.206 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.694 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 7.0 m120 -62.5 -37.83 87.54 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.776 -0.824 . . . . 0.36 108.776 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -84.08 -47.64 10.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 2.07 112.309 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.839 HG13 ' HB ' ' A' ' 46' ' ' VAL . 25.0 mm -54.2 -52.38 38.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.654 0.782 . . . . 1.31 111.427 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -118.51 -56.66 2.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.118 0.485 . . . . 1.18 110.832 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 16' ' ' ASN . . . 135.95 40.6 0.14 Allowed Glycine 0 CA--C 1.49 -1.529 0 C-N-CA 120.292 -0.956 . . . . 0.43 112.29 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.8 HG22 HG21 ' A' ' 26' ' ' VAL . 1.4 mp -75.64 147.31 81.45 Favored Pre-proline 0 C--O 1.202 -1.413 0 N-CA-C 109.06 -0.719 . . . . 1.06 109.06 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.3 Cg_exo -85.44 34.5 0.49 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 123.232 2.621 . . . . 1.08 113.992 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.274 9.8 p 56.9 -15.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 C-N-CA 127.326 2.251 . . . . 1.28 116.513 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 22' ' ' PRO . 12.2 pt-20 -96.24 -18.6 19.92 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.638 -0.664 . . . . 2.31 111.615 -176.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -85.42 -24.7 27.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 120.29 -0.564 . . . . 1.59 110.609 -170.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.8 HG21 HG22 ' A' ' 21' ' ' ILE . 42.6 t -72.54 92.58 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.852 -1.166 . . . . 1.07 107.852 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 69' ' ' VAL . 9.4 tppt? -125.16 160.37 29.3 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.801 -2.296 . . . . 2.11 104.801 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.485 ' HA ' HG23 ' A' ' 69' ' ' VAL . 6.4 mp -64.22 148.72 49.46 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 118.624 0.647 . . . . 1.75 109.651 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 t70 76.98 11.58 2.4 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.506 -1.225 . . . . 0.72 110.665 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 35.8 mmtp -99.04 122.95 42.96 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 108.927 -0.768 . . . . 2.01 108.927 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 39.2 m -76.82 28.04 0.13 Allowed 'General case' 1 C--N 1.242 -4.071 0 C-N-CA 126.643 1.977 . . . . 1.32 114.854 -172.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.692 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 91.0 m-85 44.62 -93.0 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.71 113.698 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.3 t -77.27 44.02 0.4 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.399 1.095 . . . . 1.36 111.229 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.9 t70 -159.46 -55.47 0.06 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 108.858 -0.793 . . . . 1.74 108.858 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.524 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 33.4 m-20 -84.2 -34.95 23.83 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.134 -0.939 . . . . 1.29 111.955 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 33.3 mt -85.11 -88.94 0.11 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.31 -0.626 . . . . 1.11 109.31 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.6 t70 157.11 64.67 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.609 -1.997 . . . . 1.12 105.609 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.599 HG13 ' HE2' ' A' ' 43' ' ' MET . 4.9 t -118.81 150.77 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.635 -0.712 . . . . 1.21 110.142 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.16 110.12 9.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.752 . . . . 2.0 108.968 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.448 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 29.5 t -41.06 -47.45 3.13 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.735 1.614 . . . . 0.99 114.071 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.67 -34.49 78.41 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.063 -0.398 . . . . 1.81 111.45 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -82.2 -13.12 57.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.195 0.522 . . . . 0.91 111.002 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.692 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.26 -36.97 79.02 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 123.361 0.665 . . . . 1.3 110.289 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.11 -47.13 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 O-C-N 123.836 0.71 . . . . 1.07 110.31 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -56.69 -53.64 55.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.216 0.607 . . . . 0.68 110.358 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.839 ' HB ' HG13 ' A' ' 18' ' ' ILE 0.34 1.7 p -61.92 -22.59 29.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 N-CA-C 114.228 1.195 . . . . 1.31 114.228 -178.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.92 HG21 HG11 ' A' ' 63' ' ' VAL . 44.5 t -71.23 -50.38 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.746 -1.205 . . . . 1.29 107.746 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.28 -35.24 73.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 108.397 -0.964 . . . . 1.1 108.397 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 46' ' ' VAL . . . -68.06 -35.25 77.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.308 -0.86 . . . . 1.0 109.947 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.73 -59.08 4.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.508 -1.224 . . . . 1.05 109.102 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.273 0.0 OUTLIER -59.96 -39.31 85.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 114.461 1.282 . . . . 0.64 114.461 -175.135 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -58.92 -40.58 85.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.92 0.391 . . . . 2.07 111.835 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.9 -27.14 43.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.109 -0.496 . . . . 3.11 111.059 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.462 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 7.1 m-85 -104.27 3.06 32.25 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.675 -0.81 . . . . 0.81 112.322 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.0 t70 80.46 -5.68 1.75 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.821 1.248 . . . . 1.99 112.851 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.532 HG23 ' HA ' ' A' ' 76' ' ' ILE . 10.6 p -82.02 173.43 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 121.29 -0.881 . . . . 1.14 109.205 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -128.62 127.28 41.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.552 -1.647 . . . . 2.7 106.552 174.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' A' ' 51' ' ' GLU . 64.0 mt -119.42 111.99 36.09 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.736 -0.386 . . . . 1.09 110.921 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.513 ' O ' HG22 ' A' ' 63' ' ' VAL . 58.7 Cg_endo -69.25 159.83 52.23 Favored 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 123.047 2.498 . . . . 0.4 110.808 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 22.1 t70 -52.78 -41.45 64.11 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.73 0.812 . . . . 1.98 112.116 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.5 -32.12 72.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.933 -0.576 . . . . 2.06 110.938 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.574 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 20.0 m-20 -86.3 -24.96 25.72 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.342 -0.543 . . . . 0.52 111.839 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.92 HG11 HG21 ' A' ' 47' ' ' VAL . 52.7 t -54.38 -51.58 47.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.588 -1.264 . . . . 1.12 107.588 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -78.51 -2.66 39.74 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.944 -1.026 . . . . 2.73 111.609 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -88.26 -29.67 20.24 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.935 -1.135 . . . . 1.92 107.935 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 72' ' ' ALA . 29.4 mt -82.56 113.41 20.26 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 107.583 -1.265 . . . . 1.04 107.583 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -106.77 -40.2 5.58 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 119.866 -0.734 . . . . 2.98 109.129 176.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 p -108.26 178.29 4.54 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 119.715 -0.794 . . . . 1.03 109.307 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.617 HG22 ' HG1' ' A' ' 73' ' ' THR . 0.5 OUTLIER -86.63 -13.06 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.296 -1.002 . . . . 1.91 108.296 175.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.63 59.59 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 108.114 -1.994 . . . . 0.33 108.114 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.1 -60.56 2.52 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.069 1.348 . . . . 1.39 109.492 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.75 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.49 -60.47 3.1 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 114.473 -1.239 . . . . 1.04 111.961 -176.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.617 ' HG1' HG22 ' A' ' 69' ' ' VAL . 61.6 m -59.39 -39.93 84.93 Favored 'General case' 0 N--CA 1.419 -2.0 0 O-C-N 124.102 0.877 . . . . 1.07 112.611 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HD3' ' N ' ' A' ' 75' ' ' TYR . 9.7 tmtt? -61.37 -50.76 71.6 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.456 -0.942 . . . . 4.04 108.456 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.489 ' HE2' HG12 ' A' ' 58' ' ' ILE . 85.2 t80 -56.51 -50.71 71.0 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.321 1.013 . . . . 0.9 110.814 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.63 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -55.2 -66.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 114.009 -1.45 . . . . 1.12 110.223 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 64.5 tp -55.45 -38.4 68.98 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 123.968 0.907 . . . . 2.08 112.349 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.49 -28.75 67.3 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.363 -0.835 . . . . 0.64 111.194 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -102.03 -14.8 17.0 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.417 0.895 . . . . 1.59 113.417 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.63 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 66.7 mt-30 . . . . . 0 CA--C 1.466 -2.275 0 CA-C-O 123.219 1.485 . . . . 1.09 107.753 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 109.954 -0.387 . . . . 1.34 109.954 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -49.12 -41.44 36.04 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.817 1.247 . . . . 0.74 113.552 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.59 -25.51 67.38 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.452 0.538 . . . . 2.66 112.452 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -87.19 -30.77 20.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.751 0.786 . . . . 2.73 109.108 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.411 HG21 ' CE2' ' A' ' 54' ' ' PHE . 96.1 mt -79.7 -65.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 CA-C-N 115.26 -0.882 . . . . 1.05 110.987 -172.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.3 t -54.18 -46.71 67.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 122.568 0.347 . . . . 1.05 111.925 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.12 73.93 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.496 0.497 . . . . 1.07 111.546 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.77 -33.24 19.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.941 -0.572 . . . . 0.21 112.906 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.733 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -69.55 -34.66 74.53 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.044 -1.095 . . . . 1.03 108.044 -178.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.706 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.05 -46.47 75.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.28 -0.873 . . . . 1.06 108.826 173.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.652 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 41.9 mt-10 -61.61 -43.02 99.64 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 124.276 0.985 . . . . 0.68 111.86 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' A' ' 11' ' ' LEU . 66.5 mt -58.71 -39.72 77.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.591 0.71 . . . . 1.16 109.644 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.733 HG11 ' HB ' ' A' ' 21' ' ' ILE . 62.7 t -70.74 -21.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.897 0.856 . . . . 1.14 110.015 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.652 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.0 m120 -80.47 -50.34 10.19 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.628 -1.249 . . . . 0.36 107.628 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.53 -50.25 59.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 2.07 112.279 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.01 -53.32 21.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.244 0.545 . . . . 1.31 109.86 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.56 -90.24 0.29 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.175 -0.466 . . . . 1.18 111.242 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.94 38.75 0.02 OUTLIER Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.599 -0.81 . . . . 0.43 113.104 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.733 ' HB ' HG11 ' A' ' 15' ' ' VAL . 1.4 mp -80.99 155.1 72.87 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 109.417 -0.586 . . . . 1.06 109.417 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 24' ' ' GLU . 4.8 Cg_exo -88.46 32.66 0.39 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.938 3.092 . . . . 1.08 114.768 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.411 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 5.2 p 60.05 -21.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.07 0 C-N-CA 127.147 2.179 . . . . 1.28 116.063 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 22' ' ' PRO . 44.9 mm-40 -93.23 -20.32 20.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 112.691 0.626 . . . . 2.31 112.691 -174.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.83 -30.77 51.25 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 120.74 -0.384 . . . . 1.59 111.258 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' A' ' 12' ' ' ALA . 34.7 t -72.89 97.88 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.28 -0.873 . . . . 1.07 109.672 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -135.69 151.03 49.78 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 104.413 -2.439 . . . . 2.11 104.413 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.426 HD21 ' HA2' ' A' ' 70' ' ' GLY . 49.3 mt -50.96 148.49 4.2 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.59 0.632 . . . . 1.75 109.574 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.7 t70 76.98 18.88 1.45 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.976 1.37 . . . . 0.72 109.94 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -119.21 128.46 54.23 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 114.703 -1.135 . . . . 2.01 108.442 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 5.7 m -87.36 112.1 21.77 Favored 'General case' 0 C--N 1.244 -3.983 0 N-CA-C 107.417 -1.327 . . . . 1.32 107.417 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.768 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.1 m-85 -46.63 -47.23 20.09 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.436 1.095 . . . . 0.71 112.708 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 t -98.86 21.75 11.1 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 112.574 0.583 . . . . 1.36 112.574 -174.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 13.6 t70 -146.48 -56.89 0.28 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 1.74 109.792 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.22 -39.27 55.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.881 -1.054 . . . . 1.29 110.402 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.698 HD11 ' HA ' ' A' ' 32' ' ' PHE . 35.6 mt -83.61 -93.17 0.07 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.513 -0.767 . . . . 1.11 110.365 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 32.6 t70 168.09 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 121.349 0.595 . . . . 1.12 111.127 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.527 HG12 ' HE3' ' A' ' 43' ' ' MET . 41.5 t -77.29 134.82 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 O-C-N 121.178 -0.951 . . . . 1.21 112.039 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.478 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 5.3 t70 -47.37 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 129.218 3.007 . . . . 2.0 117.297 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 43' ' ' MET . 30.5 t 75.03 -54.96 0.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.455 1.279 . . . . 0.99 114.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.478 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -74.58 -29.28 61.27 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.085 -1.446 . . . . 1.81 109.37 178.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 46' ' ' VAL . 67.3 m -70.6 -16.09 62.81 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.157 -0.929 . . . . 0.91 111.412 173.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.626 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -62.24 -41.35 98.34 Favored 'General case' 0 CA--C 1.473 -1.993 0 C-N-CA 123.101 0.56 . . . . 1.3 111.851 -178.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -57.29 -43.13 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 124.302 1.001 . . . . 1.07 109.734 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -56.5 -47.51 79.16 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.855 -0.611 . . . . 0.68 109.782 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 42' ' ' SER . 40.3 t -60.91 -24.59 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.32 -0.855 . . . . 1.31 111.107 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.887 HG22 HG12 ' A' ' 63' ' ' VAL . 29.2 t -81.11 -53.07 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 108.182 -1.044 . . . . 1.29 108.182 -177.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 -29.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.739 -1.119 . . . . 1.1 109.762 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.57 58.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.58 -53.63 44.73 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.103 -0.953 . . . . 1.05 109.272 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.577 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.258 0.0 OUTLIER -63.97 -34.93 79.09 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.663 0.986 . . . . 0.64 113.663 -177.716 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -64.28 -36.89 85.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.117 0.484 . . . . 2.07 111.375 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.61 -35.91 20.69 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.451 -0.795 . . . . 3.11 111.891 -172.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 11.4 m-85 -89.76 -45.1 9.54 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 118.926 -1.11 . . . . 0.81 113.185 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 13.5 t70 154.11 -33.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 124.618 1.199 . . . . 1.99 111.781 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' A' ' 79' ' ' HIS . 9.3 p -76.85 -177.0 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.449 0.537 . . . . 1.14 112.449 -165.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -135.98 131.37 34.97 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.721 -1.585 . . . . 2.7 106.721 169.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.577 HG13 ' HB3' ' A' ' 51' ' ' GLU . 45.4 mt -122.03 111.64 32.26 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 123.425 0.453 . . . . 1.09 110.347 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.596 ' O ' HG21 ' A' ' 63' ' ' VAL . 59.9 Cg_endo -72.31 160.34 47.28 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.982 2.455 . . . . 0.4 110.634 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.11 -43.32 41.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.751 . . . . 1.98 111.74 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.64 -34.22 77.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 2.06 112.68 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.603 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 67.0 m-20 -86.15 -28.22 24.1 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.113 -0.635 . . . . 0.52 110.993 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.887 HG12 HG22 ' A' ' 47' ' ' VAL . 76.8 t -55.61 -55.46 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.363 -0.977 . . . . 1.12 108.363 174.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -69.62 -1.19 8.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.927 -1.033 . . . . 2.73 112.891 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.86 -23.5 16.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.86 -1.163 . . . . 1.92 107.86 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.876 HD13 ' HA ' ' A' ' 72' ' ' ALA . 21.6 mt -91.59 125.17 36.23 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 106.726 -1.583 . . . . 1.04 106.726 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -113.24 -39.63 4.11 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.336 -0.987 . . . . 2.98 108.336 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.8 p -104.53 179.58 4.23 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-N 115.463 -0.79 . . . . 1.03 109.887 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.768 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -87.08 -13.95 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 108.237 -1.024 . . . . 1.91 108.237 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.426 ' HA2' HD21 ' A' ' 28' ' ' LEU . . . -69.03 -47.59 53.12 Favored Glycine 0 CA--C 1.492 -1.39 0 N-CA-C 107.437 -2.265 . . . . 0.33 107.437 172.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 23.7 m-20 -56.6 -55.91 28.04 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 125.271 1.429 . . . . 1.39 110.925 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.876 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -54.56 -60.49 3.28 Favored 'General case' 0 CA--C 1.479 -1.763 0 O-C-N 124.472 1.107 . . . . 1.04 112.166 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.762 HG22 HD21 ' A' ' 77' ' ' LEU . 33.7 m -54.55 -51.48 65.09 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.013 -0.994 . . . . 1.07 112.949 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 4.9 mptp? -51.07 -29.25 12.41 Favored 'General case' 0 C--O 1.197 -1.675 0 C-N-CA 126.749 2.019 . . . . 4.04 111.444 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.603 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 73.1 t80 -85.21 -48.89 8.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.61 -0.723 . . . . 0.9 109.333 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.638 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.9 mt -56.51 -63.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 114.697 -1.138 . . . . 1.12 109.372 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.762 HD21 HG22 ' A' ' 73' ' ' THR . 4.5 pp -56.97 -36.58 70.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.734 0.778 . . . . 2.08 112.622 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 5.5 t70 -76.5 -26.74 55.59 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.472 -1.24 . . . . 0.64 111.276 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.609 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 20.5 t-80 -94.98 -16.38 22.81 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.003 -0.544 . . . . 1.59 109.983 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.638 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 32.7 mt-30 . . . . . 0 CA--C 1.478 -1.789 0 CA-C-O 122.729 1.252 . . . . 1.09 108.187 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.443 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.7 t . . . . . 0 N--CA 1.419 -2.006 0 N-CA-C 105.874 -1.898 . . . . 1.34 105.874 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.407 ' HG2' HG21 ' A' ' 8' ' ' VAL . 11.5 tm0? -46.62 -46.76 19.94 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.823 1.416 . . . . 0.74 114.823 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.36 -23.54 65.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.966 1.099 . . . . 2.66 113.966 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -87.95 -33.99 18.25 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.426 -0.953 . . . . 2.73 108.426 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.603 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.3 mt -72.0 -65.35 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.515 0 CA-C-N 115.955 -0.566 . . . . 1.05 110.61 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.511 HG12 HG23 ' A' ' 69' ' ' VAL . 26.4 t -59.85 -26.7 36.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 111.934 0.346 . . . . 1.05 111.934 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.42 -37.91 68.52 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.942 -0.703 . . . . 1.07 110.124 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.68 -36.44 11.85 Favored Glycine 0 N--CA 1.419 -2.456 0 CA-C-N 116.186 -0.461 . . . . 0.21 113.068 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.724 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.07 -35.36 80.32 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.571 -0.899 . . . . 1.03 108.571 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.799 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -57.08 -44.3 82.99 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.87 -0.605 . . . . 1.06 109.74 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.678 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 46.4 mt-10 -62.69 -42.55 99.69 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.175 -0.92 . . . . 0.68 111.834 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.724 HD11 ' HA ' ' A' ' 11' ' ' LEU . 50.2 mt -61.14 -36.63 73.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.923 0.868 . . . . 1.16 109.848 177.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.682 HG13 ' HB ' ' A' ' 21' ' ' ILE . 60.5 t -74.97 -23.27 17.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.224 -0.898 . . . . 1.14 110.325 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.678 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 9.0 m120 -70.25 -46.35 64.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.631 -0.877 . . . . 0.36 108.631 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.06 -49.38 17.66 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.997 -1.001 . . . . 2.07 113.482 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.64 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.9 mt -75.64 -51.1 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 112.327 0.492 . . . . 1.31 112.327 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -91.68 -75.28 0.48 Allowed 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.273 -0.571 . . . . 1.18 110.384 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.54 41.0 0.04 OUTLIER Glycine 0 C--N 1.3 -1.442 0 CA-C-N 115.564 -0.744 . . . . 0.43 112.572 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.805 HG21 HG21 ' A' ' 26' ' ' VAL . 1.5 mp -81.98 150.66 65.66 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 109.055 -0.72 . . . . 1.06 109.055 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 8.2 Cg_exo -87.02 33.46 0.43 Allowed 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 124.348 3.365 . . . . 1.08 114.27 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.412 ' CA ' HD22 ' A' ' 16' ' ' ASN 0.324 9.2 p 60.81 -18.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.091 2.157 . . . . 1.28 116.597 175.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -96.79 -11.34 25.07 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.391 -0.818 . . . . 2.31 111.79 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.4 m-20 -79.73 -33.2 41.02 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.094 0.474 . . . . 1.59 110.495 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.805 HG21 HG21 ' A' ' 21' ' ' ILE . 40.9 t -72.83 93.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.969 -1.014 . . . . 1.07 110.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -124.7 168.23 13.46 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.69 -1.596 . . . . 2.11 106.69 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.556 ' HA ' HG22 ' A' ' 69' ' ' VAL . 5.8 mp -68.05 151.19 47.44 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.905 -1.146 . . . . 1.75 107.905 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 t70 76.68 12.84 2.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.282 1.039 . . . . 0.72 109.548 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 68' ' ' THR . 72.2 mmtt -111.65 125.21 53.71 Favored 'General case' 0 CA--C 1.458 -2.576 0 O-C-N 121.7 -0.625 . . . . 2.01 110.442 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 12.2 m -80.26 111.89 17.07 Favored 'General case' 0 C--N 1.247 -3.854 0 CA-C-N 114.428 -1.26 . . . . 1.32 108.213 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.534 ' HA ' HD12 ' A' ' 36' ' ' LEU . 90.8 m-85 -48.41 -55.48 10.73 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.445 0.698 . . . . 0.71 110.548 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 t -84.08 25.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.595 0.591 . . . . 1.36 112.595 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -156.11 -62.14 0.11 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.535 0.684 . . . . 1.74 111.237 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -70.79 -39.52 73.08 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 124.368 1.067 . . . . 1.29 110.466 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.569 HD11 HG22 ' A' ' 26' ' ' VAL . 16.4 mt -88.11 -50.44 6.39 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.202 -0.908 . . . . 1.11 110.802 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 95.03 68.66 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.852 2.061 . . . . 1.12 110.723 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.808 HG12 ' HE3' ' A' ' 43' ' ' MET . 47.4 t -101.42 132.45 47.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 CA-C-N 113.366 -1.743 . . . . 1.21 106.577 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -62.68 20.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.545 2.054 . . . . 2.0 116.545 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 43' ' ' MET . 28.6 t 61.99 -57.89 0.12 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 116.139 1.903 . . . . 0.99 116.139 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.57 -29.58 70.82 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.953 0.882 . . . . 1.81 109.987 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.64 ' HB3' HG22 ' A' ' 18' ' ' ILE . 1.6 m -75.05 -22.52 58.34 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.277 -1.329 . . . . 0.91 110.656 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.808 ' HE3' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.27 -43.75 95.9 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 123.743 0.817 . . . . 1.3 112.341 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.63 -36.95 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 O-C-N 123.946 0.779 . . . . 1.07 110.605 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.28 -43.94 93.23 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 108.768 -0.827 . . . . 0.68 108.768 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 42' ' ' SER . 58.3 t -61.96 -25.05 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.469 1.107 . . . . 1.31 111.11 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.868 HG11 HG21 ' A' ' 63' ' ' VAL . 55.3 t -77.25 -55.71 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 107.422 -1.325 . . . . 1.29 107.422 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 58.6 t -57.3 -40.79 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 O-C-N 124.806 1.316 . . . . 1.1 108.94 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' A' ' 14' ' ' ILE . . . -65.6 -35.24 80.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.373 0.606 . . . . 1.0 110.685 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.57 -57.13 6.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.351 -0.841 . . . . 1.05 109.783 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.69 -33.95 76.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.634 0.976 . . . . 0.64 113.634 -177.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 51.8 mt-10 -59.32 -53.17 61.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.643 0.259 . . . . 2.07 110.368 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -66.18 -47.12 74.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.513 0.56 . . . . 3.11 112.513 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.603 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.3 m-85 -84.37 -9.41 58.45 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.648 0.61 . . . . 0.81 112.648 -172.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 85.05 3.59 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 116.385 1.994 . . . . 1.99 116.385 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 13.9 p -82.91 171.72 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.129 -1.028 . . . . 1.14 108.863 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -120.17 128.02 53.01 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.815 -1.55 . . . . 2.7 106.815 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.507 HG12 ' HE2' ' A' ' 75' ' ' TYR . 60.3 mt -116.79 108.97 43.81 Favored Pre-proline 0 C--N 1.308 -1.198 0 C-N-CA 119.964 -0.694 . . . . 1.09 111.52 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.568 ' O ' HG23 ' A' ' 63' ' ' VAL . 51.7 Cg_endo -69.02 159.13 55.19 Favored 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 123.184 2.59 . . . . 0.4 110.928 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.22 -33.62 67.71 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.681 0.792 . . . . 1.98 110.21 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.81 -38.07 89.26 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.067 -0.97 . . . . 2.06 110.835 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 41.1 m-20 -87.04 -25.17 24.34 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.187 -0.605 . . . . 0.52 112.464 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.868 HG21 HG11 ' A' ' 47' ' ' VAL . 94.7 t -55.88 -42.09 69.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.441 -0.948 . . . . 1.12 108.441 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -78.18 -5.32 51.42 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.669 -0.696 . . . . 2.73 112.304 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.43 -25.58 16.85 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 109.822 -0.436 . . . . 1.92 109.822 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.855 HD13 ' HA ' ' A' ' 72' ' ' ALA . 22.0 mt -89.12 122.04 32.04 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 107.095 -1.446 . . . . 1.04 107.095 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 31' ' ' SER . 8.3 mptt -120.21 -34.88 3.57 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.505 -0.924 . . . . 2.98 108.505 174.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 39.4 p -106.41 173.47 6.3 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 108.894 -0.78 . . . . 1.03 108.894 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.558 HG13 HG11 ' A' ' 26' ' ' VAL . 1.4 m -81.92 -13.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 C-N-CA 119.35 -0.94 . . . . 1.91 108.535 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.46 -43.53 92.24 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 108.632 -1.787 . . . . 0.33 108.632 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.73 -56.84 13.98 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.855 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.12 -61.02 2.53 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 114.087 -1.415 . . . . 1.04 112.506 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.496 ' HG1' HG21 ' A' ' 69' ' ' VAL . 49.9 m -56.62 -46.3 81.02 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.492 1.12 . . . . 1.07 112.451 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -56.51 -52.34 65.1 Favored 'General case' 0 N--CA 1.41 -2.469 0 O-C-N 124.453 1.095 . . . . 4.04 108.765 177.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.524 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 74.4 t80 -55.18 -50.51 69.18 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 124.057 0.848 . . . . 0.9 111.515 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.62 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.8 mt -54.4 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-N 114.151 -1.386 . . . . 1.12 110.207 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.53 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 4.2 tt -57.95 -45.51 86.53 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.615 0.766 . . . . 2.08 110.182 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.85 -24.07 66.67 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.049 0.94 . . . . 0.64 111.384 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -98.8 -26.42 14.32 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 113.011 0.745 . . . . 1.59 113.011 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.45 2.7 pp0? . . . . . 0 CA--C 1.507 -0.698 0 N-CA-C 116.405 2.002 . . . . 1.09 116.405 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 7' ' ' ILE . 6.6 t . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 110.751 -0.092 . . . . 1.34 110.751 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.518 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.1 tm0? -47.79 -43.21 27.39 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.015 0.926 . . . . 0.74 113.357 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.48 -34.73 62.12 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.594 0.559 . . . . 2.66 111.709 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -87.31 -34.88 18.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.884 -0.598 . . . . 2.73 109.941 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.519 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.7 mt -68.54 -65.72 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 CA-C-N 116.497 -0.319 . . . . 1.05 110.528 -174.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -41.52 67.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 112.386 0.513 . . . . 1.05 112.386 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -61.54 -42.28 98.59 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.033 0.444 . . . . 1.07 110.348 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.0 -40.91 28.93 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 121.028 -0.606 . . . . 0.21 113.081 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.648 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.16 -38.53 91.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.775 -0.824 . . . . 1.03 108.775 -178.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.608 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -58.13 -48.24 80.84 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.792 -0.64 . . . . 1.06 109.573 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.684 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 52.5 mt-10 -60.21 -39.37 86.33 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.895 0.747 . . . . 0.68 111.998 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.648 HD11 ' HA ' ' A' ' 11' ' ' LEU . 62.9 mt -61.24 -41.88 91.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.009 -0.541 . . . . 1.16 109.754 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 11' ' ' LEU . 46.7 t -71.42 -23.55 22.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.357 0.599 . . . . 1.14 109.945 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.684 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.5 m120 -68.2 -48.81 64.21 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.905 -1.146 . . . . 0.36 107.905 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -69.88 -42.98 72.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.895 -1.048 . . . . 2.07 111.821 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.719 HG13 HG22 ' A' ' 46' ' ' VAL . 19.2 mm -73.85 -53.71 16.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 116.01 -0.541 . . . . 1.31 111.707 -177.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.52 -62.99 1.38 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.171 0.51 . . . . 1.18 111.403 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.33 39.13 0.07 OUTLIER Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.414 -0.898 . . . . 0.43 112.964 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.718 HG21 HG23 ' A' ' 26' ' ' VAL . 1.2 mp -78.03 152.35 79.54 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.459 -0.571 . . . . 1.06 109.459 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.6 Cg_endo -89.85 25.37 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.984 2.456 . . . . 1.08 115.052 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 5.0 p 53.62 15.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 125.447 1.499 . . . . 1.28 113.857 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.585 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.0 pt-20 -123.13 -16.07 7.08 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.888 -0.596 . . . . 2.31 110.338 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.425 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 22.0 t70 -92.41 -25.64 18.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.675 0.75 . . . . 1.59 110.108 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.718 HG23 HG21 ' A' ' 21' ' ' ILE . 43.0 t -76.09 92.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.444 -1.253 . . . . 1.07 108.863 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -125.87 166.78 16.25 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.576 -1.268 . . . . 2.11 107.576 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 mp -63.53 146.0 54.54 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.45 -0.574 . . . . 1.75 109.45 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.48 12.47 3.87 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.119 1.367 . . . . 0.72 110.431 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 68' ' ' THR . 73.7 mmtt -103.57 124.79 49.45 Favored 'General case' 0 CA--C 1.47 -2.11 0 O-C-N 121.791 -0.568 . . . . 2.01 109.777 176.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 6.3 m -83.23 110.86 18.43 Favored 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 114.488 -1.233 . . . . 1.32 108.427 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.737 ' HB3' ' HE1' ' A' ' 43' ' ' MET . 98.2 m-85 -42.02 -67.23 0.28 Allowed 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 125.725 1.61 . . . . 0.71 112.426 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.507 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 14.8 t -101.56 49.35 0.87 Allowed 'General case' 0 C--N 1.275 -2.658 0 C-N-CA 118.776 -1.17 . . . . 1.36 111.134 -177.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 29.4 t70 -154.62 -53.72 0.1 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.73 -1.123 . . . . 1.74 109.773 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -86.23 -44.5 12.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.207 1.003 . . . . 1.29 110.771 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.681 HD13 ' HA ' ' A' ' 32' ' ' PHE . 32.7 mt -71.75 -91.24 0.02 OUTLIER 'General case' 0 C--O 1.249 1.036 0 O-C-N 123.715 0.634 . . . . 1.11 111.4 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 25.4 t70 158.25 61.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 126.099 1.76 . . . . 1.12 108.459 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.533 HG13 ' HE2' ' A' ' 43' ' ' MET . 26.8 t -101.72 165.81 2.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.694 -0.684 . . . . 1.21 110.022 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' N ' HG12 ' A' ' 38' ' ' VAL . 10.0 m-20 -83.26 6.15 20.62 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.681 0.793 . . . . 2.0 112.879 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 43' ' ' MET . 20.5 t 66.66 -66.5 0.18 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.579 1.152 . . . . 0.99 113.245 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.02 -26.52 65.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.583 0.706 . . . . 1.81 110.802 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 15.7 m -80.54 -13.46 59.06 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.548 -0.751 . . . . 0.91 110.569 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.737 ' HE1' ' HB3' ' A' ' 32' ' ' PHE . 18.0 tpp -73.04 -31.65 64.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.002 -0.544 . . . . 1.3 110.978 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -55.15 -42.59 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 N-CA-C 108.784 -0.821 . . . . 1.07 108.784 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' SER . 26.0 mm-40 -54.53 -53.14 58.38 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 123.781 0.832 . . . . 0.68 110.282 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.719 HG22 HG13 ' A' ' 18' ' ' ILE . 51.6 t -54.16 -32.14 22.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 124.374 1.07 . . . . 1.31 112.048 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.811 HG21 HG12 ' A' ' 63' ' ' VAL . 27.9 t -73.32 -48.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.567 -0.901 . . . . 1.29 108.567 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.43 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 43.8 t -68.3 -31.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.272 -1.01 . . . . 1.1 108.272 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.418 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -69.66 -34.17 73.62 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.41 0.624 . . . . 1.0 109.738 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.48 42.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.974 -1.012 . . . . 1.05 108.994 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.633 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.261 0.0 OUTLIER -66.77 -29.63 69.64 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.714 1.005 . . . . 0.64 113.714 -177.727 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 41.4 mt-10 -63.34 -38.16 90.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.274 0.559 . . . . 2.07 110.627 174.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -86.86 -35.37 19.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.272 0.471 . . . . 3.11 112.272 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 8.1 m-85 -97.72 -0.03 46.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 120.025 -0.67 . . . . 0.81 112.186 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 78.44 -2.77 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.584 1.327 . . . . 1.99 114.584 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.62 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 14.8 p -75.73 175.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 O-C-N 121.098 -1.001 . . . . 1.14 108.947 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 36.5 tptt -124.61 128.96 49.68 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.82 -1.178 . . . . 2.7 107.82 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 51' ' ' GLU . 27.1 mt -123.09 110.98 30.8 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 120.165 -0.614 . . . . 1.09 110.825 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 63' ' ' VAL . 67.8 Cg_endo -73.89 158.4 46.39 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.591 2.194 . . . . 0.4 109.582 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.69 -36.57 62.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.194 0.597 . . . . 1.98 110.806 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.44 -42.69 87.89 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.575 0.75 . . . . 2.06 111.63 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.5 m-20 -86.32 -24.92 25.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 121.017 -0.273 . . . . 0.52 111.581 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.811 HG12 HG21 ' A' ' 47' ' ' VAL . 55.8 t -53.06 -58.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.138 -1.06 . . . . 1.12 108.138 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -72.87 -1.49 17.01 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.213 -0.903 . . . . 2.73 111.705 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -87.61 -34.41 18.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.847 -1.168 . . . . 1.92 107.847 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.834 HD11 ' HA ' ' A' ' 72' ' ' ALA . 12.8 mt -79.42 131.38 36.07 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 106.459 -1.682 . . . . 1.04 106.459 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 31' ' ' SER . 12.7 mptt -116.77 -42.34 2.98 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.997 -1.112 . . . . 2.98 107.997 171.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 81.9 p -101.88 170.38 8.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.901 -1.045 . . . . 1.03 110.224 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.501 HG22 ' HG1' ' A' ' 73' ' ' THR . 1.4 m -80.5 -13.6 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.104 -1.073 . . . . 1.91 108.104 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.58 -30.47 68.72 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.244 -1.143 . . . . 0.33 110.244 176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -81.97 -51.28 8.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.066 -1.087 . . . . 1.39 108.066 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.834 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -49.79 -60.42 2.91 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 114.323 -1.308 . . . . 1.04 111.967 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.518 HG21 ' HG2' ' A' ' 4' ' ' GLN . 45.8 m -57.24 -42.27 81.14 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.671 -1.149 . . . . 1.07 112.508 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -57.29 -53.25 60.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.974 -1.121 . . . . 4.04 107.974 176.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.558 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 82.1 t80 -56.48 -50.54 71.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 124.19 0.931 . . . . 0.9 111.148 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.611 ' HA ' HG22 ' A' ' 56' ' ' VAL . 70.8 mt -55.73 -66.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.278 -1.328 . . . . 1.12 109.98 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.46 -47.18 66.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.8 0.84 . . . . 2.08 110.538 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.09 -22.97 65.8 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.221 -0.899 . . . . 0.64 112.285 -172.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -102.79 4.27 37.7 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.303 0.853 . . . . 1.59 113.303 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.62 ' HG2' ' HB ' ' A' ' 56' ' ' VAL 0.309 0.7 OUTLIER . . . . . 0 CA--C 1.474 -1.957 0 N-CA-C 113.832 1.049 . . . . 1.09 113.832 175.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.542 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 6.4 t . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 108.814 -0.81 . . . . 1.34 108.814 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.655 ' HA ' HD11 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -48.71 -42.2 34.26 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.941 1.296 . . . . 0.74 112.653 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.35 -22.56 63.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.821 0.674 . . . . 2.66 112.821 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 3' ' ' THR . 4.1 tp10 -81.34 -36.77 29.29 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.412 -0.959 . . . . 2.73 108.412 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 4' ' ' GLN . 71.2 mt -79.03 -67.91 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.117 0 CA-C-N 115.294 -0.866 . . . . 1.05 110.844 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 t -59.09 -41.88 84.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 112.568 0.581 . . . . 1.05 112.568 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.38 82.72 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.317 0.386 . . . . 1.07 111.288 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.38 -40.53 8.39 Favored Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 120.393 -0.908 . . . . 0.21 112.2 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.721 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -59.46 -42.72 92.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.277 1.031 . . . . 1.03 108.278 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.58 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -54.43 -48.12 72.04 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.664 0.603 . . . . 1.06 110.615 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.715 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 54.4 mt-10 -65.71 -35.71 81.53 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 123.709 0.631 . . . . 0.68 111.746 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.721 HD11 ' HA ' ' A' ' 11' ' ' LEU . 64.4 mt -60.73 -42.47 92.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.618 -0.719 . . . . 1.16 109.595 174.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' ' 11' ' ' LEU . 41.3 t -68.47 -23.94 28.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 121.845 0.831 . . . . 1.14 109.864 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.715 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.9 m120 -75.57 -52.35 10.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.176 -1.046 . . . . 0.36 108.176 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -66.66 -46.42 75.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.615 -1.175 . . . . 2.07 112.476 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.592 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.2 mm -70.79 -53.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.878 0.371 . . . . 1.31 110.27 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.74 -74.31 0.65 Allowed 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.664 -0.414 . . . . 1.18 111.519 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.18 54.45 0.02 OUTLIER Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 120.291 -0.957 . . . . 0.43 112.045 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.629 ' HB ' HG11 ' A' ' 15' ' ' VAL . 1.4 mp -95.62 154.57 39.17 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.493 -0.558 . . . . 1.06 109.493 175.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 6.2 Cg_exo -88.02 29.45 0.47 Allowed 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 124.224 3.283 . . . . 1.08 115.673 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.5 p 57.87 -0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 117.838 2.533 . . . . 1.28 117.838 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 43.7 mt-10 -117.93 -13.39 10.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.34 -1.475 . . . . 2.31 111.225 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.532 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.0 m-20 -87.03 -29.28 22.06 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.005 -1.452 . . . . 1.59 110.127 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 12' ' ' ALA . 41.9 t -69.35 97.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 1.07 108.79 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.1 mttt -138.35 170.04 16.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 109.069 -0.715 . . . . 2.11 109.069 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.405 HD23 ' HE2' ' A' ' 74' ' ' LYS . 7.8 mp -61.13 143.03 56.23 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.174 -0.676 . . . . 1.75 109.174 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t70 81.99 1.04 1.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.029 1.332 . . . . 0.72 110.898 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.568 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 44.2 mmtm -92.8 120.35 33.08 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 119.589 -0.844 . . . . 2.01 109.644 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.479 ' CB ' ' HB3' ' A' ' 34' ' ' ASP . 15.9 m -79.12 27.09 0.25 Allowed 'General case' 1 C--N 1.244 -4.019 0 C-N-CA 125.968 1.707 . . . . 1.32 113.876 -172.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.591 ' CZ ' HG23 ' A' ' 69' ' ' VAL . 96.7 m-85 46.13 -88.58 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.495 1.518 . . . . 0.71 113.989 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.6 t -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.133 0.573 . . . . 1.36 111.374 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' HB3' ' CB ' ' A' ' 31' ' ' SER . 32.3 t70 -88.17 -39.72 14.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.978 0.418 . . . . 1.74 111.298 -175.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.568 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -93.21 -41.31 9.97 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.514 0.931 . . . . 1.29 113.514 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.6 mt -88.19 -72.42 0.53 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.388 -0.525 . . . . 1.11 110.68 -173.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.0 t70 163.83 -22.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 124.321 1.013 . . . . 1.12 109.612 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.658 HG12 ' HE3' ' A' ' 43' ' ' MET . 3.0 t -45.99 105.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.77 1.628 . . . . 1.21 112.939 -170.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.494 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 24.9 t70 -54.04 124.15 14.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 124.04 0.838 . . . . 2.0 112.589 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 43' ' ' MET . 29.9 t -37.51 -45.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.612 2.078 . . . . 0.99 116.612 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.494 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 3.9 pp -75.92 -23.15 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 117.607 -1.637 . . . . 1.81 112.26 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.592 ' HB3' HG22 ' A' ' 18' ' ' ILE . 42.9 m -84.2 -18.91 35.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.735 -0.666 . . . . 0.91 109.665 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.658 ' HE3' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -56.95 -43.55 81.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.19 0.996 . . . . 1.3 112.715 -178.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.25 -40.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 123.845 0.716 . . . . 1.07 110.171 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -63.36 -44.45 94.77 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.969 -0.56 . . . . 0.68 109.722 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.525 HG11 HG22 ' A' ' 15' ' ' VAL . 42.0 t -60.0 -25.13 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.425 -0.807 . . . . 1.31 110.903 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.913 HG21 HG13 ' A' ' 63' ' ' VAL . 21.5 t -82.27 -53.75 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 108.79 -0.818 . . . . 1.29 108.79 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.14 -36.73 74.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.72 -1.127 . . . . 1.1 109.171 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -31.61 67.37 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . . . -61.55 -58.21 9.04 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.285 -0.87 . . . . 1.05 109.094 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -64.47 -36.06 82.95 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.906 1.076 . . . . 0.64 113.906 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.99 -29.74 69.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 2.07 111.512 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -88.41 -32.34 18.38 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.227 -0.442 . . . . 3.11 111.559 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 4.6 m-30 -93.13 -11.14 33.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 120.386 -0.526 . . . . 0.81 111.938 -173.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t70 81.38 6.77 1.2 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.493 1.517 . . . . 1.99 111.987 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 76' ' ' ILE . 14.5 p -84.7 171.15 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 107.584 -1.265 . . . . 1.14 107.584 174.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 19.5 tptt -124.6 123.06 39.24 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.654 -0.869 . . . . 2.7 108.654 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.493 HG12 ' HE2' ' A' ' 75' ' ' TYR . 62.8 mt -118.9 112.73 36.32 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 109.835 -0.432 . . . . 1.09 109.835 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.512 ' O ' HG23 ' A' ' 63' ' ' VAL . 37.7 Cg_endo -67.43 158.2 58.18 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.747 2.298 . . . . 0.4 110.282 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 6.2 p-10 -58.55 -30.43 67.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.399 -0.364 . . . . 1.98 111.422 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.74 -34.03 69.2 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 112.428 0.529 . . . . 2.06 112.428 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 52.5 m-20 -78.73 -25.07 44.57 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 119.524 -0.87 . . . . 0.52 110.985 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.913 HG13 HG21 ' A' ' 47' ' ' VAL . 70.0 t -54.27 -39.7 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.229 -1.026 . . . . 1.12 108.229 170.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 60' ' ' ASP . 81.9 mttt -73.98 -14.63 61.06 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.0 -1.0 . . . . 2.73 112.22 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -96.49 -36.17 10.88 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.594 0.358 . . . . 1.92 111.511 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.791 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -68.71 113.05 5.84 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 105.678 -1.971 . . . . 1.04 105.678 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -108.21 -31.3 7.95 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 119.762 -0.775 . . . . 2.98 109.807 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.9 p -121.01 178.42 4.74 Favored 'General case' 0 N--CA 1.392 -3.338 0 N-CA-C 108.557 -0.905 . . . . 1.03 108.557 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.591 HG23 ' CZ ' ' A' ' 32' ' ' PHE . 6.4 t -77.45 -13.56 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 107.683 -1.228 . . . . 1.91 107.683 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.84 -49.04 37.93 Favored Glycine 0 CA--C 1.489 -1.583 0 N-CA-C 109.871 -1.292 . . . . 0.33 109.871 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.77 -44.36 77.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.963 -0.618 . . . . 1.39 109.373 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.791 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -56.61 -61.64 2.28 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.019 -0.992 . . . . 1.04 111.266 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.597 ' HA ' HG22 ' A' ' 7' ' ' ILE . 60.7 m -54.36 -43.71 71.54 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.696 -1.138 . . . . 1.07 113.804 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.1 mptp? -61.03 -50.9 71.48 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.99 -0.744 . . . . 4.04 108.99 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.493 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.8 t80 -54.47 -51.82 63.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.643 -1.162 . . . . 0.9 110.225 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.622 ' HA ' HG21 ' A' ' 56' ' ' VAL . 78.3 mt -55.37 -65.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 114.19 -1.368 . . . . 1.12 110.716 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 5.2 tt -51.73 -43.61 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.9 0.88 . . . . 2.08 110.57 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.07 -25.53 64.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.875 -1.057 . . . . 0.64 111.823 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -101.51 -5.83 24.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.794 -0.639 . . . . 1.59 112.344 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.475 HE21 HG23 ' A' ' 76' ' ' ILE 0.302 1.0 OUTLIER . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 113.636 0.976 . . . . 1.09 113.636 175.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.584 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 13.1 t . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 108.673 -0.862 . . . . 1.34 108.673 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -46.9 -48.25 21.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.141 1.163 . . . . 0.74 114.141 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -51.98 -32.33 33.17 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.567 0.951 . . . . 2.66 113.567 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -87.45 -40.45 14.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.292 0.637 . . . . 2.73 109.87 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.625 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 99.5 mt -63.56 -58.74 6.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 116.139 -0.482 . . . . 1.05 110.016 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.54 HG21 HD12 ' A' ' 28' ' ' LEU . 46.0 t -66.29 -22.91 30.86 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.871 -0.604 . . . . 1.05 111.695 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.92 55.78 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.759 -0.776 . . . . 1.07 109.177 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.15 -44.09 24.12 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 115.008 -0.996 . . . . 0.21 113.225 -176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.701 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -63.13 -33.08 74.68 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 123.448 0.699 . . . . 1.03 109.376 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.691 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -60.75 -51.14 70.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.659 -0.701 . . . . 1.06 109.263 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.633 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 51.2 mt-10 -59.44 -41.83 90.53 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 124.183 0.927 . . . . 0.68 111.809 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.701 HD13 ' HA ' ' A' ' 11' ' ' LEU . 71.4 mt -56.79 -42.17 77.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.461 -0.79 . . . . 1.16 109.85 175.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.62 HG12 ' HB ' ' A' ' 21' ' ' ILE . 88.0 t -70.92 -23.73 23.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.703 0.764 . . . . 1.14 110.306 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.633 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -72.79 -43.32 62.91 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.177 -1.046 . . . . 0.36 108.177 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -71.39 -50.33 33.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.214 -0.903 . . . . 2.07 110.926 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.628 HG13 HG23 ' A' ' 46' ' ' VAL . 20.9 mm -66.76 -54.24 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.1 -0.5 . . . . 1.31 111.667 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.434 ' HB3' HG12 ' A' ' 38' ' ' VAL . . . -102.96 -66.07 0.96 Allowed 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.389 0.614 . . . . 1.18 111.036 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.7 50.87 0.06 OUTLIER Glycine 0 C--N 1.29 -1.999 0 CA-C-N 115.142 -0.936 . . . . 0.43 111.714 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.62 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -91.33 155.66 44.17 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.408 -0.396 . . . . 1.06 109.983 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD2' HG22 ' A' ' 21' ' ' ILE . 6.0 Cg_exo -86.62 23.02 0.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.343 2.695 . . . . 1.08 115.698 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.624 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.9 p 48.1 26.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 C-N-CA 124.694 1.198 . . . . 1.28 113.154 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -138.9 4.72 2.31 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.345 -0.843 . . . . 2.31 110.685 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.35 -27.91 9.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.075 -0.966 . . . . 1.59 110.065 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.755 HG22 HD11 ' A' ' 36' ' ' LEU . 23.7 t -79.6 99.1 3.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.33 -1.304 . . . . 1.07 108.972 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -127.98 170.57 12.72 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.164 -1.421 . . . . 2.11 107.164 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.54 HD12 HG21 ' A' ' 8' ' ' VAL . 7.9 mp -66.41 148.55 51.7 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.287 -1.005 . . . . 1.75 108.287 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 81.51 4.22 1.39 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 124.451 1.101 . . . . 0.72 110.533 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 73.6 mmtt -96.61 118.99 34.26 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 119.831 -0.748 . . . . 2.01 110.636 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 71.4 m -75.53 32.88 0.11 Allowed 'General case' 0 C--N 1.248 -3.833 0 C-N-CA 127.189 2.195 . . . . 1.32 114.039 -175.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.571 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 86.8 m-85 41.23 -89.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.454 1.501 . . . . 0.71 115.025 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.538 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.9 t -63.15 -29.17 70.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.468 0.707 . . . . 1.36 111.05 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -96.45 -31.21 12.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.826 0.676 . . . . 1.74 112.826 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.491 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -99.29 -36.79 9.51 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.777 1.029 . . . . 1.29 113.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.755 HD11 HG22 ' A' ' 26' ' ' VAL . 16.0 mt -94.91 -39.7 10.08 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.245 -0.434 . . . . 1.11 109.998 -174.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 t70 93.33 69.53 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.579 0 C-N-CA 126.531 1.933 . . . . 1.12 108.934 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.694 HG11 ' HE1' ' A' ' 43' ' ' MET . 13.3 t -108.09 143.4 18.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 105.002 -2.222 . . . . 1.21 105.002 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.37 117.73 15.48 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.374 -0.93 . . . . 2.0 109.63 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.476 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.0 t -38.67 -47.37 1.34 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.573 1.694 . . . . 0.99 115.573 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -70.58 -26.37 63.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.368 -0.933 . . . . 1.81 111.628 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.2 m -84.94 -16.96 39.25 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.474 0.709 . . . . 0.91 110.507 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.694 ' HE1' HG11 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -56.01 -38.65 70.79 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 124.084 0.953 . . . . 1.3 111.598 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.21 -47.1 77.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 O-C-N 124.451 1.095 . . . . 1.07 109.984 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.03 -45.12 83.35 Favored 'General case' 0 C--O 1.21 -1.026 0 C-N-CA 122.873 0.469 . . . . 0.68 109.796 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 18' ' ' ILE . 44.2 t -59.01 -28.86 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.783 0.833 . . . . 1.31 110.958 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.863 HG23 HG13 ' A' ' 63' ' ' VAL . 54.0 t -78.6 -51.43 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.766 -1.198 . . . . 1.29 107.766 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -56.0 -42.42 71.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.419 -1.264 . . . . 1.1 109.447 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.419 ' HB3' HG22 ' A' ' 14' ' ' ILE . . . -63.85 -39.07 93.34 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-O 121.499 0.666 . . . . 1.0 110.454 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.28 -52.57 57.95 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.87 -1.059 . . . . 1.05 109.886 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.625 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.325 0.0 OUTLIER -62.54 -35.89 80.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.708 1.003 . . . . 0.64 113.708 -179.242 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.4 -44.03 95.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.221 0.326 . . . . 2.07 111.581 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -76.66 -44.54 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.534 0.568 . . . . 3.11 112.534 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.625 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 11.8 m-85 -89.27 -5.22 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.301 -0.56 . . . . 0.81 112.434 -172.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 83.17 10.73 0.52 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 115.389 1.625 . . . . 1.99 115.389 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.578 HG23 ' HA ' ' A' ' 76' ' ' ILE . 11.6 p -87.19 179.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.273 -1.01 . . . . 1.14 108.273 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 46.7 tptt -132.89 128.55 36.84 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 106.434 -1.691 . . . . 2.7 106.434 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.625 HG13 ' HB3' ' A' ' 51' ' ' GLU . 42.0 mt -124.11 111.57 28.66 Favored Pre-proline 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.787 . . . . 1.09 111.054 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.5 Cg_endo -73.29 162.18 41.03 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.158 2.572 . . . . 0.4 110.793 176.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.39 -41.98 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.942 0.897 . . . . 1.98 110.616 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 30.2 t70 -60.72 -37.56 82.13 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 114.685 -1.143 . . . . 2.06 111.549 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.539 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 20.4 m-20 -86.89 -28.01 23.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 113.414 0.894 . . . . 0.52 113.414 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.863 HG13 HG23 ' A' ' 47' ' ' VAL . 95.8 t -53.62 -48.72 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.767 -0.827 . . . . 1.12 108.767 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 48.3 pttt -69.73 -13.59 62.37 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.886 -1.052 . . . . 2.73 112.45 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.79 -13.08 46.18 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.405 0.621 . . . . 1.92 109.716 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.834 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.5 mt -97.52 110.37 22.95 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 106.49 -1.67 . . . . 1.04 106.49 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.7 mptp? -100.64 -44.65 5.76 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.311 -0.996 . . . . 2.98 108.311 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 20.1 p -110.25 -177.9 3.37 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.697 -0.853 . . . . 1.03 108.697 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.444 HG22 ' HG1' ' A' ' 73' ' ' THR . 0.7 OUTLIER -87.05 -13.43 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 108.344 -0.984 . . . . 1.91 108.344 176.018 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.561 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -72.33 -24.78 75.79 Favored Glycine 0 C--O 1.2 -2.014 0 N-CA-C 108.683 -1.767 . . . . 0.33 108.683 174.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 68' ' ' THR . 8.7 m-20 -82.66 -57.13 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.781 -1.21 . . . . 1.39 108.542 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.834 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -47.8 -60.32 2.66 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 114.881 -1.054 . . . . 1.04 112.155 -178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.453 ' HA ' HG21 ' A' ' 7' ' ' ILE . 44.9 m -56.79 -48.09 78.71 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.354 -1.294 . . . . 1.07 113.451 -174.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.0 mptp? -56.57 -47.08 80.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.069 0.856 . . . . 4.04 109.58 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.539 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 85.1 t80 -60.44 -51.8 67.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.081 -0.963 . . . . 0.9 111.544 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.578 ' HA ' HG23 ' A' ' 56' ' ' VAL . 69.9 mt -54.57 -65.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.584 -1.189 . . . . 1.12 110.542 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.584 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.1 tt -51.79 -46.55 64.23 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.356 1.062 . . . . 2.08 109.511 -175.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 22.2 t70 -60.99 -30.56 70.35 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.55 -1.205 . . . . 0.64 111.502 -172.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -100.13 0.0 39.77 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 113.923 1.083 . . . . 1.59 113.923 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.476 -1.867 0 N-CA-C 113.768 1.025 . . . . 1.09 113.768 176.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.427 -1.576 0 N-CA-C 109.11 -0.7 . . . . 1.34 109.11 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.66 -41.49 55.55 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.331 1.452 . . . . 0.74 114.518 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -52.51 -52.03 56.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.206 0.316 . . . . 2.66 110.581 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.03 -48.67 64.43 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 124.848 1.259 . . . . 2.73 111.184 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 73' ' ' THR . 81.4 mt -70.21 -64.13 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.275 -1.33 . . . . 1.05 110.255 -170.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.07 -40.42 76.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 N-CA-C 112.738 0.644 . . . . 1.05 112.738 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -62.12 -44.37 96.79 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.736 -0.468 . . . . 1.07 109.736 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -76.01 -38.24 35.97 Favored Glycine 0 N--CA 1.415 -2.742 0 CA-C-N 115.572 -0.74 . . . . 0.21 113.446 -175.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.62 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.49 -39.16 88.59 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.609 -0.885 . . . . 1.03 108.609 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.576 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -58.97 -47.49 84.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.207 -0.664 . . . . 1.06 109.207 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.629 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 44.6 mt-10 -54.89 -45.8 74.72 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 124.368 1.042 . . . . 0.68 111.806 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 11' ' ' LEU . 56.9 mt -59.55 -42.68 88.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.467 -0.788 . . . . 1.16 110.058 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.535 HG13 ' HB ' ' A' ' 21' ' ' ILE . 48.4 t -71.86 -22.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.409 0.623 . . . . 1.14 109.931 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.629 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 7.0 m120 -66.19 -43.19 87.53 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.039 -0.726 . . . . 0.36 109.039 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -80.42 -49.3 11.63 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.518 -0.765 . . . . 2.07 111.259 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.681 HG13 HG23 ' A' ' 46' ' ' VAL . 16.8 mm -62.35 -53.56 45.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.822 -0.626 . . . . 1.31 111.374 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -104.55 -72.64 0.7 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.509 0.671 . . . . 1.18 109.857 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.31 34.65 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.563 0 CA-C-N 114.993 -1.003 . . . . 0.43 111.973 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.603 HG22 HG23 ' A' ' 26' ' ' VAL . 1.3 mp -72.96 150.43 90.33 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 109.557 -0.534 . . . . 1.06 109.557 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.7 Cg_exo -88.89 31.23 0.4 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.732 2.954 . . . . 1.08 114.758 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 12' ' ' ALA 0.25 5.6 p 58.4 -6.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 126.984 2.114 . . . . 1.28 116.393 175.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -114.85 -6.33 12.63 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.937 -1.102 . . . . 2.31 111.064 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -83.28 -30.88 27.25 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.4 1.095 . . . . 1.59 108.917 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 36' ' ' LEU . 22.8 t -76.3 96.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 113.35 -1.75 . . . . 1.07 109.935 -176.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' O ' HG12 ' A' ' 69' ' ' VAL . 12.5 mptt -127.83 158.37 37.92 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.355 -1.35 . . . . 2.11 107.355 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.424 HD22 ' HA2' ' A' ' 70' ' ' GLY . 54.8 mt -52.83 144.83 13.64 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.9 -0.778 . . . . 1.75 108.9 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 78.67 10.55 1.76 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.938 1.295 . . . . 0.72 110.824 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.59 ' HD2' ' CG ' ' A' ' 35' ' ' ASP . 31.3 mmtp -96.91 122.63 40.1 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 108.617 -0.882 . . . . 2.01 108.617 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 30.3 m -76.29 36.18 0.15 Allowed 'General case' 0 C--N 1.252 -3.662 0 C-N-CA 125.279 1.432 . . . . 1.32 113.519 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.676 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 76.0 m-85 42.75 -94.12 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 125.673 1.589 . . . . 0.71 114.697 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 t -68.57 -24.66 64.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.081 0.467 . . . . 1.36 110.059 -174.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 11.0 t70 -81.32 -53.03 6.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.298 -0.864 . . . . 1.74 111.772 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.59 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t70 -84.22 -56.59 3.57 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 119.585 -0.846 . . . . 1.29 110.267 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.61 HD13 HG21 ' A' ' 26' ' ' VAL . 22.4 mt -65.91 -38.12 87.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.12 -1.4 . . . . 1.11 111.286 -170.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 24.2 t70 88.22 70.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 124.919 1.387 . . . . 1.12 109.186 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.408 HG11 ' HB1' ' A' ' 19' ' ' ALA . 18.4 t -102.58 170.88 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.374 -2.194 . . . . 1.21 108.741 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 42' ' ' SER . 2.2 m-20 -78.01 -3.42 41.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.094 1.146 . . . . 2.0 114.094 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' ' 43' ' ' MET . 29.0 t 65.87 -65.4 0.18 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.136 0.975 . . . . 0.99 113.053 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.506 HD11 ' H ' ' A' ' 42' ' ' SER . 0.7 OUTLIER -62.67 -36.41 82.77 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.305 0.574 . . . . 1.81 111.572 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 46' ' ' VAL . 12.6 m -78.23 -13.73 59.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.499 -0.773 . . . . 0.91 110.065 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.538 ' HB3' ' O ' ' A' ' 40' ' ' SER . 12.2 tpp -73.69 -35.61 65.19 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 116.254 -0.43 . . . . 1.3 110.127 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.8 t -55.72 -37.72 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 109.487 -0.56 . . . . 1.07 109.487 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -61.89 -47.89 82.93 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.275 -0.639 . . . . 0.68 109.275 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.681 HG23 HG13 ' A' ' 18' ' ' ILE . 61.1 t -57.73 -28.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 CA-C-N 114.834 -1.075 . . . . 1.31 111.475 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.853 HG22 HG11 ' A' ' 63' ' ' VAL . 27.6 t -71.69 -52.68 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.377 0 N-CA-C 107.764 -1.199 . . . . 1.29 107.764 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 78.5 t -61.08 -38.63 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.23 -1.35 . . . . 1.1 108.55 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.74 -38.99 90.65 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.932 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.53 -58.37 8.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.731 -1.122 . . . . 1.05 109.779 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.26 0.0 OUTLIER -59.36 -39.76 84.26 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.233 1.197 . . . . 0.64 114.233 -176.384 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 54.5 mt-10 -59.92 -35.7 75.45 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.39 0.431 . . . . 2.07 111.846 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -86.42 -30.36 22.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.116 -0.493 . . . . 3.11 110.143 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.435 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 7.0 m-85 -100.03 1.47 42.47 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.208 0.447 . . . . 0.81 112.208 -173.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.7 t70 79.5 4.1 2.17 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 124.344 1.058 . . . . 1.99 112.98 174.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.62 HG23 ' HA ' ' A' ' 76' ' ' ILE . 7.8 p -90.93 -179.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 O-C-N 121.256 -0.902 . . . . 1.14 108.703 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -135.62 128.69 31.61 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.748 -1.575 . . . . 2.7 106.748 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.488 HG13 ' HB3' ' A' ' 51' ' ' GLU . 59.5 mt -122.07 110.47 32.89 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.128 -0.629 . . . . 1.09 111.109 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.562 ' O ' HG21 ' A' ' 63' ' ' VAL . 91.1 Cg_endo -74.94 164.94 32.41 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.125 2.55 . . . . 0.4 110.961 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 20.2 t70 -51.57 -44.12 62.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 1.98 112.101 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -58.78 -40.59 84.43 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.612 0.57 . . . . 2.06 111.301 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 24.7 m-20 -81.52 -31.11 32.94 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.777 -0.769 . . . . 0.52 112.005 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.853 HG11 HG22 ' A' ' 47' ' ' VAL . 82.7 t -53.83 -50.72 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.056 -1.09 . . . . 1.12 108.056 172.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 13.8 ptmm? -73.17 -2.7 22.67 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.372 0.878 . . . . 2.73 113.372 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -105.79 -16.81 14.57 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.993 -0.442 . . . . 1.92 111.76 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 72' ' ' ALA . 44.2 mt -82.14 107.44 14.84 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 105.711 -1.959 . . . . 1.04 105.711 176.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -97.13 -39.29 9.37 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.181 -1.008 . . . . 2.98 109.744 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 27.7 p -114.97 179.64 3.89 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.46 0.648 . . . . 1.03 109.587 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.676 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -87.09 -13.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.797 -0.816 . . . . 1.91 108.797 175.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -68.12 -43.56 80.47 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 107.032 -2.427 . . . . 0.33 107.032 172.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -65.25 -56.06 14.87 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.888 -1.656 . . . . 1.39 110.895 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.81 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -49.9 -60.95 2.43 Favored 'General case' 0 CA--C 1.482 -1.665 0 O-C-N 124.304 1.002 . . . . 1.04 111.42 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.645 ' HA ' HG22 ' A' ' 7' ' ' ILE . 56.8 m -53.31 -54.59 34.26 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.589 -1.187 . . . . 1.07 113.303 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.9 mptm? -56.08 -37.5 69.42 Favored 'General case' 0 C--O 1.198 -1.658 0 C-N-CA 124.158 0.983 . . . . 4.04 110.78 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.476 ' HE2' HG12 ' A' ' 58' ' ' ILE . 90.7 t80 -66.93 -47.59 71.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.535 0.683 . . . . 0.9 109.377 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.625 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 72.7 mt -59.09 -65.87 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-N 114.2 -1.364 . . . . 1.12 109.441 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.574 HD23 HG21 ' A' ' 73' ' ' THR . 4.4 pp -53.41 -38.41 63.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 113.475 0.917 . . . . 2.08 113.475 -176.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 7.7 t70 -72.03 -25.75 61.93 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.92 -1.036 . . . . 0.64 110.777 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -102.56 -6.03 23.28 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.649 -0.705 . . . . 1.59 112.083 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 85.0 mt-30 . . . . . 0 CA--C 1.455 -2.676 0 CA-C-O 122.866 1.317 . . . . 1.09 107.933 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 7' ' ' ILE . 11.3 t . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.047 -1.464 . . . . 1.34 107.047 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -45.86 -40.27 9.69 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.749 1.018 . . . . 0.74 113.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.49 -28.19 69.12 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.489 0.493 . . . . 2.66 111.949 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -88.83 -35.91 16.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.368 -0.605 . . . . 2.73 109.368 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.67 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 93.9 mt -72.53 -66.37 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.059 0 CA-C-N 116.126 -0.488 . . . . 1.05 111.846 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.05 -40.39 76.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 122.081 0.153 . . . . 1.05 111.169 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.39 81.46 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.01 -0.541 . . . . 1.07 111.25 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.48 -39.42 8.99 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 116.232 -0.44 . . . . 0.21 112.399 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.721 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.79 -37.4 87.47 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.577 -0.897 . . . . 1.03 108.577 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.853 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -55.21 -47.13 75.73 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.748 -0.66 . . . . 1.06 109.847 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.678 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 41.1 mt-10 -60.94 -41.47 96.31 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 124.135 0.897 . . . . 0.68 111.658 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.721 HD13 ' HA ' ' A' ' 11' ' ' LEU . 71.2 mt -60.74 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.277 -0.874 . . . . 1.16 109.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.817 HG11 ' HB ' ' A' ' 21' ' ' ILE . 73.9 t -67.99 -23.76 29.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 123.872 0.869 . . . . 1.14 111.038 -176.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.678 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 8.0 m120 -71.62 -45.16 62.9 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.107 -0.952 . . . . 0.36 109.142 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -83.77 -36.73 23.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.286 -0.87 . . . . 2.07 112.945 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.602 HG13 HG22 ' A' ' 46' ' ' VAL . 28.1 mm -70.2 -53.19 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.044 -0.724 . . . . 1.31 109.044 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.599 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -103.16 -88.9 0.4 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.836 -0.62 . . . . 1.18 109.556 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.03 39.53 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 120.338 -0.934 . . . . 0.43 112.88 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.817 ' HB ' HG11 ' A' ' 15' ' ' VAL . 1.4 mp -75.12 151.83 86.11 Favored Pre-proline 0 C--O 1.205 -1.257 0 N-CA-C 109.618 -0.512 . . . . 1.06 109.618 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.2 Cg_exo -87.36 31.88 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.53 2.82 . . . . 1.08 114.771 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.287 9.8 p 60.45 -22.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 C-N-CA 127.057 2.143 . . . . 1.28 116.416 175.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -93.12 -15.16 26.34 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.281 0.562 . . . . 2.31 111.021 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.28 -26.63 30.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.385 -0.825 . . . . 1.59 111.454 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.853 HG23 ' HA ' ' A' ' 12' ' ' ALA . 43.1 t -71.84 98.41 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.133 -0.939 . . . . 1.07 108.811 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -130.12 161.92 29.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.845 -1.539 . . . . 2.11 106.845 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.477 ' HA ' HG23 ' A' ' 69' ' ' VAL . 91.1 mt -61.73 145.4 52.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.164 -0.68 . . . . 1.75 109.164 177.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 74.49 9.72 4.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.503 1.121 . . . . 0.72 110.586 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.5 mmtt -103.44 127.26 50.85 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 109.512 -0.551 . . . . 2.01 109.512 177.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 7.1 m -84.63 108.68 17.5 Favored 'General case' 1 C--N 1.239 -4.203 0 CA-C-N 114.736 -1.12 . . . . 1.32 108.34 178.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.683 ' HB2' ' SD ' ' A' ' 43' ' ' MET . 34.4 m-85 -46.51 -54.28 9.61 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 124.534 1.133 . . . . 0.71 110.207 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 12.1 t -77.61 19.82 0.35 Allowed 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 125.681 1.592 . . . . 1.36 113.771 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 15.2 t70 -158.76 -62.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.276 -0.89 . . . . 1.74 110.886 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -69.31 -40.13 77.85 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.634 -1.166 . . . . 1.29 109.849 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.633 HD11 ' HA ' ' A' ' 32' ' ' PHE . 19.0 mt -80.78 -91.23 0.06 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 114.915 -1.039 . . . . 1.11 110.907 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 31.0 t70 168.01 20.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 121.966 0.889 . . . . 1.12 109.685 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.763 HG12 ' HE2' ' A' ' 43' ' ' MET . 13.5 t -87.67 144.98 8.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.364 -0.835 . . . . 1.21 108.986 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.11 124.28 29.71 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.694 -0.684 . . . . 2.0 109.81 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' MET . 11.3 t -36.27 -46.05 0.5 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.412 1.485 . . . . 0.99 114.421 172.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.95 -30.8 70.18 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.31 -0.556 . . . . 1.81 111.689 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 m -83.76 -18.27 38.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.388 0.613 . . . . 0.91 109.782 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.763 ' HE2' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -57.4 -38.27 74.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.229 1.012 . . . . 1.3 112.134 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.1 t -51.46 -51.14 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.109 0.881 . . . . 1.07 109.723 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -53.89 -48.73 69.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.68 109.949 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.602 HG22 HG13 ' A' ' 18' ' ' ILE . 46.2 t -58.71 -31.6 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.839 1.256 . . . . 1.31 111.481 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.702 HG21 HG11 ' A' ' 63' ' ' VAL . 34.2 t -76.96 -47.24 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 N-CA-C 108.491 -0.929 . . . . 1.29 108.491 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.97 -36.3 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 114.787 -1.097 . . . . 1.1 108.462 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.32 -36.16 82.23 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.844 -0.616 . . . . 1.0 109.935 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -56.53 19.13 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.797 -1.092 . . . . 1.05 110.015 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.692 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -63.19 -33.11 74.77 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.724 -0.79 . . . . 0.64 113.069 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.98 -40.45 95.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.078 0.399 . . . . 2.07 112.078 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -84.56 -38.07 20.42 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.494 -0.482 . . . . 3.11 111.933 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.67 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.0 m-85 -97.41 20.12 12.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.053 0.76 . . . . 0.81 113.053 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.9 t70 69.5 -2.07 2.03 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 114.675 1.361 . . . . 1.99 114.675 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 51' ' ' GLU . 8.5 p -89.51 178.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 O-C-N 120.476 -1.39 . . . . 1.14 108.907 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -131.96 131.51 42.68 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 106.022 -1.844 . . . . 2.7 106.022 170.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.692 HG13 ' HB3' ' A' ' 51' ' ' GLU . 65.3 mt -120.62 114.99 32.55 Favored Pre-proline 0 C--N 1.293 -1.854 0 C-N-CA 120.532 -0.467 . . . . 1.09 110.205 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.55 ' HG2' ' HB2' ' A' ' 62' ' ' ASP . 28.9 Cg_endo -62.4 155.2 59.02 Favored 'Trans proline' 0 CA--C 1.509 -0.774 0 C-N-CA 123.124 2.549 . . . . 0.4 110.883 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -54.8 -28.82 52.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.499 0.499 . . . . 1.98 111.895 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.666 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 29.8 t70 -73.88 -39.51 63.86 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 120.384 -0.526 . . . . 2.06 111.317 176.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.55 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 11.5 m-20 -77.37 -24.4 50.63 Favored 'General case' 0 CA--C 1.482 -1.663 0 C-N-CA 119.231 -0.987 . . . . 0.52 112.644 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 47' ' ' VAL . 68.8 t -51.85 -49.85 35.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 107.958 -1.126 . . . . 1.12 107.958 171.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 5.1 ptmm? -77.76 -2.01 34.18 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.431 0.9 . . . . 2.73 113.431 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 91.7 m-20 -98.08 -16.97 19.35 Favored 'General case' 0 CA--C 1.485 -1.539 0 O-C-N 121.72 -0.612 . . . . 1.92 110.368 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.759 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.0 mt -87.32 128.72 35.18 Favored 'General case' 0 N--CA 1.391 -3.407 0 N-CA-C 103.788 -2.671 . . . . 1.04 103.788 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.85 -42.02 2.64 Favored 'General case' 0 C--N 1.268 -2.956 0 N-CA-C 108.149 -1.056 . . . . 2.98 108.149 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 61.6 p -102.7 174.97 5.65 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 1.03 108.894 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.477 HG23 ' HA ' ' A' ' 28' ' ' LEU . 1.5 m -81.64 -13.51 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 107.798 -1.186 . . . . 1.91 107.798 174.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.23 -27.16 66.62 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.193 -1.003 . . . . 0.33 110.661 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.513 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 5.9 t70 -83.64 -48.34 10.29 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.525 -0.917 . . . . 1.39 108.525 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.759 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.33 -59.98 3.62 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-N 114.028 -1.442 . . . . 1.04 111.833 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.473 ' HA ' HG23 ' A' ' 7' ' ' ILE . 60.0 m -56.91 -61.6 2.33 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.081 -0.963 . . . . 1.07 111.507 -173.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.513 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.3 OUTLIER -41.16 -46.75 3.13 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.86 2.064 . . . . 4.04 111.438 171.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.464 ' N ' ' HD2' ' A' ' 74' ' ' LYS . 88.4 t80 -63.22 -47.09 83.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.292 0.568 . . . . 0.9 110.336 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.631 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 64.0 mt -60.77 -66.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.32 -1.309 . . . . 1.12 109.259 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.472 HD11 ' N ' ' A' ' 78' ' ' ASP . 4.5 pp -58.58 -36.66 74.32 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.369 1.248 . . . . 2.08 114.369 -174.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.6 t70 -75.28 -22.63 57.62 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.952 -0.567 . . . . 0.64 111.666 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.38 -24.6 18.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.896 0.702 . . . . 1.59 112.896 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.36 0.0 OUTLIER . . . . . 0 CA--C 1.48 -1.735 0 N-CA-C 116.101 1.889 . . . . 1.09 116.101 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.702 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 15.2 t . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 109.907 -0.405 . . . . 1.34 109.907 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -52.84 -41.87 64.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.85 1.26 . . . . 0.74 113.09 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.93 -32.49 33.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.003 0.521 . . . . 2.66 112.299 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.21 -36.25 27.44 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.969 -0.56 . . . . 2.73 110.336 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.459 HG21 ' HA ' ' A' ' 73' ' ' THR . 74.9 mt -77.56 -66.49 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.218 0 CA-C-N 115.645 -0.707 . . . . 1.05 111.723 -171.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.2 t -55.91 -42.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 112.178 0.436 . . . . 1.05 112.178 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.96 89.49 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 123.713 0.633 . . . . 1.07 110.446 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.99 -39.0 13.78 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.895 -0.593 . . . . 0.21 113.08 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.716 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.21 -35.48 80.54 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.863 -1.162 . . . . 1.03 107.863 -177.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.71 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -57.02 -51.17 70.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.458 -0.571 . . . . 1.06 109.458 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.567 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 40.4 mt-10 -56.02 -44.32 78.61 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.417 1.073 . . . . 0.68 111.29 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' A' ' 11' ' ' LEU . 72.2 mt -56.96 -45.4 83.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.263 -0.881 . . . . 1.16 110.37 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 11' ' ' LEU . 58.5 t -66.78 -23.98 31.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.848 0.832 . . . . 1.14 110.138 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.567 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 2.6 m120 -75.48 -53.11 9.19 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.321 -0.992 . . . . 0.36 108.321 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 7.3 mm-40 -67.23 -39.98 86.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.964 -1.016 . . . . 2.07 111.374 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.6 mm -74.98 -53.73 15.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.667 -0.494 . . . . 1.31 109.667 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.55 -86.76 0.39 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.979 -0.555 . . . . 1.18 111.566 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.98 50.25 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.684 0 CA-C-N 115.817 -0.629 . . . . 0.43 112.302 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.794 HG22 HG21 ' A' ' 26' ' ' VAL . 1.6 mp -93.74 152.89 41.07 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 110.107 -0.331 . . . . 1.06 110.107 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 3.0 Cg_exo -84.87 30.88 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.671 2.914 . . . . 1.08 114.453 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p 54.84 2.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 115.81 1.782 . . . . 1.28 115.81 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 22' ' ' PRO . 10.0 pt-20 -127.6 0.5 6.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.063 -1.023 . . . . 2.31 111.374 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 22.6 t0 -89.33 -24.06 22.1 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.589 -1.187 . . . . 1.59 109.072 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.794 HG21 HG22 ' A' ' 21' ' ' ILE . 42.1 t -81.07 93.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.107 -1.406 . . . . 1.07 109.527 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -121.55 166.12 14.66 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.504 -0.924 . . . . 2.11 108.504 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 67.6 mt -67.31 143.26 56.51 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.138 -1.43 . . . . 1.75 107.138 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 33.1 t70 85.64 1.43 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 124.343 1.057 . . . . 0.72 110.565 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 68' ' ' THR . 45.4 mmtm -95.42 120.29 35.41 Favored 'General case' 0 CA--C 1.474 -1.972 0 O-C-N 121.502 -0.749 . . . . 2.01 109.879 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 10.4 t -83.02 35.22 0.47 Allowed 'General case' 1 C--N 1.24 -4.174 0 C-N-CA 126.483 1.913 . . . . 1.32 112.388 -171.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CZ ' HG22 ' A' ' 69' ' ' VAL . 96.6 m-85 41.64 -90.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.363 1.865 . . . . 0.71 115.293 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.4 t -62.73 -27.69 69.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.281 0.633 . . . . 1.36 111.398 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 11.3 t70 -87.16 -56.35 3.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.524 -0.307 . . . . 1.74 110.564 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.08 -38.29 27.56 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 113.466 0.913 . . . . 1.29 113.466 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 25.3 mt -82.62 -76.24 0.28 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.482 -0.487 . . . . 1.11 112.117 -171.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 170.9 -20.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 122.961 0.504 . . . . 1.12 110.349 -174.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 t -47.84 139.96 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.362 1.065 . . . . 1.21 111.978 -174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -81.27 126.17 31.22 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.895 -1.15 . . . . 2.0 107.895 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 t -42.53 -35.63 1.12 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 114.452 1.279 . . . . 0.99 114.452 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.417 HD11 ' N ' ' A' ' 42' ' ' SER . 3.6 pp -73.18 -33.28 65.34 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 119.067 -1.053 . . . . 1.81 111.976 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 46' ' ' VAL . 19.8 m -84.66 -13.36 51.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.965 0.888 . . . . 0.91 109.674 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.676 ' HA ' ' HE2' ' A' ' 43' ' ' MET . 3.6 tpt -61.9 -38.42 88.3 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 125.707 1.603 . . . . 1.3 110.568 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.65 -27.16 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.023 -0.535 . . . . 1.07 110.553 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.6 -45.59 68.21 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.384 -0.969 . . . . 0.68 108.384 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 42' ' ' SER . 41.8 t -58.07 -25.69 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.486 -1.233 . . . . 1.31 110.819 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.729 HG11 HG22 ' A' ' 63' ' ' VAL . 29.6 t -81.03 -54.3 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 N-CA-C 108.968 -0.753 . . . . 1.29 108.968 -176.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.14 -33.38 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.214 -0.903 . . . . 1.1 109.33 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.62 70.89 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.268 0.556 . . . . 1.0 109.991 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.49 -56.17 20.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.18 -0.918 . . . . 1.05 109.717 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -67.87 -31.11 70.69 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.127 1.158 . . . . 0.64 114.127 -176.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -60.53 -34.45 74.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.824 0.345 . . . . 2.07 110.306 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -86.83 -46.0 10.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.324 -0.398 . . . . 3.11 111.993 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' HZ ' ' N ' ' A' ' 11' ' ' LEU . 8.5 m-85 -84.67 -2.27 57.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.997 1.11 . . . . 0.81 113.997 -169.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.3 t70 80.76 -0.07 1.84 Allowed 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 124.401 1.08 . . . . 1.99 112.406 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 76' ' ' ILE . 12.9 p -81.56 176.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.41 -1.33 . . . . 1.14 107.41 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 33.7 tptt -134.02 123.94 25.4 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.836 -1.172 . . . . 2.7 107.836 173.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.56 HG12 ' HE2' ' A' ' 75' ' ' TYR . 41.3 mt -120.13 102.76 45.85 Favored Pre-proline 0 C--N 1.312 -1.026 0 C-N-CA 120.92 -0.312 . . . . 1.09 110.34 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.569 ' O ' HG21 ' A' ' 63' ' ' VAL . 64.4 Cg_endo -70.08 158.69 55.74 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 123.056 2.504 . . . . 0.4 110.44 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 9.8 t70 -46.24 -42.49 14.4 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.049 0.94 . . . . 1.98 110.525 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -53.85 -44.69 70.55 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 125.155 1.382 . . . . 2.06 112.716 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -86.68 -29.95 22.08 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.522 -0.471 . . . . 0.52 111.617 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.729 HG22 HG11 ' A' ' 47' ' ' VAL . 79.5 t -50.94 -51.42 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.886 -0.783 . . . . 1.12 108.886 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 21.3 ptmt -69.65 -4.18 18.33 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 114.152 1.167 . . . . 2.73 114.152 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.83 -23.8 14.87 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.696 0.76 . . . . 1.92 109.112 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.882 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.0 mt -82.46 133.83 35.21 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 105.965 -1.865 . . . . 1.04 105.965 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.494 ' HG2' HG21 ' A' ' 68' ' ' THR . 0.2 OUTLIER -126.11 -38.1 2.19 Favored 'General case' 0 C--N 1.259 -3.335 0 C-N-CA 119.919 -0.712 . . . . 2.98 109.995 174.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 26.9 p -107.46 -179.32 3.88 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 119.568 -0.853 . . . . 1.03 110.385 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.592 HG22 ' CZ ' ' A' ' 32' ' ' PHE . 13.0 t -83.12 -19.53 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 106.793 -1.558 . . . . 1.91 106.793 177.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.524 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -68.5 -47.2 58.55 Favored Glycine 0 CA--C 1.489 -1.545 0 N-CA-C 107.791 -2.124 . . . . 0.33 107.791 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.19 -55.85 29.63 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.638 -1.281 . . . . 1.39 110.471 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.882 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -53.69 -60.92 2.7 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.562 1.164 . . . . 1.04 111.732 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.459 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.2 m -58.77 -41.97 87.83 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 113.663 0.986 . . . . 1.07 113.663 -174.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.524 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 1.9 mptm? -61.28 -48.52 81.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 108.678 -0.86 . . . . 4.04 108.678 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.56 ' HE2' HG12 ' A' ' 58' ' ' ILE . 86.8 t80 -57.81 -51.53 69.21 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 124.536 1.148 . . . . 0.9 110.74 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.709 ' HA ' HG23 ' A' ' 56' ' ' VAL . 72.5 mt -54.94 -66.75 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.718 0 CA-C-N 114.545 -1.207 . . . . 1.12 111.019 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.702 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.8 tt -52.17 -45.36 65.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.574 1.55 . . . . 2.08 109.359 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 28.1 t70 -71.15 -24.74 62.32 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.165 -1.38 . . . . 0.64 111.501 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -103.7 -9.0 19.47 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 113.759 1.022 . . . . 1.59 113.759 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 92.3 mt-30 . . . . . 0 CA--C 1.449 -2.925 0 CA-C-O 122.909 1.338 . . . . 1.09 108.841 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.499 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.8 t . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 109.556 -0.535 . . . . 1.34 109.556 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.594 ' HG2' HG23 ' A' ' 73' ' ' THR . 1.0 OUTLIER -54.54 -35.84 63.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.41 1.484 . . . . 0.74 111.67 179.014 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -52.79 -47.99 67.17 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 124.12 0.887 . . . . 2.66 110.395 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.52 -30.73 64.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.804 -0.634 . . . . 2.73 110.347 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.608 HG21 ' CE2' ' A' ' 54' ' ' PHE . 97.9 mt -76.61 -66.56 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 CA-C-N 116.086 -0.506 . . . . 1.05 111.307 -172.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.52 HG23 HD12 ' A' ' 28' ' ' LEU . 91.1 t -58.36 -36.07 56.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.714 0.635 . . . . 1.05 112.714 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -66.03 -37.55 86.17 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.549 -0.46 . . . . 1.07 111.0 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.413 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.18 -36.95 11.76 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 111.842 -0.503 . . . . 0.21 111.842 -176.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.745 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.82 -40.68 95.59 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.611 -0.885 . . . . 1.03 108.611 -178.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.745 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -56.21 -47.57 78.13 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.556 -0.747 . . . . 1.06 109.691 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.509 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.1 mt-10 -60.74 -39.68 89.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 123.99 0.806 . . . . 0.68 112.548 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.745 HD11 ' HA ' ' A' ' 11' ' ' LEU . 63.4 mt -59.97 -44.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.688 0.756 . . . . 1.16 109.0 176.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.7 HG12 ' HB ' ' A' ' 21' ' ' ILE . 64.7 t -67.78 -25.87 33.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.019 -0.991 . . . . 1.14 110.788 -175.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 5.6 m120 -70.5 -38.6 74.35 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.396 -0.82 . . . . 0.36 109.311 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.23 -43.62 15.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.6 -0.727 . . . . 2.07 111.58 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.656 HG13 HG23 ' A' ' 46' ' ' VAL . 17.3 mm -62.12 -52.71 57.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.988 0.515 . . . . 1.31 110.885 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -109.84 -85.56 0.54 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.435 -0.506 . . . . 1.18 110.858 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.84 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 110.931 -0.868 . . . . 0.43 110.931 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.7 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.6 mp -87.2 149.82 48.09 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 109.405 -0.591 . . . . 1.06 109.405 178.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 5.0 Cg_exo -88.25 37.87 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.757 2.971 . . . . 1.08 113.723 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.259 3.7 p 57.74 -14.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 117.006 2.225 . . . . 1.28 117.006 176.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.09 2.9 12.71 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 120.641 -1.287 . . . . 2.31 110.708 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.545 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 7.3 t70 -78.78 -31.72 46.19 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.119 -1.067 . . . . 1.59 108.119 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' A' ' 12' ' ' ALA . 24.8 t -74.46 92.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 113.129 -1.851 . . . . 1.07 110.498 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' O ' HG13 ' A' ' 69' ' ' VAL . 95.6 mttt -118.03 163.37 16.7 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.043 0.449 . . . . 2.11 110.152 177.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.52 HD12 HG23 ' A' ' 8' ' ' VAL . 5.6 mp -70.98 136.24 48.32 Favored 'General case' 0 N--CA 1.406 -2.675 0 N-CA-C 108.822 -0.807 . . . . 1.75 108.822 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.4 t70 84.62 9.89 0.4 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.297 1.439 . . . . 0.72 109.701 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -102.08 128.4 48.56 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 115.648 -0.705 . . . . 2.01 109.22 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.4 m -79.92 114.12 18.6 Favored 'General case' 0 C--N 1.244 -3.987 0 CA-C-N 114.779 -1.101 . . . . 1.32 108.491 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.62 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 94.1 m-85 -45.41 -64.53 0.7 Allowed 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 124.253 1.021 . . . . 0.71 112.057 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.1 t -59.01 -46.02 89.24 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 113.131 0.789 . . . . 1.36 113.131 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -86.55 -55.91 3.66 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.57 0.581 . . . . 1.74 112.57 -172.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.62 -49.14 15.19 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.659 0.783 . . . . 1.29 111.628 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 HG21 ' A' ' 26' ' ' VAL . 14.0 mt -77.32 -51.41 10.92 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.754 -0.657 . . . . 1.11 111.539 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 101.99 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.219 2.208 . . . . 1.12 111.275 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' THR . 22.0 t -110.09 118.84 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.607 -1.627 . . . . 1.21 106.607 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.15 113.52 0.82 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.228 0.955 . . . . 2.0 109.741 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.3 p -49.7 -21.45 1.06 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.279 1.431 . . . . 0.99 114.359 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 42' ' ' SER . 3.3 pp -81.84 -36.89 27.79 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.887 0.699 . . . . 1.81 112.887 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.443 ' N ' HD12 ' A' ' 41' ' ' LEU . 3.3 m -81.71 -13.39 57.89 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.461 1.124 . . . . 0.91 108.546 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.655 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 3.7 tpt -55.49 -36.72 66.96 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 126.804 2.042 . . . . 1.3 111.061 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.74 -45.91 96.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 115.809 -0.632 . . . . 1.07 109.776 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -57.39 -41.37 80.12 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 115.906 -0.588 . . . . 0.68 109.903 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.656 HG23 HG13 ' A' ' 18' ' ' ILE . 40.1 t -59.53 -28.8 40.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-N 115.496 -0.774 . . . . 1.31 111.16 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.76 HG22 HG13 ' A' ' 63' ' ' VAL . 20.8 t -78.98 -54.94 10.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.151 -1.055 . . . . 1.29 108.151 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.4 -19.65 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.85 -1.523 . . . . 1.1 110.904 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.84 -38.91 16.36 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 121.226 0.536 . . . . 1.0 109.633 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . . . -61.17 -64.19 1.04 Allowed 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.99 -1.005 . . . . 1.05 111.567 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.341 0.0 OUTLIER -59.43 -44.12 92.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 114.882 1.438 . . . . 0.64 114.882 -173.822 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -54.12 -39.2 66.22 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.206 1.003 . . . . 2.07 112.244 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.914 -0.585 . . . . 3.11 110.781 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 7' ' ' ILE . 8.2 m-85 -86.66 -44.89 11.49 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.467 -0.893 . . . . 0.81 111.839 -173.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 22.9 t70 155.14 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.751 1.282 . . . . 1.99 112.682 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 76' ' ' ILE . 3.8 p -79.96 178.37 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 112.072 0.397 . . . . 1.14 112.072 -168.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.31 125.56 29.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.355 -1.35 . . . . 2.7 107.355 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.602 HG12 ' HE2' ' A' ' 75' ' ' TYR . 64.8 mt -113.36 118.9 43.05 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.348 -0.387 . . . . 1.09 110.683 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.6 Cg_endo -66.78 154.18 75.39 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.482 2.788 . . . . 0.4 110.588 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -51.66 -37.42 50.41 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.591 0.557 . . . . 1.98 111.673 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -59.56 -44.43 93.26 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.202 -0.454 . . . . 2.06 110.682 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 21.7 m-20 -82.68 -28.89 30.3 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 112.662 0.615 . . . . 0.52 112.662 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.76 HG13 HG22 ' A' ' 47' ' ' VAL . 53.0 t -52.01 -53.45 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 108.183 -1.043 . . . . 1.12 108.183 174.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -74.98 -1.91 24.77 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.975 -1.011 . . . . 2.73 113.549 -177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.92 -33.56 14.84 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.576 -0.898 . . . . 1.92 108.576 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 72' ' ' ALA . 32.5 mt -69.25 133.34 47.8 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 106.267 -1.753 . . . . 1.04 106.267 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -128.39 -32.29 2.22 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-O 121.252 0.548 . . . . 2.98 110.126 175.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 28.5 p -112.07 172.81 6.69 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.683 -0.858 . . . . 1.03 108.683 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -80.4 -12.93 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.782 0.801 . . . . 1.91 109.478 175.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.74 -37.92 76.6 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.368 -1.493 . . . . 0.33 109.368 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.565 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 24.3 m-20 -69.44 -54.33 14.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 108.772 -0.825 . . . . 1.39 108.772 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.844 ' HA ' HD12 ' A' ' 66' ' ' LEU . . . -51.19 -60.67 2.86 Favored 'General case' 0 CA--C 1.469 -2.168 0 O-C-N 124.676 1.235 . . . . 1.04 111.043 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.594 HG23 ' HG2' ' A' ' 4' ' ' GLN . 35.9 m -54.97 -49.28 71.83 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.459 1.099 . . . . 1.07 113.585 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.7 mptm? -67.17 -28.64 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.222 0.534 . . . . 4.04 111.051 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.602 ' HE2' HG12 ' A' ' 58' ' ' ILE . 84.9 t80 -71.52 -51.9 21.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.966 -0.753 . . . . 0.9 108.966 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.663 ' HA ' HG11 ' A' ' 56' ' ' VAL . 60.3 mt -57.41 -66.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.521 -1.218 . . . . 1.12 111.134 -177.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 4.5 tt -50.19 -50.34 49.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.211 1.404 . . . . 2.08 110.972 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.9 t70 -69.5 -25.72 64.19 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.995 -1.457 . . . . 0.64 111.417 -170.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -91.26 -22.67 20.46 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.674 -0.694 . . . . 1.59 111.682 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.415 HE21 HG21 ' A' ' 76' ' ' ILE . 2.4 pt20 . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 122.482 1.134 . . . . 1.09 113.385 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.428 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 12.3 t . . . . . 0 N--CA 1.435 -1.18 0 N-CA-C 108.996 -0.742 . . . . 1.34 108.996 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -40.19 60.56 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.593 1.157 . . . . 0.74 113.202 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.54 -23.73 64.83 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.865 0.691 . . . . 2.66 112.865 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.52 -39.9 21.76 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.018 -0.734 . . . . 2.73 109.018 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.435 HG23 ' HA ' ' A' ' 73' ' ' THR . 76.3 mt -76.66 -66.48 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 CA-C-N 114.719 -1.128 . . . . 1.05 111.692 -170.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -56.72 -42.41 77.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.376 0.51 . . . . 1.05 112.376 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.82 72.84 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.589 0.556 . . . . 1.07 111.362 176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.91 -40.09 8.3 Favored Glycine 0 N--CA 1.405 -3.418 0 C-N-CA 120.596 -0.811 . . . . 0.21 113.059 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.701 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -63.12 -41.04 99.25 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.613 0.765 . . . . 1.03 109.079 -177.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.588 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.09 -48.17 67.99 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 123.747 0.654 . . . . 1.06 109.588 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.663 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 48.3 mt-10 -62.36 -42.34 99.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 124.266 0.979 . . . . 0.68 112.05 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.701 HD13 ' HA ' ' A' ' 11' ' ' LEU . 54.7 mt -59.49 -39.43 79.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.332 0.587 . . . . 1.16 110.179 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 11' ' ' LEU . 46.4 t -69.48 -23.52 26.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 CA-C-O 122.082 0.944 . . . . 1.14 109.722 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.663 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -77.98 -37.78 46.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.25 -1.018 . . . . 0.36 108.25 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 20.7 mm-40 -74.23 -55.52 5.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.853 -1.067 . . . . 2.07 111.296 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.599 HG13 HG22 ' A' ' 46' ' ' VAL . 21.3 mm -63.87 -53.1 48.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.448 -0.796 . . . . 1.31 110.811 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB1' HG12 ' A' ' 38' ' ' VAL . . . -103.12 -83.1 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.438 -0.505 . . . . 1.18 110.436 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.03 44.93 0.02 OUTLIER Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 120.061 -1.066 . . . . 0.43 112.199 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.59 HG21 HG22 ' A' ' 26' ' ' VAL . 1.6 mp -78.05 149.79 77.03 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 110.05 -0.352 . . . . 1.06 110.05 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.523 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 8.9 Cg_exo -82.86 24.54 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 124.526 3.484 . . . . 1.08 115.429 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.9 p 52.55 22.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 125.55 1.54 . . . . 1.28 114.909 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -130.16 -13.14 4.02 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 120.909 -1.119 . . . . 2.31 111.399 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.523 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -93.38 -26.25 17.34 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 115.324 -0.853 . . . . 1.59 110.251 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.59 HG22 HG21 ' A' ' 21' ' ' ILE . 39.5 t -71.24 91.23 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.201 -0.908 . . . . 1.07 109.357 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.463 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 34.4 mmtp -130.74 169.98 14.96 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.294 -1.373 . . . . 2.11 107.294 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.416 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 8.3 mp -64.74 148.38 51.25 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.819 -0.808 . . . . 1.75 108.819 177.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 t70 81.76 -3.52 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.766 1.226 . . . . 0.72 110.766 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.726 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 10.4 mmpt? -98.13 124.05 42.48 Favored 'General case' 0 CA--C 1.454 -2.744 0 C-N-CA 119.713 -0.795 . . . . 2.01 110.856 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 19.2 m -79.78 115.5 19.41 Favored 'General case' 1 C--N 1.237 -4.316 0 N-CA-C 108.02 -1.104 . . . . 1.32 108.02 178.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.816 ' HA ' HD11 ' A' ' 36' ' ' LEU . 83.3 m-85 -51.78 -49.35 62.84 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.566 0.698 . . . . 0.71 112.228 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.4 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.0 t -81.36 -44.46 17.56 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.291 -0.88 . . . . 1.36 111.305 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 25.0 t70 -74.15 -50.92 17.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.032 0.753 . . . . 1.74 113.032 -175.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.421 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 12.7 t70 -83.78 -58.03 2.97 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 122.049 0.928 . . . . 1.29 109.393 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.816 HD11 ' HA ' ' A' ' 32' ' ' PHE . 25.4 mt -72.88 -32.65 65.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.48 -1.691 . . . . 1.11 112.363 -169.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 20.1 t70 83.1 66.48 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 123.193 1.473 . . . . 1.12 110.803 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.615 HG12 ' HB1' ' A' ' 19' ' ' ALA . 49.4 t -105.62 141.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 112.767 -2.015 . . . . 1.21 107.94 170.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.44 ' HB2' ' OG ' ' A' ' 42' ' ' SER . 4.8 m-20 -56.08 7.93 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 116.618 2.081 . . . . 2.0 116.618 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.435 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.5 t 66.6 -57.44 0.39 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 114.383 1.253 . . . . 0.99 114.383 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 pp -63.31 -30.72 71.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.949 0.88 . . . . 1.81 109.749 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.542 ' O ' HG21 ' A' ' 46' ' ' VAL . 1.5 m -77.94 -15.55 58.89 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.751 -1.113 . . . . 0.91 110.506 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.606 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -67.08 -40.62 87.04 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-N 116.306 -0.407 . . . . 1.3 111.967 -174.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.19 -40.84 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 124.246 0.966 . . . . 1.07 109.767 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.88 -48.02 83.72 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.578 -0.737 . . . . 0.68 109.526 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.599 HG22 HG13 ' A' ' 18' ' ' ILE . 11.9 t -60.78 -23.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.988 0.915 . . . . 1.31 110.918 -177.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.891 HG22 HG12 ' A' ' 63' ' ' VAL . 36.8 t -78.99 -54.74 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 107.885 -1.154 . . . . 1.29 107.885 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -60.65 -37.06 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.882 -1.054 . . . . 1.1 108.89 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.501 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -70.01 -31.51 69.21 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.061 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.67 -58.16 6.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.363 -0.835 . . . . 1.05 109.266 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.619 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.269 0.0 OUTLIER -66.42 -31.83 72.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 114.914 1.45 . . . . 0.64 114.914 -175.59 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -59.24 -33.32 70.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.908 0.861 . . . . 2.07 109.881 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -88.59 -32.33 18.17 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.11 -0.95 . . . . 3.11 111.968 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.23 18.42 21.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.397 0.518 . . . . 0.81 112.397 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 75.37 -26.02 0.2 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 114.438 1.273 . . . . 1.99 114.438 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.619 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 7.2 p -72.26 170.81 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 122.324 -0.235 . . . . 1.14 110.379 -173.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.615 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 2.8 tppp? -124.13 126.67 46.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.31 -0.996 . . . . 2.7 108.31 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.614 HG12 ' HE2' ' A' ' 75' ' ' TYR . 36.0 mt -119.99 105.02 43.26 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 120.592 -0.443 . . . . 1.09 110.457 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.55 ' O ' HG22 ' A' ' 63' ' ' VAL . 79.9 Cg_endo -73.8 166.6 29.31 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.106 2.537 . . . . 0.4 111.004 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.33 -46.97 37.16 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 1.98 111.487 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.16 -35.44 77.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.876 -0.602 . . . . 2.06 112.02 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.55 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 10.9 m-20 -86.03 -31.63 21.9 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.275 -0.57 . . . . 0.52 111.222 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.891 HG12 HG22 ' A' ' 47' ' ' VAL . 75.1 t -52.84 -50.52 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.843 -0.799 . . . . 1.12 108.843 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -72.41 -9.15 58.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.199 -0.909 . . . . 2.73 113.195 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.42 -25.91 21.28 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.478 0.656 . . . . 1.92 110.071 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.858 HD12 ' HA ' ' A' ' 72' ' ' ALA . 19.7 mt -82.18 110.92 17.82 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.077 -1.823 . . . . 1.04 106.077 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -112.25 -43.88 3.48 Favored 'General case' 0 C--N 1.271 -2.834 0 N-CA-C 107.718 -1.216 . . . . 2.98 107.718 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 67.4 p -102.54 174.73 5.77 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 114.917 -1.038 . . . . 1.03 109.039 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.474 HG21 ' CE2' ' A' ' 32' ' ' PHE . 10.1 t -77.3 -14.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 107.781 -1.192 . . . . 1.91 107.781 175.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.416 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -69.01 -51.09 30.41 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 109.39 -1.484 . . . . 0.33 109.39 175.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -60.38 -51.24 70.32 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 114.269 -0.966 . . . . 1.39 109.371 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.858 ' HA ' HD12 ' A' ' 66' ' ' LEU . . . -54.29 -61.57 2.22 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 124.494 1.122 . . . . 1.04 111.528 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.435 ' HA ' HG23 ' A' ' 7' ' ' ILE . 34.3 m -58.1 -45.83 86.56 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.437 -1.256 . . . . 1.07 113.861 -174.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.2 mptm? -57.64 -50.8 71.98 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 123.851 0.72 . . . . 4.04 109.194 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.614 ' HE2' HG12 ' A' ' 58' ' ' ILE . 49.4 t80 -54.55 -51.22 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.124 0.89 . . . . 0.9 111.283 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.676 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.1 mt -55.09 -66.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.66 0 CA-C-N 114.671 -1.149 . . . . 1.12 110.611 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.428 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 4.2 tt -52.54 -43.66 65.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.796 1.638 . . . . 2.08 110.678 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 7.0 t70 -71.07 -26.3 63.01 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.218 -1.355 . . . . 0.64 110.96 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -103.24 -7.73 20.93 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.389 0.885 . . . . 1.59 113.389 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.676 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 84.0 mt-30 . . . . . 0 CA--C 1.448 -2.967 0 CA-C-O 122.974 1.369 . . . . 1.09 107.623 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.429 -1.514 0 N-CA-C 109.309 -0.626 . . . . 1.34 109.309 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.9 OUTLIER -48.39 -36.91 15.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.016 1.327 . . . . 0.74 112.973 178.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -52.19 -54.49 30.23 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.787 0.68 . . . . 2.66 110.512 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.16 -37.07 71.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.728 0.811 . . . . 2.73 110.092 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.537 HG23 ' HA ' ' A' ' 73' ' ' THR . 82.3 mt -74.37 -66.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 115.099 -0.955 . . . . 1.05 111.149 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.26 -46.71 92.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 112.347 0.499 . . . . 1.05 112.347 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.654 -0.419 . . . . 1.07 110.808 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.55 -38.22 9.93 Favored Glycine 0 N--CA 1.415 -2.756 0 CA-C-N 116.099 -0.501 . . . . 0.21 113.362 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.672 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.47 -38.61 91.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.033 -1.099 . . . . 1.03 108.033 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.665 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -56.96 -44.73 82.89 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.812 -0.631 . . . . 1.06 109.966 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.652 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 42.8 mt-10 -64.09 -35.24 80.12 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.872 0.732 . . . . 0.68 111.843 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 11' ' ' LEU . 51.7 mt -67.54 -43.2 87.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.85 -0.614 . . . . 1.16 109.589 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 11' ' ' LEU . 21.3 t -67.72 -24.65 31.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 121.885 0.85 . . . . 1.14 109.221 -177.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.652 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 13.7 m120 -64.58 -43.29 94.31 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 114.776 -1.102 . . . . 0.36 109.26 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -80.44 -49.15 11.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.189 -0.914 . . . . 2.07 111.591 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.684 HG13 HG22 ' A' ' 46' ' ' VAL . 22.1 mm -61.2 -53.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.057 -0.52 . . . . 1.31 111.283 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.8 -76.59 0.6 Allowed 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.226 -0.59 . . . . 1.18 110.384 -176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.84 50.33 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 110.146 -1.182 . . . . 0.43 110.146 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.448 ' HB ' HG13 ' A' ' 15' ' ' VAL . 1.2 mp -88.46 159.77 46.4 Favored Pre-proline 0 C--N 1.278 -2.508 0 CA-C-N 114.395 -0.902 . . . . 1.06 108.577 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -92.53 141.13 2.14 Favored 'Trans proline' 0 N--CA 1.414 -3.154 0 C-N-CA 122.108 1.872 . . . . 1.08 108.954 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.446 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.5 p -73.41 54.2 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-O 122.779 1.276 . . . . 1.28 113.111 -173.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -163.74 -9.39 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.109 -1.405 . . . . 2.31 111.087 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -83.71 -28.45 28.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.763 0.792 . . . . 1.59 109.394 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.665 HG22 ' HA ' ' A' ' 12' ' ' ALA . 43.3 t -77.46 92.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.525 -1.216 . . . . 1.07 109.304 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.6 mttt -121.14 172.81 7.7 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.895 -1.15 . . . . 2.11 107.895 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -65.81 145.48 55.91 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.822 -1.177 . . . . 1.75 107.822 176.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 77.0 8.7 2.88 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.246 0.966 . . . . 0.72 110.804 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.1 mmtt -92.3 119.78 32.21 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 108.387 -0.968 . . . . 2.01 108.387 174.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 17.4 m -78.58 36.69 0.26 Allowed 'General case' 1 C--N 1.243 -4.058 0 C-N-CA 125.688 1.595 . . . . 1.32 113.515 -172.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.646 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 97.4 m-85 39.96 -95.78 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 125.328 1.451 . . . . 0.71 114.622 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.411 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 15.0 t -84.72 37.57 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.546 1.165 . . . . 1.36 111.342 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 32' ' ' PHE . 32.5 t70 -145.41 -48.5 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.23 -1.35 . . . . 1.74 107.76 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 3.2 m-20 -87.35 -38.05 16.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 1.29 112.914 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 26' ' ' VAL . 59.7 mt -85.35 -48.84 8.66 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.186 0.81 . . . . 1.11 113.186 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.0 t70 102.59 69.48 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.323 1.849 . . . . 1.12 109.696 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.547 HG13 ' H ' ' A' ' 39' ' ' ASP . 11.5 t -105.14 175.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 113.803 -1.544 . . . . 1.21 109.733 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.547 ' H ' HG13 ' A' ' 38' ' ' VAL . 17.2 t70 -79.04 -18.29 53.78 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.261 0.837 . . . . 2.0 113.261 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 43' ' ' MET . 3.3 t 74.5 -41.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.686 1.194 . . . . 0.99 113.154 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.45 -49.59 10.44 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 106.879 -1.526 . . . . 1.81 106.879 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 19.5 m -67.08 -11.96 58.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.045 -1.434 . . . . 0.91 111.023 176.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.646 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 4.0 tpt -60.23 -33.3 72.07 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 125.073 1.349 . . . . 1.3 109.324 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.74 -40.02 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.602 -0.726 . . . . 1.07 109.53 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.23 -43.18 82.64 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.374 -0.375 . . . . 0.68 110.53 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.684 HG22 HG13 ' A' ' 18' ' ' ILE . 6.5 t -60.97 -24.43 32.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 C-N-CA 123.526 0.73 . . . . 1.31 110.845 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.696 HG23 HG11 ' A' ' 63' ' ' VAL . 22.0 t -80.4 -53.77 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 107.78 -1.193 . . . . 1.29 107.78 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.65 -32.91 52.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 113.895 -1.502 . . . . 1.1 110.03 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB3' HG23 ' A' ' 14' ' ' ILE . . . -77.67 -31.31 52.46 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.207 0.527 . . . . 1.0 109.73 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.58 -57.09 12.35 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.398 -0.819 . . . . 1.05 109.131 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.527 ' OE2' ' HD3' ' A' ' 57' ' ' LYS 0.279 0.0 OUTLIER -61.88 -38.67 89.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 114.161 1.171 . . . . 0.64 114.161 -176.274 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.19 -34.47 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.527 0.517 . . . . 2.07 112.128 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -82.88 -36.08 25.66 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.064 -0.516 . . . . 3.11 110.205 -175.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.508 ' CE2' HG21 ' A' ' 7' ' ' ILE . 7.1 m-85 -86.85 -45.08 11.2 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.2 -1.0 . . . . 0.81 112.435 -172.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 152.29 -35.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 O-C-N 124.891 1.37 . . . . 1.99 112.169 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.595 ' CG1' HG23 ' A' ' 76' ' ' ILE . 14.5 p -75.92 172.37 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 112.726 0.639 . . . . 1.14 112.726 -165.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.527 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 3.1 tppp? -125.04 119.71 29.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.368 -1.715 . . . . 2.7 106.368 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.548 HG12 ' HE2' ' A' ' 75' ' ' TYR . 58.5 mt -111.85 113.22 52.74 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 120.693 -0.403 . . . . 1.09 110.226 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.548 ' O ' HG21 ' A' ' 63' ' ' VAL . 93.8 Cg_endo -73.15 157.62 50.25 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.822 2.348 . . . . 0.4 110.668 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.16 -41.17 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.523 1.129 . . . . 1.98 111.617 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 2.3 m-20 -61.81 -51.02 69.96 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 115.573 -0.74 . . . . 2.06 111.247 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 m-20 -71.46 -30.32 65.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.971 0.36 . . . . 0.52 111.971 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.696 HG11 HG23 ' A' ' 47' ' ' VAL . 53.0 t -51.43 -55.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.941 -0.763 . . . . 1.12 108.941 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.5 pttp -75.64 -1.92 26.9 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 115.401 -0.818 . . . . 2.73 112.674 -175.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.38 -19.57 22.76 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.656 0.741 . . . . 1.92 109.383 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.867 HD11 ' HA ' ' A' ' 72' ' ' ALA . 33.2 mt -86.11 118.33 25.51 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 104.728 -2.323 . . . . 1.04 104.728 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -110.95 -46.69 3.3 Favored 'General case' 0 C--N 1.259 -3.341 0 N-CA-C 108.289 -1.004 . . . . 2.98 108.289 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 42.5 p -105.07 173.57 6.25 Favored 'General case' 1 N--CA 1.379 -4.004 0 CA-C-N 115.052 -0.977 . . . . 1.03 109.321 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 27' ' ' LYS . 5.5 t -77.49 -13.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 107.454 -1.313 . . . . 1.91 107.454 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.543 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.46 -45.69 58.97 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.201 -1.56 . . . . 0.33 109.201 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -68.17 -48.21 65.9 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.122 -1.039 . . . . 1.39 109.59 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.867 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -53.62 -61.13 2.5 Favored 'General case' 0 CA--C 1.482 -1.655 0 O-C-N 124.56 1.162 . . . . 1.04 111.124 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.537 ' HA ' HG23 ' A' ' 7' ' ' ILE . 58.5 m -54.89 -51.54 65.66 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.615 -1.175 . . . . 1.07 113.838 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.1 mptm? -54.75 -47.85 73.33 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.867 0.729 . . . . 4.04 109.456 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.548 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.0 t80 -58.19 -52.55 65.11 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 124.204 0.94 . . . . 0.9 111.412 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.595 HG23 ' CG1' ' A' ' 56' ' ' VAL . 75.8 mt -51.41 -65.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.789 -1.096 . . . . 1.12 110.298 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 tt -54.52 -42.21 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.077 1.351 . . . . 2.08 109.855 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 26.6 t70 -59.62 -41.04 89.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.163 0.985 . . . . 0.64 110.285 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.58 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 1.9 t-80 -90.07 -12.4 38.58 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.141 -1.39 . . . . 1.59 111.222 -173.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 34.0 mt-30 . . . . . 0 CA--C 1.471 -2.075 0 CA-C-O 122.722 1.248 . . . . 1.09 108.351 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.552 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 t . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 109.908 -0.405 . . . . 1.34 109.908 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.405 ' HG2' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -50.26 -41.9 51.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.855 1.662 . . . . 0.74 113.534 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -62.42 -23.69 66.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.78 0.659 . . . . 2.66 112.78 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -87.56 -35.7 17.97 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.108 -0.701 . . . . 2.73 109.108 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 73' ' ' THR . 92.9 mt -75.73 -65.48 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-N 115.523 -0.762 . . . . 1.05 110.996 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG22 ' HG2' ' A' ' 4' ' ' GLN . 67.6 t -52.16 -45.04 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 122.869 0.468 . . . . 1.05 111.523 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.1 76.64 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 123.64 0.588 . . . . 1.07 111.604 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.58 9.94 Favored Glycine 0 N--CA 1.412 -2.949 0 CA-C-N 116.419 -0.355 . . . . 0.21 112.493 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.735 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.61 -36.55 82.86 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.243 -1.021 . . . . 1.03 108.243 -178.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.691 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -58.68 -44.41 90.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.482 -0.781 . . . . 1.06 110.022 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.668 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 47.0 mt-10 -62.39 -38.6 90.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 123.935 0.772 . . . . 0.68 111.746 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.735 HD11 ' HA ' ' A' ' 11' ' ' LEU . 61.1 mt -61.53 -42.33 93.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.749 0.785 . . . . 1.16 109.161 176.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.781 HG11 ' HB ' ' A' ' 21' ' ' ILE . 86.4 t -71.16 -23.72 23.56 Favored 'Isoleucine or valine' 0 C--O 1.255 1.39 0 CA-C-N 115.182 -0.917 . . . . 1.14 111.08 -175.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.668 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 8.9 m120 -67.02 -46.31 74.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.1 -1.074 . . . . 0.36 108.1 177.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -74.97 -50.03 18.0 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.924 -1.035 . . . . 2.07 111.859 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.712 HG13 HG23 ' A' ' 46' ' ' VAL . 24.4 mm -59.71 -52.53 59.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.983 0.513 . . . . 1.31 111.403 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.57 ' HB2' HG11 ' A' ' 38' ' ' VAL . . . -110.28 -60.0 1.86 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.077 0.465 . . . . 1.18 111.552 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.07 28.63 0.31 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 120.559 -0.829 . . . . 0.43 112.638 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.781 ' HB ' HG11 ' A' ' 15' ' ' VAL . 1.5 mp -70.41 151.73 95.62 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 109.569 -0.53 . . . . 1.06 109.569 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.7 Cg_exo -89.8 33.97 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.993 3.128 . . . . 1.08 115.222 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 3.3 p 61.41 -11.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 116.444 2.016 . . . . 1.28 116.444 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -115.16 -3.42 12.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.416 -0.803 . . . . 2.31 112.231 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.31 -29.54 28.24 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-O 121.638 0.733 . . . . 1.59 109.19 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.743 HG23 HG22 ' A' ' 21' ' ' ILE . 47.4 t -71.72 90.44 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.149 -1.387 . . . . 1.07 108.126 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' O ' HG12 ' A' ' 69' ' ' VAL . 1.5 tppp? -124.11 158.81 31.41 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.384 -1.71 . . . . 2.11 106.384 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.4 mt -57.54 140.29 51.2 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.001 0.429 . . . . 1.75 110.531 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t70 74.75 13.97 3.43 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.467 1.507 . . . . 0.72 110.911 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' THR . 69.6 mmtt -100.91 125.99 47.5 Favored 'General case' 0 CA--C 1.467 -2.238 0 CA-C-O 121.474 0.655 . . . . 2.01 109.308 175.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 9.3 m -80.2 111.38 16.52 Favored 'General case' 1 C--N 1.239 -4.234 0 CA-C-N 114.071 -1.422 . . . . 1.32 109.129 -177.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.581 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 93.7 m-85 -45.74 -64.92 0.62 Allowed 'General case' 0 C--N 1.271 -2.808 0 C-N-CA 124.367 1.067 . . . . 0.71 112.374 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -90.25 32.97 0.9 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.204 -0.935 . . . . 1.36 112.783 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.8 t70 -147.71 -55.83 0.23 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.671 0.748 . . . . 1.74 110.741 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.59 -50.6 8.61 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.189 -0.914 . . . . 1.29 110.394 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 32' ' ' PHE . 17.3 mt -76.36 -45.5 31.67 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.682 -0.69 . . . . 1.11 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.6 t70 88.66 61.73 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.844 1.658 . . . . 1.12 109.921 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.57 HG11 ' HB2' ' A' ' 19' ' ' ALA . 18.6 t -104.21 143.55 15.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 113.591 -1.64 . . . . 1.21 106.766 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 43' ' ' MET . 36.9 m-20 -60.53 109.67 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 111.876 0.325 . . . . 2.0 111.876 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.465 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 28.6 t -34.84 -50.43 0.47 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 126.527 1.931 . . . . 0.99 114.429 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.12 -27.83 63.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.438 0.637 . . . . 1.81 111.918 -176.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.418 ' O ' HG22 ' A' ' 46' ' ' VAL . 18.5 m -85.11 -13.38 50.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.386 0.675 . . . . 0.91 110.425 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.581 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -61.58 -38.15 86.48 Favored 'General case' 0 CA--C 1.47 -2.103 0 C-N-CA 123.289 0.636 . . . . 1.3 111.576 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.6 -42.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 124.341 1.025 . . . . 1.07 109.413 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -57.01 -50.32 73.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.374 0.606 . . . . 0.68 109.387 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.712 HG23 HG13 ' A' ' 18' ' ' ILE . 40.8 t -55.83 -28.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 124.92 1.288 . . . . 1.31 111.67 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 63' ' ' VAL . 21.2 t -78.17 -49.25 21.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.02 -1.104 . . . . 1.29 108.02 -176.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.39 -38.6 78.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.291 -1.322 . . . . 1.1 108.517 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -38.03 77.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.003 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.22 33.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.108 -0.951 . . . . 1.05 110.008 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.324 1.9 pp20? -62.22 -38.49 89.4 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 113.996 1.11 . . . . 0.64 113.996 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.32 -25.86 66.22 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.649 0.593 . . . . 2.07 112.505 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -83.93 -52.17 6.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.644 -0.423 . . . . 3.11 110.583 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 14.2 m-85 -73.94 -44.17 55.87 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 114.629 1.344 . . . . 0.81 114.629 -169.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 17.3 t70 146.52 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 O-C-N 124.732 1.27 . . . . 1.99 110.636 176.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 76' ' ' ILE . 11.8 p -73.18 173.53 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.004 -0.998 . . . . 1.14 112.303 -166.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -120.69 123.3 42.41 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.449 -1.315 . . . . 2.7 107.449 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.562 HG13 ' HB3' ' A' ' 51' ' ' GLU . 55.3 mt -120.31 106.96 39.83 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.478 -0.934 . . . . 1.09 108.478 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.605 ' O ' HG21 ' A' ' 63' ' ' VAL . 45.7 Cg_endo -70.29 166.84 26.91 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.013 2.476 . . . . 0.4 111.517 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.406 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 14.9 t70 -50.43 -43.2 54.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.144 0.978 . . . . 1.98 109.339 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -49.6 -59.17 4.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.539 -1.21 . . . . 2.06 111.642 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.545 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 27.6 m-20 -74.19 -26.28 60.18 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.84 0.681 . . . . 0.52 112.84 -176.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.918 HG11 HG22 ' A' ' 47' ' ' VAL . 62.0 t -53.26 -41.93 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 108.919 -0.771 . . . . 1.12 108.919 174.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 60' ' ' ASP . 32.3 mtmt -80.24 -7.18 58.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.665 -1.152 . . . . 2.73 112.185 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.67 -36.91 11.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 108.862 -0.792 . . . . 1.92 108.862 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.866 HD11 ' HA ' ' A' ' 72' ' ' ALA . 19.6 mt -73.2 125.1 26.95 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 106.596 -1.631 . . . . 1.04 106.596 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.552 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -130.15 -24.24 2.62 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 120.312 -0.555 . . . . 2.98 111.474 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 43.0 p -116.5 171.83 7.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 107.721 -1.214 . . . . 1.03 107.721 173.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -78.75 -13.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 C-N-CA 120.087 -0.645 . . . . 1.91 109.599 176.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.32 -46.78 67.91 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 109.713 -1.355 . . . . 0.33 109.713 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.552 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 15.0 m-20 -61.33 -55.42 31.92 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.378 -0.971 . . . . 1.39 108.378 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.866 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -51.62 -61.19 2.4 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.0 -1.454 . . . . 1.04 111.769 -175.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.43 ' HA ' HG21 ' A' ' 7' ' ' ILE . 37.6 m -57.96 -46.33 85.28 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.96 -1.018 . . . . 1.07 113.472 -174.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 14.1 mptt -56.88 -44.75 82.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 123.771 0.669 . . . . 4.04 109.45 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.464 ' HE2' HG12 ' A' ' 58' ' ' ILE . 85.6 t80 -65.31 -48.19 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.37 1.043 . . . . 0.9 111.65 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.62 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -54.94 -65.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.71 -1.132 . . . . 1.12 110.239 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.0 tt -51.7 -41.78 61.71 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.775 1.23 . . . . 2.08 109.358 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 11.5 t70 -58.28 -41.11 83.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.917 1.287 . . . . 0.64 109.549 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -102.1 3.78 38.96 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.979 1.103 . . . . 1.59 113.979 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 46.3 mt-30 . . . . . 0 CA--C 1.48 -1.715 0 N-CA-C 107.552 -1.277 . . . . 1.09 107.552 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . . . . . . 0 N--CA 1.441 -0.893 0 N-CA-C 109.182 -0.673 . . . . 2.01 109.182 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . . . -124.31 -76.16 0.59 Allowed 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.986 -0.552 . . . . 2.35 110.744 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.768 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.6 t -179.37 -169.11 0.14 Allowed 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.864 -1.161 . . . . 1.34 107.864 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.88 -42.72 48.47 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.363 1.065 . . . . 0.74 113.757 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -58.53 -23.79 59.04 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.173 0.511 . . . . 2.66 112.148 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 34.9 tt0 -84.33 -45.14 13.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.272 -0.64 . . . . 2.73 109.272 175.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.505 HG23 ' HA ' ' A' ' 73' ' ' THR . 79.8 mt -71.57 -65.44 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.03 0 CA-C-N 115.001 -0.999 . . . . 1.05 110.484 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.39 -48.81 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 C-N-CA 123.768 0.827 . . . . 1.05 112.614 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.68 77.64 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 123.327 0.392 . . . . 1.07 111.206 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -81.45 -40.5 11.03 Favored Glycine 0 N--CA 1.405 -3.424 0 C-N-CA 120.709 -0.758 . . . . 0.21 112.952 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.742 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -65.39 -38.09 88.94 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.161 0.984 . . . . 1.03 108.879 -176.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.549 ' HB1' HG21 ' A' ' 23' ' ' VAL . . . -61.82 -43.39 98.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.608 -0.724 . . . . 1.06 109.846 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.675 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.9 mt-10 -63.91 -35.74 81.65 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.754 0.659 . . . . 0.68 112.282 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.742 HD13 ' HA ' ' A' ' 11' ' ' LEU . 60.7 mt -62.25 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.621 -0.881 . . . . 1.16 108.621 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.3 t -68.34 -23.86 28.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 CA-C-O 121.591 0.71 . . . . 1.14 110.659 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.675 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -66.35 -46.18 77.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.235 -0.893 . . . . 0.36 109.096 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.75 -44.8 15.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.233 -0.894 . . . . 2.07 111.614 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.694 HG13 HG22 ' A' ' 46' ' ' VAL . 21.0 mm -59.57 -51.91 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.783 0.433 . . . . 1.31 110.793 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.524 ' HB2' HG11 ' A' ' 38' ' ' VAL . . . -108.33 -81.42 0.57 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.52 0.676 . . . . 1.18 110.631 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.45 55.7 0.01 OUTLIER Glycine 0 CA--C 1.484 -1.86 0 N-CA-C 110.322 -1.111 . . . . 0.43 110.322 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.648 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -97.82 160.79 27.68 Favored Pre-proline 0 C--N 1.278 -2.52 0 N-CA-C 107.976 -1.12 . . . . 1.06 107.976 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -93.24 143.57 2.1 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 122.523 2.148 . . . . 1.08 109.192 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.549 HG21 ' HB1' ' A' ' 12' ' ' ALA . 13.8 p -74.1 56.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 123.287 1.518 . . . . 1.28 112.802 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.51 -14.48 0.2 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.26 -1.336 . . . . 2.31 110.068 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.437 ' O ' ' HE3' ' A' ' 30' ' ' LYS . 1.6 t70 -87.61 -37.14 17.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.861 0.839 . . . . 1.59 109.172 -173.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.599 HG23 HD12 ' A' ' 36' ' ' LEU . 21.7 t -77.7 90.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.991 -1.114 . . . . 1.07 107.991 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -101.84 -96.29 0.28 Allowed 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.955 0.883 . . . . 2.11 109.014 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.418 ' HA ' HG11 ' A' ' 69' ' ' VAL . 95.4 mt -153.15 157.13 39.88 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 104.238 -2.505 . . . . 1.75 104.238 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' H ' ' CA ' ' A' ' 70' ' ' GLY . 30.5 t70 68.69 9.31 7.27 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.501 1.125 . . . . 0.72 110.657 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 68' ' ' THR . 46.6 mmtt -93.57 126.2 38.59 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-N 115.586 -0.734 . . . . 2.01 109.282 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.528 ' CB ' ' HB3' ' A' ' 34' ' ' ASP . 7.1 m -74.38 25.51 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 C-N-CA 126.501 1.92 . . . . 1.32 114.63 -171.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.735 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 70.2 m-85 41.84 -97.29 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.625 1.57 . . . . 0.71 113.746 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.7 HG21 H37A ' A' ' 101' ' ' SYO . 10.2 t -57.58 -35.44 70.41 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 123.565 0.746 . . . . 1.36 111.141 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HB3' ' CB ' ' A' ' 31' ' ' SER . 19.3 t70 -83.67 -40.82 18.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.482 -0.326 . . . . 1.74 111.098 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.84 -54.45 3.96 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 118.683 -1.207 . . . . 1.29 110.821 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.599 HD12 HG23 ' A' ' 26' ' ' VAL . 17.3 mt -74.06 -38.37 63.97 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.457 -1.247 . . . . 1.11 111.405 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.6 t70 89.4 69.37 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.538 1.535 . . . . 1.12 109.605 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.55 ' H ' ' HA ' ' A' ' 33' ' ' THR . 15.0 t -111.68 155.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.927 -1.942 . . . . 1.21 106.57 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 43' ' ' MET . 12.2 m-20 -76.5 119.85 20.91 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.251 -0.648 . . . . 2.0 109.251 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.449 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 10.2 t -42.51 -50.71 5.25 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.584 1.153 . . . . 0.99 113.58 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.62 -29.54 70.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.46 0.648 . . . . 1.81 111.43 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.436 ' O ' HG21 ' A' ' 46' ' ' VAL . 21.7 m -84.43 -15.12 47.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.17 -0.468 . . . . 0.91 110.688 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.772 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -62.8 -35.01 78.49 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 123.429 0.692 . . . . 1.3 110.579 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.76 -42.62 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.138 -0.689 . . . . 1.07 109.138 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.99 -44.54 94.45 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.194 -0.669 . . . . 0.68 109.194 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.694 HG22 HG13 ' A' ' 18' ' ' ILE . 47.8 t -59.65 -29.03 41.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 114.998 -1.001 . . . . 1.31 111.244 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 1.011 HG21 HG11 ' A' ' 63' ' ' VAL . 40.4 t -77.78 -51.77 17.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.876 -0.787 . . . . 1.29 108.876 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.2 -21.57 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.429 -0.805 . . . . 1.1 109.272 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.22 -38.0 31.96 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' CB ' ' H8B' ' A' ' 101' ' ' SYO . . . -63.71 -56.36 16.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.337 -0.847 . . . . 1.05 110.253 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.297 0.6 OUTLIER -63.47 -36.7 84.62 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 114.379 1.251 . . . . 0.64 114.379 -176.328 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.73 -24.12 64.43 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.892 0.377 . . . . 2.07 111.486 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -88.26 -40.91 13.28 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.737 0.303 . . . . 3.11 110.554 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.456 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 8.5 m-85 -94.52 -2.1 52.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.81 113.032 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 1' ' ' ALA . 14.1 m-20 81.77 7.18 1.07 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.3 1.04 . . . . 1.99 113.723 175.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 76' ' ' ILE . 11.5 p -89.73 178.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.328 -0.99 . . . . 1.14 108.328 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -133.45 130.51 38.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.241 -1.392 . . . . 2.7 107.241 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.44 HG12 ' HE2' ' A' ' 75' ' ' TYR . 61.9 mt -124.68 113.36 27.17 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.182 -0.673 . . . . 1.09 109.182 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HG23 ' A' ' 63' ' ' VAL . 73.3 Cg_endo -72.56 164.42 35.65 Favored 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 123.089 2.526 . . . . 0.4 110.518 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.9 -30.31 70.8 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.929 0.344 . . . . 1.98 111.929 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.51 -31.39 72.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.693 0.282 . . . . 2.06 111.094 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.609 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 15.2 m-20 -86.61 -28.21 23.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.034 0.383 . . . . 0.52 112.034 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 1.011 HG11 HG21 ' A' ' 47' ' ' VAL . 69.7 t -55.05 -48.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.415 -0.957 . . . . 1.12 108.415 173.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -80.65 -1.92 44.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.253 -0.885 . . . . 2.73 111.772 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.406 ' CB ' ' HA ' ' A' ' 62' ' ' ASP . 38.5 t30 -92.21 -29.47 16.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.597 -0.89 . . . . 1.92 108.597 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.874 HD13 ' HA ' ' A' ' 72' ' ' ALA . 25.6 mt -85.7 112.29 20.9 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.432 -1.322 . . . . 1.04 107.432 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.523 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -104.76 -21.99 13.27 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.705 -1.198 . . . . 2.98 110.966 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 30.6 p -127.79 169.85 13.4 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 108.804 -0.813 . . . . 1.03 108.804 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.656 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 1.6 p -73.88 -13.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.804 0.811 . . . . 1.91 110.419 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.432 ' CA ' ' H ' ' A' ' 29' ' ' ASP . . . -68.95 -47.28 55.61 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 108.772 -1.731 . . . . 0.33 108.772 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.523 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.6 m-20 -58.19 -56.36 23.1 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.014 -0.736 . . . . 1.39 109.014 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.874 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.65 -61.64 2.08 Favored 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 124.718 1.262 . . . . 1.04 111.926 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.505 ' HA ' HG23 ' A' ' 7' ' ' ILE . 31.6 m -57.92 -44.03 86.58 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 113.643 0.979 . . . . 1.07 113.643 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 0.6 OUTLIER -65.2 -33.3 75.69 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 122.905 0.482 . . . . 4.04 109.842 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.44 ' HE2' HG12 ' A' ' 58' ' ' ILE . 88.4 t80 -72.68 -52.72 14.12 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.422 -0.808 . . . . 0.9 110.023 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.714 ' HA ' HG22 ' A' ' 56' ' ' VAL . 70.7 mt -52.88 -66.26 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.698 0 C-N-CA 124.717 1.207 . . . . 1.12 111.519 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.768 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.4 tt -50.41 -49.08 55.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.596 1.558 . . . . 2.08 109.484 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.3 t70 -67.56 -23.42 65.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.424 -1.716 . . . . 0.64 111.575 -174.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -101.96 -12.88 17.86 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.868 -0.606 . . . . 1.59 112.448 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 68.0 mt-30 -71.68 -62.39 1.43 Allowed 'General case' 0 CA--C 1.464 -2.33 0 N-CA-C 107.1 -1.444 . . . . 1.09 107.1 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.268 -2.967 0 CA-C-N 111.526 -2.579 . . . . 1.97 109.378 -179.8 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.895 H28A HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.57 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 0 C--O 1.247 0.94 0 CA-C-O 119.816 -0.135 . . . . 2.01 110.707 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 176.8 -81.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.322 1.049 . . . . 2.35 110.406 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t -165.76 -173.85 2.85 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.362 -0.607 . . . . 1.34 109.362 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 73' ' ' THR . 1.0 OUTLIER -50.3 -46.4 55.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 125.615 1.566 . . . . 0.74 113.419 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.97 -23.59 63.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.58 0.585 . . . . 2.66 112.58 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -84.64 -32.2 23.79 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.821 -1.177 . . . . 2.73 107.821 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.496 HG21 ' HA ' ' A' ' 73' ' ' THR . 74.2 mt -79.88 -64.81 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.112 -0.949 . . . . 1.05 109.238 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -55.6 -42.59 69.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 112.626 0.602 . . . . 1.05 112.626 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -60.92 -40.07 91.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.57 -0.452 . . . . 1.07 110.691 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.69 -35.89 21.03 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 120.889 -0.672 . . . . 0.21 112.6 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.694 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -65.9 -39.75 90.9 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.508 -1.293 . . . . 1.03 107.508 -179.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.703 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.77 -49.84 67.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 123.926 0.766 . . . . 1.06 109.867 175.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.59 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 35.1 mt-10 -58.58 -42.68 88.59 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 124.223 0.952 . . . . 0.68 111.521 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.694 HD11 ' HA ' ' A' ' 11' ' ' LEU . 66.4 mt -59.4 -38.75 76.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.509 -0.769 . . . . 1.16 110.232 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 11' ' ' LEU . 61.9 t -71.83 -30.16 36.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.614 -0.721 . . . . 1.14 109.845 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.59 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.8 m120 -67.33 -42.65 83.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.102 -0.703 . . . . 0.36 109.102 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 37.1 mm-40 -70.68 -58.8 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.917 -1.038 . . . . 2.07 111.887 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.772 HG21 ' HB3' ' A' ' 42' ' ' SER . 28.0 mt -72.82 -39.36 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 112.619 0.6 . . . . 1.31 112.619 -174.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB2' HG11 ' A' ' 38' ' ' VAL . . . -106.27 -80.37 0.56 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.13 -0.628 . . . . 1.18 111.441 -178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.69 53.17 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.656 -0.783 . . . . 0.43 112.756 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.795 HG21 HG22 ' A' ' 26' ' ' VAL . 1.6 mp -98.02 155.22 37.27 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.612 -0.514 . . . . 1.06 109.612 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 24' ' ' GLU . 5.7 Cg_exo -88.76 40.14 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.017 2.478 . . . . 1.08 114.362 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.29 8.0 p 53.2 -18.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 117.383 2.364 . . . . 1.28 117.383 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 22' ' ' PRO . 12.9 pt-20 -103.58 -12.8 16.85 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.351 -0.843 . . . . 2.31 111.401 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.59 -29.87 46.34 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.923 -0.769 . . . . 1.59 108.923 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.795 HG22 HG21 ' A' ' 21' ' ' ILE . 41.8 t -73.23 95.05 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.557 -1.201 . . . . 1.07 108.136 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -130.62 149.51 52.25 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 103.751 -2.685 . . . . 2.11 103.751 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 mt -48.63 145.97 3.33 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 124.007 0.923 . . . . 1.75 109.862 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 80.05 10.37 1.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.539 1.149 . . . . 0.72 110.707 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.722 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 34.2 mmtp -99.9 124.28 45.05 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.675 -0.861 . . . . 2.01 108.675 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 15.2 m -81.46 38.01 0.48 Allowed 'General case' 0 C--N 1.249 -3.781 0 C-N-CA 126.058 1.743 . . . . 1.32 113.007 -173.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.664 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 88.4 m-85 36.42 -91.83 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.991 1.716 . . . . 0.71 114.524 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.928 HG22 H37A ' A' ' 101' ' ' SYO . 10.9 t -53.72 -33.12 54.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.091 0.956 . . . . 1.36 112.27 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -94.04 -44.41 8.05 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.879 0.371 . . . . 1.74 111.484 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.722 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 6.7 m-20 -88.63 -33.55 17.59 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.784 1.031 . . . . 1.29 113.784 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.599 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.0 mt -98.7 -31.42 11.92 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.038 -0.356 . . . . 1.11 110.038 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 84.55 62.79 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.223 1.487 . . . . 1.12 108.975 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.659 HG11 ' HB2' ' A' ' 19' ' ' ALA . 26.7 t -109.39 124.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.701 -2.045 . . . . 1.21 107.71 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.45 122.66 15.15 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 121.064 -0.254 . . . . 2.0 111.212 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' MET . 26.8 t -37.21 -43.04 0.49 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.938 1.459 . . . . 0.99 114.938 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.2 mt -60.91 -46.26 91.35 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.944 0.878 . . . . 1.81 109.56 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.772 ' HB3' HG21 ' A' ' 18' ' ' ILE . 8.3 m -71.71 -29.3 64.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.511 -1.222 . . . . 0.91 110.501 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.885 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -53.16 -47.25 68.92 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 124.966 1.307 . . . . 1.3 112.798 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 48' ' ' VAL . 59.9 t -55.9 -45.6 79.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.013 0.82 . . . . 1.07 109.995 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -60.32 -44.1 95.78 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 109.34 -0.615 . . . . 0.68 109.34 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 42' ' ' SER . 94.6 t -58.82 -28.54 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.027 0.931 . . . . 1.31 111.677 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.847 HG22 HG11 ' A' ' 63' ' ' VAL . 32.1 t -79.72 -50.98 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 108.04 -1.096 . . . . 1.29 108.04 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 44' ' ' VAL . 49.0 t -59.35 -38.74 76.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.214 -1.357 . . . . 1.1 108.91 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -71.21 -35.04 71.39 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.42 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.75 11.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.267 -0.879 . . . . 1.05 109.339 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.279 0.0 OUTLIER -63.95 -34.07 77.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 113.721 1.008 . . . . 0.64 113.721 -176.95 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.49 -24.73 66.45 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.445 0.535 . . . . 2.07 112.445 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -88.85 -41.56 12.4 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.503 -0.479 . . . . 3.11 111.629 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.447 ' HZ ' ' N ' ' A' ' 11' ' ' LEU . 8.8 m-85 -88.87 -0.83 57.72 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 113.267 0.84 . . . . 0.81 113.267 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 80.2 -0.07 2.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.435 1.084 . . . . 1.99 112.837 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' A' ' 76' ' ' ILE . 7.6 p -84.75 177.45 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.389 -0.967 . . . . 1.14 108.389 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -137.11 131.76 33.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.934 -0.765 . . . . 2.7 108.934 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.563 HG12 ' HE2' ' A' ' 75' ' ' TYR . 54.0 mt -124.43 113.59 27.52 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.804 -0.635 . . . . 1.09 109.382 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.563 ' O ' HG22 ' A' ' 63' ' ' VAL . 36.5 Cg_endo -67.07 157.82 59.88 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 122.564 2.176 . . . . 0.4 109.917 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.81 -29.88 63.18 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.685 0.755 . . . . 1.98 109.359 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.91 -47.2 87.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.569 -1.196 . . . . 2.06 111.452 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 59.3 m-20 -83.12 -24.94 32.39 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 111.812 0.301 . . . . 0.52 111.812 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.847 HG11 HG22 ' A' ' 47' ' ' VAL . 67.2 t -52.53 -48.11 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.324 -0.991 . . . . 1.12 108.324 173.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -75.57 -2.39 28.94 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.153 0.797 . . . . 2.73 113.153 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.87 -25.92 14.46 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.002 0.429 . . . . 1.92 110.418 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.859 HD13 ' HA ' ' A' ' 72' ' ' ALA . 37.4 mt -79.72 119.51 22.74 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 106.017 -1.846 . . . . 1.04 106.017 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -110.37 -35.04 6.17 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.58 -0.848 . . . . 2.98 110.571 176.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 31.6 p -111.43 177.65 4.59 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 109.089 -0.708 . . . . 1.03 109.089 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.664 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -86.99 -13.03 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 N-CA-C 108.263 -1.014 . . . . 1.91 108.263 174.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.35 -35.95 59.81 Favored Glycine 0 C--O 1.216 -0.981 0 N-CA-C 108.385 -1.886 . . . . 0.33 108.385 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' CG ' ' HZ1' ' A' ' 67' ' ' LYS . 11.7 m-20 -66.74 -60.27 2.84 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.821 1.249 . . . . 1.39 109.501 173.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.859 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.75 -61.1 2.41 Favored 'General case' 0 CA--C 1.469 -2.164 0 CA-C-N 113.474 -1.694 . . . . 1.04 112.317 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.658 HG22 ' HG2' ' A' ' 4' ' ' GLN . 59.2 m -59.75 -34.34 72.83 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.914 -1.039 . . . . 1.07 113.324 -175.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -43.4 70.06 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 108.027 -1.101 . . . . 4.04 108.027 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.563 ' HE2' HG12 ' A' ' 58' ' ' ILE . 87.1 t80 -61.27 -50.86 71.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.856 -1.065 . . . . 0.9 109.611 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.712 ' HA ' HG21 ' A' ' 56' ' ' VAL . 76.7 mt -54.79 -65.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.037 -1.438 . . . . 1.12 110.634 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.13 -41.74 62.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.634 0.773 . . . . 2.08 109.939 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.34 -34.51 76.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.14 -0.936 . . . . 0.64 111.723 -175.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -95.71 -7.16 38.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 113.631 0.974 . . . . 1.59 113.631 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.57 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -105.17 -70.93 0.76 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 113.97 1.1 . . . . 1.09 113.97 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.828 0 CA-C-N 115.084 -0.962 . . . . 1.97 110.505 -176.474 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.928 H37A HG22 ' A' ' 33' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.69 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 0 CA--C 1.495 -1.136 0 CA-C-O 121.42 0.629 . . . . 2.01 110.376 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.85 177.46 4.66 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.62 -1.173 . . . . 2.35 108.482 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.456 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.0 t -118.76 179.91 4.0 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 116.615 -0.266 . . . . 1.34 111.083 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.25 -37.06 45.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.945 1.298 . . . . 0.74 112.848 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -48.76 66.92 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.895 0.747 . . . . 2.66 110.854 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.35 -38.18 87.01 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.505 0.722 . . . . 2.73 109.907 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.504 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.7 mt -72.13 -66.79 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.028 0 CA-C-N 115.681 -0.691 . . . . 1.05 112.344 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.449 HG22 HD12 ' A' ' 28' ' ' LEU . 58.3 t -60.0 -41.12 85.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 112.377 0.51 . . . . 1.05 112.377 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.36 86.84 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.269 0.355 . . . . 1.07 110.54 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.62 -40.15 10.04 Favored Glycine 0 N--CA 1.414 -2.825 0 CA-C-N 115.815 -0.629 . . . . 0.21 113.584 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.26 -37.14 86.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.605 -0.887 . . . . 1.03 108.605 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -58.12 -49.23 77.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.893 -0.594 . . . . 1.06 109.418 175.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.707 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 49.7 mt-10 -60.23 -41.57 93.39 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 124.131 0.894 . . . . 0.68 112.244 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.67 HD11 ' HA ' ' A' ' 11' ' ' LEU . 69.1 mt -56.84 -42.15 77.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.618 -0.719 . . . . 1.16 109.887 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.631 HG12 ' HB ' ' A' ' 21' ' ' ILE . 98.4 t -70.16 -22.85 24.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.778 0.799 . . . . 1.14 110.879 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.707 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.9 m120 -76.34 -42.2 45.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.55 -1.278 . . . . 0.36 107.55 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -76.92 -39.76 49.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.551 -1.204 . . . . 2.07 112.252 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 HG23 ' A' ' 46' ' ' VAL . 20.7 mm -71.96 -53.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.895 0.379 . . . . 1.31 110.563 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.33 -74.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.374 -0.531 . . . . 1.18 111.26 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.55 44.77 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.353 -0.927 . . . . 0.43 112.221 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.816 HG21 HG21 ' A' ' 26' ' ' VAL . 1.5 mp -84.9 151.0 57.01 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.984 -0.747 . . . . 1.06 108.984 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 13.3 Cg_exo -83.27 29.24 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 124.277 3.318 . . . . 1.08 115.004 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p 54.1 7.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 C-N-CA 126.195 1.798 . . . . 1.28 114.351 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -107.95 -27.1 10.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.943 -0.473 . . . . 2.31 111.834 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' HB3' HD21 ' A' ' 36' ' ' LEU . 11.1 m-20 -83.17 -28.64 29.19 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 116.054 -0.521 . . . . 1.59 112.094 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 21' ' ' ILE . 22.1 t -78.37 87.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.118 -0.633 . . . . 1.07 110.399 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' HG13 ' A' ' 69' ' ' VAL . 96.5 mttt -125.6 168.84 13.15 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.473 -0.785 . . . . 2.11 109.422 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.449 HD12 HG22 ' A' ' 8' ' ' VAL . 5.5 mp -60.19 139.3 57.63 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.255 -0.43 . . . . 1.75 110.081 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 79.28 12.68 1.23 Allowed 'General case' 0 C--N 1.316 -0.855 0 O-C-N 125.044 1.465 . . . . 0.72 111.252 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.7 mmtt -99.47 124.75 44.91 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 109.301 -0.629 . . . . 2.01 109.301 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.5 m -78.9 34.42 0.23 Allowed 'General case' 0 C--N 1.254 -3.578 0 C-N-CA 126.356 1.862 . . . . 1.32 114.377 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.789 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 79.9 m-85 43.04 -93.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.499 1.519 . . . . 0.71 114.913 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -67.35 -24.37 65.71 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.993 -0.442 . . . . 1.36 111.98 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -89.45 -52.99 4.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.935 0.398 . . . . 1.74 110.952 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.55 -41.31 19.78 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 116.155 -0.475 . . . . 1.29 112.221 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 26' ' ' VAL . 16.1 mt -83.4 -76.32 0.29 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 119.097 -0.478 . . . . 1.11 110.525 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 34.2 t70 159.82 -16.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 O-C-N 124.411 1.069 . . . . 1.12 110.608 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 36' ' ' LEU . 3.0 t -47.13 135.37 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.037 1.335 . . . . 1.21 113.276 -171.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 43' ' ' MET . 11.3 t70 -59.49 112.8 1.91 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.516 -0.766 . . . . 2.0 111.805 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 17.3 t -40.82 -43.31 2.0 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 116.069 1.877 . . . . 0.99 116.069 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.22 -30.69 38.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.254 -1.378 . . . . 1.81 110.66 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 46' ' ' VAL . 20.1 m -76.14 -13.92 60.18 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.601 -0.727 . . . . 0.91 110.165 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.789 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.13 -36.09 76.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 123.44 0.696 . . . . 1.3 110.301 177.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.97 -44.68 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 123.959 0.787 . . . . 1.07 109.36 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.65 -43.09 94.03 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.181 -0.674 . . . . 0.68 109.181 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 18' ' ' ILE . 57.6 t -59.26 -24.98 29.15 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.015 -0.993 . . . . 1.31 111.455 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.968 HG23 HG11 ' A' ' 63' ' ' VAL . 42.3 t -80.18 -54.32 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 N-CA-C 106.933 -1.506 . . . . 1.29 106.933 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.2 t -53.85 -40.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.372 -1.74 . . . . 1.1 110.07 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.91 -37.08 64.76 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-O 121.233 0.54 . . . . 1.0 110.27 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' CB ' ' H8A' ' A' ' 101' ' ' SYO . . . -62.19 -59.97 4.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.059 -0.973 . . . . 1.05 109.905 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.296 0.9 OUTLIER -62.8 -35.53 80.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 114.377 1.251 . . . . 0.64 114.377 -176.1 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.67 -30.46 71.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.356 0.502 . . . . 2.07 112.356 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -82.82 -36.72 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.777 -0.369 . . . . 3.11 110.979 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 7.7 m-85 -87.58 -19.43 27.83 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.766 1.024 . . . . 0.81 113.766 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.0 t70 103.76 -5.35 0.02 OUTLIER 'General case' 0 N--CA 1.532 3.641 0 O-C-N 125.29 1.619 . . . . 1.99 114.227 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 76' ' ' ILE . 8.1 p -87.17 172.96 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 O-C-N 121.141 -0.974 . . . . 1.14 109.513 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.838 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -126.6 118.79 25.54 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.208 -1.405 . . . . 2.7 107.208 174.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.591 HG12 ' HE2' ' A' ' 75' ' ' TYR . 57.5 mt -111.64 114.03 52.69 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 120.88 -0.328 . . . . 1.09 110.929 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' VAL . 83.2 Cg_endo -72.82 164.6 35.11 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.524 2.816 . . . . 0.4 110.913 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.45 -38.71 74.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.905 0.482 . . . . 1.98 111.058 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.556 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.0 m-20 -61.82 -34.71 76.42 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-N 115.816 -0.629 . . . . 2.06 111.592 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.56 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.0 m-20 -87.36 -23.98 24.4 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.659 -0.816 . . . . 0.52 113.177 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.968 HG11 HG23 ' A' ' 47' ' ' VAL . 79.4 t -55.96 -45.68 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.093 -1.077 . . . . 1.12 108.093 172.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 17.4 ptmt -74.78 -10.27 59.35 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.202 -0.908 . . . . 2.73 111.84 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -91.56 -13.52 31.87 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.264 0.554 . . . . 1.92 110.168 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' A' ' 72' ' ' ALA . 24.9 mt -95.96 109.54 21.9 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 107.101 -1.444 . . . . 1.04 107.101 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.54 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -105.72 -45.22 4.46 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.742 -1.206 . . . . 2.98 107.742 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 62.8 p -102.86 170.44 7.99 Favored 'General case' 0 N--CA 1.383 -3.808 0 CA-C-N 114.937 -1.028 . . . . 1.03 108.821 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -79.31 -12.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.464 -0.939 . . . . 1.91 108.464 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.66 -46.98 64.36 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 108.597 -1.801 . . . . 0.33 108.597 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.92 -52.42 65.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 109.026 -0.731 . . . . 1.39 109.026 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.845 ' HA ' HD12 ' A' ' 66' ' ' LEU . . . -52.25 -61.26 2.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 O-C-N 124.635 1.209 . . . . 1.04 111.365 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.491 ' HA ' HG21 ' A' ' 7' ' ' ILE . 52.5 m -55.7 -50.87 69.15 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 124.211 0.945 . . . . 1.07 113.471 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.548 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.5 mptm? -60.52 -34.14 73.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 123.3 0.64 . . . . 4.04 110.185 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.591 ' HE2' HG12 ' A' ' 58' ' ' ILE . 77.1 t80 -70.37 -55.89 8.0 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.771 -0.455 . . . . 0.9 109.771 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.591 ' HA ' HG12 ' A' ' 56' ' ' VAL . 63.8 mt -50.31 -66.44 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 124.662 1.185 . . . . 1.12 110.909 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.88 -54.32 36.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.781 1.232 . . . . 2.08 110.047 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 11.9 t70 -70.57 -24.4 62.77 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.542 -1.208 . . . . 0.64 112.02 -169.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.27 -4.87 48.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.416 0.895 . . . . 1.59 113.416 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.69 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 2.0 pt20 -103.24 -55.48 2.4 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-O 122.391 1.091 . . . . 1.09 110.898 173.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 1 C--N 1.243 -4.033 0 CA-C-N 112.944 -1.934 . . . . 1.97 110.681 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.832 H28A HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.693 0 CA-C-O 121.072 0.463 . . . . 2.01 109.793 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -95.67 128.94 42.96 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 109.009 -0.737 . . . . 2.35 109.009 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.46 ' O ' HG13 ' A' ' 7' ' ' ILE . 2.5 t -85.93 176.21 8.19 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 119.114 -0.469 . . . . 1.34 109.93 -176.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.405 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -48.32 -40.32 24.86 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.398 0.888 . . . . 0.74 113.398 -176.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.27 -33.74 65.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.046 0.841 . . . . 2.66 110.411 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.465 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 15.4 tp10 -87.15 -37.74 17.07 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.403 -0.817 . . . . 2.73 109.837 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.639 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.1 mt -65.67 -65.75 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 116.392 -0.367 . . . . 1.05 111.711 -172.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.682 HG22 HD13 ' A' ' 28' ' ' LEU . 59.1 t -56.91 -42.31 78.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 122.126 0.17 . . . . 1.05 111.394 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -38.74 78.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.813 0.696 . . . . 1.07 111.278 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.66 -38.45 10.63 Favored Glycine 0 N--CA 1.419 -2.47 0 CA-C-N 116.183 -0.462 . . . . 0.21 113.117 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.716 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -63.97 -40.48 96.49 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.978 -0.749 . . . . 1.03 108.978 -178.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.639 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.34 -50.77 64.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.127 0.892 . . . . 1.06 109.685 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.602 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 55.6 mt-10 -61.54 -38.91 89.14 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 124.0 0.813 . . . . 0.68 111.927 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.716 HD13 ' HA ' ' A' ' 11' ' ' LEU . 66.7 mt -59.85 -45.01 95.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.843 -0.617 . . . . 1.16 109.548 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 11' ' ' LEU . 62.0 t -67.6 -24.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-O 121.747 0.784 . . . . 1.14 110.131 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.602 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.9 m120 -72.09 -38.49 69.37 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.281 -0.872 . . . . 0.36 109.322 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -82.13 -48.87 10.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.659 -0.7 . . . . 2.07 111.349 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.624 HG23 ' HB3' ' A' ' 42' ' ' SER . 33.4 mm -62.77 -53.14 50.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.902 -0.59 . . . . 1.31 110.545 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -104.5 -78.27 0.57 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.421 -0.585 . . . . 1.18 109.421 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.27 45.96 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 120.747 -0.74 . . . . 0.43 112.031 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' HG11 ' A' ' 15' ' ' VAL . 1.5 mp -80.69 152.47 72.42 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 109.037 -0.727 . . . . 1.06 109.037 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.8 Cg_exo -84.83 23.34 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.104 2.536 . . . . 1.08 115.089 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.8 p 58.88 -9.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.69 1.996 . . . . 1.28 115.489 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.8 pt-20 -103.79 -7.02 20.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.365 0.602 . . . . 2.31 111.176 -174.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -99.66 -16.49 18.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.775 0.798 . . . . 1.59 110.676 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' A' ' 12' ' ' ALA . 12.8 t -78.11 86.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 114.385 -1.28 . . . . 1.07 110.468 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.52 148.94 37.19 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.186 -1.042 . . . . 2.11 108.186 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.682 HD13 HG22 ' A' ' 8' ' ' VAL . 6.0 mp -59.89 140.27 56.78 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.578 -0.527 . . . . 1.75 109.578 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 87.26 7.21 0.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.545 1.538 . . . . 0.72 109.642 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -104.03 128.44 51.61 Favored 'General case' 0 CA--C 1.465 -2.316 0 CA-C-N 115.269 -0.878 . . . . 2.01 109.214 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.635 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 3.0 m -80.65 105.8 12.17 Favored 'General case' 1 C--N 1.238 -4.269 0 CA-C-N 114.188 -1.369 . . . . 1.32 108.316 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.749 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.4 m-85 -43.51 -55.26 4.33 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.596 0.758 . . . . 0.71 112.081 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 t -78.23 6.3 8.48 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 113.431 0.9 . . . . 1.36 113.431 -173.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -139.92 -62.18 0.52 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.318 -0.553 . . . . 1.74 110.037 -174.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.05 -44.91 75.3 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.096 -0.957 . . . . 1.29 110.146 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.618 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 16.9 mt -81.38 -44.6 17.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.137 -0.938 . . . . 1.11 109.279 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 93.84 65.32 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 126.632 1.973 . . . . 1.12 111.908 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.7 HG13 ' HE3' ' A' ' 43' ' ' MET . 48.8 t -96.04 149.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 113.485 -1.689 . . . . 1.21 107.587 171.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.405 ' O ' HD22 ' A' ' 41' ' ' LEU . 5.3 m-20 -73.96 17.82 0.16 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 115.99 1.848 . . . . 2.0 115.99 -174.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 43' ' ' MET . 28.7 t 68.0 -53.65 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.271 1.952 . . . . 0.99 116.271 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.405 HD22 ' O ' ' A' ' 39' ' ' ASP . 1.7 pt? -71.36 -34.15 70.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.257 1.027 . . . . 1.81 108.491 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.624 ' HB3' HG23 ' A' ' 18' ' ' ILE . 2.1 m -65.81 -22.84 66.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.968 -1.469 . . . . 0.91 110.045 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.733 ' HB3' ' H2A' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -61.99 -43.44 98.83 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 115.375 -0.829 . . . . 1.3 112.021 -176.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.35 -43.83 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 O-C-N 124.398 1.061 . . . . 1.07 110.034 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.41 -46.82 85.69 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.917 -0.771 . . . . 0.68 108.917 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 42' ' ' SER . 61.9 t -58.54 -27.0 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.731 -1.122 . . . . 1.31 111.484 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.99 HG22 HG13 ' A' ' 63' ' ' VAL . 44.5 t -80.15 -52.53 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 107.658 -1.238 . . . . 1.29 107.658 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.28 -44.51 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 124.728 1.268 . . . . 1.1 108.919 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.69 88.33 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 121.244 0.545 . . . . 1.0 110.811 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -64.68 -55.9 17.19 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.472 -0.785 . . . . 1.05 110.239 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.561 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.262 0.0 OUTLIER -62.81 -34.03 76.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.754 1.02 . . . . 0.64 113.754 -178.188 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -67.84 -28.66 67.75 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.77 0.285 . . . . 2.07 111.77 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -87.52 -38.16 16.27 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.775 0.321 . . . . 3.11 111.52 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.639 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 10.0 m-85 -94.46 -3.91 49.18 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.106 0.78 . . . . 0.81 113.106 -172.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 87.66 -2.5 0.55 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 125.16 1.384 . . . . 1.99 114.719 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.74 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 13.9 p -81.2 173.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.363 -0.935 . . . . 1.14 108.772 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 22.2 tptp -127.58 124.91 39.26 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 107.462 -1.31 . . . . 2.7 107.462 171.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.555 HG12 ' HE2' ' A' ' 75' ' ' TYR . 59.7 mt -114.43 113.21 45.71 Favored Pre-proline 0 N--CA 1.429 -1.496 0 C-N-CA 120.599 -0.441 . . . . 1.09 111.106 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.568 ' O ' HG23 ' A' ' 63' ' ' VAL . 30.9 Cg_endo -66.87 152.53 80.26 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 122.642 2.228 . . . . 0.4 109.845 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 3.9 p-10 -59.1 -27.87 65.98 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.307 0.379 . . . . 1.98 111.123 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.76 -46.04 87.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 2.06 110.379 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -74.76 -26.91 60.1 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 112.01 0.374 . . . . 0.52 112.01 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.99 HG13 HG22 ' A' ' 47' ' ' VAL . 86.8 t -55.57 -41.44 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.86 -1.163 . . . . 1.12 107.86 172.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 60' ' ' ASP . 57.8 mttp -73.94 -7.83 53.81 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.067 -0.97 . . . . 2.73 112.564 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.06 -24.47 15.32 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.233 0.539 . . . . 1.92 110.316 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.892 HD11 ' HA ' ' A' ' 72' ' ' ALA . 39.1 mt -85.48 118.44 25.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.889 -1.152 . . . . 1.04 107.889 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.54 ' HG2' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -112.17 -29.16 7.68 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.918 -1.113 . . . . 2.98 110.591 175.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 13.6 p -116.55 179.5 3.99 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 109.477 -0.564 . . . . 1.03 109.477 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.749 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -87.23 -12.89 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 122.062 0.934 . . . . 1.91 109.787 176.045 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.439 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -76.6 -30.99 55.56 Favored Glycine 0 C--O 1.207 -1.542 0 N-CA-C 108.305 -1.918 . . . . 0.33 108.305 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.27 -60.35 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.21 -0.995 . . . . 1.39 109.144 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.892 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -49.03 -60.95 2.34 Favored 'General case' 0 CA--C 1.479 -1.771 0 O-C-N 124.569 1.168 . . . . 1.04 112.361 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.45 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.3 m -57.45 -47.99 80.36 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.894 -1.048 . . . . 1.07 113.006 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 5.7 mptp? -55.83 -50.52 70.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 124.213 0.945 . . . . 4.04 109.815 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.555 ' HE2' HG12 ' A' ' 58' ' ' ILE . 82.8 t80 -56.23 -51.51 67.82 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.364 1.04 . . . . 0.9 111.43 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 69.8 mt -54.27 -65.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.424 -1.262 . . . . 1.12 110.432 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tt -54.33 -42.8 70.6 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.11 0.964 . . . . 2.08 109.589 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 36.9 t70 -62.4 -26.81 68.68 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.41 1.084 . . . . 0.64 111.561 -172.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -102.13 -8.04 21.72 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.836 1.05 . . . . 1.59 113.836 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.74 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -120.89 -45.67 2.37 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 115.191 1.552 . . . . 1.09 115.191 -178.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.5 ' HB2' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 1 C--N 1.237 -4.307 0 CA-C-N 113.877 -1.51 . . . . 1.97 111.159 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.733 ' H2A' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.379 0 CA-C-O 120.892 0.377 . . . . 2.01 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . . . -147.06 131.85 17.99 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 107.069 -1.456 . . . . 2.35 107.069 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 7' ' ' ILE . 15.2 t -81.77 -179.73 7.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.147 0.28 . . . . 1.34 111.162 -173.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.618 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -49.85 -46.97 51.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.157 0.983 . . . . 0.74 113.363 -178.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.64 -24.79 66.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.873 0.368 . . . . 2.66 111.624 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 2' ' ' ALA . 7.8 tp10 -87.7 -31.08 19.9 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.152 -0.684 . . . . 2.73 109.152 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.573 HG21 ' CE2' ' A' ' 54' ' ' PHE . 97.4 mt -74.39 -65.98 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.141 0 CA-C-N 116.145 -0.48 . . . . 1.05 110.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.49 -40.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 112.365 0.506 . . . . 1.05 112.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.91 98.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.37 -0.532 . . . . 1.07 110.632 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.48 -35.07 33.96 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 115.783 -0.644 . . . . 0.21 112.235 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.741 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -67.44 -39.37 85.4 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.16 -1.052 . . . . 1.03 108.16 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.616 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -55.36 -50.32 69.98 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.832 -0.803 . . . . 1.06 108.832 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.579 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 46.6 mt-10 -59.24 -42.48 91.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.113 0.883 . . . . 0.68 112.704 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.741 HD11 ' HA ' ' A' ' 11' ' ' LEU . 65.6 mt -56.07 -43.06 74.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.315 0.579 . . . . 1.16 109.923 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.726 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.8 t -68.86 -25.34 30.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.755 0.788 . . . . 1.14 110.168 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.579 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.6 m120 -74.07 -42.18 60.58 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.923 -1.139 . . . . 0.36 107.923 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.56 -47.95 51.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.311 -0.858 . . . . 2.07 111.445 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.4 mm -67.14 -53.16 35.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.896 -0.593 . . . . 1.31 111.317 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.73 -78.42 0.58 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.559 -0.456 . . . . 1.18 111.695 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.02 43.17 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.094 -1.051 . . . . 0.43 112.916 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.848 HG21 HG21 ' A' ' 26' ' ' VAL . 1.4 mp -79.41 151.25 74.75 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.033 -0.729 . . . . 1.06 109.033 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' GLU . 4.6 Cg_exo -89.74 37.5 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.613 2.876 . . . . 1.08 113.276 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 9.2 p 56.11 -22.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.982 2.113 . . . . 1.28 116.021 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' PRO . 29.8 mm-40 -88.73 -22.8 23.16 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.603 0.761 . . . . 2.31 111.873 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.582 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 6.6 t70 -74.57 -32.71 62.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.583 0.706 . . . . 1.59 110.494 -171.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.848 HG21 HG21 ' A' ' 21' ' ' ILE . 22.0 t -78.96 94.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.908 -1.042 . . . . 1.07 111.104 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -124.3 158.55 32.32 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.315 -0.995 . . . . 2.11 108.315 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 69' ' ' VAL . 90.6 mt -54.97 141.22 34.66 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 122.934 0.494 . . . . 1.75 110.288 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.54 ' H ' ' N ' ' A' ' 70' ' ' GLY . 27.1 t70 77.22 10.55 2.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.36 1.464 . . . . 0.72 111.009 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 69' ' ' VAL . 72.1 mmtt -100.36 129.06 46.29 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 115.374 -0.83 . . . . 2.01 109.226 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 30.6 t -74.85 119.89 19.65 Favored 'General case' 1 C--N 1.244 -4.011 0 CA-C-N 115.078 -0.965 . . . . 1.32 109.901 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.636 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 74.0 m-85 -51.49 -55.87 16.5 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 123.975 0.91 . . . . 0.71 111.892 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 3.5 p -66.47 -57.45 7.33 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 122.11 0.957 . . . . 1.36 111.942 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.498 ' HB2' ' OG ' ' A' ' 31' ' ' SER . 8.0 m-20 -82.64 -41.17 19.77 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 115.202 1.556 . . . . 1.74 115.202 -166.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.474 ' HB2' ' N ' ' A' ' 31' ' ' SER . 5.3 m-20 -91.66 -43.81 9.39 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.719 0.295 . . . . 1.29 111.113 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.699 HD13 HG22 ' A' ' 26' ' ' VAL . 17.8 mt -76.09 -90.11 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.758 -0.656 . . . . 1.11 110.418 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 38.9 t70 163.56 10.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.364 1.066 . . . . 1.12 109.047 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.484 HG21 HG11 ' A' ' 15' ' ' VAL . 12.4 t -77.57 119.14 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 108.764 -0.828 . . . . 1.21 108.764 -172.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.7 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 13.2 t70 -58.44 120.99 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 124.106 0.879 . . . . 2.0 111.456 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.8 t -41.78 -30.91 0.27 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 127.455 2.302 . . . . 0.99 116.128 175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.7 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 4.3 pp -86.32 -31.96 21.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 120.4 1.455 . . . . 1.81 111.023 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -80.15 -13.76 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.46 1.124 . . . . 0.91 109.401 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.736 ' HG3' ' H1 ' ' A' ' 101' ' ' SYO . 3.8 tpt -60.03 -36.09 76.51 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 127.334 2.253 . . . . 1.3 110.403 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 47' ' ' VAL . 58.1 t -66.68 -25.15 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 CA-C-N 115.213 -0.903 . . . . 1.07 110.943 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -77.02 -41.02 44.36 Favored 'General case' 0 C--O 1.215 -0.739 0 O-C-N 121.515 -0.741 . . . . 0.68 109.6 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 t -59.57 -25.83 32.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.177 -0.919 . . . . 1.31 111.66 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.767 HG22 ' H6 ' ' A' ' 101' ' ' SYO . 10.7 p -81.48 -47.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 CA-C-O 122.201 1.0 . . . . 1.29 110.145 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.02 -39.5 85.9 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 CA-C-N 112.869 -1.969 . . . . 1.1 108.749 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 -32.04 72.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.004 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.79 -59.16 4.17 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.952 -1.022 . . . . 1.05 110.122 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.288 0.0 OUTLIER -62.44 -34.69 77.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 114.014 1.116 . . . . 0.64 114.014 -175.635 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.29 -41.82 80.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.449 0.642 . . . . 2.07 111.321 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -81.68 -41.14 21.79 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.259 -0.882 . . . . 3.11 110.812 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.573 ' CE2' HG21 ' A' ' 7' ' ' ILE . 10.4 m-85 -83.65 -44.38 14.6 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 117.735 -1.126 . . . . 0.81 113.454 -172.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 15.8 t70 155.91 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 124.616 1.198 . . . . 1.99 112.55 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.617 HG13 ' HA ' ' A' ' 76' ' ' ILE . 8.6 p -75.29 174.56 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.301 -0.863 . . . . 1.14 112.924 -164.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.3 127.04 52.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.207 -1.775 . . . . 2.7 106.207 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 ' HE2' ' A' ' 75' ' ' TYR . 59.8 mt -118.87 112.42 36.62 Favored Pre-proline 0 C--N 1.293 -1.871 0 C-N-CA 120.216 -0.594 . . . . 1.09 110.09 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.535 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.5 Cg_endo -69.27 155.95 66.05 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.361 2.707 . . . . 0.4 110.554 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.183 0.593 . . . . 1.98 112.128 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.7 m-20 -65.44 -54.24 31.28 Favored 'General case' 0 C--O 1.209 -1.044 0 O-C-N 123.22 0.325 . . . . 2.06 110.538 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.526 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 11.6 m-20 -66.92 -31.85 72.72 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.509 0.559 . . . . 0.52 112.509 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.725 HG12 HG11 ' A' ' 47' ' ' VAL . 41.3 t -50.22 -59.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.281 0.988 . . . . 1.12 109.015 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 14.6 ptmm? -72.61 -1.86 17.75 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.574 -0.739 . . . . 2.73 112.916 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.68 -18.17 21.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.733 0.777 . . . . 1.92 109.418 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.84 HD13 ' HA ' ' A' ' 72' ' ' ALA . 40.1 mt -84.9 116.09 23.14 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.579 -2.008 . . . . 1.04 105.579 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.655 ' HG2' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -111.68 -30.05 7.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 117.982 -1.487 . . . . 2.98 109.65 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.655 HG21 ' HG2' ' A' ' 67' ' ' LYS . 31.1 p -119.14 173.46 6.91 Favored 'General case' 0 N--CA 1.395 -3.204 0 N-CA-C 109.183 -0.673 . . . . 1.03 109.183 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 30' ' ' LYS . 23.7 t -72.01 -18.98 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 108.492 -0.929 . . . . 1.91 108.492 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.54 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -70.13 -40.96 71.36 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 110.142 -1.183 . . . . 0.33 110.142 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.554 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.2 m-20 -67.89 -55.04 14.35 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.547 -0.908 . . . . 1.39 108.547 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.84 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.46 -61.33 2.31 Favored 'General case' 0 CA--C 1.471 -2.058 0 O-C-N 124.875 1.359 . . . . 1.04 111.97 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.618 HG21 ' HG2' ' A' ' 4' ' ' GLN . 50.0 m -57.64 -51.19 70.51 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.591 -1.186 . . . . 1.07 112.682 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.4 OUTLIER -53.49 -49.53 67.3 Favored 'General case' 0 N--CA 1.422 -1.827 0 O-C-N 124.325 1.016 . . . . 4.04 109.601 177.241 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 87.1 t80 -56.96 -52.01 66.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.747 0.819 . . . . 0.9 111.208 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.617 ' HA ' HG13 ' A' ' 56' ' ' VAL . 69.9 mt -52.01 -65.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 124.812 1.32 . . . . 1.12 109.79 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.76 -45.01 70.48 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.144 1.378 . . . . 2.08 110.346 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.59 -30.32 71.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.916 -1.038 . . . . 0.64 111.105 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -100.32 -11.62 20.15 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 113.82 1.044 . . . . 1.59 113.82 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 14.8 mt-30 -80.59 -51.93 8.17 Favored 'General case' 0 CA--C 1.476 -1.898 0 CA-C-O 122.798 1.285 . . . . 1.09 107.641 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.271 -2.846 0 CA-C-N 112.417 -2.174 . . . . 1.97 110.275 -175.569 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.767 ' H6 ' HG22 ' A' ' 47' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.504 -0.822 0 N-CA-C 108.423 -0.954 . . . . 2.01 108.423 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.93 -70.23 0.15 Allowed 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.882 -0.327 . . . . 2.35 111.291 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -159.7 171.2 19.98 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.609 -0.436 . . . . 1.34 111.231 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.587 ' HG2' HG22 ' A' ' 73' ' ' THR . 0.8 OUTLIER -51.85 -37.08 50.57 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.138 1.775 . . . . 0.74 112.423 177.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.4 -35.33 65.23 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 123.735 0.647 . . . . 2.66 111.869 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.48 -31.18 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.358 0.599 . . . . 2.73 109.504 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.608 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 80.4 mt -73.27 -66.44 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 115.775 -0.648 . . . . 1.05 109.985 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 28' ' ' LEU . 96.7 t -52.62 -38.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.067 0.765 . . . . 1.05 113.067 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.27 98.69 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.419 -0.512 . . . . 1.07 109.86 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.473 ' HA2' ' NH1' ' A' ' 53' ' ' ARG . . . -76.34 -39.93 29.8 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.366 -0.834 . . . . 0.21 112.313 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.742 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -67.04 -39.04 86.88 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 123.745 0.818 . . . . 1.03 109.377 -176.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -58.47 -43.68 89.0 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.687 -0.486 . . . . 1.06 109.687 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.556 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 44.4 mt-10 -61.31 -42.78 99.24 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.889 0.743 . . . . 0.68 111.46 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.742 HD13 ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -60.7 -40.76 85.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.342 0.591 . . . . 1.16 110.046 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.731 HG12 ' HB ' ' A' ' 21' ' ' ILE . 23.9 t -73.65 -22.61 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.472 0.654 . . . . 1.14 110.162 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -72.59 -54.04 10.25 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.205 -1.035 . . . . 0.36 108.205 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.14 -44.8 62.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.342 -1.299 . . . . 2.07 113.602 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 42' ' ' SER . 14.5 mt -76.27 -53.33 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.985 -0.686 . . . . 1.31 111.106 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.636 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -91.91 -80.14 0.36 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 1.18 110.809 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.93 40.04 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.16 0 C-N-CA 121.076 -0.583 . . . . 0.43 111.755 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.731 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -82.55 161.14 60.03 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 109.473 -0.566 . . . . 1.06 109.473 178.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.43 ' O ' HG21 ' A' ' 21' ' ' ILE . 6.0 Cg_endo -90.62 141.64 3.26 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.895 2.396 . . . . 1.08 108.415 171.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -72.61 45.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.086 0 N-CA-C 113.98 1.104 . . . . 1.28 113.98 -171.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.51 -20.96 0.43 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.31 1.044 . . . . 2.31 110.548 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.65 -36.44 65.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.122 -0.49 . . . . 1.59 112.105 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.594 HG22 HD12 ' A' ' 36' ' ' LEU . 41.1 t -75.91 93.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.998 -0.546 . . . . 1.07 109.582 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 69' ' ' VAL . 30.8 mmtp -133.17 168.55 18.32 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.821 -1.178 . . . . 2.11 107.821 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.471 HD22 ' HE2' ' A' ' 74' ' ' LYS . 6.3 mp -63.67 146.92 52.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.845 -0.798 . . . . 1.75 108.845 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 t70 78.3 8.39 2.28 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.702 1.251 . . . . 0.72 110.241 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 71.4 mmtt -106.08 125.57 51.16 Favored 'General case' 0 CA--C 1.473 -1.993 0 CA-C-N 115.709 -0.678 . . . . 2.01 109.679 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 4.2 m -81.85 108.78 15.65 Favored 'General case' 0 C--N 1.245 -3.96 0 CA-C-N 114.248 -1.342 . . . . 1.32 108.763 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.866 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.4 m-85 -37.27 -66.69 0.22 Allowed 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.547 1.539 . . . . 0.71 114.197 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.537 ' CG2' H37A ' A' ' 101' ' ' SYO . 4.3 t -85.87 15.5 4.84 Favored 'General case' 0 C--N 1.275 -2.67 0 O-C-N 121.1 -1.0 . . . . 1.36 112.742 -174.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.25 -65.72 0.64 Allowed 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.627 -0.671 . . . . 1.74 111.364 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 21.5 m-20 -68.94 -41.4 78.12 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.311 -0.858 . . . . 1.29 109.962 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.692 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 27.0 mt -79.38 -50.1 11.36 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.618 -0.719 . . . . 1.11 111.024 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 11.2 t70 94.5 68.89 0.0 OUTLIER 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.278 1.611 . . . . 1.12 110.557 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.636 HG11 ' HB1' ' A' ' 19' ' ' ALA . 40.5 t -105.81 162.69 4.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.277 -1.783 . . . . 1.21 110.156 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.25 3.6 5.55 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.49 1.116 . . . . 2.0 113.028 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.413 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.1 p 67.41 -47.58 0.49 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.328 1.851 . . . . 0.99 113.081 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.68 -49.15 77.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.997 0.919 . . . . 1.81 108.783 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.581 ' O ' HG21 ' A' ' 46' ' ' VAL . 2.2 m -63.75 -16.26 60.71 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.987 -1.461 . . . . 0.91 112.314 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.866 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -66.22 -34.48 78.11 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 123.406 0.682 . . . . 1.3 111.393 -176.351 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.59 -38.33 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 109.125 -0.694 . . . . 1.07 109.125 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.87 -44.94 91.58 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.943 -1.132 . . . . 0.68 107.943 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 42' ' ' SER . 97.8 t -57.25 -24.72 21.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.354 -1.294 . . . . 1.31 112.091 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.971 HG11 HG21 ' A' ' 63' ' ' VAL . 23.2 t -78.69 -53.66 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.957 -1.127 . . . . 1.29 107.957 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.73 -31.9 50.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.573 -1.194 . . . . 1.1 109.413 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB1' HG22 ' A' ' 14' ' ' ILE . . . -76.35 -32.01 58.41 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.158 0.504 . . . . 1.0 110.285 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' CB ' ' H8B' ' A' ' 101' ' ' SYO . . . -67.11 -62.86 1.22 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.486 -0.779 . . . . 1.05 109.973 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.264 0.0 OUTLIER -60.69 -37.23 80.95 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 114.411 1.263 . . . . 0.64 114.411 -174.594 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.87 -30.7 67.94 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.4 0.519 . . . . 2.07 112.4 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.473 ' NH1' ' HA2' ' A' ' 10' ' ' GLY . 64.0 ttt180 -88.05 -32.92 18.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.78 0.324 . . . . 3.11 110.96 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.608 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.6 m-85 -95.54 -1.9 49.63 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.066 0.765 . . . . 0.81 113.066 -171.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 1' ' ' ALA . 7.8 m-20 79.75 -2.91 2.06 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.447 1.099 . . . . 1.99 113.328 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.556 ' CG1' HG21 ' A' ' 76' ' ' ILE . 10.0 p -83.92 178.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 N-CA-C 107.985 -1.117 . . . . 1.14 107.985 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HD2' ' OE2' ' A' ' 51' ' ' GLU . 21.3 tptm -136.27 130.76 33.51 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.197 -1.038 . . . . 2.7 108.197 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.509 HG12 ' HE2' ' A' ' 75' ' ' TYR . 37.2 mt -128.96 110.21 18.41 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 123.1 0.25 . . . . 1.09 110.612 -175.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.536 ' O ' HG23 ' A' ' 63' ' ' VAL . 70.1 Cg_endo -74.47 166.84 28.51 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.581 2.187 . . . . 0.4 109.811 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -59.93 -29.24 68.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.149 0.5 . . . . 1.98 110.124 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 25.6 t70 -62.81 -38.92 92.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.288 -0.869 . . . . 2.06 111.307 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.434 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 29.5 m-20 -87.14 -28.33 22.53 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.485 -0.486 . . . . 0.52 111.455 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.971 HG21 HG11 ' A' ' 47' ' ' VAL . 54.1 t -52.1 -46.71 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.16 -0.682 . . . . 1.12 109.16 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 45.7 pttt -70.9 -2.16 14.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.064 -0.971 . . . . 2.73 113.086 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 95.4 m-20 -96.06 -34.93 11.55 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.828 0.347 . . . . 1.92 110.399 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.731 HD11 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -76.32 112.68 13.06 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.913 -0.773 . . . . 1.04 108.913 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -33.52 7.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.551 0.691 . . . . 2.98 110.361 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.0 p -116.02 169.36 9.32 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.795 -1.187 . . . . 1.03 107.795 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.487 HG22 ' HG1' ' A' ' 73' ' ' THR . 0.5 OUTLIER -78.65 -13.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 119.831 -0.747 . . . . 1.91 109.293 175.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.14 -44.63 86.63 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.953 -1.659 . . . . 0.33 108.953 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.34 -48.99 71.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.498 -0.926 . . . . 1.39 108.498 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.731 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -57.26 -61.65 2.32 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 114.851 -1.068 . . . . 1.04 111.424 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.587 HG22 ' HG2' ' A' ' 4' ' ' GLN . 28.1 m -58.64 -39.67 81.2 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 113.997 1.11 . . . . 1.07 113.997 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.471 ' HE2' HD22 ' A' ' 28' ' ' LEU . 5.3 mptp? -60.91 -51.08 70.8 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.2 -1.037 . . . . 4.04 108.2 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.509 ' HE2' HG12 ' A' ' 58' ' ' ILE . 89.6 t80 -55.88 -49.13 74.23 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.29 0.994 . . . . 0.9 110.687 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.629 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 78.1 mt -57.67 -66.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.022 -0.99 . . . . 1.12 111.109 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -52.46 -47.1 66.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.532 1.533 . . . . 2.08 109.799 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 14.0 t70 -66.72 -28.17 68.21 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.238 -1.346 . . . . 0.64 110.931 -172.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -103.47 -2.4 26.92 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 113.403 0.89 . . . . 1.59 113.403 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 59.8 mt-30 -78.78 -63.58 1.38 Allowed 'General case' 0 CA--C 1.468 -2.201 0 N-CA-C 106.699 -1.593 . . . . 1.09 106.699 175.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.277 -2.565 0 CA-C-N 111.5 -2.591 . . . . 1.97 109.805 -178.738 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.712 ' H8A' ' HB1' ' A' ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.504 -0.815 0 N-CA-C 108.285 -1.006 . . . . 2.01 108.285 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.68 -72.48 0.4 Allowed 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.089 -0.645 . . . . 2.35 111.876 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 t -171.08 -179.11 2.63 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 120.569 -0.452 . . . . 1.34 111.02 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.455 ' HG2' HG23 ' A' ' 8' ' ' VAL . 6.1 tm0? -57.43 -35.04 69.58 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 125.679 1.591 . . . . 0.74 112.469 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.76 -24.36 67.67 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.632 0.583 . . . . 2.66 111.335 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 -44.02 11.46 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.854 -0.795 . . . . 2.73 108.854 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.582 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 79.3 mt -64.31 -64.99 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.72 0 CA-C-N 116.158 -0.474 . . . . 1.05 112.012 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.455 HG23 ' HG2' ' A' ' 4' ' ' GLN . 55.2 t -56.97 -39.26 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 112.026 0.38 . . . . 1.05 112.026 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.74 -36.49 84.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.231 0.539 . . . . 1.07 110.576 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.55 -40.87 8.67 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 115.779 -0.646 . . . . 0.21 112.92 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -64.84 -36.07 83.15 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.491 -0.929 . . . . 1.03 108.491 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.711 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.52 -51.67 67.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.771 -0.65 . . . . 1.06 109.39 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.638 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.6 mt-10 -58.12 -41.9 84.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 124.204 0.94 . . . . 0.68 112.499 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 11' ' ' LEU . 76.7 mt -58.11 -43.42 85.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.503 -0.771 . . . . 1.16 109.701 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.576 HG12 ' HB ' ' A' ' 21' ' ' ILE . 86.1 t -68.82 -23.89 28.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.872 0.844 . . . . 1.14 110.679 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.638 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.2 m120 -75.06 -42.62 56.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.335 -0.987 . . . . 0.36 108.335 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.31 -41.19 57.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.845 -1.07 . . . . 2.07 111.636 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.709 HG13 HG21 ' A' ' 46' ' ' VAL . 30.8 mm -70.45 -53.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 116.701 -0.227 . . . . 1.31 111.007 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' HG12 ' A' ' 38' ' ' VAL . . . -106.31 -82.45 0.54 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.013 0.435 . . . . 1.18 110.607 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.34 43.96 0.02 OUTLIER Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.561 -0.828 . . . . 0.43 112.419 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.641 HG21 HG22 ' A' ' 26' ' ' VAL . 1.6 mp -80.52 151.06 71.33 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.859 -0.423 . . . . 1.06 109.859 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.9 Cg_exo -86.17 33.3 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.155 2.57 . . . . 1.08 114.056 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.265 9.8 p 56.61 -20.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 C-N-CA 127.052 2.141 . . . . 1.28 116.433 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' PRO . 11.4 pt-20 -95.51 -13.94 24.08 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.554 -0.716 . . . . 2.31 112.54 -174.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 29.8 t0 -84.45 -28.2 26.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.728 0.775 . . . . 1.59 110.023 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.711 HG21 ' HA ' ' A' ' 12' ' ' ALA . 25.5 t -73.6 93.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.577 -1.192 . . . . 1.07 109.072 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' O ' HG11 ' A' ' 69' ' ' VAL . 33.3 mmtp -131.09 151.88 50.97 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 106.954 -1.498 . . . . 2.11 106.954 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.7 mt -50.09 143.53 8.07 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.763 0.665 . . . . 1.75 109.531 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 82.8 4.81 0.97 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.9 1.28 . . . . 0.72 111.129 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -103.6 132.83 49.5 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 108.936 -0.764 . . . . 2.01 108.936 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 57.9 m -86.53 116.96 25.0 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 124.047 0.842 . . . . 1.32 109.666 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.717 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 94.6 m-85 -45.65 -67.46 0.28 Allowed 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 125.17 1.388 . . . . 0.71 114.178 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 t -71.79 -25.85 62.19 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.685 -1.259 . . . . 1.36 111.843 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 7.3 m-20 -87.62 -64.18 1.19 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.406 0.622 . . . . 1.74 110.972 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 31' ' ' SER . 4.5 m-20 -74.29 -57.6 3.84 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 115.282 -0.872 . . . . 1.29 110.439 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.65 HD11 HG23 ' A' ' 26' ' ' VAL . 16.8 mt -68.17 -38.24 81.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.015 -0.993 . . . . 1.11 111.122 -172.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 30.2 t70 82.84 64.98 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.459 1.6 . . . . 1.12 109.558 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 19' ' ' ALA . 21.8 t -108.78 159.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 112.463 -2.153 . . . . 1.21 106.548 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.63 120.23 19.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.361 -0.977 . . . . 2.0 108.361 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.425 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 5.0 p -49.11 -38.15 23.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.078 0.951 . . . . 0.99 112.306 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.406 HD13 ' N ' ' A' ' 42' ' ' SER . 3.9 pp -70.63 -28.42 64.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.16 0.43 . . . . 1.81 112.16 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 46' ' ' VAL . 50.0 m -82.04 -15.7 52.72 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.425 0.631 . . . . 0.91 110.266 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.657 ' O ' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -58.92 -37.35 76.48 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-N 115.445 -0.798 . . . . 1.3 111.715 -179.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.29 -45.72 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 124.087 0.867 . . . . 1.07 109.421 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.31 -49.79 74.99 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 108.615 -0.883 . . . . 0.68 108.615 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.709 HG21 HG13 ' A' ' 18' ' ' ILE . 54.2 t -57.34 -29.98 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.971 1.308 . . . . 1.31 111.672 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.843 HG23 HG13 ' A' ' 63' ' ' VAL . 38.3 t -76.96 -49.68 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.336 0 N-CA-C 108.294 -1.002 . . . . 1.29 108.294 -176.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.27 -35.5 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-N 114.692 -1.14 . . . . 1.1 108.777 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.29 76.25 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.538 0.685 . . . . 1.0 109.915 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.71 -58.35 7.77 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 114.932 -1.031 . . . . 1.05 109.843 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.627 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.257 0.0 OUTLIER -61.15 -37.03 81.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.056 1.132 . . . . 0.64 114.056 -177.375 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.69 -37.58 76.39 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.296 0.373 . . . . 2.07 111.401 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -84.73 -37.84 20.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.052 0.389 . . . . 3.11 112.052 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.582 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.0 m-85 -92.68 -11.03 35.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.352 1.242 . . . . 0.81 114.352 -170.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 1' ' ' ALA . 25.2 m-20 87.51 4.22 0.33 Allowed 'General case' 0 N--CA 1.519 2.995 0 N-CA-C 114.448 1.277 . . . . 1.99 114.448 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.1 p -84.12 175.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.183 -1.414 . . . . 1.14 107.183 175.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 20.5 tptp -131.75 122.35 25.7 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.887 -1.894 . . . . 2.7 105.887 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.568 HG13 ' HB3' ' A' ' 51' ' ' GLU . 52.4 mt -113.72 107.05 53.25 Favored Pre-proline 0 C--N 1.291 -1.969 0 C-N-CA 119.754 -0.778 . . . . 1.09 110.618 -174.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.553 ' O ' HG23 ' A' ' 63' ' ' VAL . 36.3 Cg_endo -64.8 152.38 82.3 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 C-N-CA 122.948 2.432 . . . . 0.4 109.739 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.2 -33.57 53.34 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.561 0.744 . . . . 1.98 111.153 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 21.5 t70 -62.43 -43.51 98.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.546 -0.752 . . . . 2.06 111.679 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 40.9 m-20 -86.46 -21.83 26.82 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.403 0.52 . . . . 0.52 112.403 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.843 HG13 HG23 ' A' ' 47' ' ' VAL . 51.1 t -53.68 -50.43 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.246 -1.02 . . . . 1.12 108.246 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.1 pttp -79.55 -1.47 37.96 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.523 -1.217 . . . . 2.73 111.332 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.25 -18.84 24.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.295 -1.002 . . . . 1.92 108.295 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.838 HD13 ' HA ' ' A' ' 72' ' ' ALA . 27.6 mt -90.38 117.82 29.39 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 106.783 -1.562 . . . . 1.04 106.783 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HZ1' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -104.82 -37.63 6.96 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.695 -0.802 . . . . 2.98 110.769 175.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 41.1 p -109.73 178.87 4.29 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 109.486 -0.561 . . . . 1.03 109.486 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.717 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -85.08 -13.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.365 -0.976 . . . . 1.91 108.365 173.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -67.5 -49.07 53.52 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 107.165 -2.374 . . . . 0.33 107.165 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' CG ' ' HZ1' ' A' ' 67' ' ' LYS . 8.6 m-20 -56.43 -57.09 13.81 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 124.95 1.3 . . . . 1.39 110.411 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.838 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.34 -60.99 2.56 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.442 1.089 . . . . 1.04 111.667 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.406 ' HA ' HG21 ' A' ' 7' ' ' ILE . 34.4 m -60.39 -45.33 93.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 113.26 0.837 . . . . 1.07 113.26 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.502 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.6 mptm? -63.52 -22.72 67.05 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 122.651 0.38 . . . . 4.04 110.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -82.2 -52.92 6.49 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 116.041 -0.527 . . . . 0.9 109.599 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.722 ' HA ' HG21 ' A' ' 56' ' ' VAL . 71.6 mt -52.74 -66.93 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 C-N-CA 124.827 1.251 . . . . 1.12 111.351 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 HD22 ' C ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -52.95 -39.91 63.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.552 1.541 . . . . 2.08 111.9 -177.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 6.1 t70 -72.69 -26.29 61.56 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 113.261 -1.791 . . . . 0.64 111.481 -175.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -103.08 -8.59 20.42 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.994 0.739 . . . . 1.59 112.994 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 60.7 mt-30 -76.79 -65.8 0.9 Allowed 'General case' 0 CA--C 1.476 -1.88 0 CA-C-O 123.104 1.43 . . . . 1.09 108.225 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.418 ' H ' ' HB2' ' A' ' 80' ' ' GLN . . . . . . . . 0 C--N 1.268 -2.966 0 CA-C-N 111.821 -2.445 . . . . 1.97 109.694 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.634 ' H2A' ' N41' ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.479 ' H3 ' ' CD ' ' A' ' 6' ' ' GLU . . . . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 109.354 -0.61 . . . . 2.01 109.354 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.49 -71.56 0.1 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.994 -0.548 . . . . 2.35 109.571 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 15.1 t -166.43 175.13 8.37 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 116.241 -0.436 . . . . 1.34 109.869 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.566 ' HA ' HD13 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -47.71 -39.92 18.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.163 1.385 . . . . 0.74 113.238 174.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -59.2 -22.56 61.2 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.519 0.933 . . . . 2.66 113.519 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' CD ' ' H3 ' ' A' ' 1' ' ' ALA . 29.9 tt0 -79.15 -39.82 32.5 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.806 -0.812 . . . . 2.73 108.806 174.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.634 ' CD1' ' HB2' ' A' ' 77' ' ' LEU . 63.9 mt -76.7 -66.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.643 -1.162 . . . . 1.05 111.526 -169.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 28' ' ' LEU . 48.1 t -56.51 -47.08 82.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 111.554 0.205 . . . . 1.05 111.554 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.35 -36.2 66.04 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.75 0.656 . . . . 1.07 112.212 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.4 -43.87 6.79 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 120.907 -0.663 . . . . 0.21 112.21 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.505 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -61.09 -39.9 91.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 124.402 1.081 . . . . 1.03 109.216 -177.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.679 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -56.31 -48.2 77.17 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 115.897 -0.592 . . . . 1.06 109.905 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.694 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 97.3 mt-10 -63.59 -34.09 77.04 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.983 0.802 . . . . 0.68 112.278 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.505 HD11 ' HA ' ' A' ' 11' ' ' LEU . 58.9 mt -68.26 -38.8 80.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.829 -0.623 . . . . 1.16 109.495 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 11' ' ' LEU . 59.7 t -72.26 -23.6 21.61 Favored 'Isoleucine or valine' 0 C--O 1.253 1.279 0 CA-C-O 121.427 0.632 . . . . 1.14 110.206 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.694 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 7.0 m120 -62.5 -37.83 87.54 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.776 -0.824 . . . . 0.36 108.776 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -84.08 -47.64 10.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 2.07 112.309 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.839 HG13 ' HB ' ' A' ' 46' ' ' VAL . 25.0 mm -54.2 -52.38 38.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.654 0.782 . . . . 1.31 111.427 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -118.51 -56.66 2.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.118 0.485 . . . . 1.18 110.832 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 16' ' ' ASN . . . 135.95 40.6 0.14 Allowed Glycine 0 CA--C 1.49 -1.529 0 C-N-CA 120.292 -0.956 . . . . 0.43 112.29 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.8 HG22 HG21 ' A' ' 26' ' ' VAL . 1.4 mp -75.64 147.31 81.45 Favored Pre-proline 0 C--O 1.202 -1.413 0 N-CA-C 109.06 -0.719 . . . . 1.06 109.06 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.3 Cg_exo -85.44 34.5 0.49 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 123.232 2.621 . . . . 1.08 113.992 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.274 9.8 p 56.9 -15.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 C-N-CA 127.326 2.251 . . . . 1.28 116.513 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 22' ' ' PRO . 12.2 pt-20 -96.24 -18.6 19.92 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.638 -0.664 . . . . 2.31 111.615 -176.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -85.42 -24.7 27.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 120.29 -0.564 . . . . 1.59 110.609 -170.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.8 HG21 HG22 ' A' ' 21' ' ' ILE . 42.6 t -72.54 92.58 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.852 -1.166 . . . . 1.07 107.852 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 69' ' ' VAL . 9.4 tppt? -125.16 160.37 29.3 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.801 -2.296 . . . . 2.11 104.801 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.485 ' HA ' HG23 ' A' ' 69' ' ' VAL . 6.4 mp -64.22 148.72 49.46 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 118.624 0.647 . . . . 1.75 109.651 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 t70 76.98 11.58 2.4 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.506 -1.225 . . . . 0.72 110.665 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 35.8 mmtp -99.04 122.95 42.96 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 108.927 -0.768 . . . . 2.01 108.927 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 39.2 m -76.82 28.04 0.13 Allowed 'General case' 1 C--N 1.242 -4.071 0 C-N-CA 126.643 1.977 . . . . 1.32 114.854 -172.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.692 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 91.0 m-85 44.62 -93.0 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.71 113.698 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.3 t -77.27 44.02 0.4 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.399 1.095 . . . . 1.36 111.229 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.9 t70 -159.46 -55.47 0.06 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 108.858 -0.793 . . . . 1.74 108.858 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.524 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 33.4 m-20 -84.2 -34.95 23.83 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.134 -0.939 . . . . 1.29 111.955 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 33.3 mt -85.11 -88.94 0.11 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.31 -0.626 . . . . 1.11 109.31 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.6 t70 157.11 64.67 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.609 -1.997 . . . . 1.12 105.609 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.599 HG13 ' HE2' ' A' ' 43' ' ' MET . 4.9 t -118.81 150.77 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.635 -0.712 . . . . 1.21 110.142 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.16 110.12 9.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.752 . . . . 2.0 108.968 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.448 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 29.5 t -41.06 -47.45 3.13 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.735 1.614 . . . . 0.99 114.071 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.67 -34.49 78.41 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.063 -0.398 . . . . 1.81 111.45 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -82.2 -13.12 57.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.195 0.522 . . . . 0.91 111.002 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.692 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.26 -36.97 79.02 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 123.361 0.665 . . . . 1.3 110.289 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.11 -47.13 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 O-C-N 123.836 0.71 . . . . 1.07 110.31 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -56.69 -53.64 55.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.216 0.607 . . . . 0.68 110.358 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.839 ' HB ' HG13 ' A' ' 18' ' ' ILE 0.34 1.7 p -61.92 -22.59 29.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 N-CA-C 114.228 1.195 . . . . 1.31 114.228 -178.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.968 HG23 ' H6A' ' A' ' 101' ' ' SYO . 44.5 t -71.23 -50.38 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.746 -1.205 . . . . 1.29 107.746 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.28 -35.24 73.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 108.397 -0.964 . . . . 1.1 108.397 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 46' ' ' VAL . . . -68.06 -35.25 77.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.308 -0.86 . . . . 1.0 109.947 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.73 -59.08 4.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.508 -1.224 . . . . 1.05 109.102 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.273 0.0 OUTLIER -59.96 -39.31 85.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 114.461 1.282 . . . . 0.64 114.461 -175.135 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -58.92 -40.58 85.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.92 0.391 . . . . 2.07 111.835 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.9 -27.14 43.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.109 -0.496 . . . . 3.11 111.059 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.462 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 7.1 m-85 -104.27 3.06 32.25 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.675 -0.81 . . . . 0.81 112.322 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.479 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 28.0 t70 80.46 -5.68 1.75 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.821 1.248 . . . . 1.99 112.851 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.532 HG23 ' HA ' ' A' ' 76' ' ' ILE . 10.6 p -82.02 173.43 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 121.29 -0.881 . . . . 1.14 109.205 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -128.62 127.28 41.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.552 -1.647 . . . . 2.7 106.552 174.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' A' ' 51' ' ' GLU . 64.0 mt -119.42 111.99 36.09 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.736 -0.386 . . . . 1.09 110.921 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.513 ' O ' HG22 ' A' ' 63' ' ' VAL . 58.7 Cg_endo -69.25 159.83 52.23 Favored 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 123.047 2.498 . . . . 0.4 110.808 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 22.1 t70 -52.78 -41.45 64.11 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.73 0.812 . . . . 1.98 112.116 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.5 -32.12 72.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.933 -0.576 . . . . 2.06 110.938 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.574 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 20.0 m-20 -86.3 -24.96 25.72 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.342 -0.543 . . . . 0.52 111.839 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.92 HG11 HG21 ' A' ' 47' ' ' VAL . 52.7 t -54.38 -51.58 47.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.588 -1.264 . . . . 1.12 107.588 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -78.51 -2.66 39.74 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.944 -1.026 . . . . 2.73 111.609 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -88.26 -29.67 20.24 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.935 -1.135 . . . . 1.92 107.935 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 72' ' ' ALA . 29.4 mt -82.56 113.41 20.26 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 107.583 -1.265 . . . . 1.04 107.583 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -106.77 -40.2 5.58 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 119.866 -0.734 . . . . 2.98 109.129 176.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 p -108.26 178.29 4.54 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 119.715 -0.794 . . . . 1.03 109.307 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.617 HG22 ' HG1' ' A' ' 73' ' ' THR . 0.5 OUTLIER -86.63 -13.06 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.296 -1.002 . . . . 1.91 108.296 175.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.63 59.59 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 108.114 -1.994 . . . . 0.33 108.114 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.1 -60.56 2.52 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.069 1.348 . . . . 1.39 109.492 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.75 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.49 -60.47 3.1 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 114.473 -1.239 . . . . 1.04 111.961 -176.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.617 ' HG1' HG22 ' A' ' 69' ' ' VAL . 61.6 m -59.39 -39.93 84.93 Favored 'General case' 0 N--CA 1.419 -2.0 0 O-C-N 124.102 0.877 . . . . 1.07 112.611 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HD3' ' N ' ' A' ' 75' ' ' TYR . 9.7 tmtt? -61.37 -50.76 71.6 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.456 -0.942 . . . . 4.04 108.456 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.489 ' HE2' HG12 ' A' ' 58' ' ' ILE . 85.2 t80 -56.51 -50.71 71.0 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.321 1.013 . . . . 0.9 110.814 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.63 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -55.2 -66.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 114.009 -1.45 . . . . 1.12 110.223 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 64.5 tp -55.45 -38.4 68.98 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 123.968 0.907 . . . . 2.08 112.349 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.49 -28.75 67.3 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.363 -0.835 . . . . 0.64 111.194 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -102.03 -14.8 17.0 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.417 0.895 . . . . 1.59 113.417 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.63 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 66.7 mt-30 -66.43 -59.44 3.67 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 123.219 1.485 . . . . 1.09 107.753 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.259 -3.337 0 CA-C-N 111.092 -2.776 . . . . 1.97 108.823 -179.263 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.968 ' H6A' HG23 ' A' ' 47' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 109.546 -0.539 . . . . 2.01 109.546 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.06 -155.64 0.23 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.457 -1.312 . . . . 2.35 107.457 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t -131.96 -170.99 2.51 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.954 -0.387 . . . . 1.34 109.954 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -49.12 -41.44 36.04 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.817 1.247 . . . . 0.74 113.552 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.59 -25.51 67.38 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.452 0.538 . . . . 2.66 112.452 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -87.19 -30.77 20.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.751 0.786 . . . . 2.73 109.108 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.411 HG21 ' CE2' ' A' ' 54' ' ' PHE . 96.1 mt -79.7 -65.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 CA-C-N 115.26 -0.882 . . . . 1.05 110.987 -172.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.3 t -54.18 -46.71 67.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 122.568 0.347 . . . . 1.05 111.925 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.12 73.93 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.496 0.497 . . . . 1.07 111.546 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.77 -33.24 19.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.941 -0.572 . . . . 0.21 112.906 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.733 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -69.55 -34.66 74.53 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.044 -1.095 . . . . 1.03 108.044 -178.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.706 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.05 -46.47 75.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.28 -0.873 . . . . 1.06 108.826 173.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.652 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 41.9 mt-10 -61.61 -43.02 99.64 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 124.276 0.985 . . . . 0.68 111.86 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' A' ' 11' ' ' LEU . 66.5 mt -58.71 -39.72 77.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.591 0.71 . . . . 1.16 109.644 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.733 HG11 ' HB ' ' A' ' 21' ' ' ILE . 62.7 t -70.74 -21.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.897 0.856 . . . . 1.14 110.015 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.652 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.0 m120 -80.47 -50.34 10.19 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.628 -1.249 . . . . 0.36 107.628 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.53 -50.25 59.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 2.07 112.279 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.01 -53.32 21.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.244 0.545 . . . . 1.31 109.86 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.56 -90.24 0.29 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.175 -0.466 . . . . 1.18 111.242 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.94 38.75 0.02 OUTLIER Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.599 -0.81 . . . . 0.43 113.104 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.733 ' HB ' HG11 ' A' ' 15' ' ' VAL . 1.4 mp -80.99 155.1 72.87 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 109.417 -0.586 . . . . 1.06 109.417 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 24' ' ' GLU . 4.8 Cg_exo -88.46 32.66 0.39 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.938 3.092 . . . . 1.08 114.768 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.411 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 5.2 p 60.05 -21.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.07 0 C-N-CA 127.147 2.179 . . . . 1.28 116.063 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 22' ' ' PRO . 44.9 mm-40 -93.23 -20.32 20.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 112.691 0.626 . . . . 2.31 112.691 -174.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.83 -30.77 51.25 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 120.74 -0.384 . . . . 1.59 111.258 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' A' ' 12' ' ' ALA . 34.7 t -72.89 97.88 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.28 -0.873 . . . . 1.07 109.672 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -135.69 151.03 49.78 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 104.413 -2.439 . . . . 2.11 104.413 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD21 ' HA2' ' A' ' 70' ' ' GLY . 49.3 mt -50.96 148.49 4.2 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.59 0.632 . . . . 1.75 109.574 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.7 t70 76.98 18.88 1.45 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.976 1.37 . . . . 0.72 109.94 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -119.21 128.46 54.23 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 114.703 -1.135 . . . . 2.01 108.442 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 5.7 m -87.36 112.1 21.77 Favored 'General case' 0 C--N 1.244 -3.983 0 N-CA-C 107.417 -1.327 . . . . 1.32 107.417 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.768 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.1 m-85 -46.63 -47.23 20.09 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.436 1.095 . . . . 0.71 112.708 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.421 HG22 ' C37' ' A' ' 101' ' ' SYO . 15.3 t -98.86 21.75 11.1 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 112.574 0.583 . . . . 1.36 112.574 -174.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 13.6 t70 -146.48 -56.89 0.28 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 1.74 109.792 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.22 -39.27 55.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.881 -1.054 . . . . 1.29 110.402 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.698 HD11 ' HA ' ' A' ' 32' ' ' PHE . 35.6 mt -83.61 -93.17 0.07 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.513 -0.767 . . . . 1.11 110.365 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 32.6 t70 168.09 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 121.349 0.595 . . . . 1.12 111.127 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG12 ' HE3' ' A' ' 43' ' ' MET . 41.5 t -77.29 134.82 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 O-C-N 121.178 -0.951 . . . . 1.21 112.039 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.478 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 5.3 t70 -47.37 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 129.218 3.007 . . . . 2.0 117.297 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 43' ' ' MET . 30.5 t 75.03 -54.96 0.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.455 1.279 . . . . 0.99 114.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -74.58 -29.28 61.27 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.085 -1.446 . . . . 1.81 109.37 178.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 46' ' ' VAL . 67.3 m -70.6 -16.09 62.81 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.157 -0.929 . . . . 0.91 111.412 173.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.626 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -62.24 -41.35 98.34 Favored 'General case' 0 CA--C 1.473 -1.993 0 C-N-CA 123.101 0.56 . . . . 1.3 111.851 -178.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -57.29 -43.13 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 124.302 1.001 . . . . 1.07 109.734 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -56.5 -47.51 79.16 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.855 -0.611 . . . . 0.68 109.782 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 42' ' ' SER . 40.3 t -60.91 -24.59 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.32 -0.855 . . . . 1.31 111.107 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 1.031 HG21 ' H6A' ' A' ' 101' ' ' SYO . 29.2 t -81.11 -53.07 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 108.182 -1.044 . . . . 1.29 108.182 -177.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 -29.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.739 -1.119 . . . . 1.1 109.762 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.57 58.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.58 -53.63 44.73 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.103 -0.953 . . . . 1.05 109.272 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.577 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.258 0.0 OUTLIER -63.97 -34.93 79.09 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.663 0.986 . . . . 0.64 113.663 -177.716 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -64.28 -36.89 85.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.117 0.484 . . . . 2.07 111.375 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.61 -35.91 20.69 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.451 -0.795 . . . . 3.11 111.891 -172.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 11.4 m-85 -89.76 -45.1 9.54 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 118.926 -1.11 . . . . 0.81 113.185 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 13.5 t70 154.11 -33.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 124.618 1.199 . . . . 1.99 111.781 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' A' ' 79' ' ' HIS . 9.3 p -76.85 -177.0 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.449 0.537 . . . . 1.14 112.449 -165.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -135.98 131.37 34.97 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.721 -1.585 . . . . 2.7 106.721 169.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.577 HG13 ' HB3' ' A' ' 51' ' ' GLU . 45.4 mt -122.03 111.64 32.26 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 123.425 0.453 . . . . 1.09 110.347 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.596 ' O ' HG21 ' A' ' 63' ' ' VAL . 59.9 Cg_endo -72.31 160.34 47.28 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.982 2.455 . . . . 0.4 110.634 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.11 -43.32 41.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.751 . . . . 1.98 111.74 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.64 -34.22 77.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 2.06 112.68 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.603 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 67.0 m-20 -86.15 -28.22 24.1 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.113 -0.635 . . . . 0.52 110.993 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.887 HG12 HG22 ' A' ' 47' ' ' VAL . 76.8 t -55.61 -55.46 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.363 -0.977 . . . . 1.12 108.363 174.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -69.62 -1.19 8.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.927 -1.033 . . . . 2.73 112.891 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.86 -23.5 16.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.86 -1.163 . . . . 1.92 107.86 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 1.043 ' HB2' ' H4A' ' A' ' 101' ' ' SYO . 21.6 mt -91.59 125.17 36.23 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 106.726 -1.583 . . . . 1.04 106.726 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -113.24 -39.63 4.11 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.336 -0.987 . . . . 2.98 108.336 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.8 p -104.53 179.58 4.23 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-N 115.463 -0.79 . . . . 1.03 109.887 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.768 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -87.08 -13.95 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 108.237 -1.024 . . . . 1.91 108.237 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.426 ' HA2' HD21 ' A' ' 28' ' ' LEU . . . -69.03 -47.59 53.12 Favored Glycine 0 CA--C 1.492 -1.39 0 N-CA-C 107.437 -2.265 . . . . 0.33 107.437 172.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 23.7 m-20 -56.6 -55.91 28.04 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 125.271 1.429 . . . . 1.39 110.925 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.876 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -54.56 -60.49 3.28 Favored 'General case' 0 CA--C 1.479 -1.763 0 O-C-N 124.472 1.107 . . . . 1.04 112.166 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.762 HG22 HD21 ' A' ' 77' ' ' LEU . 33.7 m -54.55 -51.48 65.09 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.013 -0.994 . . . . 1.07 112.949 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 4.9 mptp? -51.07 -29.25 12.41 Favored 'General case' 0 C--O 1.197 -1.675 0 C-N-CA 126.749 2.019 . . . . 4.04 111.444 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.603 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 73.1 t80 -85.21 -48.89 8.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.61 -0.723 . . . . 0.9 109.333 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.638 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.9 mt -56.51 -63.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 114.697 -1.138 . . . . 1.12 109.372 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.762 HD21 HG22 ' A' ' 73' ' ' THR . 4.5 pp -56.97 -36.58 70.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.734 0.778 . . . . 2.08 112.622 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 5.5 t70 -76.5 -26.74 55.59 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.472 -1.24 . . . . 0.64 111.276 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.609 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 20.5 t-80 -94.98 -16.38 22.81 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.003 -0.544 . . . . 1.59 109.983 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.638 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 32.7 mt-30 -76.07 -56.67 4.44 Favored 'General case' 0 CA--C 1.478 -1.789 0 CA-C-O 122.729 1.252 . . . . 1.09 108.187 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.735 0 CA-C-N 112.328 -2.215 . . . . 1.97 110.821 -173.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 1.043 ' H4A' ' HB2' ' A' ' 66' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.965 0 N-CA-C 106.945 -1.502 . . . . 2.01 106.945 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . . . -146.57 132.69 19.33 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 116.405 -0.361 . . . . 2.35 111.169 -169.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.443 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.7 t -89.34 176.1 7.07 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 105.874 -1.898 . . . . 1.34 105.874 171.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.407 ' HG2' HG21 ' A' ' 8' ' ' VAL . 11.5 tm0? -46.62 -46.76 19.94 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.823 1.416 . . . . 0.74 114.823 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.36 -23.54 65.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.966 1.099 . . . . 2.66 113.966 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 2' ' ' ALA . 8.8 tp10 -87.95 -33.99 18.25 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.426 -0.953 . . . . 2.73 108.426 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.603 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.3 mt -72.0 -65.35 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.515 0 CA-C-N 115.955 -0.566 . . . . 1.05 110.61 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.511 HG12 HG23 ' A' ' 69' ' ' VAL . 26.4 t -59.85 -26.7 36.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 111.934 0.346 . . . . 1.05 111.934 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.42 -37.91 68.52 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.942 -0.703 . . . . 1.07 110.124 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.68 -36.44 11.85 Favored Glycine 0 N--CA 1.419 -2.456 0 CA-C-N 116.186 -0.461 . . . . 0.21 113.068 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.724 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.07 -35.36 80.32 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.571 -0.899 . . . . 1.03 108.571 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.799 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -57.08 -44.3 82.99 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.87 -0.605 . . . . 1.06 109.74 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.678 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 46.4 mt-10 -62.69 -42.55 99.69 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.175 -0.92 . . . . 0.68 111.834 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.724 HD11 ' HA ' ' A' ' 11' ' ' LEU . 50.2 mt -61.14 -36.63 73.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.923 0.868 . . . . 1.16 109.848 177.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.682 HG13 ' HB ' ' A' ' 21' ' ' ILE . 60.5 t -74.97 -23.27 17.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.224 -0.898 . . . . 1.14 110.325 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.678 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 9.0 m120 -70.25 -46.35 64.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.631 -0.877 . . . . 0.36 108.631 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.06 -49.38 17.66 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.997 -1.001 . . . . 2.07 113.482 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.64 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.9 mt -75.64 -51.1 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 112.327 0.492 . . . . 1.31 112.327 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -91.68 -75.28 0.48 Allowed 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.273 -0.571 . . . . 1.18 110.384 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.54 41.0 0.04 OUTLIER Glycine 0 C--N 1.3 -1.442 0 CA-C-N 115.564 -0.744 . . . . 0.43 112.572 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.805 HG21 HG21 ' A' ' 26' ' ' VAL . 1.5 mp -81.98 150.66 65.66 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 109.055 -0.72 . . . . 1.06 109.055 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 8.2 Cg_exo -87.02 33.46 0.43 Allowed 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 124.348 3.365 . . . . 1.08 114.27 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.412 ' CA ' HD22 ' A' ' 16' ' ' ASN 0.324 9.2 p 60.81 -18.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.091 2.157 . . . . 1.28 116.597 175.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -96.79 -11.34 25.07 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.391 -0.818 . . . . 2.31 111.79 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.4 m-20 -79.73 -33.2 41.02 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.094 0.474 . . . . 1.59 110.495 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.805 HG21 HG21 ' A' ' 21' ' ' ILE . 40.9 t -72.83 93.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.969 -1.014 . . . . 1.07 110.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -124.7 168.23 13.46 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.69 -1.596 . . . . 2.11 106.69 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.556 ' HA ' HG22 ' A' ' 69' ' ' VAL . 5.8 mp -68.05 151.19 47.44 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.905 -1.146 . . . . 1.75 107.905 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 t70 76.68 12.84 2.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.282 1.039 . . . . 0.72 109.548 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 68' ' ' THR . 72.2 mmtt -111.65 125.21 53.71 Favored 'General case' 0 CA--C 1.458 -2.576 0 O-C-N 121.7 -0.625 . . . . 2.01 110.442 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 12.2 m -80.26 111.89 17.07 Favored 'General case' 0 C--N 1.247 -3.854 0 CA-C-N 114.428 -1.26 . . . . 1.32 108.213 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.534 ' HA ' HD12 ' A' ' 36' ' ' LEU . 90.8 m-85 -48.41 -55.48 10.73 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.445 0.698 . . . . 0.71 110.548 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.649 HG23 H37A ' A' ' 101' ' ' SYO . 12.3 t -84.08 25.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.595 0.591 . . . . 1.36 112.595 -175.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -156.11 -62.14 0.11 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.535 0.684 . . . . 1.74 111.237 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -70.79 -39.52 73.08 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 124.368 1.067 . . . . 1.29 110.466 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.569 HD11 HG22 ' A' ' 26' ' ' VAL . 16.4 mt -88.11 -50.44 6.39 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.202 -0.908 . . . . 1.11 110.802 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 95.03 68.66 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.852 2.061 . . . . 1.12 110.723 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.808 HG12 ' HE3' ' A' ' 43' ' ' MET . 47.4 t -101.42 132.45 47.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 CA-C-N 113.366 -1.743 . . . . 1.21 106.577 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -62.68 20.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.545 2.054 . . . . 2.0 116.545 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 43' ' ' MET . 28.6 t 61.99 -57.89 0.12 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 116.139 1.903 . . . . 0.99 116.139 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.57 -29.58 70.82 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.953 0.882 . . . . 1.81 109.987 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.64 ' HB3' HG22 ' A' ' 18' ' ' ILE . 1.6 m -75.05 -22.52 58.34 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.277 -1.329 . . . . 0.91 110.656 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.808 ' HE3' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.27 -43.75 95.9 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 123.743 0.817 . . . . 1.3 112.341 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.63 -36.95 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 O-C-N 123.946 0.779 . . . . 1.07 110.605 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.28 -43.94 93.23 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 108.768 -0.827 . . . . 0.68 108.768 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 42' ' ' SER . 58.3 t -61.96 -25.05 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.469 1.107 . . . . 1.31 111.11 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.868 HG11 HG21 ' A' ' 63' ' ' VAL . 55.3 t -77.25 -55.71 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 107.422 -1.325 . . . . 1.29 107.422 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 58.6 t -57.3 -40.79 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 O-C-N 124.806 1.316 . . . . 1.1 108.94 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' A' ' 14' ' ' ILE . . . -65.6 -35.24 80.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.373 0.606 . . . . 1.0 110.685 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' CB ' ' H8B' ' A' ' 101' ' ' SYO . . . -68.57 -57.13 6.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.351 -0.841 . . . . 1.05 109.783 178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.69 -33.95 76.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.634 0.976 . . . . 0.64 113.634 -177.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 51.8 mt-10 -59.32 -53.17 61.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.643 0.259 . . . . 2.07 110.368 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -66.18 -47.12 74.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.513 0.56 . . . . 3.11 112.513 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.603 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.3 m-85 -84.37 -9.41 58.45 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.648 0.61 . . . . 0.81 112.648 -172.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 85.05 3.59 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 116.385 1.994 . . . . 1.99 116.385 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 13.9 p -82.91 171.72 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.129 -1.028 . . . . 1.14 108.863 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -120.17 128.02 53.01 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.815 -1.55 . . . . 2.7 106.815 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.507 HG12 ' HE2' ' A' ' 75' ' ' TYR . 60.3 mt -116.79 108.97 43.81 Favored Pre-proline 0 C--N 1.308 -1.198 0 C-N-CA 119.964 -0.694 . . . . 1.09 111.52 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.568 ' O ' HG23 ' A' ' 63' ' ' VAL . 51.7 Cg_endo -69.02 159.13 55.19 Favored 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 123.184 2.59 . . . . 0.4 110.928 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.22 -33.62 67.71 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.681 0.792 . . . . 1.98 110.21 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.81 -38.07 89.26 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.067 -0.97 . . . . 2.06 110.835 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 41.1 m-20 -87.04 -25.17 24.34 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.187 -0.605 . . . . 0.52 112.464 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.868 HG21 HG11 ' A' ' 47' ' ' VAL . 94.7 t -55.88 -42.09 69.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.441 -0.948 . . . . 1.12 108.441 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -78.18 -5.32 51.42 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.669 -0.696 . . . . 2.73 112.304 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.43 -25.58 16.85 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 109.822 -0.436 . . . . 1.92 109.822 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.855 HD13 ' HA ' ' A' ' 72' ' ' ALA . 22.0 mt -89.12 122.04 32.04 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 107.095 -1.446 . . . . 1.04 107.095 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 31' ' ' SER . 8.3 mptt -120.21 -34.88 3.57 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.505 -0.924 . . . . 2.98 108.505 174.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 39.4 p -106.41 173.47 6.3 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 108.894 -0.78 . . . . 1.03 108.894 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.558 HG13 HG11 ' A' ' 26' ' ' VAL . 1.4 m -81.92 -13.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 C-N-CA 119.35 -0.94 . . . . 1.91 108.535 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.46 -43.53 92.24 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 108.632 -1.787 . . . . 0.33 108.632 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.73 -56.84 13.98 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.855 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.12 -61.02 2.53 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 114.087 -1.415 . . . . 1.04 112.506 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.496 ' HG1' HG21 ' A' ' 69' ' ' VAL . 49.9 m -56.62 -46.3 81.02 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.492 1.12 . . . . 1.07 112.451 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -56.51 -52.34 65.1 Favored 'General case' 0 N--CA 1.41 -2.469 0 O-C-N 124.453 1.095 . . . . 4.04 108.765 177.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.524 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 74.4 t80 -55.18 -50.51 69.18 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 124.057 0.848 . . . . 0.9 111.515 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.62 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.8 mt -54.4 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-N 114.151 -1.386 . . . . 1.12 110.207 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.53 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 4.2 tt -57.95 -45.51 86.53 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.615 0.766 . . . . 2.08 110.182 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.85 -24.07 66.67 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.049 0.94 . . . . 0.64 111.384 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -98.8 -26.42 14.32 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 113.011 0.745 . . . . 1.59 113.011 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.45 2.7 pp0? -99.99 -99.02 0.24 Allowed 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 116.405 2.002 . . . . 1.09 116.405 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.416 ' H ' ' CD ' ' A' ' 80' ' ' GLN . . . . . . . . 0 C--N 1.258 -3.375 0 CA-C-N 116.098 -0.501 . . . . 1.97 111.271 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.829 ' H4A' ' HB2' ' A' ' 66' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 0 CA--C 1.508 -0.654 0 N-CA-C 108.629 -0.878 . . . . 2.01 108.629 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . . . -157.4 133.83 9.77 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.306 -1.368 . . . . 2.35 107.306 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 7' ' ' ILE . 6.6 t -89.06 -178.05 5.59 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.736 -0.786 . . . . 1.34 110.751 -174.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.518 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.1 tm0? -47.79 -43.21 27.39 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.015 0.926 . . . . 0.74 113.357 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.48 -34.73 62.12 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.594 0.559 . . . . 2.66 111.709 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 19.3 tp10 -87.31 -34.88 18.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.884 -0.598 . . . . 2.73 109.941 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.519 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.7 mt -68.54 -65.72 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 CA-C-N 116.497 -0.319 . . . . 1.05 110.528 -174.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -41.52 67.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 112.386 0.513 . . . . 1.05 112.386 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -61.54 -42.28 98.59 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.033 0.444 . . . . 1.07 110.348 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.0 -40.91 28.93 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 121.028 -0.606 . . . . 0.21 113.081 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.648 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.16 -38.53 91.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.775 -0.824 . . . . 1.03 108.775 -178.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.608 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -58.13 -48.24 80.84 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.792 -0.64 . . . . 1.06 109.573 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.684 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 52.5 mt-10 -60.21 -39.37 86.33 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.895 0.747 . . . . 0.68 111.998 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.648 HD11 ' HA ' ' A' ' 11' ' ' LEU . 62.9 mt -61.24 -41.88 91.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.009 -0.541 . . . . 1.16 109.754 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 11' ' ' LEU . 46.7 t -71.42 -23.55 22.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.357 0.599 . . . . 1.14 109.945 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.684 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.5 m120 -68.2 -48.81 64.21 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.905 -1.146 . . . . 0.36 107.905 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -69.88 -42.98 72.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.895 -1.048 . . . . 2.07 111.821 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.719 HG13 HG22 ' A' ' 46' ' ' VAL . 19.2 mm -73.85 -53.71 16.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 116.01 -0.541 . . . . 1.31 111.707 -177.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.52 -62.99 1.38 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.171 0.51 . . . . 1.18 111.403 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.33 39.13 0.07 OUTLIER Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.414 -0.898 . . . . 0.43 112.964 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.718 HG21 HG23 ' A' ' 26' ' ' VAL . 1.2 mp -78.03 152.35 79.54 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.459 -0.571 . . . . 1.06 109.459 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.6 Cg_endo -89.85 25.37 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.984 2.456 . . . . 1.08 115.052 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 5.0 p 53.62 15.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 125.447 1.499 . . . . 1.28 113.857 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.585 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.0 pt-20 -123.13 -16.07 7.08 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.888 -0.596 . . . . 2.31 110.338 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 22.0 t70 -92.41 -25.64 18.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.675 0.75 . . . . 1.59 110.108 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.718 HG23 HG21 ' A' ' 21' ' ' ILE . 43.0 t -76.09 92.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.444 -1.253 . . . . 1.07 108.863 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -125.87 166.78 16.25 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.576 -1.268 . . . . 2.11 107.576 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 mp -63.53 146.0 54.54 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.45 -0.574 . . . . 1.75 109.45 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.48 12.47 3.87 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.119 1.367 . . . . 0.72 110.431 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 68' ' ' THR . 73.7 mmtt -103.57 124.79 49.45 Favored 'General case' 0 CA--C 1.47 -2.11 0 O-C-N 121.791 -0.568 . . . . 2.01 109.777 176.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 6.3 m -83.23 110.86 18.43 Favored 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 114.488 -1.233 . . . . 1.32 108.427 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.737 ' HB3' ' HE1' ' A' ' 43' ' ' MET . 98.2 m-85 -42.02 -67.23 0.28 Allowed 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 125.725 1.61 . . . . 0.71 112.426 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.507 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 14.8 t -101.56 49.35 0.87 Allowed 'General case' 0 C--N 1.275 -2.658 0 C-N-CA 118.776 -1.17 . . . . 1.36 111.134 -177.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 29.4 t70 -154.62 -53.72 0.1 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.73 -1.123 . . . . 1.74 109.773 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -86.23 -44.5 12.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.207 1.003 . . . . 1.29 110.771 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.681 HD13 ' HA ' ' A' ' 32' ' ' PHE . 32.7 mt -71.75 -91.24 0.02 OUTLIER 'General case' 0 C--O 1.249 1.036 0 O-C-N 123.715 0.634 . . . . 1.11 111.4 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 25.4 t70 158.25 61.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 126.099 1.76 . . . . 1.12 108.459 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.533 HG13 ' HE2' ' A' ' 43' ' ' MET . 26.8 t -101.72 165.81 2.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.694 -0.684 . . . . 1.21 110.022 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' N ' HG12 ' A' ' 38' ' ' VAL . 10.0 m-20 -83.26 6.15 20.62 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.681 0.793 . . . . 2.0 112.879 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 43' ' ' MET . 20.5 t 66.66 -66.5 0.18 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.579 1.152 . . . . 0.99 113.245 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.02 -26.52 65.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.583 0.706 . . . . 1.81 110.802 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 15.7 m -80.54 -13.46 59.06 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.548 -0.751 . . . . 0.91 110.569 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.737 ' HE1' ' HB3' ' A' ' 32' ' ' PHE . 18.0 tpp -73.04 -31.65 64.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.002 -0.544 . . . . 1.3 110.978 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.631 HG23 ' S1 ' ' A' ' 101' ' ' SYO . 24.8 t -55.15 -42.59 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 N-CA-C 108.784 -0.821 . . . . 1.07 108.784 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' SER . 26.0 mm-40 -54.53 -53.14 58.38 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 123.781 0.832 . . . . 0.68 110.282 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.719 HG22 HG13 ' A' ' 18' ' ' ILE . 51.6 t -54.16 -32.14 22.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 124.374 1.07 . . . . 1.31 112.048 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.811 HG21 HG12 ' A' ' 63' ' ' VAL . 27.9 t -73.32 -48.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.567 -0.901 . . . . 1.29 108.567 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.43 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 43.8 t -68.3 -31.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.272 -1.01 . . . . 1.1 108.272 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.418 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -69.66 -34.17 73.62 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.41 0.624 . . . . 1.0 109.738 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.48 42.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.974 -1.012 . . . . 1.05 108.994 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.633 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.261 0.0 OUTLIER -66.77 -29.63 69.64 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.714 1.005 . . . . 0.64 113.714 -177.727 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 41.4 mt-10 -63.34 -38.16 90.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.274 0.559 . . . . 2.07 110.627 174.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -86.86 -35.37 19.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.272 0.471 . . . . 3.11 112.272 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 8.1 m-85 -97.72 -0.03 46.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 120.025 -0.67 . . . . 0.81 112.186 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 78.44 -2.77 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.584 1.327 . . . . 1.99 114.584 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.62 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 14.8 p -75.73 175.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 O-C-N 121.098 -1.001 . . . . 1.14 108.947 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 36.5 tptt -124.61 128.96 49.68 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.82 -1.178 . . . . 2.7 107.82 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 51' ' ' GLU . 27.1 mt -123.09 110.98 30.8 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 120.165 -0.614 . . . . 1.09 110.825 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 63' ' ' VAL . 67.8 Cg_endo -73.89 158.4 46.39 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.591 2.194 . . . . 0.4 109.582 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.69 -36.57 62.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.194 0.597 . . . . 1.98 110.806 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.44 -42.69 87.89 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.575 0.75 . . . . 2.06 111.63 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.5 m-20 -86.32 -24.92 25.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 121.017 -0.273 . . . . 0.52 111.581 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.811 HG12 HG21 ' A' ' 47' ' ' VAL . 55.8 t -53.06 -58.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.138 -1.06 . . . . 1.12 108.138 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -72.87 -1.49 17.01 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.213 -0.903 . . . . 2.73 111.705 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -87.61 -34.41 18.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.847 -1.168 . . . . 1.92 107.847 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.834 HD11 ' HA ' ' A' ' 72' ' ' ALA . 12.8 mt -79.42 131.38 36.07 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 106.459 -1.682 . . . . 1.04 106.459 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.745 ' HG3' H38A ' A' ' 101' ' ' SYO . 12.7 mptt -116.77 -42.34 2.98 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.997 -1.112 . . . . 2.98 107.997 171.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 81.9 p -101.88 170.38 8.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.901 -1.045 . . . . 1.03 110.224 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.501 HG22 ' HG1' ' A' ' 73' ' ' THR . 1.4 m -80.5 -13.6 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.104 -1.073 . . . . 1.91 108.104 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.58 -30.47 68.72 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.244 -1.143 . . . . 0.33 110.244 176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -81.97 -51.28 8.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.066 -1.087 . . . . 1.39 108.066 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.834 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -49.79 -60.42 2.91 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 114.323 -1.308 . . . . 1.04 111.967 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.518 HG21 ' HG2' ' A' ' 4' ' ' GLN . 45.8 m -57.24 -42.27 81.14 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.671 -1.149 . . . . 1.07 112.508 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -57.29 -53.25 60.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.974 -1.121 . . . . 4.04 107.974 176.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.558 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 82.1 t80 -56.48 -50.54 71.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 124.19 0.931 . . . . 0.9 111.148 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.611 ' HA ' HG22 ' A' ' 56' ' ' VAL . 70.8 mt -55.73 -66.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.278 -1.328 . . . . 1.12 109.98 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.46 -47.18 66.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.8 0.84 . . . . 2.08 110.538 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.09 -22.97 65.8 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.221 -0.899 . . . . 0.64 112.285 -172.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -102.79 4.27 37.7 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.303 0.853 . . . . 1.59 113.303 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.62 ' HG2' ' HB ' ' A' ' 56' ' ' VAL 0.309 0.7 OUTLIER -124.01 -84.61 0.65 Allowed 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 113.832 1.049 . . . . 1.09 113.832 175.573 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.253 -3.627 0 CA-C-O 118.496 -0.764 . . . . 1.97 112.106 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.781 H28A HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 108.534 -0.913 . . . . 2.01 108.534 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . . . -165.59 -73.18 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.709 0.29 . . . . 2.35 111.696 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.542 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 6.4 t -171.71 -170.96 0.84 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.814 -0.81 . . . . 1.34 108.814 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.655 ' HA ' HD11 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -48.71 -42.2 34.26 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.941 1.296 . . . . 0.74 112.653 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.35 -22.56 63.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.821 0.674 . . . . 2.66 112.821 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 3' ' ' THR . 4.1 tp10 -81.34 -36.77 29.29 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.412 -0.959 . . . . 2.73 108.412 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 4' ' ' GLN . 71.2 mt -79.03 -67.91 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.117 0 CA-C-N 115.294 -0.866 . . . . 1.05 110.844 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 t -59.09 -41.88 84.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 112.568 0.581 . . . . 1.05 112.568 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.38 82.72 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.317 0.386 . . . . 1.07 111.288 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.38 -40.53 8.39 Favored Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 120.393 -0.908 . . . . 0.21 112.2 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.721 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -59.46 -42.72 92.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.277 1.031 . . . . 1.03 108.278 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.58 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -54.43 -48.12 72.04 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.664 0.603 . . . . 1.06 110.615 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.715 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 54.4 mt-10 -65.71 -35.71 81.53 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 123.709 0.631 . . . . 0.68 111.746 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.721 HD11 ' HA ' ' A' ' 11' ' ' LEU . 64.4 mt -60.73 -42.47 92.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.618 -0.719 . . . . 1.16 109.595 174.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' ' 11' ' ' LEU . 41.3 t -68.47 -23.94 28.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 121.845 0.831 . . . . 1.14 109.864 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.715 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.9 m120 -75.57 -52.35 10.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.176 -1.046 . . . . 0.36 108.176 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -66.66 -46.42 75.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.615 -1.175 . . . . 2.07 112.476 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.592 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.2 mm -70.79 -53.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.878 0.371 . . . . 1.31 110.27 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.74 -74.31 0.65 Allowed 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.664 -0.414 . . . . 1.18 111.519 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.18 54.45 0.02 OUTLIER Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 120.291 -0.957 . . . . 0.43 112.045 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.629 ' HB ' HG11 ' A' ' 15' ' ' VAL . 1.4 mp -95.62 154.57 39.17 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.493 -0.558 . . . . 1.06 109.493 175.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 6.2 Cg_exo -88.02 29.45 0.47 Allowed 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 124.224 3.283 . . . . 1.08 115.673 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.5 p 57.87 -0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 117.838 2.533 . . . . 1.28 117.838 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 43.7 mt-10 -117.93 -13.39 10.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.34 -1.475 . . . . 2.31 111.225 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.532 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.0 m-20 -87.03 -29.28 22.06 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.005 -1.452 . . . . 1.59 110.127 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 12' ' ' ALA . 41.9 t -69.35 97.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 1.07 108.79 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.1 mttt -138.35 170.04 16.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 109.069 -0.715 . . . . 2.11 109.069 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.405 HD23 ' HE2' ' A' ' 74' ' ' LYS . 7.8 mp -61.13 143.03 56.23 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.174 -0.676 . . . . 1.75 109.174 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t70 81.99 1.04 1.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.029 1.332 . . . . 0.72 110.898 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.568 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 44.2 mmtm -92.8 120.35 33.08 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 119.589 -0.844 . . . . 2.01 109.644 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.479 ' CB ' ' HB3' ' A' ' 34' ' ' ASP . 15.9 m -79.12 27.09 0.25 Allowed 'General case' 1 C--N 1.244 -4.019 0 C-N-CA 125.968 1.707 . . . . 1.32 113.876 -172.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.591 ' CZ ' HG23 ' A' ' 69' ' ' VAL . 96.7 m-85 46.13 -88.58 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.495 1.518 . . . . 0.71 113.989 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.428 HG21 H37A ' A' ' 101' ' ' SYO . 8.6 t -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.133 0.573 . . . . 1.36 111.374 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' HB3' ' CB ' ' A' ' 31' ' ' SER . 32.3 t70 -88.17 -39.72 14.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.978 0.418 . . . . 1.74 111.298 -175.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.568 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -93.21 -41.31 9.97 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.514 0.931 . . . . 1.29 113.514 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.6 mt -88.19 -72.42 0.53 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.388 -0.525 . . . . 1.11 110.68 -173.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.0 t70 163.83 -22.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 124.321 1.013 . . . . 1.12 109.612 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.658 HG12 ' HE3' ' A' ' 43' ' ' MET . 3.0 t -45.99 105.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.77 1.628 . . . . 1.21 112.939 -170.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.494 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 24.9 t70 -54.04 124.15 14.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 124.04 0.838 . . . . 2.0 112.589 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 43' ' ' MET . 29.9 t -37.51 -45.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.612 2.078 . . . . 0.99 116.612 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.494 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 3.9 pp -75.92 -23.15 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 117.607 -1.637 . . . . 1.81 112.26 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.592 ' HB3' HG22 ' A' ' 18' ' ' ILE . 42.9 m -84.2 -18.91 35.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.735 -0.666 . . . . 0.91 109.665 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.851 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -56.95 -43.55 81.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.19 0.996 . . . . 1.3 112.715 -178.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.25 -40.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 123.845 0.716 . . . . 1.07 110.171 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -63.36 -44.45 94.77 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.969 -0.56 . . . . 0.68 109.722 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.525 HG11 HG22 ' A' ' 15' ' ' VAL . 42.0 t -60.0 -25.13 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.425 -0.807 . . . . 1.31 110.903 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.913 HG21 HG13 ' A' ' 63' ' ' VAL . 21.5 t -82.27 -53.75 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 108.79 -0.818 . . . . 1.29 108.79 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.14 -36.73 74.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.72 -1.127 . . . . 1.1 109.171 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -31.61 67.37 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . . . -61.55 -58.21 9.04 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.285 -0.87 . . . . 1.05 109.094 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -64.47 -36.06 82.95 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.906 1.076 . . . . 0.64 113.906 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.99 -29.74 69.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 2.07 111.512 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -88.41 -32.34 18.38 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.227 -0.442 . . . . 3.11 111.559 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 4.6 m-30 -93.13 -11.14 33.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 120.386 -0.526 . . . . 0.81 111.938 -173.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.669 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 25.7 t70 81.38 6.77 1.2 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.493 1.517 . . . . 1.99 111.987 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 76' ' ' ILE . 14.5 p -84.7 171.15 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 107.584 -1.265 . . . . 1.14 107.584 174.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 19.5 tptt -124.6 123.06 39.24 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.654 -0.869 . . . . 2.7 108.654 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.493 HG12 ' HE2' ' A' ' 75' ' ' TYR . 62.8 mt -118.9 112.73 36.32 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 109.835 -0.432 . . . . 1.09 109.835 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.512 ' O ' HG23 ' A' ' 63' ' ' VAL . 37.7 Cg_endo -67.43 158.2 58.18 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.747 2.298 . . . . 0.4 110.282 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 6.2 p-10 -58.55 -30.43 67.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.399 -0.364 . . . . 1.98 111.422 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.74 -34.03 69.2 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 112.428 0.529 . . . . 2.06 112.428 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 52.5 m-20 -78.73 -25.07 44.57 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 119.524 -0.87 . . . . 0.52 110.985 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.913 HG13 HG21 ' A' ' 47' ' ' VAL . 70.0 t -54.27 -39.7 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.229 -1.026 . . . . 1.12 108.229 170.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 60' ' ' ASP . 81.9 mttt -73.98 -14.63 61.06 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.0 -1.0 . . . . 2.73 112.22 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -96.49 -36.17 10.88 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.594 0.358 . . . . 1.92 111.511 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.791 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -68.71 113.05 5.84 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 105.678 -1.971 . . . . 1.04 105.678 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -108.21 -31.3 7.95 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 119.762 -0.775 . . . . 2.98 109.807 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.9 p -121.01 178.42 4.74 Favored 'General case' 0 N--CA 1.392 -3.338 0 N-CA-C 108.557 -0.905 . . . . 1.03 108.557 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.591 HG23 ' CZ ' ' A' ' 32' ' ' PHE . 6.4 t -77.45 -13.56 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 107.683 -1.228 . . . . 1.91 107.683 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.84 -49.04 37.93 Favored Glycine 0 CA--C 1.489 -1.583 0 N-CA-C 109.871 -1.292 . . . . 0.33 109.871 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.77 -44.36 77.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.963 -0.618 . . . . 1.39 109.373 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.791 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -56.61 -61.64 2.28 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.019 -0.992 . . . . 1.04 111.266 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.597 ' HA ' HG22 ' A' ' 7' ' ' ILE . 60.7 m -54.36 -43.71 71.54 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.696 -1.138 . . . . 1.07 113.804 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.1 mptp? -61.03 -50.9 71.48 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.99 -0.744 . . . . 4.04 108.99 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.493 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.8 t80 -54.47 -51.82 63.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.643 -1.162 . . . . 0.9 110.225 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.622 ' HA ' HG21 ' A' ' 56' ' ' VAL . 78.3 mt -55.37 -65.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 114.19 -1.368 . . . . 1.12 110.716 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 5.2 tt -51.73 -43.61 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.9 0.88 . . . . 2.08 110.57 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.07 -25.53 64.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.875 -1.057 . . . . 0.64 111.823 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -101.51 -5.83 24.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.794 -0.639 . . . . 1.59 112.344 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.475 HE21 HG23 ' A' ' 76' ' ' ILE 0.302 1.0 OUTLIER -106.18 -92.55 0.39 Allowed 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 113.636 0.976 . . . . 1.09 113.636 175.911 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.266 -3.044 0 CA-C-N 115.264 -0.88 . . . . 1.97 111.027 -175.288 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.851 ' H1 ' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.811 ' HB1' ' HB3' ' A' ' 81' ' ' ALA . . . . . . . . 0 CA--C 1.503 -0.849 0 N-CA-C 109.247 -0.649 . . . . 2.01 109.247 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -127.93 136.03 50.78 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.713 -0.676 . . . . 2.35 109.801 -174.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.584 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 13.1 t -94.89 -178.75 4.61 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.673 -0.862 . . . . 1.34 108.673 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -46.9 -48.25 21.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.141 1.163 . . . . 0.74 114.141 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -51.98 -32.33 33.17 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.567 0.951 . . . . 2.66 113.567 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.554 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 11.1 tp10 -87.45 -40.45 14.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.292 0.637 . . . . 2.73 109.87 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.625 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 99.5 mt -63.56 -58.74 6.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 116.139 -0.482 . . . . 1.05 110.016 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.54 HG21 HD12 ' A' ' 28' ' ' LEU . 46.0 t -66.29 -22.91 30.86 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.871 -0.604 . . . . 1.05 111.695 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.92 55.78 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.759 -0.776 . . . . 1.07 109.177 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.15 -44.09 24.12 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 115.008 -0.996 . . . . 0.21 113.225 -176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.701 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -63.13 -33.08 74.68 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 123.448 0.699 . . . . 1.03 109.376 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.691 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -60.75 -51.14 70.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.659 -0.701 . . . . 1.06 109.263 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.633 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 51.2 mt-10 -59.44 -41.83 90.53 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 124.183 0.927 . . . . 0.68 111.809 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.701 HD13 ' HA ' ' A' ' 11' ' ' LEU . 71.4 mt -56.79 -42.17 77.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.461 -0.79 . . . . 1.16 109.85 175.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.62 HG12 ' HB ' ' A' ' 21' ' ' ILE . 88.0 t -70.92 -23.73 23.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.703 0.764 . . . . 1.14 110.306 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.633 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -72.79 -43.32 62.91 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.177 -1.046 . . . . 0.36 108.177 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -71.39 -50.33 33.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.214 -0.903 . . . . 2.07 110.926 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.628 HG13 HG23 ' A' ' 46' ' ' VAL . 20.9 mm -66.76 -54.24 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.1 -0.5 . . . . 1.31 111.667 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.434 ' HB3' HG12 ' A' ' 38' ' ' VAL . . . -102.96 -66.07 0.96 Allowed 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.389 0.614 . . . . 1.18 111.036 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.7 50.87 0.06 OUTLIER Glycine 0 C--N 1.29 -1.999 0 CA-C-N 115.142 -0.936 . . . . 0.43 111.714 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.62 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -91.33 155.66 44.17 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.408 -0.396 . . . . 1.06 109.983 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD2' HG22 ' A' ' 21' ' ' ILE . 6.0 Cg_exo -86.62 23.02 0.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.343 2.695 . . . . 1.08 115.698 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.624 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.9 p 48.1 26.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 C-N-CA 124.694 1.198 . . . . 1.28 113.154 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -138.9 4.72 2.31 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.345 -0.843 . . . . 2.31 110.685 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.35 -27.91 9.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.075 -0.966 . . . . 1.59 110.065 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.755 HG22 HD11 ' A' ' 36' ' ' LEU . 23.7 t -79.6 99.1 3.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.33 -1.304 . . . . 1.07 108.972 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -127.98 170.57 12.72 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.164 -1.421 . . . . 2.11 107.164 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.54 HD12 HG21 ' A' ' 8' ' ' VAL . 7.9 mp -66.41 148.55 51.7 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.287 -1.005 . . . . 1.75 108.287 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 81.51 4.22 1.39 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 124.451 1.101 . . . . 0.72 110.533 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 73.6 mmtt -96.61 118.99 34.26 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 119.831 -0.748 . . . . 2.01 110.636 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 71.4 m -75.53 32.88 0.11 Allowed 'General case' 0 C--N 1.248 -3.833 0 C-N-CA 127.189 2.195 . . . . 1.32 114.039 -175.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.641 ' CE2' ' H5 ' ' A' ' 101' ' ' SYO . 86.8 m-85 41.23 -89.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.454 1.501 . . . . 0.71 115.025 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.538 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.9 t -63.15 -29.17 70.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.468 0.707 . . . . 1.36 111.05 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -96.45 -31.21 12.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.826 0.676 . . . . 1.74 112.826 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.491 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -99.29 -36.79 9.51 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.777 1.029 . . . . 1.29 113.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.755 HD11 HG22 ' A' ' 26' ' ' VAL . 16.0 mt -94.91 -39.7 10.08 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.245 -0.434 . . . . 1.11 109.998 -174.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 t70 93.33 69.53 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.579 0 C-N-CA 126.531 1.933 . . . . 1.12 108.934 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.694 HG11 ' HE1' ' A' ' 43' ' ' MET . 13.3 t -108.09 143.4 18.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 105.002 -2.222 . . . . 1.21 105.002 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.37 117.73 15.48 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.374 -0.93 . . . . 2.0 109.63 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.476 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.0 t -38.67 -47.37 1.34 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.573 1.694 . . . . 0.99 115.573 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -70.58 -26.37 63.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.368 -0.933 . . . . 1.81 111.628 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.2 m -84.94 -16.96 39.25 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.474 0.709 . . . . 0.91 110.507 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.694 ' HE1' HG11 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -56.01 -38.65 70.79 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 124.084 0.953 . . . . 1.3 111.598 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.21 -47.1 77.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 O-C-N 124.451 1.095 . . . . 1.07 109.984 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.03 -45.12 83.35 Favored 'General case' 0 C--O 1.21 -1.026 0 C-N-CA 122.873 0.469 . . . . 0.68 109.796 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 18' ' ' ILE . 44.2 t -59.01 -28.86 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.783 0.833 . . . . 1.31 110.958 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.863 HG23 HG13 ' A' ' 63' ' ' VAL . 54.0 t -78.6 -51.43 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.766 -1.198 . . . . 1.29 107.766 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -56.0 -42.42 71.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.419 -1.264 . . . . 1.1 109.447 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.419 ' HB3' HG22 ' A' ' 14' ' ' ILE . . . -63.85 -39.07 93.34 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-O 121.499 0.666 . . . . 1.0 110.454 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.527 ' CB ' ' H8B' ' A' ' 101' ' ' SYO . . . -64.28 -52.57 57.95 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.87 -1.059 . . . . 1.05 109.886 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.625 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.325 0.0 OUTLIER -62.54 -35.89 80.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.708 1.003 . . . . 0.64 113.708 -179.242 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.4 -44.03 95.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.221 0.326 . . . . 2.07 111.581 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -76.66 -44.54 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.534 0.568 . . . . 3.11 112.534 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.625 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 11.8 m-85 -89.27 -5.22 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.301 -0.56 . . . . 0.81 112.434 -172.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 83.17 10.73 0.52 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 115.389 1.625 . . . . 1.99 115.389 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.578 HG23 ' HA ' ' A' ' 76' ' ' ILE . 11.6 p -87.19 179.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.273 -1.01 . . . . 1.14 108.273 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 46.7 tptt -132.89 128.55 36.84 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 106.434 -1.691 . . . . 2.7 106.434 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.625 HG13 ' HB3' ' A' ' 51' ' ' GLU . 42.0 mt -124.11 111.57 28.66 Favored Pre-proline 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.787 . . . . 1.09 111.054 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.5 Cg_endo -73.29 162.18 41.03 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.158 2.572 . . . . 0.4 110.793 176.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.39 -41.98 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.942 0.897 . . . . 1.98 110.616 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 30.2 t70 -60.72 -37.56 82.13 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 114.685 -1.143 . . . . 2.06 111.549 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.539 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 20.4 m-20 -86.89 -28.01 23.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 113.414 0.894 . . . . 0.52 113.414 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.863 HG13 HG23 ' A' ' 47' ' ' VAL . 95.8 t -53.62 -48.72 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.767 -0.827 . . . . 1.12 108.767 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 48.3 pttt -69.73 -13.59 62.37 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.886 -1.052 . . . . 2.73 112.45 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.79 -13.08 46.18 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.405 0.621 . . . . 1.92 109.716 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.834 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.5 mt -97.52 110.37 22.95 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 106.49 -1.67 . . . . 1.04 106.49 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.7 mptp? -100.64 -44.65 5.76 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.311 -0.996 . . . . 2.98 108.311 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 20.1 p -110.25 -177.9 3.37 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.697 -0.853 . . . . 1.03 108.697 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.444 HG22 ' HG1' ' A' ' 73' ' ' THR . 0.7 OUTLIER -87.05 -13.43 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 108.344 -0.984 . . . . 1.91 108.344 176.018 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.561 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -72.33 -24.78 75.79 Favored Glycine 0 C--O 1.2 -2.014 0 N-CA-C 108.683 -1.767 . . . . 0.33 108.683 174.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 68' ' ' THR . 8.7 m-20 -82.66 -57.13 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.781 -1.21 . . . . 1.39 108.542 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.834 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -47.8 -60.32 2.66 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 114.881 -1.054 . . . . 1.04 112.155 -178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.453 ' HA ' HG21 ' A' ' 7' ' ' ILE . 44.9 m -56.79 -48.09 78.71 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.354 -1.294 . . . . 1.07 113.451 -174.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.0 mptp? -56.57 -47.08 80.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.069 0.856 . . . . 4.04 109.58 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.539 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 85.1 t80 -60.44 -51.8 67.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.081 -0.963 . . . . 0.9 111.544 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.578 ' HA ' HG23 ' A' ' 56' ' ' VAL . 69.9 mt -54.57 -65.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.584 -1.189 . . . . 1.12 110.542 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.584 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.1 tt -51.79 -46.55 64.23 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.356 1.062 . . . . 2.08 109.511 -175.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 22.2 t70 -60.99 -30.56 70.35 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.55 -1.205 . . . . 0.64 111.502 -172.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -100.13 0.0 39.77 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 113.923 1.083 . . . . 1.59 113.923 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -116.27 -51.44 2.62 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 113.768 1.025 . . . . 1.09 113.768 176.155 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.811 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . . . . . . . . 1 C--N 1.243 -4.049 0 CA-C-N 114.728 -1.123 . . . . 1.97 110.31 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.788 H28A HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.479 ' H1 ' ' CD ' ' A' ' 6' ' ' GLU . . . . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 109.832 -0.432 . . . . 2.01 109.832 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.51 -74.26 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.822 -0.807 . . . . 2.35 108.822 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t -174.6 -171.69 0.59 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.11 -0.7 . . . . 1.34 109.11 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.66 -41.49 55.55 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.331 1.452 . . . . 0.74 114.518 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -52.51 -52.03 56.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.206 0.316 . . . . 2.66 110.581 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' CD ' ' H1 ' ' A' ' 1' ' ' ALA . 40.8 tt0 -52.03 -48.67 64.43 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 124.848 1.259 . . . . 2.73 111.184 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 73' ' ' THR . 81.4 mt -70.21 -64.13 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.275 -1.33 . . . . 1.05 110.255 -170.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.07 -40.42 76.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 N-CA-C 112.738 0.644 . . . . 1.05 112.738 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -62.12 -44.37 96.79 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.736 -0.468 . . . . 1.07 109.736 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -76.01 -38.24 35.97 Favored Glycine 0 N--CA 1.415 -2.742 0 CA-C-N 115.572 -0.74 . . . . 0.21 113.446 -175.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.62 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.49 -39.16 88.59 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.609 -0.885 . . . . 1.03 108.609 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.576 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -58.97 -47.49 84.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.207 -0.664 . . . . 1.06 109.207 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.629 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 44.6 mt-10 -54.89 -45.8 74.72 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 124.368 1.042 . . . . 0.68 111.806 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 11' ' ' LEU . 56.9 mt -59.55 -42.68 88.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.467 -0.788 . . . . 1.16 110.058 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.535 HG13 ' HB ' ' A' ' 21' ' ' ILE . 48.4 t -71.86 -22.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.409 0.623 . . . . 1.14 109.931 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.629 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 7.0 m120 -66.19 -43.19 87.53 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.039 -0.726 . . . . 0.36 109.039 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -80.42 -49.3 11.63 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.518 -0.765 . . . . 2.07 111.259 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.681 HG13 HG23 ' A' ' 46' ' ' VAL . 16.8 mm -62.35 -53.56 45.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.822 -0.626 . . . . 1.31 111.374 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -104.55 -72.64 0.7 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.509 0.671 . . . . 1.18 109.857 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.31 34.65 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.563 0 CA-C-N 114.993 -1.003 . . . . 0.43 111.973 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.603 HG22 HG23 ' A' ' 26' ' ' VAL . 1.3 mp -72.96 150.43 90.33 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 109.557 -0.534 . . . . 1.06 109.557 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.7 Cg_exo -88.89 31.23 0.4 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.732 2.954 . . . . 1.08 114.758 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 12' ' ' ALA 0.25 5.6 p 58.4 -6.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 126.984 2.114 . . . . 1.28 116.393 175.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -114.85 -6.33 12.63 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.937 -1.102 . . . . 2.31 111.064 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -83.28 -30.88 27.25 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.4 1.095 . . . . 1.59 108.917 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 36' ' ' LEU . 22.8 t -76.3 96.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 113.35 -1.75 . . . . 1.07 109.935 -176.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' O ' HG12 ' A' ' 69' ' ' VAL . 12.5 mptt -127.83 158.37 37.92 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.355 -1.35 . . . . 2.11 107.355 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD22 ' HA2' ' A' ' 70' ' ' GLY . 54.8 mt -52.83 144.83 13.64 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.9 -0.778 . . . . 1.75 108.9 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 78.67 10.55 1.76 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.938 1.295 . . . . 0.72 110.824 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.59 ' HD2' ' CG ' ' A' ' 35' ' ' ASP . 31.3 mmtp -96.91 122.63 40.1 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 108.617 -0.882 . . . . 2.01 108.617 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 30.3 m -76.29 36.18 0.15 Allowed 'General case' 0 C--N 1.252 -3.662 0 C-N-CA 125.279 1.432 . . . . 1.32 113.519 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.676 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 76.0 m-85 42.75 -94.12 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 125.673 1.589 . . . . 0.71 114.697 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 t -68.57 -24.66 64.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.081 0.467 . . . . 1.36 110.059 -174.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 11.0 t70 -81.32 -53.03 6.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.298 -0.864 . . . . 1.74 111.772 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.59 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t70 -84.22 -56.59 3.57 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 119.585 -0.846 . . . . 1.29 110.267 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.61 HD13 HG21 ' A' ' 26' ' ' VAL . 22.4 mt -65.91 -38.12 87.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.12 -1.4 . . . . 1.11 111.286 -170.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 24.2 t70 88.22 70.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 124.919 1.387 . . . . 1.12 109.186 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.408 HG11 ' HB1' ' A' ' 19' ' ' ALA . 18.4 t -102.58 170.88 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.374 -2.194 . . . . 1.21 108.741 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 42' ' ' SER . 2.2 m-20 -78.01 -3.42 41.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.094 1.146 . . . . 2.0 114.094 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' ' 43' ' ' MET . 29.0 t 65.87 -65.4 0.18 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.136 0.975 . . . . 0.99 113.053 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.506 HD11 ' H ' ' A' ' 42' ' ' SER . 0.7 OUTLIER -62.67 -36.41 82.77 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.305 0.574 . . . . 1.81 111.572 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 46' ' ' VAL . 12.6 m -78.23 -13.73 59.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.499 -0.773 . . . . 0.91 110.065 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 1.033 ' HG3' ' H1 ' ' A' ' 101' ' ' SYO . 12.2 tpp -73.69 -35.61 65.19 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 116.254 -0.43 . . . . 1.3 110.127 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.8 t -55.72 -37.72 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 109.487 -0.56 . . . . 1.07 109.487 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -61.89 -47.89 82.93 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.275 -0.639 . . . . 0.68 109.275 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.681 HG23 HG13 ' A' ' 18' ' ' ILE . 61.1 t -57.73 -28.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 CA-C-N 114.834 -1.075 . . . . 1.31 111.475 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.853 HG22 HG11 ' A' ' 63' ' ' VAL . 27.6 t -71.69 -52.68 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.377 0 N-CA-C 107.764 -1.199 . . . . 1.29 107.764 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 78.5 t -61.08 -38.63 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.23 -1.35 . . . . 1.1 108.55 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.74 -38.99 90.65 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.932 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' CB ' ' H8B' ' A' ' 101' ' ' SYO . . . -61.53 -58.37 8.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.731 -1.122 . . . . 1.05 109.779 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.26 0.0 OUTLIER -59.36 -39.76 84.26 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.233 1.197 . . . . 0.64 114.233 -176.384 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 54.5 mt-10 -59.92 -35.7 75.45 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.39 0.431 . . . . 2.07 111.846 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -86.42 -30.36 22.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.116 -0.493 . . . . 3.11 110.143 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.435 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 7.0 m-85 -100.03 1.47 42.47 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.208 0.447 . . . . 0.81 112.208 -173.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 33.7 t70 79.5 4.1 2.17 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 124.344 1.058 . . . . 1.99 112.98 174.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.62 HG23 ' HA ' ' A' ' 76' ' ' ILE . 7.8 p -90.93 -179.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 O-C-N 121.256 -0.902 . . . . 1.14 108.703 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -135.62 128.69 31.61 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.748 -1.575 . . . . 2.7 106.748 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.488 HG13 ' HB3' ' A' ' 51' ' ' GLU . 59.5 mt -122.07 110.47 32.89 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.128 -0.629 . . . . 1.09 111.109 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.562 ' O ' HG21 ' A' ' 63' ' ' VAL . 91.1 Cg_endo -74.94 164.94 32.41 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.125 2.55 . . . . 0.4 110.961 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 20.2 t70 -51.57 -44.12 62.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 1.98 112.101 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -58.78 -40.59 84.43 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.612 0.57 . . . . 2.06 111.301 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 24.7 m-20 -81.52 -31.11 32.94 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.777 -0.769 . . . . 0.52 112.005 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.853 HG11 HG22 ' A' ' 47' ' ' VAL . 82.7 t -53.83 -50.72 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.056 -1.09 . . . . 1.12 108.056 172.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 13.8 ptmm? -73.17 -2.7 22.67 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.372 0.878 . . . . 2.73 113.372 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -105.79 -16.81 14.57 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.993 -0.442 . . . . 1.92 111.76 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 72' ' ' ALA . 44.2 mt -82.14 107.44 14.84 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 105.711 -1.959 . . . . 1.04 105.711 176.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -97.13 -39.29 9.37 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.181 -1.008 . . . . 2.98 109.744 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 27.7 p -114.97 179.64 3.89 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.46 0.648 . . . . 1.03 109.587 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.676 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -87.09 -13.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.797 -0.816 . . . . 1.91 108.797 175.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -68.12 -43.56 80.47 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 107.032 -2.427 . . . . 0.33 107.032 172.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -65.25 -56.06 14.87 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.888 -1.656 . . . . 1.39 110.895 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.81 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -49.9 -60.95 2.43 Favored 'General case' 0 CA--C 1.482 -1.665 0 O-C-N 124.304 1.002 . . . . 1.04 111.42 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.645 ' HA ' HG22 ' A' ' 7' ' ' ILE . 56.8 m -53.31 -54.59 34.26 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.589 -1.187 . . . . 1.07 113.303 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.9 mptm? -56.08 -37.5 69.42 Favored 'General case' 0 C--O 1.198 -1.658 0 C-N-CA 124.158 0.983 . . . . 4.04 110.78 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.476 ' HE2' HG12 ' A' ' 58' ' ' ILE . 90.7 t80 -66.93 -47.59 71.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.535 0.683 . . . . 0.9 109.377 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.625 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 72.7 mt -59.09 -65.87 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-N 114.2 -1.364 . . . . 1.12 109.441 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.574 HD23 HG21 ' A' ' 73' ' ' THR . 4.4 pp -53.41 -38.41 63.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 113.475 0.917 . . . . 2.08 113.475 -176.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 7.7 t70 -72.03 -25.75 61.93 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.92 -1.036 . . . . 0.64 110.777 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -102.56 -6.03 23.28 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.649 -0.705 . . . . 1.59 112.083 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 85.0 mt-30 -74.49 -65.17 0.89 Allowed 'General case' 0 CA--C 1.455 -2.676 0 CA-C-O 122.866 1.317 . . . . 1.09 107.933 176.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.259 -3.359 0 CA-C-N 111.982 -2.372 . . . . 1.97 109.492 -178.645 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 1.033 ' H1 ' ' HG3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.492 ' HA ' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.489 -1.399 0 N-CA-C 109.478 -0.564 . . . . 2.01 109.478 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -154.4 129.77 9.78 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.914 -0.772 . . . . 2.35 108.914 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 7' ' ' ILE . 11.3 t -92.42 175.65 6.76 Favored 'General case' 0 C--N 1.264 -3.128 0 N-CA-C 107.047 -1.464 . . . . 1.34 107.047 175.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -45.86 -40.27 9.69 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.749 1.018 . . . . 0.74 113.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.49 -28.19 69.12 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.489 0.493 . . . . 2.66 111.949 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 7.8 tp10 -88.83 -35.91 16.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.368 -0.605 . . . . 2.73 109.368 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.67 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 93.9 mt -72.53 -66.37 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.059 0 CA-C-N 116.126 -0.488 . . . . 1.05 111.846 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.05 -40.39 76.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 122.081 0.153 . . . . 1.05 111.169 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.39 81.46 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.01 -0.541 . . . . 1.07 111.25 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.48 -39.42 8.99 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 116.232 -0.44 . . . . 0.21 112.399 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.721 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.79 -37.4 87.47 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.577 -0.897 . . . . 1.03 108.577 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.853 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -55.21 -47.13 75.73 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.748 -0.66 . . . . 1.06 109.847 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.678 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 41.1 mt-10 -60.94 -41.47 96.31 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 124.135 0.897 . . . . 0.68 111.658 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.721 HD13 ' HA ' ' A' ' 11' ' ' LEU . 71.2 mt -60.74 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.277 -0.874 . . . . 1.16 109.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.817 HG11 ' HB ' ' A' ' 21' ' ' ILE . 73.9 t -67.99 -23.76 29.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 123.872 0.869 . . . . 1.14 111.038 -176.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.678 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 8.0 m120 -71.62 -45.16 62.9 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.107 -0.952 . . . . 0.36 109.142 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -83.77 -36.73 23.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.286 -0.87 . . . . 2.07 112.945 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.602 HG13 HG22 ' A' ' 46' ' ' VAL . 28.1 mm -70.2 -53.19 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.044 -0.724 . . . . 1.31 109.044 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.599 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -103.16 -88.9 0.4 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.836 -0.62 . . . . 1.18 109.556 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.03 39.53 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 120.338 -0.934 . . . . 0.43 112.88 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.817 ' HB ' HG11 ' A' ' 15' ' ' VAL . 1.4 mp -75.12 151.83 86.11 Favored Pre-proline 0 C--O 1.205 -1.257 0 N-CA-C 109.618 -0.512 . . . . 1.06 109.618 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.2 Cg_exo -87.36 31.88 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.53 2.82 . . . . 1.08 114.771 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.287 9.8 p 60.45 -22.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 C-N-CA 127.057 2.143 . . . . 1.28 116.416 175.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -93.12 -15.16 26.34 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.281 0.562 . . . . 2.31 111.021 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.28 -26.63 30.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.385 -0.825 . . . . 1.59 111.454 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.853 HG23 ' HA ' ' A' ' 12' ' ' ALA . 43.1 t -71.84 98.41 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.133 -0.939 . . . . 1.07 108.811 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -130.12 161.92 29.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.845 -1.539 . . . . 2.11 106.845 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.477 ' HA ' HG23 ' A' ' 69' ' ' VAL . 91.1 mt -61.73 145.4 52.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.164 -0.68 . . . . 1.75 109.164 177.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 74.49 9.72 4.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.503 1.121 . . . . 0.72 110.586 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.5 mmtt -103.44 127.26 50.85 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 109.512 -0.551 . . . . 2.01 109.512 177.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 7.1 m -84.63 108.68 17.5 Favored 'General case' 1 C--N 1.239 -4.203 0 CA-C-N 114.736 -1.12 . . . . 1.32 108.34 178.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.683 ' HB2' ' SD ' ' A' ' 43' ' ' MET . 34.4 m-85 -46.51 -54.28 9.61 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 124.534 1.133 . . . . 0.71 110.207 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.986 HG22 H37A ' A' ' 101' ' ' SYO . 12.1 t -77.61 19.82 0.35 Allowed 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 125.681 1.592 . . . . 1.36 113.771 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 15.2 t70 -158.76 -62.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.276 -0.89 . . . . 1.74 110.886 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -69.31 -40.13 77.85 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.634 -1.166 . . . . 1.29 109.849 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.633 HD11 ' HA ' ' A' ' 32' ' ' PHE . 19.0 mt -80.78 -91.23 0.06 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 114.915 -1.039 . . . . 1.11 110.907 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 31.0 t70 168.01 20.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 121.966 0.889 . . . . 1.12 109.685 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.763 HG12 ' HE2' ' A' ' 43' ' ' MET . 13.5 t -87.67 144.98 8.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.364 -0.835 . . . . 1.21 108.986 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.11 124.28 29.71 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.694 -0.684 . . . . 2.0 109.81 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' MET . 11.3 t -36.27 -46.05 0.5 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.412 1.485 . . . . 0.99 114.421 172.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.95 -30.8 70.18 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.31 -0.556 . . . . 1.81 111.689 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 m -83.76 -18.27 38.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.388 0.613 . . . . 0.91 109.782 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.763 ' HE2' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -57.4 -38.27 74.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.229 1.012 . . . . 1.3 112.134 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.1 t -51.46 -51.14 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.109 0.881 . . . . 1.07 109.723 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -53.89 -48.73 69.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.68 109.949 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.602 HG22 HG13 ' A' ' 18' ' ' ILE . 46.2 t -58.71 -31.6 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.839 1.256 . . . . 1.31 111.481 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.709 HG23 ' H6 ' ' A' ' 101' ' ' SYO . 34.2 t -76.96 -47.24 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 N-CA-C 108.491 -0.929 . . . . 1.29 108.491 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.97 -36.3 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 114.787 -1.097 . . . . 1.1 108.462 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.32 -36.16 82.23 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.844 -0.616 . . . . 1.0 109.935 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -56.53 19.13 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.797 -1.092 . . . . 1.05 110.015 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.692 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -63.19 -33.11 74.77 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.724 -0.79 . . . . 0.64 113.069 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.98 -40.45 95.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.078 0.399 . . . . 2.07 112.078 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -84.56 -38.07 20.42 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.494 -0.482 . . . . 3.11 111.933 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.67 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.0 m-85 -97.41 20.12 12.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.053 0.76 . . . . 0.81 113.053 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.492 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 32.9 t70 69.5 -2.07 2.03 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 114.675 1.361 . . . . 1.99 114.675 171.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 51' ' ' GLU . 8.5 p -89.51 178.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 O-C-N 120.476 -1.39 . . . . 1.14 108.907 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -131.96 131.51 42.68 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 106.022 -1.844 . . . . 2.7 106.022 170.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.692 HG13 ' HB3' ' A' ' 51' ' ' GLU . 65.3 mt -120.62 114.99 32.55 Favored Pre-proline 0 C--N 1.293 -1.854 0 C-N-CA 120.532 -0.467 . . . . 1.09 110.205 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.55 ' HG2' ' HB2' ' A' ' 62' ' ' ASP . 28.9 Cg_endo -62.4 155.2 59.02 Favored 'Trans proline' 0 CA--C 1.509 -0.774 0 C-N-CA 123.124 2.549 . . . . 0.4 110.883 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -54.8 -28.82 52.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.499 0.499 . . . . 1.98 111.895 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.666 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 29.8 t70 -73.88 -39.51 63.86 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 120.384 -0.526 . . . . 2.06 111.317 176.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.55 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 11.5 m-20 -77.37 -24.4 50.63 Favored 'General case' 0 CA--C 1.482 -1.663 0 C-N-CA 119.231 -0.987 . . . . 0.52 112.644 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 47' ' ' VAL . 68.8 t -51.85 -49.85 35.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 107.958 -1.126 . . . . 1.12 107.958 171.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 5.1 ptmm? -77.76 -2.01 34.18 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.431 0.9 . . . . 2.73 113.431 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 91.7 m-20 -98.08 -16.97 19.35 Favored 'General case' 0 CA--C 1.485 -1.539 0 O-C-N 121.72 -0.612 . . . . 1.92 110.368 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.759 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.0 mt -87.32 128.72 35.18 Favored 'General case' 0 N--CA 1.391 -3.407 0 N-CA-C 103.788 -2.671 . . . . 1.04 103.788 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.85 -42.02 2.64 Favored 'General case' 0 C--N 1.268 -2.956 0 N-CA-C 108.149 -1.056 . . . . 2.98 108.149 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 61.6 p -102.7 174.97 5.65 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 1.03 108.894 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.477 HG23 ' HA ' ' A' ' 28' ' ' LEU . 1.5 m -81.64 -13.51 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 107.798 -1.186 . . . . 1.91 107.798 174.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.23 -27.16 66.62 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.193 -1.003 . . . . 0.33 110.661 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.513 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 5.9 t70 -83.64 -48.34 10.29 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.525 -0.917 . . . . 1.39 108.525 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.759 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.33 -59.98 3.62 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-N 114.028 -1.442 . . . . 1.04 111.833 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.473 ' HA ' HG23 ' A' ' 7' ' ' ILE . 60.0 m -56.91 -61.6 2.33 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.081 -0.963 . . . . 1.07 111.507 -173.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.513 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.3 OUTLIER -41.16 -46.75 3.13 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.86 2.064 . . . . 4.04 111.438 171.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.464 ' N ' ' HD2' ' A' ' 74' ' ' LYS . 88.4 t80 -63.22 -47.09 83.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.292 0.568 . . . . 0.9 110.336 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.631 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 64.0 mt -60.77 -66.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.32 -1.309 . . . . 1.12 109.259 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.472 HD11 ' N ' ' A' ' 78' ' ' ASP . 4.5 pp -58.58 -36.66 74.32 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.369 1.248 . . . . 2.08 114.369 -174.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.6 t70 -75.28 -22.63 57.62 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.952 -0.567 . . . . 0.64 111.666 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.38 -24.6 18.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.896 0.702 . . . . 1.59 112.896 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.36 0.0 OUTLIER -90.73 -56.35 3.22 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 116.101 1.889 . . . . 1.09 116.101 -179.029 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 1 C--N 1.235 -4.411 0 CA-C-N 115.545 -0.752 . . . . 1.97 110.456 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.986 H37A HG22 ' A' ' 33' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 108.844 -0.799 . . . . 2.01 108.844 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.61 -74.08 0.52 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.145 -0.479 . . . . 2.35 111.175 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.702 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 15.2 t -175.03 -171.09 0.49 Allowed 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 116.289 -0.414 . . . . 1.34 109.907 -175.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -52.84 -41.87 64.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.85 1.26 . . . . 0.74 113.09 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.93 -32.49 33.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.003 0.521 . . . . 2.66 112.299 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.21 -36.25 27.44 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.969 -0.56 . . . . 2.73 110.336 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.459 HG21 ' HA ' ' A' ' 73' ' ' THR . 74.9 mt -77.56 -66.49 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.218 0 CA-C-N 115.645 -0.707 . . . . 1.05 111.723 -171.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.2 t -55.91 -42.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 112.178 0.436 . . . . 1.05 112.178 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.96 89.49 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 123.713 0.633 . . . . 1.07 110.446 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.99 -39.0 13.78 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.895 -0.593 . . . . 0.21 113.08 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.716 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.21 -35.48 80.54 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.863 -1.162 . . . . 1.03 107.863 -177.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.71 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -57.02 -51.17 70.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.458 -0.571 . . . . 1.06 109.458 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 40.4 mt-10 -56.02 -44.32 78.61 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.417 1.073 . . . . 0.68 111.29 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' A' ' 11' ' ' LEU . 72.2 mt -56.96 -45.4 83.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.263 -0.881 . . . . 1.16 110.37 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 11' ' ' LEU . 58.5 t -66.78 -23.98 31.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.848 0.832 . . . . 1.14 110.138 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.567 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 2.6 m120 -75.48 -53.11 9.19 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.321 -0.992 . . . . 0.36 108.321 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 7.3 mm-40 -67.23 -39.98 86.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.964 -1.016 . . . . 2.07 111.374 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.6 mm -74.98 -53.73 15.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.667 -0.494 . . . . 1.31 109.667 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.55 -86.76 0.39 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.979 -0.555 . . . . 1.18 111.566 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.98 50.25 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.684 0 CA-C-N 115.817 -0.629 . . . . 0.43 112.302 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.794 HG22 HG21 ' A' ' 26' ' ' VAL . 1.6 mp -93.74 152.89 41.07 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 110.107 -0.331 . . . . 1.06 110.107 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 3.0 Cg_exo -84.87 30.88 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.671 2.914 . . . . 1.08 114.453 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p 54.84 2.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 115.81 1.782 . . . . 1.28 115.81 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 22' ' ' PRO . 10.0 pt-20 -127.6 0.5 6.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.063 -1.023 . . . . 2.31 111.374 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 22.6 t0 -89.33 -24.06 22.1 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.589 -1.187 . . . . 1.59 109.072 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.794 HG21 HG22 ' A' ' 21' ' ' ILE . 42.1 t -81.07 93.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.107 -1.406 . . . . 1.07 109.527 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -121.55 166.12 14.66 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.504 -0.924 . . . . 2.11 108.504 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 67.6 mt -67.31 143.26 56.51 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.138 -1.43 . . . . 1.75 107.138 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 33.1 t70 85.64 1.43 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 124.343 1.057 . . . . 0.72 110.565 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 68' ' ' THR . 45.4 mmtm -95.42 120.29 35.41 Favored 'General case' 0 CA--C 1.474 -1.972 0 O-C-N 121.502 -0.749 . . . . 2.01 109.879 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 10.4 t -83.02 35.22 0.47 Allowed 'General case' 1 C--N 1.24 -4.174 0 C-N-CA 126.483 1.913 . . . . 1.32 112.388 -171.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CZ ' HG22 ' A' ' 69' ' ' VAL . 96.6 m-85 41.64 -90.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.363 1.865 . . . . 0.71 115.293 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.4 t -62.73 -27.69 69.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.281 0.633 . . . . 1.36 111.398 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 11.3 t70 -87.16 -56.35 3.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.524 -0.307 . . . . 1.74 110.564 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.08 -38.29 27.56 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 113.466 0.913 . . . . 1.29 113.466 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 25.3 mt -82.62 -76.24 0.28 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.482 -0.487 . . . . 1.11 112.117 -171.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 170.9 -20.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 122.961 0.504 . . . . 1.12 110.349 -174.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 t -47.84 139.96 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.362 1.065 . . . . 1.21 111.978 -174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -81.27 126.17 31.22 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.895 -1.15 . . . . 2.0 107.895 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 t -42.53 -35.63 1.12 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 114.452 1.279 . . . . 0.99 114.452 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.417 HD11 ' N ' ' A' ' 42' ' ' SER . 3.6 pp -73.18 -33.28 65.34 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 119.067 -1.053 . . . . 1.81 111.976 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 46' ' ' VAL . 19.8 m -84.66 -13.36 51.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.965 0.888 . . . . 0.91 109.674 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.907 ' HG3' ' H1 ' ' A' ' 101' ' ' SYO . 3.6 tpt -61.9 -38.42 88.3 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 125.707 1.603 . . . . 1.3 110.568 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.65 -27.16 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.023 -0.535 . . . . 1.07 110.553 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.6 -45.59 68.21 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.384 -0.969 . . . . 0.68 108.384 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 42' ' ' SER . 41.8 t -58.07 -25.69 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.486 -1.233 . . . . 1.31 110.819 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.729 HG11 HG22 ' A' ' 63' ' ' VAL . 29.6 t -81.03 -54.3 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 N-CA-C 108.968 -0.753 . . . . 1.29 108.968 -176.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.14 -33.38 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.214 -0.903 . . . . 1.1 109.33 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.62 70.89 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.268 0.556 . . . . 1.0 109.991 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.49 -56.17 20.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.18 -0.918 . . . . 1.05 109.717 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -67.87 -31.11 70.69 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.127 1.158 . . . . 0.64 114.127 -176.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -60.53 -34.45 74.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.824 0.345 . . . . 2.07 110.306 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -86.83 -46.0 10.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.324 -0.398 . . . . 3.11 111.993 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' HZ ' ' N ' ' A' ' 11' ' ' LEU . 8.5 m-85 -84.67 -2.27 57.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.997 1.11 . . . . 0.81 113.997 -169.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.434 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 22.3 t70 80.76 -0.07 1.84 Allowed 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 124.401 1.08 . . . . 1.99 112.406 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 76' ' ' ILE . 12.9 p -81.56 176.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.41 -1.33 . . . . 1.14 107.41 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 33.7 tptt -134.02 123.94 25.4 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.836 -1.172 . . . . 2.7 107.836 173.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.56 HG12 ' HE2' ' A' ' 75' ' ' TYR . 41.3 mt -120.13 102.76 45.85 Favored Pre-proline 0 C--N 1.312 -1.026 0 C-N-CA 120.92 -0.312 . . . . 1.09 110.34 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.569 ' O ' HG21 ' A' ' 63' ' ' VAL . 64.4 Cg_endo -70.08 158.69 55.74 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 123.056 2.504 . . . . 0.4 110.44 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 9.8 t70 -46.24 -42.49 14.4 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.049 0.94 . . . . 1.98 110.525 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -53.85 -44.69 70.55 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 125.155 1.382 . . . . 2.06 112.716 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -86.68 -29.95 22.08 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.522 -0.471 . . . . 0.52 111.617 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.729 HG22 HG11 ' A' ' 47' ' ' VAL . 79.5 t -50.94 -51.42 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.886 -0.783 . . . . 1.12 108.886 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 21.3 ptmt -69.65 -4.18 18.33 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 114.152 1.167 . . . . 2.73 114.152 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.83 -23.8 14.87 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.696 0.76 . . . . 1.92 109.112 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.882 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.0 mt -82.46 133.83 35.21 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 105.965 -1.865 . . . . 1.04 105.965 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.494 ' HG2' HG21 ' A' ' 68' ' ' THR . 0.2 OUTLIER -126.11 -38.1 2.19 Favored 'General case' 0 C--N 1.259 -3.335 0 C-N-CA 119.919 -0.712 . . . . 2.98 109.995 174.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 26.9 p -107.46 -179.32 3.88 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 119.568 -0.853 . . . . 1.03 110.385 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.592 HG22 ' CZ ' ' A' ' 32' ' ' PHE . 13.0 t -83.12 -19.53 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 106.793 -1.558 . . . . 1.91 106.793 177.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.524 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -68.5 -47.2 58.55 Favored Glycine 0 CA--C 1.489 -1.545 0 N-CA-C 107.791 -2.124 . . . . 0.33 107.791 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.19 -55.85 29.63 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.638 -1.281 . . . . 1.39 110.471 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.882 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -53.69 -60.92 2.7 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.562 1.164 . . . . 1.04 111.732 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.459 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.2 m -58.77 -41.97 87.83 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 113.663 0.986 . . . . 1.07 113.663 -174.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.524 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 1.9 mptm? -61.28 -48.52 81.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 108.678 -0.86 . . . . 4.04 108.678 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.56 ' HE2' HG12 ' A' ' 58' ' ' ILE . 86.8 t80 -57.81 -51.53 69.21 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 124.536 1.148 . . . . 0.9 110.74 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.709 ' HA ' HG23 ' A' ' 56' ' ' VAL . 72.5 mt -54.94 -66.75 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.718 0 CA-C-N 114.545 -1.207 . . . . 1.12 111.019 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.702 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.8 tt -52.17 -45.36 65.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.574 1.55 . . . . 2.08 109.359 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 28.1 t70 -71.15 -24.74 62.32 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.165 -1.38 . . . . 0.64 111.501 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -103.7 -9.0 19.47 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 113.759 1.022 . . . . 1.59 113.759 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 92.3 mt-30 -68.77 -65.57 0.69 Allowed 'General case' 0 CA--C 1.449 -2.925 0 CA-C-O 122.909 1.338 . . . . 1.09 108.841 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.402 ' H ' ' HB2' ' A' ' 80' ' ' GLN . . . . . . . . 0 C--N 1.257 -3.438 0 CA-C-N 111.549 -2.569 . . . . 1.97 110.274 -175.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.907 ' H1 ' ' HG3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . . . . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 109.89 -0.411 . . . . 2.01 109.89 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.62 -96.36 0.11 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 111.958 0.355 . . . . 2.35 111.958 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.499 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.8 t -176.57 -177.88 0.86 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.556 -0.535 . . . . 1.34 109.556 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.594 ' HG2' HG23 ' A' ' 73' ' ' THR . 1.0 OUTLIER -54.54 -35.84 63.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.41 1.484 . . . . 0.74 111.67 179.014 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -52.79 -47.99 67.17 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 124.12 0.887 . . . . 2.66 110.395 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.52 -30.73 64.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.804 -0.634 . . . . 2.73 110.347 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.608 HG21 ' CE2' ' A' ' 54' ' ' PHE . 97.9 mt -76.61 -66.56 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 CA-C-N 116.086 -0.506 . . . . 1.05 111.307 -172.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.52 HG23 HD12 ' A' ' 28' ' ' LEU . 91.1 t -58.36 -36.07 56.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.714 0.635 . . . . 1.05 112.714 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -66.03 -37.55 86.17 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.549 -0.46 . . . . 1.07 111.0 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.413 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.18 -36.95 11.76 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 111.842 -0.503 . . . . 0.21 111.842 -176.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.745 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.82 -40.68 95.59 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.611 -0.885 . . . . 1.03 108.611 -178.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.745 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -56.21 -47.57 78.13 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.556 -0.747 . . . . 1.06 109.691 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.1 mt-10 -60.74 -39.68 89.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 123.99 0.806 . . . . 0.68 112.548 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.745 HD11 ' HA ' ' A' ' 11' ' ' LEU . 63.4 mt -59.97 -44.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.688 0.756 . . . . 1.16 109.0 176.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.7 HG12 ' HB ' ' A' ' 21' ' ' ILE . 64.7 t -67.78 -25.87 33.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.019 -0.991 . . . . 1.14 110.788 -175.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 5.6 m120 -70.5 -38.6 74.35 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.396 -0.82 . . . . 0.36 109.311 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.23 -43.62 15.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.6 -0.727 . . . . 2.07 111.58 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.656 HG13 HG23 ' A' ' 46' ' ' VAL . 17.3 mm -62.12 -52.71 57.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.988 0.515 . . . . 1.31 110.885 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -109.84 -85.56 0.54 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.435 -0.506 . . . . 1.18 110.858 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.84 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 110.931 -0.868 . . . . 0.43 110.931 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.7 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.6 mp -87.2 149.82 48.09 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 109.405 -0.591 . . . . 1.06 109.405 178.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 5.0 Cg_exo -88.25 37.87 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.757 2.971 . . . . 1.08 113.723 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.259 3.7 p 57.74 -14.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 117.006 2.225 . . . . 1.28 117.006 176.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.09 2.9 12.71 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 120.641 -1.287 . . . . 2.31 110.708 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.545 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 7.3 t70 -78.78 -31.72 46.19 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.119 -1.067 . . . . 1.59 108.119 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' A' ' 12' ' ' ALA . 24.8 t -74.46 92.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 113.129 -1.851 . . . . 1.07 110.498 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' O ' HG13 ' A' ' 69' ' ' VAL . 95.6 mttt -118.03 163.37 16.7 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.043 0.449 . . . . 2.11 110.152 177.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.52 HD12 HG23 ' A' ' 8' ' ' VAL . 5.6 mp -70.98 136.24 48.32 Favored 'General case' 0 N--CA 1.406 -2.675 0 N-CA-C 108.822 -0.807 . . . . 1.75 108.822 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.4 t70 84.62 9.89 0.4 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.297 1.439 . . . . 0.72 109.701 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -102.08 128.4 48.56 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 115.648 -0.705 . . . . 2.01 109.22 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.4 m -79.92 114.12 18.6 Favored 'General case' 0 C--N 1.244 -3.987 0 CA-C-N 114.779 -1.101 . . . . 1.32 108.491 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.62 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 94.1 m-85 -45.41 -64.53 0.7 Allowed 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 124.253 1.021 . . . . 0.71 112.057 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.791 HG21 H37A ' A' ' 101' ' ' SYO . 10.1 t -59.01 -46.02 89.24 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 113.131 0.789 . . . . 1.36 113.131 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -86.55 -55.91 3.66 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.57 0.581 . . . . 1.74 112.57 -172.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.62 -49.14 15.19 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.659 0.783 . . . . 1.29 111.628 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 HG21 ' A' ' 26' ' ' VAL . 14.0 mt -77.32 -51.41 10.92 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.754 -0.657 . . . . 1.11 111.539 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 101.99 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.219 2.208 . . . . 1.12 111.275 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' THR . 22.0 t -110.09 118.84 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.607 -1.627 . . . . 1.21 106.607 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.15 113.52 0.82 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.228 0.955 . . . . 2.0 109.741 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.3 p -49.7 -21.45 1.06 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.279 1.431 . . . . 0.99 114.359 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 42' ' ' SER . 3.3 pp -81.84 -36.89 27.79 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.887 0.699 . . . . 1.81 112.887 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.443 ' N ' HD12 ' A' ' 41' ' ' LEU . 3.3 m -81.71 -13.39 57.89 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.461 1.124 . . . . 0.91 108.546 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.655 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 3.7 tpt -55.49 -36.72 66.96 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 126.804 2.042 . . . . 1.3 111.061 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.74 -45.91 96.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 115.809 -0.632 . . . . 1.07 109.776 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -57.39 -41.37 80.12 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 115.906 -0.588 . . . . 0.68 109.903 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.656 HG23 HG13 ' A' ' 18' ' ' ILE . 40.1 t -59.53 -28.8 40.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-N 115.496 -0.774 . . . . 1.31 111.16 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.76 HG22 HG13 ' A' ' 63' ' ' VAL . 20.8 t -78.98 -54.94 10.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.151 -1.055 . . . . 1.29 108.151 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.4 -19.65 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.85 -1.523 . . . . 1.1 110.904 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.84 -38.91 16.36 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 121.226 0.536 . . . . 1.0 109.633 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . . . -61.17 -64.19 1.04 Allowed 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.99 -1.005 . . . . 1.05 111.567 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.341 0.0 OUTLIER -59.43 -44.12 92.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 114.882 1.438 . . . . 0.64 114.882 -173.822 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -54.12 -39.2 66.22 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.206 1.003 . . . . 2.07 112.244 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.914 -0.585 . . . . 3.11 110.781 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 7' ' ' ILE . 8.2 m-85 -86.66 -44.89 11.49 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.467 -0.893 . . . . 0.81 111.839 -173.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 22.9 t70 155.14 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.751 1.282 . . . . 1.99 112.682 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 76' ' ' ILE . 3.8 p -79.96 178.37 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 112.072 0.397 . . . . 1.14 112.072 -168.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.31 125.56 29.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.355 -1.35 . . . . 2.7 107.355 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.602 HG12 ' HE2' ' A' ' 75' ' ' TYR . 64.8 mt -113.36 118.9 43.05 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.348 -0.387 . . . . 1.09 110.683 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.6 Cg_endo -66.78 154.18 75.39 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.482 2.788 . . . . 0.4 110.588 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -51.66 -37.42 50.41 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.591 0.557 . . . . 1.98 111.673 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -59.56 -44.43 93.26 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.202 -0.454 . . . . 2.06 110.682 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 21.7 m-20 -82.68 -28.89 30.3 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 112.662 0.615 . . . . 0.52 112.662 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.76 HG13 HG22 ' A' ' 47' ' ' VAL . 53.0 t -52.01 -53.45 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 108.183 -1.043 . . . . 1.12 108.183 174.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -74.98 -1.91 24.77 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.975 -1.011 . . . . 2.73 113.549 -177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.92 -33.56 14.84 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.576 -0.898 . . . . 1.92 108.576 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 72' ' ' ALA . 32.5 mt -69.25 133.34 47.8 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 106.267 -1.753 . . . . 1.04 106.267 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -128.39 -32.29 2.22 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-O 121.252 0.548 . . . . 2.98 110.126 175.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 28.5 p -112.07 172.81 6.69 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.683 -0.858 . . . . 1.03 108.683 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -80.4 -12.93 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.782 0.801 . . . . 1.91 109.478 175.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.74 -37.92 76.6 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.368 -1.493 . . . . 0.33 109.368 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.565 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 24.3 m-20 -69.44 -54.33 14.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 108.772 -0.825 . . . . 1.39 108.772 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.844 ' HA ' HD12 ' A' ' 66' ' ' LEU . . . -51.19 -60.67 2.86 Favored 'General case' 0 CA--C 1.469 -2.168 0 O-C-N 124.676 1.235 . . . . 1.04 111.043 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.594 HG23 ' HG2' ' A' ' 4' ' ' GLN . 35.9 m -54.97 -49.28 71.83 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.459 1.099 . . . . 1.07 113.585 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.7 mptm? -67.17 -28.64 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.222 0.534 . . . . 4.04 111.051 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.602 ' HE2' HG12 ' A' ' 58' ' ' ILE . 84.9 t80 -71.52 -51.9 21.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.966 -0.753 . . . . 0.9 108.966 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.663 ' HA ' HG11 ' A' ' 56' ' ' VAL . 60.3 mt -57.41 -66.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.521 -1.218 . . . . 1.12 111.134 -177.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 4.5 tt -50.19 -50.34 49.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.211 1.404 . . . . 2.08 110.972 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.9 t70 -69.5 -25.72 64.19 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.995 -1.457 . . . . 0.64 111.417 -170.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -91.26 -22.67 20.46 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.674 -0.694 . . . . 1.59 111.682 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.415 HE21 HG21 ' A' ' 76' ' ' ILE . 2.4 pt20 -90.62 -54.95 3.77 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.482 1.134 . . . . 1.09 113.385 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . . . . . . . . 0 C--N 1.249 -3.766 0 CA-C-N 113.459 -1.7 . . . . 1.97 110.331 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.791 H37A HG21 ' A' ' 33' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 109.557 -0.534 . . . . 2.01 109.557 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.59 -74.87 0.6 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.263 -0.426 . . . . 2.35 110.611 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.428 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 12.3 t -174.46 -169.68 0.46 Allowed 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.996 -0.742 . . . . 1.34 108.996 -178.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -40.19 60.56 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.593 1.157 . . . . 0.74 113.202 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.54 -23.73 64.83 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.865 0.691 . . . . 2.66 112.865 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.52 -39.9 21.76 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.018 -0.734 . . . . 2.73 109.018 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.435 HG23 ' HA ' ' A' ' 73' ' ' THR . 76.3 mt -76.66 -66.48 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 CA-C-N 114.719 -1.128 . . . . 1.05 111.692 -170.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -56.72 -42.41 77.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.376 0.51 . . . . 1.05 112.376 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.82 72.84 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.589 0.556 . . . . 1.07 111.362 176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.91 -40.09 8.3 Favored Glycine 0 N--CA 1.405 -3.418 0 C-N-CA 120.596 -0.811 . . . . 0.21 113.059 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.701 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -63.12 -41.04 99.25 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.613 0.765 . . . . 1.03 109.079 -177.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.588 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.09 -48.17 67.99 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 123.747 0.654 . . . . 1.06 109.588 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.663 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 48.3 mt-10 -62.36 -42.34 99.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 124.266 0.979 . . . . 0.68 112.05 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.701 HD13 ' HA ' ' A' ' 11' ' ' LEU . 54.7 mt -59.49 -39.43 79.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.332 0.587 . . . . 1.16 110.179 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 11' ' ' LEU . 46.4 t -69.48 -23.52 26.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 CA-C-O 122.082 0.944 . . . . 1.14 109.722 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.663 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -77.98 -37.78 46.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.25 -1.018 . . . . 0.36 108.25 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 20.7 mm-40 -74.23 -55.52 5.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.853 -1.067 . . . . 2.07 111.296 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.599 HG13 HG22 ' A' ' 46' ' ' VAL . 21.3 mm -63.87 -53.1 48.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.448 -0.796 . . . . 1.31 110.811 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB1' HG12 ' A' ' 38' ' ' VAL . . . -103.12 -83.1 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.438 -0.505 . . . . 1.18 110.436 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.03 44.93 0.02 OUTLIER Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 120.061 -1.066 . . . . 0.43 112.199 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.59 HG21 HG22 ' A' ' 26' ' ' VAL . 1.6 mp -78.05 149.79 77.03 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 110.05 -0.352 . . . . 1.06 110.05 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.523 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 8.9 Cg_exo -82.86 24.54 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 124.526 3.484 . . . . 1.08 115.429 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.9 p 52.55 22.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 125.55 1.54 . . . . 1.28 114.909 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -130.16 -13.14 4.02 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 120.909 -1.119 . . . . 2.31 111.399 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.523 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -93.38 -26.25 17.34 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 115.324 -0.853 . . . . 1.59 110.251 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.59 HG22 HG21 ' A' ' 21' ' ' ILE . 39.5 t -71.24 91.23 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.201 -0.908 . . . . 1.07 109.357 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 34.4 mmtp -130.74 169.98 14.96 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.294 -1.373 . . . . 2.11 107.294 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.416 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 8.3 mp -64.74 148.38 51.25 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.819 -0.808 . . . . 1.75 108.819 177.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 t70 81.76 -3.52 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.766 1.226 . . . . 0.72 110.766 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.726 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 10.4 mmpt? -98.13 124.05 42.48 Favored 'General case' 0 CA--C 1.454 -2.744 0 C-N-CA 119.713 -0.795 . . . . 2.01 110.856 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 19.2 m -79.78 115.5 19.41 Favored 'General case' 1 C--N 1.237 -4.316 0 N-CA-C 108.02 -1.104 . . . . 1.32 108.02 178.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.816 ' HA ' HD11 ' A' ' 36' ' ' LEU . 83.3 m-85 -51.78 -49.35 62.84 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.566 0.698 . . . . 0.71 112.228 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.4 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.0 t -81.36 -44.46 17.56 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.291 -0.88 . . . . 1.36 111.305 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 25.0 t70 -74.15 -50.92 17.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.032 0.753 . . . . 1.74 113.032 -175.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.421 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 12.7 t70 -83.78 -58.03 2.97 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 122.049 0.928 . . . . 1.29 109.393 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.816 HD11 ' HA ' ' A' ' 32' ' ' PHE . 25.4 mt -72.88 -32.65 65.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.48 -1.691 . . . . 1.11 112.363 -169.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 20.1 t70 83.1 66.48 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 123.193 1.473 . . . . 1.12 110.803 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.615 HG12 ' HB1' ' A' ' 19' ' ' ALA . 49.4 t -105.62 141.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 112.767 -2.015 . . . . 1.21 107.94 170.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.44 ' HB2' ' OG ' ' A' ' 42' ' ' SER . 4.8 m-20 -56.08 7.93 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 116.618 2.081 . . . . 2.0 116.618 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.435 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.5 t 66.6 -57.44 0.39 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 114.383 1.253 . . . . 0.99 114.383 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 pp -63.31 -30.72 71.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.949 0.88 . . . . 1.81 109.749 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.542 ' O ' HG21 ' A' ' 46' ' ' VAL . 1.5 m -77.94 -15.55 58.89 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.751 -1.113 . . . . 0.91 110.506 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.826 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -67.08 -40.62 87.04 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-N 116.306 -0.407 . . . . 1.3 111.967 -174.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.19 -40.84 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 124.246 0.966 . . . . 1.07 109.767 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.88 -48.02 83.72 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.578 -0.737 . . . . 0.68 109.526 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.599 HG22 HG13 ' A' ' 18' ' ' ILE . 11.9 t -60.78 -23.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.988 0.915 . . . . 1.31 110.918 -177.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.891 HG22 HG12 ' A' ' 63' ' ' VAL . 36.8 t -78.99 -54.74 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 107.885 -1.154 . . . . 1.29 107.885 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -60.65 -37.06 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.882 -1.054 . . . . 1.1 108.89 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.501 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -70.01 -31.51 69.21 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.061 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' CB ' ' H8A' ' A' ' 101' ' ' SYO . . . -65.67 -58.16 6.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.363 -0.835 . . . . 1.05 109.266 176.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.619 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.269 0.0 OUTLIER -66.42 -31.83 72.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 114.914 1.45 . . . . 0.64 114.914 -175.59 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -59.24 -33.32 70.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.908 0.861 . . . . 2.07 109.881 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -88.59 -32.33 18.17 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.11 -0.95 . . . . 3.11 111.968 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.23 18.42 21.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.397 0.518 . . . . 0.81 112.397 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 75.37 -26.02 0.2 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 114.438 1.273 . . . . 1.99 114.438 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.619 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 7.2 p -72.26 170.81 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 122.324 -0.235 . . . . 1.14 110.379 -173.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.615 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 2.8 tppp? -124.13 126.67 46.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.31 -0.996 . . . . 2.7 108.31 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.614 HG12 ' HE2' ' A' ' 75' ' ' TYR . 36.0 mt -119.99 105.02 43.26 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 120.592 -0.443 . . . . 1.09 110.457 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.55 ' O ' HG22 ' A' ' 63' ' ' VAL . 79.9 Cg_endo -73.8 166.6 29.31 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.106 2.537 . . . . 0.4 111.004 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.33 -46.97 37.16 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 1.98 111.487 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.16 -35.44 77.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.876 -0.602 . . . . 2.06 112.02 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.55 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 10.9 m-20 -86.03 -31.63 21.9 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.275 -0.57 . . . . 0.52 111.222 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.891 HG12 HG22 ' A' ' 47' ' ' VAL . 75.1 t -52.84 -50.52 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.843 -0.799 . . . . 1.12 108.843 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -72.41 -9.15 58.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.199 -0.909 . . . . 2.73 113.195 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.42 -25.91 21.28 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.478 0.656 . . . . 1.92 110.071 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.858 HD12 ' HA ' ' A' ' 72' ' ' ALA . 19.7 mt -82.18 110.92 17.82 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.077 -1.823 . . . . 1.04 106.077 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -112.25 -43.88 3.48 Favored 'General case' 0 C--N 1.271 -2.834 0 N-CA-C 107.718 -1.216 . . . . 2.98 107.718 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 67.4 p -102.54 174.73 5.77 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 114.917 -1.038 . . . . 1.03 109.039 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.474 HG21 ' CE2' ' A' ' 32' ' ' PHE . 10.1 t -77.3 -14.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 107.781 -1.192 . . . . 1.91 107.781 175.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.416 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -69.01 -51.09 30.41 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 109.39 -1.484 . . . . 0.33 109.39 175.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -60.38 -51.24 70.32 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 114.269 -0.966 . . . . 1.39 109.371 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.858 ' HA ' HD12 ' A' ' 66' ' ' LEU . . . -54.29 -61.57 2.22 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 124.494 1.122 . . . . 1.04 111.528 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.435 ' HA ' HG23 ' A' ' 7' ' ' ILE . 34.3 m -58.1 -45.83 86.56 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.437 -1.256 . . . . 1.07 113.861 -174.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.2 mptm? -57.64 -50.8 71.98 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 123.851 0.72 . . . . 4.04 109.194 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.614 ' HE2' HG12 ' A' ' 58' ' ' ILE . 49.4 t80 -54.55 -51.22 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.124 0.89 . . . . 0.9 111.283 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.676 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.1 mt -55.09 -66.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.66 0 CA-C-N 114.671 -1.149 . . . . 1.12 110.611 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.428 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 4.2 tt -52.54 -43.66 65.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.796 1.638 . . . . 2.08 110.678 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 7.0 t70 -71.07 -26.3 63.01 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.218 -1.355 . . . . 0.64 110.96 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -103.24 -7.73 20.93 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.389 0.885 . . . . 1.59 113.389 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.676 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 84.0 mt-30 -71.9 -61.08 1.91 Allowed 'General case' 0 CA--C 1.448 -2.967 0 CA-C-O 122.974 1.369 . . . . 1.09 107.623 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.257 -3.421 0 CA-C-N 112.203 -2.272 . . . . 1.97 110.198 -178.893 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.826 ' H1 ' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 109.44 -0.578 . . . . 2.01 109.44 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.04 -155.27 0.65 Allowed 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.098 -1.075 . . . . 2.35 108.098 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -134.65 174.79 10.17 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.309 -0.626 . . . . 1.34 109.309 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.9 OUTLIER -48.39 -36.91 15.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.016 1.327 . . . . 0.74 112.973 178.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -52.19 -54.49 30.23 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.787 0.68 . . . . 2.66 110.512 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.16 -37.07 71.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.728 0.811 . . . . 2.73 110.092 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.537 HG23 ' HA ' ' A' ' 73' ' ' THR . 82.3 mt -74.37 -66.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 115.099 -0.955 . . . . 1.05 111.149 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.26 -46.71 92.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 112.347 0.499 . . . . 1.05 112.347 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.654 -0.419 . . . . 1.07 110.808 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.55 -38.22 9.93 Favored Glycine 0 N--CA 1.415 -2.756 0 CA-C-N 116.099 -0.501 . . . . 0.21 113.362 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.672 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.47 -38.61 91.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.033 -1.099 . . . . 1.03 108.033 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.665 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -56.96 -44.73 82.89 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.812 -0.631 . . . . 1.06 109.966 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.652 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 42.8 mt-10 -64.09 -35.24 80.12 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.872 0.732 . . . . 0.68 111.843 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 11' ' ' LEU . 51.7 mt -67.54 -43.2 87.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.85 -0.614 . . . . 1.16 109.589 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 11' ' ' LEU . 21.3 t -67.72 -24.65 31.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 121.885 0.85 . . . . 1.14 109.221 -177.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.652 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 13.7 m120 -64.58 -43.29 94.31 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 114.776 -1.102 . . . . 0.36 109.26 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -80.44 -49.15 11.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.189 -0.914 . . . . 2.07 111.591 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.684 HG13 HG22 ' A' ' 46' ' ' VAL . 22.1 mm -61.2 -53.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.057 -0.52 . . . . 1.31 111.283 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.8 -76.59 0.6 Allowed 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.226 -0.59 . . . . 1.18 110.384 -176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.84 50.33 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 110.146 -1.182 . . . . 0.43 110.146 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.448 ' HB ' HG13 ' A' ' 15' ' ' VAL . 1.2 mp -88.46 159.77 46.4 Favored Pre-proline 0 C--N 1.278 -2.508 0 CA-C-N 114.395 -0.902 . . . . 1.06 108.577 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -92.53 141.13 2.14 Favored 'Trans proline' 0 N--CA 1.414 -3.154 0 C-N-CA 122.108 1.872 . . . . 1.08 108.954 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.446 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.5 p -73.41 54.2 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-O 122.779 1.276 . . . . 1.28 113.111 -173.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -163.74 -9.39 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.109 -1.405 . . . . 2.31 111.087 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -83.71 -28.45 28.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.763 0.792 . . . . 1.59 109.394 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.665 HG22 ' HA ' ' A' ' 12' ' ' ALA . 43.3 t -77.46 92.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.525 -1.216 . . . . 1.07 109.304 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.6 mttt -121.14 172.81 7.7 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.895 -1.15 . . . . 2.11 107.895 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -65.81 145.48 55.91 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.822 -1.177 . . . . 1.75 107.822 176.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 77.0 8.7 2.88 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.246 0.966 . . . . 0.72 110.804 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.1 mmtt -92.3 119.78 32.21 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 108.387 -0.968 . . . . 2.01 108.387 174.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 17.4 m -78.58 36.69 0.26 Allowed 'General case' 1 C--N 1.243 -4.058 0 C-N-CA 125.688 1.595 . . . . 1.32 113.515 -172.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.646 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 97.4 m-85 39.96 -95.78 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 125.328 1.451 . . . . 0.71 114.622 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.411 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 15.0 t -84.72 37.57 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.546 1.165 . . . . 1.36 111.342 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 32' ' ' PHE . 32.5 t70 -145.41 -48.5 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.23 -1.35 . . . . 1.74 107.76 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 3.2 m-20 -87.35 -38.05 16.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 1.29 112.914 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 26' ' ' VAL . 59.7 mt -85.35 -48.84 8.66 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.186 0.81 . . . . 1.11 113.186 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.0 t70 102.59 69.48 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.323 1.849 . . . . 1.12 109.696 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG13 ' H ' ' A' ' 39' ' ' ASP . 11.5 t -105.14 175.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 113.803 -1.544 . . . . 1.21 109.733 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.547 ' H ' HG13 ' A' ' 38' ' ' VAL . 17.2 t70 -79.04 -18.29 53.78 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.261 0.837 . . . . 2.0 113.261 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 43' ' ' MET . 3.3 t 74.5 -41.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.686 1.194 . . . . 0.99 113.154 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.45 -49.59 10.44 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 106.879 -1.526 . . . . 1.81 106.879 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 19.5 m -67.08 -11.96 58.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.045 -1.434 . . . . 0.91 111.023 176.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.646 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 4.0 tpt -60.23 -33.3 72.07 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 125.073 1.349 . . . . 1.3 109.324 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.537 HG22 ' S1 ' ' A' ' 101' ' ' SYO . 60.7 t -64.74 -40.02 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.602 -0.726 . . . . 1.07 109.53 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.23 -43.18 82.64 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.374 -0.375 . . . . 0.68 110.53 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.684 HG22 HG13 ' A' ' 18' ' ' ILE . 6.5 t -60.97 -24.43 32.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 C-N-CA 123.526 0.73 . . . . 1.31 110.845 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.696 HG23 HG11 ' A' ' 63' ' ' VAL . 22.0 t -80.4 -53.77 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 107.78 -1.193 . . . . 1.29 107.78 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.65 -32.91 52.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 113.895 -1.502 . . . . 1.1 110.03 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB3' HG23 ' A' ' 14' ' ' ILE . . . -77.67 -31.31 52.46 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.207 0.527 . . . . 1.0 109.73 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.58 -57.09 12.35 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.398 -0.819 . . . . 1.05 109.131 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.527 ' OE2' ' HD3' ' A' ' 57' ' ' LYS 0.279 0.0 OUTLIER -61.88 -38.67 89.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 114.161 1.171 . . . . 0.64 114.161 -176.274 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.19 -34.47 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.527 0.517 . . . . 2.07 112.128 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -82.88 -36.08 25.66 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.064 -0.516 . . . . 3.11 110.205 -175.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.508 ' CE2' HG21 ' A' ' 7' ' ' ILE . 7.1 m-85 -86.85 -45.08 11.2 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.2 -1.0 . . . . 0.81 112.435 -172.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 152.29 -35.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 O-C-N 124.891 1.37 . . . . 1.99 112.169 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.595 ' CG1' HG23 ' A' ' 76' ' ' ILE . 14.5 p -75.92 172.37 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 112.726 0.639 . . . . 1.14 112.726 -165.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.527 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 3.1 tppp? -125.04 119.71 29.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.368 -1.715 . . . . 2.7 106.368 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.548 HG12 ' HE2' ' A' ' 75' ' ' TYR . 58.5 mt -111.85 113.22 52.74 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 120.693 -0.403 . . . . 1.09 110.226 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.548 ' O ' HG21 ' A' ' 63' ' ' VAL . 93.8 Cg_endo -73.15 157.62 50.25 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.822 2.348 . . . . 0.4 110.668 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.16 -41.17 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.523 1.129 . . . . 1.98 111.617 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 2.3 m-20 -61.81 -51.02 69.96 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 115.573 -0.74 . . . . 2.06 111.247 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 m-20 -71.46 -30.32 65.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.971 0.36 . . . . 0.52 111.971 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.696 HG11 HG23 ' A' ' 47' ' ' VAL . 53.0 t -51.43 -55.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.941 -0.763 . . . . 1.12 108.941 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.5 pttp -75.64 -1.92 26.9 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 115.401 -0.818 . . . . 2.73 112.674 -175.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.38 -19.57 22.76 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.656 0.741 . . . . 1.92 109.383 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.867 HD11 ' HA ' ' A' ' 72' ' ' ALA . 33.2 mt -86.11 118.33 25.51 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 104.728 -2.323 . . . . 1.04 104.728 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -110.95 -46.69 3.3 Favored 'General case' 0 C--N 1.259 -3.341 0 N-CA-C 108.289 -1.004 . . . . 2.98 108.289 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 42.5 p -105.07 173.57 6.25 Favored 'General case' 1 N--CA 1.379 -4.004 0 CA-C-N 115.052 -0.977 . . . . 1.03 109.321 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 27' ' ' LYS . 5.5 t -77.49 -13.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 107.454 -1.313 . . . . 1.91 107.454 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.543 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.46 -45.69 58.97 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.201 -1.56 . . . . 0.33 109.201 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -68.17 -48.21 65.9 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.122 -1.039 . . . . 1.39 109.59 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.867 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -53.62 -61.13 2.5 Favored 'General case' 0 CA--C 1.482 -1.655 0 O-C-N 124.56 1.162 . . . . 1.04 111.124 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.537 ' HA ' HG23 ' A' ' 7' ' ' ILE . 58.5 m -54.89 -51.54 65.66 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.615 -1.175 . . . . 1.07 113.838 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.1 mptm? -54.75 -47.85 73.33 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.867 0.729 . . . . 4.04 109.456 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.548 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.0 t80 -58.19 -52.55 65.11 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 124.204 0.94 . . . . 0.9 111.412 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.595 HG23 ' CG1' ' A' ' 56' ' ' VAL . 75.8 mt -51.41 -65.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.789 -1.096 . . . . 1.12 110.298 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 tt -54.52 -42.21 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.077 1.351 . . . . 2.08 109.855 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 26.6 t70 -59.62 -41.04 89.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.163 0.985 . . . . 0.64 110.285 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.58 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 1.9 t-80 -90.07 -12.4 38.58 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.141 -1.39 . . . . 1.59 111.222 -173.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 34.0 mt-30 -81.53 -49.49 10.51 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-O 122.722 1.248 . . . . 1.09 108.351 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -2.859 0 CA-C-N 112.381 -2.19 . . . . 1.97 110.458 -175.342 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.673 ' H2A' ' N41' ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 N-CA-C 108.248 -1.019 . . . . 2.01 108.248 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.06 -89.47 0.47 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 112.445 0.535 . . . . 2.35 112.445 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.552 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 t -169.64 -172.47 1.43 Allowed 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.908 -0.405 . . . . 1.34 109.908 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.405 ' HG2' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -50.26 -41.9 51.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.855 1.662 . . . . 0.74 113.534 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -62.42 -23.69 66.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.78 0.659 . . . . 2.66 112.78 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -87.56 -35.7 17.97 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.108 -0.701 . . . . 2.73 109.108 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 73' ' ' THR . 92.9 mt -75.73 -65.48 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-N 115.523 -0.762 . . . . 1.05 110.996 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG22 ' HG2' ' A' ' 4' ' ' GLN . 67.6 t -52.16 -45.04 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 122.869 0.468 . . . . 1.05 111.523 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.1 76.64 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 123.64 0.588 . . . . 1.07 111.604 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.58 9.94 Favored Glycine 0 N--CA 1.412 -2.949 0 CA-C-N 116.419 -0.355 . . . . 0.21 112.493 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.735 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.61 -36.55 82.86 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.243 -1.021 . . . . 1.03 108.243 -178.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.691 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -58.68 -44.41 90.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.482 -0.781 . . . . 1.06 110.022 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.668 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 47.0 mt-10 -62.39 -38.6 90.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 123.935 0.772 . . . . 0.68 111.746 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.735 HD11 ' HA ' ' A' ' 11' ' ' LEU . 61.1 mt -61.53 -42.33 93.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.749 0.785 . . . . 1.16 109.161 176.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.781 HG11 ' HB ' ' A' ' 21' ' ' ILE . 86.4 t -71.16 -23.72 23.56 Favored 'Isoleucine or valine' 0 C--O 1.255 1.39 0 CA-C-N 115.182 -0.917 . . . . 1.14 111.08 -175.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.668 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 8.9 m120 -67.02 -46.31 74.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.1 -1.074 . . . . 0.36 108.1 177.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -74.97 -50.03 18.0 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.924 -1.035 . . . . 2.07 111.859 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.712 HG13 HG23 ' A' ' 46' ' ' VAL . 24.4 mm -59.71 -52.53 59.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.983 0.513 . . . . 1.31 111.403 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.57 ' HB2' HG11 ' A' ' 38' ' ' VAL . . . -110.28 -60.0 1.86 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.077 0.465 . . . . 1.18 111.552 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.07 28.63 0.31 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 120.559 -0.829 . . . . 0.43 112.638 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.781 ' HB ' HG11 ' A' ' 15' ' ' VAL . 1.5 mp -70.41 151.73 95.62 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 109.569 -0.53 . . . . 1.06 109.569 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.7 Cg_exo -89.8 33.97 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.993 3.128 . . . . 1.08 115.222 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 3.3 p 61.41 -11.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 116.444 2.016 . . . . 1.28 116.444 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -115.16 -3.42 12.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.416 -0.803 . . . . 2.31 112.231 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.31 -29.54 28.24 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-O 121.638 0.733 . . . . 1.59 109.19 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.743 HG23 HG22 ' A' ' 21' ' ' ILE . 47.4 t -71.72 90.44 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.149 -1.387 . . . . 1.07 108.126 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' O ' HG12 ' A' ' 69' ' ' VAL . 1.5 tppp? -124.11 158.81 31.41 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.384 -1.71 . . . . 2.11 106.384 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.4 mt -57.54 140.29 51.2 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.001 0.429 . . . . 1.75 110.531 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t70 74.75 13.97 3.43 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.467 1.507 . . . . 0.72 110.911 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' THR . 69.6 mmtt -100.91 125.99 47.5 Favored 'General case' 0 CA--C 1.467 -2.238 0 CA-C-O 121.474 0.655 . . . . 2.01 109.308 175.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 9.3 m -80.2 111.38 16.52 Favored 'General case' 1 C--N 1.239 -4.234 0 CA-C-N 114.071 -1.422 . . . . 1.32 109.129 -177.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.581 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 93.7 m-85 -45.74 -64.92 0.62 Allowed 'General case' 0 C--N 1.271 -2.808 0 C-N-CA 124.367 1.067 . . . . 0.71 112.374 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -90.25 32.97 0.9 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.204 -0.935 . . . . 1.36 112.783 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.8 t70 -147.71 -55.83 0.23 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.671 0.748 . . . . 1.74 110.741 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.59 -50.6 8.61 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.189 -0.914 . . . . 1.29 110.394 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 32' ' ' PHE . 17.3 mt -76.36 -45.5 31.67 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.682 -0.69 . . . . 1.11 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.6 t70 88.66 61.73 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.844 1.658 . . . . 1.12 109.921 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.57 HG11 ' HB2' ' A' ' 19' ' ' ALA . 18.6 t -104.21 143.55 15.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 113.591 -1.64 . . . . 1.21 106.766 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 43' ' ' MET . 36.9 m-20 -60.53 109.67 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 111.876 0.325 . . . . 2.0 111.876 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.465 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 28.6 t -34.84 -50.43 0.47 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 126.527 1.931 . . . . 0.99 114.429 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.12 -27.83 63.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.438 0.637 . . . . 1.81 111.918 -176.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.418 ' O ' HG22 ' A' ' 46' ' ' VAL . 18.5 m -85.11 -13.38 50.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.386 0.675 . . . . 0.91 110.425 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.92 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -61.58 -38.15 86.48 Favored 'General case' 0 CA--C 1.47 -2.103 0 C-N-CA 123.289 0.636 . . . . 1.3 111.576 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.6 -42.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 124.341 1.025 . . . . 1.07 109.413 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -57.01 -50.32 73.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.374 0.606 . . . . 0.68 109.387 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.712 HG23 HG13 ' A' ' 18' ' ' ILE . 40.8 t -55.83 -28.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 124.92 1.288 . . . . 1.31 111.67 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 63' ' ' VAL . 21.2 t -78.17 -49.25 21.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.02 -1.104 . . . . 1.29 108.02 -176.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.39 -38.6 78.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.291 -1.322 . . . . 1.1 108.517 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -38.03 77.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.003 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' CB ' ' H8A' ' A' ' 101' ' ' SYO . . . -61.42 -55.22 33.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.108 -0.951 . . . . 1.05 110.008 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.324 1.9 pp20? -62.22 -38.49 89.4 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 113.996 1.11 . . . . 0.64 113.996 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.32 -25.86 66.22 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.649 0.593 . . . . 2.07 112.505 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -83.93 -52.17 6.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.644 -0.423 . . . . 3.11 110.583 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 14.2 m-85 -73.94 -44.17 55.87 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 114.629 1.344 . . . . 0.81 114.629 -169.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 17.3 t70 146.52 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 O-C-N 124.732 1.27 . . . . 1.99 110.636 176.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 76' ' ' ILE . 11.8 p -73.18 173.53 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.004 -0.998 . . . . 1.14 112.303 -166.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -120.69 123.3 42.41 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.449 -1.315 . . . . 2.7 107.449 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.562 HG13 ' HB3' ' A' ' 51' ' ' GLU . 55.3 mt -120.31 106.96 39.83 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.478 -0.934 . . . . 1.09 108.478 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.605 ' O ' HG21 ' A' ' 63' ' ' VAL . 45.7 Cg_endo -70.29 166.84 26.91 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.013 2.476 . . . . 0.4 111.517 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.406 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 14.9 t70 -50.43 -43.2 54.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.144 0.978 . . . . 1.98 109.339 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -49.6 -59.17 4.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.539 -1.21 . . . . 2.06 111.642 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.545 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 27.6 m-20 -74.19 -26.28 60.18 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.84 0.681 . . . . 0.52 112.84 -176.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.918 HG11 HG22 ' A' ' 47' ' ' VAL . 62.0 t -53.26 -41.93 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 108.919 -0.771 . . . . 1.12 108.919 174.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 60' ' ' ASP . 32.3 mtmt -80.24 -7.18 58.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.665 -1.152 . . . . 2.73 112.185 -177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.67 -36.91 11.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 108.862 -0.792 . . . . 1.92 108.862 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.866 HD11 ' HA ' ' A' ' 72' ' ' ALA . 19.6 mt -73.2 125.1 26.95 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 106.596 -1.631 . . . . 1.04 106.596 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.552 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -130.15 -24.24 2.62 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 120.312 -0.555 . . . . 2.98 111.474 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 43.0 p -116.5 171.83 7.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 107.721 -1.214 . . . . 1.03 107.721 173.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -78.75 -13.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 C-N-CA 120.087 -0.645 . . . . 1.91 109.599 176.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.32 -46.78 67.91 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 109.713 -1.355 . . . . 0.33 109.713 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.552 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 15.0 m-20 -61.33 -55.42 31.92 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.378 -0.971 . . . . 1.39 108.378 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.866 ' HA ' HD11 ' A' ' 66' ' ' LEU . . . -51.62 -61.19 2.4 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.0 -1.454 . . . . 1.04 111.769 -175.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.43 ' HA ' HG21 ' A' ' 7' ' ' ILE . 37.6 m -57.96 -46.33 85.28 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.96 -1.018 . . . . 1.07 113.472 -174.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 14.1 mptt -56.88 -44.75 82.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 123.771 0.669 . . . . 4.04 109.45 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.464 ' HE2' HG12 ' A' ' 58' ' ' ILE . 85.6 t80 -65.31 -48.19 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.37 1.043 . . . . 0.9 111.65 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.62 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -54.94 -65.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.71 -1.132 . . . . 1.12 110.239 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.0 tt -51.7 -41.78 61.71 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.775 1.23 . . . . 2.08 109.358 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 11.5 t70 -58.28 -41.11 83.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.917 1.287 . . . . 0.64 109.549 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -102.1 3.78 38.96 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.979 1.103 . . . . 1.59 113.979 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 46.3 mt-30 -87.14 -60.53 1.95 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.552 -1.277 . . . . 1.09 107.552 175.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.417 0 CA-C-N 111.736 -2.484 . . . . 1.97 112.158 -174.135 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SYO . . . . . 0.92 ' H1 ' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.748 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.6 t . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 107.864 -1.161 . . . . 0.66 107.864 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.88 -42.72 48.47 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.363 1.065 . . . . 0.74 113.757 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -58.53 -23.79 59.04 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.173 0.511 . . . . 2.66 112.148 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -84.33 -45.14 13.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.272 -0.64 . . . . 2.73 109.272 175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.497 HG21 ' HA ' ' A' ' 73' ' ' THR . 79.8 mt -71.57 -65.44 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.03 0 CA-C-N 115.001 -0.999 . . . . 0.23 110.484 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.39 -48.81 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 C-N-CA 123.768 0.827 . . . . 0.27 112.614 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.68 77.64 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 123.327 0.392 . . . . 0.27 111.206 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -81.45 -40.5 11.03 Favored Glycine 0 N--CA 1.405 -3.424 0 C-N-CA 120.709 -0.758 . . . . 0.18 112.952 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.732 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -65.39 -38.09 88.94 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.161 0.984 . . . . 0.2 108.879 -176.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.536 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -61.82 -43.39 98.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.608 -0.724 . . . . 0.14 109.846 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.684 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.9 mt-10 -63.91 -35.74 81.65 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.754 0.659 . . . . 0.68 112.282 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 11' ' ' LEU . 60.7 mt -62.25 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.621 -0.881 . . . . 0.28 108.621 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.3 t -68.34 -23.86 28.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 CA-C-O 121.591 0.71 . . . . 0.27 110.659 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.684 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -66.35 -46.18 77.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.235 -0.893 . . . . 0.34 109.096 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.75 -44.8 15.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.233 -0.894 . . . . 2.07 111.614 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.714 HG13 HG22 ' A' ' 46' ' ' VAL . 21.0 mm -59.57 -51.91 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.783 0.433 . . . . 0.65 110.793 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -108.33 -81.42 0.57 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.52 0.676 . . . . 0.54 110.631 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.45 55.7 0.01 OUTLIER Glycine 0 CA--C 1.484 -1.86 0 N-CA-C 110.322 -1.111 . . . . 0.43 110.322 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.664 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -97.82 160.79 27.68 Favored Pre-proline 0 C--N 1.278 -2.52 0 N-CA-C 107.976 -1.12 . . . . 0.31 107.976 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -93.24 143.57 2.1 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 122.523 2.148 . . . . 1.08 109.192 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 12' ' ' ALA . 13.8 p -74.1 56.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 123.287 1.518 . . . . 0.81 112.802 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.418 ' H ' ' H ' ' A' ' 25' ' ' ASP . 10.5 pt-20 -151.51 -14.48 0.2 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.26 -1.336 . . . . 2.31 110.068 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' A' ' 30' ' ' LYS . 1.6 t70 -87.61 -37.14 17.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.861 0.839 . . . . 1.59 109.172 -173.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.633 HG22 HD13 ' A' ' 36' ' ' LEU . 21.7 t -77.7 90.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.991 -1.114 . . . . 0.3 107.991 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 66.2 mttm -101.84 -96.29 0.28 Allowed 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.955 0.883 . . . . 1.58 109.014 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.41 ' H ' ' HB2' ' A' ' 27' ' ' LYS . 95.4 mt -153.15 157.13 39.88 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 104.238 -2.505 . . . . 1.05 104.238 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.469 ' H ' ' CA ' ' A' ' 70' ' ' GLY . 30.5 t70 68.69 9.31 7.27 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.501 1.125 . . . . 0.72 110.657 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HB2' HG12 ' A' ' 69' ' ' VAL . 46.6 mmtt -93.57 126.2 38.59 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-N 115.586 -0.734 . . . . 1.48 109.282 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 34' ' ' ASP . 7.1 m -74.38 25.51 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 C-N-CA 126.501 1.92 . . . . 1.25 114.63 -171.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.748 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 70.2 m-85 41.84 -97.29 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.625 1.57 . . . . 0.4 113.746 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.677 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 10.2 t -57.58 -35.44 70.41 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 123.565 0.746 . . . . 1.06 111.141 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB3' ' CB ' ' A' ' 31' ' ' SER . 19.3 t70 -83.67 -40.82 18.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.482 -0.326 . . . . 1.74 111.098 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.84 -54.45 3.96 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 118.683 -1.207 . . . . 1.29 110.821 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.633 HD13 HG22 ' A' ' 26' ' ' VAL . 17.3 mt -74.06 -38.37 63.97 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.457 -1.247 . . . . 0.81 111.405 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.6 t70 89.4 69.37 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.538 1.535 . . . . 1.12 109.605 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.677 ' H ' ' HA ' ' A' ' 33' ' ' THR . 15.0 t -111.68 155.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.927 -1.942 . . . . 0.79 106.57 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 43' ' ' MET . 12.2 m-20 -76.5 119.85 20.91 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.251 -0.648 . . . . 2.0 109.251 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.563 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 10.2 t -42.51 -50.71 5.25 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.584 1.153 . . . . 0.78 113.58 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.62 -29.54 70.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.46 0.648 . . . . 1.18 111.43 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 46' ' ' VAL . 21.7 m -84.43 -15.12 47.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.17 -0.468 . . . . 0.6 110.688 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.748 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -62.8 -35.01 78.49 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 123.429 0.692 . . . . 0.86 110.579 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.76 -42.62 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.138 -0.689 . . . . 0.31 109.138 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.99 -44.54 94.45 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.194 -0.669 . . . . 0.68 109.194 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.714 HG22 HG13 ' A' ' 18' ' ' ILE . 47.8 t -59.65 -29.03 41.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 114.998 -1.001 . . . . 0.63 111.244 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.031 HG21 HG13 ' A' ' 63' ' ' VAL . 40.4 t -77.78 -51.77 17.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.876 -0.787 . . . . 0.55 108.876 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.2 -21.57 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.429 -0.805 . . . . 0.42 109.272 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.22 -38.0 31.96 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 109.012 -0.736 . . . . 0.21 109.012 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.71 -56.36 16.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.337 -0.847 . . . . 0.21 110.253 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.297 0.6 OUTLIER -63.47 -36.7 84.62 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 114.379 1.251 . . . . 0.64 114.379 -176.328 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.73 -24.12 64.43 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.892 0.377 . . . . 2.07 111.486 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -88.26 -40.91 13.28 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.737 0.303 . . . . 2.48 110.554 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -94.52 -2.1 52.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.81 113.032 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 81.77 7.18 1.07 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.3 1.04 . . . . 1.99 113.723 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.748 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.5 p -89.73 178.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.328 -0.99 . . . . 0.37 108.328 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.432 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.2 tptt -133.45 130.51 38.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.241 -1.392 . . . . 2.12 107.241 171.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 76' ' ' ILE . 61.9 mt -124.68 113.36 27.17 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.182 -0.673 . . . . 0.25 109.182 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.581 ' O ' HG23 ' A' ' 63' ' ' VAL . 73.3 Cg_endo -72.56 164.42 35.65 Favored 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 123.089 2.526 . . . . 0.33 110.518 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.9 -30.31 70.8 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.929 0.344 . . . . 1.98 111.929 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.51 -31.39 72.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.693 0.282 . . . . 2.06 111.094 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.627 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 15.2 m-20 -86.61 -28.21 23.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.034 0.383 . . . . 0.52 112.034 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.031 HG13 HG21 ' A' ' 47' ' ' VAL . 69.7 t -55.05 -48.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.415 -0.957 . . . . 0.38 108.415 173.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 64' ' ' LYS . 15.6 ptpt -80.65 -1.92 44.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.253 -0.885 . . . . 2.16 111.772 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 38.5 t30 -92.21 -29.47 16.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.597 -0.89 . . . . 1.59 108.597 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.872 HD13 ' HA ' ' A' ' 72' ' ' ALA . 25.6 mt -85.7 112.29 20.9 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.432 -1.322 . . . . 0.31 107.432 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.537 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -104.76 -21.99 13.27 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.705 -1.198 . . . . 2.55 110.966 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.464 HG23 ' HG2' ' A' ' 67' ' ' LYS . 30.6 p -127.79 169.85 13.4 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 108.804 -0.813 . . . . 0.23 108.804 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.685 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 1.6 p -73.88 -13.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.804 0.811 . . . . 1.21 110.419 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.469 ' CA ' ' H ' ' A' ' 29' ' ' ASP . . . -68.95 -47.28 55.61 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 108.772 -1.731 . . . . 0.33 108.772 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.537 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.6 m-20 -58.19 -56.36 23.1 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.014 -0.736 . . . . 1.39 109.014 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.872 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.65 -61.64 2.08 Favored 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 124.718 1.262 . . . . 0.15 111.926 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.497 ' HA ' HG21 ' A' ' 7' ' ' ILE . 31.6 m -57.92 -44.03 86.58 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 113.643 0.979 . . . . 0.24 113.643 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -65.2 -33.3 75.69 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 122.905 0.482 . . . . 3.63 109.842 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HE2' HG12 ' A' ' 58' ' ' ILE . 88.4 t80 -72.68 -52.72 14.12 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.422 -0.808 . . . . 0.4 110.023 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.748 ' HA ' HG21 ' A' ' 56' ' ' VAL . 70.7 mt -52.88 -66.26 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.698 0 C-N-CA 124.717 1.207 . . . . 0.21 111.519 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.748 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.4 tt -50.41 -49.08 55.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.596 1.558 . . . . 1.44 109.484 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.3 t70 -67.56 -23.42 65.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.424 -1.716 . . . . 0.63 111.575 -174.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -101.96 -12.88 17.86 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.868 -0.606 . . . . 1.25 112.448 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 11.8 mt-30 . . . . . 0 CA--C 1.464 -2.33 0 N-CA-C 107.1 -1.444 . . . . 0.87 107.1 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.432 -1.335 0 N-CA-C 109.362 -0.607 . . . . 0.66 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.711 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -50.3 -46.4 55.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 125.615 1.566 . . . . 0.74 113.419 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.97 -23.59 63.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.58 0.585 . . . . 2.66 112.58 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -84.64 -32.2 23.79 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.821 -1.177 . . . . 2.73 107.821 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 73' ' ' THR . 74.2 mt -79.88 -64.81 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.112 -0.949 . . . . 0.23 109.238 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -55.6 -42.59 69.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 112.626 0.602 . . . . 0.27 112.626 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -60.92 -40.07 91.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.57 -0.452 . . . . 0.27 110.691 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.69 -35.89 21.03 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 120.889 -0.672 . . . . 0.18 112.6 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.683 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -65.9 -39.75 90.9 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.508 -1.293 . . . . 0.2 107.508 -179.263 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.77 -49.84 67.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 123.926 0.766 . . . . 0.14 109.867 175.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.756 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 35.1 mt-10 -58.58 -42.68 88.59 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 124.223 0.952 . . . . 0.68 111.521 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.4 mt -59.4 -38.75 76.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.509 -0.769 . . . . 0.28 110.232 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 11' ' ' LEU . 61.9 t -71.83 -30.16 36.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.614 -0.721 . . . . 0.27 109.845 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.756 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 13.2 m-20 -67.33 -42.65 83.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.102 -0.703 . . . . 0.34 109.102 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 37.1 mm-40 -70.68 -58.8 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.917 -1.038 . . . . 2.07 111.887 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.803 HG22 ' HB3' ' A' ' 42' ' ' SER . 28.0 mt -72.82 -39.36 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 112.619 0.6 . . . . 0.65 112.619 -174.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -106.27 -80.37 0.56 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.13 -0.628 . . . . 0.54 111.441 -178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.69 53.17 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.656 -0.783 . . . . 0.43 112.756 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.824 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -98.02 155.22 37.27 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.612 -0.514 . . . . 0.31 109.612 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 21' ' ' ILE . 5.7 Cg_exo -88.76 40.14 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.017 2.478 . . . . 1.08 114.362 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.596 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.29 8.0 p 53.2 -18.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 117.383 2.364 . . . . 0.81 117.383 178.079 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -103.58 -12.8 16.85 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.351 -0.843 . . . . 2.31 111.401 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.59 -29.87 46.34 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.923 -0.769 . . . . 1.59 108.923 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.824 HG23 HG21 ' A' ' 21' ' ' ILE . 41.8 t -73.23 95.05 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.557 -1.201 . . . . 0.3 108.136 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -130.62 149.51 52.25 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 103.751 -2.685 . . . . 1.58 103.751 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD22 ' HA2' ' A' ' 70' ' ' GLY . 57.0 mt -48.63 145.97 3.33 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 124.007 0.923 . . . . 1.05 109.862 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 80.05 10.37 1.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.539 1.149 . . . . 0.72 110.707 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.762 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 34.2 mmtp -99.9 124.28 45.05 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.675 -0.861 . . . . 1.48 108.675 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 15.2 m -81.46 38.01 0.48 Allowed 'General case' 0 C--N 1.249 -3.781 0 C-N-CA 126.058 1.743 . . . . 1.25 113.007 -173.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.675 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 88.4 m-85 36.42 -91.83 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.991 1.716 . . . . 0.4 114.524 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.9 t -53.72 -33.12 54.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.091 0.956 . . . . 1.06 112.27 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 27.6 t70 -94.04 -44.41 8.05 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.879 0.371 . . . . 1.74 111.484 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.762 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 6.7 m-20 -88.63 -33.55 17.59 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.784 1.031 . . . . 1.29 113.784 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.629 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.0 mt -98.7 -31.42 11.92 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.038 -0.356 . . . . 0.81 110.038 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 84.55 62.79 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.223 1.487 . . . . 1.12 108.975 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 19' ' ' ALA . 26.7 t -109.39 124.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.701 -2.045 . . . . 0.79 107.71 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.45 122.66 15.15 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 121.064 -0.254 . . . . 2.0 111.212 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.537 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 26.8 t -37.21 -43.04 0.49 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.938 1.459 . . . . 0.78 114.938 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.2 mt -60.91 -46.26 91.35 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.944 0.878 . . . . 1.18 109.56 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.803 ' HB3' HG22 ' A' ' 18' ' ' ILE . 8.3 m -71.71 -29.3 64.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.511 -1.222 . . . . 0.6 110.501 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.698 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -53.16 -47.25 68.92 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 124.966 1.307 . . . . 0.86 112.798 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 48' ' ' VAL . 59.9 t -55.9 -45.6 79.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.013 0.82 . . . . 0.31 109.995 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -60.32 -44.1 95.78 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 109.34 -0.615 . . . . 0.68 109.34 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 15' ' ' VAL . 94.6 t -58.82 -28.54 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.027 0.931 . . . . 0.63 111.677 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.861 HG21 HG13 ' A' ' 63' ' ' VAL . 32.1 t -79.72 -50.98 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 108.04 -1.096 . . . . 0.55 108.04 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 44' ' ' VAL . 49.0 t -59.35 -38.74 76.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.214 -1.357 . . . . 0.42 108.91 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.21 -35.04 71.39 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.994 -0.548 . . . . 0.21 110.42 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.75 11.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.267 -0.879 . . . . 0.21 109.339 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.279 0.0 OUTLIER -63.95 -34.07 77.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 113.721 1.008 . . . . 0.64 113.721 -176.95 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.49 -24.73 66.45 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.445 0.535 . . . . 2.07 112.445 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -88.85 -41.56 12.4 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.503 -0.479 . . . . 2.48 111.629 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HZ ' ' N ' ' A' ' 11' ' ' LEU . 8.8 m-85 -88.87 -0.83 57.72 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 113.267 0.84 . . . . 0.81 113.267 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 80.2 -0.07 2.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.435 1.084 . . . . 1.99 112.837 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.738 HG21 ' HA ' ' A' ' 76' ' ' ILE . 7.6 p -84.75 177.45 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.389 -0.967 . . . . 0.37 108.389 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' H ' HG22 ' A' ' 56' ' ' VAL . 9.1 ttmm -137.11 131.76 33.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.934 -0.765 . . . . 2.12 108.934 172.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.563 HG12 ' HE2' ' A' ' 75' ' ' TYR . 54.0 mt -124.43 113.59 27.52 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.804 -0.635 . . . . 0.25 109.382 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HG23 ' A' ' 63' ' ' VAL . 36.5 Cg_endo -67.07 157.82 59.88 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 122.564 2.176 . . . . 0.33 109.917 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.81 -29.88 63.18 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.685 0.755 . . . . 1.98 109.359 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 29.7 t70 -60.91 -47.2 87.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.569 -1.196 . . . . 2.06 111.452 177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 59.3 m-20 -83.12 -24.94 32.39 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 111.812 0.301 . . . . 0.52 111.812 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.861 HG13 HG21 ' A' ' 47' ' ' VAL . 67.2 t -52.53 -48.11 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.324 -0.991 . . . . 0.38 108.324 173.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 25.8 pttm -75.57 -2.39 28.94 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.153 0.797 . . . . 2.16 113.153 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -98.87 -25.92 14.46 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.002 0.429 . . . . 1.59 110.418 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' HA ' ' A' ' 72' ' ' ALA . 37.4 mt -79.72 119.51 22.74 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 106.017 -1.846 . . . . 0.31 106.017 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -110.37 -35.04 6.17 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.58 -0.848 . . . . 2.55 110.571 176.195 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 31.6 p -111.43 177.65 4.59 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 109.089 -0.708 . . . . 0.23 109.089 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.675 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -86.99 -13.03 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 N-CA-C 108.263 -1.014 . . . . 1.21 108.263 174.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.469 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -72.35 -35.95 59.81 Favored Glycine 0 C--O 1.216 -0.981 0 N-CA-C 108.385 -1.886 . . . . 0.33 108.385 173.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 68' ' ' THR . 11.7 m-20 -66.74 -60.27 2.84 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.821 1.249 . . . . 1.39 109.501 173.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.75 -61.1 2.41 Favored 'General case' 0 CA--C 1.469 -2.164 0 CA-C-N 113.474 -1.694 . . . . 0.15 112.317 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.711 HG21 ' HG2' ' A' ' 4' ' ' GLN . 59.2 m -59.75 -34.34 72.83 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.914 -1.039 . . . . 0.24 113.324 -175.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -43.4 70.06 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 108.027 -1.101 . . . . 3.63 108.027 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.563 ' HE2' HG12 ' A' ' 58' ' ' ILE . 87.1 t80 -61.27 -50.86 71.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.856 -1.065 . . . . 0.4 109.611 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.738 ' HA ' HG21 ' A' ' 56' ' ' VAL . 76.7 mt -54.79 -65.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.037 -1.438 . . . . 0.21 110.634 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.13 -41.74 62.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.634 0.773 . . . . 1.44 109.939 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.34 -34.51 76.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.14 -0.936 . . . . 0.63 111.723 -175.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -95.71 -7.16 38.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 113.631 0.974 . . . . 1.25 113.631 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.397 0 N-CA-C 113.97 1.1 . . . . 0.87 113.97 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.452 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.0 t . . . . . 0 N--CA 1.437 -1.101 0 N-CA-C 111.083 0.031 . . . . 0.66 111.083 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -51.25 -37.06 45.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.945 1.298 . . . . 0.74 112.848 -178.08 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -48.76 66.92 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.895 0.747 . . . . 2.66 110.854 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.35 -38.18 87.01 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.505 0.722 . . . . 2.73 109.907 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.542 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.7 mt -72.13 -66.79 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.028 0 CA-C-N 115.681 -0.691 . . . . 0.23 112.344 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.573 HG21 HD11 ' A' ' 28' ' ' LEU . 58.3 t -60.0 -41.12 85.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 112.377 0.51 . . . . 0.27 112.377 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.36 86.84 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.269 0.355 . . . . 0.27 110.54 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.62 -40.15 10.04 Favored Glycine 0 N--CA 1.414 -2.825 0 CA-C-N 115.815 -0.629 . . . . 0.18 113.584 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.26 -37.14 86.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.605 -0.887 . . . . 0.2 108.605 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.12 -49.23 77.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.893 -0.594 . . . . 0.14 109.418 175.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.868 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 49.7 mt-10 -60.23 -41.57 93.39 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 124.131 0.894 . . . . 0.68 112.244 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 11' ' ' LEU . 69.1 mt -56.84 -42.15 77.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.618 -0.719 . . . . 0.28 109.887 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.626 HG12 ' HB ' ' A' ' 21' ' ' ILE . 98.4 t -70.16 -22.85 24.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.778 0.799 . . . . 0.27 110.879 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.868 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 15.1 m-20 -76.34 -42.2 45.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.55 -1.278 . . . . 0.34 107.55 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -76.92 -39.76 49.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.551 -1.204 . . . . 2.07 112.252 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.553 HG13 HG22 ' A' ' 46' ' ' VAL . 20.7 mm -71.96 -53.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.895 0.379 . . . . 0.65 110.563 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.33 -74.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.374 -0.531 . . . . 0.54 111.26 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.55 44.77 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.353 -0.927 . . . . 0.43 112.221 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.843 HG21 HG23 ' A' ' 26' ' ' VAL . 1.5 mp -84.9 151.0 57.01 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.984 -0.747 . . . . 0.31 108.984 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 13.3 Cg_exo -83.27 29.24 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 124.277 3.318 . . . . 1.08 115.004 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.558 ' HB ' HD22 ' A' ' 16' ' ' ASN . 5.7 p 54.1 7.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 C-N-CA 126.195 1.798 . . . . 0.81 114.351 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -107.95 -27.1 10.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.943 -0.473 . . . . 2.31 111.834 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 36' ' ' LEU . 11.1 m-20 -83.17 -28.64 29.19 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 116.054 -0.521 . . . . 1.59 112.094 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.843 HG23 HG21 ' A' ' 21' ' ' ILE . 22.1 t -78.37 87.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.118 -0.633 . . . . 0.3 110.399 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 69' ' ' VAL . 96.5 mttt -125.6 168.84 13.15 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.473 -0.785 . . . . 1.58 109.422 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 8' ' ' VAL . 5.5 mp -60.19 139.3 57.63 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.255 -0.43 . . . . 1.05 110.081 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 79.28 12.68 1.23 Allowed 'General case' 0 C--N 1.316 -0.855 0 O-C-N 125.044 1.465 . . . . 0.72 111.252 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.7 mmtt -99.47 124.75 44.91 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 109.301 -0.629 . . . . 1.48 109.301 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.5 m -78.9 34.42 0.23 Allowed 'General case' 0 C--N 1.254 -3.578 0 C-N-CA 126.356 1.862 . . . . 1.25 114.377 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.797 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 79.9 m-85 43.04 -93.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.499 1.519 . . . . 0.4 114.913 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -67.35 -24.37 65.71 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.993 -0.442 . . . . 1.06 111.98 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -89.45 -52.99 4.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.935 0.398 . . . . 1.74 110.952 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.55 -41.31 19.78 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 116.155 -0.475 . . . . 1.29 112.221 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.585 HD13 HG22 ' A' ' 26' ' ' VAL . 16.1 mt -83.4 -76.32 0.29 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 119.097 -0.478 . . . . 0.81 110.525 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 34.2 t70 159.82 -16.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 O-C-N 124.411 1.069 . . . . 1.12 110.608 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 36' ' ' LEU . 3.0 t -47.13 135.37 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.037 1.335 . . . . 0.79 113.276 -171.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 43' ' ' MET . 11.3 t70 -59.49 112.8 1.91 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.516 -0.766 . . . . 2.0 111.805 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.565 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 17.3 t -40.82 -43.31 2.0 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 116.069 1.877 . . . . 0.78 116.069 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 4.2 pp -80.22 -30.69 38.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.254 -1.378 . . . . 1.18 110.66 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 46' ' ' VAL . 20.1 m -76.14 -13.92 60.18 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.601 -0.727 . . . . 0.6 110.165 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.797 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.13 -36.09 76.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 123.44 0.696 . . . . 0.86 110.301 177.277 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.97 -44.68 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 123.959 0.787 . . . . 0.31 109.36 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.65 -43.09 94.03 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.181 -0.674 . . . . 0.68 109.181 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.553 HG22 HG13 ' A' ' 18' ' ' ILE . 57.6 t -59.26 -24.98 29.15 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.015 -0.993 . . . . 0.63 111.455 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.978 HG21 HG13 ' A' ' 63' ' ' VAL . 42.3 t -80.18 -54.32 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 N-CA-C 106.933 -1.506 . . . . 0.55 106.933 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HA ' ' OE2' ' A' ' 51' ' ' GLU . 74.2 t -53.85 -40.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.372 -1.74 . . . . 0.42 110.07 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.91 -37.08 64.76 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-O 121.233 0.54 . . . . 0.21 110.27 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.97 4.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.059 -0.973 . . . . 0.21 109.905 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.296 0.9 OUTLIER -62.8 -35.53 80.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 114.377 1.251 . . . . 0.64 114.377 -176.1 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.67 -30.46 71.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.356 0.502 . . . . 2.07 112.356 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -82.82 -36.72 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.777 -0.369 . . . . 2.48 110.979 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.542 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 7.7 m-85 -87.58 -19.43 27.83 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.766 1.024 . . . . 0.81 113.766 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.0 t70 103.76 -5.35 0.02 OUTLIER 'General case' 0 N--CA 1.532 3.641 0 O-C-N 125.29 1.619 . . . . 1.99 114.227 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 76' ' ' ILE . 8.1 p -87.17 172.96 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 O-C-N 121.141 -0.974 . . . . 0.37 109.513 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.88 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -126.6 118.79 25.54 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.208 -1.405 . . . . 2.12 107.208 174.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.585 HG12 ' HE2' ' A' ' 75' ' ' TYR . 57.5 mt -111.64 114.03 52.69 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 120.88 -0.328 . . . . 0.25 110.929 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HG23 ' A' ' 63' ' ' VAL . 83.2 Cg_endo -72.82 164.6 35.11 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.524 2.816 . . . . 0.33 110.913 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.45 -38.71 74.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.905 0.482 . . . . 1.98 111.058 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.577 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.0 m-20 -61.82 -34.71 76.42 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-N 115.816 -0.629 . . . . 2.06 111.592 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.575 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.0 m-20 -87.36 -23.98 24.4 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.659 -0.816 . . . . 0.52 113.177 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.978 HG13 HG21 ' A' ' 47' ' ' VAL . 79.4 t -55.96 -45.68 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.093 -1.077 . . . . 0.38 108.093 172.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 17.4 ptmt -74.78 -10.27 59.35 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.202 -0.908 . . . . 2.16 111.84 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -91.56 -13.52 31.87 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.264 0.554 . . . . 1.59 110.168 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.821 HD13 ' HA ' ' A' ' 72' ' ' ALA . 24.9 mt -95.96 109.54 21.9 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 107.101 -1.444 . . . . 0.31 107.101 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.514 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -105.72 -45.22 4.46 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.742 -1.206 . . . . 2.55 107.742 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 62.8 p -102.86 170.44 7.99 Favored 'General case' 0 N--CA 1.383 -3.808 0 CA-C-N 114.937 -1.028 . . . . 0.23 108.821 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -79.31 -12.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.464 -0.939 . . . . 1.21 108.464 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.66 -46.98 64.36 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 108.597 -1.801 . . . . 0.33 108.597 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.92 -52.42 65.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 109.026 -0.731 . . . . 1.39 109.026 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.821 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.25 -61.26 2.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 O-C-N 124.635 1.209 . . . . 0.15 111.365 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' HG21 ' A' ' 7' ' ' ILE . 52.5 m -55.7 -50.87 69.15 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 124.211 0.945 . . . . 0.24 113.471 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.5 mptm? -60.52 -34.14 73.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 123.3 0.64 . . . . 3.63 110.185 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.585 ' HE2' HG12 ' A' ' 58' ' ' ILE . 77.1 t80 -70.37 -55.89 8.0 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.771 -0.455 . . . . 0.4 109.771 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.608 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 63.8 mt -50.31 -66.44 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 124.662 1.185 . . . . 0.21 110.909 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.41 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.5 tt -52.88 -54.32 36.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.781 1.232 . . . . 1.44 110.047 -175.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 11.9 t70 -70.57 -24.4 62.77 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.542 -1.208 . . . . 0.63 112.02 -169.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.27 -4.87 48.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.416 0.895 . . . . 1.25 113.416 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 76' ' ' ILE . 2.0 pt20 . . . . . 0 CA--C 1.473 -2.012 0 CA-C-O 122.391 1.091 . . . . 0.87 110.898 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 7' ' ' ILE . 2.5 t . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 119.114 -0.469 . . . . 0.66 109.93 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.451 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -48.32 -40.32 24.86 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.398 0.888 . . . . 0.74 113.398 -176.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.27 -33.74 65.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.046 0.841 . . . . 2.66 110.411 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -87.15 -37.74 17.07 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.403 -0.817 . . . . 2.73 109.837 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.667 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.1 mt -65.67 -65.75 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 116.392 -0.367 . . . . 0.23 111.711 -172.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.756 HG21 HD11 ' A' ' 28' ' ' LEU . 59.1 t -56.91 -42.31 78.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 122.126 0.17 . . . . 0.27 111.394 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -38.74 78.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.813 0.696 . . . . 0.27 111.278 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.66 -38.45 10.63 Favored Glycine 0 N--CA 1.419 -2.47 0 CA-C-N 116.183 -0.462 . . . . 0.18 113.117 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -63.97 -40.48 96.49 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.978 -0.749 . . . . 0.2 108.978 -178.254 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.641 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.34 -50.77 64.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.127 0.892 . . . . 0.14 109.685 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.614 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 55.6 mt-10 -61.54 -38.91 89.14 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 124.0 0.813 . . . . 0.68 111.927 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.7 mt -59.85 -45.01 95.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.843 -0.617 . . . . 0.28 109.548 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 11' ' ' LEU . 62.0 t -67.6 -24.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-O 121.747 0.784 . . . . 0.27 110.131 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.614 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.9 m120 -72.09 -38.49 69.37 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.281 -0.872 . . . . 0.34 109.322 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -82.13 -48.87 10.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.659 -0.7 . . . . 2.07 111.349 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.64 HG22 ' HB3' ' A' ' 42' ' ' SER . 33.4 mm -62.77 -53.14 50.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.902 -0.59 . . . . 0.65 110.545 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -104.5 -78.27 0.57 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.421 -0.585 . . . . 0.54 109.421 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.27 45.96 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 120.747 -0.74 . . . . 0.43 112.031 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.583 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -80.69 152.47 72.42 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 109.037 -0.727 . . . . 0.31 109.037 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.8 Cg_exo -84.83 23.34 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.104 2.536 . . . . 1.08 115.089 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.8 p 58.88 -9.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.69 1.996 . . . . 0.81 115.489 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.8 pt-20 -103.79 -7.02 20.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.365 0.602 . . . . 2.31 111.176 -174.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -99.66 -16.49 18.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.775 0.798 . . . . 1.59 110.676 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 12' ' ' ALA . 12.8 t -78.11 86.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 114.385 -1.28 . . . . 0.3 110.468 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -114.52 148.94 37.19 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.186 -1.042 . . . . 1.58 108.186 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.756 HD11 HG21 ' A' ' 8' ' ' VAL . 6.0 mp -59.89 140.27 56.78 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.578 -0.527 . . . . 1.05 109.578 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 87.26 7.21 0.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.545 1.538 . . . . 0.72 109.642 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -104.03 128.44 51.61 Favored 'General case' 0 CA--C 1.465 -2.316 0 CA-C-N 115.269 -0.878 . . . . 1.48 109.214 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 3.0 m -80.65 105.8 12.17 Favored 'General case' 1 C--N 1.238 -4.269 0 CA-C-N 114.188 -1.369 . . . . 1.25 108.316 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.765 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.4 m-85 -43.51 -55.26 4.33 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.596 0.758 . . . . 0.4 112.081 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 t -78.23 6.3 8.48 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 113.431 0.9 . . . . 1.06 113.431 -173.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -139.92 -62.18 0.52 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.318 -0.553 . . . . 1.74 110.037 -174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.05 -44.91 75.3 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.096 -0.957 . . . . 1.29 110.146 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.596 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 16.9 mt -81.38 -44.6 17.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.137 -0.938 . . . . 0.81 109.279 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 93.84 65.32 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 126.632 1.973 . . . . 1.12 111.908 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 43' ' ' MET . 48.8 t -96.04 149.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 113.485 -1.689 . . . . 0.79 107.587 171.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.475 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.3 m-20 -73.96 17.82 0.16 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 115.99 1.848 . . . . 2.0 115.99 -174.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 43' ' ' MET . 28.7 t 68.0 -53.65 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.271 1.952 . . . . 0.78 116.271 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 39' ' ' ASP . 1.7 pt? -71.36 -34.15 70.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.257 1.027 . . . . 1.18 108.491 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.64 ' HB3' HG22 ' A' ' 18' ' ' ILE . 2.1 m -65.81 -22.84 66.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.968 -1.469 . . . . 0.6 110.045 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.652 ' HE3' HG11 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.99 -43.44 98.83 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 115.375 -0.829 . . . . 0.86 112.021 -176.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.35 -43.83 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 O-C-N 124.398 1.061 . . . . 0.31 110.034 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.41 -46.82 85.69 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.917 -0.771 . . . . 0.68 108.917 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 42' ' ' SER . 61.9 t -58.54 -27.0 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.731 -1.122 . . . . 0.63 111.484 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.978 HG21 HG13 ' A' ' 63' ' ' VAL . 44.5 t -80.15 -52.53 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 107.658 -1.238 . . . . 0.55 107.658 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.28 -44.51 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 124.728 1.268 . . . . 0.42 108.919 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.69 88.33 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 121.244 0.545 . . . . 0.21 110.811 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 -55.9 17.19 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.472 -0.785 . . . . 0.21 110.239 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.566 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.262 0.0 OUTLIER -62.81 -34.03 76.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.754 1.02 . . . . 0.64 113.754 -178.188 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -67.84 -28.66 67.75 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.77 0.285 . . . . 2.07 111.77 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -87.52 -38.16 16.27 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.775 0.321 . . . . 2.48 111.52 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.667 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 10.0 m-85 -94.46 -3.91 49.18 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.106 0.78 . . . . 0.81 113.106 -172.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 87.66 -2.5 0.55 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 125.16 1.384 . . . . 1.99 114.719 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.781 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 13.9 p -81.2 173.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.363 -0.935 . . . . 0.37 108.772 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 22.2 tptp -127.58 124.91 39.26 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 107.462 -1.31 . . . . 2.12 107.462 171.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.538 HG12 ' HE2' ' A' ' 75' ' ' TYR . 59.7 mt -114.43 113.21 45.71 Favored Pre-proline 0 N--CA 1.429 -1.496 0 C-N-CA 120.599 -0.441 . . . . 0.25 111.106 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 63' ' ' VAL . 30.9 Cg_endo -66.87 152.53 80.26 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 122.642 2.228 . . . . 0.33 109.845 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 3.9 p-10 -59.1 -27.87 65.98 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.307 0.379 . . . . 1.98 111.123 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.76 -46.04 87.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 2.06 110.379 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.409 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.5 m-20 -74.76 -26.91 60.1 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 112.01 0.374 . . . . 0.52 112.01 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.978 HG13 HG21 ' A' ' 47' ' ' VAL . 86.8 t -55.57 -41.44 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.86 -1.163 . . . . 0.38 107.86 172.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 60' ' ' ASP . 57.8 mttp -73.94 -7.83 53.81 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.067 -0.97 . . . . 2.16 112.564 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.06 -24.47 15.32 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.233 0.539 . . . . 1.59 110.316 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.852 HD13 ' HA ' ' A' ' 72' ' ' ALA . 39.1 mt -85.48 118.44 25.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.889 -1.152 . . . . 0.31 107.889 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.488 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -112.17 -29.16 7.68 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.918 -1.113 . . . . 2.55 110.591 175.286 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 13.6 p -116.55 179.5 3.99 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 109.477 -0.564 . . . . 0.23 109.477 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.765 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -87.23 -12.89 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 122.062 0.934 . . . . 1.21 109.787 176.045 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -76.6 -30.99 55.56 Favored Glycine 0 C--O 1.207 -1.542 0 N-CA-C 108.305 -1.918 . . . . 0.33 108.305 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.27 -60.35 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.21 -0.995 . . . . 1.39 109.144 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.852 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.03 -60.95 2.34 Favored 'General case' 0 CA--C 1.479 -1.771 0 O-C-N 124.569 1.168 . . . . 0.15 112.361 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.458 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.3 m -57.45 -47.99 80.36 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.894 -1.048 . . . . 0.24 113.006 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 5.7 mptp? -55.83 -50.52 70.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 124.213 0.945 . . . . 3.63 109.815 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.538 ' HE2' HG12 ' A' ' 58' ' ' ILE . 82.8 t80 -56.23 -51.51 67.82 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.364 1.04 . . . . 0.4 111.43 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.578 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 69.8 mt -54.27 -65.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.424 -1.262 . . . . 0.21 110.432 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tt -54.33 -42.8 70.6 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.11 0.964 . . . . 1.44 109.589 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 36.9 t70 -62.4 -26.81 68.68 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.41 1.084 . . . . 0.63 111.561 -172.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -102.13 -8.04 21.72 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.836 1.05 . . . . 1.25 113.836 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.781 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 115.191 1.552 . . . . 0.87 115.191 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.44 ' O ' HG13 ' A' ' 7' ' ' ILE . 15.2 t . . . . . 0 C--O 1.219 -0.544 0 N-CA-C 111.162 0.06 . . . . 0.66 111.162 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.661 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -49.85 -46.97 51.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.157 0.983 . . . . 0.74 113.363 -178.208 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.64 -24.79 66.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.873 0.368 . . . . 2.66 111.624 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -87.7 -31.08 19.9 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.152 -0.684 . . . . 2.73 109.152 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.583 HG23 ' CE2' ' A' ' 54' ' ' PHE . 97.4 mt -74.39 -65.98 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.141 0 CA-C-N 116.145 -0.48 . . . . 0.23 110.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.49 -40.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 112.365 0.506 . . . . 0.27 112.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -62.48 -40.91 98.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.37 -0.532 . . . . 0.27 110.632 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.48 -35.07 33.96 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 115.783 -0.644 . . . . 0.18 112.235 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.738 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -67.44 -39.37 85.4 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.16 -1.052 . . . . 0.2 108.16 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.628 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.36 -50.32 69.98 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.832 -0.803 . . . . 0.14 108.832 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.742 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 46.6 mt-10 -59.24 -42.48 91.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.113 0.883 . . . . 0.68 112.704 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' A' ' 11' ' ' LEU . 65.6 mt -56.07 -43.06 74.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.315 0.579 . . . . 0.28 109.923 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.716 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.8 t -68.86 -25.34 30.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.755 0.788 . . . . 0.27 110.168 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.742 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 11.4 m-20 -74.07 -42.18 60.58 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.923 -1.139 . . . . 0.34 107.923 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.56 -47.95 51.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.311 -0.858 . . . . 2.07 111.445 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.4 HG13 HG22 ' A' ' 46' ' ' VAL . 28.4 mm -67.14 -53.16 35.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.896 -0.593 . . . . 0.65 111.317 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.73 -78.42 0.58 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.559 -0.456 . . . . 0.54 111.695 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.02 43.17 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.094 -1.051 . . . . 0.43 112.916 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.863 HG21 HG23 ' A' ' 26' ' ' VAL . 1.4 mp -79.41 151.25 74.75 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.033 -0.729 . . . . 0.31 109.033 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 4.6 Cg_exo -89.74 37.5 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.613 2.876 . . . . 1.08 113.276 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.409 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.26 9.2 p 56.11 -22.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.982 2.113 . . . . 0.81 116.021 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 22' ' ' PRO . 29.8 mm-40 -88.73 -22.8 23.16 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.603 0.761 . . . . 2.31 111.873 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.602 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 6.6 t70 -74.57 -32.71 62.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.583 0.706 . . . . 1.59 110.494 -171.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 21' ' ' ILE . 22.0 t -78.96 94.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.908 -1.042 . . . . 0.3 111.104 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -124.3 158.55 32.32 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.315 -0.995 . . . . 1.58 108.315 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 69' ' ' VAL . 90.6 mt -54.97 141.22 34.66 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 122.934 0.494 . . . . 1.05 110.288 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.599 ' H ' ' N ' ' A' ' 70' ' ' GLY . 27.1 t70 77.22 10.55 2.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.36 1.464 . . . . 0.72 111.009 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 69' ' ' VAL . 72.1 mmtt -100.36 129.06 46.29 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 115.374 -0.83 . . . . 1.48 109.226 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 30.6 t -74.85 119.89 19.65 Favored 'General case' 1 C--N 1.244 -4.011 0 CA-C-N 115.078 -0.965 . . . . 1.25 109.901 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.617 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 74.0 m-85 -51.49 -55.87 16.5 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 123.975 0.91 . . . . 0.4 111.892 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 3.5 p -66.47 -57.45 7.33 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 122.11 0.957 . . . . 1.06 111.942 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' HB2' ' OG ' ' A' ' 31' ' ' SER . 8.0 m-20 -82.64 -41.17 19.77 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 115.202 1.556 . . . . 1.74 115.202 -166.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HB2' ' N ' ' A' ' 31' ' ' SER . 5.3 m-20 -91.66 -43.81 9.39 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.719 0.295 . . . . 1.29 111.113 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.744 HD13 HG22 ' A' ' 26' ' ' VAL . 17.8 mt -76.09 -90.11 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.758 -0.656 . . . . 0.81 110.418 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 38.9 t70 163.56 10.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.364 1.066 . . . . 1.12 109.047 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 15' ' ' VAL . 12.4 t -77.57 119.14 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 108.764 -0.828 . . . . 0.79 108.764 -172.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.714 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 13.2 t70 -58.44 120.99 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 124.106 0.879 . . . . 2.0 111.456 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.8 t -41.78 -30.91 0.27 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 127.455 2.302 . . . . 0.78 116.128 175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.714 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 4.3 pp -86.32 -31.96 21.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 120.4 1.455 . . . . 1.18 111.023 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -80.15 -13.76 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.46 1.124 . . . . 0.6 109.401 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.549 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 3.8 tpt -60.03 -36.09 76.51 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 127.334 2.253 . . . . 0.86 110.403 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 47' ' ' VAL . 58.1 t -66.68 -25.15 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 CA-C-N 115.213 -0.903 . . . . 0.31 110.943 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -77.02 -41.02 44.36 Favored 'General case' 0 C--O 1.215 -0.739 0 O-C-N 121.515 -0.741 . . . . 0.68 109.6 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.4 HG22 HG13 ' A' ' 18' ' ' ILE . 31.5 t -59.57 -25.83 32.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.177 -0.919 . . . . 0.63 111.66 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.725 HG11 HG13 ' A' ' 63' ' ' VAL . 10.7 p -81.48 -47.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 CA-C-O 122.201 1.0 . . . . 0.55 110.145 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.02 -39.5 85.9 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 CA-C-N 112.869 -1.969 . . . . 0.42 108.749 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 -32.04 72.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.856 -0.611 . . . . 0.21 110.004 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.79 -59.16 4.17 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.952 -1.022 . . . . 0.21 110.122 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.288 0.0 OUTLIER -62.44 -34.69 77.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 114.014 1.116 . . . . 0.64 114.014 -175.635 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.29 -41.82 80.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.449 0.642 . . . . 2.07 111.321 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -81.68 -41.14 21.79 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.259 -0.882 . . . . 2.48 110.812 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 7' ' ' ILE . 10.4 m-85 -83.65 -44.38 14.6 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 117.735 -1.126 . . . . 0.81 113.454 -172.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 15.8 t70 155.91 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 124.616 1.198 . . . . 1.99 112.55 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.641 HG11 ' HA ' ' A' ' 76' ' ' ILE . 8.6 p -75.29 174.56 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.301 -0.863 . . . . 0.37 112.924 -164.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.3 127.04 52.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.207 -1.775 . . . . 2.12 106.207 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 76' ' ' ILE . 59.8 mt -118.87 112.42 36.62 Favored Pre-proline 0 C--N 1.293 -1.871 0 C-N-CA 120.216 -0.594 . . . . 0.25 110.09 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.5 Cg_endo -69.27 155.95 66.05 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.361 2.707 . . . . 0.33 110.554 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.5 p-10 -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.183 0.593 . . . . 1.98 112.128 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.7 m-20 -65.44 -54.24 31.28 Favored 'General case' 0 C--O 1.209 -1.044 0 O-C-N 123.22 0.325 . . . . 2.06 110.538 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.53 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 11.6 m-20 -66.92 -31.85 72.72 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.509 0.559 . . . . 0.52 112.509 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.725 HG13 HG11 ' A' ' 47' ' ' VAL . 41.3 t -50.22 -59.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.281 0.988 . . . . 0.38 109.015 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 14.6 ptmm? -72.61 -1.86 17.75 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.574 -0.739 . . . . 2.16 112.916 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.68 -18.17 21.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.733 0.777 . . . . 1.59 109.418 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' HA ' ' A' ' 72' ' ' ALA . 40.1 mt -84.9 116.09 23.14 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.579 -2.008 . . . . 0.31 105.579 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.634 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -111.68 -30.05 7.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 117.982 -1.487 . . . . 2.55 109.65 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 67' ' ' LYS . 31.1 p -119.14 173.46 6.91 Favored 'General case' 0 N--CA 1.395 -3.204 0 N-CA-C 109.183 -0.673 . . . . 0.23 109.183 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 30' ' ' LYS . 23.7 t -72.01 -18.98 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 108.492 -0.929 . . . . 1.21 108.492 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.599 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -70.13 -40.96 71.36 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 110.142 -1.183 . . . . 0.33 110.142 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.575 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.2 m-20 -67.89 -55.04 14.35 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.547 -0.908 . . . . 1.39 108.547 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.46 -61.33 2.31 Favored 'General case' 0 CA--C 1.471 -2.058 0 O-C-N 124.875 1.359 . . . . 0.15 111.97 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.661 HG21 ' HG2' ' A' ' 4' ' ' GLN . 50.0 m -57.64 -51.19 70.51 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.591 -1.186 . . . . 0.24 112.682 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.4 OUTLIER -53.49 -49.53 67.3 Favored 'General case' 0 N--CA 1.422 -1.827 0 O-C-N 124.325 1.016 . . . . 3.63 109.601 177.241 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 87.1 t80 -56.96 -52.01 66.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.747 0.819 . . . . 0.4 111.208 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.641 ' HA ' HG11 ' A' ' 56' ' ' VAL . 69.9 mt -52.01 -65.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 124.812 1.32 . . . . 0.21 109.79 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.76 -45.01 70.48 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.144 1.378 . . . . 1.44 110.346 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.59 -30.32 71.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.916 -1.038 . . . . 0.63 111.105 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -100.32 -11.62 20.15 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 113.82 1.044 . . . . 1.25 113.82 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 14.8 mt-30 . . . . . 0 CA--C 1.476 -1.898 0 CA-C-O 122.798 1.285 . . . . 0.87 107.641 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.434 -1.27 0 CA-C-O 120.652 0.263 . . . . 0.66 111.231 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.635 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.8 OUTLIER -51.85 -37.08 50.57 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.138 1.775 . . . . 0.74 112.423 177.136 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.4 -35.33 65.23 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 123.735 0.647 . . . . 2.66 111.869 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.48 -31.18 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.358 0.599 . . . . 2.73 109.504 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.636 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 80.4 mt -73.27 -66.44 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 115.775 -0.648 . . . . 0.23 109.985 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 28' ' ' LEU . 96.7 t -52.62 -38.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.067 0.765 . . . . 0.27 113.067 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.27 98.69 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.419 -0.512 . . . . 0.27 109.86 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' HA2' ' NH1' ' A' ' 53' ' ' ARG . . . -76.34 -39.93 29.8 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.366 -0.834 . . . . 0.18 112.313 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -67.04 -39.04 86.88 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 123.745 0.818 . . . . 0.2 109.377 -176.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.47 -43.68 89.0 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.687 -0.486 . . . . 0.14 109.687 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.57 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 44.4 mt-10 -61.31 -42.78 99.24 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.889 0.743 . . . . 0.68 111.46 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -60.7 -40.76 85.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.342 0.591 . . . . 0.28 110.046 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.732 HG12 ' HB ' ' A' ' 21' ' ' ILE . 23.9 t -73.65 -22.61 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.472 0.654 . . . . 0.27 110.162 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.57 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -72.59 -54.04 10.25 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.205 -1.035 . . . . 0.34 108.205 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.14 -44.8 62.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.342 -1.299 . . . . 2.07 113.602 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.588 HG22 ' HB3' ' A' ' 42' ' ' SER . 14.5 mt -76.27 -53.33 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.985 -0.686 . . . . 0.65 111.106 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.662 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -91.91 -80.14 0.36 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 0.54 110.809 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.93 40.04 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.16 0 C-N-CA 121.076 -0.583 . . . . 0.43 111.755 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.732 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -82.55 161.14 60.03 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 109.473 -0.566 . . . . 0.31 109.473 178.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.0 Cg_endo -90.62 141.64 3.26 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.895 2.396 . . . . 1.08 108.415 171.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -72.61 45.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.086 0 N-CA-C 113.98 1.104 . . . . 0.81 113.98 -171.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.51 -20.96 0.43 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.31 1.044 . . . . 2.31 110.548 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.65 -36.44 65.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.122 -0.49 . . . . 1.59 112.105 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.649 HG22 HD13 ' A' ' 36' ' ' LEU . 41.1 t -75.91 93.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.998 -0.546 . . . . 0.3 109.582 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 69' ' ' VAL . 30.8 mmtp -133.17 168.55 18.32 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.821 -1.178 . . . . 1.58 107.821 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.487 HD23 ' HE2' ' A' ' 74' ' ' LYS . 6.3 mp -63.67 146.92 52.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.845 -0.798 . . . . 1.05 108.845 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 t70 78.3 8.39 2.28 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.702 1.251 . . . . 0.72 110.241 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 71.4 mmtt -106.08 125.57 51.16 Favored 'General case' 0 CA--C 1.473 -1.993 0 CA-C-N 115.709 -0.678 . . . . 1.48 109.679 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 4.2 m -81.85 108.78 15.65 Favored 'General case' 0 C--N 1.245 -3.96 0 CA-C-N 114.248 -1.342 . . . . 1.25 108.763 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.879 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.4 m-85 -37.27 -66.69 0.22 Allowed 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.547 1.539 . . . . 0.4 114.197 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 t -85.87 15.5 4.84 Favored 'General case' 0 C--N 1.275 -2.67 0 O-C-N 121.1 -1.0 . . . . 1.06 112.742 -174.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 1.9 m-20 -134.25 -65.72 0.64 Allowed 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.627 -0.671 . . . . 1.74 111.364 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 21.5 m-20 -68.94 -41.4 78.12 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.311 -0.858 . . . . 1.29 109.962 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.678 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 27.0 mt -79.38 -50.1 11.36 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.618 -0.719 . . . . 0.81 111.024 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 11.2 t70 94.5 68.89 0.0 OUTLIER 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.278 1.611 . . . . 1.12 110.557 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 19' ' ' ALA . 40.5 t -105.81 162.69 4.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.277 -1.783 . . . . 0.79 110.156 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.25 3.6 5.55 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.49 1.116 . . . . 2.0 113.028 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.1 p 67.41 -47.58 0.49 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.328 1.851 . . . . 0.78 113.081 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.68 -49.15 77.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.997 0.919 . . . . 1.18 108.783 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.588 ' HB3' HG22 ' A' ' 18' ' ' ILE . 2.2 m -63.75 -16.26 60.71 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.987 -1.461 . . . . 0.6 112.314 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.879 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -66.22 -34.48 78.11 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 123.406 0.682 . . . . 0.86 111.393 -176.351 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.59 -38.33 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 109.125 -0.694 . . . . 0.31 109.125 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.87 -44.94 91.58 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.943 -1.132 . . . . 0.68 107.943 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 42' ' ' SER . 97.8 t -57.25 -24.72 21.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.354 -1.294 . . . . 0.63 112.091 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.991 HG11 HG22 ' A' ' 63' ' ' VAL . 23.2 t -78.69 -53.66 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.957 -1.127 . . . . 0.55 107.957 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.73 -31.9 50.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.573 -1.194 . . . . 0.42 109.413 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -76.35 -32.01 58.41 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.158 0.504 . . . . 0.21 110.285 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.11 -62.86 1.22 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.486 -0.779 . . . . 0.21 109.973 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.264 0.0 OUTLIER -60.69 -37.23 80.95 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 114.411 1.263 . . . . 0.64 114.411 -174.594 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.87 -30.7 67.94 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.4 0.519 . . . . 2.07 112.4 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.446 ' NH1' ' HA2' ' A' ' 10' ' ' GLY . 64.0 ttt180 -88.05 -32.92 18.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.78 0.324 . . . . 2.48 110.96 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.6 m-85 -95.54 -1.9 49.63 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.066 0.765 . . . . 0.81 113.066 -171.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 79.75 -2.91 2.06 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.447 1.099 . . . . 1.99 113.328 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.565 ' CG1' HG23 ' A' ' 76' ' ' ILE . 10.0 p -83.92 178.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 N-CA-C 107.985 -1.117 . . . . 0.37 107.985 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 21.3 tptm -136.27 130.76 33.51 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.197 -1.038 . . . . 2.12 108.197 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.511 HG12 ' HE2' ' A' ' 75' ' ' TYR . 37.2 mt -128.96 110.21 18.41 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 123.1 0.25 . . . . 0.25 110.612 -175.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.544 ' O ' HG23 ' A' ' 63' ' ' VAL . 70.1 Cg_endo -74.47 166.84 28.51 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.581 2.187 . . . . 0.33 109.811 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -59.93 -29.24 68.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.149 0.5 . . . . 1.98 110.124 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 25.6 t70 -62.81 -38.92 92.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.288 -0.869 . . . . 2.06 111.307 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 29.5 m-20 -87.14 -28.33 22.53 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.485 -0.486 . . . . 0.52 111.455 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.991 HG22 HG11 ' A' ' 47' ' ' VAL . 54.1 t -52.1 -46.71 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.16 -0.682 . . . . 0.38 109.16 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 45.7 pttt -70.9 -2.16 14.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.064 -0.971 . . . . 2.16 113.086 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 95.4 m-20 -96.06 -34.93 11.55 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.828 0.347 . . . . 1.59 110.399 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -76.32 112.68 13.06 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.913 -0.773 . . . . 0.31 108.913 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -33.52 7.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.551 0.691 . . . . 2.55 110.361 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.0 p -116.02 169.36 9.32 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.795 -1.187 . . . . 0.23 107.795 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.47 HG11 HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -78.65 -13.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 119.831 -0.747 . . . . 1.21 109.293 175.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -67.14 -44.63 86.63 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.953 -1.659 . . . . 0.33 108.953 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.34 -48.99 71.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.498 -0.926 . . . . 1.39 108.498 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.686 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -57.26 -61.65 2.32 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 114.851 -1.068 . . . . 0.15 111.424 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.635 HG21 ' HG2' ' A' ' 4' ' ' GLN . 28.1 m -58.64 -39.67 81.2 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 113.997 1.11 . . . . 0.24 113.997 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.487 ' HE2' HD23 ' A' ' 28' ' ' LEU . 5.3 mptp? -60.91 -51.08 70.8 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.2 -1.037 . . . . 3.63 108.2 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.511 ' HE2' HG12 ' A' ' 58' ' ' ILE . 89.6 t80 -55.88 -49.13 74.23 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.29 0.994 . . . . 0.4 110.687 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.662 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 78.1 mt -57.67 -66.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.022 -0.99 . . . . 0.21 111.109 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -52.46 -47.1 66.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.532 1.533 . . . . 1.44 109.799 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.72 -28.17 68.21 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.238 -1.346 . . . . 0.63 110.931 -172.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -103.47 -2.4 26.92 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 113.403 0.89 . . . . 1.25 113.403 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 10.4 mt-30 . . . . . 0 CA--C 1.468 -2.201 0 N-CA-C 106.699 -1.593 . . . . 0.87 106.699 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.432 -1.372 0 CA-C-O 120.815 0.34 . . . . 0.66 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.482 ' HG2' HG23 ' A' ' 8' ' ' VAL . 6.1 tm0? -57.43 -35.04 69.58 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 125.679 1.591 . . . . 0.74 112.469 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.76 -24.36 67.67 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.632 0.583 . . . . 2.66 111.335 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 -44.02 11.46 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.854 -0.795 . . . . 2.73 108.854 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.617 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 79.3 mt -64.31 -64.99 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.72 0 CA-C-N 116.158 -0.474 . . . . 0.23 112.012 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG23 ' HG2' ' A' ' 4' ' ' GLN . 55.2 t -56.97 -39.26 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 112.026 0.38 . . . . 0.27 112.026 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.74 -36.49 84.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.231 0.539 . . . . 0.27 110.576 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.55 -40.87 8.67 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 115.779 -0.646 . . . . 0.18 112.92 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.651 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -64.84 -36.07 83.15 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.491 -0.929 . . . . 0.2 108.491 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.52 -51.67 67.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.771 -0.65 . . . . 0.14 109.39 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.805 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 50.6 mt-10 -58.12 -41.9 84.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 124.204 0.94 . . . . 0.68 112.499 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 11' ' ' LEU . 76.7 mt -58.11 -43.42 85.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.503 -0.771 . . . . 0.28 109.701 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 21' ' ' ILE . 86.1 t -68.82 -23.89 28.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.872 0.844 . . . . 0.27 110.679 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.805 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 15.0 m-20 -75.06 -42.62 56.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.335 -0.987 . . . . 0.34 108.335 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.31 -41.19 57.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.845 -1.07 . . . . 2.07 111.636 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.731 HG13 HG22 ' A' ' 46' ' ' VAL . 30.8 mm -70.45 -53.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 116.701 -0.227 . . . . 0.65 111.007 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.594 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -106.31 -82.45 0.54 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.013 0.435 . . . . 0.54 110.607 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.34 43.96 0.02 OUTLIER Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.561 -0.828 . . . . 0.43 112.419 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.654 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -80.52 151.06 71.33 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.859 -0.423 . . . . 0.31 109.859 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.9 Cg_exo -86.17 33.3 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.155 2.57 . . . . 1.08 114.056 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.265 9.8 p 56.61 -20.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 C-N-CA 127.052 2.141 . . . . 0.81 116.433 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -95.51 -13.94 24.08 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.554 -0.716 . . . . 2.31 112.54 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 29.8 t0 -84.45 -28.2 26.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.728 0.775 . . . . 1.59 110.023 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 12' ' ' ALA . 25.5 t -73.6 93.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.577 -1.192 . . . . 0.3 109.072 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 69' ' ' VAL . 33.3 mmtp -131.09 151.88 50.97 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 106.954 -1.498 . . . . 1.58 106.954 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.44 HD22 ' HA2' ' A' ' 70' ' ' GLY . 50.7 mt -50.09 143.53 8.07 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.763 0.665 . . . . 1.05 109.531 177.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 82.8 4.81 0.97 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.9 1.28 . . . . 0.72 111.129 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -103.6 132.83 49.5 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 108.936 -0.764 . . . . 1.48 108.936 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 57.9 m -86.53 116.96 25.0 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 124.047 0.842 . . . . 1.25 109.666 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.734 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 94.6 m-85 -45.65 -67.46 0.28 Allowed 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 125.17 1.388 . . . . 0.4 114.178 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.467 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 14.7 t -71.79 -25.85 62.19 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.685 -1.259 . . . . 1.06 111.843 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.593 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 7.3 m-20 -87.62 -64.18 1.19 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.406 0.622 . . . . 1.74 110.972 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' SER . 4.5 m-20 -74.29 -57.6 3.84 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 115.282 -0.872 . . . . 1.29 110.439 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 26' ' ' VAL . 16.8 mt -68.17 -38.24 81.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.015 -0.993 . . . . 0.81 111.122 -172.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.2 t70 82.84 64.98 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.459 1.6 . . . . 1.12 109.558 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 19' ' ' ALA . 21.8 t -108.78 159.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 112.463 -2.153 . . . . 0.79 106.548 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.63 120.23 19.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.361 -0.977 . . . . 2.0 108.361 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.531 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 5.0 p -49.11 -38.15 23.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.078 0.951 . . . . 0.78 112.306 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 42' ' ' SER . 3.9 pp -70.63 -28.42 64.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.16 0.43 . . . . 1.18 112.16 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 46' ' ' VAL . 50.0 m -82.04 -15.7 52.72 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.425 0.631 . . . . 0.6 110.266 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -58.92 -37.35 76.48 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-N 115.445 -0.798 . . . . 0.86 111.715 -179.094 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.29 -45.72 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 124.087 0.867 . . . . 0.31 109.421 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.31 -49.79 74.99 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 108.615 -0.883 . . . . 0.68 108.615 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.731 HG22 HG13 ' A' ' 18' ' ' ILE . 54.2 t -57.34 -29.98 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.971 1.308 . . . . 0.63 111.672 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.86 HG21 HG13 ' A' ' 63' ' ' VAL . 38.3 t -76.96 -49.68 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.336 0 N-CA-C 108.294 -1.002 . . . . 0.55 108.294 -176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.27 -35.5 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-N 114.692 -1.14 . . . . 0.42 108.777 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.29 76.25 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.538 0.685 . . . . 0.21 109.915 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.71 -58.35 7.77 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 114.932 -1.031 . . . . 0.21 109.843 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.631 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.257 0.0 OUTLIER -61.15 -37.03 81.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.056 1.132 . . . . 0.64 114.056 -177.375 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.69 -37.58 76.39 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.296 0.373 . . . . 2.07 111.401 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -84.73 -37.84 20.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.052 0.389 . . . . 2.48 112.052 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.0 m-85 -92.68 -11.03 35.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.352 1.242 . . . . 0.81 114.352 -170.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 87.51 4.22 0.33 Allowed 'General case' 0 N--CA 1.519 2.995 0 N-CA-C 114.448 1.277 . . . . 1.99 114.448 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.75 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.1 p -84.12 175.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.183 -1.414 . . . . 0.37 107.183 175.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 20.5 tptp -131.75 122.35 25.7 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.887 -1.894 . . . . 2.12 105.887 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.564 HG13 ' HB3' ' A' ' 51' ' ' GLU . 52.4 mt -113.72 107.05 53.25 Favored Pre-proline 0 C--N 1.291 -1.969 0 C-N-CA 119.754 -0.778 . . . . 0.25 110.618 -174.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 63' ' ' VAL . 36.3 Cg_endo -64.8 152.38 82.3 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 C-N-CA 122.948 2.432 . . . . 0.33 109.739 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.2 -33.57 53.34 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.561 0.744 . . . . 1.98 111.153 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 21.5 t70 -62.43 -43.51 98.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.546 -0.752 . . . . 2.06 111.679 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.452 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 40.9 m-20 -86.46 -21.83 26.82 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.403 0.52 . . . . 0.52 112.403 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.86 HG13 HG21 ' A' ' 47' ' ' VAL . 51.1 t -53.68 -50.43 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.246 -1.02 . . . . 0.38 108.246 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.1 pttp -79.55 -1.47 37.96 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.523 -1.217 . . . . 2.16 111.332 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.25 -18.84 24.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.295 -1.002 . . . . 1.59 108.295 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.824 HD13 ' HA ' ' A' ' 72' ' ' ALA . 27.6 mt -90.38 117.82 29.39 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 106.783 -1.562 . . . . 0.31 106.783 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.82 -37.63 6.96 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.695 -0.802 . . . . 2.55 110.769 175.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 41.1 p -109.73 178.87 4.29 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 109.486 -0.561 . . . . 0.23 109.486 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.734 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -85.08 -13.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.365 -0.976 . . . . 1.21 108.365 173.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -67.5 -49.07 53.52 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 107.165 -2.374 . . . . 0.33 107.165 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 68' ' ' THR . 8.6 m-20 -56.43 -57.09 13.81 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 124.95 1.3 . . . . 1.39 110.411 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.824 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.34 -60.99 2.56 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.442 1.089 . . . . 0.15 111.667 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 7' ' ' ILE . 34.4 m -60.39 -45.33 93.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 113.26 0.837 . . . . 0.24 113.26 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.6 mptm? -63.52 -22.72 67.05 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 122.651 0.38 . . . . 3.63 110.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -82.2 -52.92 6.49 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 116.041 -0.527 . . . . 0.4 109.599 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.75 ' HA ' HG21 ' A' ' 56' ' ' VAL . 71.6 mt -52.74 -66.93 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 C-N-CA 124.827 1.251 . . . . 0.21 111.351 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -52.95 -39.91 63.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.552 1.541 . . . . 1.44 111.9 -177.267 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -72.69 -26.29 61.56 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 113.261 -1.791 . . . . 0.63 111.481 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -103.08 -8.59 20.42 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.994 0.739 . . . . 1.25 112.994 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.709 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 9.4 mt-30 . . . . . 0 CA--C 1.476 -1.88 0 CA-C-O 123.104 1.43 . . . . 0.87 108.225 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.479 ' HA ' HD13 ' A' ' 77' ' ' LEU . 15.1 t . . . . . 0 N--CA 1.423 -1.803 0 N-CA-C 109.869 -0.419 . . . . 0.66 109.869 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.601 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.8 OUTLIER -47.71 -39.92 18.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.163 1.385 . . . . 0.74 113.238 174.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -59.2 -22.56 61.2 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.519 0.933 . . . . 2.66 113.519 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 3' ' ' THR . 29.9 tt0 -79.15 -39.82 32.5 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.806 -0.812 . . . . 2.73 108.806 174.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 77' ' ' LEU . 63.9 mt -76.7 -66.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.643 -1.162 . . . . 0.23 111.526 -169.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 28' ' ' LEU . 48.1 t -56.51 -47.08 82.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 111.554 0.205 . . . . 0.27 111.554 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.35 -36.2 66.04 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.75 0.656 . . . . 0.27 112.212 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.4 -43.87 6.79 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 120.907 -0.663 . . . . 0.18 112.21 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -61.09 -39.9 91.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 124.402 1.081 . . . . 0.2 109.216 -177.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.31 -48.2 77.17 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 115.897 -0.592 . . . . 0.14 109.905 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.855 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 97.3 mt-10 -63.59 -34.09 77.04 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.983 0.802 . . . . 0.68 112.278 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 11' ' ' LEU . 58.9 mt -68.26 -38.8 80.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.829 -0.623 . . . . 0.28 109.495 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 11' ' ' LEU . 59.7 t -72.26 -23.6 21.61 Favored 'Isoleucine or valine' 0 C--O 1.253 1.279 0 CA-C-O 121.427 0.632 . . . . 0.27 110.206 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.855 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 32.4 m-20 -62.5 -37.83 87.54 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.776 -0.824 . . . . 0.34 108.776 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -84.08 -47.64 10.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 2.07 112.309 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.835 HG13 ' HB ' ' A' ' 46' ' ' VAL . 25.0 mm -54.2 -52.38 38.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.654 0.782 . . . . 0.65 111.427 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -118.51 -56.66 2.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.118 0.485 . . . . 0.54 110.832 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 16' ' ' ASN . . . 135.95 40.6 0.14 Allowed Glycine 0 CA--C 1.49 -1.529 0 C-N-CA 120.292 -0.956 . . . . 0.43 112.29 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.816 HG21 HG23 ' A' ' 26' ' ' VAL . 1.4 mp -75.64 147.31 81.45 Favored Pre-proline 0 C--O 1.202 -1.413 0 N-CA-C 109.06 -0.719 . . . . 0.31 109.06 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.3 Cg_exo -85.44 34.5 0.49 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 123.232 2.621 . . . . 1.08 113.992 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.274 9.8 p 56.9 -15.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 C-N-CA 127.326 2.251 . . . . 0.81 116.513 177.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.24 -18.6 19.92 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.638 -0.664 . . . . 2.31 111.615 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 25.5 t0 -85.42 -24.7 27.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 120.29 -0.564 . . . . 1.59 110.609 -170.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.816 HG23 HG21 ' A' ' 21' ' ' ILE . 42.6 t -72.54 92.58 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.852 -1.166 . . . . 0.3 107.852 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 69' ' ' VAL . 9.4 tppt? -125.16 160.37 29.3 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.801 -2.296 . . . . 1.58 104.801 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.517 ' HA ' HG22 ' A' ' 69' ' ' VAL . 6.4 mp -64.22 148.72 49.46 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 118.624 0.647 . . . . 1.05 109.651 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.408 ' H ' ' N ' ' A' ' 70' ' ' GLY . 31.2 t70 76.98 11.58 2.4 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.506 -1.225 . . . . 0.72 110.665 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 35.8 mmtp -99.04 122.95 42.96 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 108.927 -0.768 . . . . 1.48 108.927 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 39.2 m -76.82 28.04 0.13 Allowed 'General case' 1 C--N 1.242 -4.071 0 C-N-CA 126.643 1.977 . . . . 1.25 114.854 -172.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.704 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 91.0 m-85 44.62 -93.0 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.4 113.698 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.3 t -77.27 44.02 0.4 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.399 1.095 . . . . 1.06 111.229 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.9 t70 -159.46 -55.47 0.06 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 108.858 -0.793 . . . . 1.74 108.858 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.557 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 33.4 m-20 -84.2 -34.95 23.83 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.134 -0.939 . . . . 1.29 111.955 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 33.3 mt -85.11 -88.94 0.11 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.31 -0.626 . . . . 0.81 109.31 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.449 ' H ' ' HB2' ' A' ' 36' ' ' LEU . 21.6 t70 157.11 64.67 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.609 -1.997 . . . . 1.12 105.609 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 19' ' ' ALA . 4.9 t -118.81 150.77 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.635 -0.712 . . . . 0.79 110.142 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.16 110.12 9.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.752 . . . . 2.0 108.968 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.568 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 29.5 t -41.06 -47.45 3.13 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.735 1.614 . . . . 0.78 114.071 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.9 pt? -64.67 -34.49 78.41 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.063 -0.398 . . . . 1.18 111.45 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 18' ' ' ILE . 14.7 m -82.2 -13.12 57.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.195 0.522 . . . . 0.6 111.002 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.704 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.26 -36.97 79.02 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 123.361 0.665 . . . . 0.86 110.289 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.11 -47.13 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 O-C-N 123.836 0.71 . . . . 0.31 110.31 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -56.69 -53.64 55.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.216 0.607 . . . . 0.68 110.358 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.835 ' HB ' HG13 ' A' ' 18' ' ' ILE 0.34 1.7 p -61.92 -22.59 29.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 N-CA-C 114.228 1.195 . . . . 0.63 114.228 -178.423 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.935 HG21 HG13 ' A' ' 63' ' ' VAL . 44.5 t -71.23 -50.38 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.746 -1.205 . . . . 0.55 107.746 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.28 -35.24 73.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 108.397 -0.964 . . . . 0.42 108.397 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 46' ' ' VAL . . . -68.06 -35.25 77.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.308 -0.86 . . . . 0.21 109.947 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.73 -59.08 4.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.508 -1.224 . . . . 0.21 109.102 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.273 0.0 OUTLIER -59.96 -39.31 85.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 114.461 1.282 . . . . 0.64 114.461 -175.135 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -58.92 -40.58 85.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.92 0.391 . . . . 2.07 111.835 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.9 -27.14 43.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.109 -0.496 . . . . 2.48 111.059 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CD2' HG23 ' A' ' 7' ' ' ILE . 7.1 m-85 -104.27 3.06 32.25 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.675 -0.81 . . . . 0.81 112.322 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.0 t70 80.46 -5.68 1.75 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.821 1.248 . . . . 1.99 112.851 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 76' ' ' ILE . 10.6 p -82.02 173.43 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 121.29 -0.881 . . . . 0.37 109.205 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 18.4 tptm -128.62 127.28 41.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.552 -1.647 . . . . 2.12 106.552 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.509 HG13 ' HB3' ' A' ' 51' ' ' GLU . 64.0 mt -119.42 111.99 36.09 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.736 -0.386 . . . . 0.25 110.921 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.522 ' O ' HG23 ' A' ' 63' ' ' VAL . 58.7 Cg_endo -69.25 159.83 52.23 Favored 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 123.047 2.498 . . . . 0.33 110.808 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 22.1 t70 -52.78 -41.45 64.11 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.73 0.812 . . . . 1.98 112.116 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.5 -32.12 72.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.933 -0.576 . . . . 2.06 110.938 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 20.0 m-20 -86.3 -24.96 25.72 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.342 -0.543 . . . . 0.52 111.839 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.935 HG13 HG21 ' A' ' 47' ' ' VAL . 52.7 t -54.38 -51.58 47.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.588 -1.264 . . . . 0.38 107.588 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 13.8 ptmm? -78.51 -2.66 39.74 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.944 -1.026 . . . . 2.16 111.609 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -88.26 -29.67 20.24 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.935 -1.135 . . . . 1.59 107.935 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.693 HD13 ' HA ' ' A' ' 72' ' ' ALA . 29.4 mt -82.56 113.41 20.26 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 107.583 -1.265 . . . . 0.31 107.583 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -106.77 -40.2 5.58 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 119.866 -0.734 . . . . 2.55 109.129 176.003 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 p -108.26 178.29 4.54 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 119.715 -0.794 . . . . 0.23 109.307 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -86.63 -13.06 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.296 -1.002 . . . . 1.21 108.296 175.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.408 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -72.17 -37.63 59.59 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 108.114 -1.994 . . . . 0.33 108.114 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.1 -60.56 2.52 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.069 1.348 . . . . 1.39 109.492 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.693 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.49 -60.47 3.1 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 114.473 -1.239 . . . . 0.15 111.961 -176.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.601 HG21 ' HG2' ' A' ' 4' ' ' GLN . 61.6 m -59.39 -39.93 84.93 Favored 'General case' 0 N--CA 1.419 -2.0 0 O-C-N 124.102 0.877 . . . . 0.24 112.611 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 75' ' ' TYR . 9.7 tmtt? -61.37 -50.76 71.6 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.456 -0.942 . . . . 3.63 108.456 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' HE2' HG12 ' A' ' 58' ' ' ILE . 85.2 t80 -56.51 -50.71 71.0 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.321 1.013 . . . . 0.4 110.814 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.648 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -55.2 -66.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 114.009 -1.45 . . . . 0.21 110.223 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.646 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 64.5 tp -55.45 -38.4 68.98 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 123.968 0.907 . . . . 1.44 112.349 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.49 -28.75 67.3 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.363 -0.835 . . . . 0.63 111.194 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -102.03 -14.8 17.0 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.417 0.895 . . . . 1.25 113.417 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 12.9 mt-30 . . . . . 0 CA--C 1.466 -2.275 0 CA-C-O 123.219 1.485 . . . . 0.87 107.753 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 109.954 -0.387 . . . . 0.66 109.954 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.402 ' HG2' HG23 ' A' ' 8' ' ' VAL . 10.5 tm0? -49.12 -41.44 36.04 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.817 1.247 . . . . 0.74 113.552 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.59 -25.51 67.38 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.452 0.538 . . . . 2.66 112.452 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -87.19 -30.77 20.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.751 0.786 . . . . 2.73 109.108 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.419 HG23 ' CE2' ' A' ' 54' ' ' PHE . 96.1 mt -79.7 -65.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 CA-C-N 115.26 -0.882 . . . . 0.23 110.987 -172.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 4' ' ' GLN . 82.3 t -54.18 -46.71 67.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 122.568 0.347 . . . . 0.27 111.925 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.12 73.93 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.496 0.497 . . . . 0.27 111.546 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.77 -33.24 19.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.941 -0.572 . . . . 0.18 112.906 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -69.55 -34.66 74.53 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.044 -1.095 . . . . 0.2 108.044 -178.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.05 -46.47 75.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.28 -0.873 . . . . 0.14 108.826 173.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.808 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 41.9 mt-10 -61.61 -43.02 99.64 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 124.276 0.985 . . . . 0.68 111.86 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.5 mt -58.71 -39.72 77.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.591 0.71 . . . . 0.28 109.644 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.743 HG12 ' HB ' ' A' ' 21' ' ' ILE . 62.7 t -70.74 -21.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.897 0.856 . . . . 0.27 110.015 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.808 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 16.1 m-20 -80.47 -50.34 10.19 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.628 -1.249 . . . . 0.34 107.628 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.53 -50.25 59.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 2.07 112.279 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.01 -53.32 21.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.244 0.545 . . . . 0.65 109.86 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.56 -90.24 0.29 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.175 -0.466 . . . . 0.54 111.242 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.94 38.75 0.02 OUTLIER Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.599 -0.81 . . . . 0.43 113.104 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.743 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -80.99 155.1 72.87 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 109.417 -0.586 . . . . 0.31 109.417 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 4.8 Cg_exo -88.46 32.66 0.39 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.938 3.092 . . . . 1.08 114.768 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.533 ' HB ' HD22 ' A' ' 16' ' ' ASN . 5.2 p 60.05 -21.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.07 0 C-N-CA 127.147 2.179 . . . . 0.81 116.063 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -93.23 -20.32 20.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 112.691 0.626 . . . . 2.31 112.691 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.83 -30.77 51.25 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 120.74 -0.384 . . . . 1.59 111.258 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' A' ' 12' ' ' ALA . 34.7 t -72.89 97.88 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.28 -0.873 . . . . 0.3 109.672 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -135.69 151.03 49.78 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 104.413 -2.439 . . . . 1.58 104.413 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.548 HD22 ' HA2' ' A' ' 70' ' ' GLY . 49.3 mt -50.96 148.49 4.2 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.59 0.632 . . . . 1.05 109.574 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.7 t70 76.98 18.88 1.45 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.976 1.37 . . . . 0.72 109.94 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -119.21 128.46 54.23 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 114.703 -1.135 . . . . 1.48 108.442 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 5.7 m -87.36 112.1 21.77 Favored 'General case' 0 C--N 1.244 -3.983 0 N-CA-C 107.417 -1.327 . . . . 1.25 107.417 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.792 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.1 m-85 -46.63 -47.23 20.09 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.436 1.095 . . . . 0.4 112.708 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 t -98.86 21.75 11.1 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 112.574 0.583 . . . . 1.06 112.574 -174.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 13.6 t70 -146.48 -56.89 0.28 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 1.74 109.792 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.22 -39.27 55.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.881 -1.054 . . . . 1.29 110.402 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' HA ' ' A' ' 32' ' ' PHE . 35.6 mt -83.61 -93.17 0.07 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.513 -0.767 . . . . 0.81 110.365 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 32.6 t70 168.09 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 121.349 0.595 . . . . 1.12 111.127 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.541 HG11 ' HE3' ' A' ' 43' ' ' MET . 41.5 t -77.29 134.82 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 O-C-N 121.178 -0.951 . . . . 0.79 112.039 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 5.3 t70 -47.37 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 129.218 3.007 . . . . 2.0 117.297 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 43' ' ' MET . 30.5 t 75.03 -54.96 0.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.455 1.279 . . . . 0.78 114.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.488 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -74.58 -29.28 61.27 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.085 -1.446 . . . . 1.18 109.37 178.014 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 46' ' ' VAL . 67.3 m -70.6 -16.09 62.81 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.157 -0.929 . . . . 0.6 111.412 173.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.629 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -62.24 -41.35 98.34 Favored 'General case' 0 CA--C 1.473 -1.993 0 C-N-CA 123.101 0.56 . . . . 0.86 111.851 -178.171 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -57.29 -43.13 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 124.302 1.001 . . . . 0.31 109.734 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -56.5 -47.51 79.16 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.855 -0.611 . . . . 0.68 109.782 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 42' ' ' SER . 40.3 t -60.91 -24.59 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.32 -0.855 . . . . 0.63 111.107 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.928 HG21 HG13 ' A' ' 63' ' ' VAL . 29.2 t -81.11 -53.07 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 108.182 -1.044 . . . . 0.55 108.182 -177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 -29.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.739 -1.119 . . . . 0.42 109.762 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.57 58.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.282 -0.636 . . . . 0.21 109.282 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.58 -53.63 44.73 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.103 -0.953 . . . . 0.21 109.272 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.584 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.258 0.0 OUTLIER -63.97 -34.93 79.09 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.663 0.986 . . . . 0.64 113.663 -177.716 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -64.28 -36.89 85.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.117 0.484 . . . . 2.07 111.375 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.61 -35.91 20.69 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.451 -0.795 . . . . 2.48 111.891 -172.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 11.4 m-85 -89.76 -45.1 9.54 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 118.926 -1.11 . . . . 0.81 113.185 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 13.5 t70 154.11 -33.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 124.618 1.199 . . . . 1.99 111.781 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' A' ' 79' ' ' HIS . 9.3 p -76.85 -177.0 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.449 0.537 . . . . 0.37 112.449 -165.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' H ' HG22 ' A' ' 56' ' ' VAL . 7.4 ttmm -135.98 131.37 34.97 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.721 -1.585 . . . . 2.12 106.721 169.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.621 HG23 ' HE2' ' A' ' 75' ' ' TYR . 45.4 mt -122.03 111.64 32.26 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 123.425 0.453 . . . . 0.25 110.347 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.602 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.9 Cg_endo -72.31 160.34 47.28 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.982 2.455 . . . . 0.33 110.634 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.11 -43.32 41.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.751 . . . . 1.98 111.74 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 35.0 t70 -63.64 -34.22 77.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 2.06 112.68 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.589 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 67.0 m-20 -86.15 -28.22 24.1 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.113 -0.635 . . . . 0.52 110.993 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.928 HG13 HG21 ' A' ' 47' ' ' VAL . 76.8 t -55.61 -55.46 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.363 -0.977 . . . . 0.38 108.363 174.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 61' ' ' ASP . 17.1 pttp -69.62 -1.19 8.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.927 -1.033 . . . . 2.16 112.891 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.86 -23.5 16.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.86 -1.163 . . . . 1.59 107.86 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.894 HD13 ' HA ' ' A' ' 72' ' ' ALA . 21.6 mt -91.59 125.17 36.23 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 106.726 -1.583 . . . . 0.31 106.726 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -113.24 -39.63 4.11 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.336 -0.987 . . . . 2.55 108.336 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.702 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.8 p -104.53 179.58 4.23 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-N 115.463 -0.79 . . . . 0.23 109.887 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.792 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -87.08 -13.95 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 108.237 -1.024 . . . . 1.21 108.237 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.548 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -69.03 -47.59 53.12 Favored Glycine 0 CA--C 1.492 -1.39 0 N-CA-C 107.437 -2.265 . . . . 0.33 107.437 172.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 23.7 m-20 -56.6 -55.91 28.04 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 125.271 1.429 . . . . 1.39 110.925 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.894 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -54.56 -60.49 3.28 Favored 'General case' 0 CA--C 1.479 -1.763 0 O-C-N 124.472 1.107 . . . . 0.15 112.166 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.8 HG22 HD23 ' A' ' 77' ' ' LEU . 33.7 m -54.55 -51.48 65.09 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.013 -0.994 . . . . 0.24 112.949 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -51.07 -29.25 12.41 Favored 'General case' 0 C--O 1.197 -1.675 0 C-N-CA 126.749 2.019 . . . . 3.63 111.444 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.621 ' HE2' HG23 ' A' ' 58' ' ' ILE . 73.1 t80 -85.21 -48.89 8.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.61 -0.723 . . . . 0.4 109.333 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.666 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.9 mt -56.51 -63.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 114.697 -1.138 . . . . 0.21 109.372 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.8 HD23 HG22 ' A' ' 73' ' ' THR . 4.5 pp -56.97 -36.58 70.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.734 0.778 . . . . 1.44 112.622 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.47 ' N ' HD12 ' A' ' 77' ' ' LEU . 5.5 t70 -76.5 -26.74 55.59 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.472 -1.24 . . . . 0.63 111.276 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.617 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 20.5 t-80 -94.98 -16.38 22.81 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.003 -0.544 . . . . 1.25 109.983 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 32.7 mt-30 . . . . . 0 CA--C 1.478 -1.789 0 CA-C-O 122.729 1.252 . . . . 0.87 108.187 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.44 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.7 t . . . . . 0 N--CA 1.419 -2.006 0 N-CA-C 105.874 -1.898 . . . . 0.66 105.874 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.419 ' HG2' HG23 ' A' ' 8' ' ' VAL . 11.5 tm0? -46.62 -46.76 19.94 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.823 1.416 . . . . 0.74 114.823 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.36 -23.54 65.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.966 1.099 . . . . 2.66 113.966 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -87.95 -33.99 18.25 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.426 -0.953 . . . . 2.73 108.426 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.621 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.3 mt -72.0 -65.35 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.515 0 CA-C-N 115.955 -0.566 . . . . 0.23 110.61 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.518 HG13 HG21 ' A' ' 69' ' ' VAL . 26.4 t -59.85 -26.7 36.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 111.934 0.346 . . . . 0.27 111.934 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.42 -37.91 68.52 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.942 -0.703 . . . . 0.27 110.124 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.68 -36.44 11.85 Favored Glycine 0 N--CA 1.419 -2.456 0 CA-C-N 116.186 -0.461 . . . . 0.18 113.068 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.07 -35.36 80.32 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.571 -0.899 . . . . 0.2 108.571 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.792 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -57.08 -44.3 82.99 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.87 -0.605 . . . . 0.14 109.74 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.835 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 46.4 mt-10 -62.69 -42.55 99.69 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.175 -0.92 . . . . 0.68 111.834 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 11' ' ' LEU . 50.2 mt -61.14 -36.63 73.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.923 0.868 . . . . 0.28 109.848 177.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.677 HG12 ' HB ' ' A' ' 21' ' ' ILE . 60.5 t -74.97 -23.27 17.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.224 -0.898 . . . . 0.27 110.325 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.835 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 52.6 m-20 -70.25 -46.35 64.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.631 -0.877 . . . . 0.34 108.631 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.06 -49.38 17.66 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.997 -1.001 . . . . 2.07 113.482 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.652 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.9 mt -75.64 -51.1 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 112.327 0.492 . . . . 0.65 112.327 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.717 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -91.68 -75.28 0.48 Allowed 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.273 -0.571 . . . . 0.54 110.384 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.54 41.0 0.04 OUTLIER Glycine 0 C--N 1.3 -1.442 0 CA-C-N 115.564 -0.744 . . . . 0.43 112.572 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.833 HG21 HG23 ' A' ' 26' ' ' VAL . 1.5 mp -81.98 150.66 65.66 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 109.055 -0.72 . . . . 0.31 109.055 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 8.2 Cg_exo -87.02 33.46 0.43 Allowed 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 124.348 3.365 . . . . 1.08 114.27 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.567 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.324 9.2 p 60.81 -18.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.091 2.157 . . . . 0.81 116.597 175.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -96.79 -11.34 25.07 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.391 -0.818 . . . . 2.31 111.79 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.494 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.4 m-20 -79.73 -33.2 41.02 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.094 0.474 . . . . 1.59 110.495 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.833 HG23 HG21 ' A' ' 21' ' ' ILE . 40.9 t -72.83 93.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.969 -1.014 . . . . 0.3 110.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -124.7 168.23 13.46 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.69 -1.596 . . . . 1.58 106.69 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.573 ' HA ' HG22 ' A' ' 69' ' ' VAL . 5.8 mp -68.05 151.19 47.44 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.905 -1.146 . . . . 1.05 107.905 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 t70 76.68 12.84 2.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.282 1.039 . . . . 0.72 109.548 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -111.65 125.21 53.71 Favored 'General case' 0 CA--C 1.458 -2.576 0 O-C-N 121.7 -0.625 . . . . 1.48 110.442 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 12.2 m -80.26 111.89 17.07 Favored 'General case' 0 C--N 1.247 -3.854 0 CA-C-N 114.428 -1.26 . . . . 1.25 108.213 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 36' ' ' LEU . 90.8 m-85 -48.41 -55.48 10.73 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.445 0.698 . . . . 0.4 110.548 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 t -84.08 25.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.595 0.591 . . . . 1.06 112.595 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -156.11 -62.14 0.11 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.535 0.684 . . . . 1.74 111.237 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -70.79 -39.52 73.08 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 124.368 1.067 . . . . 1.29 110.466 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.608 HD13 HG22 ' A' ' 26' ' ' VAL . 16.4 mt -88.11 -50.44 6.39 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.202 -0.908 . . . . 0.81 110.802 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 95.03 68.66 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.852 2.061 . . . . 1.12 110.723 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 19' ' ' ALA . 47.4 t -101.42 132.45 47.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 CA-C-N 113.366 -1.743 . . . . 0.79 106.577 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -62.68 20.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.545 2.054 . . . . 2.0 116.545 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.484 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 28.6 t 61.99 -57.89 0.12 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 116.139 1.903 . . . . 0.78 116.139 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.57 -29.58 70.82 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.953 0.882 . . . . 1.18 109.987 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.652 ' HB3' HG22 ' A' ' 18' ' ' ILE . 1.6 m -75.05 -22.52 58.34 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.277 -1.329 . . . . 0.6 110.656 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.632 ' HE3' HG11 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.27 -43.75 95.9 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 123.743 0.817 . . . . 0.86 112.341 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.63 -36.95 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 O-C-N 123.946 0.779 . . . . 0.31 110.605 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.28 -43.94 93.23 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 108.768 -0.827 . . . . 0.68 108.768 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 42' ' ' SER . 58.3 t -61.96 -25.05 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.469 1.107 . . . . 0.63 111.11 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.884 HG11 HG22 ' A' ' 63' ' ' VAL . 55.3 t -77.25 -55.71 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 107.422 -1.325 . . . . 0.55 107.422 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 58.6 t -57.3 -40.79 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 O-C-N 124.806 1.316 . . . . 0.42 108.94 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -65.6 -35.24 80.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.373 0.606 . . . . 0.21 110.685 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.57 -57.13 6.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.351 -0.841 . . . . 0.21 109.783 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.69 -33.95 76.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.634 0.976 . . . . 0.64 113.634 -177.198 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 51.8 mt-10 -59.32 -53.17 61.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.643 0.259 . . . . 2.07 110.368 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -66.18 -47.12 74.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.513 0.56 . . . . 2.48 112.513 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.621 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.3 m-85 -84.37 -9.41 58.45 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.648 0.61 . . . . 0.81 112.648 -172.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 85.05 3.59 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 116.385 1.994 . . . . 1.99 116.385 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 13.9 p -82.91 171.72 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.129 -1.028 . . . . 0.37 108.863 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -120.17 128.02 53.01 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.815 -1.55 . . . . 2.12 106.815 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.506 HG13 ' HB3' ' A' ' 51' ' ' GLU . 60.3 mt -116.79 108.97 43.81 Favored Pre-proline 0 C--N 1.308 -1.198 0 C-N-CA 119.964 -0.694 . . . . 0.25 111.52 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 63' ' ' VAL . 51.7 Cg_endo -69.02 159.13 55.19 Favored 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 123.184 2.59 . . . . 0.33 110.928 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.22 -33.62 67.71 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.681 0.792 . . . . 1.98 110.21 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.81 -38.07 89.26 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.067 -0.97 . . . . 2.06 110.835 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.544 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 41.1 m-20 -87.04 -25.17 24.34 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.187 -0.605 . . . . 0.52 112.464 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.884 HG22 HG11 ' A' ' 47' ' ' VAL . 94.7 t -55.88 -42.09 69.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.441 -0.948 . . . . 0.38 108.441 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -78.18 -5.32 51.42 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.669 -0.696 . . . . 2.16 112.304 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.43 -25.58 16.85 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 109.822 -0.436 . . . . 1.59 109.822 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.866 HD13 ' HA ' ' A' ' 72' ' ' ALA . 22.0 mt -89.12 122.04 32.04 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 107.095 -1.446 . . . . 0.31 107.095 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' SER . 8.3 mptt -120.21 -34.88 3.57 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.505 -0.924 . . . . 2.55 108.505 174.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 39.4 p -106.41 173.47 6.3 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 108.894 -0.78 . . . . 0.23 108.894 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 28' ' ' LEU . 1.4 m -81.92 -13.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 C-N-CA 119.35 -0.94 . . . . 1.21 108.535 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.46 -43.53 92.24 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 108.632 -1.787 . . . . 0.33 108.632 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.73 -56.84 13.98 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.866 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.12 -61.02 2.53 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 114.087 -1.415 . . . . 0.15 112.506 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.492 ' HA ' HG21 ' A' ' 7' ' ' ILE . 49.9 m -56.62 -46.3 81.02 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.492 1.12 . . . . 0.24 112.451 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -56.51 -52.34 65.1 Favored 'General case' 0 N--CA 1.41 -2.469 0 O-C-N 124.453 1.095 . . . . 3.63 108.765 177.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.545 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 74.4 t80 -55.18 -50.51 69.18 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 124.057 0.848 . . . . 0.4 111.515 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.631 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.8 mt -54.4 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-N 114.151 -1.386 . . . . 0.21 110.207 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 tt -57.95 -45.51 86.53 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.615 0.766 . . . . 1.44 110.182 -177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.85 -24.07 66.67 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.049 0.94 . . . . 0.63 111.384 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -98.8 -26.42 14.32 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 113.011 0.745 . . . . 1.25 113.011 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.45 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.698 0 N-CA-C 116.405 2.002 . . . . 0.87 116.405 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 7' ' ' ILE . 6.6 t . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 110.751 -0.092 . . . . 0.66 110.751 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.1 tm0? -47.79 -43.21 27.39 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.015 0.926 . . . . 0.74 113.357 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.48 -34.73 62.12 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.594 0.559 . . . . 2.66 111.709 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -87.31 -34.88 18.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.884 -0.598 . . . . 2.73 109.941 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.538 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.7 mt -68.54 -65.72 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 CA-C-N 116.497 -0.319 . . . . 0.23 110.528 -174.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -41.52 67.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 112.386 0.513 . . . . 0.27 112.386 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -61.54 -42.28 98.59 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.033 0.444 . . . . 0.27 110.348 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.0 -40.91 28.93 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 121.028 -0.606 . . . . 0.18 113.081 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.16 -38.53 91.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.775 -0.824 . . . . 0.2 108.775 -178.558 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.619 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.13 -48.24 80.84 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.792 -0.64 . . . . 0.14 109.573 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.69 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 52.5 mt-10 -60.21 -39.37 86.33 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.895 0.747 . . . . 0.68 111.998 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 11' ' ' LEU . 62.9 mt -61.24 -41.88 91.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.009 -0.541 . . . . 0.28 109.754 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 11' ' ' LEU . 46.7 t -71.42 -23.55 22.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.357 0.599 . . . . 0.27 109.945 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.69 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.5 m120 -68.2 -48.81 64.21 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.905 -1.146 . . . . 0.34 107.905 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -69.88 -42.98 72.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.895 -1.048 . . . . 2.07 111.821 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.747 HG13 HG22 ' A' ' 46' ' ' VAL . 19.2 mm -73.85 -53.71 16.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 116.01 -0.541 . . . . 0.65 111.707 -177.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.52 -62.99 1.38 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.171 0.51 . . . . 0.54 111.403 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.33 39.13 0.07 OUTLIER Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.414 -0.898 . . . . 0.43 112.964 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.721 HG21 HG23 ' A' ' 26' ' ' VAL . 1.2 mp -78.03 152.35 79.54 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.459 -0.571 . . . . 0.31 109.459 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.6 Cg_endo -89.85 25.37 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.984 2.456 . . . . 1.08 115.052 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.477 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 5.0 p 53.62 15.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 125.447 1.499 . . . . 0.81 113.857 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.0 pt-20 -123.13 -16.07 7.08 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.888 -0.596 . . . . 2.31 110.338 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.441 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 22.0 t70 -92.41 -25.64 18.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.675 0.75 . . . . 1.59 110.108 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.721 HG23 HG21 ' A' ' 21' ' ' ILE . 43.0 t -76.09 92.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.444 -1.253 . . . . 0.3 108.863 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -125.87 166.78 16.25 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.576 -1.268 . . . . 1.58 107.576 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.403 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 9.5 mp -63.53 146.0 54.54 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.45 -0.574 . . . . 1.05 109.45 176.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.48 12.47 3.87 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.119 1.367 . . . . 0.72 110.431 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 68' ' ' THR . 73.7 mmtt -103.57 124.79 49.45 Favored 'General case' 0 CA--C 1.47 -2.11 0 O-C-N 121.791 -0.568 . . . . 1.48 109.777 176.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 6.3 m -83.23 110.86 18.43 Favored 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 114.488 -1.233 . . . . 1.25 108.427 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.662 ' HA ' HD12 ' A' ' 36' ' ' LEU . 98.2 m-85 -42.02 -67.23 0.28 Allowed 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 125.725 1.61 . . . . 0.4 112.426 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.505 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 14.8 t -101.56 49.35 0.87 Allowed 'General case' 0 C--N 1.275 -2.658 0 C-N-CA 118.776 -1.17 . . . . 1.06 111.134 -177.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 29.4 t70 -154.62 -53.72 0.1 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.73 -1.123 . . . . 1.74 109.773 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -86.23 -44.5 12.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.207 1.003 . . . . 1.29 110.771 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 32' ' ' PHE . 32.7 mt -71.75 -91.24 0.02 OUTLIER 'General case' 0 C--O 1.249 1.036 0 O-C-N 123.715 0.634 . . . . 0.81 111.4 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 25.4 t70 158.25 61.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 126.099 1.76 . . . . 1.12 108.459 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 33' ' ' THR . 26.8 t -101.72 165.81 2.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.694 -0.684 . . . . 0.79 110.022 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 38' ' ' VAL . 10.0 m-20 -83.26 6.15 20.62 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.681 0.793 . . . . 2.0 112.879 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 43' ' ' MET . 20.5 t 66.66 -66.5 0.18 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.579 1.152 . . . . 0.78 113.245 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.02 -26.52 65.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.583 0.706 . . . . 1.18 110.802 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 15.7 m -80.54 -13.46 59.06 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.548 -0.751 . . . . 0.6 110.569 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.588 ' O ' HG23 ' A' ' 47' ' ' VAL . 18.0 tpp -73.04 -31.65 64.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.002 -0.544 . . . . 0.86 110.978 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -55.15 -42.59 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 N-CA-C 108.784 -0.821 . . . . 0.31 108.784 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' SER . 26.0 mm-40 -54.53 -53.14 58.38 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 123.781 0.832 . . . . 0.68 110.282 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.747 HG22 HG13 ' A' ' 18' ' ' ILE . 51.6 t -54.16 -32.14 22.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 124.374 1.07 . . . . 0.63 112.048 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.83 HG21 HG13 ' A' ' 63' ' ' VAL . 27.9 t -73.32 -48.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.567 -0.901 . . . . 0.55 108.567 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.415 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 43.8 t -68.3 -31.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.272 -1.01 . . . . 0.42 108.272 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -69.66 -34.17 73.62 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.41 0.624 . . . . 0.21 109.738 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.48 42.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.974 -1.012 . . . . 0.21 108.994 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.261 0.0 OUTLIER -66.77 -29.63 69.64 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.714 1.005 . . . . 0.64 113.714 -177.727 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 41.4 mt-10 -63.34 -38.16 90.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.274 0.559 . . . . 2.07 110.627 174.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -86.86 -35.37 19.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.272 0.471 . . . . 2.48 112.272 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 8.1 m-85 -97.72 -0.03 46.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 120.025 -0.67 . . . . 0.81 112.186 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 78.44 -2.77 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.584 1.327 . . . . 1.99 114.584 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.671 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 14.8 p -75.73 175.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 O-C-N 121.098 -1.001 . . . . 0.37 108.947 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 36.5 tptt -124.61 128.96 49.68 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.82 -1.178 . . . . 2.12 107.82 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 51' ' ' GLU . 27.1 mt -123.09 110.98 30.8 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 120.165 -0.614 . . . . 0.25 110.825 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.581 ' HD2' ' OH ' ' A' ' 75' ' ' TYR . 67.8 Cg_endo -73.89 158.4 46.39 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.591 2.194 . . . . 0.33 109.582 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.69 -36.57 62.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.194 0.597 . . . . 1.98 110.806 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.44 -42.69 87.89 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.575 0.75 . . . . 2.06 111.63 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.5 m-20 -86.32 -24.92 25.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 121.017 -0.273 . . . . 0.52 111.581 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.83 HG13 HG21 ' A' ' 47' ' ' VAL . 55.8 t -53.06 -58.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.138 -1.06 . . . . 0.38 108.138 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -72.87 -1.49 17.01 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.213 -0.903 . . . . 2.16 111.705 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 38.3 t30 -87.61 -34.41 18.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.847 -1.168 . . . . 1.59 107.847 -177.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 72' ' ' ALA . 12.8 mt -79.42 131.38 36.07 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 106.459 -1.682 . . . . 0.31 106.459 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 31' ' ' SER . 12.7 mptt -116.77 -42.34 2.98 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.997 -1.112 . . . . 2.55 107.997 171.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 81.9 p -101.88 170.38 8.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.901 -1.045 . . . . 0.23 110.224 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.5 -13.6 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.104 -1.073 . . . . 1.21 108.104 174.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.403 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -70.58 -30.47 68.72 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.244 -1.143 . . . . 0.33 110.244 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -81.97 -51.28 8.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.066 -1.087 . . . . 1.39 108.066 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.773 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.79 -60.42 2.91 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 114.323 -1.308 . . . . 0.15 111.967 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 4' ' ' GLN . 45.8 m -57.24 -42.27 81.14 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.671 -1.149 . . . . 0.24 112.508 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.54 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -57.29 -53.25 60.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.974 -1.121 . . . . 3.63 107.974 176.599 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.581 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 82.1 t80 -56.48 -50.54 71.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 124.19 0.931 . . . . 0.4 111.148 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.634 ' HA ' HG21 ' A' ' 56' ' ' VAL . 70.8 mt -55.73 -66.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.278 -1.328 . . . . 0.21 109.98 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.46 -47.18 66.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.8 0.84 . . . . 1.44 110.538 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.09 -22.97 65.8 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.221 -0.899 . . . . 0.63 112.285 -172.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -102.79 4.27 37.7 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.303 0.853 . . . . 1.25 113.303 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.671 ' HG2' ' HB ' ' A' ' 56' ' ' VAL 0.309 0.0 OUTLIER . . . . . 0 CA--C 1.474 -1.957 0 N-CA-C 113.832 1.049 . . . . 0.87 113.832 175.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 6.4 t . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 108.814 -0.81 . . . . 0.66 108.814 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.653 ' HA ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -48.71 -42.2 34.26 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.941 1.296 . . . . 0.74 112.653 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.35 -22.56 63.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.821 0.674 . . . . 2.66 112.821 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 3' ' ' THR . 4.1 tp10 -81.34 -36.77 29.29 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.412 -0.959 . . . . 2.73 108.412 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 4' ' ' GLN . 71.2 mt -79.03 -67.91 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.117 0 CA-C-N 115.294 -0.866 . . . . 0.23 110.844 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 t -59.09 -41.88 84.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 112.568 0.581 . . . . 0.27 112.568 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.38 82.72 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.317 0.386 . . . . 0.27 111.288 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.38 -40.53 8.39 Favored Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 120.393 -0.908 . . . . 0.18 112.2 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.72 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -59.46 -42.72 92.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.277 1.031 . . . . 0.2 108.278 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -54.43 -48.12 72.04 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.664 0.603 . . . . 0.14 110.615 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.86 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 54.4 mt-10 -65.71 -35.71 81.53 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 123.709 0.631 . . . . 0.68 111.746 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 11' ' ' LEU . 64.4 mt -60.73 -42.47 92.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.618 -0.719 . . . . 0.28 109.595 174.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 11' ' ' LEU . 41.3 t -68.47 -23.94 28.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 121.845 0.831 . . . . 0.27 109.864 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.86 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 20.8 m-20 -75.57 -52.35 10.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.176 -1.046 . . . . 0.34 108.176 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -66.66 -46.42 75.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.615 -1.175 . . . . 2.07 112.476 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.62 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.2 mm -70.79 -53.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.878 0.371 . . . . 0.65 110.27 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.74 -74.31 0.65 Allowed 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.664 -0.414 . . . . 0.54 111.519 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.18 54.45 0.02 OUTLIER Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 120.291 -0.957 . . . . 0.43 112.045 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.615 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -95.62 154.57 39.17 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.493 -0.558 . . . . 0.31 109.493 175.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.533 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 6.2 Cg_exo -88.02 29.45 0.47 Allowed 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 124.224 3.283 . . . . 1.08 115.673 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.672 ' HB ' HD22 ' A' ' 16' ' ' ASN . 6.5 p 57.87 -0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 117.838 2.533 . . . . 0.81 117.838 171.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.479 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 43.7 mt-10 -117.93 -13.39 10.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.34 -1.475 . . . . 2.31 111.225 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.0 m-20 -87.03 -29.28 22.06 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.005 -1.452 . . . . 1.59 110.127 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 12' ' ' ALA . 41.9 t -69.35 97.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 0.3 108.79 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.1 mttt -138.35 170.04 16.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 109.069 -0.715 . . . . 1.58 109.069 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 7.8 mp -61.13 143.03 56.23 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.174 -0.676 . . . . 1.05 109.174 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t70 81.99 1.04 1.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.029 1.332 . . . . 0.72 110.898 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.596 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 44.2 mmtm -92.8 120.35 33.08 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 119.589 -0.844 . . . . 1.48 109.644 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.529 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 15.9 m -79.12 27.09 0.25 Allowed 'General case' 1 C--N 1.244 -4.019 0 C-N-CA 125.968 1.707 . . . . 1.25 113.876 -172.483 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.59 ' CZ ' HG22 ' A' ' 69' ' ' VAL . 96.7 m-85 46.13 -88.58 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.495 1.518 . . . . 0.4 113.989 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.6 t -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.133 0.573 . . . . 1.06 111.374 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 32.3 t70 -88.17 -39.72 14.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.978 0.418 . . . . 1.74 111.298 -175.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.596 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -93.21 -41.31 9.97 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.514 0.931 . . . . 1.29 113.514 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.6 mt -88.19 -72.42 0.53 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.388 -0.525 . . . . 0.81 110.68 -173.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.0 t70 163.83 -22.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 124.321 1.013 . . . . 1.12 109.612 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 36' ' ' LEU . 3.0 t -45.99 105.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.77 1.628 . . . . 0.79 112.939 -170.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.523 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 24.9 t70 -54.04 124.15 14.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 124.04 0.838 . . . . 2.0 112.589 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.588 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 29.9 t -37.51 -45.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.612 2.078 . . . . 0.78 116.612 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.523 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 3.9 pp -75.92 -23.15 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 117.607 -1.637 . . . . 1.18 112.26 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.62 ' HB3' HG22 ' A' ' 18' ' ' ILE . 42.9 m -84.2 -18.91 35.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.735 -0.666 . . . . 0.6 109.665 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.644 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -56.95 -43.55 81.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.19 0.996 . . . . 0.86 112.715 -178.205 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.25 -40.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 123.845 0.716 . . . . 0.31 110.171 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -63.36 -44.45 94.77 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.969 -0.56 . . . . 0.68 109.722 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.589 HG11 HG22 ' A' ' 15' ' ' VAL . 42.0 t -60.0 -25.13 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.425 -0.807 . . . . 0.63 110.903 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.926 HG21 HG13 ' A' ' 63' ' ' VAL . 21.5 t -82.27 -53.75 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 108.79 -0.818 . . . . 0.55 108.79 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.14 -36.73 74.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.72 -1.127 . . . . 0.42 109.171 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -31.61 67.37 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.824 -0.435 . . . . 0.21 109.824 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -61.55 -58.21 9.04 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.285 -0.87 . . . . 0.21 109.094 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -64.47 -36.06 82.95 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.906 1.076 . . . . 0.64 113.906 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.99 -29.74 69.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 2.07 111.512 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -88.41 -32.34 18.38 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.227 -0.442 . . . . 2.48 111.559 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CE2' ' HB1' ' A' ' 50' ' ' ALA . 4.6 m-30 -93.13 -11.14 33.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 120.386 -0.526 . . . . 0.81 111.938 -173.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t70 81.38 6.77 1.2 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.493 1.517 . . . . 1.99 111.987 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' A' ' 76' ' ' ILE . 14.5 p -84.7 171.15 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 107.584 -1.265 . . . . 0.37 107.584 174.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 19.5 tptt -124.6 123.06 39.24 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.654 -0.869 . . . . 2.12 108.654 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.542 HG12 ' HE2' ' A' ' 75' ' ' TYR . 62.8 mt -118.9 112.73 36.32 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 109.835 -0.432 . . . . 0.25 109.835 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 63' ' ' VAL . 37.7 Cg_endo -67.43 158.2 58.18 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.747 2.298 . . . . 0.33 110.282 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 6.2 p-10 -58.55 -30.43 67.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.399 -0.364 . . . . 1.98 111.422 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.74 -34.03 69.2 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 112.428 0.529 . . . . 2.06 112.428 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.497 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 52.5 m-20 -78.73 -25.07 44.57 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 119.524 -0.87 . . . . 0.52 110.985 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.926 HG13 HG21 ' A' ' 47' ' ' VAL . 70.0 t -54.27 -39.7 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.229 -1.026 . . . . 0.38 108.229 170.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 60' ' ' ASP . 81.9 mttt -73.98 -14.63 61.06 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.0 -1.0 . . . . 2.16 112.22 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -96.49 -36.17 10.88 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.594 0.358 . . . . 1.59 111.511 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -68.71 113.05 5.84 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 105.678 -1.971 . . . . 0.31 105.678 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -108.21 -31.3 7.95 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 119.762 -0.775 . . . . 2.55 109.807 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 67.9 p -121.01 178.42 4.74 Favored 'General case' 0 N--CA 1.392 -3.338 0 N-CA-C 108.557 -0.905 . . . . 0.23 108.557 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.59 HG22 ' CZ ' ' A' ' 32' ' ' PHE . 6.4 t -77.45 -13.56 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 107.683 -1.228 . . . . 1.21 107.683 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.84 -49.04 37.93 Favored Glycine 0 CA--C 1.489 -1.583 0 N-CA-C 109.871 -1.292 . . . . 0.33 109.871 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.77 -44.36 77.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.963 -0.618 . . . . 1.39 109.373 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -56.61 -61.64 2.28 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.019 -0.992 . . . . 0.15 111.266 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.613 ' HA ' HG21 ' A' ' 7' ' ' ILE . 60.7 m -54.36 -43.71 71.54 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.696 -1.138 . . . . 0.24 113.804 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.1 mptp? -61.03 -50.9 71.48 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.99 -0.744 . . . . 3.63 108.99 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.542 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.8 t80 -54.47 -51.82 63.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.643 -1.162 . . . . 0.4 110.225 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.655 ' HA ' HG21 ' A' ' 56' ' ' VAL . 78.3 mt -55.37 -65.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 114.19 -1.368 . . . . 0.21 110.716 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 5.2 tt -51.73 -43.61 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.9 0.88 . . . . 1.44 110.57 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.07 -25.53 64.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.875 -1.057 . . . . 0.63 111.823 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -101.51 -5.83 24.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.794 -0.639 . . . . 1.25 112.344 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.458 ' HG2' ' HB ' ' A' ' 56' ' ' VAL 0.302 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 113.636 0.976 . . . . 0.87 113.636 175.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.596 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 13.1 t . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 108.673 -0.862 . . . . 0.66 108.673 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' HG2' HG21 ' A' ' 73' ' ' THR . 16.0 tm0? -46.9 -48.25 21.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.141 1.163 . . . . 0.74 114.141 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.478 ' HG3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -51.98 -32.33 33.17 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.567 0.951 . . . . 2.66 113.567 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -87.45 -40.45 14.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.292 0.637 . . . . 2.73 109.87 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.635 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 99.5 mt -63.56 -58.74 6.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 116.139 -0.482 . . . . 0.23 110.016 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.547 HG21 HD11 ' A' ' 28' ' ' LEU . 46.0 t -66.29 -22.91 30.86 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.871 -0.604 . . . . 0.27 111.695 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.92 55.78 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.759 -0.776 . . . . 0.27 109.177 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.15 -44.09 24.12 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 115.008 -0.996 . . . . 0.18 113.225 -176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -63.13 -33.08 74.68 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 123.448 0.699 . . . . 0.2 109.376 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -60.75 -51.14 70.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.659 -0.701 . . . . 0.14 109.263 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 51.2 mt-10 -59.44 -41.83 90.53 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 124.183 0.927 . . . . 0.68 111.809 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 11' ' ' LEU . 71.4 mt -56.79 -42.17 77.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.461 -0.79 . . . . 0.28 109.85 175.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.613 HG12 ' HB ' ' A' ' 21' ' ' ILE . 88.0 t -70.92 -23.73 23.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.703 0.764 . . . . 0.27 110.306 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.645 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -72.79 -43.32 62.91 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.177 -1.046 . . . . 0.34 108.177 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -71.39 -50.33 33.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.214 -0.903 . . . . 2.07 110.926 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.653 HG13 HG22 ' A' ' 46' ' ' VAL . 20.9 mm -66.76 -54.24 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.1 -0.5 . . . . 0.65 111.667 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -102.96 -66.07 0.96 Allowed 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.389 0.614 . . . . 0.54 111.036 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.7 50.87 0.06 OUTLIER Glycine 0 C--N 1.29 -1.999 0 CA-C-N 115.142 -0.936 . . . . 0.43 111.714 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.613 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -91.33 155.66 44.17 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.408 -0.396 . . . . 0.31 109.983 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 21' ' ' ILE . 6.0 Cg_exo -86.62 23.02 0.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.343 2.695 . . . . 1.08 115.698 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.633 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.9 p 48.1 26.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 C-N-CA 124.694 1.198 . . . . 0.81 113.154 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -138.9 4.72 2.31 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.345 -0.843 . . . . 2.31 110.685 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.35 -27.91 9.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.075 -0.966 . . . . 1.59 110.065 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.744 HG22 HD13 ' A' ' 36' ' ' LEU . 23.7 t -79.6 99.1 3.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.33 -1.304 . . . . 0.3 108.972 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -127.98 170.57 12.72 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.164 -1.421 . . . . 1.58 107.164 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 8' ' ' VAL . 7.9 mp -66.41 148.55 51.7 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.287 -1.005 . . . . 1.05 108.287 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 81.51 4.22 1.39 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 124.451 1.101 . . . . 0.72 110.533 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.518 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 73.6 mmtt -96.61 118.99 34.26 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 119.831 -0.748 . . . . 1.48 110.636 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 71.4 m -75.53 32.88 0.11 Allowed 'General case' 0 C--N 1.248 -3.833 0 C-N-CA 127.189 2.195 . . . . 1.25 114.039 -175.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.582 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 86.8 m-85 41.23 -89.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.454 1.501 . . . . 0.4 115.025 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.645 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.9 t -63.15 -29.17 70.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.468 0.707 . . . . 1.06 111.05 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -96.45 -31.21 12.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.826 0.676 . . . . 1.74 112.826 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -99.29 -36.79 9.51 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.777 1.029 . . . . 1.29 113.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.744 HD13 HG22 ' A' ' 26' ' ' VAL . 16.0 mt -94.91 -39.7 10.08 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.245 -0.434 . . . . 0.81 109.998 -174.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 t70 93.33 69.53 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.579 0 C-N-CA 126.531 1.933 . . . . 1.12 108.934 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.645 ' H ' ' HA ' ' A' ' 33' ' ' THR . 13.3 t -108.09 143.4 18.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 105.002 -2.222 . . . . 0.79 105.002 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.37 117.73 15.48 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.374 -0.93 . . . . 2.0 109.63 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.593 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.0 t -38.67 -47.37 1.34 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.573 1.694 . . . . 0.78 115.573 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -70.58 -26.37 63.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.368 -0.933 . . . . 1.18 111.628 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.2 m -84.94 -16.96 39.25 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.474 0.709 . . . . 0.6 110.507 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.723 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -56.01 -38.65 70.79 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 124.084 0.953 . . . . 0.86 111.598 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.21 -47.1 77.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 O-C-N 124.451 1.095 . . . . 0.31 109.984 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.03 -45.12 83.35 Favored 'General case' 0 C--O 1.21 -1.026 0 C-N-CA 122.873 0.469 . . . . 0.68 109.796 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.653 HG22 HG13 ' A' ' 18' ' ' ILE . 44.2 t -59.01 -28.86 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.783 0.833 . . . . 0.63 110.958 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.849 HG21 HG13 ' A' ' 63' ' ' VAL . 54.0 t -78.6 -51.43 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.766 -1.198 . . . . 0.55 107.766 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -56.0 -42.42 71.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.419 -1.264 . . . . 0.42 109.447 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -63.85 -39.07 93.34 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-O 121.499 0.666 . . . . 0.21 110.454 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.28 -52.57 57.95 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.87 -1.059 . . . . 0.21 109.886 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.325 0.0 OUTLIER -62.54 -35.89 80.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.708 1.003 . . . . 0.64 113.708 -179.242 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.4 -44.03 95.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.221 0.326 . . . . 2.07 111.581 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -76.66 -44.54 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.534 0.568 . . . . 2.48 112.534 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.635 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 11.8 m-85 -89.27 -5.22 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.301 -0.56 . . . . 0.81 112.434 -172.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 83.17 10.73 0.52 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 115.389 1.625 . . . . 1.99 115.389 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.6 p -87.19 179.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.273 -1.01 . . . . 0.37 108.273 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.498 ' H ' HG22 ' A' ' 56' ' ' VAL . 46.7 tptt -132.89 128.55 36.84 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 106.434 -1.691 . . . . 2.12 106.434 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.604 HG13 ' HB3' ' A' ' 51' ' ' GLU . 42.0 mt -124.11 111.57 28.66 Favored Pre-proline 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.787 . . . . 0.25 111.054 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.628 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.5 Cg_endo -73.29 162.18 41.03 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.158 2.572 . . . . 0.33 110.793 176.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.39 -41.98 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.942 0.897 . . . . 1.98 110.616 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 30.2 t70 -60.72 -37.56 82.13 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 114.685 -1.143 . . . . 2.06 111.549 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 20.4 m-20 -86.89 -28.01 23.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 113.414 0.894 . . . . 0.52 113.414 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.849 HG13 HG21 ' A' ' 47' ' ' VAL . 95.8 t -53.62 -48.72 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.767 -0.827 . . . . 0.38 108.767 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 48.3 pttt -69.73 -13.59 62.37 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.886 -1.052 . . . . 2.16 112.45 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.79 -13.08 46.18 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.405 0.621 . . . . 1.59 109.716 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.771 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.5 mt -97.52 110.37 22.95 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 106.49 -1.67 . . . . 0.31 106.49 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.7 mptp? -100.64 -44.65 5.76 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.311 -0.996 . . . . 2.55 108.311 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 20.1 p -110.25 -177.9 3.37 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.697 -0.853 . . . . 0.23 108.697 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -87.05 -13.43 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 108.344 -0.984 . . . . 1.21 108.344 176.018 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.554 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -72.33 -24.78 75.79 Favored Glycine 0 C--O 1.2 -2.014 0 N-CA-C 108.683 -1.767 . . . . 0.33 108.683 174.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' THR . 8.7 m-20 -82.66 -57.13 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.781 -1.21 . . . . 1.39 108.542 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.771 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -47.8 -60.32 2.66 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 114.881 -1.054 . . . . 0.15 112.155 -178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.467 ' HA ' HG21 ' A' ' 7' ' ' ILE . 44.9 m -56.79 -48.09 78.71 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.354 -1.294 . . . . 0.24 113.451 -174.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.0 mptp? -56.57 -47.08 80.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.069 0.856 . . . . 3.63 109.58 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.538 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 85.1 t80 -60.44 -51.8 67.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.081 -0.963 . . . . 0.4 111.544 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.592 ' HA ' HG21 ' A' ' 56' ' ' VAL . 69.9 mt -54.57 -65.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.584 -1.189 . . . . 0.21 110.542 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.596 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.1 tt -51.79 -46.55 64.23 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.356 1.062 . . . . 1.44 109.511 -175.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.99 -30.56 70.35 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.55 -1.205 . . . . 0.63 111.502 -172.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -100.13 0.0 39.77 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 113.923 1.083 . . . . 1.25 113.923 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.476 -1.867 0 N-CA-C 113.768 1.025 . . . . 0.87 113.768 176.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.427 -1.576 0 N-CA-C 109.11 -0.7 . . . . 0.66 109.11 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' HG2' HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -50.66 -41.49 55.55 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.331 1.452 . . . . 0.74 114.518 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -52.51 -52.03 56.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.206 0.316 . . . . 2.66 110.581 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.03 -48.67 64.43 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 124.848 1.259 . . . . 2.73 111.184 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 73' ' ' THR . 81.4 mt -70.21 -64.13 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.275 -1.33 . . . . 0.23 110.255 -170.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.401 HG23 ' HG2' ' A' ' 4' ' ' GLN . 76.0 t -58.07 -40.42 76.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 N-CA-C 112.738 0.644 . . . . 0.27 112.738 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -62.12 -44.37 96.79 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.736 -0.468 . . . . 0.27 109.736 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -76.01 -38.24 35.97 Favored Glycine 0 N--CA 1.415 -2.742 0 CA-C-N 115.572 -0.74 . . . . 0.18 113.446 -175.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.614 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.49 -39.16 88.59 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.609 -0.885 . . . . 0.2 108.609 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.596 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.97 -47.49 84.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.207 -0.664 . . . . 0.14 109.207 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.781 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 44.6 mt-10 -54.89 -45.8 74.72 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 124.368 1.042 . . . . 0.68 111.806 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 11' ' ' LEU . 56.9 mt -59.55 -42.68 88.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.467 -0.788 . . . . 0.28 110.058 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 21' ' ' ILE . 48.4 t -71.86 -22.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.409 0.623 . . . . 0.27 109.931 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.781 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 33.1 m-20 -66.19 -43.19 87.53 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.039 -0.726 . . . . 0.34 109.039 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -80.42 -49.3 11.63 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.518 -0.765 . . . . 2.07 111.259 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.699 HG13 HG22 ' A' ' 46' ' ' VAL . 16.8 mm -62.35 -53.56 45.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.822 -0.626 . . . . 0.65 111.374 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.409 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -104.55 -72.64 0.7 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.509 0.671 . . . . 0.54 109.857 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.31 34.65 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.563 0 CA-C-N 114.993 -1.003 . . . . 0.43 111.973 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.603 HG21 HG23 ' A' ' 26' ' ' VAL . 1.3 mp -72.96 150.43 90.33 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 109.557 -0.534 . . . . 0.31 109.557 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.7 Cg_exo -88.89 31.23 0.4 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.732 2.954 . . . . 1.08 114.758 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.25 5.6 p 58.4 -6.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 126.984 2.114 . . . . 0.81 116.393 175.605 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -114.85 -6.33 12.63 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.937 -1.102 . . . . 2.31 111.064 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -83.28 -30.88 27.25 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.4 1.095 . . . . 1.59 108.917 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.678 HG22 HD13 ' A' ' 36' ' ' LEU . 22.8 t -76.3 96.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 113.35 -1.75 . . . . 0.3 109.935 -176.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 69' ' ' VAL . 12.5 mptt -127.83 158.37 37.92 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.355 -1.35 . . . . 1.58 107.355 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.53 HD22 ' HA2' ' A' ' 70' ' ' GLY . 54.8 mt -52.83 144.83 13.64 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.9 -0.778 . . . . 1.05 108.9 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 78.67 10.55 1.76 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.938 1.295 . . . . 0.72 110.824 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.632 ' HD2' ' CG ' ' A' ' 35' ' ' ASP . 31.3 mmtp -96.91 122.63 40.1 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 108.617 -0.882 . . . . 1.48 108.617 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 30.3 m -76.29 36.18 0.15 Allowed 'General case' 0 C--N 1.252 -3.662 0 C-N-CA 125.279 1.432 . . . . 1.25 113.519 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.686 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 76.0 m-85 42.75 -94.12 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 125.673 1.589 . . . . 0.4 114.697 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.525 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 5.4 t -68.57 -24.66 64.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.081 0.467 . . . . 1.06 110.059 -174.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 11.0 t70 -81.32 -53.03 6.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.298 -0.864 . . . . 1.74 111.772 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.632 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t70 -84.22 -56.59 3.57 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 119.585 -0.846 . . . . 1.29 110.267 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.678 HD13 HG22 ' A' ' 26' ' ' VAL . 22.4 mt -65.91 -38.12 87.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.12 -1.4 . . . . 0.81 111.286 -170.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t70 88.22 70.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 124.919 1.387 . . . . 1.12 109.186 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.525 ' H ' ' HA ' ' A' ' 33' ' ' THR . 18.4 t -102.58 170.88 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.374 -2.194 . . . . 0.79 108.741 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 42' ' ' SER . 2.2 m-20 -78.01 -3.42 41.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.094 1.146 . . . . 2.0 114.094 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 43' ' ' MET . 29.0 t 65.87 -65.4 0.18 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.136 0.975 . . . . 0.78 113.053 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 42' ' ' SER . 0.7 OUTLIER -62.67 -36.41 82.77 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.305 0.574 . . . . 1.18 111.572 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.54 ' O ' HG23 ' A' ' 46' ' ' VAL . 12.6 m -78.23 -13.73 59.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.499 -0.773 . . . . 0.6 110.065 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.543 ' O ' HG23 ' A' ' 47' ' ' VAL . 12.2 tpp -73.69 -35.61 65.19 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 116.254 -0.43 . . . . 0.86 110.127 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.8 t -55.72 -37.72 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 109.487 -0.56 . . . . 0.31 109.487 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -61.89 -47.89 82.93 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.275 -0.639 . . . . 0.68 109.275 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.699 HG22 HG13 ' A' ' 18' ' ' ILE . 61.1 t -57.73 -28.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 CA-C-N 114.834 -1.075 . . . . 0.63 111.475 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.87 HG21 HG13 ' A' ' 63' ' ' VAL . 27.6 t -71.69 -52.68 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.377 0 N-CA-C 107.764 -1.199 . . . . 0.55 107.764 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.08 -38.63 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.23 -1.35 . . . . 0.42 108.55 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.74 -38.99 90.65 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.862 -0.608 . . . . 0.21 109.932 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.53 -58.37 8.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.731 -1.122 . . . . 0.21 109.779 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.481 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.26 0.0 OUTLIER -59.36 -39.76 84.26 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.233 1.197 . . . . 0.64 114.233 -176.384 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -59.92 -35.7 75.45 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.39 0.431 . . . . 2.07 111.846 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -86.42 -30.36 22.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.116 -0.493 . . . . 2.48 110.143 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -100.03 1.47 42.47 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.208 0.447 . . . . 0.81 112.208 -173.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.7 t70 79.5 4.1 2.17 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 124.344 1.058 . . . . 1.99 112.98 174.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 76' ' ' ILE . 7.8 p -90.93 -179.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 O-C-N 121.256 -0.902 . . . . 0.37 108.703 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.508 ' H ' HG22 ' A' ' 56' ' ' VAL . 21.4 tptm -135.62 128.69 31.61 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.748 -1.575 . . . . 2.12 106.748 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.481 HG13 ' HB3' ' A' ' 51' ' ' GLU . 59.5 mt -122.07 110.47 32.89 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.128 -0.629 . . . . 0.25 111.109 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.571 ' O ' HG23 ' A' ' 63' ' ' VAL . 91.1 Cg_endo -74.94 164.94 32.41 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.125 2.55 . . . . 0.33 110.961 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 20.2 t70 -51.57 -44.12 62.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 1.98 112.101 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -58.78 -40.59 84.43 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.612 0.57 . . . . 2.06 111.301 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 24.7 m-20 -81.52 -31.11 32.94 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.777 -0.769 . . . . 0.52 112.005 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.87 HG13 HG21 ' A' ' 47' ' ' VAL . 82.7 t -53.83 -50.72 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.056 -1.09 . . . . 0.38 108.056 172.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 13.8 ptmm? -73.17 -2.7 22.67 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.372 0.878 . . . . 2.16 113.372 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -105.79 -16.81 14.57 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.993 -0.442 . . . . 1.59 111.76 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.762 HD13 ' HA ' ' A' ' 72' ' ' ALA . 44.2 mt -82.14 107.44 14.84 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 105.711 -1.959 . . . . 0.31 105.711 176.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -97.13 -39.29 9.37 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.181 -1.008 . . . . 2.55 109.744 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 27.7 p -114.97 179.64 3.89 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.46 0.648 . . . . 0.23 109.587 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.686 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -87.09 -13.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.797 -0.816 . . . . 1.21 108.797 175.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.53 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -68.12 -43.56 80.47 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 107.032 -2.427 . . . . 0.33 107.032 172.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -65.25 -56.06 14.87 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.888 -1.656 . . . . 1.39 110.895 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.762 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.9 -60.95 2.43 Favored 'General case' 0 CA--C 1.482 -1.665 0 O-C-N 124.304 1.002 . . . . 0.15 111.42 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.646 ' HA ' HG21 ' A' ' 7' ' ' ILE . 56.8 m -53.31 -54.59 34.26 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.589 -1.187 . . . . 0.24 113.303 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.9 mptm? -56.08 -37.5 69.42 Favored 'General case' 0 C--O 1.198 -1.658 0 C-N-CA 124.158 0.983 . . . . 3.63 110.78 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' HE2' HG12 ' A' ' 58' ' ' ILE . 90.7 t80 -66.93 -47.59 71.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.535 0.683 . . . . 0.4 109.377 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.656 ' HA ' HG21 ' A' ' 56' ' ' VAL . 72.7 mt -59.09 -65.87 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-N 114.2 -1.364 . . . . 0.21 109.441 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.626 HD23 HG22 ' A' ' 73' ' ' THR . 4.4 pp -53.41 -38.41 63.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 113.475 0.917 . . . . 1.44 113.475 -176.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.512 ' N ' HD12 ' A' ' 77' ' ' LEU . 7.7 t70 -72.03 -25.75 61.93 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.92 -1.036 . . . . 0.63 110.777 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -102.56 -6.03 23.28 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.649 -0.705 . . . . 1.25 112.083 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 18.4 mt-30 . . . . . 0 CA--C 1.455 -2.676 0 CA-C-O 122.866 1.317 . . . . 0.87 107.933 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 7' ' ' ILE . 11.3 t . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.047 -1.464 . . . . 0.66 107.047 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -45.86 -40.27 9.69 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.749 1.018 . . . . 0.74 113.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.49 -28.19 69.12 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.489 0.493 . . . . 2.66 111.949 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -88.83 -35.91 16.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.368 -0.605 . . . . 2.73 109.368 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.694 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 93.9 mt -72.53 -66.37 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.059 0 CA-C-N 116.126 -0.488 . . . . 0.23 111.846 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.05 -40.39 76.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 122.081 0.153 . . . . 0.27 111.169 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.39 81.46 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.01 -0.541 . . . . 0.27 111.25 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.48 -39.42 8.99 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 116.232 -0.44 . . . . 0.18 112.399 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.709 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.79 -37.4 87.47 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.577 -0.897 . . . . 0.2 108.577 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.865 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.21 -47.13 75.73 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.748 -0.66 . . . . 0.14 109.847 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.829 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 41.1 mt-10 -60.94 -41.47 96.31 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 124.135 0.897 . . . . 0.68 111.658 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 11' ' ' LEU . 71.2 mt -60.74 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.277 -0.874 . . . . 0.28 109.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.834 HG12 ' HB ' ' A' ' 21' ' ' ILE . 73.9 t -67.99 -23.76 29.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 123.872 0.869 . . . . 0.27 111.038 -176.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.829 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 45.3 m-20 -71.62 -45.16 62.9 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.107 -0.952 . . . . 0.34 109.142 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -83.77 -36.73 23.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.286 -0.87 . . . . 2.07 112.945 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.626 HG13 HG22 ' A' ' 46' ' ' VAL . 28.1 mm -70.2 -53.19 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.044 -0.724 . . . . 0.65 109.044 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -103.16 -88.9 0.4 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.836 -0.62 . . . . 0.54 109.556 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.03 39.53 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 120.338 -0.934 . . . . 0.43 112.88 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.834 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -75.12 151.83 86.11 Favored Pre-proline 0 C--O 1.205 -1.257 0 N-CA-C 109.618 -0.512 . . . . 0.31 109.618 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.2 Cg_exo -87.36 31.88 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.53 2.82 . . . . 1.08 114.771 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' H ' HG22 ' A' ' 21' ' ' ILE 0.287 9.8 p 60.45 -22.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 C-N-CA 127.057 2.143 . . . . 0.81 116.416 175.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -93.12 -15.16 26.34 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.281 0.562 . . . . 2.31 111.021 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.28 -26.63 30.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.385 -0.825 . . . . 1.59 111.454 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.865 HG21 ' HA ' ' A' ' 12' ' ' ALA . 43.1 t -71.84 98.41 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.133 -0.939 . . . . 0.3 108.811 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -130.12 161.92 29.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.845 -1.539 . . . . 1.58 106.845 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.508 ' HA ' HG22 ' A' ' 69' ' ' VAL . 91.1 mt -61.73 145.4 52.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.164 -0.68 . . . . 1.05 109.164 177.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 74.49 9.72 4.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.503 1.121 . . . . 0.72 110.586 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.44 127.26 50.85 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 109.512 -0.551 . . . . 1.48 109.512 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.668 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 7.1 m -84.63 108.68 17.5 Favored 'General case' 1 C--N 1.239 -4.203 0 CA-C-N 114.736 -1.12 . . . . 1.25 108.34 178.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.699 ' HB2' ' SD ' ' A' ' 43' ' ' MET . 34.4 m-85 -46.51 -54.28 9.61 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 124.534 1.133 . . . . 0.4 110.207 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 12.1 t -77.61 19.82 0.35 Allowed 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 125.681 1.592 . . . . 1.06 113.771 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 15.2 t70 -158.76 -62.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.276 -0.89 . . . . 1.74 110.886 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -69.31 -40.13 77.85 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.634 -1.166 . . . . 1.29 109.849 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 32' ' ' PHE . 19.0 mt -80.78 -91.23 0.06 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 114.915 -1.039 . . . . 0.81 110.907 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 31.0 t70 168.01 20.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 121.966 0.889 . . . . 1.12 109.685 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.601 HG13 ' HB2' ' A' ' 19' ' ' ALA . 13.5 t -87.67 144.98 8.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.364 -0.835 . . . . 0.79 108.986 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.11 124.28 29.71 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.694 -0.684 . . . . 2.0 109.81 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.546 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 11.3 t -36.27 -46.05 0.5 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.412 1.485 . . . . 0.78 114.421 172.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.95 -30.8 70.18 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.31 -0.556 . . . . 1.18 111.689 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 m -83.76 -18.27 38.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.388 0.613 . . . . 0.6 109.782 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.699 ' SD ' ' HB2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -57.4 -38.27 74.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.229 1.012 . . . . 0.86 112.134 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.1 t -51.46 -51.14 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.109 0.881 . . . . 0.31 109.723 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -53.89 -48.73 69.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.68 109.949 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.626 HG22 HG13 ' A' ' 18' ' ' ILE . 46.2 t -58.71 -31.6 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.839 1.256 . . . . 0.63 111.481 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.718 HG21 HG13 ' A' ' 63' ' ' VAL . 34.2 t -76.96 -47.24 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 N-CA-C 108.491 -0.929 . . . . 0.55 108.491 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.97 -36.3 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 114.787 -1.097 . . . . 0.42 108.462 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.32 -36.16 82.23 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.844 -0.616 . . . . 0.21 109.935 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -56.53 19.13 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.797 -1.092 . . . . 0.21 110.015 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.645 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -63.19 -33.11 74.77 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.724 -0.79 . . . . 0.64 113.069 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.98 -40.45 95.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.078 0.399 . . . . 2.07 112.078 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -84.56 -38.07 20.42 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.494 -0.482 . . . . 2.48 111.933 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.694 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.0 m-85 -97.41 20.12 12.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.053 0.76 . . . . 0.81 113.053 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.9 t70 69.5 -2.07 2.03 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 114.675 1.361 . . . . 1.99 114.675 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.53 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 8.5 p -89.51 178.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 O-C-N 120.476 -1.39 . . . . 0.37 108.907 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.472 ' H ' HG22 ' A' ' 56' ' ' VAL . 19.4 ttpt -131.96 131.51 42.68 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 106.022 -1.844 . . . . 2.12 106.022 170.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.645 HG13 ' HB3' ' A' ' 51' ' ' GLU . 65.3 mt -120.62 114.99 32.55 Favored Pre-proline 0 C--N 1.293 -1.854 0 C-N-CA 120.532 -0.467 . . . . 0.25 110.205 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.558 ' O ' HG23 ' A' ' 63' ' ' VAL . 28.9 Cg_endo -62.4 155.2 59.02 Favored 'Trans proline' 0 CA--C 1.509 -0.774 0 C-N-CA 123.124 2.549 . . . . 0.33 110.883 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -54.8 -28.82 52.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.499 0.499 . . . . 1.98 111.895 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.682 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 29.8 t70 -73.88 -39.51 63.86 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 120.384 -0.526 . . . . 2.06 111.317 176.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 11.5 m-20 -77.37 -24.4 50.63 Favored 'General case' 0 CA--C 1.482 -1.663 0 C-N-CA 119.231 -0.987 . . . . 0.52 112.644 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 47' ' ' VAL . 68.8 t -51.85 -49.85 35.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 107.958 -1.126 . . . . 0.38 107.958 171.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.682 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 5.1 ptmm? -77.76 -2.01 34.18 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.431 0.9 . . . . 2.16 113.431 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 91.7 m-20 -98.08 -16.97 19.35 Favored 'General case' 0 CA--C 1.485 -1.539 0 O-C-N 121.72 -0.612 . . . . 1.59 110.368 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.0 mt -87.32 128.72 35.18 Favored 'General case' 0 N--CA 1.391 -3.407 0 N-CA-C 103.788 -2.671 . . . . 0.31 103.788 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -119.85 -42.02 2.64 Favored 'General case' 0 C--N 1.268 -2.956 0 N-CA-C 108.149 -1.056 . . . . 2.55 108.149 174.41 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 61.6 p -102.7 174.97 5.65 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 0.23 108.894 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.508 HG22 ' HA ' ' A' ' 28' ' ' LEU . 1.5 m -81.64 -13.51 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 107.798 -1.186 . . . . 1.21 107.798 174.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.426 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -74.23 -27.16 66.62 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.193 -1.003 . . . . 0.33 110.661 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.498 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 5.9 t70 -83.64 -48.34 10.29 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.525 -0.917 . . . . 1.39 108.525 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.7 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.33 -59.98 3.62 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-N 114.028 -1.442 . . . . 0.15 111.833 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.5 ' HA ' HG21 ' A' ' 7' ' ' ILE . 60.0 m -56.91 -61.6 2.33 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.081 -0.963 . . . . 0.24 111.507 -173.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.3 OUTLIER -41.16 -46.75 3.13 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.86 2.064 . . . . 3.63 111.438 171.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -63.22 -47.09 83.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.292 0.568 . . . . 0.4 110.336 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.632 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 64.0 mt -60.77 -66.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.32 -1.309 . . . . 0.21 109.259 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.5 HD23 HG22 ' A' ' 73' ' ' THR . 4.5 pp -58.58 -36.66 74.32 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.369 1.248 . . . . 1.44 114.369 -174.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.473 ' N ' HD12 ' A' ' 77' ' ' LEU . 12.6 t70 -75.28 -22.63 57.62 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.952 -0.567 . . . . 0.63 111.666 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.38 -24.6 18.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.896 0.702 . . . . 1.25 112.896 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.632 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.36 0.0 OUTLIER . . . . . 0 CA--C 1.48 -1.735 0 N-CA-C 116.101 1.889 . . . . 0.87 116.101 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.685 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 15.2 t . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 109.907 -0.405 . . . . 0.66 109.907 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -52.84 -41.87 64.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.85 1.26 . . . . 0.74 113.09 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.93 -32.49 33.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.003 0.521 . . . . 2.66 112.299 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.21 -36.25 27.44 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.969 -0.56 . . . . 2.73 110.336 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.471 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 74.9 mt -77.56 -66.49 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.218 0 CA-C-N 115.645 -0.707 . . . . 0.23 111.723 -171.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.2 t -55.91 -42.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 112.178 0.436 . . . . 0.27 112.178 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.96 89.49 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 123.713 0.633 . . . . 0.27 110.446 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.99 -39.0 13.78 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.895 -0.593 . . . . 0.18 113.08 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.714 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.21 -35.48 80.54 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.863 -1.162 . . . . 0.2 107.863 -177.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -57.02 -51.17 70.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.458 -0.571 . . . . 0.14 109.458 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.728 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 40.4 mt-10 -56.02 -44.32 78.61 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.417 1.073 . . . . 0.68 111.29 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 11' ' ' LEU . 72.2 mt -56.96 -45.4 83.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.263 -0.881 . . . . 0.28 110.37 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 11' ' ' LEU . 58.5 t -66.78 -23.98 31.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.848 0.832 . . . . 0.27 110.138 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.728 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 8.8 m-20 -75.48 -53.11 9.19 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.321 -0.992 . . . . 0.34 108.321 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 7.3 mm-40 -67.23 -39.98 86.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.964 -1.016 . . . . 2.07 111.374 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.6 mm -74.98 -53.73 15.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.667 -0.494 . . . . 0.65 109.667 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -100.55 -86.76 0.39 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.979 -0.555 . . . . 0.54 111.566 -173.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.98 50.25 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.684 0 CA-C-N 115.817 -0.629 . . . . 0.43 112.302 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.802 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -93.74 152.89 41.07 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 110.107 -0.331 . . . . 0.31 110.107 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 3.0 Cg_exo -84.87 30.88 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.671 2.914 . . . . 1.08 114.453 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.584 ' HB ' HD22 ' A' ' 16' ' ' ASN . 5.8 p 54.84 2.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 115.81 1.782 . . . . 0.81 115.81 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 22' ' ' PRO . 10.0 pt-20 -127.6 0.5 6.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.063 -1.023 . . . . 2.31 111.374 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 22.6 t0 -89.33 -24.06 22.1 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.589 -1.187 . . . . 1.59 109.072 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.802 HG23 HG21 ' A' ' 21' ' ' ILE . 42.1 t -81.07 93.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.107 -1.406 . . . . 0.3 109.527 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -121.55 166.12 14.66 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.504 -0.924 . . . . 1.58 108.504 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.447 HD22 ' HA2' ' A' ' 70' ' ' GLY . 67.6 mt -67.31 143.26 56.51 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.138 -1.43 . . . . 1.05 107.138 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 33.1 t70 85.64 1.43 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 124.343 1.057 . . . . 0.72 110.565 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 69' ' ' VAL . 45.4 mmtm -95.42 120.29 35.41 Favored 'General case' 0 CA--C 1.474 -1.972 0 O-C-N 121.502 -0.749 . . . . 1.48 109.879 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 10.4 t -83.02 35.22 0.47 Allowed 'General case' 1 C--N 1.24 -4.174 0 C-N-CA 126.483 1.913 . . . . 1.25 112.388 -171.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CZ ' HG22 ' A' ' 69' ' ' VAL . 96.6 m-85 41.64 -90.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.363 1.865 . . . . 0.4 115.293 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.412 ' HB ' ' SD ' ' A' ' 43' ' ' MET . 12.4 t -62.73 -27.69 69.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.281 0.633 . . . . 1.06 111.398 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 11.3 t70 -87.16 -56.35 3.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.524 -0.307 . . . . 1.74 110.564 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.08 -38.29 27.56 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 113.466 0.913 . . . . 1.29 113.466 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 25.3 mt -82.62 -76.24 0.28 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.482 -0.487 . . . . 0.81 112.117 -171.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 170.9 -20.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 122.961 0.504 . . . . 1.12 110.349 -174.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 19' ' ' ALA . 10.6 t -47.84 139.96 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.362 1.065 . . . . 0.79 111.978 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -81.27 126.17 31.22 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.895 -1.15 . . . . 2.0 107.895 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 43' ' ' MET . 15.4 t -42.53 -35.63 1.12 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 114.452 1.279 . . . . 0.78 114.452 173.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 42' ' ' SER . 3.6 pp -73.18 -33.28 65.34 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 119.067 -1.053 . . . . 1.18 111.976 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 46' ' ' VAL . 19.8 m -84.66 -13.36 51.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.965 0.888 . . . . 0.6 109.674 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.709 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 3.6 tpt -61.9 -38.42 88.3 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 125.707 1.603 . . . . 0.86 110.568 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.65 -27.16 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.023 -0.535 . . . . 0.31 110.553 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.6 -45.59 68.21 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.384 -0.969 . . . . 0.68 108.384 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 42' ' ' SER . 41.8 t -58.07 -25.69 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.486 -1.233 . . . . 0.63 110.819 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.742 HG11 HG22 ' A' ' 63' ' ' VAL . 29.6 t -81.03 -54.3 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 N-CA-C 108.968 -0.753 . . . . 0.55 108.968 -176.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.14 -33.38 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.214 -0.903 . . . . 0.42 109.33 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.62 70.89 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.268 0.556 . . . . 0.21 109.991 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.49 -56.17 20.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.18 -0.918 . . . . 0.21 109.717 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -67.87 -31.11 70.69 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.127 1.158 . . . . 0.64 114.127 -176.74 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -60.53 -34.45 74.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.824 0.345 . . . . 2.07 110.306 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -86.83 -46.0 10.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.324 -0.398 . . . . 2.48 111.993 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 8.5 m-85 -84.67 -2.27 57.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.997 1.11 . . . . 0.81 113.997 -169.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.3 t70 80.76 -0.07 1.84 Allowed 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 124.401 1.08 . . . . 1.99 112.406 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 76' ' ' ILE . 12.9 p -81.56 176.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.41 -1.33 . . . . 0.37 107.41 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 33.7 tptt -134.02 123.94 25.4 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.836 -1.172 . . . . 2.12 107.836 173.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.555 HG12 ' HE2' ' A' ' 75' ' ' TYR . 41.3 mt -120.13 102.76 45.85 Favored Pre-proline 0 C--N 1.312 -1.026 0 C-N-CA 120.92 -0.312 . . . . 0.25 110.34 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.577 ' O ' HG23 ' A' ' 63' ' ' VAL . 64.4 Cg_endo -70.08 158.69 55.74 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 123.056 2.504 . . . . 0.33 110.44 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 9.8 t70 -46.24 -42.49 14.4 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.049 0.94 . . . . 1.98 110.525 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -53.85 -44.69 70.55 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 125.155 1.382 . . . . 2.06 112.716 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -86.68 -29.95 22.08 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.522 -0.471 . . . . 0.52 111.617 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.742 HG22 HG11 ' A' ' 47' ' ' VAL . 79.5 t -50.94 -51.42 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.886 -0.783 . . . . 0.38 108.886 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 21.3 ptmt -69.65 -4.18 18.33 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 114.152 1.167 . . . . 2.16 114.152 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.83 -23.8 14.87 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.696 0.76 . . . . 1.59 109.112 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.91 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.0 mt -82.46 133.83 35.21 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 105.965 -1.865 . . . . 0.31 105.965 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -126.11 -38.1 2.19 Favored 'General case' 0 C--N 1.259 -3.335 0 C-N-CA 119.919 -0.712 . . . . 2.55 109.995 174.655 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 26.9 p -107.46 -179.32 3.88 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 119.568 -0.853 . . . . 0.23 110.385 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.602 HG22 ' CZ ' ' A' ' 32' ' ' PHE . 13.0 t -83.12 -19.53 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 106.793 -1.558 . . . . 1.21 106.793 177.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.532 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -68.5 -47.2 58.55 Favored Glycine 0 CA--C 1.489 -1.545 0 N-CA-C 107.791 -2.124 . . . . 0.33 107.791 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.19 -55.85 29.63 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.638 -1.281 . . . . 1.39 110.471 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.91 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -53.69 -60.92 2.7 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.562 1.164 . . . . 0.15 111.732 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.459 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.2 m -58.77 -41.97 87.83 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 113.663 0.986 . . . . 0.24 113.663 -174.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 1.9 mptm? -61.28 -48.52 81.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 108.678 -0.86 . . . . 3.63 108.678 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.555 ' HE2' HG12 ' A' ' 58' ' ' ILE . 86.8 t80 -57.81 -51.53 69.21 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 124.536 1.148 . . . . 0.4 110.74 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 56' ' ' VAL . 72.5 mt -54.94 -66.75 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.718 0 CA-C-N 114.545 -1.207 . . . . 0.21 111.019 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.8 tt -52.17 -45.36 65.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.574 1.55 . . . . 1.44 109.359 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -71.15 -24.74 62.32 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.165 -1.38 . . . . 0.63 111.501 -172.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -103.7 -9.0 19.47 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 113.759 1.022 . . . . 1.25 113.759 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 19.2 mt-30 . . . . . 0 CA--C 1.449 -2.925 0 CA-C-O 122.909 1.338 . . . . 0.87 108.841 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.466 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.8 t . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 109.556 -0.535 . . . . 0.66 109.556 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.647 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -54.54 -35.84 63.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.41 1.484 . . . . 0.74 111.67 179.014 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -52.79 -47.99 67.17 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 124.12 0.887 . . . . 2.66 110.395 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.52 -30.73 64.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.804 -0.634 . . . . 2.73 110.347 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.619 HG23 ' CE2' ' A' ' 54' ' ' PHE . 97.9 mt -76.61 -66.56 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 CA-C-N 116.086 -0.506 . . . . 0.23 111.307 -172.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 28' ' ' LEU . 91.1 t -58.36 -36.07 56.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.714 0.635 . . . . 0.27 112.714 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -66.03 -37.55 86.17 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.549 -0.46 . . . . 0.27 111.0 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.18 -36.95 11.76 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 111.842 -0.503 . . . . 0.18 111.842 -176.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.746 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.82 -40.68 95.59 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.611 -0.885 . . . . 0.2 108.611 -178.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.764 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.21 -47.57 78.13 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.556 -0.747 . . . . 0.14 109.691 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.671 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 50.1 mt-10 -60.74 -39.68 89.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 123.99 0.806 . . . . 0.68 112.548 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.746 HD12 ' HA ' ' A' ' 11' ' ' LEU . 63.4 mt -59.97 -44.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.688 0.756 . . . . 0.28 109.0 176.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.707 HG12 ' HB ' ' A' ' 21' ' ' ILE . 64.7 t -67.78 -25.87 33.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.019 -0.991 . . . . 0.27 110.788 -175.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.671 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 21.0 m-20 -70.5 -38.6 74.35 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.396 -0.82 . . . . 0.34 109.311 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.23 -43.62 15.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.6 -0.727 . . . . 2.07 111.58 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.695 HG13 HG22 ' A' ' 46' ' ' VAL . 17.3 mm -62.12 -52.71 57.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.988 0.515 . . . . 0.65 110.885 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -109.84 -85.56 0.54 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.435 -0.506 . . . . 0.54 110.858 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.84 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 110.931 -0.868 . . . . 0.43 110.931 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.707 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.6 mp -87.2 149.82 48.09 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 109.405 -0.591 . . . . 0.31 109.405 178.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 5.0 Cg_exo -88.25 37.87 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.757 2.971 . . . . 1.08 113.723 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG23 HD22 ' A' ' 16' ' ' ASN 0.259 3.7 p 57.74 -14.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 117.006 2.225 . . . . 0.81 117.006 176.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.09 2.9 12.71 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 120.641 -1.287 . . . . 2.31 110.708 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.596 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 7.3 t70 -78.78 -31.72 46.19 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.119 -1.067 . . . . 1.59 108.119 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.764 HG21 ' HA ' ' A' ' 12' ' ' ALA . 24.8 t -74.46 92.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 113.129 -1.851 . . . . 0.3 110.498 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 69' ' ' VAL . 95.6 mttt -118.03 163.37 16.7 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.043 0.449 . . . . 1.58 110.152 177.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 8' ' ' VAL . 5.6 mp -70.98 136.24 48.32 Favored 'General case' 0 N--CA 1.406 -2.675 0 N-CA-C 108.822 -0.807 . . . . 1.05 108.822 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' H ' ' N ' ' A' ' 70' ' ' GLY . 22.4 t70 84.62 9.89 0.4 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.297 1.439 . . . . 0.72 109.701 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -102.08 128.4 48.56 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 115.648 -0.705 . . . . 1.48 109.22 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.4 m -79.92 114.12 18.6 Favored 'General case' 0 C--N 1.244 -3.987 0 CA-C-N 114.779 -1.101 . . . . 1.25 108.491 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.595 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 94.1 m-85 -45.41 -64.53 0.7 Allowed 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 124.253 1.021 . . . . 0.4 112.057 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.1 t -59.01 -46.02 89.24 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 113.131 0.789 . . . . 1.06 113.131 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -86.55 -55.91 3.66 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.57 0.581 . . . . 1.74 112.57 -172.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.62 -49.14 15.19 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.659 0.783 . . . . 1.29 111.628 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.73 HD13 HG22 ' A' ' 26' ' ' VAL . 14.0 mt -77.32 -51.41 10.92 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.754 -0.657 . . . . 0.81 111.539 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 101.99 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.219 2.208 . . . . 1.12 111.275 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' THR . 22.0 t -110.09 118.84 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.607 -1.627 . . . . 0.79 106.607 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.15 113.52 0.82 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.228 0.955 . . . . 2.0 109.741 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 43' ' ' MET . 39.3 p -49.7 -21.45 1.06 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.279 1.431 . . . . 0.78 114.359 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 42' ' ' SER . 3.3 pp -81.84 -36.89 27.79 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.887 0.699 . . . . 1.18 112.887 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.447 ' N ' HD12 ' A' ' 41' ' ' LEU . 3.3 m -81.71 -13.39 57.89 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.461 1.124 . . . . 0.6 108.546 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.574 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 3.7 tpt -55.49 -36.72 66.96 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 126.804 2.042 . . . . 0.86 111.061 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.74 -45.91 96.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 115.809 -0.632 . . . . 0.31 109.776 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -57.39 -41.37 80.12 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 115.906 -0.588 . . . . 0.68 109.903 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.695 HG22 HG13 ' A' ' 18' ' ' ILE . 40.1 t -59.53 -28.8 40.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-N 115.496 -0.774 . . . . 0.63 111.16 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.778 HG21 HG13 ' A' ' 63' ' ' VAL . 20.8 t -78.98 -54.94 10.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.151 -1.055 . . . . 0.55 108.151 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.4 -19.65 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.85 -1.523 . . . . 0.42 110.904 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.84 -38.91 16.36 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 121.226 0.536 . . . . 0.21 109.633 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -61.17 -64.19 1.04 Allowed 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.99 -1.005 . . . . 0.21 111.567 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.341 0.0 OUTLIER -59.43 -44.12 92.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 114.882 1.438 . . . . 0.64 114.882 -173.822 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -54.12 -39.2 66.22 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.206 1.003 . . . . 2.07 112.244 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.914 -0.585 . . . . 2.48 110.781 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CE2' HG23 ' A' ' 7' ' ' ILE . 8.2 m-85 -86.66 -44.89 11.49 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.467 -0.893 . . . . 0.81 111.839 -173.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 22.9 t70 155.14 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.751 1.282 . . . . 1.99 112.682 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.7 HG11 ' HA ' ' A' ' 76' ' ' ILE . 3.8 p -79.96 178.37 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 112.072 0.397 . . . . 0.37 112.072 -168.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.555 ' H ' HG22 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -133.31 125.56 29.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.355 -1.35 . . . . 2.12 107.355 174.53 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.596 HG12 ' HE2' ' A' ' 75' ' ' TYR . 64.8 mt -113.36 118.9 43.05 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.348 -0.387 . . . . 0.25 110.683 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.552 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.6 Cg_endo -66.78 154.18 75.39 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.482 2.788 . . . . 0.33 110.588 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -51.66 -37.42 50.41 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.591 0.557 . . . . 1.98 111.673 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -59.56 -44.43 93.26 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.202 -0.454 . . . . 2.06 110.682 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.468 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 21.7 m-20 -82.68 -28.89 30.3 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 112.662 0.615 . . . . 0.52 112.662 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.778 HG13 HG21 ' A' ' 47' ' ' VAL . 53.0 t -52.01 -53.45 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 108.183 -1.043 . . . . 0.38 108.183 174.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -74.98 -1.91 24.77 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.975 -1.011 . . . . 2.16 113.549 -177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.92 -33.56 14.84 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.576 -0.898 . . . . 1.59 108.576 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.893 HD13 ' HA ' ' A' ' 72' ' ' ALA . 32.5 mt -69.25 133.34 47.8 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 106.267 -1.753 . . . . 0.31 106.267 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.579 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -128.39 -32.29 2.22 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-O 121.252 0.548 . . . . 2.55 110.126 175.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.628 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 28.5 p -112.07 172.81 6.69 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.683 -0.858 . . . . 0.23 108.683 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -80.4 -12.93 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.782 0.801 . . . . 1.21 109.478 175.257 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -69.74 -37.92 76.6 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.368 -1.493 . . . . 0.33 109.368 176.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.579 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 24.3 m-20 -69.44 -54.33 14.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 108.772 -0.825 . . . . 1.39 108.772 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.893 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.19 -60.67 2.86 Favored 'General case' 0 CA--C 1.469 -2.168 0 O-C-N 124.676 1.235 . . . . 0.15 111.043 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.647 HG21 ' HG2' ' A' ' 4' ' ' GLN . 35.9 m -54.97 -49.28 71.83 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.459 1.099 . . . . 0.24 113.585 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.7 mptm? -67.17 -28.64 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.222 0.534 . . . . 3.63 111.051 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.596 ' HE2' HG12 ' A' ' 58' ' ' ILE . 84.9 t80 -71.52 -51.9 21.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.966 -0.753 . . . . 0.4 108.966 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.7 ' HA ' HG11 ' A' ' 56' ' ' VAL . 60.3 mt -57.41 -66.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.521 -1.218 . . . . 0.21 111.134 -177.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.466 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 4.5 tt -50.19 -50.34 49.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.211 1.404 . . . . 1.44 110.972 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.9 t70 -69.5 -25.72 64.19 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.995 -1.457 . . . . 0.63 111.417 -170.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -91.26 -22.67 20.46 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.674 -0.694 . . . . 1.25 111.682 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 76' ' ' ILE . 1.2 pt20 . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 122.482 1.134 . . . . 0.87 113.385 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.435 -1.18 0 N-CA-C 108.996 -0.742 . . . . 0.66 108.996 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -40.19 60.56 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.593 1.157 . . . . 0.74 113.202 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.54 -23.73 64.83 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.865 0.691 . . . . 2.66 112.865 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.52 -39.9 21.76 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.018 -0.734 . . . . 2.73 109.018 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.446 HG21 ' HA ' ' A' ' 73' ' ' THR . 76.3 mt -76.66 -66.48 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 CA-C-N 114.719 -1.128 . . . . 0.23 111.692 -170.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -56.72 -42.41 77.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.376 0.51 . . . . 0.27 112.376 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.82 72.84 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.589 0.556 . . . . 0.27 111.362 176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.91 -40.09 8.3 Favored Glycine 0 N--CA 1.405 -3.418 0 C-N-CA 120.596 -0.811 . . . . 0.18 113.059 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -63.12 -41.04 99.25 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.613 0.765 . . . . 0.2 109.079 -177.05 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.09 -48.17 67.99 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 123.747 0.654 . . . . 0.14 109.588 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.664 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 48.3 mt-10 -62.36 -42.34 99.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 124.266 0.979 . . . . 0.68 112.05 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 11' ' ' LEU . 54.7 mt -59.49 -39.43 79.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.332 0.587 . . . . 0.28 110.179 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 11' ' ' LEU . 46.4 t -69.48 -23.52 26.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 CA-C-O 122.082 0.944 . . . . 0.27 109.722 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -77.98 -37.78 46.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.25 -1.018 . . . . 0.34 108.25 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 20.7 mm-40 -74.23 -55.52 5.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.853 -1.067 . . . . 2.07 111.296 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 46' ' ' VAL . 21.3 mm -63.87 -53.1 48.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.448 -0.796 . . . . 0.65 110.811 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -103.12 -83.1 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.438 -0.505 . . . . 0.54 110.436 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.03 44.93 0.02 OUTLIER Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 120.061 -1.066 . . . . 0.43 112.199 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -78.05 149.79 77.03 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 110.05 -0.352 . . . . 0.31 110.05 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.522 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 8.9 Cg_exo -82.86 24.54 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 124.526 3.484 . . . . 1.08 115.429 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.505 ' H ' HG22 ' A' ' 21' ' ' ILE . 6.9 p 52.55 22.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 125.55 1.54 . . . . 0.81 114.909 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -130.16 -13.14 4.02 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 120.909 -1.119 . . . . 2.31 111.399 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.522 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -93.38 -26.25 17.34 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 115.324 -0.853 . . . . 1.59 110.251 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.601 HG23 HG21 ' A' ' 21' ' ' ILE . 39.5 t -71.24 91.23 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.201 -0.908 . . . . 0.3 109.357 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 34.4 mmtp -130.74 169.98 14.96 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.294 -1.373 . . . . 1.58 107.294 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 8.3 mp -64.74 148.38 51.25 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.819 -0.808 . . . . 1.05 108.819 177.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 t70 81.76 -3.52 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.766 1.226 . . . . 0.72 110.766 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.775 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 10.4 mmpt? -98.13 124.05 42.48 Favored 'General case' 0 CA--C 1.454 -2.744 0 C-N-CA 119.713 -0.795 . . . . 1.48 110.856 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 19.2 m -79.78 115.5 19.41 Favored 'General case' 1 C--N 1.237 -4.316 0 N-CA-C 108.02 -1.104 . . . . 1.25 108.02 178.387 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' LEU . 83.3 m-85 -51.78 -49.35 62.84 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.566 0.698 . . . . 0.4 112.228 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.523 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.0 t -81.36 -44.46 17.56 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.291 -0.88 . . . . 1.06 111.305 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 25.0 t70 -74.15 -50.92 17.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.032 0.753 . . . . 1.74 113.032 -175.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.442 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 12.7 t70 -83.78 -58.03 2.97 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 122.049 0.928 . . . . 1.29 109.393 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.758 HD12 ' HA ' ' A' ' 32' ' ' PHE . 25.4 mt -72.88 -32.65 65.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.48 -1.691 . . . . 0.81 112.363 -169.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 20.1 t70 83.1 66.48 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 123.193 1.473 . . . . 1.12 110.803 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 19' ' ' ALA . 49.4 t -105.62 141.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 112.767 -2.015 . . . . 0.79 107.94 170.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.456 ' HB2' ' OG ' ' A' ' 42' ' ' SER . 4.8 m-20 -56.08 7.93 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 116.618 2.081 . . . . 2.0 116.618 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.517 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.5 t 66.6 -57.44 0.39 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 114.383 1.253 . . . . 0.78 114.383 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 pp -63.31 -30.72 71.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.949 0.88 . . . . 1.18 109.749 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.56 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.5 m -77.94 -15.55 58.89 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.751 -1.113 . . . . 0.6 110.506 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.615 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -67.08 -40.62 87.04 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-N 116.306 -0.407 . . . . 0.86 111.967 -174.333 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.19 -40.84 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 124.246 0.966 . . . . 0.31 109.767 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.88 -48.02 83.72 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.578 -0.737 . . . . 0.68 109.526 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.63 HG22 HG13 ' A' ' 18' ' ' ILE . 11.9 t -60.78 -23.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.988 0.915 . . . . 0.63 110.918 -177.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.904 HG21 HG13 ' A' ' 63' ' ' VAL . 36.8 t -78.99 -54.74 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 107.885 -1.154 . . . . 0.55 107.885 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -60.65 -37.06 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.882 -1.054 . . . . 0.42 108.89 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -70.01 -31.51 69.21 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 116.167 -0.47 . . . . 0.21 110.061 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.67 -58.16 6.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.363 -0.835 . . . . 0.21 109.266 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.631 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.269 0.0 OUTLIER -66.42 -31.83 72.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 114.914 1.45 . . . . 0.64 114.914 -175.59 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -59.24 -33.32 70.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.908 0.861 . . . . 2.07 109.881 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -88.59 -32.33 18.17 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.11 -0.95 . . . . 2.48 111.968 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.23 18.42 21.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.397 0.518 . . . . 0.81 112.397 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 75.37 -26.02 0.2 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 114.438 1.273 . . . . 1.99 114.438 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.631 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 7.2 p -72.26 170.81 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 122.324 -0.235 . . . . 0.37 110.379 -173.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.625 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 2.8 tppp? -124.13 126.67 46.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.31 -0.996 . . . . 2.12 108.31 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.64 HG12 ' HE2' ' A' ' 75' ' ' TYR . 36.0 mt -119.99 105.02 43.26 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 120.592 -0.443 . . . . 0.25 110.457 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 63' ' ' VAL . 79.9 Cg_endo -73.8 166.6 29.31 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.106 2.537 . . . . 0.33 111.004 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.33 -46.97 37.16 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 1.98 111.487 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.16 -35.44 77.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.876 -0.602 . . . . 2.06 112.02 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.566 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 10.9 m-20 -86.03 -31.63 21.9 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.275 -0.57 . . . . 0.52 111.222 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.904 HG13 HG21 ' A' ' 47' ' ' VAL . 75.1 t -52.84 -50.52 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.843 -0.799 . . . . 0.38 108.843 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -72.41 -9.15 58.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.199 -0.909 . . . . 2.16 113.195 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.42 -25.91 21.28 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.478 0.656 . . . . 1.59 110.071 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.802 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.7 mt -82.18 110.92 17.82 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.077 -1.823 . . . . 0.31 106.077 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 47.5 mtpt -112.25 -43.88 3.48 Favored 'General case' 0 C--N 1.271 -2.834 0 N-CA-C 107.718 -1.216 . . . . 2.55 107.718 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 67.4 p -102.54 174.73 5.77 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 114.917 -1.038 . . . . 0.23 109.039 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.491 HG22 ' CE2' ' A' ' 32' ' ' PHE . 10.1 t -77.3 -14.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 107.781 -1.192 . . . . 1.21 107.781 175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.478 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -69.01 -51.09 30.41 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 109.39 -1.484 . . . . 0.33 109.39 175.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -60.38 -51.24 70.32 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 114.269 -0.966 . . . . 1.39 109.371 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.802 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -54.29 -61.57 2.22 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 124.494 1.122 . . . . 0.15 111.528 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.446 ' HA ' HG21 ' A' ' 7' ' ' ILE . 34.3 m -58.1 -45.83 86.56 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.437 -1.256 . . . . 0.24 113.861 -174.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -57.64 -50.8 71.98 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 123.851 0.72 . . . . 3.63 109.194 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.64 ' HE2' HG12 ' A' ' 58' ' ' ILE . 49.4 t80 -54.55 -51.22 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.124 0.89 . . . . 0.4 111.283 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.1 mt -55.09 -66.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.66 0 CA-C-N 114.671 -1.149 . . . . 0.21 110.611 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 tt -52.54 -43.66 65.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.796 1.638 . . . . 1.44 110.678 -177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -71.07 -26.3 63.01 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.218 -1.355 . . . . 0.63 110.96 -173.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -103.24 -7.73 20.93 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.389 0.885 . . . . 1.25 113.389 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.69 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 17.5 mt-30 . . . . . 0 CA--C 1.448 -2.967 0 CA-C-O 122.974 1.369 . . . . 0.87 107.623 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.429 -1.514 0 N-CA-C 109.309 -0.626 . . . . 0.66 109.309 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.554 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -48.39 -36.91 15.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.016 1.327 . . . . 0.74 112.973 178.563 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -52.19 -54.49 30.23 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.787 0.68 . . . . 2.66 110.512 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.16 -37.07 71.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.728 0.811 . . . . 2.73 110.092 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' A' ' 73' ' ' THR . 82.3 mt -74.37 -66.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 115.099 -0.955 . . . . 0.23 111.149 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.26 -46.71 92.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 112.347 0.499 . . . . 0.27 112.347 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.654 -0.419 . . . . 0.27 110.808 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.55 -38.22 9.93 Favored Glycine 0 N--CA 1.415 -2.756 0 CA-C-N 116.099 -0.501 . . . . 0.18 113.362 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.667 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.47 -38.61 91.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.033 -1.099 . . . . 0.2 108.033 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.96 -44.73 82.89 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.14 109.966 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.665 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 42.8 mt-10 -64.09 -35.24 80.12 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.872 0.732 . . . . 0.68 111.843 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 11' ' ' LEU . 51.7 mt -67.54 -43.2 87.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.85 -0.614 . . . . 0.28 109.589 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.688 HG22 HG11 ' A' ' 46' ' ' VAL . 21.3 t -67.72 -24.65 31.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 121.885 0.85 . . . . 0.27 109.221 -177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.665 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 13.7 m120 -64.58 -43.29 94.31 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 114.776 -1.102 . . . . 0.34 109.26 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -80.44 -49.15 11.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.189 -0.914 . . . . 2.07 111.591 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.735 HG13 HG22 ' A' ' 46' ' ' VAL . 22.1 mm -61.2 -53.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.057 -0.52 . . . . 0.65 111.283 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.8 -76.59 0.6 Allowed 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.226 -0.59 . . . . 0.54 110.384 -176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.84 50.33 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 110.146 -1.182 . . . . 0.43 110.146 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.449 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.2 mp -88.46 159.77 46.4 Favored Pre-proline 0 C--N 1.278 -2.508 0 CA-C-N 114.395 -0.902 . . . . 0.31 108.577 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -92.53 141.13 2.14 Favored 'Trans proline' 0 N--CA 1.414 -3.154 0 C-N-CA 122.108 1.872 . . . . 1.08 108.954 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.5 p -73.41 54.2 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-O 122.779 1.276 . . . . 0.81 113.111 -173.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 25' ' ' ASP . 12.2 pt-20 -163.74 -9.39 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.109 -1.405 . . . . 2.31 111.087 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.42 ' H ' ' H ' ' A' ' 24' ' ' GLU . 27.6 t0 -83.71 -28.45 28.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.763 0.792 . . . . 1.59 109.394 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' A' ' 12' ' ' ALA . 43.3 t -77.46 92.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.525 -1.216 . . . . 0.3 109.304 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.6 mttt -121.14 172.81 7.7 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.895 -1.15 . . . . 1.58 107.895 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 8.6 mp -65.81 145.48 55.91 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.822 -1.177 . . . . 1.05 107.822 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 77.0 8.7 2.88 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.246 0.966 . . . . 0.72 110.804 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.1 mmtt -92.3 119.78 32.21 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 108.387 -0.968 . . . . 1.48 108.387 174.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 17.4 m -78.58 36.69 0.26 Allowed 'General case' 1 C--N 1.243 -4.058 0 C-N-CA 125.688 1.595 . . . . 1.25 113.515 -172.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.663 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 97.4 m-85 39.96 -95.78 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 125.328 1.451 . . . . 0.4 114.622 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 15.0 t -84.72 37.57 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.546 1.165 . . . . 1.06 111.342 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 32.5 t70 -145.41 -48.5 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.23 -1.35 . . . . 1.74 107.76 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 3.2 m-20 -87.35 -38.05 16.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 1.29 112.914 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 26' ' ' VAL . 59.7 mt -85.35 -48.84 8.66 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.186 0.81 . . . . 0.81 113.186 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.0 t70 102.59 69.48 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.323 1.849 . . . . 1.12 109.696 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 39' ' ' ASP . 11.5 t -105.14 175.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 113.803 -1.544 . . . . 0.79 109.733 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 38' ' ' VAL . 17.2 t70 -79.04 -18.29 53.78 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.261 0.837 . . . . 2.0 113.261 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' MET . 3.3 t 74.5 -41.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.686 1.194 . . . . 0.78 113.154 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.45 -49.59 10.44 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 106.879 -1.526 . . . . 1.18 106.879 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 19.5 m -67.08 -11.96 58.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.045 -1.434 . . . . 0.6 111.023 176.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.663 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 4.0 tpt -60.23 -33.3 72.07 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 125.073 1.349 . . . . 0.86 109.324 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.74 -40.02 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.602 -0.726 . . . . 0.31 109.53 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.23 -43.18 82.64 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.374 -0.375 . . . . 0.68 110.53 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 HG13 ' A' ' 18' ' ' ILE . 6.5 t -60.97 -24.43 32.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 C-N-CA 123.526 0.73 . . . . 0.63 110.845 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.685 HG21 HG13 ' A' ' 63' ' ' VAL . 22.0 t -80.4 -53.77 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 107.78 -1.193 . . . . 0.55 107.78 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.65 -32.91 52.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 113.895 -1.502 . . . . 0.42 110.03 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -77.67 -31.31 52.46 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.207 0.527 . . . . 0.21 109.73 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.421 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -62.58 -57.09 12.35 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.398 -0.819 . . . . 0.21 109.131 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.536 ' OE2' ' HD3' ' A' ' 57' ' ' LYS 0.279 0.0 OUTLIER -61.88 -38.67 89.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 114.161 1.171 . . . . 0.64 114.161 -176.274 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.19 -34.47 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.527 0.517 . . . . 2.07 112.128 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -82.88 -36.08 25.66 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.064 -0.516 . . . . 2.48 110.205 -175.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.516 ' CE2' HG23 ' A' ' 7' ' ' ILE . 7.1 m-85 -86.85 -45.08 11.2 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.2 -1.0 . . . . 0.81 112.435 -172.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 152.29 -35.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 O-C-N 124.891 1.37 . . . . 1.99 112.169 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.604 ' CG1' HG23 ' A' ' 76' ' ' ILE . 14.5 p -75.92 172.37 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 112.726 0.639 . . . . 0.37 112.726 -165.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 3.1 tppp? -125.04 119.71 29.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.368 -1.715 . . . . 2.12 106.368 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.535 HG12 ' HE2' ' A' ' 75' ' ' TYR . 58.5 mt -111.85 113.22 52.74 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 120.693 -0.403 . . . . 0.25 110.226 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 63' ' ' VAL . 93.8 Cg_endo -73.15 157.62 50.25 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.822 2.348 . . . . 0.33 110.668 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.16 -41.17 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.523 1.129 . . . . 1.98 111.617 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 2.3 m-20 -61.81 -51.02 69.96 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 115.573 -0.74 . . . . 2.06 111.247 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 m-20 -71.46 -30.32 65.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.971 0.36 . . . . 0.52 111.971 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 47' ' ' VAL . 53.0 t -51.43 -55.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.941 -0.763 . . . . 0.38 108.941 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.5 pttp -75.64 -1.92 26.9 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 115.401 -0.818 . . . . 2.16 112.674 -175.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -91.38 -19.57 22.76 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.656 0.741 . . . . 1.59 109.383 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.2 mt -86.11 118.33 25.51 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 104.728 -2.323 . . . . 0.31 104.728 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -110.95 -46.69 3.3 Favored 'General case' 0 C--N 1.259 -3.341 0 N-CA-C 108.289 -1.004 . . . . 2.55 108.289 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 42.5 p -105.07 173.57 6.25 Favored 'General case' 1 N--CA 1.379 -4.004 0 CA-C-N 115.052 -0.977 . . . . 0.23 109.321 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 27' ' ' LYS . 5.5 t -77.49 -13.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 107.454 -1.313 . . . . 1.21 107.454 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.548 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.46 -45.69 58.97 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.201 -1.56 . . . . 0.33 109.201 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -68.17 -48.21 65.9 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.122 -1.039 . . . . 1.39 109.59 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -53.62 -61.13 2.5 Favored 'General case' 0 CA--C 1.482 -1.655 0 O-C-N 124.56 1.162 . . . . 0.15 111.124 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.568 ' HA ' HG21 ' A' ' 7' ' ' ILE . 58.5 m -54.89 -51.54 65.66 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.615 -1.175 . . . . 0.24 113.838 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.1 mptm? -54.75 -47.85 73.33 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.867 0.729 . . . . 3.63 109.456 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.535 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.0 t80 -58.19 -52.55 65.11 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 124.204 0.94 . . . . 0.4 111.412 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.604 HG23 ' CG1' ' A' ' 56' ' ' VAL . 75.8 mt -51.41 -65.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.789 -1.096 . . . . 0.21 110.298 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 tt -54.52 -42.21 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.077 1.351 . . . . 1.44 109.855 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 26.6 t70 -59.62 -41.04 89.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.163 0.985 . . . . 0.63 110.285 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.595 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 1.9 t-80 -90.07 -12.4 38.58 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.141 -1.39 . . . . 1.25 111.222 -173.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 34.0 mt-30 . . . . . 0 CA--C 1.471 -2.075 0 CA-C-O 122.722 1.248 . . . . 0.87 108.351 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.513 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 t . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 109.908 -0.405 . . . . 0.66 109.908 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HG2' HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -50.26 -41.9 51.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.855 1.662 . . . . 0.74 113.534 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -62.42 -23.69 66.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.78 0.659 . . . . 2.66 112.78 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -87.56 -35.7 17.97 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.108 -0.701 . . . . 2.73 109.108 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' A' ' 73' ' ' THR . 92.9 mt -75.73 -65.48 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-N 115.523 -0.762 . . . . 0.23 110.996 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.427 HG23 ' HG2' ' A' ' 4' ' ' GLN . 67.6 t -52.16 -45.04 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 122.869 0.468 . . . . 0.27 111.523 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.1 76.64 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 123.64 0.588 . . . . 0.27 111.604 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.58 9.94 Favored Glycine 0 N--CA 1.412 -2.949 0 CA-C-N 116.419 -0.355 . . . . 0.18 112.493 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.728 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.61 -36.55 82.86 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.243 -1.021 . . . . 0.2 108.243 -178.046 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.68 -44.41 90.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.482 -0.781 . . . . 0.14 110.022 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.827 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 47.0 mt-10 -62.39 -38.6 90.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 123.935 0.772 . . . . 0.68 111.746 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 11' ' ' LEU . 61.1 mt -61.53 -42.33 93.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.749 0.785 . . . . 0.28 109.161 176.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.813 HG12 ' HB ' ' A' ' 21' ' ' ILE . 86.4 t -71.16 -23.72 23.56 Favored 'Isoleucine or valine' 0 C--O 1.255 1.39 0 CA-C-N 115.182 -0.917 . . . . 0.27 111.08 -175.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.827 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 52.3 m-20 -67.02 -46.31 74.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.1 -1.074 . . . . 0.34 108.1 177.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -74.97 -50.03 18.0 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.924 -1.035 . . . . 2.07 111.859 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.737 HG13 HG22 ' A' ' 46' ' ' VAL . 24.4 mm -59.71 -52.53 59.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.983 0.513 . . . . 0.65 111.403 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -110.28 -60.0 1.86 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.077 0.465 . . . . 0.54 111.552 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.07 28.63 0.31 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 120.559 -0.829 . . . . 0.43 112.638 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.813 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -70.41 151.73 95.62 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 109.569 -0.53 . . . . 0.31 109.569 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.7 Cg_exo -89.8 33.97 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.993 3.128 . . . . 1.08 115.222 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 3.3 p 61.41 -11.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 116.444 2.016 . . . . 0.81 116.444 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -115.16 -3.42 12.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.416 -0.803 . . . . 2.31 112.231 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.31 -29.54 28.24 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-O 121.638 0.733 . . . . 1.59 109.19 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.749 HG23 HG21 ' A' ' 21' ' ' ILE . 47.4 t -71.72 90.44 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.149 -1.387 . . . . 0.3 108.126 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 69' ' ' VAL . 1.5 tppp? -124.11 158.81 31.41 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.384 -1.71 . . . . 1.58 106.384 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.455 HD22 ' HA2' ' A' ' 70' ' ' GLY . 88.4 mt -57.54 140.29 51.2 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.001 0.429 . . . . 1.05 110.531 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t70 74.75 13.97 3.43 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.467 1.507 . . . . 0.72 110.911 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -100.91 125.99 47.5 Favored 'General case' 0 CA--C 1.467 -2.238 0 CA-C-O 121.474 0.655 . . . . 1.48 109.308 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 9.3 m -80.2 111.38 16.52 Favored 'General case' 1 C--N 1.239 -4.234 0 CA-C-N 114.071 -1.422 . . . . 1.25 109.129 -177.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.583 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 93.7 m-85 -45.74 -64.92 0.62 Allowed 'General case' 0 C--N 1.271 -2.808 0 C-N-CA 124.367 1.067 . . . . 0.4 112.374 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -90.25 32.97 0.9 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.204 -0.935 . . . . 1.06 112.783 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.8 t70 -147.71 -55.83 0.23 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.671 0.748 . . . . 1.74 110.741 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.59 -50.6 8.61 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.189 -0.914 . . . . 1.29 110.394 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.634 HD13 HG22 ' A' ' 26' ' ' VAL . 17.3 mt -76.36 -45.5 31.67 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.682 -0.69 . . . . 0.81 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.6 t70 88.66 61.73 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.844 1.658 . . . . 1.12 109.921 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 19' ' ' ALA . 18.6 t -104.21 143.55 15.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 113.591 -1.64 . . . . 0.79 106.766 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 43' ' ' MET . 36.9 m-20 -60.53 109.67 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 111.876 0.325 . . . . 2.0 111.876 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.602 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 28.6 t -34.84 -50.43 0.47 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 126.527 1.931 . . . . 0.78 114.429 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 42' ' ' SER . 3.3 pp -71.12 -27.83 63.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.438 0.637 . . . . 1.18 111.918 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 46' ' ' VAL . 18.5 m -85.11 -13.38 50.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.386 0.675 . . . . 0.6 110.425 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.602 ' HG3' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.58 -38.15 86.48 Favored 'General case' 0 CA--C 1.47 -2.103 0 C-N-CA 123.289 0.636 . . . . 0.86 111.576 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.6 -42.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 124.341 1.025 . . . . 0.31 109.413 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -57.01 -50.32 73.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.374 0.606 . . . . 0.68 109.387 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.737 HG22 HG13 ' A' ' 18' ' ' ILE . 40.8 t -55.83 -28.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 124.92 1.288 . . . . 0.63 111.67 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.934 HG21 HG13 ' A' ' 63' ' ' VAL . 21.2 t -78.17 -49.25 21.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.02 -1.104 . . . . 0.55 108.02 -176.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.39 -38.6 78.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.291 -1.322 . . . . 0.42 108.517 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -38.03 77.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.703 -0.68 . . . . 0.21 110.003 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.22 33.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.108 -0.951 . . . . 0.21 110.008 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.324 1.9 pp20? -62.22 -38.49 89.4 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 113.996 1.11 . . . . 0.64 113.996 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.32 -25.86 66.22 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.649 0.593 . . . . 2.07 112.505 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -83.93 -52.17 6.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.644 -0.423 . . . . 2.48 110.583 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 14.2 m-85 -73.94 -44.17 55.87 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 114.629 1.344 . . . . 0.81 114.629 -169.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 17.3 t70 146.52 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 O-C-N 124.732 1.27 . . . . 1.99 110.636 176.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.8 p -73.18 173.53 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.004 -0.998 . . . . 0.37 112.303 -166.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 56' ' ' VAL . 20.9 tptm -120.69 123.3 42.41 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.449 -1.315 . . . . 2.12 107.449 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.565 HG13 ' HB3' ' A' ' 51' ' ' GLU . 55.3 mt -120.31 106.96 39.83 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.478 -0.934 . . . . 0.25 108.478 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 63' ' ' VAL . 45.7 Cg_endo -70.29 166.84 26.91 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.013 2.476 . . . . 0.33 111.517 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -50.43 -43.2 54.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.144 0.978 . . . . 1.98 109.339 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -49.6 -59.17 4.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.539 -1.21 . . . . 2.06 111.642 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.565 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 27.6 m-20 -74.19 -26.28 60.18 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.84 0.681 . . . . 0.52 112.84 -176.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.934 HG13 HG21 ' A' ' 47' ' ' VAL . 62.0 t -53.26 -41.93 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 108.919 -0.771 . . . . 0.38 108.919 174.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -80.24 -7.18 58.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.665 -1.152 . . . . 2.16 112.185 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -94.67 -36.91 11.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 108.862 -0.792 . . . . 1.59 108.862 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.859 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.6 mt -73.2 125.1 26.95 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 106.596 -1.631 . . . . 0.31 106.596 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.55 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -130.15 -24.24 2.62 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 120.312 -0.555 . . . . 2.55 111.474 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 43.0 p -116.5 171.83 7.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 107.721 -1.214 . . . . 0.23 107.721 173.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -78.75 -13.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 C-N-CA 120.087 -0.645 . . . . 1.21 109.599 176.547 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.455 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -67.32 -46.78 67.91 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 109.713 -1.355 . . . . 0.33 109.713 175.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.55 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 15.0 m-20 -61.33 -55.42 31.92 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.378 -0.971 . . . . 1.39 108.378 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.859 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.62 -61.19 2.4 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.0 -1.454 . . . . 0.15 111.769 -175.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.44 ' HA ' HG21 ' A' ' 7' ' ' ILE . 37.6 m -57.96 -46.33 85.28 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.96 -1.018 . . . . 0.24 113.472 -174.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 14.1 mptt -56.88 -44.75 82.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 123.771 0.669 . . . . 3.63 109.45 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.464 ' CE2' HG12 ' A' ' 58' ' ' ILE . 85.6 t80 -65.31 -48.19 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.37 1.043 . . . . 0.4 111.65 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.657 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -54.94 -65.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.71 -1.132 . . . . 0.21 110.239 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.0 tt -51.7 -41.78 61.71 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.775 1.23 . . . . 1.44 109.358 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 11.5 t70 -58.28 -41.11 83.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.917 1.287 . . . . 0.63 109.549 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -102.1 3.78 38.96 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.979 1.103 . . . . 1.25 113.979 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 7.7 mt-30 . . . . . 0 CA--C 1.48 -1.715 0 N-CA-C 107.552 -1.277 . . . . 0.87 107.552 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . . . . . . 0 N--CA 1.441 -0.893 0 N-CA-C 109.182 -0.673 . . . . 1.42 109.182 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . . . -124.31 -76.16 0.59 Allowed 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.986 -0.552 . . . . 1.85 110.744 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.748 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.6 t -179.37 -169.11 0.14 Allowed 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.864 -1.161 . . . . 0.66 107.864 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.88 -42.72 48.47 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.363 1.065 . . . . 0.74 113.757 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -58.53 -23.79 59.04 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.173 0.511 . . . . 2.66 112.148 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 34.9 tt0 -84.33 -45.14 13.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.272 -0.64 . . . . 2.73 109.272 175.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.497 HG21 ' HA ' ' A' ' 73' ' ' THR . 79.8 mt -71.57 -65.44 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.03 0 CA-C-N 115.001 -0.999 . . . . 0.23 110.484 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.39 -48.81 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 C-N-CA 123.768 0.827 . . . . 0.27 112.614 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.68 77.64 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 123.327 0.392 . . . . 0.27 111.206 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -81.45 -40.5 11.03 Favored Glycine 0 N--CA 1.405 -3.424 0 C-N-CA 120.709 -0.758 . . . . 0.18 112.952 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.732 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -65.39 -38.09 88.94 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.161 0.984 . . . . 0.2 108.879 -176.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.536 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -61.82 -43.39 98.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.608 -0.724 . . . . 0.14 109.846 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.684 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.9 mt-10 -63.91 -35.74 81.65 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.754 0.659 . . . . 0.68 112.282 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 11' ' ' LEU . 60.7 mt -62.25 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.621 -0.881 . . . . 0.28 108.621 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.3 t -68.34 -23.86 28.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 CA-C-O 121.591 0.71 . . . . 0.27 110.659 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.684 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -66.35 -46.18 77.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.235 -0.893 . . . . 0.34 109.096 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.75 -44.8 15.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.233 -0.894 . . . . 2.07 111.614 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.714 HG13 HG22 ' A' ' 46' ' ' VAL . 21.0 mm -59.57 -51.91 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.783 0.433 . . . . 0.65 110.793 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -108.33 -81.42 0.57 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.52 0.676 . . . . 0.54 110.631 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.45 55.7 0.01 OUTLIER Glycine 0 CA--C 1.484 -1.86 0 N-CA-C 110.322 -1.111 . . . . 0.43 110.322 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.664 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -97.82 160.79 27.68 Favored Pre-proline 0 C--N 1.278 -2.52 0 N-CA-C 107.976 -1.12 . . . . 0.31 107.976 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -93.24 143.57 2.1 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 122.523 2.148 . . . . 1.08 109.192 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 12' ' ' ALA . 13.8 p -74.1 56.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 123.287 1.518 . . . . 0.81 112.802 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.418 ' H ' ' H ' ' A' ' 25' ' ' ASP . 10.5 pt-20 -151.51 -14.48 0.2 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.26 -1.336 . . . . 2.31 110.068 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' A' ' 30' ' ' LYS . 1.6 t70 -87.61 -37.14 17.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.861 0.839 . . . . 1.59 109.172 -173.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.633 HG22 HD13 ' A' ' 36' ' ' LEU . 21.7 t -77.7 90.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.991 -1.114 . . . . 0.3 107.991 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 66.2 mttm -101.84 -96.29 0.28 Allowed 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.955 0.883 . . . . 1.58 109.014 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.41 ' H ' ' HB2' ' A' ' 27' ' ' LYS . 95.4 mt -153.15 157.13 39.88 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 104.238 -2.505 . . . . 1.05 104.238 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' H ' ' CA ' ' A' ' 70' ' ' GLY . 30.5 t70 68.69 9.31 7.27 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.501 1.125 . . . . 0.72 110.657 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HB2' HG12 ' A' ' 69' ' ' VAL . 46.6 mmtt -93.57 126.2 38.59 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-N 115.586 -0.734 . . . . 1.48 109.282 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 34' ' ' ASP . 7.1 m -74.38 25.51 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 C-N-CA 126.501 1.92 . . . . 1.25 114.63 -171.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.748 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 70.2 m-85 41.84 -97.29 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.625 1.57 . . . . 0.4 113.746 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.713 HG21 ' H37' ' A' ' 101' ' ' SYO . 10.2 t -57.58 -35.44 70.41 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 123.565 0.746 . . . . 1.06 111.141 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB3' ' CB ' ' A' ' 31' ' ' SER . 19.3 t70 -83.67 -40.82 18.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.482 -0.326 . . . . 1.74 111.098 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.84 -54.45 3.96 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 118.683 -1.207 . . . . 1.29 110.821 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.633 HD13 HG22 ' A' ' 26' ' ' VAL . 17.3 mt -74.06 -38.37 63.97 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.457 -1.247 . . . . 0.81 111.405 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.6 t70 89.4 69.37 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.538 1.535 . . . . 1.12 109.605 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.677 ' H ' ' HA ' ' A' ' 33' ' ' THR . 15.0 t -111.68 155.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.927 -1.942 . . . . 0.79 106.57 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 43' ' ' MET . 12.2 m-20 -76.5 119.85 20.91 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.251 -0.648 . . . . 2.0 109.251 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.563 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 10.2 t -42.51 -50.71 5.25 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.584 1.153 . . . . 0.78 113.58 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.62 -29.54 70.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.46 0.648 . . . . 1.18 111.43 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 46' ' ' VAL . 21.7 m -84.43 -15.12 47.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.17 -0.468 . . . . 0.6 110.688 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.792 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -62.8 -35.01 78.49 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 123.429 0.692 . . . . 0.86 110.579 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.76 -42.62 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.138 -0.689 . . . . 0.31 109.138 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.99 -44.54 94.45 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.194 -0.669 . . . . 0.68 109.194 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.714 HG22 HG13 ' A' ' 18' ' ' ILE . 47.8 t -59.65 -29.03 41.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 114.998 -1.001 . . . . 0.63 111.244 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.031 HG21 HG13 ' A' ' 63' ' ' VAL . 40.4 t -77.78 -51.77 17.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.876 -0.787 . . . . 0.55 108.876 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.2 -21.57 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.429 -0.805 . . . . 0.42 109.272 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.22 -38.0 31.96 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 109.012 -0.736 . . . . 0.21 109.012 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -63.71 -56.36 16.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.337 -0.847 . . . . 0.21 110.253 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.297 0.6 OUTLIER -63.47 -36.7 84.62 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 114.379 1.251 . . . . 0.64 114.379 -176.328 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.73 -24.12 64.43 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.892 0.377 . . . . 2.07 111.486 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -88.26 -40.91 13.28 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.737 0.303 . . . . 2.48 110.554 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -94.52 -2.1 52.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.81 113.032 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 1' ' ' ALA . 14.1 m-20 81.77 7.18 1.07 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.3 1.04 . . . . 1.99 113.723 175.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.748 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.5 p -89.73 178.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.328 -0.99 . . . . 0.37 108.328 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.432 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.2 tptt -133.45 130.51 38.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.241 -1.392 . . . . 2.12 107.241 171.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 76' ' ' ILE . 61.9 mt -124.68 113.36 27.17 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.182 -0.673 . . . . 0.25 109.182 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.581 ' O ' HG23 ' A' ' 63' ' ' VAL . 73.3 Cg_endo -72.56 164.42 35.65 Favored 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 123.089 2.526 . . . . 0.33 110.518 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.9 -30.31 70.8 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.929 0.344 . . . . 1.98 111.929 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.51 -31.39 72.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.693 0.282 . . . . 2.06 111.094 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.627 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 15.2 m-20 -86.61 -28.21 23.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.034 0.383 . . . . 0.52 112.034 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.031 HG13 HG21 ' A' ' 47' ' ' VAL . 69.7 t -55.05 -48.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.415 -0.957 . . . . 0.38 108.415 173.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 64' ' ' LYS . 15.6 ptpt -80.65 -1.92 44.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.253 -0.885 . . . . 2.16 111.772 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 38.5 t30 -92.21 -29.47 16.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.597 -0.89 . . . . 1.59 108.597 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.872 HD13 ' HA ' ' A' ' 72' ' ' ALA . 25.6 mt -85.7 112.29 20.9 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.432 -1.322 . . . . 0.31 107.432 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.537 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -104.76 -21.99 13.27 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.705 -1.198 . . . . 2.55 110.966 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.464 HG23 ' HG2' ' A' ' 67' ' ' LYS . 30.6 p -127.79 169.85 13.4 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 108.804 -0.813 . . . . 0.23 108.804 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.685 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 1.6 p -73.88 -13.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.804 0.811 . . . . 1.21 110.419 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.469 ' CA ' ' H ' ' A' ' 29' ' ' ASP . . . -68.95 -47.28 55.61 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 108.772 -1.731 . . . . 0.33 108.772 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.6 m-20 -58.19 -56.36 23.1 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.014 -0.736 . . . . 1.39 109.014 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.872 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.65 -61.64 2.08 Favored 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 124.718 1.262 . . . . 0.15 111.926 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.497 ' HA ' HG21 ' A' ' 7' ' ' ILE . 31.6 m -57.92 -44.03 86.58 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 113.643 0.979 . . . . 0.24 113.643 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -65.2 -33.3 75.69 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 122.905 0.482 . . . . 3.63 109.842 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HE2' HG12 ' A' ' 58' ' ' ILE . 88.4 t80 -72.68 -52.72 14.12 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.422 -0.808 . . . . 0.4 110.023 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.748 ' HA ' HG21 ' A' ' 56' ' ' VAL . 70.7 mt -52.88 -66.26 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.698 0 C-N-CA 124.717 1.207 . . . . 0.21 111.519 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.748 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.4 tt -50.41 -49.08 55.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.596 1.558 . . . . 1.44 109.484 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.3 t70 -67.56 -23.42 65.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.424 -1.716 . . . . 0.63 111.575 -174.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -101.96 -12.88 17.86 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.868 -0.606 . . . . 1.25 112.448 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 11.8 mt-30 -71.68 -62.39 1.43 Allowed 'General case' 0 CA--C 1.464 -2.33 0 N-CA-C 107.1 -1.444 . . . . 0.87 107.1 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.268 -2.967 0 CA-C-N 111.526 -2.579 . . . . 1.97 109.378 -179.8 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.864 ' H28' HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.575 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 0 C--O 1.247 0.94 0 CA-C-O 119.816 -0.135 . . . . 1.42 110.707 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 176.8 -81.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.322 1.049 . . . . 1.85 110.406 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t -165.76 -173.85 2.85 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.362 -0.607 . . . . 0.66 109.362 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.711 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -50.3 -46.4 55.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 125.615 1.566 . . . . 0.74 113.419 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.97 -23.59 63.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.58 0.585 . . . . 2.66 112.58 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -84.64 -32.2 23.79 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.821 -1.177 . . . . 2.73 107.821 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 73' ' ' THR . 74.2 mt -79.88 -64.81 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.112 -0.949 . . . . 0.23 109.238 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -55.6 -42.59 69.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 112.626 0.602 . . . . 0.27 112.626 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -60.92 -40.07 91.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.57 -0.452 . . . . 0.27 110.691 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.69 -35.89 21.03 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 120.889 -0.672 . . . . 0.18 112.6 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.683 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -65.9 -39.75 90.9 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.508 -1.293 . . . . 0.2 107.508 -179.263 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.77 -49.84 67.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 123.926 0.766 . . . . 0.14 109.867 175.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.756 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 35.1 mt-10 -58.58 -42.68 88.59 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 124.223 0.952 . . . . 0.68 111.521 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.4 mt -59.4 -38.75 76.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.509 -0.769 . . . . 0.28 110.232 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 11' ' ' LEU . 61.9 t -71.83 -30.16 36.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.614 -0.721 . . . . 0.27 109.845 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.756 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 13.2 m-20 -67.33 -42.65 83.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.102 -0.703 . . . . 0.34 109.102 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 37.1 mm-40 -70.68 -58.8 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.917 -1.038 . . . . 2.07 111.887 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.803 HG22 ' HB3' ' A' ' 42' ' ' SER . 28.0 mt -72.82 -39.36 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 112.619 0.6 . . . . 0.65 112.619 -174.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -106.27 -80.37 0.56 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.13 -0.628 . . . . 0.54 111.441 -178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.69 53.17 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.656 -0.783 . . . . 0.43 112.756 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.824 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -98.02 155.22 37.27 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.612 -0.514 . . . . 0.31 109.612 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 21' ' ' ILE . 5.7 Cg_exo -88.76 40.14 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.017 2.478 . . . . 1.08 114.362 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.596 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.29 8.0 p 53.2 -18.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 117.383 2.364 . . . . 0.81 117.383 178.079 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -103.58 -12.8 16.85 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.351 -0.843 . . . . 2.31 111.401 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.59 -29.87 46.34 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.923 -0.769 . . . . 1.59 108.923 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.824 HG23 HG21 ' A' ' 21' ' ' ILE . 41.8 t -73.23 95.05 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.557 -1.201 . . . . 0.3 108.136 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -130.62 149.51 52.25 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 103.751 -2.685 . . . . 1.58 103.751 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD22 ' HA2' ' A' ' 70' ' ' GLY . 57.0 mt -48.63 145.97 3.33 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 124.007 0.923 . . . . 1.05 109.862 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 80.05 10.37 1.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.539 1.149 . . . . 0.72 110.707 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.762 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 34.2 mmtp -99.9 124.28 45.05 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.675 -0.861 . . . . 1.48 108.675 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 15.2 m -81.46 38.01 0.48 Allowed 'General case' 0 C--N 1.249 -3.781 0 C-N-CA 126.058 1.743 . . . . 1.25 113.007 -173.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.675 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 88.4 m-85 36.42 -91.83 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.991 1.716 . . . . 0.4 114.524 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.962 HG21 ' H37' ' A' ' 101' ' ' SYO . 10.9 t -53.72 -33.12 54.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.091 0.956 . . . . 1.06 112.27 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 27.6 t70 -94.04 -44.41 8.05 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.879 0.371 . . . . 1.74 111.484 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.762 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 6.7 m-20 -88.63 -33.55 17.59 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.784 1.031 . . . . 1.29 113.784 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.629 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.0 mt -98.7 -31.42 11.92 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.038 -0.356 . . . . 0.81 110.038 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 84.55 62.79 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.223 1.487 . . . . 1.12 108.975 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 19' ' ' ALA . 26.7 t -109.39 124.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.701 -2.045 . . . . 0.79 107.71 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.45 122.66 15.15 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 121.064 -0.254 . . . . 2.0 111.212 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.537 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 26.8 t -37.21 -43.04 0.49 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.938 1.459 . . . . 0.78 114.938 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.2 mt -60.91 -46.26 91.35 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.944 0.878 . . . . 1.18 109.56 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.803 ' HB3' HG22 ' A' ' 18' ' ' ILE . 8.3 m -71.71 -29.3 64.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.511 -1.222 . . . . 0.6 110.501 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.913 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -53.16 -47.25 68.92 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 124.966 1.307 . . . . 0.86 112.798 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 48' ' ' VAL . 59.9 t -55.9 -45.6 79.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.013 0.82 . . . . 0.31 109.995 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -60.32 -44.1 95.78 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 109.34 -0.615 . . . . 0.68 109.34 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 15' ' ' VAL . 94.6 t -58.82 -28.54 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.027 0.931 . . . . 0.63 111.677 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.861 HG21 HG13 ' A' ' 63' ' ' VAL . 32.1 t -79.72 -50.98 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 108.04 -1.096 . . . . 0.55 108.04 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 44' ' ' VAL . 49.0 t -59.35 -38.74 76.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.214 -1.357 . . . . 0.42 108.91 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.21 -35.04 71.39 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.994 -0.548 . . . . 0.21 110.42 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.75 11.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.267 -0.879 . . . . 0.21 109.339 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.279 0.0 OUTLIER -63.95 -34.07 77.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 113.721 1.008 . . . . 0.64 113.721 -176.95 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.49 -24.73 66.45 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.445 0.535 . . . . 2.07 112.445 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -88.85 -41.56 12.4 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.503 -0.479 . . . . 2.48 111.629 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HZ ' ' N ' ' A' ' 11' ' ' LEU . 8.8 m-85 -88.87 -0.83 57.72 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 113.267 0.84 . . . . 0.81 113.267 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 80.2 -0.07 2.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.435 1.084 . . . . 1.99 112.837 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.738 HG21 ' HA ' ' A' ' 76' ' ' ILE . 7.6 p -84.75 177.45 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.389 -0.967 . . . . 0.37 108.389 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' H ' HG22 ' A' ' 56' ' ' VAL . 9.1 ttmm -137.11 131.76 33.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.934 -0.765 . . . . 2.12 108.934 172.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.563 HG12 ' HE2' ' A' ' 75' ' ' TYR . 54.0 mt -124.43 113.59 27.52 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.804 -0.635 . . . . 0.25 109.382 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HG23 ' A' ' 63' ' ' VAL . 36.5 Cg_endo -67.07 157.82 59.88 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 122.564 2.176 . . . . 0.33 109.917 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.81 -29.88 63.18 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.685 0.755 . . . . 1.98 109.359 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 29.7 t70 -60.91 -47.2 87.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.569 -1.196 . . . . 2.06 111.452 177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 59.3 m-20 -83.12 -24.94 32.39 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 111.812 0.301 . . . . 0.52 111.812 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.861 HG13 HG21 ' A' ' 47' ' ' VAL . 67.2 t -52.53 -48.11 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.324 -0.991 . . . . 0.38 108.324 173.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HA ' H42A ' A' ' 101' ' ' SYO . 25.8 pttm -75.57 -2.39 28.94 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.153 0.797 . . . . 2.16 113.153 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -98.87 -25.92 14.46 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.002 0.429 . . . . 1.59 110.418 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' HA ' ' A' ' 72' ' ' ALA . 37.4 mt -79.72 119.51 22.74 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 106.017 -1.846 . . . . 0.31 106.017 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -110.37 -35.04 6.17 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.58 -0.848 . . . . 2.55 110.571 176.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 31.6 p -111.43 177.65 4.59 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 109.089 -0.708 . . . . 0.23 109.089 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.675 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -86.99 -13.03 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 N-CA-C 108.263 -1.014 . . . . 1.21 108.263 174.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.469 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -72.35 -35.95 59.81 Favored Glycine 0 C--O 1.216 -0.981 0 N-CA-C 108.385 -1.886 . . . . 0.33 108.385 173.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 68' ' ' THR . 11.7 m-20 -66.74 -60.27 2.84 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.821 1.249 . . . . 1.39 109.501 173.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.75 -61.1 2.41 Favored 'General case' 0 CA--C 1.469 -2.164 0 CA-C-N 113.474 -1.694 . . . . 0.15 112.317 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.711 HG21 ' HG2' ' A' ' 4' ' ' GLN . 59.2 m -59.75 -34.34 72.83 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.914 -1.039 . . . . 0.24 113.324 -175.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -43.4 70.06 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 108.027 -1.101 . . . . 3.63 108.027 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.563 ' HE2' HG12 ' A' ' 58' ' ' ILE . 87.1 t80 -61.27 -50.86 71.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.856 -1.065 . . . . 0.4 109.611 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.738 ' HA ' HG21 ' A' ' 56' ' ' VAL . 76.7 mt -54.79 -65.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.037 -1.438 . . . . 0.21 110.634 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.13 -41.74 62.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.634 0.773 . . . . 1.44 109.939 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.34 -34.51 76.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.14 -0.936 . . . . 0.63 111.723 -175.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -95.71 -7.16 38.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 113.631 0.974 . . . . 1.25 113.631 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.578 HE21 HG22 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -105.17 -70.93 0.76 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 113.97 1.1 . . . . 0.87 113.97 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.828 0 CA-C-N 115.084 -0.962 . . . . 1.97 110.505 -176.474 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.962 ' H37' HG21 ' A' ' 33' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.671 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 0 CA--C 1.495 -1.136 0 CA-C-O 121.42 0.629 . . . . 1.42 110.376 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.85 177.46 4.66 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.62 -1.173 . . . . 1.85 108.482 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.452 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.0 t -118.76 179.91 4.0 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 116.615 -0.266 . . . . 0.66 111.083 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -51.25 -37.06 45.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.945 1.298 . . . . 0.74 112.848 -178.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -48.76 66.92 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.895 0.747 . . . . 2.66 110.854 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.35 -38.18 87.01 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.505 0.722 . . . . 2.73 109.907 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.542 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.7 mt -72.13 -66.79 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.028 0 CA-C-N 115.681 -0.691 . . . . 0.23 112.344 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.573 HG21 HD11 ' A' ' 28' ' ' LEU . 58.3 t -60.0 -41.12 85.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 112.377 0.51 . . . . 0.27 112.377 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.36 86.84 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.269 0.355 . . . . 0.27 110.54 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.62 -40.15 10.04 Favored Glycine 0 N--CA 1.414 -2.825 0 CA-C-N 115.815 -0.629 . . . . 0.18 113.584 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.26 -37.14 86.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.605 -0.887 . . . . 0.2 108.605 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.12 -49.23 77.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.893 -0.594 . . . . 0.14 109.418 175.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.868 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 49.7 mt-10 -60.23 -41.57 93.39 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 124.131 0.894 . . . . 0.68 112.244 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 11' ' ' LEU . 69.1 mt -56.84 -42.15 77.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.618 -0.719 . . . . 0.28 109.887 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.626 HG12 ' HB ' ' A' ' 21' ' ' ILE . 98.4 t -70.16 -22.85 24.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.778 0.799 . . . . 0.27 110.879 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.868 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 15.1 m-20 -76.34 -42.2 45.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.55 -1.278 . . . . 0.34 107.55 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -76.92 -39.76 49.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.551 -1.204 . . . . 2.07 112.252 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.553 HG13 HG22 ' A' ' 46' ' ' VAL . 20.7 mm -71.96 -53.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.895 0.379 . . . . 0.65 110.563 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.33 -74.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.374 -0.531 . . . . 0.54 111.26 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.55 44.77 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.353 -0.927 . . . . 0.43 112.221 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.843 HG21 HG23 ' A' ' 26' ' ' VAL . 1.5 mp -84.9 151.0 57.01 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.984 -0.747 . . . . 0.31 108.984 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 13.3 Cg_exo -83.27 29.24 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 124.277 3.318 . . . . 1.08 115.004 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.558 ' HB ' HD22 ' A' ' 16' ' ' ASN . 5.7 p 54.1 7.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 C-N-CA 126.195 1.798 . . . . 0.81 114.351 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -107.95 -27.1 10.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.943 -0.473 . . . . 2.31 111.834 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 36' ' ' LEU . 11.1 m-20 -83.17 -28.64 29.19 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 116.054 -0.521 . . . . 1.59 112.094 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.843 HG23 HG21 ' A' ' 21' ' ' ILE . 22.1 t -78.37 87.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.118 -0.633 . . . . 0.3 110.399 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 69' ' ' VAL . 96.5 mttt -125.6 168.84 13.15 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.473 -0.785 . . . . 1.58 109.422 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 8' ' ' VAL . 5.5 mp -60.19 139.3 57.63 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.255 -0.43 . . . . 1.05 110.081 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 79.28 12.68 1.23 Allowed 'General case' 0 C--N 1.316 -0.855 0 O-C-N 125.044 1.465 . . . . 0.72 111.252 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.7 mmtt -99.47 124.75 44.91 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 109.301 -0.629 . . . . 1.48 109.301 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.5 m -78.9 34.42 0.23 Allowed 'General case' 0 C--N 1.254 -3.578 0 C-N-CA 126.356 1.862 . . . . 1.25 114.377 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.797 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 79.9 m-85 43.04 -93.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.499 1.519 . . . . 0.4 114.913 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -67.35 -24.37 65.71 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.993 -0.442 . . . . 1.06 111.98 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -89.45 -52.99 4.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.935 0.398 . . . . 1.74 110.952 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.55 -41.31 19.78 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 116.155 -0.475 . . . . 1.29 112.221 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.585 HD13 HG22 ' A' ' 26' ' ' VAL . 16.1 mt -83.4 -76.32 0.29 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 119.097 -0.478 . . . . 0.81 110.525 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 34.2 t70 159.82 -16.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 O-C-N 124.411 1.069 . . . . 1.12 110.608 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 36' ' ' LEU . 3.0 t -47.13 135.37 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.037 1.335 . . . . 0.79 113.276 -171.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 43' ' ' MET . 11.3 t70 -59.49 112.8 1.91 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.516 -0.766 . . . . 2.0 111.805 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.565 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 17.3 t -40.82 -43.31 2.0 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 116.069 1.877 . . . . 0.78 116.069 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 4.2 pp -80.22 -30.69 38.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.254 -1.378 . . . . 1.18 110.66 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 46' ' ' VAL . 20.1 m -76.14 -13.92 60.18 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.601 -0.727 . . . . 0.6 110.165 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.797 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.13 -36.09 76.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 123.44 0.696 . . . . 0.86 110.301 177.277 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.97 -44.68 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 123.959 0.787 . . . . 0.31 109.36 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.65 -43.09 94.03 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.181 -0.674 . . . . 0.68 109.181 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.553 HG22 HG13 ' A' ' 18' ' ' ILE . 57.6 t -59.26 -24.98 29.15 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.015 -0.993 . . . . 0.63 111.455 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.978 HG21 HG13 ' A' ' 63' ' ' VAL . 42.3 t -80.18 -54.32 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 N-CA-C 106.933 -1.506 . . . . 0.55 106.933 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HA ' ' OE2' ' A' ' 51' ' ' GLU . 74.2 t -53.85 -40.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.372 -1.74 . . . . 0.42 110.07 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.91 -37.08 64.76 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-O 121.233 0.54 . . . . 0.21 110.27 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.507 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -62.19 -59.97 4.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.059 -0.973 . . . . 0.21 109.905 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.296 0.9 OUTLIER -62.8 -35.53 80.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 114.377 1.251 . . . . 0.64 114.377 -176.1 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.67 -30.46 71.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.356 0.502 . . . . 2.07 112.356 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -82.82 -36.72 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.777 -0.369 . . . . 2.48 110.979 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 7.7 m-85 -87.58 -19.43 27.83 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.766 1.024 . . . . 0.81 113.766 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.0 t70 103.76 -5.35 0.02 OUTLIER 'General case' 0 N--CA 1.532 3.641 0 O-C-N 125.29 1.619 . . . . 1.99 114.227 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 76' ' ' ILE . 8.1 p -87.17 172.96 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 O-C-N 121.141 -0.974 . . . . 0.37 109.513 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.88 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -126.6 118.79 25.54 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.208 -1.405 . . . . 2.12 107.208 174.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.585 HG12 ' HE2' ' A' ' 75' ' ' TYR . 57.5 mt -111.64 114.03 52.69 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 120.88 -0.328 . . . . 0.25 110.929 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HG23 ' A' ' 63' ' ' VAL . 83.2 Cg_endo -72.82 164.6 35.11 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.524 2.816 . . . . 0.33 110.913 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.45 -38.71 74.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.905 0.482 . . . . 1.98 111.058 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.577 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.0 m-20 -61.82 -34.71 76.42 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-N 115.816 -0.629 . . . . 2.06 111.592 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.575 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.0 m-20 -87.36 -23.98 24.4 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.659 -0.816 . . . . 0.52 113.177 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.978 HG13 HG21 ' A' ' 47' ' ' VAL . 79.4 t -55.96 -45.68 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.093 -1.077 . . . . 0.38 108.093 172.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 17.4 ptmt -74.78 -10.27 59.35 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.202 -0.908 . . . . 2.16 111.84 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -91.56 -13.52 31.87 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.264 0.554 . . . . 1.59 110.168 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.821 HD13 ' HA ' ' A' ' 72' ' ' ALA . 24.9 mt -95.96 109.54 21.9 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 107.101 -1.444 . . . . 0.31 107.101 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.514 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -105.72 -45.22 4.46 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.742 -1.206 . . . . 2.55 107.742 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 62.8 p -102.86 170.44 7.99 Favored 'General case' 0 N--CA 1.383 -3.808 0 CA-C-N 114.937 -1.028 . . . . 0.23 108.821 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -79.31 -12.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.464 -0.939 . . . . 1.21 108.464 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.66 -46.98 64.36 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 108.597 -1.801 . . . . 0.33 108.597 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.92 -52.42 65.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 109.026 -0.731 . . . . 1.39 109.026 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.821 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.25 -61.26 2.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 O-C-N 124.635 1.209 . . . . 0.15 111.365 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' HG21 ' A' ' 7' ' ' ILE . 52.5 m -55.7 -50.87 69.15 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 124.211 0.945 . . . . 0.24 113.471 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.5 mptm? -60.52 -34.14 73.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 123.3 0.64 . . . . 3.63 110.185 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.585 ' HE2' HG12 ' A' ' 58' ' ' ILE . 77.1 t80 -70.37 -55.89 8.0 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.771 -0.455 . . . . 0.4 109.771 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.608 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 63.8 mt -50.31 -66.44 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 124.662 1.185 . . . . 0.21 110.909 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.41 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.5 tt -52.88 -54.32 36.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.781 1.232 . . . . 1.44 110.047 -175.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 11.9 t70 -70.57 -24.4 62.77 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.542 -1.208 . . . . 0.63 112.02 -169.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.27 -4.87 48.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.416 0.895 . . . . 1.25 113.416 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.671 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 2.0 pt20 -103.24 -55.48 2.4 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-O 122.391 1.091 . . . . 0.87 110.898 173.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 1 C--N 1.243 -4.033 0 CA-C-N 112.944 -1.934 . . . . 1.97 110.681 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.839 ' H28' HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.693 0 CA-C-O 121.072 0.463 . . . . 1.42 109.793 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -95.67 128.94 42.96 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 109.009 -0.737 . . . . 1.85 109.009 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 7' ' ' ILE . 2.5 t -85.93 176.21 8.19 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 119.114 -0.469 . . . . 0.66 109.93 -176.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.451 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -48.32 -40.32 24.86 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.398 0.888 . . . . 0.74 113.398 -176.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.27 -33.74 65.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.046 0.841 . . . . 2.66 110.411 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 15.4 tp10 -87.15 -37.74 17.07 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.403 -0.817 . . . . 2.73 109.837 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.667 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.1 mt -65.67 -65.75 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 116.392 -0.367 . . . . 0.23 111.711 -172.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.756 HG21 HD11 ' A' ' 28' ' ' LEU . 59.1 t -56.91 -42.31 78.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 122.126 0.17 . . . . 0.27 111.394 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -38.74 78.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.813 0.696 . . . . 0.27 111.278 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.66 -38.45 10.63 Favored Glycine 0 N--CA 1.419 -2.47 0 CA-C-N 116.183 -0.462 . . . . 0.18 113.117 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -63.97 -40.48 96.49 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.978 -0.749 . . . . 0.2 108.978 -178.254 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.641 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.34 -50.77 64.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.127 0.892 . . . . 0.14 109.685 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.614 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 55.6 mt-10 -61.54 -38.91 89.14 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 124.0 0.813 . . . . 0.68 111.927 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.7 mt -59.85 -45.01 95.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.843 -0.617 . . . . 0.28 109.548 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 11' ' ' LEU . 62.0 t -67.6 -24.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-O 121.747 0.784 . . . . 0.27 110.131 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.614 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.9 m120 -72.09 -38.49 69.37 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.281 -0.872 . . . . 0.34 109.322 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -82.13 -48.87 10.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.659 -0.7 . . . . 2.07 111.349 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.64 HG22 ' HB3' ' A' ' 42' ' ' SER . 33.4 mm -62.77 -53.14 50.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.902 -0.59 . . . . 0.65 110.545 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -104.5 -78.27 0.57 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.421 -0.585 . . . . 0.54 109.421 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.27 45.96 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 120.747 -0.74 . . . . 0.43 112.031 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.583 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -80.69 152.47 72.42 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 109.037 -0.727 . . . . 0.31 109.037 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.8 Cg_exo -84.83 23.34 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.104 2.536 . . . . 1.08 115.089 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.8 p 58.88 -9.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.69 1.996 . . . . 0.81 115.489 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.8 pt-20 -103.79 -7.02 20.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.365 0.602 . . . . 2.31 111.176 -174.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -99.66 -16.49 18.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.775 0.798 . . . . 1.59 110.676 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 12' ' ' ALA . 12.8 t -78.11 86.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 114.385 -1.28 . . . . 0.3 110.468 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -114.52 148.94 37.19 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.186 -1.042 . . . . 1.58 108.186 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.756 HD11 HG21 ' A' ' 8' ' ' VAL . 6.0 mp -59.89 140.27 56.78 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.578 -0.527 . . . . 1.05 109.578 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 87.26 7.21 0.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.545 1.538 . . . . 0.72 109.642 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -104.03 128.44 51.61 Favored 'General case' 0 CA--C 1.465 -2.316 0 CA-C-N 115.269 -0.878 . . . . 1.48 109.214 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 3.0 m -80.65 105.8 12.17 Favored 'General case' 1 C--N 1.238 -4.269 0 CA-C-N 114.188 -1.369 . . . . 1.25 108.316 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.765 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.4 m-85 -43.51 -55.26 4.33 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.596 0.758 . . . . 0.4 112.081 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 t -78.23 6.3 8.48 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 113.431 0.9 . . . . 1.06 113.431 -173.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -139.92 -62.18 0.52 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.318 -0.553 . . . . 1.74 110.037 -174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.05 -44.91 75.3 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.096 -0.957 . . . . 1.29 110.146 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.596 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 16.9 mt -81.38 -44.6 17.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.137 -0.938 . . . . 0.81 109.279 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 93.84 65.32 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 126.632 1.973 . . . . 1.12 111.908 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 43' ' ' MET . 48.8 t -96.04 149.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 113.485 -1.689 . . . . 0.79 107.587 171.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.475 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.3 m-20 -73.96 17.82 0.16 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 115.99 1.848 . . . . 2.0 115.99 -174.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 43' ' ' MET . 28.7 t 68.0 -53.65 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.271 1.952 . . . . 0.78 116.271 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 39' ' ' ASP . 1.7 pt? -71.36 -34.15 70.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.257 1.027 . . . . 1.18 108.491 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.64 ' HB3' HG22 ' A' ' 18' ' ' ILE . 2.1 m -65.81 -22.84 66.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.968 -1.469 . . . . 0.6 110.045 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.752 ' HB3' ' H2A' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -61.99 -43.44 98.83 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 115.375 -0.829 . . . . 0.86 112.021 -176.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.35 -43.83 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 O-C-N 124.398 1.061 . . . . 0.31 110.034 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.41 -46.82 85.69 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.917 -0.771 . . . . 0.68 108.917 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 42' ' ' SER . 61.9 t -58.54 -27.0 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.731 -1.122 . . . . 0.63 111.484 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.978 HG21 HG13 ' A' ' 63' ' ' VAL . 44.5 t -80.15 -52.53 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 107.658 -1.238 . . . . 0.55 107.658 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.28 -44.51 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 124.728 1.268 . . . . 0.42 108.919 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.69 88.33 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 121.244 0.545 . . . . 0.21 110.811 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -64.68 -55.9 17.19 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.472 -0.785 . . . . 0.21 110.239 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.262 0.0 OUTLIER -62.81 -34.03 76.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.754 1.02 . . . . 0.64 113.754 -178.188 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -67.84 -28.66 67.75 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.77 0.285 . . . . 2.07 111.77 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -87.52 -38.16 16.27 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.775 0.321 . . . . 2.48 111.52 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.667 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 10.0 m-85 -94.46 -3.91 49.18 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.106 0.78 . . . . 0.81 113.106 -172.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 87.66 -2.5 0.55 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 125.16 1.384 . . . . 1.99 114.719 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.781 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 13.9 p -81.2 173.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.363 -0.935 . . . . 0.37 108.772 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 22.2 tptp -127.58 124.91 39.26 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 107.462 -1.31 . . . . 2.12 107.462 171.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.538 HG12 ' HE2' ' A' ' 75' ' ' TYR . 59.7 mt -114.43 113.21 45.71 Favored Pre-proline 0 N--CA 1.429 -1.496 0 C-N-CA 120.599 -0.441 . . . . 0.25 111.106 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 63' ' ' VAL . 30.9 Cg_endo -66.87 152.53 80.26 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 122.642 2.228 . . . . 0.33 109.845 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 3.9 p-10 -59.1 -27.87 65.98 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.307 0.379 . . . . 1.98 111.123 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.76 -46.04 87.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 2.06 110.379 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.409 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.5 m-20 -74.76 -26.91 60.1 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 112.01 0.374 . . . . 0.52 112.01 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.978 HG13 HG21 ' A' ' 47' ' ' VAL . 86.8 t -55.57 -41.44 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.86 -1.163 . . . . 0.38 107.86 172.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HA ' H42A ' A' ' 101' ' ' SYO . 57.8 mttp -73.94 -7.83 53.81 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.067 -0.97 . . . . 2.16 112.564 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.06 -24.47 15.32 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.233 0.539 . . . . 1.59 110.316 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.852 HD13 ' HA ' ' A' ' 72' ' ' ALA . 39.1 mt -85.48 118.44 25.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.889 -1.152 . . . . 0.31 107.889 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.488 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -112.17 -29.16 7.68 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.918 -1.113 . . . . 2.55 110.591 175.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 13.6 p -116.55 179.5 3.99 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 109.477 -0.564 . . . . 0.23 109.477 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.765 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -87.23 -12.89 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 122.062 0.934 . . . . 1.21 109.787 176.045 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -76.6 -30.99 55.56 Favored Glycine 0 C--O 1.207 -1.542 0 N-CA-C 108.305 -1.918 . . . . 0.33 108.305 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.27 -60.35 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.21 -0.995 . . . . 1.39 109.144 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.852 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.03 -60.95 2.34 Favored 'General case' 0 CA--C 1.479 -1.771 0 O-C-N 124.569 1.168 . . . . 0.15 112.361 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.458 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.3 m -57.45 -47.99 80.36 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.894 -1.048 . . . . 0.24 113.006 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 5.7 mptp? -55.83 -50.52 70.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 124.213 0.945 . . . . 3.63 109.815 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.538 ' HE2' HG12 ' A' ' 58' ' ' ILE . 82.8 t80 -56.23 -51.51 67.82 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.364 1.04 . . . . 0.4 111.43 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.578 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 69.8 mt -54.27 -65.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.424 -1.262 . . . . 0.21 110.432 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tt -54.33 -42.8 70.6 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.11 0.964 . . . . 1.44 109.589 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 36.9 t70 -62.4 -26.81 68.68 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.41 1.084 . . . . 0.63 111.561 -172.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -102.13 -8.04 21.72 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.836 1.05 . . . . 1.25 113.836 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.781 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -120.89 -45.67 2.37 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 115.191 1.552 . . . . 0.87 115.191 -178.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 1 C--N 1.237 -4.307 0 CA-C-N 113.877 -1.51 . . . . 1.97 111.159 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.752 ' H2A' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.379 0 CA-C-O 120.892 0.377 . . . . 1.42 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -147.06 131.85 17.99 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 107.069 -1.456 . . . . 1.85 107.069 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.44 ' O ' HG13 ' A' ' 7' ' ' ILE . 15.2 t -81.77 -179.73 7.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.147 0.28 . . . . 0.66 111.162 -173.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.661 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -49.85 -46.97 51.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.157 0.983 . . . . 0.74 113.363 -178.208 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.64 -24.79 66.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.873 0.368 . . . . 2.66 111.624 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 7.8 tp10 -87.7 -31.08 19.9 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.152 -0.684 . . . . 2.73 109.152 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.583 HG23 ' CE2' ' A' ' 54' ' ' PHE . 97.4 mt -74.39 -65.98 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.141 0 CA-C-N 116.145 -0.48 . . . . 0.23 110.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.49 -40.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 112.365 0.506 . . . . 0.27 112.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -62.48 -40.91 98.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.37 -0.532 . . . . 0.27 110.632 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.48 -35.07 33.96 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 115.783 -0.644 . . . . 0.18 112.235 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.738 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -67.44 -39.37 85.4 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.16 -1.052 . . . . 0.2 108.16 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.628 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.36 -50.32 69.98 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.832 -0.803 . . . . 0.14 108.832 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.742 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 46.6 mt-10 -59.24 -42.48 91.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.113 0.883 . . . . 0.68 112.704 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' A' ' 11' ' ' LEU . 65.6 mt -56.07 -43.06 74.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.315 0.579 . . . . 0.28 109.923 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.716 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.8 t -68.86 -25.34 30.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.755 0.788 . . . . 0.27 110.168 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.742 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 11.4 m-20 -74.07 -42.18 60.58 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.923 -1.139 . . . . 0.34 107.923 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.56 -47.95 51.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.311 -0.858 . . . . 2.07 111.445 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.4 HG13 HG22 ' A' ' 46' ' ' VAL . 28.4 mm -67.14 -53.16 35.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.896 -0.593 . . . . 0.65 111.317 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.73 -78.42 0.58 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.559 -0.456 . . . . 0.54 111.695 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.02 43.17 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.094 -1.051 . . . . 0.43 112.916 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.863 HG21 HG23 ' A' ' 26' ' ' VAL . 1.4 mp -79.41 151.25 74.75 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.033 -0.729 . . . . 0.31 109.033 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 4.6 Cg_exo -89.74 37.5 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.613 2.876 . . . . 1.08 113.276 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.409 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.26 9.2 p 56.11 -22.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.982 2.113 . . . . 0.81 116.021 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 22' ' ' PRO . 29.8 mm-40 -88.73 -22.8 23.16 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.603 0.761 . . . . 2.31 111.873 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.602 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 6.6 t70 -74.57 -32.71 62.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.583 0.706 . . . . 1.59 110.494 -171.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 21' ' ' ILE . 22.0 t -78.96 94.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.908 -1.042 . . . . 0.3 111.104 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -124.3 158.55 32.32 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.315 -0.995 . . . . 1.58 108.315 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 69' ' ' VAL . 90.6 mt -54.97 141.22 34.66 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 122.934 0.494 . . . . 1.05 110.288 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.599 ' H ' ' N ' ' A' ' 70' ' ' GLY . 27.1 t70 77.22 10.55 2.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.36 1.464 . . . . 0.72 111.009 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 69' ' ' VAL . 72.1 mmtt -100.36 129.06 46.29 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 115.374 -0.83 . . . . 1.48 109.226 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 30.6 t -74.85 119.89 19.65 Favored 'General case' 1 C--N 1.244 -4.011 0 CA-C-N 115.078 -0.965 . . . . 1.25 109.901 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.617 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 74.0 m-85 -51.49 -55.87 16.5 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 123.975 0.91 . . . . 0.4 111.892 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 3.5 p -66.47 -57.45 7.33 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 122.11 0.957 . . . . 1.06 111.942 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' HB2' ' OG ' ' A' ' 31' ' ' SER . 8.0 m-20 -82.64 -41.17 19.77 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 115.202 1.556 . . . . 1.74 115.202 -166.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HB2' ' N ' ' A' ' 31' ' ' SER . 5.3 m-20 -91.66 -43.81 9.39 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.719 0.295 . . . . 1.29 111.113 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.744 HD13 HG22 ' A' ' 26' ' ' VAL . 17.8 mt -76.09 -90.11 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.758 -0.656 . . . . 0.81 110.418 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 38.9 t70 163.56 10.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.364 1.066 . . . . 1.12 109.047 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 15' ' ' VAL . 12.4 t -77.57 119.14 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 108.764 -0.828 . . . . 0.79 108.764 -172.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.714 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 13.2 t70 -58.44 120.99 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 124.106 0.879 . . . . 2.0 111.456 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.8 t -41.78 -30.91 0.27 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 127.455 2.302 . . . . 0.78 116.128 175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.714 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 4.3 pp -86.32 -31.96 21.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 120.4 1.455 . . . . 1.18 111.023 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -80.15 -13.76 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.46 1.124 . . . . 0.6 109.401 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.759 ' HG3' ' H1 ' ' A' ' 101' ' ' SYO . 3.8 tpt -60.03 -36.09 76.51 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 127.334 2.253 . . . . 0.86 110.403 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 47' ' ' VAL . 58.1 t -66.68 -25.15 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 CA-C-N 115.213 -0.903 . . . . 0.31 110.943 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -77.02 -41.02 44.36 Favored 'General case' 0 C--O 1.215 -0.739 0 O-C-N 121.515 -0.741 . . . . 0.68 109.6 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.4 HG22 HG13 ' A' ' 18' ' ' ILE . 31.5 t -59.57 -25.83 32.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.177 -0.919 . . . . 0.63 111.66 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.769 HG23 ' H6 ' ' A' ' 101' ' ' SYO . 10.7 p -81.48 -47.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 CA-C-O 122.201 1.0 . . . . 0.55 110.145 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.02 -39.5 85.9 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 CA-C-N 112.869 -1.969 . . . . 0.42 108.749 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 -32.04 72.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.856 -0.611 . . . . 0.21 110.004 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.79 -59.16 4.17 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.952 -1.022 . . . . 0.21 110.122 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.288 0.0 OUTLIER -62.44 -34.69 77.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 114.014 1.116 . . . . 0.64 114.014 -175.635 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.29 -41.82 80.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.449 0.642 . . . . 2.07 111.321 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -81.68 -41.14 21.79 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.259 -0.882 . . . . 2.48 110.812 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 7' ' ' ILE . 10.4 m-85 -83.65 -44.38 14.6 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 117.735 -1.126 . . . . 0.81 113.454 -172.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 15.8 t70 155.91 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 124.616 1.198 . . . . 1.99 112.55 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.641 HG11 ' HA ' ' A' ' 76' ' ' ILE . 8.6 p -75.29 174.56 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.301 -0.863 . . . . 0.37 112.924 -164.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.3 127.04 52.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.207 -1.775 . . . . 2.12 106.207 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 76' ' ' ILE . 59.8 mt -118.87 112.42 36.62 Favored Pre-proline 0 C--N 1.293 -1.871 0 C-N-CA 120.216 -0.594 . . . . 0.25 110.09 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.5 Cg_endo -69.27 155.95 66.05 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.361 2.707 . . . . 0.33 110.554 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.5 p-10 -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.183 0.593 . . . . 1.98 112.128 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.7 m-20 -65.44 -54.24 31.28 Favored 'General case' 0 C--O 1.209 -1.044 0 O-C-N 123.22 0.325 . . . . 2.06 110.538 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.53 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 11.6 m-20 -66.92 -31.85 72.72 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.509 0.559 . . . . 0.52 112.509 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.725 HG13 HG11 ' A' ' 47' ' ' VAL . 41.3 t -50.22 -59.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.281 0.988 . . . . 0.38 109.015 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 14.6 ptmm? -72.61 -1.86 17.75 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.574 -0.739 . . . . 2.16 112.916 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.68 -18.17 21.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.733 0.777 . . . . 1.59 109.418 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' HA ' ' A' ' 72' ' ' ALA . 40.1 mt -84.9 116.09 23.14 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.579 -2.008 . . . . 0.31 105.579 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.634 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -111.68 -30.05 7.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 117.982 -1.487 . . . . 2.55 109.65 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 67' ' ' LYS . 31.1 p -119.14 173.46 6.91 Favored 'General case' 0 N--CA 1.395 -3.204 0 N-CA-C 109.183 -0.673 . . . . 0.23 109.183 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 30' ' ' LYS . 23.7 t -72.01 -18.98 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 108.492 -0.929 . . . . 1.21 108.492 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.599 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -70.13 -40.96 71.36 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 110.142 -1.183 . . . . 0.33 110.142 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.575 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.2 m-20 -67.89 -55.04 14.35 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.547 -0.908 . . . . 1.39 108.547 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.46 -61.33 2.31 Favored 'General case' 0 CA--C 1.471 -2.058 0 O-C-N 124.875 1.359 . . . . 0.15 111.97 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.661 HG21 ' HG2' ' A' ' 4' ' ' GLN . 50.0 m -57.64 -51.19 70.51 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.591 -1.186 . . . . 0.24 112.682 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.4 OUTLIER -53.49 -49.53 67.3 Favored 'General case' 0 N--CA 1.422 -1.827 0 O-C-N 124.325 1.016 . . . . 3.63 109.601 177.241 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 87.1 t80 -56.96 -52.01 66.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.747 0.819 . . . . 0.4 111.208 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.641 ' HA ' HG11 ' A' ' 56' ' ' VAL . 69.9 mt -52.01 -65.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 124.812 1.32 . . . . 0.21 109.79 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.76 -45.01 70.48 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.144 1.378 . . . . 1.44 110.346 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.59 -30.32 71.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.916 -1.038 . . . . 0.63 111.105 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -100.32 -11.62 20.15 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 113.82 1.044 . . . . 1.25 113.82 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 14.8 mt-30 -80.59 -51.93 8.17 Favored 'General case' 0 CA--C 1.476 -1.898 0 CA-C-O 122.798 1.285 . . . . 0.87 107.641 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.271 -2.846 0 CA-C-N 112.417 -2.174 . . . . 1.97 110.275 -175.569 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.769 ' H6 ' HG23 ' A' ' 47' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.504 -0.822 0 N-CA-C 108.423 -0.954 . . . . 1.42 108.423 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.93 -70.23 0.15 Allowed 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.882 -0.327 . . . . 1.85 111.291 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -159.7 171.2 19.98 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.609 -0.436 . . . . 0.66 111.231 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.635 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.8 OUTLIER -51.85 -37.08 50.57 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.138 1.775 . . . . 0.74 112.423 177.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.4 -35.33 65.23 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 123.735 0.647 . . . . 2.66 111.869 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.48 -31.18 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.358 0.599 . . . . 2.73 109.504 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.636 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 80.4 mt -73.27 -66.44 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 115.775 -0.648 . . . . 0.23 109.985 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 28' ' ' LEU . 96.7 t -52.62 -38.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.067 0.765 . . . . 0.27 113.067 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.27 98.69 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.419 -0.512 . . . . 0.27 109.86 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' HA2' ' NH1' ' A' ' 53' ' ' ARG . . . -76.34 -39.93 29.8 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.366 -0.834 . . . . 0.18 112.313 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -67.04 -39.04 86.88 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 123.745 0.818 . . . . 0.2 109.377 -176.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.47 -43.68 89.0 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.687 -0.486 . . . . 0.14 109.687 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.57 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 44.4 mt-10 -61.31 -42.78 99.24 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.889 0.743 . . . . 0.68 111.46 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -60.7 -40.76 85.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.342 0.591 . . . . 0.28 110.046 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.732 HG12 ' HB ' ' A' ' 21' ' ' ILE . 23.9 t -73.65 -22.61 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.472 0.654 . . . . 0.27 110.162 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.57 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -72.59 -54.04 10.25 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.205 -1.035 . . . . 0.34 108.205 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.14 -44.8 62.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.342 -1.299 . . . . 2.07 113.602 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.588 HG22 ' HB3' ' A' ' 42' ' ' SER . 14.5 mt -76.27 -53.33 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.985 -0.686 . . . . 0.65 111.106 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.662 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -91.91 -80.14 0.36 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 0.54 110.809 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.93 40.04 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.16 0 C-N-CA 121.076 -0.583 . . . . 0.43 111.755 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.732 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -82.55 161.14 60.03 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 109.473 -0.566 . . . . 0.31 109.473 178.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.0 Cg_endo -90.62 141.64 3.26 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.895 2.396 . . . . 1.08 108.415 171.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -72.61 45.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.086 0 N-CA-C 113.98 1.104 . . . . 0.81 113.98 -171.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.51 -20.96 0.43 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.31 1.044 . . . . 2.31 110.548 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.65 -36.44 65.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.122 -0.49 . . . . 1.59 112.105 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.649 HG22 HD13 ' A' ' 36' ' ' LEU . 41.1 t -75.91 93.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.998 -0.546 . . . . 0.3 109.582 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 69' ' ' VAL . 30.8 mmtp -133.17 168.55 18.32 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.821 -1.178 . . . . 1.58 107.821 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.487 HD23 ' HE2' ' A' ' 74' ' ' LYS . 6.3 mp -63.67 146.92 52.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.845 -0.798 . . . . 1.05 108.845 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 t70 78.3 8.39 2.28 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.702 1.251 . . . . 0.72 110.241 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 71.4 mmtt -106.08 125.57 51.16 Favored 'General case' 0 CA--C 1.473 -1.993 0 CA-C-N 115.709 -0.678 . . . . 1.48 109.679 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 4.2 m -81.85 108.78 15.65 Favored 'General case' 0 C--N 1.245 -3.96 0 CA-C-N 114.248 -1.342 . . . . 1.25 108.763 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.879 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.4 m-85 -37.27 -66.69 0.22 Allowed 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.547 1.539 . . . . 0.4 114.197 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.54 ' CG2' ' H37' ' A' ' 101' ' ' SYO . 4.3 t -85.87 15.5 4.84 Favored 'General case' 0 C--N 1.275 -2.67 0 O-C-N 121.1 -1.0 . . . . 1.06 112.742 -174.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 1.9 m-20 -134.25 -65.72 0.64 Allowed 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.627 -0.671 . . . . 1.74 111.364 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 21.5 m-20 -68.94 -41.4 78.12 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.311 -0.858 . . . . 1.29 109.962 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.678 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 27.0 mt -79.38 -50.1 11.36 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.618 -0.719 . . . . 0.81 111.024 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 11.2 t70 94.5 68.89 0.0 OUTLIER 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.278 1.611 . . . . 1.12 110.557 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 19' ' ' ALA . 40.5 t -105.81 162.69 4.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.277 -1.783 . . . . 0.79 110.156 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.25 3.6 5.55 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.49 1.116 . . . . 2.0 113.028 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.1 p 67.41 -47.58 0.49 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.328 1.851 . . . . 0.78 113.081 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.68 -49.15 77.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.997 0.919 . . . . 1.18 108.783 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.588 ' HB3' HG22 ' A' ' 18' ' ' ILE . 2.2 m -63.75 -16.26 60.71 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.987 -1.461 . . . . 0.6 112.314 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.879 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -66.22 -34.48 78.11 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 123.406 0.682 . . . . 0.86 111.393 -176.351 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.59 -38.33 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 109.125 -0.694 . . . . 0.31 109.125 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.87 -44.94 91.58 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.943 -1.132 . . . . 0.68 107.943 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 42' ' ' SER . 97.8 t -57.25 -24.72 21.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.354 -1.294 . . . . 0.63 112.091 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.991 HG11 HG22 ' A' ' 63' ' ' VAL . 23.2 t -78.69 -53.66 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.957 -1.127 . . . . 0.55 107.957 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.73 -31.9 50.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.573 -1.194 . . . . 0.42 109.413 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -76.35 -32.01 58.41 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.158 0.504 . . . . 0.21 110.285 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -67.11 -62.86 1.22 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.486 -0.779 . . . . 0.21 109.973 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.264 0.0 OUTLIER -60.69 -37.23 80.95 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 114.411 1.263 . . . . 0.64 114.411 -174.594 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.87 -30.7 67.94 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.4 0.519 . . . . 2.07 112.4 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' NH1' ' HA2' ' A' ' 10' ' ' GLY . 64.0 ttt180 -88.05 -32.92 18.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.78 0.324 . . . . 2.48 110.96 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.6 m-85 -95.54 -1.9 49.63 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.066 0.765 . . . . 0.81 113.066 -171.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.555 ' HB2' ' HB2' ' A' ' 1' ' ' ALA . 7.8 m-20 79.75 -2.91 2.06 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.447 1.099 . . . . 1.99 113.328 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.565 ' CG1' HG23 ' A' ' 76' ' ' ILE . 10.0 p -83.92 178.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 N-CA-C 107.985 -1.117 . . . . 0.37 107.985 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 21.3 tptm -136.27 130.76 33.51 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.197 -1.038 . . . . 2.12 108.197 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.511 HG12 ' HE2' ' A' ' 75' ' ' TYR . 37.2 mt -128.96 110.21 18.41 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 123.1 0.25 . . . . 0.25 110.612 -175.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.544 ' O ' HG23 ' A' ' 63' ' ' VAL . 70.1 Cg_endo -74.47 166.84 28.51 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.581 2.187 . . . . 0.33 109.811 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -59.93 -29.24 68.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.149 0.5 . . . . 1.98 110.124 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 25.6 t70 -62.81 -38.92 92.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.288 -0.869 . . . . 2.06 111.307 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 29.5 m-20 -87.14 -28.33 22.53 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.485 -0.486 . . . . 0.52 111.455 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.991 HG22 HG11 ' A' ' 47' ' ' VAL . 54.1 t -52.1 -46.71 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.16 -0.682 . . . . 0.38 109.16 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 45.7 pttt -70.9 -2.16 14.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.064 -0.971 . . . . 2.16 113.086 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 95.4 m-20 -96.06 -34.93 11.55 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.828 0.347 . . . . 1.59 110.399 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -76.32 112.68 13.06 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.913 -0.773 . . . . 0.31 108.913 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -33.52 7.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.551 0.691 . . . . 2.55 110.361 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.0 p -116.02 169.36 9.32 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.795 -1.187 . . . . 0.23 107.795 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.47 HG11 HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -78.65 -13.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 119.831 -0.747 . . . . 1.21 109.293 175.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -67.14 -44.63 86.63 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.953 -1.659 . . . . 0.33 108.953 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.34 -48.99 71.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.498 -0.926 . . . . 1.39 108.498 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.686 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -57.26 -61.65 2.32 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 114.851 -1.068 . . . . 0.15 111.424 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.635 HG21 ' HG2' ' A' ' 4' ' ' GLN . 28.1 m -58.64 -39.67 81.2 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 113.997 1.11 . . . . 0.24 113.997 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.487 ' HE2' HD23 ' A' ' 28' ' ' LEU . 5.3 mptp? -60.91 -51.08 70.8 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.2 -1.037 . . . . 3.63 108.2 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.511 ' HE2' HG12 ' A' ' 58' ' ' ILE . 89.6 t80 -55.88 -49.13 74.23 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.29 0.994 . . . . 0.4 110.687 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.662 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 78.1 mt -57.67 -66.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.022 -0.99 . . . . 0.21 111.109 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -52.46 -47.1 66.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.532 1.533 . . . . 1.44 109.799 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.72 -28.17 68.21 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.238 -1.346 . . . . 0.63 110.931 -172.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -103.47 -2.4 26.92 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 113.403 0.89 . . . . 1.25 113.403 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 10.4 mt-30 -78.78 -63.58 1.38 Allowed 'General case' 0 CA--C 1.468 -2.201 0 N-CA-C 106.699 -1.593 . . . . 0.87 106.699 175.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.277 -2.565 0 CA-C-N 111.5 -2.591 . . . . 1.97 109.805 -178.738 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.68 ' H8B' ' HB1' ' A' ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.504 -0.815 0 N-CA-C 108.285 -1.006 . . . . 1.42 108.285 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.68 -72.48 0.4 Allowed 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.089 -0.645 . . . . 1.85 111.876 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 t -171.08 -179.11 2.63 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 120.569 -0.452 . . . . 0.66 111.02 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.482 ' HG2' HG23 ' A' ' 8' ' ' VAL . 6.1 tm0? -57.43 -35.04 69.58 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 125.679 1.591 . . . . 0.74 112.469 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.76 -24.36 67.67 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.632 0.583 . . . . 2.66 111.335 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 -44.02 11.46 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.854 -0.795 . . . . 2.73 108.854 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.617 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 79.3 mt -64.31 -64.99 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.72 0 CA-C-N 116.158 -0.474 . . . . 0.23 112.012 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG23 ' HG2' ' A' ' 4' ' ' GLN . 55.2 t -56.97 -39.26 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 112.026 0.38 . . . . 0.27 112.026 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.74 -36.49 84.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.231 0.539 . . . . 0.27 110.576 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.55 -40.87 8.67 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 115.779 -0.646 . . . . 0.18 112.92 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.651 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -64.84 -36.07 83.15 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.491 -0.929 . . . . 0.2 108.491 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.52 -51.67 67.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.771 -0.65 . . . . 0.14 109.39 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.805 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 50.6 mt-10 -58.12 -41.9 84.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 124.204 0.94 . . . . 0.68 112.499 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 11' ' ' LEU . 76.7 mt -58.11 -43.42 85.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.503 -0.771 . . . . 0.28 109.701 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 21' ' ' ILE . 86.1 t -68.82 -23.89 28.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.872 0.844 . . . . 0.27 110.679 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.805 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 15.0 m-20 -75.06 -42.62 56.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.335 -0.987 . . . . 0.34 108.335 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.31 -41.19 57.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.845 -1.07 . . . . 2.07 111.636 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.731 HG13 HG22 ' A' ' 46' ' ' VAL . 30.8 mm -70.45 -53.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 116.701 -0.227 . . . . 0.65 111.007 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.594 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -106.31 -82.45 0.54 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.013 0.435 . . . . 0.54 110.607 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.34 43.96 0.02 OUTLIER Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.561 -0.828 . . . . 0.43 112.419 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.654 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -80.52 151.06 71.33 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.859 -0.423 . . . . 0.31 109.859 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.9 Cg_exo -86.17 33.3 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.155 2.57 . . . . 1.08 114.056 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.265 9.8 p 56.61 -20.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 C-N-CA 127.052 2.141 . . . . 0.81 116.433 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -95.51 -13.94 24.08 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.554 -0.716 . . . . 2.31 112.54 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 29.8 t0 -84.45 -28.2 26.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.728 0.775 . . . . 1.59 110.023 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 12' ' ' ALA . 25.5 t -73.6 93.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.577 -1.192 . . . . 0.3 109.072 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 69' ' ' VAL . 33.3 mmtp -131.09 151.88 50.97 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 106.954 -1.498 . . . . 1.58 106.954 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.44 HD22 ' HA2' ' A' ' 70' ' ' GLY . 50.7 mt -50.09 143.53 8.07 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.763 0.665 . . . . 1.05 109.531 177.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 82.8 4.81 0.97 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.9 1.28 . . . . 0.72 111.129 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -103.6 132.83 49.5 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 108.936 -0.764 . . . . 1.48 108.936 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 57.9 m -86.53 116.96 25.0 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 124.047 0.842 . . . . 1.25 109.666 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.734 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 94.6 m-85 -45.65 -67.46 0.28 Allowed 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 125.17 1.388 . . . . 0.4 114.178 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.467 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 14.7 t -71.79 -25.85 62.19 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.685 -1.259 . . . . 1.06 111.843 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.593 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 7.3 m-20 -87.62 -64.18 1.19 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.406 0.622 . . . . 1.74 110.972 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' SER . 4.5 m-20 -74.29 -57.6 3.84 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 115.282 -0.872 . . . . 1.29 110.439 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 26' ' ' VAL . 16.8 mt -68.17 -38.24 81.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.015 -0.993 . . . . 0.81 111.122 -172.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.2 t70 82.84 64.98 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.459 1.6 . . . . 1.12 109.558 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 19' ' ' ALA . 21.8 t -108.78 159.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 112.463 -2.153 . . . . 0.79 106.548 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.63 120.23 19.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.361 -0.977 . . . . 2.0 108.361 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.531 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 5.0 p -49.11 -38.15 23.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.078 0.951 . . . . 0.78 112.306 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 42' ' ' SER . 3.9 pp -70.63 -28.42 64.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.16 0.43 . . . . 1.18 112.16 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 46' ' ' VAL . 50.0 m -82.04 -15.7 52.72 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.425 0.631 . . . . 0.6 110.266 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -58.92 -37.35 76.48 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-N 115.445 -0.798 . . . . 0.86 111.715 -179.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.29 -45.72 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 124.087 0.867 . . . . 0.31 109.421 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.31 -49.79 74.99 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 108.615 -0.883 . . . . 0.68 108.615 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.731 HG22 HG13 ' A' ' 18' ' ' ILE . 54.2 t -57.34 -29.98 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.971 1.308 . . . . 0.63 111.672 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.86 HG21 HG13 ' A' ' 63' ' ' VAL . 38.3 t -76.96 -49.68 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.336 0 N-CA-C 108.294 -1.002 . . . . 0.55 108.294 -176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.27 -35.5 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-N 114.692 -1.14 . . . . 0.42 108.777 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.29 76.25 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.538 0.685 . . . . 0.21 109.915 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.71 -58.35 7.77 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 114.932 -1.031 . . . . 0.21 109.843 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.631 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.257 0.0 OUTLIER -61.15 -37.03 81.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.056 1.132 . . . . 0.64 114.056 -177.375 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.69 -37.58 76.39 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.296 0.373 . . . . 2.07 111.401 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -84.73 -37.84 20.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.052 0.389 . . . . 2.48 112.052 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.0 m-85 -92.68 -11.03 35.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.352 1.242 . . . . 0.81 114.352 -170.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 1' ' ' ALA . 25.2 m-20 87.51 4.22 0.33 Allowed 'General case' 0 N--CA 1.519 2.995 0 N-CA-C 114.448 1.277 . . . . 1.99 114.448 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.75 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.1 p -84.12 175.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.183 -1.414 . . . . 0.37 107.183 175.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 20.5 tptp -131.75 122.35 25.7 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.887 -1.894 . . . . 2.12 105.887 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.564 HG13 ' HB3' ' A' ' 51' ' ' GLU . 52.4 mt -113.72 107.05 53.25 Favored Pre-proline 0 C--N 1.291 -1.969 0 C-N-CA 119.754 -0.778 . . . . 0.25 110.618 -174.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 63' ' ' VAL . 36.3 Cg_endo -64.8 152.38 82.3 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 C-N-CA 122.948 2.432 . . . . 0.33 109.739 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.2 -33.57 53.34 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.561 0.744 . . . . 1.98 111.153 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 21.5 t70 -62.43 -43.51 98.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.546 -0.752 . . . . 2.06 111.679 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.452 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 40.9 m-20 -86.46 -21.83 26.82 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.403 0.52 . . . . 0.52 112.403 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.86 HG13 HG21 ' A' ' 47' ' ' VAL . 51.1 t -53.68 -50.43 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.246 -1.02 . . . . 0.38 108.246 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.1 pttp -79.55 -1.47 37.96 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.523 -1.217 . . . . 2.16 111.332 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.25 -18.84 24.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.295 -1.002 . . . . 1.59 108.295 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.824 HD13 ' HA ' ' A' ' 72' ' ' ALA . 27.6 mt -90.38 117.82 29.39 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 106.783 -1.562 . . . . 0.31 106.783 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.82 -37.63 6.96 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.695 -0.802 . . . . 2.55 110.769 175.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 41.1 p -109.73 178.87 4.29 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 109.486 -0.561 . . . . 0.23 109.486 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.734 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -85.08 -13.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.365 -0.976 . . . . 1.21 108.365 173.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -67.5 -49.07 53.52 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 107.165 -2.374 . . . . 0.33 107.165 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 68' ' ' THR . 8.6 m-20 -56.43 -57.09 13.81 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 124.95 1.3 . . . . 1.39 110.411 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.824 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.34 -60.99 2.56 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.442 1.089 . . . . 0.15 111.667 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 7' ' ' ILE . 34.4 m -60.39 -45.33 93.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 113.26 0.837 . . . . 0.24 113.26 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.6 mptm? -63.52 -22.72 67.05 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 122.651 0.38 . . . . 3.63 110.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -82.2 -52.92 6.49 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 116.041 -0.527 . . . . 0.4 109.599 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.75 ' HA ' HG21 ' A' ' 56' ' ' VAL . 71.6 mt -52.74 -66.93 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 C-N-CA 124.827 1.251 . . . . 0.21 111.351 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -52.95 -39.91 63.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.552 1.541 . . . . 1.44 111.9 -177.267 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -72.69 -26.29 61.56 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 113.261 -1.791 . . . . 0.63 111.481 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -103.08 -8.59 20.42 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.994 0.739 . . . . 1.25 112.994 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.709 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 9.4 mt-30 -76.79 -65.8 0.9 Allowed 'General case' 0 CA--C 1.476 -1.88 0 CA-C-O 123.104 1.43 . . . . 0.87 108.225 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.268 -2.966 0 CA-C-N 111.821 -2.445 . . . . 1.97 109.694 -176.71 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.672 ' H2A' ' N41' ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 109.354 -0.61 . . . . 1.42 109.354 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.49 -71.56 0.1 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.994 -0.548 . . . . 1.85 109.571 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.479 ' HA ' HD13 ' A' ' 77' ' ' LEU . 15.1 t -166.43 175.13 8.37 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 116.241 -0.436 . . . . 0.66 109.869 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.601 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.8 OUTLIER -47.71 -39.92 18.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.163 1.385 . . . . 0.74 113.238 174.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -59.2 -22.56 61.2 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.519 0.933 . . . . 2.66 113.519 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 3' ' ' THR . 29.9 tt0 -79.15 -39.82 32.5 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.806 -0.812 . . . . 2.73 108.806 174.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 77' ' ' LEU . 63.9 mt -76.7 -66.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.643 -1.162 . . . . 0.23 111.526 -169.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 28' ' ' LEU . 48.1 t -56.51 -47.08 82.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 111.554 0.205 . . . . 0.27 111.554 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.35 -36.2 66.04 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.75 0.656 . . . . 0.27 112.212 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.4 -43.87 6.79 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 120.907 -0.663 . . . . 0.18 112.21 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -61.09 -39.9 91.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 124.402 1.081 . . . . 0.2 109.216 -177.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.31 -48.2 77.17 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 115.897 -0.592 . . . . 0.14 109.905 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.855 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 97.3 mt-10 -63.59 -34.09 77.04 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.983 0.802 . . . . 0.68 112.278 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 11' ' ' LEU . 58.9 mt -68.26 -38.8 80.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.829 -0.623 . . . . 0.28 109.495 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 11' ' ' LEU . 59.7 t -72.26 -23.6 21.61 Favored 'Isoleucine or valine' 0 C--O 1.253 1.279 0 CA-C-O 121.427 0.632 . . . . 0.27 110.206 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.855 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 32.4 m-20 -62.5 -37.83 87.54 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.776 -0.824 . . . . 0.34 108.776 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -84.08 -47.64 10.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 2.07 112.309 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.835 HG13 ' HB ' ' A' ' 46' ' ' VAL . 25.0 mm -54.2 -52.38 38.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.654 0.782 . . . . 0.65 111.427 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -118.51 -56.66 2.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.118 0.485 . . . . 0.54 110.832 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 16' ' ' ASN . . . 135.95 40.6 0.14 Allowed Glycine 0 CA--C 1.49 -1.529 0 C-N-CA 120.292 -0.956 . . . . 0.43 112.29 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.816 HG21 HG23 ' A' ' 26' ' ' VAL . 1.4 mp -75.64 147.31 81.45 Favored Pre-proline 0 C--O 1.202 -1.413 0 N-CA-C 109.06 -0.719 . . . . 0.31 109.06 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.3 Cg_exo -85.44 34.5 0.49 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 123.232 2.621 . . . . 1.08 113.992 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.274 9.8 p 56.9 -15.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 C-N-CA 127.326 2.251 . . . . 0.81 116.513 177.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.24 -18.6 19.92 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.638 -0.664 . . . . 2.31 111.615 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 25.5 t0 -85.42 -24.7 27.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 120.29 -0.564 . . . . 1.59 110.609 -170.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.816 HG23 HG21 ' A' ' 21' ' ' ILE . 42.6 t -72.54 92.58 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.852 -1.166 . . . . 0.3 107.852 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 69' ' ' VAL . 9.4 tppt? -125.16 160.37 29.3 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.801 -2.296 . . . . 1.58 104.801 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.517 ' HA ' HG22 ' A' ' 69' ' ' VAL . 6.4 mp -64.22 148.72 49.46 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 118.624 0.647 . . . . 1.05 109.651 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.408 ' H ' ' N ' ' A' ' 70' ' ' GLY . 31.2 t70 76.98 11.58 2.4 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.506 -1.225 . . . . 0.72 110.665 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 35.8 mmtp -99.04 122.95 42.96 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 108.927 -0.768 . . . . 1.48 108.927 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 39.2 m -76.82 28.04 0.13 Allowed 'General case' 1 C--N 1.242 -4.071 0 C-N-CA 126.643 1.977 . . . . 1.25 114.854 -172.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.704 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 91.0 m-85 44.62 -93.0 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.4 113.698 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.3 t -77.27 44.02 0.4 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.399 1.095 . . . . 1.06 111.229 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.9 t70 -159.46 -55.47 0.06 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 108.858 -0.793 . . . . 1.74 108.858 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.557 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 33.4 m-20 -84.2 -34.95 23.83 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.134 -0.939 . . . . 1.29 111.955 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 33.3 mt -85.11 -88.94 0.11 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.31 -0.626 . . . . 0.81 109.31 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.449 ' H ' ' HB2' ' A' ' 36' ' ' LEU . 21.6 t70 157.11 64.67 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.609 -1.997 . . . . 1.12 105.609 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.54 HG11 ' HE3' ' A' ' 43' ' ' MET . 4.9 t -118.81 150.77 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.635 -0.712 . . . . 0.79 110.142 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.16 110.12 9.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.752 . . . . 2.0 108.968 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.568 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 29.5 t -41.06 -47.45 3.13 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.735 1.614 . . . . 0.78 114.071 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.9 pt? -64.67 -34.49 78.41 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.063 -0.398 . . . . 1.18 111.45 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 18' ' ' ILE . 14.7 m -82.2 -13.12 57.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.195 0.522 . . . . 0.6 111.002 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.704 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.26 -36.97 79.02 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 123.361 0.665 . . . . 0.86 110.289 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.11 -47.13 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 O-C-N 123.836 0.71 . . . . 0.31 110.31 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -56.69 -53.64 55.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.216 0.607 . . . . 0.68 110.358 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.835 ' HB ' HG13 ' A' ' 18' ' ' ILE 0.34 1.7 p -61.92 -22.59 29.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 N-CA-C 114.228 1.195 . . . . 0.63 114.228 -178.423 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.972 HG22 ' H6A' ' A' ' 101' ' ' SYO . 44.5 t -71.23 -50.38 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.746 -1.205 . . . . 0.55 107.746 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.28 -35.24 73.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 108.397 -0.964 . . . . 0.42 108.397 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 46' ' ' VAL . . . -68.06 -35.25 77.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.308 -0.86 . . . . 0.21 109.947 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.73 -59.08 4.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.508 -1.224 . . . . 0.21 109.102 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.273 0.0 OUTLIER -59.96 -39.31 85.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 114.461 1.282 . . . . 0.64 114.461 -175.135 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -58.92 -40.58 85.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.92 0.391 . . . . 2.07 111.835 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.9 -27.14 43.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.109 -0.496 . . . . 2.48 111.059 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.502 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 7.1 m-85 -104.27 3.06 32.25 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.675 -0.81 . . . . 0.81 112.322 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 28.0 t70 80.46 -5.68 1.75 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.821 1.248 . . . . 1.99 112.851 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 76' ' ' ILE . 10.6 p -82.02 173.43 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 121.29 -0.881 . . . . 0.37 109.205 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 18.4 tptm -128.62 127.28 41.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.552 -1.647 . . . . 2.12 106.552 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.509 HG13 ' HB3' ' A' ' 51' ' ' GLU . 64.0 mt -119.42 111.99 36.09 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.736 -0.386 . . . . 0.25 110.921 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.522 ' O ' HG23 ' A' ' 63' ' ' VAL . 58.7 Cg_endo -69.25 159.83 52.23 Favored 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 123.047 2.498 . . . . 0.33 110.808 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 22.1 t70 -52.78 -41.45 64.11 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.73 0.812 . . . . 1.98 112.116 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.5 -32.12 72.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.933 -0.576 . . . . 2.06 110.938 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 20.0 m-20 -86.3 -24.96 25.72 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.342 -0.543 . . . . 0.52 111.839 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.935 HG13 HG21 ' A' ' 47' ' ' VAL . 52.7 t -54.38 -51.58 47.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.588 -1.264 . . . . 0.38 107.588 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 13.8 ptmm? -78.51 -2.66 39.74 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.944 -1.026 . . . . 2.16 111.609 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -88.26 -29.67 20.24 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.935 -1.135 . . . . 1.59 107.935 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.693 HD13 ' HA ' ' A' ' 72' ' ' ALA . 29.4 mt -82.56 113.41 20.26 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 107.583 -1.265 . . . . 0.31 107.583 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -106.77 -40.2 5.58 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 119.866 -0.734 . . . . 2.55 109.129 176.003 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 p -108.26 178.29 4.54 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 119.715 -0.794 . . . . 0.23 109.307 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -86.63 -13.06 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.296 -1.002 . . . . 1.21 108.296 175.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.408 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -72.17 -37.63 59.59 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 108.114 -1.994 . . . . 0.33 108.114 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.1 -60.56 2.52 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.069 1.348 . . . . 1.39 109.492 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.693 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.49 -60.47 3.1 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 114.473 -1.239 . . . . 0.15 111.961 -176.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.601 HG21 ' HG2' ' A' ' 4' ' ' GLN . 61.6 m -59.39 -39.93 84.93 Favored 'General case' 0 N--CA 1.419 -2.0 0 O-C-N 124.102 0.877 . . . . 0.24 112.611 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 75' ' ' TYR . 9.7 tmtt? -61.37 -50.76 71.6 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.456 -0.942 . . . . 3.63 108.456 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' HE2' HG12 ' A' ' 58' ' ' ILE . 85.2 t80 -56.51 -50.71 71.0 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.321 1.013 . . . . 0.4 110.814 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.648 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -55.2 -66.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 114.009 -1.45 . . . . 0.21 110.223 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.646 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 64.5 tp -55.45 -38.4 68.98 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 123.968 0.907 . . . . 1.44 112.349 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.49 -28.75 67.3 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.363 -0.835 . . . . 0.63 111.194 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -102.03 -14.8 17.0 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.417 0.895 . . . . 1.25 113.417 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 66.7 mt-30 -66.43 -59.44 3.67 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 123.219 1.485 . . . . 0.87 107.753 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.259 -3.337 0 CA-C-N 111.092 -2.776 . . . . 1.97 108.823 -179.263 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.972 ' H6A' HG22 ' A' ' 47' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 109.546 -0.539 . . . . 1.42 109.546 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.06 -155.64 0.23 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.457 -1.312 . . . . 1.85 107.457 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t -131.96 -170.99 2.51 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.954 -0.387 . . . . 0.66 109.954 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.402 ' HG2' HG23 ' A' ' 8' ' ' VAL . 10.5 tm0? -49.12 -41.44 36.04 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.817 1.247 . . . . 0.74 113.552 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.59 -25.51 67.38 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.452 0.538 . . . . 2.66 112.452 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -87.19 -30.77 20.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.751 0.786 . . . . 2.73 109.108 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.419 HG23 ' CE2' ' A' ' 54' ' ' PHE . 96.1 mt -79.7 -65.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 CA-C-N 115.26 -0.882 . . . . 0.23 110.987 -172.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 4' ' ' GLN . 82.3 t -54.18 -46.71 67.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 122.568 0.347 . . . . 0.27 111.925 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.12 73.93 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.496 0.497 . . . . 0.27 111.546 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.77 -33.24 19.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.941 -0.572 . . . . 0.18 112.906 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -69.55 -34.66 74.53 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.044 -1.095 . . . . 0.2 108.044 -178.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.05 -46.47 75.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.28 -0.873 . . . . 0.14 108.826 173.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.808 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 41.9 mt-10 -61.61 -43.02 99.64 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 124.276 0.985 . . . . 0.68 111.86 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.5 mt -58.71 -39.72 77.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.591 0.71 . . . . 0.28 109.644 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.743 HG12 ' HB ' ' A' ' 21' ' ' ILE . 62.7 t -70.74 -21.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.897 0.856 . . . . 0.27 110.015 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.808 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 16.1 m-20 -80.47 -50.34 10.19 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.628 -1.249 . . . . 0.34 107.628 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.53 -50.25 59.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 2.07 112.279 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.01 -53.32 21.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.244 0.545 . . . . 0.65 109.86 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.56 -90.24 0.29 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.175 -0.466 . . . . 0.54 111.242 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.94 38.75 0.02 OUTLIER Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.599 -0.81 . . . . 0.43 113.104 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.743 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -80.99 155.1 72.87 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 109.417 -0.586 . . . . 0.31 109.417 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 4.8 Cg_exo -88.46 32.66 0.39 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.938 3.092 . . . . 1.08 114.768 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.533 ' HB ' HD22 ' A' ' 16' ' ' ASN . 5.2 p 60.05 -21.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.07 0 C-N-CA 127.147 2.179 . . . . 0.81 116.063 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -93.23 -20.32 20.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 112.691 0.626 . . . . 2.31 112.691 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.83 -30.77 51.25 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 120.74 -0.384 . . . . 1.59 111.258 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' A' ' 12' ' ' ALA . 34.7 t -72.89 97.88 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.28 -0.873 . . . . 0.3 109.672 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -135.69 151.03 49.78 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 104.413 -2.439 . . . . 1.58 104.413 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.548 HD22 ' HA2' ' A' ' 70' ' ' GLY . 49.3 mt -50.96 148.49 4.2 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.59 0.632 . . . . 1.05 109.574 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.7 t70 76.98 18.88 1.45 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.976 1.37 . . . . 0.72 109.94 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -119.21 128.46 54.23 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 114.703 -1.135 . . . . 1.48 108.442 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 5.7 m -87.36 112.1 21.77 Favored 'General case' 0 C--N 1.244 -3.983 0 N-CA-C 107.417 -1.327 . . . . 1.25 107.417 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.792 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.1 m-85 -46.63 -47.23 20.09 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.436 1.095 . . . . 0.4 112.708 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.426 HG21 ' C37' ' A' ' 101' ' ' SYO . 15.3 t -98.86 21.75 11.1 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 112.574 0.583 . . . . 1.06 112.574 -174.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 13.6 t70 -146.48 -56.89 0.28 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 1.74 109.792 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.22 -39.27 55.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.881 -1.054 . . . . 1.29 110.402 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' HA ' ' A' ' 32' ' ' PHE . 35.6 mt -83.61 -93.17 0.07 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.513 -0.767 . . . . 0.81 110.365 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 32.6 t70 168.09 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 121.349 0.595 . . . . 1.12 111.127 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.541 HG11 ' HE3' ' A' ' 43' ' ' MET . 41.5 t -77.29 134.82 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 O-C-N 121.178 -0.951 . . . . 0.79 112.039 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 5.3 t70 -47.37 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 129.218 3.007 . . . . 2.0 117.297 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 43' ' ' MET . 30.5 t 75.03 -54.96 0.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.455 1.279 . . . . 0.78 114.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.488 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -74.58 -29.28 61.27 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.085 -1.446 . . . . 1.18 109.37 178.014 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 46' ' ' VAL . 67.3 m -70.6 -16.09 62.81 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.157 -0.929 . . . . 0.6 111.412 173.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.629 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -62.24 -41.35 98.34 Favored 'General case' 0 CA--C 1.473 -1.993 0 C-N-CA 123.101 0.56 . . . . 0.86 111.851 -178.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -57.29 -43.13 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 124.302 1.001 . . . . 0.31 109.734 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -56.5 -47.51 79.16 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.855 -0.611 . . . . 0.68 109.782 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 42' ' ' SER . 40.3 t -60.91 -24.59 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.32 -0.855 . . . . 0.63 111.107 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.028 HG22 ' H6A' ' A' ' 101' ' ' SYO . 29.2 t -81.11 -53.07 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 108.182 -1.044 . . . . 0.55 108.182 -177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 -29.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.739 -1.119 . . . . 0.42 109.762 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.57 58.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.282 -0.636 . . . . 0.21 109.282 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.58 -53.63 44.73 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.103 -0.953 . . . . 0.21 109.272 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.258 0.0 OUTLIER -63.97 -34.93 79.09 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.663 0.986 . . . . 0.64 113.663 -177.716 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -64.28 -36.89 85.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.117 0.484 . . . . 2.07 111.375 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.61 -35.91 20.69 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.451 -0.795 . . . . 2.48 111.891 -172.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 11.4 m-85 -89.76 -45.1 9.54 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 118.926 -1.11 . . . . 0.81 113.185 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 13.5 t70 154.11 -33.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 124.618 1.199 . . . . 1.99 111.781 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' A' ' 79' ' ' HIS . 9.3 p -76.85 -177.0 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.449 0.537 . . . . 0.37 112.449 -165.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' H ' HG22 ' A' ' 56' ' ' VAL . 7.4 ttmm -135.98 131.37 34.97 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.721 -1.585 . . . . 2.12 106.721 169.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.621 HG23 ' HE2' ' A' ' 75' ' ' TYR . 45.4 mt -122.03 111.64 32.26 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 123.425 0.453 . . . . 0.25 110.347 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.602 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.9 Cg_endo -72.31 160.34 47.28 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.982 2.455 . . . . 0.33 110.634 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.11 -43.32 41.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.751 . . . . 1.98 111.74 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 35.0 t70 -63.64 -34.22 77.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 2.06 112.68 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.589 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 67.0 m-20 -86.15 -28.22 24.1 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.113 -0.635 . . . . 0.52 110.993 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.928 HG13 HG21 ' A' ' 47' ' ' VAL . 76.8 t -55.61 -55.46 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.363 -0.977 . . . . 0.38 108.363 174.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 61' ' ' ASP . 17.1 pttp -69.62 -1.19 8.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.927 -1.033 . . . . 2.16 112.891 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.86 -23.5 16.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.86 -1.163 . . . . 1.59 107.86 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.03 ' HB2' ' H4A' ' A' ' 101' ' ' SYO . 21.6 mt -91.59 125.17 36.23 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 106.726 -1.583 . . . . 0.31 106.726 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -113.24 -39.63 4.11 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.336 -0.987 . . . . 2.55 108.336 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.702 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.8 p -104.53 179.58 4.23 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-N 115.463 -0.79 . . . . 0.23 109.887 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.792 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -87.08 -13.95 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 108.237 -1.024 . . . . 1.21 108.237 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.548 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -69.03 -47.59 53.12 Favored Glycine 0 CA--C 1.492 -1.39 0 N-CA-C 107.437 -2.265 . . . . 0.33 107.437 172.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 23.7 m-20 -56.6 -55.91 28.04 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 125.271 1.429 . . . . 1.39 110.925 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.894 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -54.56 -60.49 3.28 Favored 'General case' 0 CA--C 1.479 -1.763 0 O-C-N 124.472 1.107 . . . . 0.15 112.166 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.8 HG22 HD23 ' A' ' 77' ' ' LEU . 33.7 m -54.55 -51.48 65.09 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.013 -0.994 . . . . 0.24 112.949 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -51.07 -29.25 12.41 Favored 'General case' 0 C--O 1.197 -1.675 0 C-N-CA 126.749 2.019 . . . . 3.63 111.444 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.621 ' HE2' HG23 ' A' ' 58' ' ' ILE . 73.1 t80 -85.21 -48.89 8.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.61 -0.723 . . . . 0.4 109.333 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.666 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.9 mt -56.51 -63.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 114.697 -1.138 . . . . 0.21 109.372 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.8 HD23 HG22 ' A' ' 73' ' ' THR . 4.5 pp -56.97 -36.58 70.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.734 0.778 . . . . 1.44 112.622 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.47 ' N ' HD12 ' A' ' 77' ' ' LEU . 5.5 t70 -76.5 -26.74 55.59 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.472 -1.24 . . . . 0.63 111.276 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.617 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 20.5 t-80 -94.98 -16.38 22.81 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.003 -0.544 . . . . 1.25 109.983 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 32.7 mt-30 -76.07 -56.67 4.44 Favored 'General case' 0 CA--C 1.478 -1.789 0 CA-C-O 122.729 1.252 . . . . 0.87 108.187 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.735 0 CA-C-N 112.328 -2.215 . . . . 1.97 110.821 -173.984 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 1.03 ' H4A' ' HB2' ' A' ' 66' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.965 0 N-CA-C 106.945 -1.502 . . . . 1.42 106.945 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.59 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -146.57 132.69 19.33 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 116.405 -0.361 . . . . 1.85 111.169 -169.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.44 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.7 t -89.34 176.1 7.07 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 105.874 -1.898 . . . . 0.66 105.874 171.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.419 ' HG2' HG23 ' A' ' 8' ' ' VAL . 11.5 tm0? -46.62 -46.76 19.94 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.823 1.416 . . . . 0.74 114.823 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.36 -23.54 65.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.966 1.099 . . . . 2.66 113.966 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.59 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 8.8 tp10 -87.95 -33.99 18.25 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.426 -0.953 . . . . 2.73 108.426 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.621 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.3 mt -72.0 -65.35 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.515 0 CA-C-N 115.955 -0.566 . . . . 0.23 110.61 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.518 HG13 HG21 ' A' ' 69' ' ' VAL . 26.4 t -59.85 -26.7 36.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 111.934 0.346 . . . . 0.27 111.934 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.42 -37.91 68.52 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.942 -0.703 . . . . 0.27 110.124 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.68 -36.44 11.85 Favored Glycine 0 N--CA 1.419 -2.456 0 CA-C-N 116.186 -0.461 . . . . 0.18 113.068 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.07 -35.36 80.32 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.571 -0.899 . . . . 0.2 108.571 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.792 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -57.08 -44.3 82.99 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.87 -0.605 . . . . 0.14 109.74 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.835 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 46.4 mt-10 -62.69 -42.55 99.69 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.175 -0.92 . . . . 0.68 111.834 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 11' ' ' LEU . 50.2 mt -61.14 -36.63 73.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.923 0.868 . . . . 0.28 109.848 177.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.677 HG12 ' HB ' ' A' ' 21' ' ' ILE . 60.5 t -74.97 -23.27 17.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.224 -0.898 . . . . 0.27 110.325 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.835 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 52.6 m-20 -70.25 -46.35 64.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.631 -0.877 . . . . 0.34 108.631 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.06 -49.38 17.66 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.997 -1.001 . . . . 2.07 113.482 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.652 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.9 mt -75.64 -51.1 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 112.327 0.492 . . . . 0.65 112.327 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.717 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -91.68 -75.28 0.48 Allowed 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.273 -0.571 . . . . 0.54 110.384 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.54 41.0 0.04 OUTLIER Glycine 0 C--N 1.3 -1.442 0 CA-C-N 115.564 -0.744 . . . . 0.43 112.572 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.833 HG21 HG23 ' A' ' 26' ' ' VAL . 1.5 mp -81.98 150.66 65.66 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 109.055 -0.72 . . . . 0.31 109.055 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 8.2 Cg_exo -87.02 33.46 0.43 Allowed 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 124.348 3.365 . . . . 1.08 114.27 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.567 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.324 9.2 p 60.81 -18.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.091 2.157 . . . . 0.81 116.597 175.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -96.79 -11.34 25.07 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.391 -0.818 . . . . 2.31 111.79 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.494 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.4 m-20 -79.73 -33.2 41.02 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.094 0.474 . . . . 1.59 110.495 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.833 HG23 HG21 ' A' ' 21' ' ' ILE . 40.9 t -72.83 93.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.969 -1.014 . . . . 0.3 110.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -124.7 168.23 13.46 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.69 -1.596 . . . . 1.58 106.69 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.573 ' HA ' HG22 ' A' ' 69' ' ' VAL . 5.8 mp -68.05 151.19 47.44 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.905 -1.146 . . . . 1.05 107.905 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 t70 76.68 12.84 2.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.282 1.039 . . . . 0.72 109.548 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -111.65 125.21 53.71 Favored 'General case' 0 CA--C 1.458 -2.576 0 O-C-N 121.7 -0.625 . . . . 1.48 110.442 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 12.2 m -80.26 111.89 17.07 Favored 'General case' 0 C--N 1.247 -3.854 0 CA-C-N 114.428 -1.26 . . . . 1.25 108.213 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 36' ' ' LEU . 90.8 m-85 -48.41 -55.48 10.73 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.445 0.698 . . . . 0.4 110.548 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.704 HG21 ' H37' ' A' ' 101' ' ' SYO . 12.3 t -84.08 25.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.595 0.591 . . . . 1.06 112.595 -175.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -156.11 -62.14 0.11 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.535 0.684 . . . . 1.74 111.237 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -70.79 -39.52 73.08 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 124.368 1.067 . . . . 1.29 110.466 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.608 HD13 HG22 ' A' ' 26' ' ' VAL . 16.4 mt -88.11 -50.44 6.39 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.202 -0.908 . . . . 0.81 110.802 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 95.03 68.66 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.852 2.061 . . . . 1.12 110.723 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 19' ' ' ALA . 47.4 t -101.42 132.45 47.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 CA-C-N 113.366 -1.743 . . . . 0.79 106.577 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -62.68 20.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.545 2.054 . . . . 2.0 116.545 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.484 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 28.6 t 61.99 -57.89 0.12 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 116.139 1.903 . . . . 0.78 116.139 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.57 -29.58 70.82 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.953 0.882 . . . . 1.18 109.987 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.652 ' HB3' HG22 ' A' ' 18' ' ' ILE . 1.6 m -75.05 -22.52 58.34 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.277 -1.329 . . . . 0.6 110.656 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.751 ' HB3' ' H2A' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -60.27 -43.75 95.9 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 123.743 0.817 . . . . 0.86 112.341 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.63 -36.95 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 O-C-N 123.946 0.779 . . . . 0.31 110.605 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.28 -43.94 93.23 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 108.768 -0.827 . . . . 0.68 108.768 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 42' ' ' SER . 58.3 t -61.96 -25.05 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.469 1.107 . . . . 0.63 111.11 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.884 HG11 HG22 ' A' ' 63' ' ' VAL . 55.3 t -77.25 -55.71 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 107.422 -1.325 . . . . 0.55 107.422 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 58.6 t -57.3 -40.79 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 O-C-N 124.806 1.316 . . . . 0.42 108.94 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -65.6 -35.24 80.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.373 0.606 . . . . 0.21 110.685 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -68.57 -57.13 6.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.351 -0.841 . . . . 0.21 109.783 178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.69 -33.95 76.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.634 0.976 . . . . 0.64 113.634 -177.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 51.8 mt-10 -59.32 -53.17 61.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.643 0.259 . . . . 2.07 110.368 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -66.18 -47.12 74.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.513 0.56 . . . . 2.48 112.513 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.621 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.3 m-85 -84.37 -9.41 58.45 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.648 0.61 . . . . 0.81 112.648 -172.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 85.05 3.59 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 116.385 1.994 . . . . 1.99 116.385 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 13.9 p -82.91 171.72 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.129 -1.028 . . . . 0.37 108.863 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -120.17 128.02 53.01 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.815 -1.55 . . . . 2.12 106.815 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.506 HG13 ' HB3' ' A' ' 51' ' ' GLU . 60.3 mt -116.79 108.97 43.81 Favored Pre-proline 0 C--N 1.308 -1.198 0 C-N-CA 119.964 -0.694 . . . . 0.25 111.52 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 63' ' ' VAL . 51.7 Cg_endo -69.02 159.13 55.19 Favored 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 123.184 2.59 . . . . 0.33 110.928 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.22 -33.62 67.71 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.681 0.792 . . . . 1.98 110.21 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.81 -38.07 89.26 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.067 -0.97 . . . . 2.06 110.835 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.544 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 41.1 m-20 -87.04 -25.17 24.34 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.187 -0.605 . . . . 0.52 112.464 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.884 HG22 HG11 ' A' ' 47' ' ' VAL . 94.7 t -55.88 -42.09 69.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.441 -0.948 . . . . 0.38 108.441 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -78.18 -5.32 51.42 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.669 -0.696 . . . . 2.16 112.304 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.43 -25.58 16.85 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 109.822 -0.436 . . . . 1.59 109.822 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.866 HD13 ' HA ' ' A' ' 72' ' ' ALA . 22.0 mt -89.12 122.04 32.04 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 107.095 -1.446 . . . . 0.31 107.095 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' SER . 8.3 mptt -120.21 -34.88 3.57 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.505 -0.924 . . . . 2.55 108.505 174.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 39.4 p -106.41 173.47 6.3 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 108.894 -0.78 . . . . 0.23 108.894 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 28' ' ' LEU . 1.4 m -81.92 -13.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 C-N-CA 119.35 -0.94 . . . . 1.21 108.535 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.46 -43.53 92.24 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 108.632 -1.787 . . . . 0.33 108.632 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.73 -56.84 13.98 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.866 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.12 -61.02 2.53 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 114.087 -1.415 . . . . 0.15 112.506 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.492 ' HA ' HG21 ' A' ' 7' ' ' ILE . 49.9 m -56.62 -46.3 81.02 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.492 1.12 . . . . 0.24 112.451 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -56.51 -52.34 65.1 Favored 'General case' 0 N--CA 1.41 -2.469 0 O-C-N 124.453 1.095 . . . . 3.63 108.765 177.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.545 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 74.4 t80 -55.18 -50.51 69.18 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 124.057 0.848 . . . . 0.4 111.515 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.631 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.8 mt -54.4 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-N 114.151 -1.386 . . . . 0.21 110.207 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.494 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 4.2 tt -57.95 -45.51 86.53 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.615 0.766 . . . . 1.44 110.182 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.85 -24.07 66.67 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.049 0.94 . . . . 0.63 111.384 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -98.8 -26.42 14.32 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 113.011 0.745 . . . . 1.25 113.011 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.45 2.7 pp0? -99.99 -99.02 0.24 Allowed 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 116.405 2.002 . . . . 0.87 116.405 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.426 ' H ' ' CD ' ' A' ' 80' ' ' GLN . . . . . . . . 0 C--N 1.258 -3.375 0 CA-C-N 116.098 -0.501 . . . . 1.97 111.271 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.851 ' H4A' ' HB2' ' A' ' 66' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.408 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 0 CA--C 1.508 -0.654 0 N-CA-C 108.629 -0.878 . . . . 1.42 108.629 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -157.4 133.83 9.77 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.306 -1.368 . . . . 1.85 107.306 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 7' ' ' ILE . 6.6 t -89.06 -178.05 5.59 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.736 -0.786 . . . . 0.66 110.751 -174.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.1 tm0? -47.79 -43.21 27.39 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.015 0.926 . . . . 0.74 113.357 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.48 -34.73 62.12 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.594 0.559 . . . . 2.66 111.709 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 19.3 tp10 -87.31 -34.88 18.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.884 -0.598 . . . . 2.73 109.941 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.538 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.7 mt -68.54 -65.72 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 CA-C-N 116.497 -0.319 . . . . 0.23 110.528 -174.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -41.52 67.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 112.386 0.513 . . . . 0.27 112.386 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -61.54 -42.28 98.59 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.033 0.444 . . . . 0.27 110.348 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.0 -40.91 28.93 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 121.028 -0.606 . . . . 0.18 113.081 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.16 -38.53 91.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.775 -0.824 . . . . 0.2 108.775 -178.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.619 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.13 -48.24 80.84 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.792 -0.64 . . . . 0.14 109.573 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.69 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 52.5 mt-10 -60.21 -39.37 86.33 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.895 0.747 . . . . 0.68 111.998 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 11' ' ' LEU . 62.9 mt -61.24 -41.88 91.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.009 -0.541 . . . . 0.28 109.754 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 11' ' ' LEU . 46.7 t -71.42 -23.55 22.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.357 0.599 . . . . 0.27 109.945 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.69 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.5 m120 -68.2 -48.81 64.21 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.905 -1.146 . . . . 0.34 107.905 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -69.88 -42.98 72.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.895 -1.048 . . . . 2.07 111.821 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.747 HG13 HG22 ' A' ' 46' ' ' VAL . 19.2 mm -73.85 -53.71 16.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 116.01 -0.541 . . . . 0.65 111.707 -177.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.52 -62.99 1.38 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.171 0.51 . . . . 0.54 111.403 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.33 39.13 0.07 OUTLIER Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.414 -0.898 . . . . 0.43 112.964 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.721 HG21 HG23 ' A' ' 26' ' ' VAL . 1.2 mp -78.03 152.35 79.54 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.459 -0.571 . . . . 0.31 109.459 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.6 Cg_endo -89.85 25.37 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.984 2.456 . . . . 1.08 115.052 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.477 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 5.0 p 53.62 15.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 125.447 1.499 . . . . 0.81 113.857 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.0 pt-20 -123.13 -16.07 7.08 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.888 -0.596 . . . . 2.31 110.338 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.441 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 22.0 t70 -92.41 -25.64 18.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.675 0.75 . . . . 1.59 110.108 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.721 HG23 HG21 ' A' ' 21' ' ' ILE . 43.0 t -76.09 92.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.444 -1.253 . . . . 0.3 108.863 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -125.87 166.78 16.25 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.576 -1.268 . . . . 1.58 107.576 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.403 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 9.5 mp -63.53 146.0 54.54 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.45 -0.574 . . . . 1.05 109.45 176.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.48 12.47 3.87 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.119 1.367 . . . . 0.72 110.431 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 68' ' ' THR . 73.7 mmtt -103.57 124.79 49.45 Favored 'General case' 0 CA--C 1.47 -2.11 0 O-C-N 121.791 -0.568 . . . . 1.48 109.777 176.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 6.3 m -83.23 110.86 18.43 Favored 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 114.488 -1.233 . . . . 1.25 108.427 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.662 ' HA ' HD12 ' A' ' 36' ' ' LEU . 98.2 m-85 -42.02 -67.23 0.28 Allowed 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 125.725 1.61 . . . . 0.4 112.426 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.505 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 14.8 t -101.56 49.35 0.87 Allowed 'General case' 0 C--N 1.275 -2.658 0 C-N-CA 118.776 -1.17 . . . . 1.06 111.134 -177.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 29.4 t70 -154.62 -53.72 0.1 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.73 -1.123 . . . . 1.74 109.773 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -86.23 -44.5 12.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.207 1.003 . . . . 1.29 110.771 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 32' ' ' PHE . 32.7 mt -71.75 -91.24 0.02 OUTLIER 'General case' 0 C--O 1.249 1.036 0 O-C-N 123.715 0.634 . . . . 0.81 111.4 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 25.4 t70 158.25 61.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 126.099 1.76 . . . . 1.12 108.459 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 33' ' ' THR . 26.8 t -101.72 165.81 2.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.694 -0.684 . . . . 0.79 110.022 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 38' ' ' VAL . 10.0 m-20 -83.26 6.15 20.62 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.681 0.793 . . . . 2.0 112.879 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 43' ' ' MET . 20.5 t 66.66 -66.5 0.18 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.579 1.152 . . . . 0.78 113.245 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.02 -26.52 65.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.583 0.706 . . . . 1.18 110.802 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 15.7 m -80.54 -13.46 59.06 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.548 -0.751 . . . . 0.6 110.569 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.694 ' SD ' ' H5A' ' A' ' 101' ' ' SYO . 18.0 tpp -73.04 -31.65 64.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.002 -0.544 . . . . 0.86 110.978 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.644 HG22 ' S1 ' ' A' ' 101' ' ' SYO . 24.8 t -55.15 -42.59 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 N-CA-C 108.784 -0.821 . . . . 0.31 108.784 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' SER . 26.0 mm-40 -54.53 -53.14 58.38 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 123.781 0.832 . . . . 0.68 110.282 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.747 HG22 HG13 ' A' ' 18' ' ' ILE . 51.6 t -54.16 -32.14 22.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 124.374 1.07 . . . . 0.63 112.048 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.83 HG21 HG13 ' A' ' 63' ' ' VAL . 27.9 t -73.32 -48.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.567 -0.901 . . . . 0.55 108.567 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.415 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 43.8 t -68.3 -31.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.272 -1.01 . . . . 0.42 108.272 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -69.66 -34.17 73.62 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.41 0.624 . . . . 0.21 109.738 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.48 42.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.974 -1.012 . . . . 0.21 108.994 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.261 0.0 OUTLIER -66.77 -29.63 69.64 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.714 1.005 . . . . 0.64 113.714 -177.727 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 41.4 mt-10 -63.34 -38.16 90.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.274 0.559 . . . . 2.07 110.627 174.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -86.86 -35.37 19.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.272 0.471 . . . . 2.48 112.272 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 8.1 m-85 -97.72 -0.03 46.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 120.025 -0.67 . . . . 0.81 112.186 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 78.44 -2.77 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.584 1.327 . . . . 1.99 114.584 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.671 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 14.8 p -75.73 175.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 O-C-N 121.098 -1.001 . . . . 0.37 108.947 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 36.5 tptt -124.61 128.96 49.68 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.82 -1.178 . . . . 2.12 107.82 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 51' ' ' GLU . 27.1 mt -123.09 110.98 30.8 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 120.165 -0.614 . . . . 0.25 110.825 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.581 ' HD2' ' OH ' ' A' ' 75' ' ' TYR . 67.8 Cg_endo -73.89 158.4 46.39 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.591 2.194 . . . . 0.33 109.582 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.69 -36.57 62.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.194 0.597 . . . . 1.98 110.806 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.44 -42.69 87.89 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.575 0.75 . . . . 2.06 111.63 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.5 m-20 -86.32 -24.92 25.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 121.017 -0.273 . . . . 0.52 111.581 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.83 HG13 HG21 ' A' ' 47' ' ' VAL . 55.8 t -53.06 -58.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.138 -1.06 . . . . 0.38 108.138 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -72.87 -1.49 17.01 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.213 -0.903 . . . . 2.16 111.705 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 38.3 t30 -87.61 -34.41 18.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.847 -1.168 . . . . 1.59 107.847 -177.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 72' ' ' ALA . 12.8 mt -79.42 131.38 36.07 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 106.459 -1.682 . . . . 0.31 106.459 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.741 ' HG3' ' H38' ' A' ' 101' ' ' SYO . 12.7 mptt -116.77 -42.34 2.98 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.997 -1.112 . . . . 2.55 107.997 171.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 81.9 p -101.88 170.38 8.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.901 -1.045 . . . . 0.23 110.224 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.5 -13.6 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.104 -1.073 . . . . 1.21 108.104 174.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.403 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -70.58 -30.47 68.72 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.244 -1.143 . . . . 0.33 110.244 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -81.97 -51.28 8.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.066 -1.087 . . . . 1.39 108.066 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.773 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.79 -60.42 2.91 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 114.323 -1.308 . . . . 0.15 111.967 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 4' ' ' GLN . 45.8 m -57.24 -42.27 81.14 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.671 -1.149 . . . . 0.24 112.508 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.54 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -57.29 -53.25 60.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.974 -1.121 . . . . 3.63 107.974 176.599 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.581 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 82.1 t80 -56.48 -50.54 71.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 124.19 0.931 . . . . 0.4 111.148 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.634 ' HA ' HG21 ' A' ' 56' ' ' VAL . 70.8 mt -55.73 -66.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.278 -1.328 . . . . 0.21 109.98 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.46 -47.18 66.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.8 0.84 . . . . 1.44 110.538 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.09 -22.97 65.8 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.221 -0.899 . . . . 0.63 112.285 -172.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -102.79 4.27 37.7 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.303 0.853 . . . . 1.25 113.303 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.671 ' HG2' ' HB ' ' A' ' 56' ' ' VAL 0.309 0.7 OUTLIER -124.01 -84.61 0.65 Allowed 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 113.832 1.049 . . . . 0.87 113.832 175.573 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.253 -3.627 0 CA-C-O 118.496 -0.764 . . . . 1.97 112.106 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.771 ' H28' HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.689 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 108.534 -0.913 . . . . 1.42 108.534 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . . . -165.59 -73.18 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.709 0.29 . . . . 1.85 111.696 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 6.4 t -171.71 -170.96 0.84 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.814 -0.81 . . . . 0.66 108.814 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.653 ' HA ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -48.71 -42.2 34.26 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.941 1.296 . . . . 0.74 112.653 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.35 -22.56 63.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.821 0.674 . . . . 2.66 112.821 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 3' ' ' THR . 4.1 tp10 -81.34 -36.77 29.29 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.412 -0.959 . . . . 2.73 108.412 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 4' ' ' GLN . 71.2 mt -79.03 -67.91 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.117 0 CA-C-N 115.294 -0.866 . . . . 0.23 110.844 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 t -59.09 -41.88 84.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 112.568 0.581 . . . . 0.27 112.568 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.38 82.72 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.317 0.386 . . . . 0.27 111.288 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.38 -40.53 8.39 Favored Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 120.393 -0.908 . . . . 0.18 112.2 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.72 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -59.46 -42.72 92.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.277 1.031 . . . . 0.2 108.278 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -54.43 -48.12 72.04 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.664 0.603 . . . . 0.14 110.615 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.86 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 54.4 mt-10 -65.71 -35.71 81.53 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 123.709 0.631 . . . . 0.68 111.746 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 11' ' ' LEU . 64.4 mt -60.73 -42.47 92.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.618 -0.719 . . . . 0.28 109.595 174.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 11' ' ' LEU . 41.3 t -68.47 -23.94 28.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 121.845 0.831 . . . . 0.27 109.864 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.86 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 20.8 m-20 -75.57 -52.35 10.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.176 -1.046 . . . . 0.34 108.176 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -66.66 -46.42 75.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.615 -1.175 . . . . 2.07 112.476 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.62 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.2 mm -70.79 -53.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.878 0.371 . . . . 0.65 110.27 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.74 -74.31 0.65 Allowed 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.664 -0.414 . . . . 0.54 111.519 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.18 54.45 0.02 OUTLIER Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 120.291 -0.957 . . . . 0.43 112.045 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.615 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -95.62 154.57 39.17 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.493 -0.558 . . . . 0.31 109.493 175.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.533 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 6.2 Cg_exo -88.02 29.45 0.47 Allowed 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 124.224 3.283 . . . . 1.08 115.673 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.672 ' HB ' HD22 ' A' ' 16' ' ' ASN . 6.5 p 57.87 -0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 117.838 2.533 . . . . 0.81 117.838 171.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.479 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 43.7 mt-10 -117.93 -13.39 10.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.34 -1.475 . . . . 2.31 111.225 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.0 m-20 -87.03 -29.28 22.06 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.005 -1.452 . . . . 1.59 110.127 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 12' ' ' ALA . 41.9 t -69.35 97.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 0.3 108.79 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.1 mttt -138.35 170.04 16.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 109.069 -0.715 . . . . 1.58 109.069 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 7.8 mp -61.13 143.03 56.23 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.174 -0.676 . . . . 1.05 109.174 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t70 81.99 1.04 1.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.029 1.332 . . . . 0.72 110.898 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.596 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 44.2 mmtm -92.8 120.35 33.08 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 119.589 -0.844 . . . . 1.48 109.644 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.529 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 15.9 m -79.12 27.09 0.25 Allowed 'General case' 1 C--N 1.244 -4.019 0 C-N-CA 125.968 1.707 . . . . 1.25 113.876 -172.483 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.59 ' CZ ' HG22 ' A' ' 69' ' ' VAL . 96.7 m-85 46.13 -88.58 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.495 1.518 . . . . 0.4 113.989 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.431 ' CG2' ' H37' ' A' ' 101' ' ' SYO . 8.6 t -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.133 0.573 . . . . 1.06 111.374 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 32.3 t70 -88.17 -39.72 14.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.978 0.418 . . . . 1.74 111.298 -175.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.596 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -93.21 -41.31 9.97 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.514 0.931 . . . . 1.29 113.514 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.6 mt -88.19 -72.42 0.53 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.388 -0.525 . . . . 0.81 110.68 -173.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.0 t70 163.83 -22.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 124.321 1.013 . . . . 1.12 109.612 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 36' ' ' LEU . 3.0 t -45.99 105.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.77 1.628 . . . . 0.79 112.939 -170.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.523 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 24.9 t70 -54.04 124.15 14.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 124.04 0.838 . . . . 2.0 112.589 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.588 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 29.9 t -37.51 -45.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.612 2.078 . . . . 0.78 116.612 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.523 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 3.9 pp -75.92 -23.15 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 117.607 -1.637 . . . . 1.18 112.26 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.62 ' HB3' HG22 ' A' ' 18' ' ' ILE . 42.9 m -84.2 -18.91 35.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.735 -0.666 . . . . 0.6 109.665 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.879 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -56.95 -43.55 81.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.19 0.996 . . . . 0.86 112.715 -178.205 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.25 -40.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 123.845 0.716 . . . . 0.31 110.171 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -63.36 -44.45 94.77 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.969 -0.56 . . . . 0.68 109.722 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.589 HG11 HG22 ' A' ' 15' ' ' VAL . 42.0 t -60.0 -25.13 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.425 -0.807 . . . . 0.63 110.903 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.926 HG21 HG13 ' A' ' 63' ' ' VAL . 21.5 t -82.27 -53.75 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 108.79 -0.818 . . . . 0.55 108.79 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.14 -36.73 74.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.72 -1.127 . . . . 0.42 109.171 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -31.61 67.37 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.824 -0.435 . . . . 0.21 109.824 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -61.55 -58.21 9.04 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.285 -0.87 . . . . 0.21 109.094 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -64.47 -36.06 82.95 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.906 1.076 . . . . 0.64 113.906 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.99 -29.74 69.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 2.07 111.512 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -88.41 -32.34 18.38 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.227 -0.442 . . . . 2.48 111.559 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CE2' ' HB1' ' A' ' 50' ' ' ALA . 4.6 m-30 -93.13 -11.14 33.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 120.386 -0.526 . . . . 0.81 111.938 -173.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.689 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 25.7 t70 81.38 6.77 1.2 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.493 1.517 . . . . 1.99 111.987 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' A' ' 76' ' ' ILE . 14.5 p -84.7 171.15 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 107.584 -1.265 . . . . 0.37 107.584 174.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 19.5 tptt -124.6 123.06 39.24 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.654 -0.869 . . . . 2.12 108.654 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.542 HG12 ' HE2' ' A' ' 75' ' ' TYR . 62.8 mt -118.9 112.73 36.32 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 109.835 -0.432 . . . . 0.25 109.835 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 63' ' ' VAL . 37.7 Cg_endo -67.43 158.2 58.18 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.747 2.298 . . . . 0.33 110.282 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 6.2 p-10 -58.55 -30.43 67.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.399 -0.364 . . . . 1.98 111.422 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.74 -34.03 69.2 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 112.428 0.529 . . . . 2.06 112.428 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.497 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 52.5 m-20 -78.73 -25.07 44.57 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 119.524 -0.87 . . . . 0.52 110.985 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.926 HG13 HG21 ' A' ' 47' ' ' VAL . 70.0 t -54.27 -39.7 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.229 -1.026 . . . . 0.38 108.229 170.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 60' ' ' ASP . 81.9 mttt -73.98 -14.63 61.06 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.0 -1.0 . . . . 2.16 112.22 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -96.49 -36.17 10.88 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.594 0.358 . . . . 1.59 111.511 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -68.71 113.05 5.84 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 105.678 -1.971 . . . . 0.31 105.678 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -108.21 -31.3 7.95 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 119.762 -0.775 . . . . 2.55 109.807 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 67.9 p -121.01 178.42 4.74 Favored 'General case' 0 N--CA 1.392 -3.338 0 N-CA-C 108.557 -0.905 . . . . 0.23 108.557 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.59 HG22 ' CZ ' ' A' ' 32' ' ' PHE . 6.4 t -77.45 -13.56 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 107.683 -1.228 . . . . 1.21 107.683 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.84 -49.04 37.93 Favored Glycine 0 CA--C 1.489 -1.583 0 N-CA-C 109.871 -1.292 . . . . 0.33 109.871 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.77 -44.36 77.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.963 -0.618 . . . . 1.39 109.373 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -56.61 -61.64 2.28 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.019 -0.992 . . . . 0.15 111.266 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.613 ' HA ' HG21 ' A' ' 7' ' ' ILE . 60.7 m -54.36 -43.71 71.54 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.696 -1.138 . . . . 0.24 113.804 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.1 mptp? -61.03 -50.9 71.48 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.99 -0.744 . . . . 3.63 108.99 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.542 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.8 t80 -54.47 -51.82 63.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.643 -1.162 . . . . 0.4 110.225 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.655 ' HA ' HG21 ' A' ' 56' ' ' VAL . 78.3 mt -55.37 -65.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 114.19 -1.368 . . . . 0.21 110.716 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 5.2 tt -51.73 -43.61 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.9 0.88 . . . . 1.44 110.57 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.07 -25.53 64.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.875 -1.057 . . . . 0.63 111.823 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -101.51 -5.83 24.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.794 -0.639 . . . . 1.25 112.344 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.582 HE21 HG22 ' A' ' 76' ' ' ILE 0.302 1.0 OUTLIER -106.18 -92.55 0.39 Allowed 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 113.636 0.976 . . . . 0.87 113.636 175.911 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.266 -3.044 0 CA-C-N 115.264 -0.88 . . . . 1.97 111.027 -175.288 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.879 ' H1 ' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.811 ' HB1' ' HB2' ' A' ' 81' ' ' ALA . . . . . . . . 0 CA--C 1.503 -0.849 0 N-CA-C 109.247 -0.649 . . . . 1.42 109.247 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -127.93 136.03 50.78 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.713 -0.676 . . . . 1.85 109.801 -174.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.596 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 13.1 t -94.89 -178.75 4.61 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.673 -0.862 . . . . 0.66 108.673 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' HG2' HG21 ' A' ' 73' ' ' THR . 16.0 tm0? -46.9 -48.25 21.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.141 1.163 . . . . 0.74 114.141 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.478 ' HG3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -51.98 -32.33 33.17 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.567 0.951 . . . . 2.66 113.567 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.589 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 11.1 tp10 -87.45 -40.45 14.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.292 0.637 . . . . 2.73 109.87 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.635 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 99.5 mt -63.56 -58.74 6.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 116.139 -0.482 . . . . 0.23 110.016 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.547 HG21 HD11 ' A' ' 28' ' ' LEU . 46.0 t -66.29 -22.91 30.86 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.871 -0.604 . . . . 0.27 111.695 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.92 55.78 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.759 -0.776 . . . . 0.27 109.177 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.15 -44.09 24.12 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 115.008 -0.996 . . . . 0.18 113.225 -176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -63.13 -33.08 74.68 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 123.448 0.699 . . . . 0.2 109.376 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -60.75 -51.14 70.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.659 -0.701 . . . . 0.14 109.263 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 51.2 mt-10 -59.44 -41.83 90.53 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 124.183 0.927 . . . . 0.68 111.809 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 11' ' ' LEU . 71.4 mt -56.79 -42.17 77.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.461 -0.79 . . . . 0.28 109.85 175.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.613 HG12 ' HB ' ' A' ' 21' ' ' ILE . 88.0 t -70.92 -23.73 23.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.703 0.764 . . . . 0.27 110.306 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.645 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -72.79 -43.32 62.91 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.177 -1.046 . . . . 0.34 108.177 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -71.39 -50.33 33.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.214 -0.903 . . . . 2.07 110.926 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.653 HG13 HG22 ' A' ' 46' ' ' VAL . 20.9 mm -66.76 -54.24 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.1 -0.5 . . . . 0.65 111.667 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -102.96 -66.07 0.96 Allowed 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.389 0.614 . . . . 0.54 111.036 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.7 50.87 0.06 OUTLIER Glycine 0 C--N 1.29 -1.999 0 CA-C-N 115.142 -0.936 . . . . 0.43 111.714 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.613 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -91.33 155.66 44.17 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.408 -0.396 . . . . 0.31 109.983 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 21' ' ' ILE . 6.0 Cg_exo -86.62 23.02 0.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.343 2.695 . . . . 1.08 115.698 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.633 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.9 p 48.1 26.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 C-N-CA 124.694 1.198 . . . . 0.81 113.154 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -138.9 4.72 2.31 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.345 -0.843 . . . . 2.31 110.685 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.35 -27.91 9.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.075 -0.966 . . . . 1.59 110.065 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.744 HG22 HD13 ' A' ' 36' ' ' LEU . 23.7 t -79.6 99.1 3.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.33 -1.304 . . . . 0.3 108.972 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -127.98 170.57 12.72 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.164 -1.421 . . . . 1.58 107.164 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 8' ' ' VAL . 7.9 mp -66.41 148.55 51.7 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.287 -1.005 . . . . 1.05 108.287 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 81.51 4.22 1.39 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 124.451 1.101 . . . . 0.72 110.533 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.518 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 73.6 mmtt -96.61 118.99 34.26 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 119.831 -0.748 . . . . 1.48 110.636 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 71.4 m -75.53 32.88 0.11 Allowed 'General case' 0 C--N 1.248 -3.833 0 C-N-CA 127.189 2.195 . . . . 1.25 114.039 -175.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.648 ' CE2' ' H5 ' ' A' ' 101' ' ' SYO . 86.8 m-85 41.23 -89.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.454 1.501 . . . . 0.4 115.025 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.645 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.9 t -63.15 -29.17 70.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.468 0.707 . . . . 1.06 111.05 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -96.45 -31.21 12.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.826 0.676 . . . . 1.74 112.826 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -99.29 -36.79 9.51 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.777 1.029 . . . . 1.29 113.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.744 HD13 HG22 ' A' ' 26' ' ' VAL . 16.0 mt -94.91 -39.7 10.08 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.245 -0.434 . . . . 0.81 109.998 -174.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 t70 93.33 69.53 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.579 0 C-N-CA 126.531 1.933 . . . . 1.12 108.934 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.645 ' H ' ' HA ' ' A' ' 33' ' ' THR . 13.3 t -108.09 143.4 18.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 105.002 -2.222 . . . . 0.79 105.002 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.37 117.73 15.48 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.374 -0.93 . . . . 2.0 109.63 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.593 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.0 t -38.67 -47.37 1.34 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.573 1.694 . . . . 0.78 115.573 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -70.58 -26.37 63.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.368 -0.933 . . . . 1.18 111.628 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.2 m -84.94 -16.96 39.25 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.474 0.709 . . . . 0.6 110.507 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.723 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -56.01 -38.65 70.79 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 124.084 0.953 . . . . 0.86 111.598 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.21 -47.1 77.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 O-C-N 124.451 1.095 . . . . 0.31 109.984 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.03 -45.12 83.35 Favored 'General case' 0 C--O 1.21 -1.026 0 C-N-CA 122.873 0.469 . . . . 0.68 109.796 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.653 HG22 HG13 ' A' ' 18' ' ' ILE . 44.2 t -59.01 -28.86 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.783 0.833 . . . . 0.63 110.958 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.849 HG21 HG13 ' A' ' 63' ' ' VAL . 54.0 t -78.6 -51.43 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.766 -1.198 . . . . 0.55 107.766 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -56.0 -42.42 71.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.419 -1.264 . . . . 0.42 109.447 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -63.85 -39.07 93.34 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-O 121.499 0.666 . . . . 0.21 110.454 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.537 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -64.28 -52.57 57.95 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.87 -1.059 . . . . 0.21 109.886 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.325 0.0 OUTLIER -62.54 -35.89 80.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.708 1.003 . . . . 0.64 113.708 -179.242 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.4 -44.03 95.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.221 0.326 . . . . 2.07 111.581 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -76.66 -44.54 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.534 0.568 . . . . 2.48 112.534 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.635 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 11.8 m-85 -89.27 -5.22 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.301 -0.56 . . . . 0.81 112.434 -172.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 83.17 10.73 0.52 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 115.389 1.625 . . . . 1.99 115.389 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.6 p -87.19 179.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.273 -1.01 . . . . 0.37 108.273 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.498 ' H ' HG22 ' A' ' 56' ' ' VAL . 46.7 tptt -132.89 128.55 36.84 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 106.434 -1.691 . . . . 2.12 106.434 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.604 HG13 ' HB3' ' A' ' 51' ' ' GLU . 42.0 mt -124.11 111.57 28.66 Favored Pre-proline 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.787 . . . . 0.25 111.054 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.628 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.5 Cg_endo -73.29 162.18 41.03 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.158 2.572 . . . . 0.33 110.793 176.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.39 -41.98 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.942 0.897 . . . . 1.98 110.616 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 30.2 t70 -60.72 -37.56 82.13 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 114.685 -1.143 . . . . 2.06 111.549 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 20.4 m-20 -86.89 -28.01 23.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 113.414 0.894 . . . . 0.52 113.414 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.849 HG13 HG21 ' A' ' 47' ' ' VAL . 95.8 t -53.62 -48.72 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.767 -0.827 . . . . 0.38 108.767 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 48.3 pttt -69.73 -13.59 62.37 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.886 -1.052 . . . . 2.16 112.45 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.79 -13.08 46.18 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.405 0.621 . . . . 1.59 109.716 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.771 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.5 mt -97.52 110.37 22.95 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 106.49 -1.67 . . . . 0.31 106.49 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.7 mptp? -100.64 -44.65 5.76 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.311 -0.996 . . . . 2.55 108.311 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 20.1 p -110.25 -177.9 3.37 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.697 -0.853 . . . . 0.23 108.697 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -87.05 -13.43 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 108.344 -0.984 . . . . 1.21 108.344 176.018 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.554 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -72.33 -24.78 75.79 Favored Glycine 0 C--O 1.2 -2.014 0 N-CA-C 108.683 -1.767 . . . . 0.33 108.683 174.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' THR . 8.7 m-20 -82.66 -57.13 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.781 -1.21 . . . . 1.39 108.542 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.771 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -47.8 -60.32 2.66 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 114.881 -1.054 . . . . 0.15 112.155 -178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.467 ' HA ' HG21 ' A' ' 7' ' ' ILE . 44.9 m -56.79 -48.09 78.71 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.354 -1.294 . . . . 0.24 113.451 -174.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.0 mptp? -56.57 -47.08 80.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.069 0.856 . . . . 3.63 109.58 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.538 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 85.1 t80 -60.44 -51.8 67.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.081 -0.963 . . . . 0.4 111.544 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.592 ' HA ' HG21 ' A' ' 56' ' ' VAL . 69.9 mt -54.57 -65.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.584 -1.189 . . . . 0.21 110.542 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.596 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.1 tt -51.79 -46.55 64.23 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.356 1.062 . . . . 1.44 109.511 -175.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.99 -30.56 70.35 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.55 -1.205 . . . . 0.63 111.502 -172.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -100.13 0.0 39.77 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 113.923 1.083 . . . . 1.25 113.923 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -116.27 -51.44 2.62 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 113.768 1.025 . . . . 0.87 113.768 176.155 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.811 ' HB2' ' HB1' ' A' ' 1' ' ' ALA . . . . . . . . 1 C--N 1.243 -4.049 0 CA-C-N 114.728 -1.123 . . . . 1.97 110.31 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.791 ' H28' HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 109.832 -0.432 . . . . 1.42 109.832 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.51 -74.26 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.822 -0.807 . . . . 1.85 108.822 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t -174.6 -171.69 0.59 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.11 -0.7 . . . . 0.66 109.11 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' HG2' HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -50.66 -41.49 55.55 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.331 1.452 . . . . 0.74 114.518 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -52.51 -52.03 56.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.206 0.316 . . . . 2.66 110.581 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.03 -48.67 64.43 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 124.848 1.259 . . . . 2.73 111.184 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 73' ' ' THR . 81.4 mt -70.21 -64.13 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.275 -1.33 . . . . 0.23 110.255 -170.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.401 HG23 ' HG2' ' A' ' 4' ' ' GLN . 76.0 t -58.07 -40.42 76.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 N-CA-C 112.738 0.644 . . . . 0.27 112.738 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -62.12 -44.37 96.79 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.736 -0.468 . . . . 0.27 109.736 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -76.01 -38.24 35.97 Favored Glycine 0 N--CA 1.415 -2.742 0 CA-C-N 115.572 -0.74 . . . . 0.18 113.446 -175.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.614 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.49 -39.16 88.59 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.609 -0.885 . . . . 0.2 108.609 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.596 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.97 -47.49 84.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.207 -0.664 . . . . 0.14 109.207 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.781 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 44.6 mt-10 -54.89 -45.8 74.72 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 124.368 1.042 . . . . 0.68 111.806 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 11' ' ' LEU . 56.9 mt -59.55 -42.68 88.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.467 -0.788 . . . . 0.28 110.058 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 21' ' ' ILE . 48.4 t -71.86 -22.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.409 0.623 . . . . 0.27 109.931 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.781 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 33.1 m-20 -66.19 -43.19 87.53 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.039 -0.726 . . . . 0.34 109.039 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -80.42 -49.3 11.63 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.518 -0.765 . . . . 2.07 111.259 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.699 HG13 HG22 ' A' ' 46' ' ' VAL . 16.8 mm -62.35 -53.56 45.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.822 -0.626 . . . . 0.65 111.374 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.409 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -104.55 -72.64 0.7 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.509 0.671 . . . . 0.54 109.857 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.31 34.65 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.563 0 CA-C-N 114.993 -1.003 . . . . 0.43 111.973 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.603 HG21 HG23 ' A' ' 26' ' ' VAL . 1.3 mp -72.96 150.43 90.33 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 109.557 -0.534 . . . . 0.31 109.557 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.7 Cg_exo -88.89 31.23 0.4 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.732 2.954 . . . . 1.08 114.758 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' ' 16' ' ' ASN 0.25 5.6 p 58.4 -6.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 126.984 2.114 . . . . 0.81 116.393 175.605 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -114.85 -6.33 12.63 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.937 -1.102 . . . . 2.31 111.064 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -83.28 -30.88 27.25 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.4 1.095 . . . . 1.59 108.917 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.678 HG22 HD13 ' A' ' 36' ' ' LEU . 22.8 t -76.3 96.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 113.35 -1.75 . . . . 0.3 109.935 -176.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 69' ' ' VAL . 12.5 mptt -127.83 158.37 37.92 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.355 -1.35 . . . . 1.58 107.355 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD22 ' HA2' ' A' ' 70' ' ' GLY . 54.8 mt -52.83 144.83 13.64 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.9 -0.778 . . . . 1.05 108.9 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 78.67 10.55 1.76 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.938 1.295 . . . . 0.72 110.824 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.632 ' HD2' ' CG ' ' A' ' 35' ' ' ASP . 31.3 mmtp -96.91 122.63 40.1 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 108.617 -0.882 . . . . 1.48 108.617 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 30.3 m -76.29 36.18 0.15 Allowed 'General case' 0 C--N 1.252 -3.662 0 C-N-CA 125.279 1.432 . . . . 1.25 113.519 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.686 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 76.0 m-85 42.75 -94.12 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 125.673 1.589 . . . . 0.4 114.697 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.525 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 5.4 t -68.57 -24.66 64.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.081 0.467 . . . . 1.06 110.059 -174.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 11.0 t70 -81.32 -53.03 6.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.298 -0.864 . . . . 1.74 111.772 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.632 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t70 -84.22 -56.59 3.57 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 119.585 -0.846 . . . . 1.29 110.267 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.678 HD13 HG22 ' A' ' 26' ' ' VAL . 22.4 mt -65.91 -38.12 87.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.12 -1.4 . . . . 0.81 111.286 -170.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t70 88.22 70.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 124.919 1.387 . . . . 1.12 109.186 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.525 ' H ' ' HA ' ' A' ' 33' ' ' THR . 18.4 t -102.58 170.88 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.374 -2.194 . . . . 0.79 108.741 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 42' ' ' SER . 2.2 m-20 -78.01 -3.42 41.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.094 1.146 . . . . 2.0 114.094 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 43' ' ' MET . 29.0 t 65.87 -65.4 0.18 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.136 0.975 . . . . 0.78 113.053 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 42' ' ' SER . 0.7 OUTLIER -62.67 -36.41 82.77 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.305 0.574 . . . . 1.18 111.572 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.54 ' O ' HG23 ' A' ' 46' ' ' VAL . 12.6 m -78.23 -13.73 59.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.499 -0.773 . . . . 0.6 110.065 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . 1.049 ' HG3' ' H1 ' ' A' ' 101' ' ' SYO . 12.2 tpp -73.69 -35.61 65.19 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 116.254 -0.43 . . . . 0.86 110.127 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.8 t -55.72 -37.72 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 109.487 -0.56 . . . . 0.31 109.487 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -61.89 -47.89 82.93 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.275 -0.639 . . . . 0.68 109.275 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.699 HG22 HG13 ' A' ' 18' ' ' ILE . 61.1 t -57.73 -28.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 CA-C-N 114.834 -1.075 . . . . 0.63 111.475 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.87 HG21 HG13 ' A' ' 63' ' ' VAL . 27.6 t -71.69 -52.68 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.377 0 N-CA-C 107.764 -1.199 . . . . 0.55 107.764 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.08 -38.63 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.23 -1.35 . . . . 0.42 108.55 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.74 -38.99 90.65 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.862 -0.608 . . . . 0.21 109.932 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -61.53 -58.37 8.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.731 -1.122 . . . . 0.21 109.779 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.481 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.26 0.0 OUTLIER -59.36 -39.76 84.26 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.233 1.197 . . . . 0.64 114.233 -176.384 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -59.92 -35.7 75.45 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.39 0.431 . . . . 2.07 111.846 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -86.42 -30.36 22.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.116 -0.493 . . . . 2.48 110.143 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.47 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 7.0 m-85 -100.03 1.47 42.47 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.208 0.447 . . . . 0.81 112.208 -173.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 33.7 t70 79.5 4.1 2.17 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 124.344 1.058 . . . . 1.99 112.98 174.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 76' ' ' ILE . 7.8 p -90.93 -179.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 O-C-N 121.256 -0.902 . . . . 0.37 108.703 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' H ' HG22 ' A' ' 56' ' ' VAL . 21.4 tptm -135.62 128.69 31.61 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.748 -1.575 . . . . 2.12 106.748 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.481 HG13 ' HB3' ' A' ' 51' ' ' GLU . 59.5 mt -122.07 110.47 32.89 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.128 -0.629 . . . . 0.25 111.109 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.571 ' O ' HG23 ' A' ' 63' ' ' VAL . 91.1 Cg_endo -74.94 164.94 32.41 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.125 2.55 . . . . 0.33 110.961 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 20.2 t70 -51.57 -44.12 62.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 1.98 112.101 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -58.78 -40.59 84.43 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.612 0.57 . . . . 2.06 111.301 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 24.7 m-20 -81.52 -31.11 32.94 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.777 -0.769 . . . . 0.52 112.005 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.87 HG13 HG21 ' A' ' 47' ' ' VAL . 82.7 t -53.83 -50.72 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.056 -1.09 . . . . 0.38 108.056 172.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 13.8 ptmm? -73.17 -2.7 22.67 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.372 0.878 . . . . 2.16 113.372 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -105.79 -16.81 14.57 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.993 -0.442 . . . . 1.59 111.76 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.762 HD13 ' HA ' ' A' ' 72' ' ' ALA . 44.2 mt -82.14 107.44 14.84 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 105.711 -1.959 . . . . 0.31 105.711 176.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -97.13 -39.29 9.37 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.181 -1.008 . . . . 2.55 109.744 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 27.7 p -114.97 179.64 3.89 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.46 0.648 . . . . 0.23 109.587 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.686 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -87.09 -13.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.797 -0.816 . . . . 1.21 108.797 175.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.53 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -68.12 -43.56 80.47 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 107.032 -2.427 . . . . 0.33 107.032 172.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -65.25 -56.06 14.87 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.888 -1.656 . . . . 1.39 110.895 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.762 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.9 -60.95 2.43 Favored 'General case' 0 CA--C 1.482 -1.665 0 O-C-N 124.304 1.002 . . . . 0.15 111.42 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.646 ' HA ' HG21 ' A' ' 7' ' ' ILE . 56.8 m -53.31 -54.59 34.26 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.589 -1.187 . . . . 0.24 113.303 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.9 mptm? -56.08 -37.5 69.42 Favored 'General case' 0 C--O 1.198 -1.658 0 C-N-CA 124.158 0.983 . . . . 3.63 110.78 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' HE2' HG12 ' A' ' 58' ' ' ILE . 90.7 t80 -66.93 -47.59 71.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.535 0.683 . . . . 0.4 109.377 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.656 ' HA ' HG21 ' A' ' 56' ' ' VAL . 72.7 mt -59.09 -65.87 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-N 114.2 -1.364 . . . . 0.21 109.441 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.626 HD23 HG22 ' A' ' 73' ' ' THR . 4.4 pp -53.41 -38.41 63.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 113.475 0.917 . . . . 1.44 113.475 -176.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.512 ' N ' HD12 ' A' ' 77' ' ' LEU . 7.7 t70 -72.03 -25.75 61.93 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.92 -1.036 . . . . 0.63 110.777 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -102.56 -6.03 23.28 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.649 -0.705 . . . . 1.25 112.083 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 85.0 mt-30 -74.49 -65.17 0.89 Allowed 'General case' 0 CA--C 1.455 -2.676 0 CA-C-O 122.866 1.317 . . . . 0.87 107.933 176.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.259 -3.359 0 CA-C-N 111.982 -2.372 . . . . 1.97 109.492 -178.645 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 1.049 ' H1 ' ' HG3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.489 -1.399 0 N-CA-C 109.478 -0.564 . . . . 1.42 109.478 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -154.4 129.77 9.78 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.914 -0.772 . . . . 1.85 108.914 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 7' ' ' ILE . 11.3 t -92.42 175.65 6.76 Favored 'General case' 0 C--N 1.264 -3.128 0 N-CA-C 107.047 -1.464 . . . . 0.66 107.047 175.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -45.86 -40.27 9.69 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.749 1.018 . . . . 0.74 113.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.49 -28.19 69.12 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.489 0.493 . . . . 2.66 111.949 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.567 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 7.8 tp10 -88.83 -35.91 16.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.368 -0.605 . . . . 2.73 109.368 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.694 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 93.9 mt -72.53 -66.37 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.059 0 CA-C-N 116.126 -0.488 . . . . 0.23 111.846 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.05 -40.39 76.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 122.081 0.153 . . . . 0.27 111.169 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.39 81.46 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.01 -0.541 . . . . 0.27 111.25 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.48 -39.42 8.99 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 116.232 -0.44 . . . . 0.18 112.399 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.709 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.79 -37.4 87.47 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.577 -0.897 . . . . 0.2 108.577 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.865 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.21 -47.13 75.73 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.748 -0.66 . . . . 0.14 109.847 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.829 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 41.1 mt-10 -60.94 -41.47 96.31 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 124.135 0.897 . . . . 0.68 111.658 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 11' ' ' LEU . 71.2 mt -60.74 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.277 -0.874 . . . . 0.28 109.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.834 HG12 ' HB ' ' A' ' 21' ' ' ILE . 73.9 t -67.99 -23.76 29.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 123.872 0.869 . . . . 0.27 111.038 -176.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.829 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 45.3 m-20 -71.62 -45.16 62.9 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.107 -0.952 . . . . 0.34 109.142 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -83.77 -36.73 23.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.286 -0.87 . . . . 2.07 112.945 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.626 HG13 HG22 ' A' ' 46' ' ' VAL . 28.1 mm -70.2 -53.19 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.044 -0.724 . . . . 0.65 109.044 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -103.16 -88.9 0.4 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.836 -0.62 . . . . 0.54 109.556 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.03 39.53 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 120.338 -0.934 . . . . 0.43 112.88 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.834 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -75.12 151.83 86.11 Favored Pre-proline 0 C--O 1.205 -1.257 0 N-CA-C 109.618 -0.512 . . . . 0.31 109.618 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.2 Cg_exo -87.36 31.88 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.53 2.82 . . . . 1.08 114.771 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' H ' HG22 ' A' ' 21' ' ' ILE 0.287 9.8 p 60.45 -22.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 C-N-CA 127.057 2.143 . . . . 0.81 116.416 175.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -93.12 -15.16 26.34 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.281 0.562 . . . . 2.31 111.021 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.28 -26.63 30.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.385 -0.825 . . . . 1.59 111.454 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.865 HG21 ' HA ' ' A' ' 12' ' ' ALA . 43.1 t -71.84 98.41 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.133 -0.939 . . . . 0.3 108.811 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -130.12 161.92 29.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.845 -1.539 . . . . 1.58 106.845 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.508 ' HA ' HG22 ' A' ' 69' ' ' VAL . 91.1 mt -61.73 145.4 52.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.164 -0.68 . . . . 1.05 109.164 177.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 74.49 9.72 4.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.503 1.121 . . . . 0.72 110.586 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.44 127.26 50.85 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 109.512 -0.551 . . . . 1.48 109.512 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.668 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 7.1 m -84.63 108.68 17.5 Favored 'General case' 1 C--N 1.239 -4.203 0 CA-C-N 114.736 -1.12 . . . . 1.25 108.34 178.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.699 ' HB2' ' SD ' ' A' ' 43' ' ' MET . 34.4 m-85 -46.51 -54.28 9.61 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 124.534 1.133 . . . . 0.4 110.207 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 1.0 HG21 ' H37' ' A' ' 101' ' ' SYO . 12.1 t -77.61 19.82 0.35 Allowed 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 125.681 1.592 . . . . 1.06 113.771 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 15.2 t70 -158.76 -62.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.276 -0.89 . . . . 1.74 110.886 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -69.31 -40.13 77.85 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.634 -1.166 . . . . 1.29 109.849 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 32' ' ' PHE . 19.0 mt -80.78 -91.23 0.06 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 114.915 -1.039 . . . . 0.81 110.907 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 31.0 t70 168.01 20.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 121.966 0.889 . . . . 1.12 109.685 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.601 HG13 ' HB2' ' A' ' 19' ' ' ALA . 13.5 t -87.67 144.98 8.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.364 -0.835 . . . . 0.79 108.986 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.11 124.28 29.71 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.694 -0.684 . . . . 2.0 109.81 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.546 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 11.3 t -36.27 -46.05 0.5 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.412 1.485 . . . . 0.78 114.421 172.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.95 -30.8 70.18 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.31 -0.556 . . . . 1.18 111.689 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 m -83.76 -18.27 38.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.388 0.613 . . . . 0.6 109.782 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.699 ' SD ' ' HB2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -57.4 -38.27 74.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.229 1.012 . . . . 0.86 112.134 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.1 t -51.46 -51.14 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.109 0.881 . . . . 0.31 109.723 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -53.89 -48.73 69.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.68 109.949 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.626 HG22 HG13 ' A' ' 18' ' ' ILE . 46.2 t -58.71 -31.6 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.839 1.256 . . . . 0.63 111.481 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.718 HG21 HG13 ' A' ' 63' ' ' VAL . 34.2 t -76.96 -47.24 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 N-CA-C 108.491 -0.929 . . . . 0.55 108.491 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.97 -36.3 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 114.787 -1.097 . . . . 0.42 108.462 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.32 -36.16 82.23 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.844 -0.616 . . . . 0.21 109.935 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -56.53 19.13 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.797 -1.092 . . . . 0.21 110.015 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.645 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -63.19 -33.11 74.77 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.724 -0.79 . . . . 0.64 113.069 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.98 -40.45 95.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.078 0.399 . . . . 2.07 112.078 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -84.56 -38.07 20.42 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.494 -0.482 . . . . 2.48 111.933 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.694 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.0 m-85 -97.41 20.12 12.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.053 0.76 . . . . 0.81 113.053 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 32.9 t70 69.5 -2.07 2.03 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 114.675 1.361 . . . . 1.99 114.675 171.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.53 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 8.5 p -89.51 178.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 O-C-N 120.476 -1.39 . . . . 0.37 108.907 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.472 ' H ' HG22 ' A' ' 56' ' ' VAL . 19.4 ttpt -131.96 131.51 42.68 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 106.022 -1.844 . . . . 2.12 106.022 170.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.645 HG13 ' HB3' ' A' ' 51' ' ' GLU . 65.3 mt -120.62 114.99 32.55 Favored Pre-proline 0 C--N 1.293 -1.854 0 C-N-CA 120.532 -0.467 . . . . 0.25 110.205 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.558 ' O ' HG23 ' A' ' 63' ' ' VAL . 28.9 Cg_endo -62.4 155.2 59.02 Favored 'Trans proline' 0 CA--C 1.509 -0.774 0 C-N-CA 123.124 2.549 . . . . 0.33 110.883 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -54.8 -28.82 52.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.499 0.499 . . . . 1.98 111.895 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.682 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 29.8 t70 -73.88 -39.51 63.86 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 120.384 -0.526 . . . . 2.06 111.317 176.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 11.5 m-20 -77.37 -24.4 50.63 Favored 'General case' 0 CA--C 1.482 -1.663 0 C-N-CA 119.231 -0.987 . . . . 0.52 112.644 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 47' ' ' VAL . 68.8 t -51.85 -49.85 35.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 107.958 -1.126 . . . . 0.38 107.958 171.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.682 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 5.1 ptmm? -77.76 -2.01 34.18 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.431 0.9 . . . . 2.16 113.431 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 91.7 m-20 -98.08 -16.97 19.35 Favored 'General case' 0 CA--C 1.485 -1.539 0 O-C-N 121.72 -0.612 . . . . 1.59 110.368 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.0 mt -87.32 128.72 35.18 Favored 'General case' 0 N--CA 1.391 -3.407 0 N-CA-C 103.788 -2.671 . . . . 0.31 103.788 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -119.85 -42.02 2.64 Favored 'General case' 0 C--N 1.268 -2.956 0 N-CA-C 108.149 -1.056 . . . . 2.55 108.149 174.41 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 61.6 p -102.7 174.97 5.65 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 0.23 108.894 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.508 HG22 ' HA ' ' A' ' 28' ' ' LEU . 1.5 m -81.64 -13.51 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 107.798 -1.186 . . . . 1.21 107.798 174.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.426 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -74.23 -27.16 66.62 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.193 -1.003 . . . . 0.33 110.661 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.498 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 5.9 t70 -83.64 -48.34 10.29 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.525 -0.917 . . . . 1.39 108.525 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.7 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.33 -59.98 3.62 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-N 114.028 -1.442 . . . . 0.15 111.833 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.5 ' HA ' HG21 ' A' ' 7' ' ' ILE . 60.0 m -56.91 -61.6 2.33 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.081 -0.963 . . . . 0.24 111.507 -173.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.3 OUTLIER -41.16 -46.75 3.13 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.86 2.064 . . . . 3.63 111.438 171.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -63.22 -47.09 83.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.292 0.568 . . . . 0.4 110.336 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.632 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 64.0 mt -60.77 -66.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.32 -1.309 . . . . 0.21 109.259 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.5 HD23 HG22 ' A' ' 73' ' ' THR . 4.5 pp -58.58 -36.66 74.32 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.369 1.248 . . . . 1.44 114.369 -174.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.473 ' N ' HD12 ' A' ' 77' ' ' LEU . 12.6 t70 -75.28 -22.63 57.62 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.952 -0.567 . . . . 0.63 111.666 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.38 -24.6 18.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.896 0.702 . . . . 1.25 112.896 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.632 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.36 0.0 OUTLIER -90.73 -56.35 3.22 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 116.101 1.889 . . . . 0.87 116.101 -179.029 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 1 C--N 1.235 -4.411 0 CA-C-N 115.545 -0.752 . . . . 1.97 110.456 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 1.0 ' H37' HG21 ' A' ' 33' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 108.844 -0.799 . . . . 1.42 108.844 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.61 -74.08 0.52 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.145 -0.479 . . . . 1.85 111.175 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.685 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 15.2 t -175.03 -171.09 0.49 Allowed 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 116.289 -0.414 . . . . 0.66 109.907 -175.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -52.84 -41.87 64.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.85 1.26 . . . . 0.74 113.09 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.93 -32.49 33.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.003 0.521 . . . . 2.66 112.299 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.21 -36.25 27.44 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.969 -0.56 . . . . 2.73 110.336 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.471 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 74.9 mt -77.56 -66.49 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.218 0 CA-C-N 115.645 -0.707 . . . . 0.23 111.723 -171.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.2 t -55.91 -42.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 112.178 0.436 . . . . 0.27 112.178 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.96 89.49 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 123.713 0.633 . . . . 0.27 110.446 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.99 -39.0 13.78 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.895 -0.593 . . . . 0.18 113.08 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.714 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.21 -35.48 80.54 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.863 -1.162 . . . . 0.2 107.863 -177.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -57.02 -51.17 70.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.458 -0.571 . . . . 0.14 109.458 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.728 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 40.4 mt-10 -56.02 -44.32 78.61 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.417 1.073 . . . . 0.68 111.29 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 11' ' ' LEU . 72.2 mt -56.96 -45.4 83.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.263 -0.881 . . . . 0.28 110.37 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 11' ' ' LEU . 58.5 t -66.78 -23.98 31.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.848 0.832 . . . . 0.27 110.138 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.728 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 8.8 m-20 -75.48 -53.11 9.19 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.321 -0.992 . . . . 0.34 108.321 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 7.3 mm-40 -67.23 -39.98 86.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.964 -1.016 . . . . 2.07 111.374 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.6 mm -74.98 -53.73 15.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.667 -0.494 . . . . 0.65 109.667 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -100.55 -86.76 0.39 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.979 -0.555 . . . . 0.54 111.566 -173.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.98 50.25 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.684 0 CA-C-N 115.817 -0.629 . . . . 0.43 112.302 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.802 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -93.74 152.89 41.07 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 110.107 -0.331 . . . . 0.31 110.107 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 3.0 Cg_exo -84.87 30.88 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.671 2.914 . . . . 1.08 114.453 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.584 ' HB ' HD22 ' A' ' 16' ' ' ASN . 5.8 p 54.84 2.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 115.81 1.782 . . . . 0.81 115.81 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 22' ' ' PRO . 10.0 pt-20 -127.6 0.5 6.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.063 -1.023 . . . . 2.31 111.374 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 22.6 t0 -89.33 -24.06 22.1 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.589 -1.187 . . . . 1.59 109.072 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.802 HG23 HG21 ' A' ' 21' ' ' ILE . 42.1 t -81.07 93.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.107 -1.406 . . . . 0.3 109.527 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -121.55 166.12 14.66 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.504 -0.924 . . . . 1.58 108.504 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.447 HD22 ' HA2' ' A' ' 70' ' ' GLY . 67.6 mt -67.31 143.26 56.51 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.138 -1.43 . . . . 1.05 107.138 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 33.1 t70 85.64 1.43 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 124.343 1.057 . . . . 0.72 110.565 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 69' ' ' VAL . 45.4 mmtm -95.42 120.29 35.41 Favored 'General case' 0 CA--C 1.474 -1.972 0 O-C-N 121.502 -0.749 . . . . 1.48 109.879 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 10.4 t -83.02 35.22 0.47 Allowed 'General case' 1 C--N 1.24 -4.174 0 C-N-CA 126.483 1.913 . . . . 1.25 112.388 -171.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CZ ' HG22 ' A' ' 69' ' ' VAL . 96.6 m-85 41.64 -90.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.363 1.865 . . . . 0.4 115.293 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.412 ' HB ' ' SD ' ' A' ' 43' ' ' MET . 12.4 t -62.73 -27.69 69.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.281 0.633 . . . . 1.06 111.398 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 11.3 t70 -87.16 -56.35 3.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.524 -0.307 . . . . 1.74 110.564 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.08 -38.29 27.56 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 113.466 0.913 . . . . 1.29 113.466 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 25.3 mt -82.62 -76.24 0.28 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.482 -0.487 . . . . 0.81 112.117 -171.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 170.9 -20.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 122.961 0.504 . . . . 1.12 110.349 -174.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 19' ' ' ALA . 10.6 t -47.84 139.96 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.362 1.065 . . . . 0.79 111.978 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -81.27 126.17 31.22 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.895 -1.15 . . . . 2.0 107.895 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 43' ' ' MET . 15.4 t -42.53 -35.63 1.12 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 114.452 1.279 . . . . 0.78 114.452 173.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 42' ' ' SER . 3.6 pp -73.18 -33.28 65.34 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 119.067 -1.053 . . . . 1.18 111.976 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 46' ' ' VAL . 19.8 m -84.66 -13.36 51.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.965 0.888 . . . . 0.6 109.674 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.921 ' HG3' ' H1 ' ' A' ' 101' ' ' SYO . 3.6 tpt -61.9 -38.42 88.3 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 125.707 1.603 . . . . 0.86 110.568 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.65 -27.16 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.023 -0.535 . . . . 0.31 110.553 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.6 -45.59 68.21 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.384 -0.969 . . . . 0.68 108.384 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 42' ' ' SER . 41.8 t -58.07 -25.69 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.486 -1.233 . . . . 0.63 110.819 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.742 HG11 HG22 ' A' ' 63' ' ' VAL . 29.6 t -81.03 -54.3 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 N-CA-C 108.968 -0.753 . . . . 0.55 108.968 -176.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.14 -33.38 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.214 -0.903 . . . . 0.42 109.33 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.62 70.89 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.268 0.556 . . . . 0.21 109.991 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.49 -56.17 20.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.18 -0.918 . . . . 0.21 109.717 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -67.87 -31.11 70.69 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.127 1.158 . . . . 0.64 114.127 -176.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -60.53 -34.45 74.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.824 0.345 . . . . 2.07 110.306 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -86.83 -46.0 10.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.324 -0.398 . . . . 2.48 111.993 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 8.5 m-85 -84.67 -2.27 57.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.997 1.11 . . . . 0.81 113.997 -169.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 22.3 t70 80.76 -0.07 1.84 Allowed 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 124.401 1.08 . . . . 1.99 112.406 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 76' ' ' ILE . 12.9 p -81.56 176.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.41 -1.33 . . . . 0.37 107.41 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 33.7 tptt -134.02 123.94 25.4 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.836 -1.172 . . . . 2.12 107.836 173.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.555 HG12 ' HE2' ' A' ' 75' ' ' TYR . 41.3 mt -120.13 102.76 45.85 Favored Pre-proline 0 C--N 1.312 -1.026 0 C-N-CA 120.92 -0.312 . . . . 0.25 110.34 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.577 ' O ' HG23 ' A' ' 63' ' ' VAL . 64.4 Cg_endo -70.08 158.69 55.74 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 123.056 2.504 . . . . 0.33 110.44 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 9.8 t70 -46.24 -42.49 14.4 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.049 0.94 . . . . 1.98 110.525 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -53.85 -44.69 70.55 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 125.155 1.382 . . . . 2.06 112.716 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -86.68 -29.95 22.08 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.522 -0.471 . . . . 0.52 111.617 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.742 HG22 HG11 ' A' ' 47' ' ' VAL . 79.5 t -50.94 -51.42 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.886 -0.783 . . . . 0.38 108.886 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 21.3 ptmt -69.65 -4.18 18.33 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 114.152 1.167 . . . . 2.16 114.152 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.83 -23.8 14.87 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.696 0.76 . . . . 1.59 109.112 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.91 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.0 mt -82.46 133.83 35.21 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 105.965 -1.865 . . . . 0.31 105.965 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -126.11 -38.1 2.19 Favored 'General case' 0 C--N 1.259 -3.335 0 C-N-CA 119.919 -0.712 . . . . 2.55 109.995 174.655 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 26.9 p -107.46 -179.32 3.88 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 119.568 -0.853 . . . . 0.23 110.385 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.602 HG22 ' CZ ' ' A' ' 32' ' ' PHE . 13.0 t -83.12 -19.53 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 106.793 -1.558 . . . . 1.21 106.793 177.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.532 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -68.5 -47.2 58.55 Favored Glycine 0 CA--C 1.489 -1.545 0 N-CA-C 107.791 -2.124 . . . . 0.33 107.791 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.19 -55.85 29.63 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.638 -1.281 . . . . 1.39 110.471 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.91 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -53.69 -60.92 2.7 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.562 1.164 . . . . 0.15 111.732 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.459 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.2 m -58.77 -41.97 87.83 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 113.663 0.986 . . . . 0.24 113.663 -174.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 1.9 mptm? -61.28 -48.52 81.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 108.678 -0.86 . . . . 3.63 108.678 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.555 ' HE2' HG12 ' A' ' 58' ' ' ILE . 86.8 t80 -57.81 -51.53 69.21 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 124.536 1.148 . . . . 0.4 110.74 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 56' ' ' VAL . 72.5 mt -54.94 -66.75 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.718 0 CA-C-N 114.545 -1.207 . . . . 0.21 111.019 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.8 tt -52.17 -45.36 65.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.574 1.55 . . . . 1.44 109.359 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -71.15 -24.74 62.32 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.165 -1.38 . . . . 0.63 111.501 -172.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -103.7 -9.0 19.47 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 113.759 1.022 . . . . 1.25 113.759 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 92.3 mt-30 -68.77 -65.57 0.69 Allowed 'General case' 0 CA--C 1.449 -2.925 0 CA-C-O 122.909 1.338 . . . . 0.87 108.841 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.257 -3.438 0 CA-C-N 111.549 -2.569 . . . . 1.97 110.274 -175.283 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.921 ' H1 ' ' HG3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 81' ' ' ALA . . . . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 109.89 -0.411 . . . . 1.42 109.89 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.62 -96.36 0.11 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 111.958 0.355 . . . . 1.85 111.958 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.466 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.8 t -176.57 -177.88 0.86 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.556 -0.535 . . . . 0.66 109.556 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.647 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -54.54 -35.84 63.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.41 1.484 . . . . 0.74 111.67 179.014 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -52.79 -47.99 67.17 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 124.12 0.887 . . . . 2.66 110.395 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.52 -30.73 64.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.804 -0.634 . . . . 2.73 110.347 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.619 HG23 ' CE2' ' A' ' 54' ' ' PHE . 97.9 mt -76.61 -66.56 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 CA-C-N 116.086 -0.506 . . . . 0.23 111.307 -172.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 28' ' ' LEU . 91.1 t -58.36 -36.07 56.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.714 0.635 . . . . 0.27 112.714 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -66.03 -37.55 86.17 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.549 -0.46 . . . . 0.27 111.0 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.18 -36.95 11.76 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 111.842 -0.503 . . . . 0.18 111.842 -176.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.746 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.82 -40.68 95.59 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.611 -0.885 . . . . 0.2 108.611 -178.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.764 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.21 -47.57 78.13 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.556 -0.747 . . . . 0.14 109.691 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.671 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 50.1 mt-10 -60.74 -39.68 89.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 123.99 0.806 . . . . 0.68 112.548 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.746 HD12 ' HA ' ' A' ' 11' ' ' LEU . 63.4 mt -59.97 -44.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.688 0.756 . . . . 0.28 109.0 176.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.707 HG12 ' HB ' ' A' ' 21' ' ' ILE . 64.7 t -67.78 -25.87 33.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.019 -0.991 . . . . 0.27 110.788 -175.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.671 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 21.0 m-20 -70.5 -38.6 74.35 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.396 -0.82 . . . . 0.34 109.311 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.23 -43.62 15.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.6 -0.727 . . . . 2.07 111.58 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.695 HG13 HG22 ' A' ' 46' ' ' VAL . 17.3 mm -62.12 -52.71 57.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.988 0.515 . . . . 0.65 110.885 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -109.84 -85.56 0.54 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.435 -0.506 . . . . 0.54 110.858 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.84 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 110.931 -0.868 . . . . 0.43 110.931 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.707 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.6 mp -87.2 149.82 48.09 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 109.405 -0.591 . . . . 0.31 109.405 178.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 5.0 Cg_exo -88.25 37.87 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.757 2.971 . . . . 1.08 113.723 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG23 HD22 ' A' ' 16' ' ' ASN 0.259 3.7 p 57.74 -14.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 117.006 2.225 . . . . 0.81 117.006 176.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.09 2.9 12.71 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 120.641 -1.287 . . . . 2.31 110.708 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.596 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 7.3 t70 -78.78 -31.72 46.19 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.119 -1.067 . . . . 1.59 108.119 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.764 HG21 ' HA ' ' A' ' 12' ' ' ALA . 24.8 t -74.46 92.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 113.129 -1.851 . . . . 0.3 110.498 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 69' ' ' VAL . 95.6 mttt -118.03 163.37 16.7 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.043 0.449 . . . . 1.58 110.152 177.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 8' ' ' VAL . 5.6 mp -70.98 136.24 48.32 Favored 'General case' 0 N--CA 1.406 -2.675 0 N-CA-C 108.822 -0.807 . . . . 1.05 108.822 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' H ' ' N ' ' A' ' 70' ' ' GLY . 22.4 t70 84.62 9.89 0.4 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.297 1.439 . . . . 0.72 109.701 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -102.08 128.4 48.56 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 115.648 -0.705 . . . . 1.48 109.22 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.4 m -79.92 114.12 18.6 Favored 'General case' 0 C--N 1.244 -3.987 0 CA-C-N 114.779 -1.101 . . . . 1.25 108.491 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.595 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 94.1 m-85 -45.41 -64.53 0.7 Allowed 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 124.253 1.021 . . . . 0.4 112.057 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.793 HG21 ' H37' ' A' ' 101' ' ' SYO . 10.1 t -59.01 -46.02 89.24 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 113.131 0.789 . . . . 1.06 113.131 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -86.55 -55.91 3.66 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.57 0.581 . . . . 1.74 112.57 -172.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.62 -49.14 15.19 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.659 0.783 . . . . 1.29 111.628 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.73 HD13 HG22 ' A' ' 26' ' ' VAL . 14.0 mt -77.32 -51.41 10.92 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.754 -0.657 . . . . 0.81 111.539 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 101.99 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.219 2.208 . . . . 1.12 111.275 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' THR . 22.0 t -110.09 118.84 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.607 -1.627 . . . . 0.79 106.607 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.15 113.52 0.82 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.228 0.955 . . . . 2.0 109.741 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 43' ' ' MET . 39.3 p -49.7 -21.45 1.06 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.279 1.431 . . . . 0.78 114.359 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 42' ' ' SER . 3.3 pp -81.84 -36.89 27.79 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.887 0.699 . . . . 1.18 112.887 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.447 ' N ' HD12 ' A' ' 41' ' ' LEU . 3.3 m -81.71 -13.39 57.89 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.461 1.124 . . . . 0.6 108.546 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.455 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 3.7 tpt -55.49 -36.72 66.96 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 126.804 2.042 . . . . 0.86 111.061 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.74 -45.91 96.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 115.809 -0.632 . . . . 0.31 109.776 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -57.39 -41.37 80.12 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 115.906 -0.588 . . . . 0.68 109.903 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.695 HG22 HG13 ' A' ' 18' ' ' ILE . 40.1 t -59.53 -28.8 40.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-N 115.496 -0.774 . . . . 0.63 111.16 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.778 HG21 HG13 ' A' ' 63' ' ' VAL . 20.8 t -78.98 -54.94 10.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.151 -1.055 . . . . 0.55 108.151 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.4 -19.65 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.85 -1.523 . . . . 0.42 110.904 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.84 -38.91 16.36 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 121.226 0.536 . . . . 0.21 109.633 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -61.17 -64.19 1.04 Allowed 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.99 -1.005 . . . . 0.21 111.567 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.341 0.0 OUTLIER -59.43 -44.12 92.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 114.882 1.438 . . . . 0.64 114.882 -173.822 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -54.12 -39.2 66.22 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.206 1.003 . . . . 2.07 112.244 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.914 -0.585 . . . . 2.48 110.781 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CE2' HG23 ' A' ' 7' ' ' ILE . 8.2 m-85 -86.66 -44.89 11.49 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.467 -0.893 . . . . 0.81 111.839 -173.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 22.9 t70 155.14 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.751 1.282 . . . . 1.99 112.682 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.7 HG11 ' HA ' ' A' ' 76' ' ' ILE . 3.8 p -79.96 178.37 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 112.072 0.397 . . . . 0.37 112.072 -168.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' H ' HG22 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -133.31 125.56 29.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.355 -1.35 . . . . 2.12 107.355 174.53 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.596 HG12 ' HE2' ' A' ' 75' ' ' TYR . 64.8 mt -113.36 118.9 43.05 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.348 -0.387 . . . . 0.25 110.683 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.552 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.6 Cg_endo -66.78 154.18 75.39 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.482 2.788 . . . . 0.33 110.588 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -51.66 -37.42 50.41 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.591 0.557 . . . . 1.98 111.673 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -59.56 -44.43 93.26 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.202 -0.454 . . . . 2.06 110.682 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.468 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 21.7 m-20 -82.68 -28.89 30.3 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 112.662 0.615 . . . . 0.52 112.662 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.778 HG13 HG21 ' A' ' 47' ' ' VAL . 53.0 t -52.01 -53.45 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 108.183 -1.043 . . . . 0.38 108.183 174.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -74.98 -1.91 24.77 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.975 -1.011 . . . . 2.16 113.549 -177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.92 -33.56 14.84 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.576 -0.898 . . . . 1.59 108.576 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.893 HD13 ' HA ' ' A' ' 72' ' ' ALA . 32.5 mt -69.25 133.34 47.8 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 106.267 -1.753 . . . . 0.31 106.267 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.579 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -128.39 -32.29 2.22 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-O 121.252 0.548 . . . . 2.55 110.126 175.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.628 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 28.5 p -112.07 172.81 6.69 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.683 -0.858 . . . . 0.23 108.683 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -80.4 -12.93 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.782 0.801 . . . . 1.21 109.478 175.257 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -69.74 -37.92 76.6 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.368 -1.493 . . . . 0.33 109.368 176.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.579 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 24.3 m-20 -69.44 -54.33 14.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 108.772 -0.825 . . . . 1.39 108.772 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.893 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.19 -60.67 2.86 Favored 'General case' 0 CA--C 1.469 -2.168 0 O-C-N 124.676 1.235 . . . . 0.15 111.043 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.647 HG21 ' HG2' ' A' ' 4' ' ' GLN . 35.9 m -54.97 -49.28 71.83 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.459 1.099 . . . . 0.24 113.585 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.7 mptm? -67.17 -28.64 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.222 0.534 . . . . 3.63 111.051 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.596 ' HE2' HG12 ' A' ' 58' ' ' ILE . 84.9 t80 -71.52 -51.9 21.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.966 -0.753 . . . . 0.4 108.966 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.7 ' HA ' HG11 ' A' ' 56' ' ' VAL . 60.3 mt -57.41 -66.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.521 -1.218 . . . . 0.21 111.134 -177.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.466 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 4.5 tt -50.19 -50.34 49.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.211 1.404 . . . . 1.44 110.972 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.9 t70 -69.5 -25.72 64.19 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.995 -1.457 . . . . 0.63 111.417 -170.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -91.26 -22.67 20.46 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.674 -0.694 . . . . 1.25 111.682 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 76' ' ' ILE . 2.4 pt20 -90.62 -54.95 3.77 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.482 1.134 . . . . 0.87 113.385 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.528 ' HB2' ' HB1' ' A' ' 1' ' ' ALA . . . . . . . . 0 C--N 1.249 -3.766 0 CA-C-N 113.459 -1.7 . . . . 1.97 110.331 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.793 ' H37' HG21 ' A' ' 33' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 109.557 -0.534 . . . . 1.42 109.557 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.59 -74.87 0.6 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.263 -0.426 . . . . 1.85 110.611 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.3 t -174.46 -169.68 0.46 Allowed 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.996 -0.742 . . . . 0.66 108.996 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -40.19 60.56 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.593 1.157 . . . . 0.74 113.202 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.54 -23.73 64.83 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.865 0.691 . . . . 2.66 112.865 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.52 -39.9 21.76 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.018 -0.734 . . . . 2.73 109.018 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.446 HG21 ' HA ' ' A' ' 73' ' ' THR . 76.3 mt -76.66 -66.48 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 CA-C-N 114.719 -1.128 . . . . 0.23 111.692 -170.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -56.72 -42.41 77.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.376 0.51 . . . . 0.27 112.376 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.82 72.84 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.589 0.556 . . . . 0.27 111.362 176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.91 -40.09 8.3 Favored Glycine 0 N--CA 1.405 -3.418 0 C-N-CA 120.596 -0.811 . . . . 0.18 113.059 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -63.12 -41.04 99.25 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.613 0.765 . . . . 0.2 109.079 -177.05 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.09 -48.17 67.99 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 123.747 0.654 . . . . 0.14 109.588 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.664 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 48.3 mt-10 -62.36 -42.34 99.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 124.266 0.979 . . . . 0.68 112.05 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 11' ' ' LEU . 54.7 mt -59.49 -39.43 79.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.332 0.587 . . . . 0.28 110.179 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 11' ' ' LEU . 46.4 t -69.48 -23.52 26.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 CA-C-O 122.082 0.944 . . . . 0.27 109.722 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -77.98 -37.78 46.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.25 -1.018 . . . . 0.34 108.25 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 20.7 mm-40 -74.23 -55.52 5.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.853 -1.067 . . . . 2.07 111.296 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 46' ' ' VAL . 21.3 mm -63.87 -53.1 48.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.448 -0.796 . . . . 0.65 110.811 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -103.12 -83.1 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.438 -0.505 . . . . 0.54 110.436 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.03 44.93 0.02 OUTLIER Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 120.061 -1.066 . . . . 0.43 112.199 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -78.05 149.79 77.03 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 110.05 -0.352 . . . . 0.31 110.05 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 8.9 Cg_exo -82.86 24.54 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 124.526 3.484 . . . . 1.08 115.429 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.505 ' H ' HG22 ' A' ' 21' ' ' ILE . 6.9 p 52.55 22.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 125.55 1.54 . . . . 0.81 114.909 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -130.16 -13.14 4.02 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 120.909 -1.119 . . . . 2.31 111.399 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.522 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -93.38 -26.25 17.34 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 115.324 -0.853 . . . . 1.59 110.251 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.601 HG23 HG21 ' A' ' 21' ' ' ILE . 39.5 t -71.24 91.23 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.201 -0.908 . . . . 0.3 109.357 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 34.4 mmtp -130.74 169.98 14.96 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.294 -1.373 . . . . 1.58 107.294 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 8.3 mp -64.74 148.38 51.25 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.819 -0.808 . . . . 1.05 108.819 177.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 t70 81.76 -3.52 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.766 1.226 . . . . 0.72 110.766 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.775 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 10.4 mmpt? -98.13 124.05 42.48 Favored 'General case' 0 CA--C 1.454 -2.744 0 C-N-CA 119.713 -0.795 . . . . 1.48 110.856 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 19.2 m -79.78 115.5 19.41 Favored 'General case' 1 C--N 1.237 -4.316 0 N-CA-C 108.02 -1.104 . . . . 1.25 108.02 178.387 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' LEU . 83.3 m-85 -51.78 -49.35 62.84 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.566 0.698 . . . . 0.4 112.228 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.523 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.0 t -81.36 -44.46 17.56 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.291 -0.88 . . . . 1.06 111.305 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 25.0 t70 -74.15 -50.92 17.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.032 0.753 . . . . 1.74 113.032 -175.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.442 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 12.7 t70 -83.78 -58.03 2.97 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 122.049 0.928 . . . . 1.29 109.393 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.758 HD12 ' HA ' ' A' ' 32' ' ' PHE . 25.4 mt -72.88 -32.65 65.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.48 -1.691 . . . . 0.81 112.363 -169.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 20.1 t70 83.1 66.48 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 123.193 1.473 . . . . 1.12 110.803 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 19' ' ' ALA . 49.4 t -105.62 141.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 112.767 -2.015 . . . . 0.79 107.94 170.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.456 ' HB2' ' OG ' ' A' ' 42' ' ' SER . 4.8 m-20 -56.08 7.93 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 116.618 2.081 . . . . 2.0 116.618 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.517 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.5 t 66.6 -57.44 0.39 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 114.383 1.253 . . . . 0.78 114.383 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 pp -63.31 -30.72 71.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.949 0.88 . . . . 1.18 109.749 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.56 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.5 m -77.94 -15.55 58.89 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.751 -1.113 . . . . 0.6 110.506 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.822 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -67.08 -40.62 87.04 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-N 116.306 -0.407 . . . . 0.86 111.967 -174.333 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.19 -40.84 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 124.246 0.966 . . . . 0.31 109.767 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.88 -48.02 83.72 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.578 -0.737 . . . . 0.68 109.526 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.63 HG22 HG13 ' A' ' 18' ' ' ILE . 11.9 t -60.78 -23.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.988 0.915 . . . . 0.63 110.918 -177.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.904 HG21 HG13 ' A' ' 63' ' ' VAL . 36.8 t -78.99 -54.74 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 107.885 -1.154 . . . . 0.55 107.885 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -60.65 -37.06 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.882 -1.054 . . . . 0.42 108.89 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -70.01 -31.51 69.21 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 116.167 -0.47 . . . . 0.21 110.061 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -65.67 -58.16 6.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.363 -0.835 . . . . 0.21 109.266 176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.631 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.269 0.0 OUTLIER -66.42 -31.83 72.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 114.914 1.45 . . . . 0.64 114.914 -175.59 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -59.24 -33.32 70.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.908 0.861 . . . . 2.07 109.881 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -88.59 -32.33 18.17 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.11 -0.95 . . . . 2.48 111.968 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.23 18.42 21.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.397 0.518 . . . . 0.81 112.397 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 75.37 -26.02 0.2 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 114.438 1.273 . . . . 1.99 114.438 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.631 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 7.2 p -72.26 170.81 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 122.324 -0.235 . . . . 0.37 110.379 -173.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.625 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 2.8 tppp? -124.13 126.67 46.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.31 -0.996 . . . . 2.12 108.31 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.64 HG12 ' HE2' ' A' ' 75' ' ' TYR . 36.0 mt -119.99 105.02 43.26 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 120.592 -0.443 . . . . 0.25 110.457 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 63' ' ' VAL . 79.9 Cg_endo -73.8 166.6 29.31 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.106 2.537 . . . . 0.33 111.004 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.33 -46.97 37.16 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 1.98 111.487 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.16 -35.44 77.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.876 -0.602 . . . . 2.06 112.02 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.566 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 10.9 m-20 -86.03 -31.63 21.9 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.275 -0.57 . . . . 0.52 111.222 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.904 HG13 HG21 ' A' ' 47' ' ' VAL . 75.1 t -52.84 -50.52 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.843 -0.799 . . . . 0.38 108.843 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -72.41 -9.15 58.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.199 -0.909 . . . . 2.16 113.195 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.42 -25.91 21.28 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.478 0.656 . . . . 1.59 110.071 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.802 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.7 mt -82.18 110.92 17.82 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.077 -1.823 . . . . 0.31 106.077 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 47.5 mtpt -112.25 -43.88 3.48 Favored 'General case' 0 C--N 1.271 -2.834 0 N-CA-C 107.718 -1.216 . . . . 2.55 107.718 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 67.4 p -102.54 174.73 5.77 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 114.917 -1.038 . . . . 0.23 109.039 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.491 HG22 ' CE2' ' A' ' 32' ' ' PHE . 10.1 t -77.3 -14.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 107.781 -1.192 . . . . 1.21 107.781 175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.478 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -69.01 -51.09 30.41 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 109.39 -1.484 . . . . 0.33 109.39 175.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -60.38 -51.24 70.32 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 114.269 -0.966 . . . . 1.39 109.371 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.802 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -54.29 -61.57 2.22 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 124.494 1.122 . . . . 0.15 111.528 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.446 ' HA ' HG21 ' A' ' 7' ' ' ILE . 34.3 m -58.1 -45.83 86.56 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.437 -1.256 . . . . 0.24 113.861 -174.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -57.64 -50.8 71.98 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 123.851 0.72 . . . . 3.63 109.194 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.64 ' HE2' HG12 ' A' ' 58' ' ' ILE . 49.4 t80 -54.55 -51.22 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.124 0.89 . . . . 0.4 111.283 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.1 mt -55.09 -66.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.66 0 CA-C-N 114.671 -1.149 . . . . 0.21 110.611 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 tt -52.54 -43.66 65.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.796 1.638 . . . . 1.44 110.678 -177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -71.07 -26.3 63.01 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.218 -1.355 . . . . 0.63 110.96 -173.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -103.24 -7.73 20.93 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.389 0.885 . . . . 1.25 113.389 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.69 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 17.5 mt-30 -71.9 -61.08 1.91 Allowed 'General case' 0 CA--C 1.448 -2.967 0 CA-C-O 122.974 1.369 . . . . 0.87 107.623 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.257 -3.421 0 CA-C-N 112.203 -2.272 . . . . 1.97 110.198 -178.893 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.822 ' H1 ' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 109.44 -0.578 . . . . 1.42 109.44 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.04 -155.27 0.65 Allowed 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.098 -1.075 . . . . 1.85 108.098 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -134.65 174.79 10.17 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.309 -0.626 . . . . 0.66 109.309 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.554 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -48.39 -36.91 15.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.016 1.327 . . . . 0.74 112.973 178.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -52.19 -54.49 30.23 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.787 0.68 . . . . 2.66 110.512 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.16 -37.07 71.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.728 0.811 . . . . 2.73 110.092 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' A' ' 73' ' ' THR . 82.3 mt -74.37 -66.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 115.099 -0.955 . . . . 0.23 111.149 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.26 -46.71 92.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 112.347 0.499 . . . . 0.27 112.347 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.654 -0.419 . . . . 0.27 110.808 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.55 -38.22 9.93 Favored Glycine 0 N--CA 1.415 -2.756 0 CA-C-N 116.099 -0.501 . . . . 0.18 113.362 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.667 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.47 -38.61 91.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.033 -1.099 . . . . 0.2 108.033 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.96 -44.73 82.89 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.14 109.966 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.665 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 42.8 mt-10 -64.09 -35.24 80.12 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.872 0.732 . . . . 0.68 111.843 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 11' ' ' LEU . 51.7 mt -67.54 -43.2 87.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.85 -0.614 . . . . 0.28 109.589 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.688 HG22 HG11 ' A' ' 46' ' ' VAL . 21.3 t -67.72 -24.65 31.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 121.885 0.85 . . . . 0.27 109.221 -177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.665 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 13.7 m120 -64.58 -43.29 94.31 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 114.776 -1.102 . . . . 0.34 109.26 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -80.44 -49.15 11.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.189 -0.914 . . . . 2.07 111.591 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.735 HG13 HG22 ' A' ' 46' ' ' VAL . 22.1 mm -61.2 -53.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.057 -0.52 . . . . 0.65 111.283 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.8 -76.59 0.6 Allowed 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.226 -0.59 . . . . 0.54 110.384 -176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.84 50.33 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 110.146 -1.182 . . . . 0.43 110.146 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.449 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.2 mp -88.46 159.77 46.4 Favored Pre-proline 0 C--N 1.278 -2.508 0 CA-C-N 114.395 -0.902 . . . . 0.31 108.577 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -92.53 141.13 2.14 Favored 'Trans proline' 0 N--CA 1.414 -3.154 0 C-N-CA 122.108 1.872 . . . . 1.08 108.954 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.5 p -73.41 54.2 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-O 122.779 1.276 . . . . 0.81 113.111 -173.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 25' ' ' ASP . 12.2 pt-20 -163.74 -9.39 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.109 -1.405 . . . . 2.31 111.087 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.42 ' H ' ' H ' ' A' ' 24' ' ' GLU . 27.6 t0 -83.71 -28.45 28.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.763 0.792 . . . . 1.59 109.394 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' A' ' 12' ' ' ALA . 43.3 t -77.46 92.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.525 -1.216 . . . . 0.3 109.304 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.6 mttt -121.14 172.81 7.7 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.895 -1.15 . . . . 1.58 107.895 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 8.6 mp -65.81 145.48 55.91 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.822 -1.177 . . . . 1.05 107.822 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 77.0 8.7 2.88 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.246 0.966 . . . . 0.72 110.804 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.1 mmtt -92.3 119.78 32.21 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 108.387 -0.968 . . . . 1.48 108.387 174.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 17.4 m -78.58 36.69 0.26 Allowed 'General case' 1 C--N 1.243 -4.058 0 C-N-CA 125.688 1.595 . . . . 1.25 113.515 -172.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.663 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 97.4 m-85 39.96 -95.78 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 125.328 1.451 . . . . 0.4 114.622 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 15.0 t -84.72 37.57 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.546 1.165 . . . . 1.06 111.342 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 32.5 t70 -145.41 -48.5 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.23 -1.35 . . . . 1.74 107.76 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 3.2 m-20 -87.35 -38.05 16.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 1.29 112.914 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 26' ' ' VAL . 59.7 mt -85.35 -48.84 8.66 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.186 0.81 . . . . 0.81 113.186 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.0 t70 102.59 69.48 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.323 1.849 . . . . 1.12 109.696 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 39' ' ' ASP . 11.5 t -105.14 175.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 113.803 -1.544 . . . . 0.79 109.733 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 38' ' ' VAL . 17.2 t70 -79.04 -18.29 53.78 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.261 0.837 . . . . 2.0 113.261 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' MET . 3.3 t 74.5 -41.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.686 1.194 . . . . 0.78 113.154 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.45 -49.59 10.44 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 106.879 -1.526 . . . . 1.18 106.879 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 19.5 m -67.08 -11.96 58.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.045 -1.434 . . . . 0.6 111.023 176.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.663 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 4.0 tpt -60.23 -33.3 72.07 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 125.073 1.349 . . . . 0.86 109.324 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.544 HG22 ' S1 ' ' A' ' 101' ' ' SYO . 60.7 t -64.74 -40.02 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.602 -0.726 . . . . 0.31 109.53 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.23 -43.18 82.64 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.374 -0.375 . . . . 0.68 110.53 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 HG13 ' A' ' 18' ' ' ILE . 6.5 t -60.97 -24.43 32.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 C-N-CA 123.526 0.73 . . . . 0.63 110.845 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.685 HG21 HG13 ' A' ' 63' ' ' VAL . 22.0 t -80.4 -53.77 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 107.78 -1.193 . . . . 0.55 107.78 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.65 -32.91 52.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 113.895 -1.502 . . . . 0.42 110.03 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -77.67 -31.31 52.46 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.207 0.527 . . . . 0.21 109.73 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -62.58 -57.09 12.35 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.398 -0.819 . . . . 0.21 109.131 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.536 ' OE2' ' HD3' ' A' ' 57' ' ' LYS 0.279 0.0 OUTLIER -61.88 -38.67 89.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 114.161 1.171 . . . . 0.64 114.161 -176.274 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.19 -34.47 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.527 0.517 . . . . 2.07 112.128 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -82.88 -36.08 25.66 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.064 -0.516 . . . . 2.48 110.205 -175.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.516 ' CE2' HG23 ' A' ' 7' ' ' ILE . 7.1 m-85 -86.85 -45.08 11.2 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.2 -1.0 . . . . 0.81 112.435 -172.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 152.29 -35.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 O-C-N 124.891 1.37 . . . . 1.99 112.169 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.604 ' CG1' HG23 ' A' ' 76' ' ' ILE . 14.5 p -75.92 172.37 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 112.726 0.639 . . . . 0.37 112.726 -165.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 3.1 tppp? -125.04 119.71 29.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.368 -1.715 . . . . 2.12 106.368 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.535 HG12 ' HE2' ' A' ' 75' ' ' TYR . 58.5 mt -111.85 113.22 52.74 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 120.693 -0.403 . . . . 0.25 110.226 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 63' ' ' VAL . 93.8 Cg_endo -73.15 157.62 50.25 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.822 2.348 . . . . 0.33 110.668 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.16 -41.17 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.523 1.129 . . . . 1.98 111.617 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 2.3 m-20 -61.81 -51.02 69.96 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 115.573 -0.74 . . . . 2.06 111.247 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 m-20 -71.46 -30.32 65.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.971 0.36 . . . . 0.52 111.971 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 47' ' ' VAL . 53.0 t -51.43 -55.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.941 -0.763 . . . . 0.38 108.941 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.5 pttp -75.64 -1.92 26.9 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 115.401 -0.818 . . . . 2.16 112.674 -175.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -91.38 -19.57 22.76 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.656 0.741 . . . . 1.59 109.383 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.2 mt -86.11 118.33 25.51 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 104.728 -2.323 . . . . 0.31 104.728 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -110.95 -46.69 3.3 Favored 'General case' 0 C--N 1.259 -3.341 0 N-CA-C 108.289 -1.004 . . . . 2.55 108.289 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 42.5 p -105.07 173.57 6.25 Favored 'General case' 1 N--CA 1.379 -4.004 0 CA-C-N 115.052 -0.977 . . . . 0.23 109.321 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 27' ' ' LYS . 5.5 t -77.49 -13.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 107.454 -1.313 . . . . 1.21 107.454 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.548 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.46 -45.69 58.97 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.201 -1.56 . . . . 0.33 109.201 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -68.17 -48.21 65.9 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.122 -1.039 . . . . 1.39 109.59 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -53.62 -61.13 2.5 Favored 'General case' 0 CA--C 1.482 -1.655 0 O-C-N 124.56 1.162 . . . . 0.15 111.124 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.568 ' HA ' HG21 ' A' ' 7' ' ' ILE . 58.5 m -54.89 -51.54 65.66 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.615 -1.175 . . . . 0.24 113.838 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.1 mptm? -54.75 -47.85 73.33 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.867 0.729 . . . . 3.63 109.456 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.535 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.0 t80 -58.19 -52.55 65.11 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 124.204 0.94 . . . . 0.4 111.412 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.604 HG23 ' CG1' ' A' ' 56' ' ' VAL . 75.8 mt -51.41 -65.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.789 -1.096 . . . . 0.21 110.298 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 tt -54.52 -42.21 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.077 1.351 . . . . 1.44 109.855 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 26.6 t70 -59.62 -41.04 89.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.163 0.985 . . . . 0.63 110.285 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.595 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 1.9 t-80 -90.07 -12.4 38.58 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.141 -1.39 . . . . 1.25 111.222 -173.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 34.0 mt-30 -81.53 -49.49 10.51 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-O 122.722 1.248 . . . . 0.87 108.351 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -2.859 0 CA-C-N 112.381 -2.19 . . . . 1.97 110.458 -175.342 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.696 ' H2A' ' N41' ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 N-CA-C 108.248 -1.019 . . . . 1.42 108.248 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.06 -89.47 0.47 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 112.445 0.535 . . . . 1.85 112.445 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.513 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 t -169.64 -172.47 1.43 Allowed 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.908 -0.405 . . . . 0.66 109.908 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HG2' HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -50.26 -41.9 51.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.855 1.662 . . . . 0.74 113.534 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -62.42 -23.69 66.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.78 0.659 . . . . 2.66 112.78 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -87.56 -35.7 17.97 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.108 -0.701 . . . . 2.73 109.108 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' A' ' 73' ' ' THR . 92.9 mt -75.73 -65.48 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-N 115.523 -0.762 . . . . 0.23 110.996 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.427 HG23 ' HG2' ' A' ' 4' ' ' GLN . 67.6 t -52.16 -45.04 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 122.869 0.468 . . . . 0.27 111.523 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.1 76.64 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 123.64 0.588 . . . . 0.27 111.604 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.58 9.94 Favored Glycine 0 N--CA 1.412 -2.949 0 CA-C-N 116.419 -0.355 . . . . 0.18 112.493 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.728 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.61 -36.55 82.86 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.243 -1.021 . . . . 0.2 108.243 -178.046 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.68 -44.41 90.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.482 -0.781 . . . . 0.14 110.022 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.827 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 47.0 mt-10 -62.39 -38.6 90.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 123.935 0.772 . . . . 0.68 111.746 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 11' ' ' LEU . 61.1 mt -61.53 -42.33 93.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.749 0.785 . . . . 0.28 109.161 176.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.813 HG12 ' HB ' ' A' ' 21' ' ' ILE . 86.4 t -71.16 -23.72 23.56 Favored 'Isoleucine or valine' 0 C--O 1.255 1.39 0 CA-C-N 115.182 -0.917 . . . . 0.27 111.08 -175.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.827 ' ND2' ' HA ' ' A' ' 13' ' ' GLU . 52.3 m-20 -67.02 -46.31 74.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.1 -1.074 . . . . 0.34 108.1 177.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -74.97 -50.03 18.0 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.924 -1.035 . . . . 2.07 111.859 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.737 HG13 HG22 ' A' ' 46' ' ' VAL . 24.4 mm -59.71 -52.53 59.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.983 0.513 . . . . 0.65 111.403 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -110.28 -60.0 1.86 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.077 0.465 . . . . 0.54 111.552 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.07 28.63 0.31 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 120.559 -0.829 . . . . 0.43 112.638 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.813 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -70.41 151.73 95.62 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 109.569 -0.53 . . . . 0.31 109.569 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.7 Cg_exo -89.8 33.97 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.993 3.128 . . . . 1.08 115.222 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 3.3 p 61.41 -11.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 116.444 2.016 . . . . 0.81 116.444 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -115.16 -3.42 12.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.416 -0.803 . . . . 2.31 112.231 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.31 -29.54 28.24 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-O 121.638 0.733 . . . . 1.59 109.19 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.749 HG23 HG21 ' A' ' 21' ' ' ILE . 47.4 t -71.72 90.44 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.149 -1.387 . . . . 0.3 108.126 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 69' ' ' VAL . 1.5 tppp? -124.11 158.81 31.41 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.384 -1.71 . . . . 1.58 106.384 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.455 HD22 ' HA2' ' A' ' 70' ' ' GLY . 88.4 mt -57.54 140.29 51.2 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.001 0.429 . . . . 1.05 110.531 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t70 74.75 13.97 3.43 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.467 1.507 . . . . 0.72 110.911 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -100.91 125.99 47.5 Favored 'General case' 0 CA--C 1.467 -2.238 0 CA-C-O 121.474 0.655 . . . . 1.48 109.308 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 9.3 m -80.2 111.38 16.52 Favored 'General case' 1 C--N 1.239 -4.234 0 CA-C-N 114.071 -1.422 . . . . 1.25 109.129 -177.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.583 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 93.7 m-85 -45.74 -64.92 0.62 Allowed 'General case' 0 C--N 1.271 -2.808 0 C-N-CA 124.367 1.067 . . . . 0.4 112.374 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -90.25 32.97 0.9 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.204 -0.935 . . . . 1.06 112.783 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.8 t70 -147.71 -55.83 0.23 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.671 0.748 . . . . 1.74 110.741 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.59 -50.6 8.61 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.189 -0.914 . . . . 1.29 110.394 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.634 HD13 HG22 ' A' ' 26' ' ' VAL . 17.3 mt -76.36 -45.5 31.67 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.682 -0.69 . . . . 0.81 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.6 t70 88.66 61.73 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.844 1.658 . . . . 1.12 109.921 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 19' ' ' ALA . 18.6 t -104.21 143.55 15.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 113.591 -1.64 . . . . 0.79 106.766 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 43' ' ' MET . 36.9 m-20 -60.53 109.67 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 111.876 0.325 . . . . 2.0 111.876 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.602 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 28.6 t -34.84 -50.43 0.47 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 126.527 1.931 . . . . 0.78 114.429 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 42' ' ' SER . 3.3 pp -71.12 -27.83 63.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.438 0.637 . . . . 1.18 111.918 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 46' ' ' VAL . 18.5 m -85.11 -13.38 50.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.386 0.675 . . . . 0.6 110.425 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.911 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -61.58 -38.15 86.48 Favored 'General case' 0 CA--C 1.47 -2.103 0 C-N-CA 123.289 0.636 . . . . 0.86 111.576 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.6 -42.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 124.341 1.025 . . . . 0.31 109.413 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -57.01 -50.32 73.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.374 0.606 . . . . 0.68 109.387 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.737 HG22 HG13 ' A' ' 18' ' ' ILE . 40.8 t -55.83 -28.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 124.92 1.288 . . . . 0.63 111.67 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.934 HG21 HG13 ' A' ' 63' ' ' VAL . 21.2 t -78.17 -49.25 21.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.02 -1.104 . . . . 0.55 108.02 -176.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.39 -38.6 78.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.291 -1.322 . . . . 0.42 108.517 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -38.03 77.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.703 -0.68 . . . . 0.21 110.003 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -61.42 -55.22 33.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.108 -0.951 . . . . 0.21 110.008 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.324 1.9 pp20? -62.22 -38.49 89.4 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 113.996 1.11 . . . . 0.64 113.996 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.32 -25.86 66.22 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.649 0.593 . . . . 2.07 112.505 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -83.93 -52.17 6.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.644 -0.423 . . . . 2.48 110.583 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 14.2 m-85 -73.94 -44.17 55.87 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 114.629 1.344 . . . . 0.81 114.629 -169.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 17.3 t70 146.52 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 O-C-N 124.732 1.27 . . . . 1.99 110.636 176.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.8 p -73.18 173.53 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.004 -0.998 . . . . 0.37 112.303 -166.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 56' ' ' VAL . 20.9 tptm -120.69 123.3 42.41 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.449 -1.315 . . . . 2.12 107.449 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.565 HG13 ' HB3' ' A' ' 51' ' ' GLU . 55.3 mt -120.31 106.96 39.83 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.478 -0.934 . . . . 0.25 108.478 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 63' ' ' VAL . 45.7 Cg_endo -70.29 166.84 26.91 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.013 2.476 . . . . 0.33 111.517 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -50.43 -43.2 54.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.144 0.978 . . . . 1.98 109.339 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -49.6 -59.17 4.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.539 -1.21 . . . . 2.06 111.642 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.565 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 27.6 m-20 -74.19 -26.28 60.18 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.84 0.681 . . . . 0.52 112.84 -176.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.934 HG13 HG21 ' A' ' 47' ' ' VAL . 62.0 t -53.26 -41.93 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 108.919 -0.771 . . . . 0.38 108.919 174.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -80.24 -7.18 58.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.665 -1.152 . . . . 2.16 112.185 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -94.67 -36.91 11.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 108.862 -0.792 . . . . 1.59 108.862 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.859 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.6 mt -73.2 125.1 26.95 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 106.596 -1.631 . . . . 0.31 106.596 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.55 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -130.15 -24.24 2.62 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 120.312 -0.555 . . . . 2.55 111.474 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 43.0 p -116.5 171.83 7.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 107.721 -1.214 . . . . 0.23 107.721 173.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -78.75 -13.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 C-N-CA 120.087 -0.645 . . . . 1.21 109.599 176.547 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.455 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -67.32 -46.78 67.91 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 109.713 -1.355 . . . . 0.33 109.713 175.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.55 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 15.0 m-20 -61.33 -55.42 31.92 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.378 -0.971 . . . . 1.39 108.378 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.859 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.62 -61.19 2.4 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.0 -1.454 . . . . 0.15 111.769 -175.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.44 ' HA ' HG21 ' A' ' 7' ' ' ILE . 37.6 m -57.96 -46.33 85.28 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.96 -1.018 . . . . 0.24 113.472 -174.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 14.1 mptt -56.88 -44.75 82.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 123.771 0.669 . . . . 3.63 109.45 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.464 ' CE2' HG12 ' A' ' 58' ' ' ILE . 85.6 t80 -65.31 -48.19 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.37 1.043 . . . . 0.4 111.65 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.657 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -54.94 -65.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.71 -1.132 . . . . 0.21 110.239 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.0 tt -51.7 -41.78 61.71 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.775 1.23 . . . . 1.44 109.358 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 11.5 t70 -58.28 -41.11 83.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.917 1.287 . . . . 0.63 109.549 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -102.1 3.78 38.96 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.979 1.103 . . . . 1.25 113.979 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 46.3 mt-30 -87.14 -60.53 1.95 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.552 -1.277 . . . . 0.87 107.552 175.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.417 0 CA-C-N 111.736 -2.484 . . . . 1.97 112.158 -174.135 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SYO . . . . . 0.911 ' H1 ' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.748 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.6 t . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 107.864 -1.161 . . . . 0.66 107.864 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.88 -42.72 48.47 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.363 1.065 . . . . 0.74 113.757 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -58.53 -23.79 59.04 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.173 0.511 . . . . 2.66 112.148 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -84.33 -45.14 13.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.272 -0.64 . . . . 2.73 109.272 175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.497 HG21 ' HA ' ' A' ' 73' ' ' THR . 79.8 mt -71.57 -65.44 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.03 0 CA-C-N 115.001 -0.999 . . . . 0.23 110.484 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.39 -48.81 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 C-N-CA 123.768 0.827 . . . . 0.27 112.614 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.68 77.64 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 123.327 0.392 . . . . 0.27 111.206 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -81.45 -40.5 11.03 Favored Glycine 0 N--CA 1.405 -3.424 0 C-N-CA 120.709 -0.758 . . . . 0.18 112.952 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.732 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -65.39 -38.09 88.94 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.161 0.984 . . . . 0.2 108.879 -176.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.536 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -61.82 -43.39 98.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.608 -0.724 . . . . 0.14 109.846 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.684 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.9 mt-10 -63.91 -35.74 81.65 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.754 0.659 . . . . 0.68 112.282 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 11' ' ' LEU . 60.7 mt -62.25 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.621 -0.881 . . . . 0.28 108.621 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.3 t -68.34 -23.86 28.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 CA-C-O 121.591 0.71 . . . . 0.27 110.659 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.684 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -66.35 -46.18 77.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.235 -0.893 . . . . 0.34 109.096 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.75 -44.8 15.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.233 -0.894 . . . . 2.07 111.614 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.714 HG13 HG22 ' A' ' 46' ' ' VAL . 21.0 mm -59.57 -51.91 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.783 0.433 . . . . 0.65 110.793 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -108.33 -81.42 0.57 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.52 0.676 . . . . 0.54 110.631 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.45 55.7 0.01 OUTLIER Glycine 0 CA--C 1.484 -1.86 0 N-CA-C 110.322 -1.111 . . . . 0.43 110.322 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.664 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -97.82 160.79 27.68 Favored Pre-proline 0 C--N 1.278 -2.52 0 N-CA-C 107.976 -1.12 . . . . 0.31 107.976 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -93.24 143.57 2.1 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 122.523 2.148 . . . . 1.08 109.192 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 12' ' ' ALA . 13.8 p -74.1 56.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 123.287 1.518 . . . . 0.81 112.802 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.418 ' H ' ' H ' ' A' ' 25' ' ' ASP . 10.5 pt-20 -151.51 -14.48 0.2 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.26 -1.336 . . . . 2.31 110.068 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' A' ' 30' ' ' LYS . 1.6 t70 -87.61 -37.14 17.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.861 0.839 . . . . 1.59 109.172 -173.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.633 HG22 HD13 ' A' ' 36' ' ' LEU . 21.7 t -77.7 90.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.991 -1.114 . . . . 0.3 107.991 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 66.2 mttm -101.84 -96.29 0.28 Allowed 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.955 0.883 . . . . 1.58 109.014 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.41 ' H ' ' HB2' ' A' ' 27' ' ' LYS . 95.4 mt -153.15 157.13 39.88 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 104.238 -2.505 . . . . 1.05 104.238 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.469 ' H ' ' CA ' ' A' ' 70' ' ' GLY . 30.5 t70 68.69 9.31 7.27 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.501 1.125 . . . . 0.72 110.657 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HB2' HG12 ' A' ' 69' ' ' VAL . 46.6 mmtt -93.57 126.2 38.59 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-N 115.586 -0.734 . . . . 1.48 109.282 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 34' ' ' ASP . 7.1 m -74.38 25.51 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 C-N-CA 126.501 1.92 . . . . 1.25 114.63 -171.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.748 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 70.2 m-85 41.84 -97.29 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.625 1.57 . . . . 0.4 113.746 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.677 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 10.2 t -57.58 -35.44 70.41 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 123.565 0.746 . . . . 1.06 111.141 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB3' ' CB ' ' A' ' 31' ' ' SER . 19.3 t70 -83.67 -40.82 18.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.482 -0.326 . . . . 1.74 111.098 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.84 -54.45 3.96 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 118.683 -1.207 . . . . 1.29 110.821 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.633 HD13 HG22 ' A' ' 26' ' ' VAL . 17.3 mt -74.06 -38.37 63.97 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.457 -1.247 . . . . 0.81 111.405 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.6 t70 89.4 69.37 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.538 1.535 . . . . 1.12 109.605 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.677 ' H ' ' HA ' ' A' ' 33' ' ' THR . 15.0 t -111.68 155.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.927 -1.942 . . . . 0.79 106.57 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 43' ' ' MET . 12.2 m-20 -76.5 119.85 20.91 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.251 -0.648 . . . . 2.0 109.251 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.563 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 10.2 t -42.51 -50.71 5.25 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.584 1.153 . . . . 0.78 113.58 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.62 -29.54 70.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.46 0.648 . . . . 1.18 111.43 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 46' ' ' VAL . 21.7 m -84.43 -15.12 47.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.17 -0.468 . . . . 0.6 110.688 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.748 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -62.8 -35.01 78.49 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 123.429 0.692 . . . . 0.86 110.579 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.76 -42.62 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.138 -0.689 . . . . 0.31 109.138 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.99 -44.54 94.45 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.194 -0.669 . . . . 0.68 109.194 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.714 HG22 HG13 ' A' ' 18' ' ' ILE . 47.8 t -59.65 -29.03 41.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 114.998 -1.001 . . . . 0.63 111.244 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.031 HG21 HG13 ' A' ' 63' ' ' VAL . 40.4 t -77.78 -51.77 17.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.876 -0.787 . . . . 0.55 108.876 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.2 -21.57 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.429 -0.805 . . . . 0.42 109.272 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.22 -38.0 31.96 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 109.012 -0.736 . . . . 0.21 109.012 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.71 -56.36 16.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.337 -0.847 . . . . 0.21 110.253 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.297 0.6 OUTLIER -63.47 -36.7 84.62 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 114.379 1.251 . . . . 0.64 114.379 -176.328 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.73 -24.12 64.43 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.892 0.377 . . . . 2.07 111.486 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -88.26 -40.91 13.28 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.737 0.303 . . . . 2.48 110.554 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.494 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 8.5 m-85 -94.52 -2.1 52.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.81 113.032 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 81.77 7.18 1.07 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.3 1.04 . . . . 1.99 113.723 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.748 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.5 p -89.73 178.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.328 -0.99 . . . . 0.37 108.328 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.432 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.2 tptt -133.45 130.51 38.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.241 -1.392 . . . . 2.12 107.241 171.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 76' ' ' ILE . 61.9 mt -124.68 113.36 27.17 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.182 -0.673 . . . . 0.25 109.182 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.581 ' O ' HG23 ' A' ' 63' ' ' VAL . 73.3 Cg_endo -72.56 164.42 35.65 Favored 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 123.089 2.526 . . . . 0.33 110.518 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.9 -30.31 70.8 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.929 0.344 . . . . 1.98 111.929 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.51 -31.39 72.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.693 0.282 . . . . 2.06 111.094 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.627 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 15.2 m-20 -86.61 -28.21 23.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.034 0.383 . . . . 0.52 112.034 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.031 HG13 HG21 ' A' ' 47' ' ' VAL . 69.7 t -55.05 -48.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.415 -0.957 . . . . 0.38 108.415 173.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 64' ' ' LYS . 15.6 ptpt -80.65 -1.92 44.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.253 -0.885 . . . . 2.16 111.772 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 38.5 t30 -92.21 -29.47 16.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.597 -0.89 . . . . 1.59 108.597 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.872 HD13 ' HA ' ' A' ' 72' ' ' ALA . 25.6 mt -85.7 112.29 20.9 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.432 -1.322 . . . . 0.31 107.432 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.537 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -104.76 -21.99 13.27 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.705 -1.198 . . . . 2.55 110.966 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.464 HG23 ' HG2' ' A' ' 67' ' ' LYS . 30.6 p -127.79 169.85 13.4 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 108.804 -0.813 . . . . 0.23 108.804 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.685 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 1.6 p -73.88 -13.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.804 0.811 . . . . 1.21 110.419 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.469 ' CA ' ' H ' ' A' ' 29' ' ' ASP . . . -68.95 -47.28 55.61 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 108.772 -1.731 . . . . 0.33 108.772 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.537 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.6 m-20 -58.19 -56.36 23.1 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.014 -0.736 . . . . 1.39 109.014 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.872 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.65 -61.64 2.08 Favored 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 124.718 1.262 . . . . 0.15 111.926 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.497 ' HA ' HG21 ' A' ' 7' ' ' ILE . 31.6 m -57.92 -44.03 86.58 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 113.643 0.979 . . . . 0.24 113.643 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -65.2 -33.3 75.69 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 122.905 0.482 . . . . 3.63 109.842 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HE2' HG12 ' A' ' 58' ' ' ILE . 88.4 t80 -72.68 -52.72 14.12 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.422 -0.808 . . . . 0.4 110.023 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.748 ' HA ' HG21 ' A' ' 56' ' ' VAL . 70.7 mt -52.88 -66.26 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.698 0 C-N-CA 124.717 1.207 . . . . 0.21 111.519 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.748 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.4 tt -50.41 -49.08 55.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.596 1.558 . . . . 1.44 109.484 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.3 t70 -67.56 -23.42 65.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.424 -1.716 . . . . 0.63 111.575 -174.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -101.96 -12.88 17.86 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.868 -0.606 . . . . 1.25 112.448 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 68.0 mt-30 . . . . . 0 CA--C 1.464 -2.33 0 N-CA-C 107.1 -1.444 . . . . 0.87 107.1 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.432 -1.335 0 N-CA-C 109.362 -0.607 . . . . 0.66 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.711 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -50.3 -46.4 55.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 125.615 1.566 . . . . 0.74 113.419 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.97 -23.59 63.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.58 0.585 . . . . 2.66 112.58 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -84.64 -32.2 23.79 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.821 -1.177 . . . . 2.73 107.821 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 73' ' ' THR . 74.2 mt -79.88 -64.81 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.112 -0.949 . . . . 0.23 109.238 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -55.6 -42.59 69.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 112.626 0.602 . . . . 0.27 112.626 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -60.92 -40.07 91.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.57 -0.452 . . . . 0.27 110.691 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.69 -35.89 21.03 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 120.889 -0.672 . . . . 0.18 112.6 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.683 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -65.9 -39.75 90.9 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.508 -1.293 . . . . 0.2 107.508 -179.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.77 -49.84 67.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 123.926 0.766 . . . . 0.14 109.867 175.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.601 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 35.1 mt-10 -58.58 -42.68 88.59 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 124.223 0.952 . . . . 0.68 111.521 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.4 mt -59.4 -38.75 76.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.509 -0.769 . . . . 0.28 110.232 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 11' ' ' LEU . 61.9 t -71.83 -30.16 36.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.614 -0.721 . . . . 0.27 109.845 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.8 m120 -67.33 -42.65 83.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.102 -0.703 . . . . 0.34 109.102 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 37.1 mm-40 -70.68 -58.8 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.917 -1.038 . . . . 2.07 111.887 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.803 HG22 ' HB3' ' A' ' 42' ' ' SER . 28.0 mt -72.82 -39.36 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 112.619 0.6 . . . . 0.65 112.619 -174.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -106.27 -80.37 0.56 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.13 -0.628 . . . . 0.54 111.441 -178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.69 53.17 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.656 -0.783 . . . . 0.43 112.756 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.824 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -98.02 155.22 37.27 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.612 -0.514 . . . . 0.31 109.612 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 21' ' ' ILE . 5.7 Cg_exo -88.76 40.14 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.017 2.478 . . . . 1.08 114.362 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.46 ' H ' ' ND2' ' A' ' 16' ' ' ASN 0.29 8.0 p 53.2 -18.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 117.383 2.364 . . . . 0.81 117.383 178.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -103.58 -12.8 16.85 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.351 -0.843 . . . . 2.31 111.401 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.59 -29.87 46.34 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.923 -0.769 . . . . 1.59 108.923 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.824 HG23 HG21 ' A' ' 21' ' ' ILE . 41.8 t -73.23 95.05 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.557 -1.201 . . . . 0.3 108.136 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -130.62 149.51 52.25 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 103.751 -2.685 . . . . 1.58 103.751 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD22 ' HA2' ' A' ' 70' ' ' GLY . 57.0 mt -48.63 145.97 3.33 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 124.007 0.923 . . . . 1.05 109.862 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 80.05 10.37 1.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.539 1.149 . . . . 0.72 110.707 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.762 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 34.2 mmtp -99.9 124.28 45.05 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.675 -0.861 . . . . 1.48 108.675 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 15.2 m -81.46 38.01 0.48 Allowed 'General case' 0 C--N 1.249 -3.781 0 C-N-CA 126.058 1.743 . . . . 1.25 113.007 -173.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.675 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 88.4 m-85 36.42 -91.83 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.991 1.716 . . . . 0.4 114.524 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.9 t -53.72 -33.12 54.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.091 0.956 . . . . 1.06 112.27 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 27.6 t70 -94.04 -44.41 8.05 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.879 0.371 . . . . 1.74 111.484 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.762 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 6.7 m-20 -88.63 -33.55 17.59 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.784 1.031 . . . . 1.29 113.784 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.629 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.0 mt -98.7 -31.42 11.92 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.038 -0.356 . . . . 0.81 110.038 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 84.55 62.79 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.223 1.487 . . . . 1.12 108.975 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 19' ' ' ALA . 26.7 t -109.39 124.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.701 -2.045 . . . . 0.79 107.71 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.45 122.66 15.15 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 121.064 -0.254 . . . . 2.0 111.212 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.537 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 26.8 t -37.21 -43.04 0.49 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.938 1.459 . . . . 0.78 114.938 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.2 mt -60.91 -46.26 91.35 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.944 0.878 . . . . 1.18 109.56 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.803 ' HB3' HG22 ' A' ' 18' ' ' ILE . 8.3 m -71.71 -29.3 64.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.511 -1.222 . . . . 0.6 110.501 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.698 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -53.16 -47.25 68.92 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 124.966 1.307 . . . . 0.86 112.798 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 48' ' ' VAL . 59.9 t -55.9 -45.6 79.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.013 0.82 . . . . 0.31 109.995 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -60.32 -44.1 95.78 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 109.34 -0.615 . . . . 0.68 109.34 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 15' ' ' VAL . 94.6 t -58.82 -28.54 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.027 0.931 . . . . 0.63 111.677 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.861 HG21 HG13 ' A' ' 63' ' ' VAL . 32.1 t -79.72 -50.98 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 108.04 -1.096 . . . . 0.55 108.04 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 44' ' ' VAL . 49.0 t -59.35 -38.74 76.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.214 -1.357 . . . . 0.42 108.91 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.21 -35.04 71.39 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.994 -0.548 . . . . 0.21 110.42 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.75 11.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.267 -0.879 . . . . 0.21 109.339 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.279 0.0 OUTLIER -63.95 -34.07 77.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 113.721 1.008 . . . . 0.64 113.721 -176.95 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.49 -24.73 66.45 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.445 0.535 . . . . 2.07 112.445 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -88.85 -41.56 12.4 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.503 -0.479 . . . . 2.48 111.629 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HZ ' ' N ' ' A' ' 11' ' ' LEU . 8.8 m-85 -88.87 -0.83 57.72 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 113.267 0.84 . . . . 0.81 113.267 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 80.2 -0.07 2.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.435 1.084 . . . . 1.99 112.837 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.738 HG21 ' HA ' ' A' ' 76' ' ' ILE . 7.6 p -84.75 177.45 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.389 -0.967 . . . . 0.37 108.389 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' H ' HG22 ' A' ' 56' ' ' VAL . 9.1 ttmm -137.11 131.76 33.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.934 -0.765 . . . . 2.12 108.934 172.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.563 HG12 ' HE2' ' A' ' 75' ' ' TYR . 54.0 mt -124.43 113.59 27.52 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.804 -0.635 . . . . 0.25 109.382 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HG23 ' A' ' 63' ' ' VAL . 36.5 Cg_endo -67.07 157.82 59.88 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 122.564 2.176 . . . . 0.33 109.917 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.81 -29.88 63.18 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.685 0.755 . . . . 1.98 109.359 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 29.7 t70 -60.91 -47.2 87.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.569 -1.196 . . . . 2.06 111.452 177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 59.3 m-20 -83.12 -24.94 32.39 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 111.812 0.301 . . . . 0.52 111.812 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.861 HG13 HG21 ' A' ' 47' ' ' VAL . 67.2 t -52.53 -48.11 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.324 -0.991 . . . . 0.38 108.324 173.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 25.8 pttm -75.57 -2.39 28.94 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.153 0.797 . . . . 2.16 113.153 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.87 -25.92 14.46 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.002 0.429 . . . . 1.59 110.418 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' HA ' ' A' ' 72' ' ' ALA . 37.4 mt -79.72 119.51 22.74 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 106.017 -1.846 . . . . 0.31 106.017 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -110.37 -35.04 6.17 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.58 -0.848 . . . . 2.55 110.571 176.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 31.6 p -111.43 177.65 4.59 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 109.089 -0.708 . . . . 0.23 109.089 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.675 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -86.99 -13.03 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 N-CA-C 108.263 -1.014 . . . . 1.21 108.263 174.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.469 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -72.35 -35.95 59.81 Favored Glycine 0 C--O 1.216 -0.981 0 N-CA-C 108.385 -1.886 . . . . 0.33 108.385 173.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 68' ' ' THR . 11.7 m-20 -66.74 -60.27 2.84 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.821 1.249 . . . . 1.39 109.501 173.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.75 -61.1 2.41 Favored 'General case' 0 CA--C 1.469 -2.164 0 CA-C-N 113.474 -1.694 . . . . 0.15 112.317 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.711 HG21 ' HG2' ' A' ' 4' ' ' GLN . 59.2 m -59.75 -34.34 72.83 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.914 -1.039 . . . . 0.24 113.324 -175.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -43.4 70.06 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 108.027 -1.101 . . . . 3.63 108.027 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.563 ' HE2' HG12 ' A' ' 58' ' ' ILE . 87.1 t80 -61.27 -50.86 71.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.856 -1.065 . . . . 0.4 109.611 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.738 ' HA ' HG21 ' A' ' 56' ' ' VAL . 76.7 mt -54.79 -65.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.037 -1.438 . . . . 0.21 110.634 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.13 -41.74 62.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.634 0.773 . . . . 1.44 109.939 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.34 -34.51 76.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.14 -0.936 . . . . 0.63 111.723 -175.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -95.71 -7.16 38.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 113.631 0.974 . . . . 1.25 113.631 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.578 HE21 HG22 ' A' ' 76' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.489 -1.397 0 N-CA-C 113.97 1.1 . . . . 0.87 113.97 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.452 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.0 t . . . . . 0 N--CA 1.437 -1.101 0 N-CA-C 111.083 0.031 . . . . 0.66 111.083 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -51.25 -37.06 45.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.945 1.298 . . . . 0.74 112.848 -178.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -48.76 66.92 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.895 0.747 . . . . 2.66 110.854 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.35 -38.18 87.01 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.505 0.722 . . . . 2.73 109.907 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.542 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.7 mt -72.13 -66.79 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.028 0 CA-C-N 115.681 -0.691 . . . . 0.23 112.344 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.573 HG21 HD11 ' A' ' 28' ' ' LEU . 58.3 t -60.0 -41.12 85.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 112.377 0.51 . . . . 0.27 112.377 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.36 86.84 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.269 0.355 . . . . 0.27 110.54 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.62 -40.15 10.04 Favored Glycine 0 N--CA 1.414 -2.825 0 CA-C-N 115.815 -0.629 . . . . 0.18 113.584 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.26 -37.14 86.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.605 -0.887 . . . . 0.2 108.605 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.12 -49.23 77.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.893 -0.594 . . . . 0.14 109.418 175.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.718 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 49.7 mt-10 -60.23 -41.57 93.39 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 124.131 0.894 . . . . 0.68 112.244 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 11' ' ' LEU . 69.1 mt -56.84 -42.15 77.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.618 -0.719 . . . . 0.28 109.887 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.626 HG12 ' HB ' ' A' ' 21' ' ' ILE . 98.4 t -70.16 -22.85 24.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.778 0.799 . . . . 0.27 110.879 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.718 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.9 m120 -76.34 -42.2 45.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.55 -1.278 . . . . 0.34 107.55 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -76.92 -39.76 49.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.551 -1.204 . . . . 2.07 112.252 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.553 HG13 HG22 ' A' ' 46' ' ' VAL . 20.7 mm -71.96 -53.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.895 0.379 . . . . 0.65 110.563 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.33 -74.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.374 -0.531 . . . . 0.54 111.26 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.55 44.77 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.353 -0.927 . . . . 0.43 112.221 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.843 HG21 HG23 ' A' ' 26' ' ' VAL . 1.5 mp -84.9 151.0 57.01 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.984 -0.747 . . . . 0.31 108.984 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 13.3 Cg_exo -83.27 29.24 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 124.277 3.318 . . . . 1.08 115.004 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.426 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 5.7 p 54.1 7.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 C-N-CA 126.195 1.798 . . . . 0.81 114.351 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -107.95 -27.1 10.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.943 -0.473 . . . . 2.31 111.834 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 36' ' ' LEU . 11.1 m-20 -83.17 -28.64 29.19 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 116.054 -0.521 . . . . 1.59 112.094 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.843 HG23 HG21 ' A' ' 21' ' ' ILE . 22.1 t -78.37 87.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.118 -0.633 . . . . 0.3 110.399 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 69' ' ' VAL . 96.5 mttt -125.6 168.84 13.15 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.473 -0.785 . . . . 1.58 109.422 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 8' ' ' VAL . 5.5 mp -60.19 139.3 57.63 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.255 -0.43 . . . . 1.05 110.081 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 79.28 12.68 1.23 Allowed 'General case' 0 C--N 1.316 -0.855 0 O-C-N 125.044 1.465 . . . . 0.72 111.252 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.7 mmtt -99.47 124.75 44.91 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 109.301 -0.629 . . . . 1.48 109.301 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.5 m -78.9 34.42 0.23 Allowed 'General case' 0 C--N 1.254 -3.578 0 C-N-CA 126.356 1.862 . . . . 1.25 114.377 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.797 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 79.9 m-85 43.04 -93.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.499 1.519 . . . . 0.4 114.913 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -67.35 -24.37 65.71 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.993 -0.442 . . . . 1.06 111.98 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -89.45 -52.99 4.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.935 0.398 . . . . 1.74 110.952 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.55 -41.31 19.78 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 116.155 -0.475 . . . . 1.29 112.221 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.585 HD13 HG22 ' A' ' 26' ' ' VAL . 16.1 mt -83.4 -76.32 0.29 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 119.097 -0.478 . . . . 0.81 110.525 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 34.2 t70 159.82 -16.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 O-C-N 124.411 1.069 . . . . 1.12 110.608 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 36' ' ' LEU . 3.0 t -47.13 135.37 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.037 1.335 . . . . 0.79 113.276 -171.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 43' ' ' MET . 11.3 t70 -59.49 112.8 1.91 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.516 -0.766 . . . . 2.0 111.805 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.565 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 17.3 t -40.82 -43.31 2.0 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 116.069 1.877 . . . . 0.78 116.069 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 4.2 pp -80.22 -30.69 38.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.254 -1.378 . . . . 1.18 110.66 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 46' ' ' VAL . 20.1 m -76.14 -13.92 60.18 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.601 -0.727 . . . . 0.6 110.165 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.797 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.13 -36.09 76.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 123.44 0.696 . . . . 0.86 110.301 177.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.97 -44.68 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 123.959 0.787 . . . . 0.31 109.36 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.65 -43.09 94.03 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.181 -0.674 . . . . 0.68 109.181 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.553 HG22 HG13 ' A' ' 18' ' ' ILE . 57.6 t -59.26 -24.98 29.15 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.015 -0.993 . . . . 0.63 111.455 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.978 HG21 HG13 ' A' ' 63' ' ' VAL . 42.3 t -80.18 -54.32 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 N-CA-C 106.933 -1.506 . . . . 0.55 106.933 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HA ' ' OE2' ' A' ' 51' ' ' GLU . 74.2 t -53.85 -40.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.372 -1.74 . . . . 0.42 110.07 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.91 -37.08 64.76 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-O 121.233 0.54 . . . . 0.21 110.27 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.97 4.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.059 -0.973 . . . . 0.21 109.905 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.296 0.9 OUTLIER -62.8 -35.53 80.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 114.377 1.251 . . . . 0.64 114.377 -176.1 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.67 -30.46 71.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.356 0.502 . . . . 2.07 112.356 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -82.82 -36.72 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.777 -0.369 . . . . 2.48 110.979 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.542 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 7.7 m-85 -87.58 -19.43 27.83 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.766 1.024 . . . . 0.81 113.766 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.0 t70 103.76 -5.35 0.02 OUTLIER 'General case' 0 N--CA 1.532 3.641 0 O-C-N 125.29 1.619 . . . . 1.99 114.227 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 76' ' ' ILE . 8.1 p -87.17 172.96 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 O-C-N 121.141 -0.974 . . . . 0.37 109.513 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.88 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -126.6 118.79 25.54 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.208 -1.405 . . . . 2.12 107.208 174.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.585 HG12 ' HE2' ' A' ' 75' ' ' TYR . 57.5 mt -111.64 114.03 52.69 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 120.88 -0.328 . . . . 0.25 110.929 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HG23 ' A' ' 63' ' ' VAL . 83.2 Cg_endo -72.82 164.6 35.11 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.524 2.816 . . . . 0.33 110.913 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.45 -38.71 74.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.905 0.482 . . . . 1.98 111.058 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.577 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.0 m-20 -61.82 -34.71 76.42 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-N 115.816 -0.629 . . . . 2.06 111.592 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.575 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.0 m-20 -87.36 -23.98 24.4 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.659 -0.816 . . . . 0.52 113.177 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.978 HG13 HG21 ' A' ' 47' ' ' VAL . 79.4 t -55.96 -45.68 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.093 -1.077 . . . . 0.38 108.093 172.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 17.4 ptmt -74.78 -10.27 59.35 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.202 -0.908 . . . . 2.16 111.84 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -91.56 -13.52 31.87 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.264 0.554 . . . . 1.59 110.168 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.821 HD13 ' HA ' ' A' ' 72' ' ' ALA . 24.9 mt -95.96 109.54 21.9 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 107.101 -1.444 . . . . 0.31 107.101 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.514 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -105.72 -45.22 4.46 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.742 -1.206 . . . . 2.55 107.742 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 62.8 p -102.86 170.44 7.99 Favored 'General case' 0 N--CA 1.383 -3.808 0 CA-C-N 114.937 -1.028 . . . . 0.23 108.821 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -79.31 -12.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.464 -0.939 . . . . 1.21 108.464 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.66 -46.98 64.36 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 108.597 -1.801 . . . . 0.33 108.597 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.92 -52.42 65.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 109.026 -0.731 . . . . 1.39 109.026 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.821 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.25 -61.26 2.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 O-C-N 124.635 1.209 . . . . 0.15 111.365 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' HG21 ' A' ' 7' ' ' ILE . 52.5 m -55.7 -50.87 69.15 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 124.211 0.945 . . . . 0.24 113.471 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.5 mptm? -60.52 -34.14 73.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 123.3 0.64 . . . . 3.63 110.185 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.585 ' HE2' HG12 ' A' ' 58' ' ' ILE . 77.1 t80 -70.37 -55.89 8.0 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.771 -0.455 . . . . 0.4 109.771 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.608 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 63.8 mt -50.31 -66.44 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 124.662 1.185 . . . . 0.21 110.909 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.41 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.5 tt -52.88 -54.32 36.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.781 1.232 . . . . 1.44 110.047 -175.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 11.9 t70 -70.57 -24.4 62.77 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.542 -1.208 . . . . 0.63 112.02 -169.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.27 -4.87 48.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.416 0.895 . . . . 1.25 113.416 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 76' ' ' ILE . 2.0 pt20 . . . . . 0 CA--C 1.473 -2.012 0 CA-C-O 122.391 1.091 . . . . 0.87 110.898 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 7' ' ' ILE . 2.5 t . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 119.114 -0.469 . . . . 0.66 109.93 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.451 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -48.32 -40.32 24.86 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.398 0.888 . . . . 0.74 113.398 -176.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.27 -33.74 65.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.046 0.841 . . . . 2.66 110.411 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -87.15 -37.74 17.07 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.403 -0.817 . . . . 2.73 109.837 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.667 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.1 mt -65.67 -65.75 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 116.392 -0.367 . . . . 0.23 111.711 -172.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.756 HG21 HD11 ' A' ' 28' ' ' LEU . 59.1 t -56.91 -42.31 78.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 122.126 0.17 . . . . 0.27 111.394 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -38.74 78.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.813 0.696 . . . . 0.27 111.278 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.66 -38.45 10.63 Favored Glycine 0 N--CA 1.419 -2.47 0 CA-C-N 116.183 -0.462 . . . . 0.18 113.117 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -63.97 -40.48 96.49 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.978 -0.749 . . . . 0.2 108.978 -178.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.641 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.34 -50.77 64.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.127 0.892 . . . . 0.14 109.685 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.614 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 55.6 mt-10 -61.54 -38.91 89.14 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 124.0 0.813 . . . . 0.68 111.927 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.7 mt -59.85 -45.01 95.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.843 -0.617 . . . . 0.28 109.548 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 11' ' ' LEU . 62.0 t -67.6 -24.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-O 121.747 0.784 . . . . 0.27 110.131 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.614 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.9 m120 -72.09 -38.49 69.37 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.281 -0.872 . . . . 0.34 109.322 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -82.13 -48.87 10.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.659 -0.7 . . . . 2.07 111.349 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.64 HG22 ' HB3' ' A' ' 42' ' ' SER . 33.4 mm -62.77 -53.14 50.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.902 -0.59 . . . . 0.65 110.545 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -104.5 -78.27 0.57 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.421 -0.585 . . . . 0.54 109.421 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.27 45.96 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 120.747 -0.74 . . . . 0.43 112.031 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.583 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -80.69 152.47 72.42 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 109.037 -0.727 . . . . 0.31 109.037 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.8 Cg_exo -84.83 23.34 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.104 2.536 . . . . 1.08 115.089 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.8 p 58.88 -9.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.69 1.996 . . . . 0.81 115.489 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.8 pt-20 -103.79 -7.02 20.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.365 0.602 . . . . 2.31 111.176 -174.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -99.66 -16.49 18.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.775 0.798 . . . . 1.59 110.676 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 12' ' ' ALA . 12.8 t -78.11 86.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 114.385 -1.28 . . . . 0.3 110.468 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -114.52 148.94 37.19 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.186 -1.042 . . . . 1.58 108.186 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.756 HD11 HG21 ' A' ' 8' ' ' VAL . 6.0 mp -59.89 140.27 56.78 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.578 -0.527 . . . . 1.05 109.578 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 87.26 7.21 0.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.545 1.538 . . . . 0.72 109.642 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -104.03 128.44 51.61 Favored 'General case' 0 CA--C 1.465 -2.316 0 CA-C-N 115.269 -0.878 . . . . 1.48 109.214 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 3.0 m -80.65 105.8 12.17 Favored 'General case' 1 C--N 1.238 -4.269 0 CA-C-N 114.188 -1.369 . . . . 1.25 108.316 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.765 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.4 m-85 -43.51 -55.26 4.33 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.596 0.758 . . . . 0.4 112.081 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 t -78.23 6.3 8.48 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 113.431 0.9 . . . . 1.06 113.431 -173.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -139.92 -62.18 0.52 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.318 -0.553 . . . . 1.74 110.037 -174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.05 -44.91 75.3 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.096 -0.957 . . . . 1.29 110.146 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.596 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 16.9 mt -81.38 -44.6 17.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.137 -0.938 . . . . 0.81 109.279 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 93.84 65.32 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 126.632 1.973 . . . . 1.12 111.908 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 43' ' ' MET . 48.8 t -96.04 149.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 113.485 -1.689 . . . . 0.79 107.587 171.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.475 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.3 m-20 -73.96 17.82 0.16 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 115.99 1.848 . . . . 2.0 115.99 -174.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 43' ' ' MET . 28.7 t 68.0 -53.65 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.271 1.952 . . . . 0.78 116.271 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 39' ' ' ASP . 1.7 pt? -71.36 -34.15 70.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.257 1.027 . . . . 1.18 108.491 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.64 ' HB3' HG22 ' A' ' 18' ' ' ILE . 2.1 m -65.81 -22.84 66.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.968 -1.469 . . . . 0.6 110.045 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.652 ' HE3' HG11 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.99 -43.44 98.83 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 115.375 -0.829 . . . . 0.86 112.021 -176.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.35 -43.83 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 O-C-N 124.398 1.061 . . . . 0.31 110.034 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.41 -46.82 85.69 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.917 -0.771 . . . . 0.68 108.917 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 42' ' ' SER . 61.9 t -58.54 -27.0 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.731 -1.122 . . . . 0.63 111.484 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.978 HG21 HG13 ' A' ' 63' ' ' VAL . 44.5 t -80.15 -52.53 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 107.658 -1.238 . . . . 0.55 107.658 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.28 -44.51 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 124.728 1.268 . . . . 0.42 108.919 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.69 88.33 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 121.244 0.545 . . . . 0.21 110.811 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 -55.9 17.19 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.472 -0.785 . . . . 0.21 110.239 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.566 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.262 0.0 OUTLIER -62.81 -34.03 76.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.754 1.02 . . . . 0.64 113.754 -178.188 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -67.84 -28.66 67.75 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.77 0.285 . . . . 2.07 111.77 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -87.52 -38.16 16.27 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.775 0.321 . . . . 2.48 111.52 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.667 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 10.0 m-85 -94.46 -3.91 49.18 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.106 0.78 . . . . 0.81 113.106 -172.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 87.66 -2.5 0.55 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 125.16 1.384 . . . . 1.99 114.719 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.781 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 13.9 p -81.2 173.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.363 -0.935 . . . . 0.37 108.772 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 22.2 tptp -127.58 124.91 39.26 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 107.462 -1.31 . . . . 2.12 107.462 171.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.538 HG12 ' HE2' ' A' ' 75' ' ' TYR . 59.7 mt -114.43 113.21 45.71 Favored Pre-proline 0 N--CA 1.429 -1.496 0 C-N-CA 120.599 -0.441 . . . . 0.25 111.106 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 63' ' ' VAL . 30.9 Cg_endo -66.87 152.53 80.26 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 122.642 2.228 . . . . 0.33 109.845 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 3.9 p-10 -59.1 -27.87 65.98 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.307 0.379 . . . . 1.98 111.123 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.76 -46.04 87.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 2.06 110.379 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.409 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.5 m-20 -74.76 -26.91 60.1 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 112.01 0.374 . . . . 0.52 112.01 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.978 HG13 HG21 ' A' ' 47' ' ' VAL . 86.8 t -55.57 -41.44 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.86 -1.163 . . . . 0.38 107.86 172.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 60' ' ' ASP . 57.8 mttp -73.94 -7.83 53.81 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.067 -0.97 . . . . 2.16 112.564 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.06 -24.47 15.32 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.233 0.539 . . . . 1.59 110.316 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.852 HD13 ' HA ' ' A' ' 72' ' ' ALA . 39.1 mt -85.48 118.44 25.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.889 -1.152 . . . . 0.31 107.889 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.488 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -112.17 -29.16 7.68 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.918 -1.113 . . . . 2.55 110.591 175.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 13.6 p -116.55 179.5 3.99 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 109.477 -0.564 . . . . 0.23 109.477 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.765 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -87.23 -12.89 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 122.062 0.934 . . . . 1.21 109.787 176.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -76.6 -30.99 55.56 Favored Glycine 0 C--O 1.207 -1.542 0 N-CA-C 108.305 -1.918 . . . . 0.33 108.305 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.27 -60.35 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.21 -0.995 . . . . 1.39 109.144 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.852 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.03 -60.95 2.34 Favored 'General case' 0 CA--C 1.479 -1.771 0 O-C-N 124.569 1.168 . . . . 0.15 112.361 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.458 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.3 m -57.45 -47.99 80.36 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.894 -1.048 . . . . 0.24 113.006 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 5.7 mptp? -55.83 -50.52 70.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 124.213 0.945 . . . . 3.63 109.815 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.538 ' HE2' HG12 ' A' ' 58' ' ' ILE . 82.8 t80 -56.23 -51.51 67.82 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.364 1.04 . . . . 0.4 111.43 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.578 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 69.8 mt -54.27 -65.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.424 -1.262 . . . . 0.21 110.432 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tt -54.33 -42.8 70.6 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.11 0.964 . . . . 1.44 109.589 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 36.9 t70 -62.4 -26.81 68.68 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.41 1.084 . . . . 0.63 111.561 -172.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -102.13 -8.04 21.72 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.836 1.05 . . . . 1.25 113.836 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.781 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 115.191 1.552 . . . . 0.87 115.191 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.44 ' O ' HG13 ' A' ' 7' ' ' ILE . 15.2 t . . . . . 0 C--O 1.219 -0.544 0 N-CA-C 111.162 0.06 . . . . 0.66 111.162 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.661 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -49.85 -46.97 51.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.157 0.983 . . . . 0.74 113.363 -178.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.64 -24.79 66.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.873 0.368 . . . . 2.66 111.624 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -87.7 -31.08 19.9 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.152 -0.684 . . . . 2.73 109.152 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.583 HG23 ' CE2' ' A' ' 54' ' ' PHE . 97.4 mt -74.39 -65.98 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.141 0 CA-C-N 116.145 -0.48 . . . . 0.23 110.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.49 -40.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 112.365 0.506 . . . . 0.27 112.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -62.48 -40.91 98.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.37 -0.532 . . . . 0.27 110.632 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.48 -35.07 33.96 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 115.783 -0.644 . . . . 0.18 112.235 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.738 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -67.44 -39.37 85.4 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.16 -1.052 . . . . 0.2 108.16 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.628 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.36 -50.32 69.98 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.832 -0.803 . . . . 0.14 108.832 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 46.6 mt-10 -59.24 -42.48 91.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.113 0.883 . . . . 0.68 112.704 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' A' ' 11' ' ' LEU . 65.6 mt -56.07 -43.06 74.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.315 0.579 . . . . 0.28 109.923 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.716 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.8 t -68.86 -25.34 30.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.755 0.788 . . . . 0.27 110.168 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.592 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.6 m120 -74.07 -42.18 60.58 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.923 -1.139 . . . . 0.34 107.923 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.56 -47.95 51.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.311 -0.858 . . . . 2.07 111.445 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.4 HG13 HG22 ' A' ' 46' ' ' VAL . 28.4 mm -67.14 -53.16 35.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.896 -0.593 . . . . 0.65 111.317 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.73 -78.42 0.58 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.559 -0.456 . . . . 0.54 111.695 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.02 43.17 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.094 -1.051 . . . . 0.43 112.916 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.863 HG21 HG23 ' A' ' 26' ' ' VAL . 1.4 mp -79.41 151.25 74.75 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.033 -0.729 . . . . 0.31 109.033 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 4.6 Cg_exo -89.74 37.5 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.613 2.876 . . . . 1.08 113.276 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 9.2 p 56.11 -22.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.982 2.113 . . . . 0.81 116.021 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 22' ' ' PRO . 29.8 mm-40 -88.73 -22.8 23.16 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.603 0.761 . . . . 2.31 111.873 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.602 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 6.6 t70 -74.57 -32.71 62.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.583 0.706 . . . . 1.59 110.494 -171.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 21' ' ' ILE . 22.0 t -78.96 94.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.908 -1.042 . . . . 0.3 111.104 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -124.3 158.55 32.32 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.315 -0.995 . . . . 1.58 108.315 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 69' ' ' VAL . 90.6 mt -54.97 141.22 34.66 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 122.934 0.494 . . . . 1.05 110.288 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.599 ' H ' ' N ' ' A' ' 70' ' ' GLY . 27.1 t70 77.22 10.55 2.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.36 1.464 . . . . 0.72 111.009 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 69' ' ' VAL . 72.1 mmtt -100.36 129.06 46.29 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 115.374 -0.83 . . . . 1.48 109.226 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 30.6 t -74.85 119.89 19.65 Favored 'General case' 1 C--N 1.244 -4.011 0 CA-C-N 115.078 -0.965 . . . . 1.25 109.901 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.617 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 74.0 m-85 -51.49 -55.87 16.5 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 123.975 0.91 . . . . 0.4 111.892 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 3.5 p -66.47 -57.45 7.33 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 122.11 0.957 . . . . 1.06 111.942 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' HB2' ' OG ' ' A' ' 31' ' ' SER . 8.0 m-20 -82.64 -41.17 19.77 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 115.202 1.556 . . . . 1.74 115.202 -166.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HB2' ' N ' ' A' ' 31' ' ' SER . 5.3 m-20 -91.66 -43.81 9.39 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.719 0.295 . . . . 1.29 111.113 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.744 HD13 HG22 ' A' ' 26' ' ' VAL . 17.8 mt -76.09 -90.11 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.758 -0.656 . . . . 0.81 110.418 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 38.9 t70 163.56 10.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.364 1.066 . . . . 1.12 109.047 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 15' ' ' VAL . 12.4 t -77.57 119.14 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 108.764 -0.828 . . . . 0.79 108.764 -172.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.714 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 13.2 t70 -58.44 120.99 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 124.106 0.879 . . . . 2.0 111.456 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.8 t -41.78 -30.91 0.27 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 127.455 2.302 . . . . 0.78 116.128 175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.714 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 4.3 pp -86.32 -31.96 21.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 120.4 1.455 . . . . 1.18 111.023 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -80.15 -13.76 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.46 1.124 . . . . 0.6 109.401 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.549 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 3.8 tpt -60.03 -36.09 76.51 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 127.334 2.253 . . . . 0.86 110.403 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 47' ' ' VAL . 58.1 t -66.68 -25.15 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 CA-C-N 115.213 -0.903 . . . . 0.31 110.943 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -77.02 -41.02 44.36 Favored 'General case' 0 C--O 1.215 -0.739 0 O-C-N 121.515 -0.741 . . . . 0.68 109.6 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.4 HG22 HG13 ' A' ' 18' ' ' ILE . 31.5 t -59.57 -25.83 32.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.177 -0.919 . . . . 0.63 111.66 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.725 HG11 HG13 ' A' ' 63' ' ' VAL . 10.7 p -81.48 -47.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 CA-C-O 122.201 1.0 . . . . 0.55 110.145 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.02 -39.5 85.9 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 CA-C-N 112.869 -1.969 . . . . 0.42 108.749 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 -32.04 72.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.856 -0.611 . . . . 0.21 110.004 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.79 -59.16 4.17 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.952 -1.022 . . . . 0.21 110.122 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.288 0.0 OUTLIER -62.44 -34.69 77.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 114.014 1.116 . . . . 0.64 114.014 -175.635 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.29 -41.82 80.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.449 0.642 . . . . 2.07 111.321 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -81.68 -41.14 21.79 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.259 -0.882 . . . . 2.48 110.812 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 7' ' ' ILE . 10.4 m-85 -83.65 -44.38 14.6 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 117.735 -1.126 . . . . 0.81 113.454 -172.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 15.8 t70 155.91 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 124.616 1.198 . . . . 1.99 112.55 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.641 HG11 ' HA ' ' A' ' 76' ' ' ILE . 8.6 p -75.29 174.56 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.301 -0.863 . . . . 0.37 112.924 -164.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.3 127.04 52.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.207 -1.775 . . . . 2.12 106.207 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 76' ' ' ILE . 59.8 mt -118.87 112.42 36.62 Favored Pre-proline 0 C--N 1.293 -1.871 0 C-N-CA 120.216 -0.594 . . . . 0.25 110.09 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.5 Cg_endo -69.27 155.95 66.05 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.361 2.707 . . . . 0.33 110.554 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.5 p-10 -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.183 0.593 . . . . 1.98 112.128 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.7 m-20 -65.44 -54.24 31.28 Favored 'General case' 0 C--O 1.209 -1.044 0 O-C-N 123.22 0.325 . . . . 2.06 110.538 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.53 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 11.6 m-20 -66.92 -31.85 72.72 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.509 0.559 . . . . 0.52 112.509 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.725 HG13 HG11 ' A' ' 47' ' ' VAL . 41.3 t -50.22 -59.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.281 0.988 . . . . 0.38 109.015 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 14.6 ptmm? -72.61 -1.86 17.75 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.574 -0.739 . . . . 2.16 112.916 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.68 -18.17 21.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.733 0.777 . . . . 1.59 109.418 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' HA ' ' A' ' 72' ' ' ALA . 40.1 mt -84.9 116.09 23.14 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.579 -2.008 . . . . 0.31 105.579 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.634 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -111.68 -30.05 7.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 117.982 -1.487 . . . . 2.55 109.65 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 67' ' ' LYS . 31.1 p -119.14 173.46 6.91 Favored 'General case' 0 N--CA 1.395 -3.204 0 N-CA-C 109.183 -0.673 . . . . 0.23 109.183 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 30' ' ' LYS . 23.7 t -72.01 -18.98 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 108.492 -0.929 . . . . 1.21 108.492 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.599 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -70.13 -40.96 71.36 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 110.142 -1.183 . . . . 0.33 110.142 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.575 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.2 m-20 -67.89 -55.04 14.35 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.547 -0.908 . . . . 1.39 108.547 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.46 -61.33 2.31 Favored 'General case' 0 CA--C 1.471 -2.058 0 O-C-N 124.875 1.359 . . . . 0.15 111.97 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.661 HG21 ' HG2' ' A' ' 4' ' ' GLN . 50.0 m -57.64 -51.19 70.51 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.591 -1.186 . . . . 0.24 112.682 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.4 OUTLIER -53.49 -49.53 67.3 Favored 'General case' 0 N--CA 1.422 -1.827 0 O-C-N 124.325 1.016 . . . . 3.63 109.601 177.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 87.1 t80 -56.96 -52.01 66.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.747 0.819 . . . . 0.4 111.208 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.641 ' HA ' HG11 ' A' ' 56' ' ' VAL . 69.9 mt -52.01 -65.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 124.812 1.32 . . . . 0.21 109.79 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.76 -45.01 70.48 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.144 1.378 . . . . 1.44 110.346 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.59 -30.32 71.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.916 -1.038 . . . . 0.63 111.105 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -100.32 -11.62 20.15 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 113.82 1.044 . . . . 1.25 113.82 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 14.8 mt-30 . . . . . 0 CA--C 1.476 -1.898 0 CA-C-O 122.798 1.285 . . . . 0.87 107.641 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.434 -1.27 0 CA-C-O 120.652 0.263 . . . . 0.66 111.231 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.635 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.8 OUTLIER -51.85 -37.08 50.57 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.138 1.775 . . . . 0.74 112.423 177.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.4 -35.33 65.23 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 123.735 0.647 . . . . 2.66 111.869 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.48 -31.18 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.358 0.599 . . . . 2.73 109.504 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.636 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 80.4 mt -73.27 -66.44 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 115.775 -0.648 . . . . 0.23 109.985 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 28' ' ' LEU . 96.7 t -52.62 -38.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.067 0.765 . . . . 0.27 113.067 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.27 98.69 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.419 -0.512 . . . . 0.27 109.86 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' HA2' ' NH1' ' A' ' 53' ' ' ARG . . . -76.34 -39.93 29.8 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.366 -0.834 . . . . 0.18 112.313 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -67.04 -39.04 86.88 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 123.745 0.818 . . . . 0.2 109.377 -176.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.47 -43.68 89.0 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.687 -0.486 . . . . 0.14 109.687 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.57 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 44.4 mt-10 -61.31 -42.78 99.24 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.889 0.743 . . . . 0.68 111.46 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -60.7 -40.76 85.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.342 0.591 . . . . 0.28 110.046 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.732 HG12 ' HB ' ' A' ' 21' ' ' ILE . 23.9 t -73.65 -22.61 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.472 0.654 . . . . 0.27 110.162 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.57 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -72.59 -54.04 10.25 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.205 -1.035 . . . . 0.34 108.205 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.14 -44.8 62.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.342 -1.299 . . . . 2.07 113.602 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.588 HG22 ' HB3' ' A' ' 42' ' ' SER . 14.5 mt -76.27 -53.33 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.985 -0.686 . . . . 0.65 111.106 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.662 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -91.91 -80.14 0.36 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 0.54 110.809 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.93 40.04 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.16 0 C-N-CA 121.076 -0.583 . . . . 0.43 111.755 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.732 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -82.55 161.14 60.03 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 109.473 -0.566 . . . . 0.31 109.473 178.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.0 Cg_endo -90.62 141.64 3.26 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.895 2.396 . . . . 1.08 108.415 171.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -72.61 45.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.086 0 N-CA-C 113.98 1.104 . . . . 0.81 113.98 -171.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.51 -20.96 0.43 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.31 1.044 . . . . 2.31 110.548 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.65 -36.44 65.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.122 -0.49 . . . . 1.59 112.105 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.649 HG22 HD13 ' A' ' 36' ' ' LEU . 41.1 t -75.91 93.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.998 -0.546 . . . . 0.3 109.582 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 69' ' ' VAL . 30.8 mmtp -133.17 168.55 18.32 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.821 -1.178 . . . . 1.58 107.821 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.487 HD23 ' HE2' ' A' ' 74' ' ' LYS . 6.3 mp -63.67 146.92 52.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.845 -0.798 . . . . 1.05 108.845 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 t70 78.3 8.39 2.28 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.702 1.251 . . . . 0.72 110.241 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 71.4 mmtt -106.08 125.57 51.16 Favored 'General case' 0 CA--C 1.473 -1.993 0 CA-C-N 115.709 -0.678 . . . . 1.48 109.679 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 4.2 m -81.85 108.78 15.65 Favored 'General case' 0 C--N 1.245 -3.96 0 CA-C-N 114.248 -1.342 . . . . 1.25 108.763 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.879 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.4 m-85 -37.27 -66.69 0.22 Allowed 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.547 1.539 . . . . 0.4 114.197 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 t -85.87 15.5 4.84 Favored 'General case' 0 C--N 1.275 -2.67 0 O-C-N 121.1 -1.0 . . . . 1.06 112.742 -174.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 1.9 m-20 -134.25 -65.72 0.64 Allowed 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.627 -0.671 . . . . 1.74 111.364 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 21.5 m-20 -68.94 -41.4 78.12 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.311 -0.858 . . . . 1.29 109.962 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.678 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 27.0 mt -79.38 -50.1 11.36 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.618 -0.719 . . . . 0.81 111.024 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 11.2 t70 94.5 68.89 0.0 OUTLIER 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.278 1.611 . . . . 1.12 110.557 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 19' ' ' ALA . 40.5 t -105.81 162.69 4.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.277 -1.783 . . . . 0.79 110.156 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.25 3.6 5.55 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.49 1.116 . . . . 2.0 113.028 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.1 p 67.41 -47.58 0.49 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.328 1.851 . . . . 0.78 113.081 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.68 -49.15 77.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.997 0.919 . . . . 1.18 108.783 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.588 ' HB3' HG22 ' A' ' 18' ' ' ILE . 2.2 m -63.75 -16.26 60.71 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.987 -1.461 . . . . 0.6 112.314 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.879 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -66.22 -34.48 78.11 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 123.406 0.682 . . . . 0.86 111.393 -176.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.59 -38.33 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 109.125 -0.694 . . . . 0.31 109.125 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.87 -44.94 91.58 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.943 -1.132 . . . . 0.68 107.943 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 42' ' ' SER . 97.8 t -57.25 -24.72 21.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.354 -1.294 . . . . 0.63 112.091 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.991 HG11 HG22 ' A' ' 63' ' ' VAL . 23.2 t -78.69 -53.66 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.957 -1.127 . . . . 0.55 107.957 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.73 -31.9 50.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.573 -1.194 . . . . 0.42 109.413 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -76.35 -32.01 58.41 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.158 0.504 . . . . 0.21 110.285 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.11 -62.86 1.22 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.486 -0.779 . . . . 0.21 109.973 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.264 0.0 OUTLIER -60.69 -37.23 80.95 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 114.411 1.263 . . . . 0.64 114.411 -174.594 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.87 -30.7 67.94 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.4 0.519 . . . . 2.07 112.4 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.446 ' NH1' ' HA2' ' A' ' 10' ' ' GLY . 64.0 ttt180 -88.05 -32.92 18.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.78 0.324 . . . . 2.48 110.96 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.6 m-85 -95.54 -1.9 49.63 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.066 0.765 . . . . 0.81 113.066 -171.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 79.75 -2.91 2.06 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.447 1.099 . . . . 1.99 113.328 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.565 ' CG1' HG23 ' A' ' 76' ' ' ILE . 10.0 p -83.92 178.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 N-CA-C 107.985 -1.117 . . . . 0.37 107.985 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 21.3 tptm -136.27 130.76 33.51 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.197 -1.038 . . . . 2.12 108.197 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.511 HG12 ' HE2' ' A' ' 75' ' ' TYR . 37.2 mt -128.96 110.21 18.41 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 123.1 0.25 . . . . 0.25 110.612 -175.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.544 ' O ' HG23 ' A' ' 63' ' ' VAL . 70.1 Cg_endo -74.47 166.84 28.51 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.581 2.187 . . . . 0.33 109.811 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -59.93 -29.24 68.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.149 0.5 . . . . 1.98 110.124 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 25.6 t70 -62.81 -38.92 92.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.288 -0.869 . . . . 2.06 111.307 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 29.5 m-20 -87.14 -28.33 22.53 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.485 -0.486 . . . . 0.52 111.455 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.991 HG22 HG11 ' A' ' 47' ' ' VAL . 54.1 t -52.1 -46.71 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.16 -0.682 . . . . 0.38 109.16 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 45.7 pttt -70.9 -2.16 14.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.064 -0.971 . . . . 2.16 113.086 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 95.4 m-20 -96.06 -34.93 11.55 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.828 0.347 . . . . 1.59 110.399 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -76.32 112.68 13.06 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.913 -0.773 . . . . 0.31 108.913 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -33.52 7.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.551 0.691 . . . . 2.55 110.361 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.0 p -116.02 169.36 9.32 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.795 -1.187 . . . . 0.23 107.795 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.47 HG11 HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -78.65 -13.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 119.831 -0.747 . . . . 1.21 109.293 175.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -67.14 -44.63 86.63 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.953 -1.659 . . . . 0.33 108.953 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.34 -48.99 71.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.498 -0.926 . . . . 1.39 108.498 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.686 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -57.26 -61.65 2.32 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 114.851 -1.068 . . . . 0.15 111.424 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.635 HG21 ' HG2' ' A' ' 4' ' ' GLN . 28.1 m -58.64 -39.67 81.2 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 113.997 1.11 . . . . 0.24 113.997 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.487 ' HE2' HD23 ' A' ' 28' ' ' LEU . 5.3 mptp? -60.91 -51.08 70.8 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.2 -1.037 . . . . 3.63 108.2 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.511 ' HE2' HG12 ' A' ' 58' ' ' ILE . 89.6 t80 -55.88 -49.13 74.23 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.29 0.994 . . . . 0.4 110.687 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.662 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 78.1 mt -57.67 -66.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.022 -0.99 . . . . 0.21 111.109 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -52.46 -47.1 66.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.532 1.533 . . . . 1.44 109.799 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.72 -28.17 68.21 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.238 -1.346 . . . . 0.63 110.931 -172.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -103.47 -2.4 26.92 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 113.403 0.89 . . . . 1.25 113.403 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 59.8 mt-30 . . . . . 0 CA--C 1.468 -2.201 0 N-CA-C 106.699 -1.593 . . . . 0.87 106.699 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.432 -1.372 0 CA-C-O 120.815 0.34 . . . . 0.66 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.482 ' HG2' HG23 ' A' ' 8' ' ' VAL . 6.1 tm0? -57.43 -35.04 69.58 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 125.679 1.591 . . . . 0.74 112.469 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.76 -24.36 67.67 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.632 0.583 . . . . 2.66 111.335 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 -44.02 11.46 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.854 -0.795 . . . . 2.73 108.854 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.617 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 79.3 mt -64.31 -64.99 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.72 0 CA-C-N 116.158 -0.474 . . . . 0.23 112.012 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG23 ' HG2' ' A' ' 4' ' ' GLN . 55.2 t -56.97 -39.26 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 112.026 0.38 . . . . 0.27 112.026 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.74 -36.49 84.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.231 0.539 . . . . 0.27 110.576 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.55 -40.87 8.67 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 115.779 -0.646 . . . . 0.18 112.92 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.651 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -64.84 -36.07 83.15 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.491 -0.929 . . . . 0.2 108.491 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.52 -51.67 67.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.771 -0.65 . . . . 0.14 109.39 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.652 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.6 mt-10 -58.12 -41.9 84.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 124.204 0.94 . . . . 0.68 112.499 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 11' ' ' LEU . 76.7 mt -58.11 -43.42 85.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.503 -0.771 . . . . 0.28 109.701 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 21' ' ' ILE . 86.1 t -68.82 -23.89 28.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.872 0.844 . . . . 0.27 110.679 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.652 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.2 m120 -75.06 -42.62 56.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.335 -0.987 . . . . 0.34 108.335 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.31 -41.19 57.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.845 -1.07 . . . . 2.07 111.636 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.731 HG13 HG22 ' A' ' 46' ' ' VAL . 30.8 mm -70.45 -53.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 116.701 -0.227 . . . . 0.65 111.007 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.594 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -106.31 -82.45 0.54 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.013 0.435 . . . . 0.54 110.607 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.34 43.96 0.02 OUTLIER Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.561 -0.828 . . . . 0.43 112.419 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.654 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -80.52 151.06 71.33 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.859 -0.423 . . . . 0.31 109.859 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.9 Cg_exo -86.17 33.3 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.155 2.57 . . . . 1.08 114.056 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.445 ' H ' HG22 ' A' ' 21' ' ' ILE 0.265 9.8 p 56.61 -20.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 C-N-CA 127.052 2.141 . . . . 0.81 116.433 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -95.51 -13.94 24.08 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.554 -0.716 . . . . 2.31 112.54 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 29.8 t0 -84.45 -28.2 26.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.728 0.775 . . . . 1.59 110.023 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 12' ' ' ALA . 25.5 t -73.6 93.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.577 -1.192 . . . . 0.3 109.072 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 69' ' ' VAL . 33.3 mmtp -131.09 151.88 50.97 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 106.954 -1.498 . . . . 1.58 106.954 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.44 HD22 ' HA2' ' A' ' 70' ' ' GLY . 50.7 mt -50.09 143.53 8.07 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.763 0.665 . . . . 1.05 109.531 177.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 82.8 4.81 0.97 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.9 1.28 . . . . 0.72 111.129 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -103.6 132.83 49.5 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 108.936 -0.764 . . . . 1.48 108.936 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 57.9 m -86.53 116.96 25.0 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 124.047 0.842 . . . . 1.25 109.666 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.734 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 94.6 m-85 -45.65 -67.46 0.28 Allowed 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 125.17 1.388 . . . . 0.4 114.178 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.467 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 14.7 t -71.79 -25.85 62.19 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.685 -1.259 . . . . 1.06 111.843 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.593 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 7.3 m-20 -87.62 -64.18 1.19 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.406 0.622 . . . . 1.74 110.972 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' SER . 4.5 m-20 -74.29 -57.6 3.84 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 115.282 -0.872 . . . . 1.29 110.439 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 26' ' ' VAL . 16.8 mt -68.17 -38.24 81.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.015 -0.993 . . . . 0.81 111.122 -172.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.2 t70 82.84 64.98 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.459 1.6 . . . . 1.12 109.558 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 19' ' ' ALA . 21.8 t -108.78 159.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 112.463 -2.153 . . . . 0.79 106.548 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.63 120.23 19.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.361 -0.977 . . . . 2.0 108.361 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.531 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 5.0 p -49.11 -38.15 23.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.078 0.951 . . . . 0.78 112.306 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 42' ' ' SER . 3.9 pp -70.63 -28.42 64.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.16 0.43 . . . . 1.18 112.16 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 46' ' ' VAL . 50.0 m -82.04 -15.7 52.72 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.425 0.631 . . . . 0.6 110.266 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -58.92 -37.35 76.48 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-N 115.445 -0.798 . . . . 0.86 111.715 -179.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.29 -45.72 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 124.087 0.867 . . . . 0.31 109.421 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.31 -49.79 74.99 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 108.615 -0.883 . . . . 0.68 108.615 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.731 HG22 HG13 ' A' ' 18' ' ' ILE . 54.2 t -57.34 -29.98 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.971 1.308 . . . . 0.63 111.672 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.86 HG21 HG13 ' A' ' 63' ' ' VAL . 38.3 t -76.96 -49.68 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.336 0 N-CA-C 108.294 -1.002 . . . . 0.55 108.294 -176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.27 -35.5 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-N 114.692 -1.14 . . . . 0.42 108.777 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.29 76.25 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.538 0.685 . . . . 0.21 109.915 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.71 -58.35 7.77 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 114.932 -1.031 . . . . 0.21 109.843 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.631 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.257 0.0 OUTLIER -61.15 -37.03 81.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.056 1.132 . . . . 0.64 114.056 -177.375 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.69 -37.58 76.39 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.296 0.373 . . . . 2.07 111.401 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -84.73 -37.84 20.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.052 0.389 . . . . 2.48 112.052 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.0 m-85 -92.68 -11.03 35.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.352 1.242 . . . . 0.81 114.352 -170.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 87.51 4.22 0.33 Allowed 'General case' 0 N--CA 1.519 2.995 0 N-CA-C 114.448 1.277 . . . . 1.99 114.448 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.75 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.1 p -84.12 175.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.183 -1.414 . . . . 0.37 107.183 175.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 20.5 tptp -131.75 122.35 25.7 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.887 -1.894 . . . . 2.12 105.887 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.564 HG13 ' HB3' ' A' ' 51' ' ' GLU . 52.4 mt -113.72 107.05 53.25 Favored Pre-proline 0 C--N 1.291 -1.969 0 C-N-CA 119.754 -0.778 . . . . 0.25 110.618 -174.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 63' ' ' VAL . 36.3 Cg_endo -64.8 152.38 82.3 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 C-N-CA 122.948 2.432 . . . . 0.33 109.739 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.2 -33.57 53.34 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.561 0.744 . . . . 1.98 111.153 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 21.5 t70 -62.43 -43.51 98.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.546 -0.752 . . . . 2.06 111.679 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.452 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 40.9 m-20 -86.46 -21.83 26.82 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.403 0.52 . . . . 0.52 112.403 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.86 HG13 HG21 ' A' ' 47' ' ' VAL . 51.1 t -53.68 -50.43 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.246 -1.02 . . . . 0.38 108.246 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.1 pttp -79.55 -1.47 37.96 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.523 -1.217 . . . . 2.16 111.332 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.25 -18.84 24.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.295 -1.002 . . . . 1.59 108.295 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.824 HD13 ' HA ' ' A' ' 72' ' ' ALA . 27.6 mt -90.38 117.82 29.39 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 106.783 -1.562 . . . . 0.31 106.783 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.82 -37.63 6.96 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.695 -0.802 . . . . 2.55 110.769 175.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 41.1 p -109.73 178.87 4.29 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 109.486 -0.561 . . . . 0.23 109.486 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.734 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -85.08 -13.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.365 -0.976 . . . . 1.21 108.365 173.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -67.5 -49.07 53.52 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 107.165 -2.374 . . . . 0.33 107.165 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 68' ' ' THR . 8.6 m-20 -56.43 -57.09 13.81 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 124.95 1.3 . . . . 1.39 110.411 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.824 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.34 -60.99 2.56 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.442 1.089 . . . . 0.15 111.667 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 7' ' ' ILE . 34.4 m -60.39 -45.33 93.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 113.26 0.837 . . . . 0.24 113.26 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.6 mptm? -63.52 -22.72 67.05 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 122.651 0.38 . . . . 3.63 110.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -82.2 -52.92 6.49 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 116.041 -0.527 . . . . 0.4 109.599 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.75 ' HA ' HG21 ' A' ' 56' ' ' VAL . 71.6 mt -52.74 -66.93 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 C-N-CA 124.827 1.251 . . . . 0.21 111.351 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -52.95 -39.91 63.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.552 1.541 . . . . 1.44 111.9 -177.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -72.69 -26.29 61.56 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 113.261 -1.791 . . . . 0.63 111.481 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -103.08 -8.59 20.42 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.994 0.739 . . . . 1.25 112.994 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.709 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 60.7 mt-30 . . . . . 0 CA--C 1.476 -1.88 0 CA-C-O 123.104 1.43 . . . . 0.87 108.225 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.479 ' HA ' HD13 ' A' ' 77' ' ' LEU . 15.1 t . . . . . 0 N--CA 1.423 -1.803 0 N-CA-C 109.869 -0.419 . . . . 0.66 109.869 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.601 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.8 OUTLIER -47.71 -39.92 18.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.163 1.385 . . . . 0.74 113.238 174.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -59.2 -22.56 61.2 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.519 0.933 . . . . 2.66 113.519 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 3' ' ' THR . 29.9 tt0 -79.15 -39.82 32.5 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.806 -0.812 . . . . 2.73 108.806 174.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 77' ' ' LEU . 63.9 mt -76.7 -66.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.643 -1.162 . . . . 0.23 111.526 -169.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 28' ' ' LEU . 48.1 t -56.51 -47.08 82.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 111.554 0.205 . . . . 0.27 111.554 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.35 -36.2 66.04 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.75 0.656 . . . . 0.27 112.212 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.4 -43.87 6.79 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 120.907 -0.663 . . . . 0.18 112.21 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -61.09 -39.9 91.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 124.402 1.081 . . . . 0.2 109.216 -177.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.31 -48.2 77.17 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 115.897 -0.592 . . . . 0.14 109.905 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.705 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 97.3 mt-10 -63.59 -34.09 77.04 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.983 0.802 . . . . 0.68 112.278 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 11' ' ' LEU . 58.9 mt -68.26 -38.8 80.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.829 -0.623 . . . . 0.28 109.495 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 11' ' ' LEU . 59.7 t -72.26 -23.6 21.61 Favored 'Isoleucine or valine' 0 C--O 1.253 1.279 0 CA-C-O 121.427 0.632 . . . . 0.27 110.206 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.705 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 7.0 m120 -62.5 -37.83 87.54 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.776 -0.824 . . . . 0.34 108.776 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -84.08 -47.64 10.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 2.07 112.309 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.835 HG13 ' HB ' ' A' ' 46' ' ' VAL . 25.0 mm -54.2 -52.38 38.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.654 0.782 . . . . 0.65 111.427 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -118.51 -56.66 2.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.118 0.485 . . . . 0.54 110.832 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 16' ' ' ASN . . . 135.95 40.6 0.14 Allowed Glycine 0 CA--C 1.49 -1.529 0 C-N-CA 120.292 -0.956 . . . . 0.43 112.29 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.816 HG21 HG23 ' A' ' 26' ' ' VAL . 1.4 mp -75.64 147.31 81.45 Favored Pre-proline 0 C--O 1.202 -1.413 0 N-CA-C 109.06 -0.719 . . . . 0.31 109.06 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.3 Cg_exo -85.44 34.5 0.49 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 123.232 2.621 . . . . 1.08 113.992 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 21' ' ' ILE 0.274 9.8 p 56.9 -15.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 C-N-CA 127.326 2.251 . . . . 0.81 116.513 177.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.24 -18.6 19.92 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.638 -0.664 . . . . 2.31 111.615 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 25.5 t0 -85.42 -24.7 27.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 120.29 -0.564 . . . . 1.59 110.609 -170.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.816 HG23 HG21 ' A' ' 21' ' ' ILE . 42.6 t -72.54 92.58 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.852 -1.166 . . . . 0.3 107.852 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 69' ' ' VAL . 9.4 tppt? -125.16 160.37 29.3 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.801 -2.296 . . . . 1.58 104.801 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.517 ' HA ' HG22 ' A' ' 69' ' ' VAL . 6.4 mp -64.22 148.72 49.46 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 118.624 0.647 . . . . 1.05 109.651 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.408 ' H ' ' N ' ' A' ' 70' ' ' GLY . 31.2 t70 76.98 11.58 2.4 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.506 -1.225 . . . . 0.72 110.665 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 35.8 mmtp -99.04 122.95 42.96 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 108.927 -0.768 . . . . 1.48 108.927 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 39.2 m -76.82 28.04 0.13 Allowed 'General case' 1 C--N 1.242 -4.071 0 C-N-CA 126.643 1.977 . . . . 1.25 114.854 -172.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.704 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 91.0 m-85 44.62 -93.0 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.4 113.698 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.3 t -77.27 44.02 0.4 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.399 1.095 . . . . 1.06 111.229 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.9 t70 -159.46 -55.47 0.06 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 108.858 -0.793 . . . . 1.74 108.858 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.557 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 33.4 m-20 -84.2 -34.95 23.83 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.134 -0.939 . . . . 1.29 111.955 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 33.3 mt -85.11 -88.94 0.11 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.31 -0.626 . . . . 0.81 109.31 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.449 ' H ' ' HB2' ' A' ' 36' ' ' LEU . 21.6 t70 157.11 64.67 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.609 -1.997 . . . . 1.12 105.609 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 19' ' ' ALA . 4.9 t -118.81 150.77 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.635 -0.712 . . . . 0.79 110.142 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.16 110.12 9.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.752 . . . . 2.0 108.968 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.568 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 29.5 t -41.06 -47.45 3.13 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.735 1.614 . . . . 0.78 114.071 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.9 pt? -64.67 -34.49 78.41 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.063 -0.398 . . . . 1.18 111.45 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 18' ' ' ILE . 14.7 m -82.2 -13.12 57.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.195 0.522 . . . . 0.6 111.002 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.704 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.26 -36.97 79.02 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 123.361 0.665 . . . . 0.86 110.289 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.11 -47.13 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 O-C-N 123.836 0.71 . . . . 0.31 110.31 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -56.69 -53.64 55.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.216 0.607 . . . . 0.68 110.358 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.835 ' HB ' HG13 ' A' ' 18' ' ' ILE 0.34 1.7 p -61.92 -22.59 29.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 N-CA-C 114.228 1.195 . . . . 0.63 114.228 -178.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.935 HG21 HG13 ' A' ' 63' ' ' VAL . 44.5 t -71.23 -50.38 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.746 -1.205 . . . . 0.55 107.746 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.28 -35.24 73.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 108.397 -0.964 . . . . 0.42 108.397 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 46' ' ' VAL . . . -68.06 -35.25 77.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.308 -0.86 . . . . 0.21 109.947 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.73 -59.08 4.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.508 -1.224 . . . . 0.21 109.102 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.273 0.0 OUTLIER -59.96 -39.31 85.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 114.461 1.282 . . . . 0.64 114.461 -175.135 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -58.92 -40.58 85.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.92 0.391 . . . . 2.07 111.835 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.9 -27.14 43.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.109 -0.496 . . . . 2.48 111.059 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.502 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 7.1 m-85 -104.27 3.06 32.25 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.675 -0.81 . . . . 0.81 112.322 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.0 t70 80.46 -5.68 1.75 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.821 1.248 . . . . 1.99 112.851 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 76' ' ' ILE . 10.6 p -82.02 173.43 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 121.29 -0.881 . . . . 0.37 109.205 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 18.4 tptm -128.62 127.28 41.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.552 -1.647 . . . . 2.12 106.552 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.509 HG13 ' HB3' ' A' ' 51' ' ' GLU . 64.0 mt -119.42 111.99 36.09 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.736 -0.386 . . . . 0.25 110.921 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.522 ' O ' HG23 ' A' ' 63' ' ' VAL . 58.7 Cg_endo -69.25 159.83 52.23 Favored 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 123.047 2.498 . . . . 0.33 110.808 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 22.1 t70 -52.78 -41.45 64.11 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.73 0.812 . . . . 1.98 112.116 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.5 -32.12 72.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.933 -0.576 . . . . 2.06 110.938 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 20.0 m-20 -86.3 -24.96 25.72 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.342 -0.543 . . . . 0.52 111.839 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.935 HG13 HG21 ' A' ' 47' ' ' VAL . 52.7 t -54.38 -51.58 47.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.588 -1.264 . . . . 0.38 107.588 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 13.8 ptmm? -78.51 -2.66 39.74 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.944 -1.026 . . . . 2.16 111.609 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -88.26 -29.67 20.24 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.935 -1.135 . . . . 1.59 107.935 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.693 HD13 ' HA ' ' A' ' 72' ' ' ALA . 29.4 mt -82.56 113.41 20.26 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 107.583 -1.265 . . . . 0.31 107.583 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -106.77 -40.2 5.58 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 119.866 -0.734 . . . . 2.55 109.129 176.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 p -108.26 178.29 4.54 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 119.715 -0.794 . . . . 0.23 109.307 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -86.63 -13.06 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.296 -1.002 . . . . 1.21 108.296 175.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.408 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -72.17 -37.63 59.59 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 108.114 -1.994 . . . . 0.33 108.114 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.1 -60.56 2.52 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.069 1.348 . . . . 1.39 109.492 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.693 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.49 -60.47 3.1 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 114.473 -1.239 . . . . 0.15 111.961 -176.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.601 HG21 ' HG2' ' A' ' 4' ' ' GLN . 61.6 m -59.39 -39.93 84.93 Favored 'General case' 0 N--CA 1.419 -2.0 0 O-C-N 124.102 0.877 . . . . 0.24 112.611 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 75' ' ' TYR . 9.7 tmtt? -61.37 -50.76 71.6 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.456 -0.942 . . . . 3.63 108.456 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' HE2' HG12 ' A' ' 58' ' ' ILE . 85.2 t80 -56.51 -50.71 71.0 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.321 1.013 . . . . 0.4 110.814 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.648 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -55.2 -66.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 114.009 -1.45 . . . . 0.21 110.223 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.646 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 64.5 tp -55.45 -38.4 68.98 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 123.968 0.907 . . . . 1.44 112.349 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.49 -28.75 67.3 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.363 -0.835 . . . . 0.63 111.194 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -102.03 -14.8 17.0 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.417 0.895 . . . . 1.25 113.417 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 66.7 mt-30 . . . . . 0 CA--C 1.466 -2.275 0 CA-C-O 123.219 1.485 . . . . 0.87 107.753 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 109.954 -0.387 . . . . 0.66 109.954 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.402 ' HG2' HG23 ' A' ' 8' ' ' VAL . 10.5 tm0? -49.12 -41.44 36.04 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.817 1.247 . . . . 0.74 113.552 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.59 -25.51 67.38 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.452 0.538 . . . . 2.66 112.452 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -87.19 -30.77 20.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.751 0.786 . . . . 2.73 109.108 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.419 HG23 ' CE2' ' A' ' 54' ' ' PHE . 96.1 mt -79.7 -65.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 CA-C-N 115.26 -0.882 . . . . 0.23 110.987 -172.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 4' ' ' GLN . 82.3 t -54.18 -46.71 67.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 122.568 0.347 . . . . 0.27 111.925 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.12 73.93 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.496 0.497 . . . . 0.27 111.546 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.77 -33.24 19.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.941 -0.572 . . . . 0.18 112.906 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -69.55 -34.66 74.53 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.044 -1.095 . . . . 0.2 108.044 -178.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.05 -46.47 75.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.28 -0.873 . . . . 0.14 108.826 173.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.667 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 41.9 mt-10 -61.61 -43.02 99.64 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 124.276 0.985 . . . . 0.68 111.86 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.5 mt -58.71 -39.72 77.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.591 0.71 . . . . 0.28 109.644 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.743 HG12 ' HB ' ' A' ' 21' ' ' ILE . 62.7 t -70.74 -21.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.897 0.856 . . . . 0.27 110.015 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.667 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.0 m120 -80.47 -50.34 10.19 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.628 -1.249 . . . . 0.34 107.628 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.53 -50.25 59.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 2.07 112.279 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.01 -53.32 21.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.244 0.545 . . . . 0.65 109.86 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.56 -90.24 0.29 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.175 -0.466 . . . . 0.54 111.242 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.94 38.75 0.02 OUTLIER Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.599 -0.81 . . . . 0.43 113.104 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.743 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -80.99 155.1 72.87 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 109.417 -0.586 . . . . 0.31 109.417 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 4.8 Cg_exo -88.46 32.66 0.39 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.938 3.092 . . . . 1.08 114.768 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.464 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 5.2 p 60.05 -21.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.07 0 C-N-CA 127.147 2.179 . . . . 0.81 116.063 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -93.23 -20.32 20.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 112.691 0.626 . . . . 2.31 112.691 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.83 -30.77 51.25 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 120.74 -0.384 . . . . 1.59 111.258 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' A' ' 12' ' ' ALA . 34.7 t -72.89 97.88 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.28 -0.873 . . . . 0.3 109.672 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -135.69 151.03 49.78 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 104.413 -2.439 . . . . 1.58 104.413 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.548 HD22 ' HA2' ' A' ' 70' ' ' GLY . 49.3 mt -50.96 148.49 4.2 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.59 0.632 . . . . 1.05 109.574 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.7 t70 76.98 18.88 1.45 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.976 1.37 . . . . 0.72 109.94 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -119.21 128.46 54.23 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 114.703 -1.135 . . . . 1.48 108.442 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 5.7 m -87.36 112.1 21.77 Favored 'General case' 0 C--N 1.244 -3.983 0 N-CA-C 107.417 -1.327 . . . . 1.25 107.417 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.792 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.1 m-85 -46.63 -47.23 20.09 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.436 1.095 . . . . 0.4 112.708 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 t -98.86 21.75 11.1 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 112.574 0.583 . . . . 1.06 112.574 -174.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 13.6 t70 -146.48 -56.89 0.28 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 1.74 109.792 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.22 -39.27 55.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.881 -1.054 . . . . 1.29 110.402 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' HA ' ' A' ' 32' ' ' PHE . 35.6 mt -83.61 -93.17 0.07 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.513 -0.767 . . . . 0.81 110.365 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 32.6 t70 168.09 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 121.349 0.595 . . . . 1.12 111.127 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.541 HG11 ' HE3' ' A' ' 43' ' ' MET . 41.5 t -77.29 134.82 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 O-C-N 121.178 -0.951 . . . . 0.79 112.039 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 5.3 t70 -47.37 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 129.218 3.007 . . . . 2.0 117.297 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 43' ' ' MET . 30.5 t 75.03 -54.96 0.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.455 1.279 . . . . 0.78 114.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.488 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -74.58 -29.28 61.27 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.085 -1.446 . . . . 1.18 109.37 178.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 46' ' ' VAL . 67.3 m -70.6 -16.09 62.81 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.157 -0.929 . . . . 0.6 111.412 173.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.629 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -62.24 -41.35 98.34 Favored 'General case' 0 CA--C 1.473 -1.993 0 C-N-CA 123.101 0.56 . . . . 0.86 111.851 -178.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -57.29 -43.13 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 124.302 1.001 . . . . 0.31 109.734 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -56.5 -47.51 79.16 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.855 -0.611 . . . . 0.68 109.782 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 42' ' ' SER . 40.3 t -60.91 -24.59 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.32 -0.855 . . . . 0.63 111.107 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.928 HG21 HG13 ' A' ' 63' ' ' VAL . 29.2 t -81.11 -53.07 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 108.182 -1.044 . . . . 0.55 108.182 -177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 -29.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.739 -1.119 . . . . 0.42 109.762 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.57 58.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.282 -0.636 . . . . 0.21 109.282 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.58 -53.63 44.73 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.103 -0.953 . . . . 0.21 109.272 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.584 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.258 0.0 OUTLIER -63.97 -34.93 79.09 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.663 0.986 . . . . 0.64 113.663 -177.716 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -64.28 -36.89 85.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.117 0.484 . . . . 2.07 111.375 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.61 -35.91 20.69 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.451 -0.795 . . . . 2.48 111.891 -172.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 11.4 m-85 -89.76 -45.1 9.54 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 118.926 -1.11 . . . . 0.81 113.185 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 13.5 t70 154.11 -33.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 124.618 1.199 . . . . 1.99 111.781 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' A' ' 79' ' ' HIS . 9.3 p -76.85 -177.0 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.449 0.537 . . . . 0.37 112.449 -165.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' H ' HG22 ' A' ' 56' ' ' VAL . 7.4 ttmm -135.98 131.37 34.97 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.721 -1.585 . . . . 2.12 106.721 169.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.621 HG23 ' HE2' ' A' ' 75' ' ' TYR . 45.4 mt -122.03 111.64 32.26 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 123.425 0.453 . . . . 0.25 110.347 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.602 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.9 Cg_endo -72.31 160.34 47.28 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.982 2.455 . . . . 0.33 110.634 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.11 -43.32 41.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.751 . . . . 1.98 111.74 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 35.0 t70 -63.64 -34.22 77.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 2.06 112.68 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.589 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 67.0 m-20 -86.15 -28.22 24.1 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.113 -0.635 . . . . 0.52 110.993 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.928 HG13 HG21 ' A' ' 47' ' ' VAL . 76.8 t -55.61 -55.46 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.363 -0.977 . . . . 0.38 108.363 174.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 61' ' ' ASP . 17.1 pttp -69.62 -1.19 8.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.927 -1.033 . . . . 2.16 112.891 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.86 -23.5 16.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.86 -1.163 . . . . 1.59 107.86 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.894 HD13 ' HA ' ' A' ' 72' ' ' ALA . 21.6 mt -91.59 125.17 36.23 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 106.726 -1.583 . . . . 0.31 106.726 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -113.24 -39.63 4.11 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.336 -0.987 . . . . 2.55 108.336 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.702 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.8 p -104.53 179.58 4.23 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-N 115.463 -0.79 . . . . 0.23 109.887 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.792 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -87.08 -13.95 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 108.237 -1.024 . . . . 1.21 108.237 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.548 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -69.03 -47.59 53.12 Favored Glycine 0 CA--C 1.492 -1.39 0 N-CA-C 107.437 -2.265 . . . . 0.33 107.437 172.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 23.7 m-20 -56.6 -55.91 28.04 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 125.271 1.429 . . . . 1.39 110.925 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.894 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -54.56 -60.49 3.28 Favored 'General case' 0 CA--C 1.479 -1.763 0 O-C-N 124.472 1.107 . . . . 0.15 112.166 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.8 HG22 HD23 ' A' ' 77' ' ' LEU . 33.7 m -54.55 -51.48 65.09 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.013 -0.994 . . . . 0.24 112.949 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -51.07 -29.25 12.41 Favored 'General case' 0 C--O 1.197 -1.675 0 C-N-CA 126.749 2.019 . . . . 3.63 111.444 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.621 ' HE2' HG23 ' A' ' 58' ' ' ILE . 73.1 t80 -85.21 -48.89 8.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.61 -0.723 . . . . 0.4 109.333 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.666 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.9 mt -56.51 -63.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 114.697 -1.138 . . . . 0.21 109.372 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.8 HD23 HG22 ' A' ' 73' ' ' THR . 4.5 pp -56.97 -36.58 70.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.734 0.778 . . . . 1.44 112.622 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.47 ' N ' HD12 ' A' ' 77' ' ' LEU . 5.5 t70 -76.5 -26.74 55.59 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.472 -1.24 . . . . 0.63 111.276 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.617 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 20.5 t-80 -94.98 -16.38 22.81 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.003 -0.544 . . . . 1.25 109.983 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 32.7 mt-30 . . . . . 0 CA--C 1.478 -1.789 0 CA-C-O 122.729 1.252 . . . . 0.87 108.187 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.44 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.7 t . . . . . 0 N--CA 1.419 -2.006 0 N-CA-C 105.874 -1.898 . . . . 0.66 105.874 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.419 ' HG2' HG23 ' A' ' 8' ' ' VAL . 11.5 tm0? -46.62 -46.76 19.94 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.823 1.416 . . . . 0.74 114.823 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.36 -23.54 65.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.966 1.099 . . . . 2.66 113.966 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -87.95 -33.99 18.25 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.426 -0.953 . . . . 2.73 108.426 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.621 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.3 mt -72.0 -65.35 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.515 0 CA-C-N 115.955 -0.566 . . . . 0.23 110.61 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.518 HG13 HG21 ' A' ' 69' ' ' VAL . 26.4 t -59.85 -26.7 36.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 111.934 0.346 . . . . 0.27 111.934 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.42 -37.91 68.52 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.942 -0.703 . . . . 0.27 110.124 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.68 -36.44 11.85 Favored Glycine 0 N--CA 1.419 -2.456 0 CA-C-N 116.186 -0.461 . . . . 0.18 113.068 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.07 -35.36 80.32 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.571 -0.899 . . . . 0.2 108.571 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.792 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -57.08 -44.3 82.99 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.87 -0.605 . . . . 0.14 109.74 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.689 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 46.4 mt-10 -62.69 -42.55 99.69 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.175 -0.92 . . . . 0.68 111.834 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 11' ' ' LEU . 50.2 mt -61.14 -36.63 73.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.923 0.868 . . . . 0.28 109.848 177.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.677 HG12 ' HB ' ' A' ' 21' ' ' ILE . 60.5 t -74.97 -23.27 17.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.224 -0.898 . . . . 0.27 110.325 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.689 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 9.0 m120 -70.25 -46.35 64.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.631 -0.877 . . . . 0.34 108.631 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.06 -49.38 17.66 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.997 -1.001 . . . . 2.07 113.482 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.652 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.9 mt -75.64 -51.1 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 112.327 0.492 . . . . 0.65 112.327 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.717 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -91.68 -75.28 0.48 Allowed 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.273 -0.571 . . . . 0.54 110.384 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.54 41.0 0.04 OUTLIER Glycine 0 C--N 1.3 -1.442 0 CA-C-N 115.564 -0.744 . . . . 0.43 112.572 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.833 HG21 HG23 ' A' ' 26' ' ' VAL . 1.5 mp -81.98 150.66 65.66 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 109.055 -0.72 . . . . 0.31 109.055 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 8.2 Cg_exo -87.02 33.46 0.43 Allowed 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 124.348 3.365 . . . . 1.08 114.27 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 21' ' ' ILE 0.324 9.2 p 60.81 -18.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.091 2.157 . . . . 0.81 116.597 175.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -96.79 -11.34 25.07 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.391 -0.818 . . . . 2.31 111.79 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.494 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.4 m-20 -79.73 -33.2 41.02 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.094 0.474 . . . . 1.59 110.495 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.833 HG23 HG21 ' A' ' 21' ' ' ILE . 40.9 t -72.83 93.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.969 -1.014 . . . . 0.3 110.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -124.7 168.23 13.46 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.69 -1.596 . . . . 1.58 106.69 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.573 ' HA ' HG22 ' A' ' 69' ' ' VAL . 5.8 mp -68.05 151.19 47.44 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.905 -1.146 . . . . 1.05 107.905 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 t70 76.68 12.84 2.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.282 1.039 . . . . 0.72 109.548 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -111.65 125.21 53.71 Favored 'General case' 0 CA--C 1.458 -2.576 0 O-C-N 121.7 -0.625 . . . . 1.48 110.442 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 12.2 m -80.26 111.89 17.07 Favored 'General case' 0 C--N 1.247 -3.854 0 CA-C-N 114.428 -1.26 . . . . 1.25 108.213 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 36' ' ' LEU . 90.8 m-85 -48.41 -55.48 10.73 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.445 0.698 . . . . 0.4 110.548 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 t -84.08 25.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.595 0.591 . . . . 1.06 112.595 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -156.11 -62.14 0.11 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.535 0.684 . . . . 1.74 111.237 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -70.79 -39.52 73.08 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 124.368 1.067 . . . . 1.29 110.466 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.608 HD13 HG22 ' A' ' 26' ' ' VAL . 16.4 mt -88.11 -50.44 6.39 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.202 -0.908 . . . . 0.81 110.802 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 95.03 68.66 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.852 2.061 . . . . 1.12 110.723 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 19' ' ' ALA . 47.4 t -101.42 132.45 47.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 CA-C-N 113.366 -1.743 . . . . 0.79 106.577 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -62.68 20.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.545 2.054 . . . . 2.0 116.545 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.484 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 28.6 t 61.99 -57.89 0.12 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 116.139 1.903 . . . . 0.78 116.139 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.57 -29.58 70.82 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.953 0.882 . . . . 1.18 109.987 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.652 ' HB3' HG22 ' A' ' 18' ' ' ILE . 1.6 m -75.05 -22.52 58.34 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.277 -1.329 . . . . 0.6 110.656 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.632 ' HE3' HG11 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.27 -43.75 95.9 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 123.743 0.817 . . . . 0.86 112.341 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.63 -36.95 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 O-C-N 123.946 0.779 . . . . 0.31 110.605 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.28 -43.94 93.23 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 108.768 -0.827 . . . . 0.68 108.768 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 42' ' ' SER . 58.3 t -61.96 -25.05 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.469 1.107 . . . . 0.63 111.11 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.884 HG11 HG22 ' A' ' 63' ' ' VAL . 55.3 t -77.25 -55.71 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 107.422 -1.325 . . . . 0.55 107.422 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 58.6 t -57.3 -40.79 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 O-C-N 124.806 1.316 . . . . 0.42 108.94 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -65.6 -35.24 80.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.373 0.606 . . . . 0.21 110.685 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.57 -57.13 6.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.351 -0.841 . . . . 0.21 109.783 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.69 -33.95 76.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.634 0.976 . . . . 0.64 113.634 -177.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 51.8 mt-10 -59.32 -53.17 61.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.643 0.259 . . . . 2.07 110.368 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -66.18 -47.12 74.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.513 0.56 . . . . 2.48 112.513 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.621 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.3 m-85 -84.37 -9.41 58.45 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.648 0.61 . . . . 0.81 112.648 -172.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 85.05 3.59 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 116.385 1.994 . . . . 1.99 116.385 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 13.9 p -82.91 171.72 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.129 -1.028 . . . . 0.37 108.863 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -120.17 128.02 53.01 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.815 -1.55 . . . . 2.12 106.815 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.506 HG13 ' HB3' ' A' ' 51' ' ' GLU . 60.3 mt -116.79 108.97 43.81 Favored Pre-proline 0 C--N 1.308 -1.198 0 C-N-CA 119.964 -0.694 . . . . 0.25 111.52 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 63' ' ' VAL . 51.7 Cg_endo -69.02 159.13 55.19 Favored 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 123.184 2.59 . . . . 0.33 110.928 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.22 -33.62 67.71 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.681 0.792 . . . . 1.98 110.21 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.81 -38.07 89.26 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.067 -0.97 . . . . 2.06 110.835 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.544 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 41.1 m-20 -87.04 -25.17 24.34 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.187 -0.605 . . . . 0.52 112.464 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.884 HG22 HG11 ' A' ' 47' ' ' VAL . 94.7 t -55.88 -42.09 69.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.441 -0.948 . . . . 0.38 108.441 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -78.18 -5.32 51.42 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.669 -0.696 . . . . 2.16 112.304 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.43 -25.58 16.85 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 109.822 -0.436 . . . . 1.59 109.822 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.866 HD13 ' HA ' ' A' ' 72' ' ' ALA . 22.0 mt -89.12 122.04 32.04 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 107.095 -1.446 . . . . 0.31 107.095 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' SER . 8.3 mptt -120.21 -34.88 3.57 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.505 -0.924 . . . . 2.55 108.505 174.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 39.4 p -106.41 173.47 6.3 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 108.894 -0.78 . . . . 0.23 108.894 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 28' ' ' LEU . 1.4 m -81.92 -13.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 C-N-CA 119.35 -0.94 . . . . 1.21 108.535 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.46 -43.53 92.24 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 108.632 -1.787 . . . . 0.33 108.632 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.73 -56.84 13.98 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.866 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.12 -61.02 2.53 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 114.087 -1.415 . . . . 0.15 112.506 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.492 ' HA ' HG21 ' A' ' 7' ' ' ILE . 49.9 m -56.62 -46.3 81.02 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.492 1.12 . . . . 0.24 112.451 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -56.51 -52.34 65.1 Favored 'General case' 0 N--CA 1.41 -2.469 0 O-C-N 124.453 1.095 . . . . 3.63 108.765 177.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.545 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 74.4 t80 -55.18 -50.51 69.18 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 124.057 0.848 . . . . 0.4 111.515 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.631 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.8 mt -54.4 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-N 114.151 -1.386 . . . . 0.21 110.207 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.494 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 4.2 tt -57.95 -45.51 86.53 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.615 0.766 . . . . 1.44 110.182 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.85 -24.07 66.67 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.049 0.94 . . . . 0.63 111.384 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -98.8 -26.42 14.32 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 113.011 0.745 . . . . 1.25 113.011 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.45 2.7 pp0? . . . . . 0 CA--C 1.507 -0.698 0 N-CA-C 116.405 2.002 . . . . 0.87 116.405 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 7' ' ' ILE . 6.6 t . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 110.751 -0.092 . . . . 0.66 110.751 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.1 tm0? -47.79 -43.21 27.39 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.015 0.926 . . . . 0.74 113.357 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.48 -34.73 62.12 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.594 0.559 . . . . 2.66 111.709 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -87.31 -34.88 18.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.884 -0.598 . . . . 2.73 109.941 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.538 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.7 mt -68.54 -65.72 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 CA-C-N 116.497 -0.319 . . . . 0.23 110.528 -174.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -41.52 67.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 112.386 0.513 . . . . 0.27 112.386 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -61.54 -42.28 98.59 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.033 0.444 . . . . 0.27 110.348 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.0 -40.91 28.93 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 121.028 -0.606 . . . . 0.18 113.081 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.16 -38.53 91.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.775 -0.824 . . . . 0.2 108.775 -178.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.619 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.13 -48.24 80.84 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.792 -0.64 . . . . 0.14 109.573 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.69 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 52.5 mt-10 -60.21 -39.37 86.33 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.895 0.747 . . . . 0.68 111.998 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 11' ' ' LEU . 62.9 mt -61.24 -41.88 91.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.009 -0.541 . . . . 0.28 109.754 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 11' ' ' LEU . 46.7 t -71.42 -23.55 22.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.357 0.599 . . . . 0.27 109.945 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.69 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.5 m120 -68.2 -48.81 64.21 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.905 -1.146 . . . . 0.34 107.905 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -69.88 -42.98 72.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.895 -1.048 . . . . 2.07 111.821 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.747 HG13 HG22 ' A' ' 46' ' ' VAL . 19.2 mm -73.85 -53.71 16.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 116.01 -0.541 . . . . 0.65 111.707 -177.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.52 -62.99 1.38 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.171 0.51 . . . . 0.54 111.403 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.33 39.13 0.07 OUTLIER Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.414 -0.898 . . . . 0.43 112.964 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.721 HG21 HG23 ' A' ' 26' ' ' VAL . 1.2 mp -78.03 152.35 79.54 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.459 -0.571 . . . . 0.31 109.459 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.6 Cg_endo -89.85 25.37 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.984 2.456 . . . . 1.08 115.052 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.477 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 5.0 p 53.62 15.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 125.447 1.499 . . . . 0.81 113.857 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.0 pt-20 -123.13 -16.07 7.08 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.888 -0.596 . . . . 2.31 110.338 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.441 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 22.0 t70 -92.41 -25.64 18.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.675 0.75 . . . . 1.59 110.108 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.721 HG23 HG21 ' A' ' 21' ' ' ILE . 43.0 t -76.09 92.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.444 -1.253 . . . . 0.3 108.863 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -125.87 166.78 16.25 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.576 -1.268 . . . . 1.58 107.576 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.403 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 9.5 mp -63.53 146.0 54.54 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.45 -0.574 . . . . 1.05 109.45 176.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.48 12.47 3.87 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.119 1.367 . . . . 0.72 110.431 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 68' ' ' THR . 73.7 mmtt -103.57 124.79 49.45 Favored 'General case' 0 CA--C 1.47 -2.11 0 O-C-N 121.791 -0.568 . . . . 1.48 109.777 176.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 6.3 m -83.23 110.86 18.43 Favored 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 114.488 -1.233 . . . . 1.25 108.427 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.662 ' HA ' HD12 ' A' ' 36' ' ' LEU . 98.2 m-85 -42.02 -67.23 0.28 Allowed 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 125.725 1.61 . . . . 0.4 112.426 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.505 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 14.8 t -101.56 49.35 0.87 Allowed 'General case' 0 C--N 1.275 -2.658 0 C-N-CA 118.776 -1.17 . . . . 1.06 111.134 -177.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 29.4 t70 -154.62 -53.72 0.1 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.73 -1.123 . . . . 1.74 109.773 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -86.23 -44.5 12.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.207 1.003 . . . . 1.29 110.771 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 32' ' ' PHE . 32.7 mt -71.75 -91.24 0.02 OUTLIER 'General case' 0 C--O 1.249 1.036 0 O-C-N 123.715 0.634 . . . . 0.81 111.4 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 25.4 t70 158.25 61.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 126.099 1.76 . . . . 1.12 108.459 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 33' ' ' THR . 26.8 t -101.72 165.81 2.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.694 -0.684 . . . . 0.79 110.022 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 38' ' ' VAL . 10.0 m-20 -83.26 6.15 20.62 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.681 0.793 . . . . 2.0 112.879 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 43' ' ' MET . 20.5 t 66.66 -66.5 0.18 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.579 1.152 . . . . 0.78 113.245 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.02 -26.52 65.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.583 0.706 . . . . 1.18 110.802 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 15.7 m -80.54 -13.46 59.06 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.548 -0.751 . . . . 0.6 110.569 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.588 ' O ' HG23 ' A' ' 47' ' ' VAL . 18.0 tpp -73.04 -31.65 64.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.002 -0.544 . . . . 0.86 110.978 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -55.15 -42.59 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 N-CA-C 108.784 -0.821 . . . . 0.31 108.784 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' SER . 26.0 mm-40 -54.53 -53.14 58.38 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 123.781 0.832 . . . . 0.68 110.282 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.747 HG22 HG13 ' A' ' 18' ' ' ILE . 51.6 t -54.16 -32.14 22.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 124.374 1.07 . . . . 0.63 112.048 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.83 HG21 HG13 ' A' ' 63' ' ' VAL . 27.9 t -73.32 -48.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.567 -0.901 . . . . 0.55 108.567 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.415 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 43.8 t -68.3 -31.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.272 -1.01 . . . . 0.42 108.272 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -69.66 -34.17 73.62 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.41 0.624 . . . . 0.21 109.738 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.48 42.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.974 -1.012 . . . . 0.21 108.994 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.261 0.0 OUTLIER -66.77 -29.63 69.64 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.714 1.005 . . . . 0.64 113.714 -177.727 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 41.4 mt-10 -63.34 -38.16 90.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.274 0.559 . . . . 2.07 110.627 174.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -86.86 -35.37 19.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.272 0.471 . . . . 2.48 112.272 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 8.1 m-85 -97.72 -0.03 46.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 120.025 -0.67 . . . . 0.81 112.186 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 78.44 -2.77 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.584 1.327 . . . . 1.99 114.584 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.671 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 14.8 p -75.73 175.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 O-C-N 121.098 -1.001 . . . . 0.37 108.947 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 36.5 tptt -124.61 128.96 49.68 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.82 -1.178 . . . . 2.12 107.82 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 51' ' ' GLU . 27.1 mt -123.09 110.98 30.8 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 120.165 -0.614 . . . . 0.25 110.825 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.581 ' HD2' ' OH ' ' A' ' 75' ' ' TYR . 67.8 Cg_endo -73.89 158.4 46.39 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.591 2.194 . . . . 0.33 109.582 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.69 -36.57 62.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.194 0.597 . . . . 1.98 110.806 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.44 -42.69 87.89 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.575 0.75 . . . . 2.06 111.63 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.5 m-20 -86.32 -24.92 25.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 121.017 -0.273 . . . . 0.52 111.581 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.83 HG13 HG21 ' A' ' 47' ' ' VAL . 55.8 t -53.06 -58.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.138 -1.06 . . . . 0.38 108.138 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -72.87 -1.49 17.01 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.213 -0.903 . . . . 2.16 111.705 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 38.3 t30 -87.61 -34.41 18.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.847 -1.168 . . . . 1.59 107.847 -177.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 72' ' ' ALA . 12.8 mt -79.42 131.38 36.07 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 106.459 -1.682 . . . . 0.31 106.459 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 31' ' ' SER . 12.7 mptt -116.77 -42.34 2.98 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.997 -1.112 . . . . 2.55 107.997 171.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 81.9 p -101.88 170.38 8.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.901 -1.045 . . . . 0.23 110.224 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.5 -13.6 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.104 -1.073 . . . . 1.21 108.104 174.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.403 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -70.58 -30.47 68.72 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.244 -1.143 . . . . 0.33 110.244 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -81.97 -51.28 8.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.066 -1.087 . . . . 1.39 108.066 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.773 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.79 -60.42 2.91 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 114.323 -1.308 . . . . 0.15 111.967 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 4' ' ' GLN . 45.8 m -57.24 -42.27 81.14 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.671 -1.149 . . . . 0.24 112.508 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.54 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -57.29 -53.25 60.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.974 -1.121 . . . . 3.63 107.974 176.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.581 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 82.1 t80 -56.48 -50.54 71.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 124.19 0.931 . . . . 0.4 111.148 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.634 ' HA ' HG21 ' A' ' 56' ' ' VAL . 70.8 mt -55.73 -66.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.278 -1.328 . . . . 0.21 109.98 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.46 -47.18 66.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.8 0.84 . . . . 1.44 110.538 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.09 -22.97 65.8 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.221 -0.899 . . . . 0.63 112.285 -172.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -102.79 4.27 37.7 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.303 0.853 . . . . 1.25 113.303 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.671 ' HG2' ' HB ' ' A' ' 56' ' ' VAL 0.309 0.7 OUTLIER . . . . . 0 CA--C 1.474 -1.957 0 N-CA-C 113.832 1.049 . . . . 0.87 113.832 175.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 6.4 t . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 108.814 -0.81 . . . . 0.66 108.814 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.653 ' HA ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -48.71 -42.2 34.26 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.941 1.296 . . . . 0.74 112.653 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.35 -22.56 63.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.821 0.674 . . . . 2.66 112.821 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 3' ' ' THR . 4.1 tp10 -81.34 -36.77 29.29 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.412 -0.959 . . . . 2.73 108.412 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 4' ' ' GLN . 71.2 mt -79.03 -67.91 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.117 0 CA-C-N 115.294 -0.866 . . . . 0.23 110.844 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 t -59.09 -41.88 84.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 112.568 0.581 . . . . 0.27 112.568 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.38 82.72 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.317 0.386 . . . . 0.27 111.288 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.38 -40.53 8.39 Favored Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 120.393 -0.908 . . . . 0.18 112.2 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.72 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -59.46 -42.72 92.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.277 1.031 . . . . 0.2 108.278 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -54.43 -48.12 72.04 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.664 0.603 . . . . 0.14 110.615 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.724 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 54.4 mt-10 -65.71 -35.71 81.53 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 123.709 0.631 . . . . 0.68 111.746 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 11' ' ' LEU . 64.4 mt -60.73 -42.47 92.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.618 -0.719 . . . . 0.28 109.595 174.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 11' ' ' LEU . 41.3 t -68.47 -23.94 28.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 121.845 0.831 . . . . 0.27 109.864 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.724 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.9 m120 -75.57 -52.35 10.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.176 -1.046 . . . . 0.34 108.176 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -66.66 -46.42 75.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.615 -1.175 . . . . 2.07 112.476 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.62 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.2 mm -70.79 -53.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.878 0.371 . . . . 0.65 110.27 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.74 -74.31 0.65 Allowed 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.664 -0.414 . . . . 0.54 111.519 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.18 54.45 0.02 OUTLIER Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 120.291 -0.957 . . . . 0.43 112.045 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.615 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -95.62 154.57 39.17 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.493 -0.558 . . . . 0.31 109.493 175.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.533 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 6.2 Cg_exo -88.02 29.45 0.47 Allowed 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 124.224 3.283 . . . . 1.08 115.673 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.483 ' H ' HG22 ' A' ' 21' ' ' ILE . 6.5 p 57.87 -0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 117.838 2.533 . . . . 0.81 117.838 171.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.479 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 43.7 mt-10 -117.93 -13.39 10.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.34 -1.475 . . . . 2.31 111.225 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.0 m-20 -87.03 -29.28 22.06 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.005 -1.452 . . . . 1.59 110.127 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 12' ' ' ALA . 41.9 t -69.35 97.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 0.3 108.79 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.1 mttt -138.35 170.04 16.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 109.069 -0.715 . . . . 1.58 109.069 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 7.8 mp -61.13 143.03 56.23 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.174 -0.676 . . . . 1.05 109.174 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t70 81.99 1.04 1.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.029 1.332 . . . . 0.72 110.898 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.596 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 44.2 mmtm -92.8 120.35 33.08 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 119.589 -0.844 . . . . 1.48 109.644 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.529 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 15.9 m -79.12 27.09 0.25 Allowed 'General case' 1 C--N 1.244 -4.019 0 C-N-CA 125.968 1.707 . . . . 1.25 113.876 -172.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.59 ' CZ ' HG22 ' A' ' 69' ' ' VAL . 96.7 m-85 46.13 -88.58 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.495 1.518 . . . . 0.4 113.989 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.6 t -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.133 0.573 . . . . 1.06 111.374 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 32.3 t70 -88.17 -39.72 14.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.978 0.418 . . . . 1.74 111.298 -175.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.596 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -93.21 -41.31 9.97 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.514 0.931 . . . . 1.29 113.514 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.6 mt -88.19 -72.42 0.53 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.388 -0.525 . . . . 0.81 110.68 -173.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.0 t70 163.83 -22.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 124.321 1.013 . . . . 1.12 109.612 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 36' ' ' LEU . 3.0 t -45.99 105.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.77 1.628 . . . . 0.79 112.939 -170.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.523 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 24.9 t70 -54.04 124.15 14.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 124.04 0.838 . . . . 2.0 112.589 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.588 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 29.9 t -37.51 -45.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.612 2.078 . . . . 0.78 116.612 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.523 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 3.9 pp -75.92 -23.15 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 117.607 -1.637 . . . . 1.18 112.26 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.62 ' HB3' HG22 ' A' ' 18' ' ' ILE . 42.9 m -84.2 -18.91 35.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.735 -0.666 . . . . 0.6 109.665 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.644 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -56.95 -43.55 81.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.19 0.996 . . . . 0.86 112.715 -178.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.25 -40.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 123.845 0.716 . . . . 0.31 110.171 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -63.36 -44.45 94.77 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.969 -0.56 . . . . 0.68 109.722 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.589 HG11 HG22 ' A' ' 15' ' ' VAL . 42.0 t -60.0 -25.13 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.425 -0.807 . . . . 0.63 110.903 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.926 HG21 HG13 ' A' ' 63' ' ' VAL . 21.5 t -82.27 -53.75 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 108.79 -0.818 . . . . 0.55 108.79 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.14 -36.73 74.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.72 -1.127 . . . . 0.42 109.171 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -31.61 67.37 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.824 -0.435 . . . . 0.21 109.824 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -61.55 -58.21 9.04 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.285 -0.87 . . . . 0.21 109.094 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -64.47 -36.06 82.95 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.906 1.076 . . . . 0.64 113.906 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.99 -29.74 69.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 2.07 111.512 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -88.41 -32.34 18.38 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.227 -0.442 . . . . 2.48 111.559 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CE2' ' HB1' ' A' ' 50' ' ' ALA . 4.6 m-30 -93.13 -11.14 33.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 120.386 -0.526 . . . . 0.81 111.938 -173.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t70 81.38 6.77 1.2 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.493 1.517 . . . . 1.99 111.987 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' A' ' 76' ' ' ILE . 14.5 p -84.7 171.15 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 107.584 -1.265 . . . . 0.37 107.584 174.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 19.5 tptt -124.6 123.06 39.24 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.654 -0.869 . . . . 2.12 108.654 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.542 HG12 ' HE2' ' A' ' 75' ' ' TYR . 62.8 mt -118.9 112.73 36.32 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 109.835 -0.432 . . . . 0.25 109.835 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 63' ' ' VAL . 37.7 Cg_endo -67.43 158.2 58.18 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.747 2.298 . . . . 0.33 110.282 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 6.2 p-10 -58.55 -30.43 67.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.399 -0.364 . . . . 1.98 111.422 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.74 -34.03 69.2 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 112.428 0.529 . . . . 2.06 112.428 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.497 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 52.5 m-20 -78.73 -25.07 44.57 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 119.524 -0.87 . . . . 0.52 110.985 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.926 HG13 HG21 ' A' ' 47' ' ' VAL . 70.0 t -54.27 -39.7 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.229 -1.026 . . . . 0.38 108.229 170.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 60' ' ' ASP . 81.9 mttt -73.98 -14.63 61.06 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.0 -1.0 . . . . 2.16 112.22 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -96.49 -36.17 10.88 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.594 0.358 . . . . 1.59 111.511 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -68.71 113.05 5.84 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 105.678 -1.971 . . . . 0.31 105.678 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -108.21 -31.3 7.95 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 119.762 -0.775 . . . . 2.55 109.807 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 67.9 p -121.01 178.42 4.74 Favored 'General case' 0 N--CA 1.392 -3.338 0 N-CA-C 108.557 -0.905 . . . . 0.23 108.557 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.59 HG22 ' CZ ' ' A' ' 32' ' ' PHE . 6.4 t -77.45 -13.56 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 107.683 -1.228 . . . . 1.21 107.683 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.84 -49.04 37.93 Favored Glycine 0 CA--C 1.489 -1.583 0 N-CA-C 109.871 -1.292 . . . . 0.33 109.871 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.77 -44.36 77.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.963 -0.618 . . . . 1.39 109.373 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -56.61 -61.64 2.28 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.019 -0.992 . . . . 0.15 111.266 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.613 ' HA ' HG21 ' A' ' 7' ' ' ILE . 60.7 m -54.36 -43.71 71.54 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.696 -1.138 . . . . 0.24 113.804 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.1 mptp? -61.03 -50.9 71.48 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.99 -0.744 . . . . 3.63 108.99 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.542 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.8 t80 -54.47 -51.82 63.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.643 -1.162 . . . . 0.4 110.225 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.655 ' HA ' HG21 ' A' ' 56' ' ' VAL . 78.3 mt -55.37 -65.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 114.19 -1.368 . . . . 0.21 110.716 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 5.2 tt -51.73 -43.61 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.9 0.88 . . . . 1.44 110.57 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.07 -25.53 64.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.875 -1.057 . . . . 0.63 111.823 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -101.51 -5.83 24.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.794 -0.639 . . . . 1.25 112.344 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.582 HE21 HG22 ' A' ' 76' ' ' ILE 0.302 1.0 OUTLIER . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 113.636 0.976 . . . . 0.87 113.636 175.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.596 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 13.1 t . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 108.673 -0.862 . . . . 0.66 108.673 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' HG2' HG21 ' A' ' 73' ' ' THR . 16.0 tm0? -46.9 -48.25 21.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.141 1.163 . . . . 0.74 114.141 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.478 ' HG3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -51.98 -32.33 33.17 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.567 0.951 . . . . 2.66 113.567 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -87.45 -40.45 14.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.292 0.637 . . . . 2.73 109.87 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.635 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 99.5 mt -63.56 -58.74 6.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 116.139 -0.482 . . . . 0.23 110.016 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.547 HG21 HD11 ' A' ' 28' ' ' LEU . 46.0 t -66.29 -22.91 30.86 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.871 -0.604 . . . . 0.27 111.695 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.92 55.78 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.759 -0.776 . . . . 0.27 109.177 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.15 -44.09 24.12 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 115.008 -0.996 . . . . 0.18 113.225 -176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -63.13 -33.08 74.68 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 123.448 0.699 . . . . 0.2 109.376 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -60.75 -51.14 70.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.659 -0.701 . . . . 0.14 109.263 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 51.2 mt-10 -59.44 -41.83 90.53 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 124.183 0.927 . . . . 0.68 111.809 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 11' ' ' LEU . 71.4 mt -56.79 -42.17 77.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.461 -0.79 . . . . 0.28 109.85 175.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.613 HG12 ' HB ' ' A' ' 21' ' ' ILE . 88.0 t -70.92 -23.73 23.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.703 0.764 . . . . 0.27 110.306 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.645 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -72.79 -43.32 62.91 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.177 -1.046 . . . . 0.34 108.177 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -71.39 -50.33 33.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.214 -0.903 . . . . 2.07 110.926 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.653 HG13 HG22 ' A' ' 46' ' ' VAL . 20.9 mm -66.76 -54.24 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.1 -0.5 . . . . 0.65 111.667 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -102.96 -66.07 0.96 Allowed 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.389 0.614 . . . . 0.54 111.036 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.7 50.87 0.06 OUTLIER Glycine 0 C--N 1.29 -1.999 0 CA-C-N 115.142 -0.936 . . . . 0.43 111.714 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.613 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -91.33 155.66 44.17 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.408 -0.396 . . . . 0.31 109.983 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 21' ' ' ILE . 6.0 Cg_exo -86.62 23.02 0.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.343 2.695 . . . . 1.08 115.698 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.633 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.9 p 48.1 26.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 C-N-CA 124.694 1.198 . . . . 0.81 113.154 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -138.9 4.72 2.31 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.345 -0.843 . . . . 2.31 110.685 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.35 -27.91 9.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.075 -0.966 . . . . 1.59 110.065 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.744 HG22 HD13 ' A' ' 36' ' ' LEU . 23.7 t -79.6 99.1 3.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.33 -1.304 . . . . 0.3 108.972 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -127.98 170.57 12.72 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.164 -1.421 . . . . 1.58 107.164 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 8' ' ' VAL . 7.9 mp -66.41 148.55 51.7 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.287 -1.005 . . . . 1.05 108.287 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 81.51 4.22 1.39 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 124.451 1.101 . . . . 0.72 110.533 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.518 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 73.6 mmtt -96.61 118.99 34.26 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 119.831 -0.748 . . . . 1.48 110.636 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 71.4 m -75.53 32.88 0.11 Allowed 'General case' 0 C--N 1.248 -3.833 0 C-N-CA 127.189 2.195 . . . . 1.25 114.039 -175.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.582 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 86.8 m-85 41.23 -89.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.454 1.501 . . . . 0.4 115.025 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.645 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.9 t -63.15 -29.17 70.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.468 0.707 . . . . 1.06 111.05 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -96.45 -31.21 12.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.826 0.676 . . . . 1.74 112.826 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -99.29 -36.79 9.51 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.777 1.029 . . . . 1.29 113.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.744 HD13 HG22 ' A' ' 26' ' ' VAL . 16.0 mt -94.91 -39.7 10.08 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.245 -0.434 . . . . 0.81 109.998 -174.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 t70 93.33 69.53 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.579 0 C-N-CA 126.531 1.933 . . . . 1.12 108.934 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.645 ' H ' ' HA ' ' A' ' 33' ' ' THR . 13.3 t -108.09 143.4 18.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 105.002 -2.222 . . . . 0.79 105.002 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.37 117.73 15.48 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.374 -0.93 . . . . 2.0 109.63 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.593 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.0 t -38.67 -47.37 1.34 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.573 1.694 . . . . 0.78 115.573 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -70.58 -26.37 63.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.368 -0.933 . . . . 1.18 111.628 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.2 m -84.94 -16.96 39.25 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.474 0.709 . . . . 0.6 110.507 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.723 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -56.01 -38.65 70.79 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 124.084 0.953 . . . . 0.86 111.598 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.21 -47.1 77.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 O-C-N 124.451 1.095 . . . . 0.31 109.984 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.03 -45.12 83.35 Favored 'General case' 0 C--O 1.21 -1.026 0 C-N-CA 122.873 0.469 . . . . 0.68 109.796 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.653 HG22 HG13 ' A' ' 18' ' ' ILE . 44.2 t -59.01 -28.86 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.783 0.833 . . . . 0.63 110.958 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.849 HG21 HG13 ' A' ' 63' ' ' VAL . 54.0 t -78.6 -51.43 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.766 -1.198 . . . . 0.55 107.766 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -56.0 -42.42 71.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.419 -1.264 . . . . 0.42 109.447 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -63.85 -39.07 93.34 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-O 121.499 0.666 . . . . 0.21 110.454 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.28 -52.57 57.95 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.87 -1.059 . . . . 0.21 109.886 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.325 0.0 OUTLIER -62.54 -35.89 80.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.708 1.003 . . . . 0.64 113.708 -179.242 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.4 -44.03 95.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.221 0.326 . . . . 2.07 111.581 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -76.66 -44.54 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.534 0.568 . . . . 2.48 112.534 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.635 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 11.8 m-85 -89.27 -5.22 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.301 -0.56 . . . . 0.81 112.434 -172.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 83.17 10.73 0.52 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 115.389 1.625 . . . . 1.99 115.389 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.6 p -87.19 179.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.273 -1.01 . . . . 0.37 108.273 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.498 ' H ' HG22 ' A' ' 56' ' ' VAL . 46.7 tptt -132.89 128.55 36.84 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 106.434 -1.691 . . . . 2.12 106.434 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.604 HG13 ' HB3' ' A' ' 51' ' ' GLU . 42.0 mt -124.11 111.57 28.66 Favored Pre-proline 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.787 . . . . 0.25 111.054 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.628 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.5 Cg_endo -73.29 162.18 41.03 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.158 2.572 . . . . 0.33 110.793 176.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.39 -41.98 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.942 0.897 . . . . 1.98 110.616 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 30.2 t70 -60.72 -37.56 82.13 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 114.685 -1.143 . . . . 2.06 111.549 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 20.4 m-20 -86.89 -28.01 23.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 113.414 0.894 . . . . 0.52 113.414 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.849 HG13 HG21 ' A' ' 47' ' ' VAL . 95.8 t -53.62 -48.72 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.767 -0.827 . . . . 0.38 108.767 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 48.3 pttt -69.73 -13.59 62.37 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.886 -1.052 . . . . 2.16 112.45 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.79 -13.08 46.18 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.405 0.621 . . . . 1.59 109.716 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.771 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.5 mt -97.52 110.37 22.95 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 106.49 -1.67 . . . . 0.31 106.49 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.7 mptp? -100.64 -44.65 5.76 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.311 -0.996 . . . . 2.55 108.311 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 20.1 p -110.25 -177.9 3.37 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.697 -0.853 . . . . 0.23 108.697 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -87.05 -13.43 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 108.344 -0.984 . . . . 1.21 108.344 176.018 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.554 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -72.33 -24.78 75.79 Favored Glycine 0 C--O 1.2 -2.014 0 N-CA-C 108.683 -1.767 . . . . 0.33 108.683 174.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' THR . 8.7 m-20 -82.66 -57.13 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.781 -1.21 . . . . 1.39 108.542 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.771 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -47.8 -60.32 2.66 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 114.881 -1.054 . . . . 0.15 112.155 -178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.467 ' HA ' HG21 ' A' ' 7' ' ' ILE . 44.9 m -56.79 -48.09 78.71 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.354 -1.294 . . . . 0.24 113.451 -174.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.0 mptp? -56.57 -47.08 80.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.069 0.856 . . . . 3.63 109.58 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.538 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 85.1 t80 -60.44 -51.8 67.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.081 -0.963 . . . . 0.4 111.544 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.592 ' HA ' HG21 ' A' ' 56' ' ' VAL . 69.9 mt -54.57 -65.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.584 -1.189 . . . . 0.21 110.542 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.596 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.1 tt -51.79 -46.55 64.23 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.356 1.062 . . . . 1.44 109.511 -175.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.99 -30.56 70.35 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.55 -1.205 . . . . 0.63 111.502 -172.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -100.13 0.0 39.77 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 113.923 1.083 . . . . 1.25 113.923 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.476 -1.867 0 N-CA-C 113.768 1.025 . . . . 0.87 113.768 176.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.427 -1.576 0 N-CA-C 109.11 -0.7 . . . . 0.66 109.11 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' HG2' HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -50.66 -41.49 55.55 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.331 1.452 . . . . 0.74 114.518 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -52.51 -52.03 56.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.206 0.316 . . . . 2.66 110.581 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.03 -48.67 64.43 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 124.848 1.259 . . . . 2.73 111.184 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 73' ' ' THR . 81.4 mt -70.21 -64.13 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.275 -1.33 . . . . 0.23 110.255 -170.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.401 HG23 ' HG2' ' A' ' 4' ' ' GLN . 76.0 t -58.07 -40.42 76.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 N-CA-C 112.738 0.644 . . . . 0.27 112.738 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -62.12 -44.37 96.79 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.736 -0.468 . . . . 0.27 109.736 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -76.01 -38.24 35.97 Favored Glycine 0 N--CA 1.415 -2.742 0 CA-C-N 115.572 -0.74 . . . . 0.18 113.446 -175.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.614 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.49 -39.16 88.59 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.609 -0.885 . . . . 0.2 108.609 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.596 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.97 -47.49 84.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.207 -0.664 . . . . 0.14 109.207 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.646 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 44.6 mt-10 -54.89 -45.8 74.72 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 124.368 1.042 . . . . 0.68 111.806 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 11' ' ' LEU . 56.9 mt -59.55 -42.68 88.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.467 -0.788 . . . . 0.28 110.058 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 21' ' ' ILE . 48.4 t -71.86 -22.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.409 0.623 . . . . 0.27 109.931 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.646 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 7.0 m120 -66.19 -43.19 87.53 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.039 -0.726 . . . . 0.34 109.039 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -80.42 -49.3 11.63 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.518 -0.765 . . . . 2.07 111.259 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.699 HG13 HG22 ' A' ' 46' ' ' VAL . 16.8 mm -62.35 -53.56 45.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.822 -0.626 . . . . 0.65 111.374 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.409 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -104.55 -72.64 0.7 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.509 0.671 . . . . 0.54 109.857 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.31 34.65 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.563 0 CA-C-N 114.993 -1.003 . . . . 0.43 111.973 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.603 HG21 HG23 ' A' ' 26' ' ' VAL . 1.3 mp -72.96 150.43 90.33 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 109.557 -0.534 . . . . 0.31 109.557 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.7 Cg_exo -88.89 31.23 0.4 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.732 2.954 . . . . 1.08 114.758 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HA ' ' HB1' ' A' ' 12' ' ' ALA 0.25 5.6 p 58.4 -6.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 126.984 2.114 . . . . 0.81 116.393 175.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -114.85 -6.33 12.63 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.937 -1.102 . . . . 2.31 111.064 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -83.28 -30.88 27.25 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.4 1.095 . . . . 1.59 108.917 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.678 HG22 HD13 ' A' ' 36' ' ' LEU . 22.8 t -76.3 96.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 113.35 -1.75 . . . . 0.3 109.935 -176.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 69' ' ' VAL . 12.5 mptt -127.83 158.37 37.92 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.355 -1.35 . . . . 1.58 107.355 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.53 HD22 ' HA2' ' A' ' 70' ' ' GLY . 54.8 mt -52.83 144.83 13.64 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.9 -0.778 . . . . 1.05 108.9 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 78.67 10.55 1.76 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.938 1.295 . . . . 0.72 110.824 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.632 ' HD2' ' CG ' ' A' ' 35' ' ' ASP . 31.3 mmtp -96.91 122.63 40.1 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 108.617 -0.882 . . . . 1.48 108.617 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 30.3 m -76.29 36.18 0.15 Allowed 'General case' 0 C--N 1.252 -3.662 0 C-N-CA 125.279 1.432 . . . . 1.25 113.519 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.686 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 76.0 m-85 42.75 -94.12 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 125.673 1.589 . . . . 0.4 114.697 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.525 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 5.4 t -68.57 -24.66 64.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.081 0.467 . . . . 1.06 110.059 -174.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 11.0 t70 -81.32 -53.03 6.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.298 -0.864 . . . . 1.74 111.772 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.632 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t70 -84.22 -56.59 3.57 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 119.585 -0.846 . . . . 1.29 110.267 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.678 HD13 HG22 ' A' ' 26' ' ' VAL . 22.4 mt -65.91 -38.12 87.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.12 -1.4 . . . . 0.81 111.286 -170.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t70 88.22 70.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 124.919 1.387 . . . . 1.12 109.186 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.525 ' H ' ' HA ' ' A' ' 33' ' ' THR . 18.4 t -102.58 170.88 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.374 -2.194 . . . . 0.79 108.741 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 42' ' ' SER . 2.2 m-20 -78.01 -3.42 41.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.094 1.146 . . . . 2.0 114.094 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 43' ' ' MET . 29.0 t 65.87 -65.4 0.18 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.136 0.975 . . . . 0.78 113.053 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 42' ' ' SER . 0.7 OUTLIER -62.67 -36.41 82.77 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.305 0.574 . . . . 1.18 111.572 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.54 ' O ' HG23 ' A' ' 46' ' ' VAL . 12.6 m -78.23 -13.73 59.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.499 -0.773 . . . . 0.6 110.065 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.543 ' O ' HG23 ' A' ' 47' ' ' VAL . 12.2 tpp -73.69 -35.61 65.19 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 116.254 -0.43 . . . . 0.86 110.127 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.8 t -55.72 -37.72 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 109.487 -0.56 . . . . 0.31 109.487 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -61.89 -47.89 82.93 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.275 -0.639 . . . . 0.68 109.275 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.699 HG22 HG13 ' A' ' 18' ' ' ILE . 61.1 t -57.73 -28.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 CA-C-N 114.834 -1.075 . . . . 0.63 111.475 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.87 HG21 HG13 ' A' ' 63' ' ' VAL . 27.6 t -71.69 -52.68 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.377 0 N-CA-C 107.764 -1.199 . . . . 0.55 107.764 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.08 -38.63 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.23 -1.35 . . . . 0.42 108.55 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.74 -38.99 90.65 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.862 -0.608 . . . . 0.21 109.932 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.53 -58.37 8.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.731 -1.122 . . . . 0.21 109.779 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.481 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.26 0.0 OUTLIER -59.36 -39.76 84.26 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.233 1.197 . . . . 0.64 114.233 -176.384 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -59.92 -35.7 75.45 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.39 0.431 . . . . 2.07 111.846 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -86.42 -30.36 22.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.116 -0.493 . . . . 2.48 110.143 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.47 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 7.0 m-85 -100.03 1.47 42.47 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.208 0.447 . . . . 0.81 112.208 -173.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.7 t70 79.5 4.1 2.17 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 124.344 1.058 . . . . 1.99 112.98 174.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 76' ' ' ILE . 7.8 p -90.93 -179.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 O-C-N 121.256 -0.902 . . . . 0.37 108.703 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.508 ' H ' HG22 ' A' ' 56' ' ' VAL . 21.4 tptm -135.62 128.69 31.61 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.748 -1.575 . . . . 2.12 106.748 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.481 HG13 ' HB3' ' A' ' 51' ' ' GLU . 59.5 mt -122.07 110.47 32.89 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.128 -0.629 . . . . 0.25 111.109 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.571 ' O ' HG23 ' A' ' 63' ' ' VAL . 91.1 Cg_endo -74.94 164.94 32.41 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.125 2.55 . . . . 0.33 110.961 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 20.2 t70 -51.57 -44.12 62.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 1.98 112.101 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -58.78 -40.59 84.43 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.612 0.57 . . . . 2.06 111.301 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 24.7 m-20 -81.52 -31.11 32.94 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.777 -0.769 . . . . 0.52 112.005 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.87 HG13 HG21 ' A' ' 47' ' ' VAL . 82.7 t -53.83 -50.72 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.056 -1.09 . . . . 0.38 108.056 172.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 13.8 ptmm? -73.17 -2.7 22.67 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.372 0.878 . . . . 2.16 113.372 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -105.79 -16.81 14.57 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.993 -0.442 . . . . 1.59 111.76 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.762 HD13 ' HA ' ' A' ' 72' ' ' ALA . 44.2 mt -82.14 107.44 14.84 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 105.711 -1.959 . . . . 0.31 105.711 176.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -97.13 -39.29 9.37 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.181 -1.008 . . . . 2.55 109.744 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 27.7 p -114.97 179.64 3.89 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.46 0.648 . . . . 0.23 109.587 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.686 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -87.09 -13.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.797 -0.816 . . . . 1.21 108.797 175.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.53 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -68.12 -43.56 80.47 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 107.032 -2.427 . . . . 0.33 107.032 172.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -65.25 -56.06 14.87 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.888 -1.656 . . . . 1.39 110.895 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.762 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.9 -60.95 2.43 Favored 'General case' 0 CA--C 1.482 -1.665 0 O-C-N 124.304 1.002 . . . . 0.15 111.42 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.646 ' HA ' HG21 ' A' ' 7' ' ' ILE . 56.8 m -53.31 -54.59 34.26 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.589 -1.187 . . . . 0.24 113.303 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.9 mptm? -56.08 -37.5 69.42 Favored 'General case' 0 C--O 1.198 -1.658 0 C-N-CA 124.158 0.983 . . . . 3.63 110.78 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' HE2' HG12 ' A' ' 58' ' ' ILE . 90.7 t80 -66.93 -47.59 71.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.535 0.683 . . . . 0.4 109.377 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.656 ' HA ' HG21 ' A' ' 56' ' ' VAL . 72.7 mt -59.09 -65.87 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-N 114.2 -1.364 . . . . 0.21 109.441 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.626 HD23 HG22 ' A' ' 73' ' ' THR . 4.4 pp -53.41 -38.41 63.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 113.475 0.917 . . . . 1.44 113.475 -176.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.512 ' N ' HD12 ' A' ' 77' ' ' LEU . 7.7 t70 -72.03 -25.75 61.93 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.92 -1.036 . . . . 0.63 110.777 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -102.56 -6.03 23.28 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.649 -0.705 . . . . 1.25 112.083 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 85.0 mt-30 . . . . . 0 CA--C 1.455 -2.676 0 CA-C-O 122.866 1.317 . . . . 0.87 107.933 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 7' ' ' ILE . 11.3 t . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.047 -1.464 . . . . 0.66 107.047 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -45.86 -40.27 9.69 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.749 1.018 . . . . 0.74 113.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.49 -28.19 69.12 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.489 0.493 . . . . 2.66 111.949 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -88.83 -35.91 16.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.368 -0.605 . . . . 2.73 109.368 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.694 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 93.9 mt -72.53 -66.37 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.059 0 CA-C-N 116.126 -0.488 . . . . 0.23 111.846 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.05 -40.39 76.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 122.081 0.153 . . . . 0.27 111.169 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.39 81.46 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.01 -0.541 . . . . 0.27 111.25 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.48 -39.42 8.99 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 116.232 -0.44 . . . . 0.18 112.399 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.709 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.79 -37.4 87.47 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.577 -0.897 . . . . 0.2 108.577 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.865 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.21 -47.13 75.73 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.748 -0.66 . . . . 0.14 109.847 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.688 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 41.1 mt-10 -60.94 -41.47 96.31 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 124.135 0.897 . . . . 0.68 111.658 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 11' ' ' LEU . 71.2 mt -60.74 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.277 -0.874 . . . . 0.28 109.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.834 HG12 ' HB ' ' A' ' 21' ' ' ILE . 73.9 t -67.99 -23.76 29.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 123.872 0.869 . . . . 0.27 111.038 -176.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.688 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 8.0 m120 -71.62 -45.16 62.9 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.107 -0.952 . . . . 0.34 109.142 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -83.77 -36.73 23.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.286 -0.87 . . . . 2.07 112.945 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.626 HG13 HG22 ' A' ' 46' ' ' VAL . 28.1 mm -70.2 -53.19 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.044 -0.724 . . . . 0.65 109.044 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -103.16 -88.9 0.4 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.836 -0.62 . . . . 0.54 109.556 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.03 39.53 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 120.338 -0.934 . . . . 0.43 112.88 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.834 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -75.12 151.83 86.11 Favored Pre-proline 0 C--O 1.205 -1.257 0 N-CA-C 109.618 -0.512 . . . . 0.31 109.618 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.2 Cg_exo -87.36 31.88 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.53 2.82 . . . . 1.08 114.771 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' H ' HG22 ' A' ' 21' ' ' ILE 0.287 9.8 p 60.45 -22.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 C-N-CA 127.057 2.143 . . . . 0.81 116.416 175.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -93.12 -15.16 26.34 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.281 0.562 . . . . 2.31 111.021 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.28 -26.63 30.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.385 -0.825 . . . . 1.59 111.454 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.865 HG21 ' HA ' ' A' ' 12' ' ' ALA . 43.1 t -71.84 98.41 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.133 -0.939 . . . . 0.3 108.811 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -130.12 161.92 29.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.845 -1.539 . . . . 1.58 106.845 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.508 ' HA ' HG22 ' A' ' 69' ' ' VAL . 91.1 mt -61.73 145.4 52.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.164 -0.68 . . . . 1.05 109.164 177.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 74.49 9.72 4.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.503 1.121 . . . . 0.72 110.586 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.44 127.26 50.85 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 109.512 -0.551 . . . . 1.48 109.512 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.668 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 7.1 m -84.63 108.68 17.5 Favored 'General case' 1 C--N 1.239 -4.203 0 CA-C-N 114.736 -1.12 . . . . 1.25 108.34 178.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.699 ' HB2' ' SD ' ' A' ' 43' ' ' MET . 34.4 m-85 -46.51 -54.28 9.61 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 124.534 1.133 . . . . 0.4 110.207 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 12.1 t -77.61 19.82 0.35 Allowed 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 125.681 1.592 . . . . 1.06 113.771 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 15.2 t70 -158.76 -62.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.276 -0.89 . . . . 1.74 110.886 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -69.31 -40.13 77.85 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.634 -1.166 . . . . 1.29 109.849 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 32' ' ' PHE . 19.0 mt -80.78 -91.23 0.06 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 114.915 -1.039 . . . . 0.81 110.907 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 31.0 t70 168.01 20.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 121.966 0.889 . . . . 1.12 109.685 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.601 HG13 ' HB2' ' A' ' 19' ' ' ALA . 13.5 t -87.67 144.98 8.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.364 -0.835 . . . . 0.79 108.986 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.11 124.28 29.71 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.694 -0.684 . . . . 2.0 109.81 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.546 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 11.3 t -36.27 -46.05 0.5 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.412 1.485 . . . . 0.78 114.421 172.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.95 -30.8 70.18 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.31 -0.556 . . . . 1.18 111.689 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 m -83.76 -18.27 38.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.388 0.613 . . . . 0.6 109.782 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.699 ' SD ' ' HB2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -57.4 -38.27 74.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.229 1.012 . . . . 0.86 112.134 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.1 t -51.46 -51.14 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.109 0.881 . . . . 0.31 109.723 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -53.89 -48.73 69.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.68 109.949 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.626 HG22 HG13 ' A' ' 18' ' ' ILE . 46.2 t -58.71 -31.6 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.839 1.256 . . . . 0.63 111.481 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.718 HG21 HG13 ' A' ' 63' ' ' VAL . 34.2 t -76.96 -47.24 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 N-CA-C 108.491 -0.929 . . . . 0.55 108.491 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.97 -36.3 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 114.787 -1.097 . . . . 0.42 108.462 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.32 -36.16 82.23 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.844 -0.616 . . . . 0.21 109.935 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -56.53 19.13 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.797 -1.092 . . . . 0.21 110.015 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.645 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -63.19 -33.11 74.77 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.724 -0.79 . . . . 0.64 113.069 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.98 -40.45 95.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.078 0.399 . . . . 2.07 112.078 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -84.56 -38.07 20.42 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.494 -0.482 . . . . 2.48 111.933 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.694 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.0 m-85 -97.41 20.12 12.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.053 0.76 . . . . 0.81 113.053 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.9 t70 69.5 -2.07 2.03 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 114.675 1.361 . . . . 1.99 114.675 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.53 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 8.5 p -89.51 178.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 O-C-N 120.476 -1.39 . . . . 0.37 108.907 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.472 ' H ' HG22 ' A' ' 56' ' ' VAL . 19.4 ttpt -131.96 131.51 42.68 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 106.022 -1.844 . . . . 2.12 106.022 170.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.645 HG13 ' HB3' ' A' ' 51' ' ' GLU . 65.3 mt -120.62 114.99 32.55 Favored Pre-proline 0 C--N 1.293 -1.854 0 C-N-CA 120.532 -0.467 . . . . 0.25 110.205 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.558 ' O ' HG23 ' A' ' 63' ' ' VAL . 28.9 Cg_endo -62.4 155.2 59.02 Favored 'Trans proline' 0 CA--C 1.509 -0.774 0 C-N-CA 123.124 2.549 . . . . 0.33 110.883 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -54.8 -28.82 52.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.499 0.499 . . . . 1.98 111.895 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.682 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 29.8 t70 -73.88 -39.51 63.86 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 120.384 -0.526 . . . . 2.06 111.317 176.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 11.5 m-20 -77.37 -24.4 50.63 Favored 'General case' 0 CA--C 1.482 -1.663 0 C-N-CA 119.231 -0.987 . . . . 0.52 112.644 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 47' ' ' VAL . 68.8 t -51.85 -49.85 35.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 107.958 -1.126 . . . . 0.38 107.958 171.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.682 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 5.1 ptmm? -77.76 -2.01 34.18 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.431 0.9 . . . . 2.16 113.431 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 91.7 m-20 -98.08 -16.97 19.35 Favored 'General case' 0 CA--C 1.485 -1.539 0 O-C-N 121.72 -0.612 . . . . 1.59 110.368 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.0 mt -87.32 128.72 35.18 Favored 'General case' 0 N--CA 1.391 -3.407 0 N-CA-C 103.788 -2.671 . . . . 0.31 103.788 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -119.85 -42.02 2.64 Favored 'General case' 0 C--N 1.268 -2.956 0 N-CA-C 108.149 -1.056 . . . . 2.55 108.149 174.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 61.6 p -102.7 174.97 5.65 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 0.23 108.894 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.508 HG22 ' HA ' ' A' ' 28' ' ' LEU . 1.5 m -81.64 -13.51 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 107.798 -1.186 . . . . 1.21 107.798 174.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.426 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -74.23 -27.16 66.62 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.193 -1.003 . . . . 0.33 110.661 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.498 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 5.9 t70 -83.64 -48.34 10.29 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.525 -0.917 . . . . 1.39 108.525 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.7 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.33 -59.98 3.62 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-N 114.028 -1.442 . . . . 0.15 111.833 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.5 ' HA ' HG21 ' A' ' 7' ' ' ILE . 60.0 m -56.91 -61.6 2.33 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.081 -0.963 . . . . 0.24 111.507 -173.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.3 OUTLIER -41.16 -46.75 3.13 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.86 2.064 . . . . 3.63 111.438 171.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -63.22 -47.09 83.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.292 0.568 . . . . 0.4 110.336 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.632 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 64.0 mt -60.77 -66.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.32 -1.309 . . . . 0.21 109.259 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.5 HD23 HG22 ' A' ' 73' ' ' THR . 4.5 pp -58.58 -36.66 74.32 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.369 1.248 . . . . 1.44 114.369 -174.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.473 ' N ' HD12 ' A' ' 77' ' ' LEU . 12.6 t70 -75.28 -22.63 57.62 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.952 -0.567 . . . . 0.63 111.666 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.38 -24.6 18.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.896 0.702 . . . . 1.25 112.896 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.632 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.36 0.0 OUTLIER . . . . . 0 CA--C 1.48 -1.735 0 N-CA-C 116.101 1.889 . . . . 0.87 116.101 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.685 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 15.2 t . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 109.907 -0.405 . . . . 0.66 109.907 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -52.84 -41.87 64.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.85 1.26 . . . . 0.74 113.09 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.93 -32.49 33.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.003 0.521 . . . . 2.66 112.299 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.21 -36.25 27.44 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.969 -0.56 . . . . 2.73 110.336 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.471 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 74.9 mt -77.56 -66.49 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.218 0 CA-C-N 115.645 -0.707 . . . . 0.23 111.723 -171.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.2 t -55.91 -42.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 112.178 0.436 . . . . 0.27 112.178 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.96 89.49 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 123.713 0.633 . . . . 0.27 110.446 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.99 -39.0 13.78 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.895 -0.593 . . . . 0.18 113.08 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.714 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.21 -35.48 80.54 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.863 -1.162 . . . . 0.2 107.863 -177.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -57.02 -51.17 70.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.458 -0.571 . . . . 0.14 109.458 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.578 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 40.4 mt-10 -56.02 -44.32 78.61 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.417 1.073 . . . . 0.68 111.29 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 11' ' ' LEU . 72.2 mt -56.96 -45.4 83.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.263 -0.881 . . . . 0.28 110.37 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 11' ' ' LEU . 58.5 t -66.78 -23.98 31.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.848 0.832 . . . . 0.27 110.138 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.578 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 2.6 m120 -75.48 -53.11 9.19 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.321 -0.992 . . . . 0.34 108.321 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 7.3 mm-40 -67.23 -39.98 86.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.964 -1.016 . . . . 2.07 111.374 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.6 mm -74.98 -53.73 15.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.667 -0.494 . . . . 0.65 109.667 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -100.55 -86.76 0.39 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.979 -0.555 . . . . 0.54 111.566 -173.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.98 50.25 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.684 0 CA-C-N 115.817 -0.629 . . . . 0.43 112.302 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.802 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -93.74 152.89 41.07 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 110.107 -0.331 . . . . 0.31 110.107 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 3.0 Cg_exo -84.87 30.88 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.671 2.914 . . . . 1.08 114.453 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 21' ' ' ILE . 5.8 p 54.84 2.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 115.81 1.782 . . . . 0.81 115.81 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 22' ' ' PRO . 10.0 pt-20 -127.6 0.5 6.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.063 -1.023 . . . . 2.31 111.374 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 22.6 t0 -89.33 -24.06 22.1 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.589 -1.187 . . . . 1.59 109.072 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.802 HG23 HG21 ' A' ' 21' ' ' ILE . 42.1 t -81.07 93.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.107 -1.406 . . . . 0.3 109.527 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -121.55 166.12 14.66 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.504 -0.924 . . . . 1.58 108.504 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.447 HD22 ' HA2' ' A' ' 70' ' ' GLY . 67.6 mt -67.31 143.26 56.51 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.138 -1.43 . . . . 1.05 107.138 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 33.1 t70 85.64 1.43 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 124.343 1.057 . . . . 0.72 110.565 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 69' ' ' VAL . 45.4 mmtm -95.42 120.29 35.41 Favored 'General case' 0 CA--C 1.474 -1.972 0 O-C-N 121.502 -0.749 . . . . 1.48 109.879 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 10.4 t -83.02 35.22 0.47 Allowed 'General case' 1 C--N 1.24 -4.174 0 C-N-CA 126.483 1.913 . . . . 1.25 112.388 -171.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CZ ' HG22 ' A' ' 69' ' ' VAL . 96.6 m-85 41.64 -90.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.363 1.865 . . . . 0.4 115.293 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.412 ' HB ' ' SD ' ' A' ' 43' ' ' MET . 12.4 t -62.73 -27.69 69.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.281 0.633 . . . . 1.06 111.398 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 11.3 t70 -87.16 -56.35 3.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.524 -0.307 . . . . 1.74 110.564 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.08 -38.29 27.56 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 113.466 0.913 . . . . 1.29 113.466 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 25.3 mt -82.62 -76.24 0.28 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.482 -0.487 . . . . 0.81 112.117 -171.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 170.9 -20.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 122.961 0.504 . . . . 1.12 110.349 -174.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 19' ' ' ALA . 10.6 t -47.84 139.96 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.362 1.065 . . . . 0.79 111.978 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -81.27 126.17 31.22 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.895 -1.15 . . . . 2.0 107.895 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 43' ' ' MET . 15.4 t -42.53 -35.63 1.12 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 114.452 1.279 . . . . 0.78 114.452 173.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 42' ' ' SER . 3.6 pp -73.18 -33.28 65.34 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 119.067 -1.053 . . . . 1.18 111.976 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 46' ' ' VAL . 19.8 m -84.66 -13.36 51.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.965 0.888 . . . . 0.6 109.674 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.709 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 3.6 tpt -61.9 -38.42 88.3 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 125.707 1.603 . . . . 0.86 110.568 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.65 -27.16 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.023 -0.535 . . . . 0.31 110.553 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.6 -45.59 68.21 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.384 -0.969 . . . . 0.68 108.384 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 42' ' ' SER . 41.8 t -58.07 -25.69 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.486 -1.233 . . . . 0.63 110.819 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.742 HG11 HG22 ' A' ' 63' ' ' VAL . 29.6 t -81.03 -54.3 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 N-CA-C 108.968 -0.753 . . . . 0.55 108.968 -176.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.14 -33.38 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.214 -0.903 . . . . 0.42 109.33 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.62 70.89 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.268 0.556 . . . . 0.21 109.991 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.49 -56.17 20.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.18 -0.918 . . . . 0.21 109.717 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -67.87 -31.11 70.69 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.127 1.158 . . . . 0.64 114.127 -176.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -60.53 -34.45 74.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.824 0.345 . . . . 2.07 110.306 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -86.83 -46.0 10.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.324 -0.398 . . . . 2.48 111.993 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 8.5 m-85 -84.67 -2.27 57.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.997 1.11 . . . . 0.81 113.997 -169.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.3 t70 80.76 -0.07 1.84 Allowed 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 124.401 1.08 . . . . 1.99 112.406 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 76' ' ' ILE . 12.9 p -81.56 176.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.41 -1.33 . . . . 0.37 107.41 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 33.7 tptt -134.02 123.94 25.4 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.836 -1.172 . . . . 2.12 107.836 173.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.555 HG12 ' HE2' ' A' ' 75' ' ' TYR . 41.3 mt -120.13 102.76 45.85 Favored Pre-proline 0 C--N 1.312 -1.026 0 C-N-CA 120.92 -0.312 . . . . 0.25 110.34 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.577 ' O ' HG23 ' A' ' 63' ' ' VAL . 64.4 Cg_endo -70.08 158.69 55.74 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 123.056 2.504 . . . . 0.33 110.44 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 9.8 t70 -46.24 -42.49 14.4 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.049 0.94 . . . . 1.98 110.525 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -53.85 -44.69 70.55 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 125.155 1.382 . . . . 2.06 112.716 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -86.68 -29.95 22.08 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.522 -0.471 . . . . 0.52 111.617 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.742 HG22 HG11 ' A' ' 47' ' ' VAL . 79.5 t -50.94 -51.42 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.886 -0.783 . . . . 0.38 108.886 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 21.3 ptmt -69.65 -4.18 18.33 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 114.152 1.167 . . . . 2.16 114.152 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.83 -23.8 14.87 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.696 0.76 . . . . 1.59 109.112 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.91 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.0 mt -82.46 133.83 35.21 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 105.965 -1.865 . . . . 0.31 105.965 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -126.11 -38.1 2.19 Favored 'General case' 0 C--N 1.259 -3.335 0 C-N-CA 119.919 -0.712 . . . . 2.55 109.995 174.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 26.9 p -107.46 -179.32 3.88 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 119.568 -0.853 . . . . 0.23 110.385 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.602 HG22 ' CZ ' ' A' ' 32' ' ' PHE . 13.0 t -83.12 -19.53 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 106.793 -1.558 . . . . 1.21 106.793 177.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.532 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -68.5 -47.2 58.55 Favored Glycine 0 CA--C 1.489 -1.545 0 N-CA-C 107.791 -2.124 . . . . 0.33 107.791 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.19 -55.85 29.63 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.638 -1.281 . . . . 1.39 110.471 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.91 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -53.69 -60.92 2.7 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.562 1.164 . . . . 0.15 111.732 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.459 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.2 m -58.77 -41.97 87.83 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 113.663 0.986 . . . . 0.24 113.663 -174.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 1.9 mptm? -61.28 -48.52 81.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 108.678 -0.86 . . . . 3.63 108.678 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.555 ' HE2' HG12 ' A' ' 58' ' ' ILE . 86.8 t80 -57.81 -51.53 69.21 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 124.536 1.148 . . . . 0.4 110.74 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 56' ' ' VAL . 72.5 mt -54.94 -66.75 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.718 0 CA-C-N 114.545 -1.207 . . . . 0.21 111.019 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.8 tt -52.17 -45.36 65.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.574 1.55 . . . . 1.44 109.359 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -71.15 -24.74 62.32 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.165 -1.38 . . . . 0.63 111.501 -172.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -103.7 -9.0 19.47 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 113.759 1.022 . . . . 1.25 113.759 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 92.3 mt-30 . . . . . 0 CA--C 1.449 -2.925 0 CA-C-O 122.909 1.338 . . . . 0.87 108.841 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.466 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.8 t . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 109.556 -0.535 . . . . 0.66 109.556 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.647 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -54.54 -35.84 63.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.41 1.484 . . . . 0.74 111.67 179.014 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -52.79 -47.99 67.17 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 124.12 0.887 . . . . 2.66 110.395 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.52 -30.73 64.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.804 -0.634 . . . . 2.73 110.347 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.619 HG23 ' CE2' ' A' ' 54' ' ' PHE . 97.9 mt -76.61 -66.56 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 CA-C-N 116.086 -0.506 . . . . 0.23 111.307 -172.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 28' ' ' LEU . 91.1 t -58.36 -36.07 56.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.714 0.635 . . . . 0.27 112.714 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -66.03 -37.55 86.17 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.549 -0.46 . . . . 0.27 111.0 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.18 -36.95 11.76 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 111.842 -0.503 . . . . 0.18 111.842 -176.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.746 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.82 -40.68 95.59 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.611 -0.885 . . . . 0.2 108.611 -178.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.764 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.21 -47.57 78.13 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.556 -0.747 . . . . 0.14 109.691 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.521 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.1 mt-10 -60.74 -39.68 89.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 123.99 0.806 . . . . 0.68 112.548 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.746 HD12 ' HA ' ' A' ' 11' ' ' LEU . 63.4 mt -59.97 -44.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.688 0.756 . . . . 0.28 109.0 176.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.707 HG12 ' HB ' ' A' ' 21' ' ' ILE . 64.7 t -67.78 -25.87 33.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.019 -0.991 . . . . 0.27 110.788 -175.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.521 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 5.6 m120 -70.5 -38.6 74.35 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.396 -0.82 . . . . 0.34 109.311 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.23 -43.62 15.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.6 -0.727 . . . . 2.07 111.58 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.695 HG13 HG22 ' A' ' 46' ' ' VAL . 17.3 mm -62.12 -52.71 57.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.988 0.515 . . . . 0.65 110.885 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -109.84 -85.56 0.54 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.435 -0.506 . . . . 0.54 110.858 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.84 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 110.931 -0.868 . . . . 0.43 110.931 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.707 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.6 mp -87.2 149.82 48.09 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 109.405 -0.591 . . . . 0.31 109.405 178.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 5.0 Cg_exo -88.25 37.87 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.757 2.971 . . . . 1.08 113.723 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.425 ' HA ' HD21 ' A' ' 16' ' ' ASN 0.259 3.7 p 57.74 -14.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 117.006 2.225 . . . . 0.81 117.006 176.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.09 2.9 12.71 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 120.641 -1.287 . . . . 2.31 110.708 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.596 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 7.3 t70 -78.78 -31.72 46.19 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.119 -1.067 . . . . 1.59 108.119 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.764 HG21 ' HA ' ' A' ' 12' ' ' ALA . 24.8 t -74.46 92.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 113.129 -1.851 . . . . 0.3 110.498 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 69' ' ' VAL . 95.6 mttt -118.03 163.37 16.7 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.043 0.449 . . . . 1.58 110.152 177.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 8' ' ' VAL . 5.6 mp -70.98 136.24 48.32 Favored 'General case' 0 N--CA 1.406 -2.675 0 N-CA-C 108.822 -0.807 . . . . 1.05 108.822 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' H ' ' N ' ' A' ' 70' ' ' GLY . 22.4 t70 84.62 9.89 0.4 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.297 1.439 . . . . 0.72 109.701 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -102.08 128.4 48.56 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 115.648 -0.705 . . . . 1.48 109.22 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.4 m -79.92 114.12 18.6 Favored 'General case' 0 C--N 1.244 -3.987 0 CA-C-N 114.779 -1.101 . . . . 1.25 108.491 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.595 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 94.1 m-85 -45.41 -64.53 0.7 Allowed 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 124.253 1.021 . . . . 0.4 112.057 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.1 t -59.01 -46.02 89.24 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 113.131 0.789 . . . . 1.06 113.131 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -86.55 -55.91 3.66 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.57 0.581 . . . . 1.74 112.57 -172.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.62 -49.14 15.19 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.659 0.783 . . . . 1.29 111.628 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.73 HD13 HG22 ' A' ' 26' ' ' VAL . 14.0 mt -77.32 -51.41 10.92 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.754 -0.657 . . . . 0.81 111.539 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 101.99 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.219 2.208 . . . . 1.12 111.275 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' THR . 22.0 t -110.09 118.84 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.607 -1.627 . . . . 0.79 106.607 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.15 113.52 0.82 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.228 0.955 . . . . 2.0 109.741 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 43' ' ' MET . 39.3 p -49.7 -21.45 1.06 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.279 1.431 . . . . 0.78 114.359 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 42' ' ' SER . 3.3 pp -81.84 -36.89 27.79 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.887 0.699 . . . . 1.18 112.887 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.447 ' N ' HD12 ' A' ' 41' ' ' LEU . 3.3 m -81.71 -13.39 57.89 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.461 1.124 . . . . 0.6 108.546 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.574 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 3.7 tpt -55.49 -36.72 66.96 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 126.804 2.042 . . . . 0.86 111.061 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.74 -45.91 96.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 115.809 -0.632 . . . . 0.31 109.776 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -57.39 -41.37 80.12 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 115.906 -0.588 . . . . 0.68 109.903 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.695 HG22 HG13 ' A' ' 18' ' ' ILE . 40.1 t -59.53 -28.8 40.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-N 115.496 -0.774 . . . . 0.63 111.16 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.778 HG21 HG13 ' A' ' 63' ' ' VAL . 20.8 t -78.98 -54.94 10.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.151 -1.055 . . . . 0.55 108.151 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.4 -19.65 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.85 -1.523 . . . . 0.42 110.904 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.84 -38.91 16.36 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 121.226 0.536 . . . . 0.21 109.633 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -61.17 -64.19 1.04 Allowed 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.99 -1.005 . . . . 0.21 111.567 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.341 0.0 OUTLIER -59.43 -44.12 92.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 114.882 1.438 . . . . 0.64 114.882 -173.822 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -54.12 -39.2 66.22 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.206 1.003 . . . . 2.07 112.244 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.914 -0.585 . . . . 2.48 110.781 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CE2' HG23 ' A' ' 7' ' ' ILE . 8.2 m-85 -86.66 -44.89 11.49 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.467 -0.893 . . . . 0.81 111.839 -173.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 22.9 t70 155.14 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.751 1.282 . . . . 1.99 112.682 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.7 HG11 ' HA ' ' A' ' 76' ' ' ILE . 3.8 p -79.96 178.37 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 112.072 0.397 . . . . 0.37 112.072 -168.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.555 ' H ' HG22 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -133.31 125.56 29.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.355 -1.35 . . . . 2.12 107.355 174.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.596 HG12 ' HE2' ' A' ' 75' ' ' TYR . 64.8 mt -113.36 118.9 43.05 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.348 -0.387 . . . . 0.25 110.683 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.552 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.6 Cg_endo -66.78 154.18 75.39 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.482 2.788 . . . . 0.33 110.588 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -51.66 -37.42 50.41 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.591 0.557 . . . . 1.98 111.673 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -59.56 -44.43 93.26 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.202 -0.454 . . . . 2.06 110.682 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.468 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 21.7 m-20 -82.68 -28.89 30.3 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 112.662 0.615 . . . . 0.52 112.662 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.778 HG13 HG21 ' A' ' 47' ' ' VAL . 53.0 t -52.01 -53.45 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 108.183 -1.043 . . . . 0.38 108.183 174.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -74.98 -1.91 24.77 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.975 -1.011 . . . . 2.16 113.549 -177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.92 -33.56 14.84 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.576 -0.898 . . . . 1.59 108.576 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.893 HD13 ' HA ' ' A' ' 72' ' ' ALA . 32.5 mt -69.25 133.34 47.8 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 106.267 -1.753 . . . . 0.31 106.267 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.579 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -128.39 -32.29 2.22 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-O 121.252 0.548 . . . . 2.55 110.126 175.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.628 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 28.5 p -112.07 172.81 6.69 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.683 -0.858 . . . . 0.23 108.683 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -80.4 -12.93 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.782 0.801 . . . . 1.21 109.478 175.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -69.74 -37.92 76.6 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.368 -1.493 . . . . 0.33 109.368 176.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.579 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 24.3 m-20 -69.44 -54.33 14.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 108.772 -0.825 . . . . 1.39 108.772 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.893 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.19 -60.67 2.86 Favored 'General case' 0 CA--C 1.469 -2.168 0 O-C-N 124.676 1.235 . . . . 0.15 111.043 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.647 HG21 ' HG2' ' A' ' 4' ' ' GLN . 35.9 m -54.97 -49.28 71.83 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.459 1.099 . . . . 0.24 113.585 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.7 mptm? -67.17 -28.64 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.222 0.534 . . . . 3.63 111.051 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.596 ' HE2' HG12 ' A' ' 58' ' ' ILE . 84.9 t80 -71.52 -51.9 21.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.966 -0.753 . . . . 0.4 108.966 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.7 ' HA ' HG11 ' A' ' 56' ' ' VAL . 60.3 mt -57.41 -66.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.521 -1.218 . . . . 0.21 111.134 -177.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.466 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 4.5 tt -50.19 -50.34 49.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.211 1.404 . . . . 1.44 110.972 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.9 t70 -69.5 -25.72 64.19 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.995 -1.457 . . . . 0.63 111.417 -170.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -91.26 -22.67 20.46 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.674 -0.694 . . . . 1.25 111.682 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 76' ' ' ILE . 2.4 pt20 . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 122.482 1.134 . . . . 0.87 113.385 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.435 -1.18 0 N-CA-C 108.996 -0.742 . . . . 0.66 108.996 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -40.19 60.56 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.593 1.157 . . . . 0.74 113.202 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.54 -23.73 64.83 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.865 0.691 . . . . 2.66 112.865 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.52 -39.9 21.76 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.018 -0.734 . . . . 2.73 109.018 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.446 HG21 ' HA ' ' A' ' 73' ' ' THR . 76.3 mt -76.66 -66.48 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 CA-C-N 114.719 -1.128 . . . . 0.23 111.692 -170.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -56.72 -42.41 77.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.376 0.51 . . . . 0.27 112.376 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.82 72.84 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.589 0.556 . . . . 0.27 111.362 176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.91 -40.09 8.3 Favored Glycine 0 N--CA 1.405 -3.418 0 C-N-CA 120.596 -0.811 . . . . 0.18 113.059 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -63.12 -41.04 99.25 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.613 0.765 . . . . 0.2 109.079 -177.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.09 -48.17 67.99 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 123.747 0.654 . . . . 0.14 109.588 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.664 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 48.3 mt-10 -62.36 -42.34 99.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 124.266 0.979 . . . . 0.68 112.05 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 11' ' ' LEU . 54.7 mt -59.49 -39.43 79.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.332 0.587 . . . . 0.28 110.179 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 11' ' ' LEU . 46.4 t -69.48 -23.52 26.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 CA-C-O 122.082 0.944 . . . . 0.27 109.722 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -77.98 -37.78 46.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.25 -1.018 . . . . 0.34 108.25 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 20.7 mm-40 -74.23 -55.52 5.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.853 -1.067 . . . . 2.07 111.296 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 46' ' ' VAL . 21.3 mm -63.87 -53.1 48.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.448 -0.796 . . . . 0.65 110.811 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -103.12 -83.1 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.438 -0.505 . . . . 0.54 110.436 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.03 44.93 0.02 OUTLIER Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 120.061 -1.066 . . . . 0.43 112.199 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -78.05 149.79 77.03 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 110.05 -0.352 . . . . 0.31 110.05 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.522 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 8.9 Cg_exo -82.86 24.54 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 124.526 3.484 . . . . 1.08 115.429 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.505 ' H ' HG22 ' A' ' 21' ' ' ILE . 6.9 p 52.55 22.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 125.55 1.54 . . . . 0.81 114.909 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -130.16 -13.14 4.02 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 120.909 -1.119 . . . . 2.31 111.399 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.522 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -93.38 -26.25 17.34 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 115.324 -0.853 . . . . 1.59 110.251 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.601 HG23 HG21 ' A' ' 21' ' ' ILE . 39.5 t -71.24 91.23 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.201 -0.908 . . . . 0.3 109.357 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 34.4 mmtp -130.74 169.98 14.96 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.294 -1.373 . . . . 1.58 107.294 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 8.3 mp -64.74 148.38 51.25 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.819 -0.808 . . . . 1.05 108.819 177.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 t70 81.76 -3.52 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.766 1.226 . . . . 0.72 110.766 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.775 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 10.4 mmpt? -98.13 124.05 42.48 Favored 'General case' 0 CA--C 1.454 -2.744 0 C-N-CA 119.713 -0.795 . . . . 1.48 110.856 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 19.2 m -79.78 115.5 19.41 Favored 'General case' 1 C--N 1.237 -4.316 0 N-CA-C 108.02 -1.104 . . . . 1.25 108.02 178.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' LEU . 83.3 m-85 -51.78 -49.35 62.84 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.566 0.698 . . . . 0.4 112.228 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.523 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.0 t -81.36 -44.46 17.56 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.291 -0.88 . . . . 1.06 111.305 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 25.0 t70 -74.15 -50.92 17.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.032 0.753 . . . . 1.74 113.032 -175.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.442 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 12.7 t70 -83.78 -58.03 2.97 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 122.049 0.928 . . . . 1.29 109.393 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.758 HD12 ' HA ' ' A' ' 32' ' ' PHE . 25.4 mt -72.88 -32.65 65.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.48 -1.691 . . . . 0.81 112.363 -169.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 20.1 t70 83.1 66.48 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 123.193 1.473 . . . . 1.12 110.803 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 19' ' ' ALA . 49.4 t -105.62 141.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 112.767 -2.015 . . . . 0.79 107.94 170.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.456 ' HB2' ' OG ' ' A' ' 42' ' ' SER . 4.8 m-20 -56.08 7.93 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 116.618 2.081 . . . . 2.0 116.618 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.517 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.5 t 66.6 -57.44 0.39 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 114.383 1.253 . . . . 0.78 114.383 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 pp -63.31 -30.72 71.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.949 0.88 . . . . 1.18 109.749 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.56 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.5 m -77.94 -15.55 58.89 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.751 -1.113 . . . . 0.6 110.506 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.615 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -67.08 -40.62 87.04 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-N 116.306 -0.407 . . . . 0.86 111.967 -174.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.19 -40.84 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 124.246 0.966 . . . . 0.31 109.767 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.88 -48.02 83.72 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.578 -0.737 . . . . 0.68 109.526 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.63 HG22 HG13 ' A' ' 18' ' ' ILE . 11.9 t -60.78 -23.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.988 0.915 . . . . 0.63 110.918 -177.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.904 HG21 HG13 ' A' ' 63' ' ' VAL . 36.8 t -78.99 -54.74 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 107.885 -1.154 . . . . 0.55 107.885 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -60.65 -37.06 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.882 -1.054 . . . . 0.42 108.89 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -70.01 -31.51 69.21 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 116.167 -0.47 . . . . 0.21 110.061 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.67 -58.16 6.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.363 -0.835 . . . . 0.21 109.266 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.631 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.269 0.0 OUTLIER -66.42 -31.83 72.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 114.914 1.45 . . . . 0.64 114.914 -175.59 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -59.24 -33.32 70.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.908 0.861 . . . . 2.07 109.881 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -88.59 -32.33 18.17 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.11 -0.95 . . . . 2.48 111.968 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.23 18.42 21.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.397 0.518 . . . . 0.81 112.397 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 75.37 -26.02 0.2 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 114.438 1.273 . . . . 1.99 114.438 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.631 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 7.2 p -72.26 170.81 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 122.324 -0.235 . . . . 0.37 110.379 -173.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.625 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 2.8 tppp? -124.13 126.67 46.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.31 -0.996 . . . . 2.12 108.31 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.64 HG12 ' HE2' ' A' ' 75' ' ' TYR . 36.0 mt -119.99 105.02 43.26 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 120.592 -0.443 . . . . 0.25 110.457 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 63' ' ' VAL . 79.9 Cg_endo -73.8 166.6 29.31 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.106 2.537 . . . . 0.33 111.004 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.33 -46.97 37.16 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 1.98 111.487 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.16 -35.44 77.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.876 -0.602 . . . . 2.06 112.02 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.566 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 10.9 m-20 -86.03 -31.63 21.9 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.275 -0.57 . . . . 0.52 111.222 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.904 HG13 HG21 ' A' ' 47' ' ' VAL . 75.1 t -52.84 -50.52 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.843 -0.799 . . . . 0.38 108.843 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -72.41 -9.15 58.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.199 -0.909 . . . . 2.16 113.195 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.42 -25.91 21.28 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.478 0.656 . . . . 1.59 110.071 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.802 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.7 mt -82.18 110.92 17.82 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.077 -1.823 . . . . 0.31 106.077 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 47.5 mtpt -112.25 -43.88 3.48 Favored 'General case' 0 C--N 1.271 -2.834 0 N-CA-C 107.718 -1.216 . . . . 2.55 107.718 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 67.4 p -102.54 174.73 5.77 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 114.917 -1.038 . . . . 0.23 109.039 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.491 HG22 ' CE2' ' A' ' 32' ' ' PHE . 10.1 t -77.3 -14.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 107.781 -1.192 . . . . 1.21 107.781 175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.478 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -69.01 -51.09 30.41 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 109.39 -1.484 . . . . 0.33 109.39 175.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -60.38 -51.24 70.32 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 114.269 -0.966 . . . . 1.39 109.371 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.802 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -54.29 -61.57 2.22 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 124.494 1.122 . . . . 0.15 111.528 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.446 ' HA ' HG21 ' A' ' 7' ' ' ILE . 34.3 m -58.1 -45.83 86.56 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.437 -1.256 . . . . 0.24 113.861 -174.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -57.64 -50.8 71.98 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 123.851 0.72 . . . . 3.63 109.194 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.64 ' HE2' HG12 ' A' ' 58' ' ' ILE . 49.4 t80 -54.55 -51.22 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.124 0.89 . . . . 0.4 111.283 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.1 mt -55.09 -66.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.66 0 CA-C-N 114.671 -1.149 . . . . 0.21 110.611 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 tt -52.54 -43.66 65.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.796 1.638 . . . . 1.44 110.678 -177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -71.07 -26.3 63.01 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.218 -1.355 . . . . 0.63 110.96 -173.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -103.24 -7.73 20.93 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.389 0.885 . . . . 1.25 113.389 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.69 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 84.0 mt-30 . . . . . 0 CA--C 1.448 -2.967 0 CA-C-O 122.974 1.369 . . . . 0.87 107.623 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.429 -1.514 0 N-CA-C 109.309 -0.626 . . . . 0.66 109.309 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.554 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -48.39 -36.91 15.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.016 1.327 . . . . 0.74 112.973 178.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -52.19 -54.49 30.23 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.787 0.68 . . . . 2.66 110.512 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.16 -37.07 71.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.728 0.811 . . . . 2.73 110.092 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' A' ' 73' ' ' THR . 82.3 mt -74.37 -66.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 115.099 -0.955 . . . . 0.23 111.149 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.26 -46.71 92.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 112.347 0.499 . . . . 0.27 112.347 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.654 -0.419 . . . . 0.27 110.808 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.55 -38.22 9.93 Favored Glycine 0 N--CA 1.415 -2.756 0 CA-C-N 116.099 -0.501 . . . . 0.18 113.362 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.667 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.47 -38.61 91.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.033 -1.099 . . . . 0.2 108.033 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.96 -44.73 82.89 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.14 109.966 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.665 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 42.8 mt-10 -64.09 -35.24 80.12 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.872 0.732 . . . . 0.68 111.843 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 11' ' ' LEU . 51.7 mt -67.54 -43.2 87.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.85 -0.614 . . . . 0.28 109.589 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.688 HG22 HG11 ' A' ' 46' ' ' VAL . 21.3 t -67.72 -24.65 31.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 121.885 0.85 . . . . 0.27 109.221 -177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.665 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 13.7 m120 -64.58 -43.29 94.31 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 114.776 -1.102 . . . . 0.34 109.26 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -80.44 -49.15 11.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.189 -0.914 . . . . 2.07 111.591 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.735 HG13 HG22 ' A' ' 46' ' ' VAL . 22.1 mm -61.2 -53.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.057 -0.52 . . . . 0.65 111.283 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.8 -76.59 0.6 Allowed 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.226 -0.59 . . . . 0.54 110.384 -176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.84 50.33 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 110.146 -1.182 . . . . 0.43 110.146 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.449 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.2 mp -88.46 159.77 46.4 Favored Pre-proline 0 C--N 1.278 -2.508 0 CA-C-N 114.395 -0.902 . . . . 0.31 108.577 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -92.53 141.13 2.14 Favored 'Trans proline' 0 N--CA 1.414 -3.154 0 C-N-CA 122.108 1.872 . . . . 1.08 108.954 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.5 p -73.41 54.2 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-O 122.779 1.276 . . . . 0.81 113.111 -173.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 25' ' ' ASP . 12.2 pt-20 -163.74 -9.39 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.109 -1.405 . . . . 2.31 111.087 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.42 ' H ' ' H ' ' A' ' 24' ' ' GLU . 27.6 t0 -83.71 -28.45 28.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.763 0.792 . . . . 1.59 109.394 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' A' ' 12' ' ' ALA . 43.3 t -77.46 92.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.525 -1.216 . . . . 0.3 109.304 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.6 mttt -121.14 172.81 7.7 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.895 -1.15 . . . . 1.58 107.895 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 8.6 mp -65.81 145.48 55.91 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.822 -1.177 . . . . 1.05 107.822 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 77.0 8.7 2.88 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.246 0.966 . . . . 0.72 110.804 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.1 mmtt -92.3 119.78 32.21 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 108.387 -0.968 . . . . 1.48 108.387 174.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 17.4 m -78.58 36.69 0.26 Allowed 'General case' 1 C--N 1.243 -4.058 0 C-N-CA 125.688 1.595 . . . . 1.25 113.515 -172.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.663 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 97.4 m-85 39.96 -95.78 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 125.328 1.451 . . . . 0.4 114.622 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 15.0 t -84.72 37.57 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.546 1.165 . . . . 1.06 111.342 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 32.5 t70 -145.41 -48.5 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.23 -1.35 . . . . 1.74 107.76 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 3.2 m-20 -87.35 -38.05 16.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 1.29 112.914 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 26' ' ' VAL . 59.7 mt -85.35 -48.84 8.66 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.186 0.81 . . . . 0.81 113.186 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.0 t70 102.59 69.48 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.323 1.849 . . . . 1.12 109.696 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 39' ' ' ASP . 11.5 t -105.14 175.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 113.803 -1.544 . . . . 0.79 109.733 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 38' ' ' VAL . 17.2 t70 -79.04 -18.29 53.78 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.261 0.837 . . . . 2.0 113.261 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' MET . 3.3 t 74.5 -41.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.686 1.194 . . . . 0.78 113.154 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.45 -49.59 10.44 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 106.879 -1.526 . . . . 1.18 106.879 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 19.5 m -67.08 -11.96 58.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.045 -1.434 . . . . 0.6 111.023 176.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.663 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 4.0 tpt -60.23 -33.3 72.07 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 125.073 1.349 . . . . 0.86 109.324 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.74 -40.02 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.602 -0.726 . . . . 0.31 109.53 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.23 -43.18 82.64 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.374 -0.375 . . . . 0.68 110.53 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 HG13 ' A' ' 18' ' ' ILE . 6.5 t -60.97 -24.43 32.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 C-N-CA 123.526 0.73 . . . . 0.63 110.845 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.685 HG21 HG13 ' A' ' 63' ' ' VAL . 22.0 t -80.4 -53.77 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 107.78 -1.193 . . . . 0.55 107.78 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.65 -32.91 52.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 113.895 -1.502 . . . . 0.42 110.03 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -77.67 -31.31 52.46 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.207 0.527 . . . . 0.21 109.73 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.421 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -62.58 -57.09 12.35 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.398 -0.819 . . . . 0.21 109.131 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.536 ' OE2' ' HD3' ' A' ' 57' ' ' LYS 0.279 0.0 OUTLIER -61.88 -38.67 89.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 114.161 1.171 . . . . 0.64 114.161 -176.274 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.19 -34.47 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.527 0.517 . . . . 2.07 112.128 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -82.88 -36.08 25.66 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.064 -0.516 . . . . 2.48 110.205 -175.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.516 ' CE2' HG23 ' A' ' 7' ' ' ILE . 7.1 m-85 -86.85 -45.08 11.2 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.2 -1.0 . . . . 0.81 112.435 -172.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 152.29 -35.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 O-C-N 124.891 1.37 . . . . 1.99 112.169 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.604 ' CG1' HG23 ' A' ' 76' ' ' ILE . 14.5 p -75.92 172.37 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 112.726 0.639 . . . . 0.37 112.726 -165.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 3.1 tppp? -125.04 119.71 29.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.368 -1.715 . . . . 2.12 106.368 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.535 HG12 ' HE2' ' A' ' 75' ' ' TYR . 58.5 mt -111.85 113.22 52.74 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 120.693 -0.403 . . . . 0.25 110.226 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 63' ' ' VAL . 93.8 Cg_endo -73.15 157.62 50.25 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.822 2.348 . . . . 0.33 110.668 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.16 -41.17 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.523 1.129 . . . . 1.98 111.617 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 2.3 m-20 -61.81 -51.02 69.96 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 115.573 -0.74 . . . . 2.06 111.247 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 m-20 -71.46 -30.32 65.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.971 0.36 . . . . 0.52 111.971 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 47' ' ' VAL . 53.0 t -51.43 -55.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.941 -0.763 . . . . 0.38 108.941 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.5 pttp -75.64 -1.92 26.9 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 115.401 -0.818 . . . . 2.16 112.674 -175.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.38 -19.57 22.76 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.656 0.741 . . . . 1.59 109.383 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.2 mt -86.11 118.33 25.51 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 104.728 -2.323 . . . . 0.31 104.728 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -110.95 -46.69 3.3 Favored 'General case' 0 C--N 1.259 -3.341 0 N-CA-C 108.289 -1.004 . . . . 2.55 108.289 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 42.5 p -105.07 173.57 6.25 Favored 'General case' 1 N--CA 1.379 -4.004 0 CA-C-N 115.052 -0.977 . . . . 0.23 109.321 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 27' ' ' LYS . 5.5 t -77.49 -13.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 107.454 -1.313 . . . . 1.21 107.454 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.548 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.46 -45.69 58.97 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.201 -1.56 . . . . 0.33 109.201 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -68.17 -48.21 65.9 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.122 -1.039 . . . . 1.39 109.59 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -53.62 -61.13 2.5 Favored 'General case' 0 CA--C 1.482 -1.655 0 O-C-N 124.56 1.162 . . . . 0.15 111.124 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.568 ' HA ' HG21 ' A' ' 7' ' ' ILE . 58.5 m -54.89 -51.54 65.66 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.615 -1.175 . . . . 0.24 113.838 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.1 mptm? -54.75 -47.85 73.33 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.867 0.729 . . . . 3.63 109.456 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.535 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.0 t80 -58.19 -52.55 65.11 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 124.204 0.94 . . . . 0.4 111.412 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.604 HG23 ' CG1' ' A' ' 56' ' ' VAL . 75.8 mt -51.41 -65.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.789 -1.096 . . . . 0.21 110.298 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 tt -54.52 -42.21 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.077 1.351 . . . . 1.44 109.855 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 26.6 t70 -59.62 -41.04 89.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.163 0.985 . . . . 0.63 110.285 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.595 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 1.9 t-80 -90.07 -12.4 38.58 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.141 -1.39 . . . . 1.25 111.222 -173.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 34.0 mt-30 . . . . . 0 CA--C 1.471 -2.075 0 CA-C-O 122.722 1.248 . . . . 0.87 108.351 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.513 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 t . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 109.908 -0.405 . . . . 0.66 109.908 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HG2' HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -50.26 -41.9 51.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.855 1.662 . . . . 0.74 113.534 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -62.42 -23.69 66.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.78 0.659 . . . . 2.66 112.78 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -87.56 -35.7 17.97 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.108 -0.701 . . . . 2.73 109.108 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' A' ' 73' ' ' THR . 92.9 mt -75.73 -65.48 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-N 115.523 -0.762 . . . . 0.23 110.996 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.427 HG23 ' HG2' ' A' ' 4' ' ' GLN . 67.6 t -52.16 -45.04 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 122.869 0.468 . . . . 0.27 111.523 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.1 76.64 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 123.64 0.588 . . . . 0.27 111.604 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.58 9.94 Favored Glycine 0 N--CA 1.412 -2.949 0 CA-C-N 116.419 -0.355 . . . . 0.18 112.493 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.728 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.61 -36.55 82.86 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.243 -1.021 . . . . 0.2 108.243 -178.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.68 -44.41 90.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.482 -0.781 . . . . 0.14 110.022 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.676 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 47.0 mt-10 -62.39 -38.6 90.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 123.935 0.772 . . . . 0.68 111.746 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 11' ' ' LEU . 61.1 mt -61.53 -42.33 93.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.749 0.785 . . . . 0.28 109.161 176.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.813 HG12 ' HB ' ' A' ' 21' ' ' ILE . 86.4 t -71.16 -23.72 23.56 Favored 'Isoleucine or valine' 0 C--O 1.255 1.39 0 CA-C-N 115.182 -0.917 . . . . 0.27 111.08 -175.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.676 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 8.9 m120 -67.02 -46.31 74.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.1 -1.074 . . . . 0.34 108.1 177.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -74.97 -50.03 18.0 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.924 -1.035 . . . . 2.07 111.859 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.737 HG13 HG22 ' A' ' 46' ' ' VAL . 24.4 mm -59.71 -52.53 59.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.983 0.513 . . . . 0.65 111.403 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -110.28 -60.0 1.86 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.077 0.465 . . . . 0.54 111.552 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.07 28.63 0.31 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 120.559 -0.829 . . . . 0.43 112.638 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.813 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -70.41 151.73 95.62 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 109.569 -0.53 . . . . 0.31 109.569 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.7 Cg_exo -89.8 33.97 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.993 3.128 . . . . 1.08 115.222 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.496 ' CA ' HD21 ' A' ' 16' ' ' ASN . 3.3 p 61.41 -11.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 116.444 2.016 . . . . 0.81 116.444 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -115.16 -3.42 12.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.416 -0.803 . . . . 2.31 112.231 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.31 -29.54 28.24 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-O 121.638 0.733 . . . . 1.59 109.19 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.749 HG23 HG21 ' A' ' 21' ' ' ILE . 47.4 t -71.72 90.44 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.149 -1.387 . . . . 0.3 108.126 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 69' ' ' VAL . 1.5 tppp? -124.11 158.81 31.41 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.384 -1.71 . . . . 1.58 106.384 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.455 HD22 ' HA2' ' A' ' 70' ' ' GLY . 88.4 mt -57.54 140.29 51.2 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.001 0.429 . . . . 1.05 110.531 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t70 74.75 13.97 3.43 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.467 1.507 . . . . 0.72 110.911 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -100.91 125.99 47.5 Favored 'General case' 0 CA--C 1.467 -2.238 0 CA-C-O 121.474 0.655 . . . . 1.48 109.308 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 9.3 m -80.2 111.38 16.52 Favored 'General case' 1 C--N 1.239 -4.234 0 CA-C-N 114.071 -1.422 . . . . 1.25 109.129 -177.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.583 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 93.7 m-85 -45.74 -64.92 0.62 Allowed 'General case' 0 C--N 1.271 -2.808 0 C-N-CA 124.367 1.067 . . . . 0.4 112.374 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -90.25 32.97 0.9 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.204 -0.935 . . . . 1.06 112.783 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.8 t70 -147.71 -55.83 0.23 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.671 0.748 . . . . 1.74 110.741 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.59 -50.6 8.61 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.189 -0.914 . . . . 1.29 110.394 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.634 HD13 HG22 ' A' ' 26' ' ' VAL . 17.3 mt -76.36 -45.5 31.67 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.682 -0.69 . . . . 0.81 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.6 t70 88.66 61.73 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.844 1.658 . . . . 1.12 109.921 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 19' ' ' ALA . 18.6 t -104.21 143.55 15.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 113.591 -1.64 . . . . 0.79 106.766 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 43' ' ' MET . 36.9 m-20 -60.53 109.67 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 111.876 0.325 . . . . 2.0 111.876 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.602 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 28.6 t -34.84 -50.43 0.47 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 126.527 1.931 . . . . 0.78 114.429 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 42' ' ' SER . 3.3 pp -71.12 -27.83 63.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.438 0.637 . . . . 1.18 111.918 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 46' ' ' VAL . 18.5 m -85.11 -13.38 50.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.386 0.675 . . . . 0.6 110.425 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.602 ' HG3' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.58 -38.15 86.48 Favored 'General case' 0 CA--C 1.47 -2.103 0 C-N-CA 123.289 0.636 . . . . 0.86 111.576 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.6 -42.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 124.341 1.025 . . . . 0.31 109.413 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -57.01 -50.32 73.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.374 0.606 . . . . 0.68 109.387 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.737 HG22 HG13 ' A' ' 18' ' ' ILE . 40.8 t -55.83 -28.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 124.92 1.288 . . . . 0.63 111.67 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.934 HG21 HG13 ' A' ' 63' ' ' VAL . 21.2 t -78.17 -49.25 21.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.02 -1.104 . . . . 0.55 108.02 -176.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.39 -38.6 78.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.291 -1.322 . . . . 0.42 108.517 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -38.03 77.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.703 -0.68 . . . . 0.21 110.003 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.22 33.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.108 -0.951 . . . . 0.21 110.008 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.324 1.9 pp20? -62.22 -38.49 89.4 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 113.996 1.11 . . . . 0.64 113.996 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.32 -25.86 66.22 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.649 0.593 . . . . 2.07 112.505 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -83.93 -52.17 6.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.644 -0.423 . . . . 2.48 110.583 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 14.2 m-85 -73.94 -44.17 55.87 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 114.629 1.344 . . . . 0.81 114.629 -169.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 17.3 t70 146.52 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 O-C-N 124.732 1.27 . . . . 1.99 110.636 176.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.8 p -73.18 173.53 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.004 -0.998 . . . . 0.37 112.303 -166.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 56' ' ' VAL . 20.9 tptm -120.69 123.3 42.41 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.449 -1.315 . . . . 2.12 107.449 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.565 HG13 ' HB3' ' A' ' 51' ' ' GLU . 55.3 mt -120.31 106.96 39.83 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.478 -0.934 . . . . 0.25 108.478 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 63' ' ' VAL . 45.7 Cg_endo -70.29 166.84 26.91 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.013 2.476 . . . . 0.33 111.517 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -50.43 -43.2 54.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.144 0.978 . . . . 1.98 109.339 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -49.6 -59.17 4.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.539 -1.21 . . . . 2.06 111.642 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.565 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 27.6 m-20 -74.19 -26.28 60.18 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.84 0.681 . . . . 0.52 112.84 -176.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.934 HG13 HG21 ' A' ' 47' ' ' VAL . 62.0 t -53.26 -41.93 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 108.919 -0.771 . . . . 0.38 108.919 174.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -80.24 -7.18 58.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.665 -1.152 . . . . 2.16 112.185 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.67 -36.91 11.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 108.862 -0.792 . . . . 1.59 108.862 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.859 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.6 mt -73.2 125.1 26.95 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 106.596 -1.631 . . . . 0.31 106.596 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.55 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -130.15 -24.24 2.62 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 120.312 -0.555 . . . . 2.55 111.474 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 43.0 p -116.5 171.83 7.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 107.721 -1.214 . . . . 0.23 107.721 173.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -78.75 -13.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 C-N-CA 120.087 -0.645 . . . . 1.21 109.599 176.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.455 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -67.32 -46.78 67.91 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 109.713 -1.355 . . . . 0.33 109.713 175.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.55 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 15.0 m-20 -61.33 -55.42 31.92 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.378 -0.971 . . . . 1.39 108.378 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.859 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.62 -61.19 2.4 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.0 -1.454 . . . . 0.15 111.769 -175.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.44 ' HA ' HG21 ' A' ' 7' ' ' ILE . 37.6 m -57.96 -46.33 85.28 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.96 -1.018 . . . . 0.24 113.472 -174.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 14.1 mptt -56.88 -44.75 82.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 123.771 0.669 . . . . 3.63 109.45 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.464 ' CE2' HG12 ' A' ' 58' ' ' ILE . 85.6 t80 -65.31 -48.19 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.37 1.043 . . . . 0.4 111.65 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.657 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -54.94 -65.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.71 -1.132 . . . . 0.21 110.239 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.0 tt -51.7 -41.78 61.71 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.775 1.23 . . . . 1.44 109.358 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 11.5 t70 -58.28 -41.11 83.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.917 1.287 . . . . 0.63 109.549 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -102.1 3.78 38.96 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.979 1.103 . . . . 1.25 113.979 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 46.3 mt-30 . . . . . 0 CA--C 1.48 -1.715 0 N-CA-C 107.552 -1.277 . . . . 0.87 107.552 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . . . . . . 0 N--CA 1.441 -0.893 0 N-CA-C 109.182 -0.673 . . . . 1.42 109.182 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . . . -124.31 -76.16 0.59 Allowed 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.986 -0.552 . . . . 1.85 110.744 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.748 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.6 t -179.37 -169.11 0.14 Allowed 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.864 -1.161 . . . . 0.66 107.864 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.88 -42.72 48.47 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.363 1.065 . . . . 0.74 113.757 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -58.53 -23.79 59.04 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.173 0.511 . . . . 2.66 112.148 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 34.9 tt0 -84.33 -45.14 13.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.272 -0.64 . . . . 2.73 109.272 175.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.497 HG21 ' HA ' ' A' ' 73' ' ' THR . 79.8 mt -71.57 -65.44 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.03 0 CA-C-N 115.001 -0.999 . . . . 0.23 110.484 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.39 -48.81 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 C-N-CA 123.768 0.827 . . . . 0.27 112.614 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.68 77.64 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 123.327 0.392 . . . . 0.27 111.206 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -81.45 -40.5 11.03 Favored Glycine 0 N--CA 1.405 -3.424 0 C-N-CA 120.709 -0.758 . . . . 0.18 112.952 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.732 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -65.39 -38.09 88.94 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.161 0.984 . . . . 0.2 108.879 -176.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.536 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -61.82 -43.39 98.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.608 -0.724 . . . . 0.14 109.846 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.684 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.9 mt-10 -63.91 -35.74 81.65 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.754 0.659 . . . . 0.68 112.282 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 11' ' ' LEU . 60.7 mt -62.25 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.621 -0.881 . . . . 0.28 108.621 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.3 t -68.34 -23.86 28.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 CA-C-O 121.591 0.71 . . . . 0.27 110.659 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.684 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -66.35 -46.18 77.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.235 -0.893 . . . . 0.34 109.096 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.75 -44.8 15.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.233 -0.894 . . . . 2.07 111.614 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.714 HG13 HG22 ' A' ' 46' ' ' VAL . 21.0 mm -59.57 -51.91 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.783 0.433 . . . . 0.65 110.793 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -108.33 -81.42 0.57 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.52 0.676 . . . . 0.54 110.631 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.45 55.7 0.01 OUTLIER Glycine 0 CA--C 1.484 -1.86 0 N-CA-C 110.322 -1.111 . . . . 0.43 110.322 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.664 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -97.82 160.79 27.68 Favored Pre-proline 0 C--N 1.278 -2.52 0 N-CA-C 107.976 -1.12 . . . . 0.31 107.976 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -93.24 143.57 2.1 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 122.523 2.148 . . . . 1.08 109.192 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 12' ' ' ALA . 13.8 p -74.1 56.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 123.287 1.518 . . . . 0.81 112.802 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.418 ' H ' ' H ' ' A' ' 25' ' ' ASP . 10.5 pt-20 -151.51 -14.48 0.2 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.26 -1.336 . . . . 2.31 110.068 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' A' ' 30' ' ' LYS . 1.6 t70 -87.61 -37.14 17.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.861 0.839 . . . . 1.59 109.172 -173.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.633 HG22 HD13 ' A' ' 36' ' ' LEU . 21.7 t -77.7 90.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.991 -1.114 . . . . 0.3 107.991 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 66.2 mttm -101.84 -96.29 0.28 Allowed 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.955 0.883 . . . . 1.58 109.014 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.41 ' H ' ' HB2' ' A' ' 27' ' ' LYS . 95.4 mt -153.15 157.13 39.88 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 104.238 -2.505 . . . . 1.05 104.238 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' H ' ' CA ' ' A' ' 70' ' ' GLY . 30.5 t70 68.69 9.31 7.27 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.501 1.125 . . . . 0.72 110.657 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HB2' HG12 ' A' ' 69' ' ' VAL . 46.6 mmtt -93.57 126.2 38.59 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-N 115.586 -0.734 . . . . 1.48 109.282 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 34' ' ' ASP . 7.1 m -74.38 25.51 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 C-N-CA 126.501 1.92 . . . . 1.25 114.63 -171.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.748 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 70.2 m-85 41.84 -97.29 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.625 1.57 . . . . 0.4 113.746 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.713 HG21 ' H37' ' A' ' 101' ' ' SYO . 10.2 t -57.58 -35.44 70.41 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 123.565 0.746 . . . . 1.06 111.141 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB3' ' CB ' ' A' ' 31' ' ' SER . 19.3 t70 -83.67 -40.82 18.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.482 -0.326 . . . . 1.74 111.098 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.84 -54.45 3.96 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 118.683 -1.207 . . . . 1.29 110.821 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.633 HD13 HG22 ' A' ' 26' ' ' VAL . 17.3 mt -74.06 -38.37 63.97 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.457 -1.247 . . . . 0.81 111.405 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.6 t70 89.4 69.37 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.538 1.535 . . . . 1.12 109.605 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.677 ' H ' ' HA ' ' A' ' 33' ' ' THR . 15.0 t -111.68 155.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.927 -1.942 . . . . 0.79 106.57 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 43' ' ' MET . 12.2 m-20 -76.5 119.85 20.91 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.251 -0.648 . . . . 2.0 109.251 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.563 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 10.2 t -42.51 -50.71 5.25 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.584 1.153 . . . . 0.78 113.58 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.62 -29.54 70.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.46 0.648 . . . . 1.18 111.43 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 46' ' ' VAL . 21.7 m -84.43 -15.12 47.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.17 -0.468 . . . . 0.6 110.688 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.792 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -62.8 -35.01 78.49 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 123.429 0.692 . . . . 0.86 110.579 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.76 -42.62 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.138 -0.689 . . . . 0.31 109.138 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.99 -44.54 94.45 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.194 -0.669 . . . . 0.68 109.194 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.714 HG22 HG13 ' A' ' 18' ' ' ILE . 47.8 t -59.65 -29.03 41.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 114.998 -1.001 . . . . 0.63 111.244 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.031 HG21 HG13 ' A' ' 63' ' ' VAL . 40.4 t -77.78 -51.77 17.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.876 -0.787 . . . . 0.55 108.876 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.2 -21.57 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.429 -0.805 . . . . 0.42 109.272 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.22 -38.0 31.96 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 109.012 -0.736 . . . . 0.21 109.012 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -63.71 -56.36 16.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.337 -0.847 . . . . 0.21 110.253 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.297 0.6 OUTLIER -63.47 -36.7 84.62 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 114.379 1.251 . . . . 0.64 114.379 -176.328 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.73 -24.12 64.43 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.892 0.377 . . . . 2.07 111.486 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -88.26 -40.91 13.28 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.737 0.303 . . . . 2.48 110.554 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.494 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 8.5 m-85 -94.52 -2.1 52.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.81 113.032 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 1' ' ' ALA . 14.1 m-20 81.77 7.18 1.07 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.3 1.04 . . . . 1.99 113.723 175.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.748 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.5 p -89.73 178.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.328 -0.99 . . . . 0.37 108.328 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.432 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.2 tptt -133.45 130.51 38.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.241 -1.392 . . . . 2.12 107.241 171.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 76' ' ' ILE . 61.9 mt -124.68 113.36 27.17 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.182 -0.673 . . . . 0.25 109.182 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.581 ' O ' HG23 ' A' ' 63' ' ' VAL . 73.3 Cg_endo -72.56 164.42 35.65 Favored 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 123.089 2.526 . . . . 0.33 110.518 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.9 -30.31 70.8 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.929 0.344 . . . . 1.98 111.929 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.51 -31.39 72.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.693 0.282 . . . . 2.06 111.094 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.627 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 15.2 m-20 -86.61 -28.21 23.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.034 0.383 . . . . 0.52 112.034 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.031 HG13 HG21 ' A' ' 47' ' ' VAL . 69.7 t -55.05 -48.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.415 -0.957 . . . . 0.38 108.415 173.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 64' ' ' LYS . 15.6 ptpt -80.65 -1.92 44.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.253 -0.885 . . . . 2.16 111.772 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 38.5 t30 -92.21 -29.47 16.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.597 -0.89 . . . . 1.59 108.597 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.872 HD13 ' HA ' ' A' ' 72' ' ' ALA . 25.6 mt -85.7 112.29 20.9 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.432 -1.322 . . . . 0.31 107.432 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.537 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -104.76 -21.99 13.27 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.705 -1.198 . . . . 2.55 110.966 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.464 HG23 ' HG2' ' A' ' 67' ' ' LYS . 30.6 p -127.79 169.85 13.4 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 108.804 -0.813 . . . . 0.23 108.804 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.685 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 1.6 p -73.88 -13.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.804 0.811 . . . . 1.21 110.419 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.469 ' CA ' ' H ' ' A' ' 29' ' ' ASP . . . -68.95 -47.28 55.61 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 108.772 -1.731 . . . . 0.33 108.772 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.6 m-20 -58.19 -56.36 23.1 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.014 -0.736 . . . . 1.39 109.014 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.872 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.65 -61.64 2.08 Favored 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 124.718 1.262 . . . . 0.15 111.926 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.497 ' HA ' HG21 ' A' ' 7' ' ' ILE . 31.6 m -57.92 -44.03 86.58 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 113.643 0.979 . . . . 0.24 113.643 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -65.2 -33.3 75.69 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 122.905 0.482 . . . . 3.63 109.842 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HE2' HG12 ' A' ' 58' ' ' ILE . 88.4 t80 -72.68 -52.72 14.12 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.422 -0.808 . . . . 0.4 110.023 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.748 ' HA ' HG21 ' A' ' 56' ' ' VAL . 70.7 mt -52.88 -66.26 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.698 0 C-N-CA 124.717 1.207 . . . . 0.21 111.519 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.748 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.4 tt -50.41 -49.08 55.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.596 1.558 . . . . 1.44 109.484 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.3 t70 -67.56 -23.42 65.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.424 -1.716 . . . . 0.63 111.575 -174.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -101.96 -12.88 17.86 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.868 -0.606 . . . . 1.25 112.448 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 68.0 mt-30 -71.68 -62.39 1.43 Allowed 'General case' 0 CA--C 1.464 -2.33 0 N-CA-C 107.1 -1.444 . . . . 0.87 107.1 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.268 -2.967 0 CA-C-N 111.526 -2.579 . . . . 1.97 109.378 -179.8 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.864 ' H28' HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.575 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 0 C--O 1.247 0.94 0 CA-C-O 119.816 -0.135 . . . . 1.42 110.707 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 176.8 -81.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.322 1.049 . . . . 1.85 110.406 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t -165.76 -173.85 2.85 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.362 -0.607 . . . . 0.66 109.362 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.711 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -50.3 -46.4 55.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 125.615 1.566 . . . . 0.74 113.419 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.97 -23.59 63.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.58 0.585 . . . . 2.66 112.58 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -84.64 -32.2 23.79 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.821 -1.177 . . . . 2.73 107.821 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 73' ' ' THR . 74.2 mt -79.88 -64.81 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.112 -0.949 . . . . 0.23 109.238 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -55.6 -42.59 69.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 112.626 0.602 . . . . 0.27 112.626 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -60.92 -40.07 91.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.57 -0.452 . . . . 0.27 110.691 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.69 -35.89 21.03 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 120.889 -0.672 . . . . 0.18 112.6 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.683 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -65.9 -39.75 90.9 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.508 -1.293 . . . . 0.2 107.508 -179.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.77 -49.84 67.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 123.926 0.766 . . . . 0.14 109.867 175.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.601 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 35.1 mt-10 -58.58 -42.68 88.59 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 124.223 0.952 . . . . 0.68 111.521 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.4 mt -59.4 -38.75 76.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.509 -0.769 . . . . 0.28 110.232 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 11' ' ' LEU . 61.9 t -71.83 -30.16 36.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.614 -0.721 . . . . 0.27 109.845 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.8 m120 -67.33 -42.65 83.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.102 -0.703 . . . . 0.34 109.102 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 37.1 mm-40 -70.68 -58.8 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.917 -1.038 . . . . 2.07 111.887 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.803 HG22 ' HB3' ' A' ' 42' ' ' SER . 28.0 mt -72.82 -39.36 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 112.619 0.6 . . . . 0.65 112.619 -174.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -106.27 -80.37 0.56 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.13 -0.628 . . . . 0.54 111.441 -178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.69 53.17 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.656 -0.783 . . . . 0.43 112.756 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.824 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -98.02 155.22 37.27 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.612 -0.514 . . . . 0.31 109.612 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 21' ' ' ILE . 5.7 Cg_exo -88.76 40.14 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.017 2.478 . . . . 1.08 114.362 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.46 ' H ' ' ND2' ' A' ' 16' ' ' ASN 0.29 8.0 p 53.2 -18.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 117.383 2.364 . . . . 0.81 117.383 178.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -103.58 -12.8 16.85 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.351 -0.843 . . . . 2.31 111.401 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.59 -29.87 46.34 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.923 -0.769 . . . . 1.59 108.923 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.824 HG23 HG21 ' A' ' 21' ' ' ILE . 41.8 t -73.23 95.05 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.557 -1.201 . . . . 0.3 108.136 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -130.62 149.51 52.25 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 103.751 -2.685 . . . . 1.58 103.751 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD22 ' HA2' ' A' ' 70' ' ' GLY . 57.0 mt -48.63 145.97 3.33 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 124.007 0.923 . . . . 1.05 109.862 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 80.05 10.37 1.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.539 1.149 . . . . 0.72 110.707 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.762 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 34.2 mmtp -99.9 124.28 45.05 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.675 -0.861 . . . . 1.48 108.675 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 15.2 m -81.46 38.01 0.48 Allowed 'General case' 0 C--N 1.249 -3.781 0 C-N-CA 126.058 1.743 . . . . 1.25 113.007 -173.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.675 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 88.4 m-85 36.42 -91.83 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.991 1.716 . . . . 0.4 114.524 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.962 HG21 ' H37' ' A' ' 101' ' ' SYO . 10.9 t -53.72 -33.12 54.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.091 0.956 . . . . 1.06 112.27 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 27.6 t70 -94.04 -44.41 8.05 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.879 0.371 . . . . 1.74 111.484 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.762 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 6.7 m-20 -88.63 -33.55 17.59 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.784 1.031 . . . . 1.29 113.784 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.629 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.0 mt -98.7 -31.42 11.92 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.038 -0.356 . . . . 0.81 110.038 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 84.55 62.79 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.223 1.487 . . . . 1.12 108.975 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 19' ' ' ALA . 26.7 t -109.39 124.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.701 -2.045 . . . . 0.79 107.71 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.45 122.66 15.15 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 121.064 -0.254 . . . . 2.0 111.212 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.537 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 26.8 t -37.21 -43.04 0.49 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.938 1.459 . . . . 0.78 114.938 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.2 mt -60.91 -46.26 91.35 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.944 0.878 . . . . 1.18 109.56 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.803 ' HB3' HG22 ' A' ' 18' ' ' ILE . 8.3 m -71.71 -29.3 64.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.511 -1.222 . . . . 0.6 110.501 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.913 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -53.16 -47.25 68.92 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 124.966 1.307 . . . . 0.86 112.798 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 48' ' ' VAL . 59.9 t -55.9 -45.6 79.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.013 0.82 . . . . 0.31 109.995 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -60.32 -44.1 95.78 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 109.34 -0.615 . . . . 0.68 109.34 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 15' ' ' VAL . 94.6 t -58.82 -28.54 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.027 0.931 . . . . 0.63 111.677 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.861 HG21 HG13 ' A' ' 63' ' ' VAL . 32.1 t -79.72 -50.98 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 108.04 -1.096 . . . . 0.55 108.04 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 44' ' ' VAL . 49.0 t -59.35 -38.74 76.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.214 -1.357 . . . . 0.42 108.91 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.21 -35.04 71.39 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.994 -0.548 . . . . 0.21 110.42 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.75 11.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.267 -0.879 . . . . 0.21 109.339 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.279 0.0 OUTLIER -63.95 -34.07 77.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 113.721 1.008 . . . . 0.64 113.721 -176.95 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.49 -24.73 66.45 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.445 0.535 . . . . 2.07 112.445 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -88.85 -41.56 12.4 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.503 -0.479 . . . . 2.48 111.629 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HZ ' ' N ' ' A' ' 11' ' ' LEU . 8.8 m-85 -88.87 -0.83 57.72 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 113.267 0.84 . . . . 0.81 113.267 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 80.2 -0.07 2.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.435 1.084 . . . . 1.99 112.837 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.738 HG21 ' HA ' ' A' ' 76' ' ' ILE . 7.6 p -84.75 177.45 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.389 -0.967 . . . . 0.37 108.389 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' H ' HG22 ' A' ' 56' ' ' VAL . 9.1 ttmm -137.11 131.76 33.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.934 -0.765 . . . . 2.12 108.934 172.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.563 HG12 ' HE2' ' A' ' 75' ' ' TYR . 54.0 mt -124.43 113.59 27.52 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.804 -0.635 . . . . 0.25 109.382 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HG23 ' A' ' 63' ' ' VAL . 36.5 Cg_endo -67.07 157.82 59.88 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 122.564 2.176 . . . . 0.33 109.917 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.81 -29.88 63.18 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.685 0.755 . . . . 1.98 109.359 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 29.7 t70 -60.91 -47.2 87.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.569 -1.196 . . . . 2.06 111.452 177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 59.3 m-20 -83.12 -24.94 32.39 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 111.812 0.301 . . . . 0.52 111.812 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.861 HG13 HG21 ' A' ' 47' ' ' VAL . 67.2 t -52.53 -48.11 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.324 -0.991 . . . . 0.38 108.324 173.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HA ' H42A ' A' ' 101' ' ' SYO . 25.8 pttm -75.57 -2.39 28.94 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.153 0.797 . . . . 2.16 113.153 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.87 -25.92 14.46 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.002 0.429 . . . . 1.59 110.418 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' HA ' ' A' ' 72' ' ' ALA . 37.4 mt -79.72 119.51 22.74 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 106.017 -1.846 . . . . 0.31 106.017 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -110.37 -35.04 6.17 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.58 -0.848 . . . . 2.55 110.571 176.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 31.6 p -111.43 177.65 4.59 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 109.089 -0.708 . . . . 0.23 109.089 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.675 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -86.99 -13.03 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 N-CA-C 108.263 -1.014 . . . . 1.21 108.263 174.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.469 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -72.35 -35.95 59.81 Favored Glycine 0 C--O 1.216 -0.981 0 N-CA-C 108.385 -1.886 . . . . 0.33 108.385 173.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 68' ' ' THR . 11.7 m-20 -66.74 -60.27 2.84 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.821 1.249 . . . . 1.39 109.501 173.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -50.75 -61.1 2.41 Favored 'General case' 0 CA--C 1.469 -2.164 0 CA-C-N 113.474 -1.694 . . . . 0.15 112.317 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.711 HG21 ' HG2' ' A' ' 4' ' ' GLN . 59.2 m -59.75 -34.34 72.83 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.914 -1.039 . . . . 0.24 113.324 -175.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -43.4 70.06 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 108.027 -1.101 . . . . 3.63 108.027 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.563 ' HE2' HG12 ' A' ' 58' ' ' ILE . 87.1 t80 -61.27 -50.86 71.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.856 -1.065 . . . . 0.4 109.611 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.738 ' HA ' HG21 ' A' ' 56' ' ' VAL . 76.7 mt -54.79 -65.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.037 -1.438 . . . . 0.21 110.634 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.13 -41.74 62.77 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.634 0.773 . . . . 1.44 109.939 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.34 -34.51 76.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.14 -0.936 . . . . 0.63 111.723 -175.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -95.71 -7.16 38.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 113.631 0.974 . . . . 1.25 113.631 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.578 HE21 HG22 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -105.17 -70.93 0.76 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 113.97 1.1 . . . . 0.87 113.97 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.828 0 CA-C-N 115.084 -0.962 . . . . 1.97 110.505 -176.474 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.962 ' H37' HG21 ' A' ' 33' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.671 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 0 CA--C 1.495 -1.136 0 CA-C-O 121.42 0.629 . . . . 1.42 110.376 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.85 177.46 4.66 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.62 -1.173 . . . . 1.85 108.482 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.452 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.0 t -118.76 179.91 4.0 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 116.615 -0.266 . . . . 0.66 111.083 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -51.25 -37.06 45.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.945 1.298 . . . . 0.74 112.848 -178.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -48.76 66.92 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.895 0.747 . . . . 2.66 110.854 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.35 -38.18 87.01 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.505 0.722 . . . . 2.73 109.907 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.542 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.7 mt -72.13 -66.79 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.028 0 CA-C-N 115.681 -0.691 . . . . 0.23 112.344 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.573 HG21 HD11 ' A' ' 28' ' ' LEU . 58.3 t -60.0 -41.12 85.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 112.377 0.51 . . . . 0.27 112.377 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.36 86.84 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.269 0.355 . . . . 0.27 110.54 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.62 -40.15 10.04 Favored Glycine 0 N--CA 1.414 -2.825 0 CA-C-N 115.815 -0.629 . . . . 0.18 113.584 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.26 -37.14 86.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.605 -0.887 . . . . 0.2 108.605 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.12 -49.23 77.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.893 -0.594 . . . . 0.14 109.418 175.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.718 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 49.7 mt-10 -60.23 -41.57 93.39 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 124.131 0.894 . . . . 0.68 112.244 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 11' ' ' LEU . 69.1 mt -56.84 -42.15 77.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.618 -0.719 . . . . 0.28 109.887 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.626 HG12 ' HB ' ' A' ' 21' ' ' ILE . 98.4 t -70.16 -22.85 24.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.778 0.799 . . . . 0.27 110.879 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.718 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.9 m120 -76.34 -42.2 45.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.55 -1.278 . . . . 0.34 107.55 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -76.92 -39.76 49.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.551 -1.204 . . . . 2.07 112.252 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.553 HG13 HG22 ' A' ' 46' ' ' VAL . 20.7 mm -71.96 -53.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.895 0.379 . . . . 0.65 110.563 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.33 -74.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.374 -0.531 . . . . 0.54 111.26 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.55 44.77 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.353 -0.927 . . . . 0.43 112.221 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.843 HG21 HG23 ' A' ' 26' ' ' VAL . 1.5 mp -84.9 151.0 57.01 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.984 -0.747 . . . . 0.31 108.984 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 13.3 Cg_exo -83.27 29.24 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 124.277 3.318 . . . . 1.08 115.004 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.426 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 5.7 p 54.1 7.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 C-N-CA 126.195 1.798 . . . . 0.81 114.351 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -107.95 -27.1 10.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.943 -0.473 . . . . 2.31 111.834 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 36' ' ' LEU . 11.1 m-20 -83.17 -28.64 29.19 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 116.054 -0.521 . . . . 1.59 112.094 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.843 HG23 HG21 ' A' ' 21' ' ' ILE . 22.1 t -78.37 87.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.118 -0.633 . . . . 0.3 110.399 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 69' ' ' VAL . 96.5 mttt -125.6 168.84 13.15 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.473 -0.785 . . . . 1.58 109.422 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 8' ' ' VAL . 5.5 mp -60.19 139.3 57.63 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.255 -0.43 . . . . 1.05 110.081 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 79.28 12.68 1.23 Allowed 'General case' 0 C--N 1.316 -0.855 0 O-C-N 125.044 1.465 . . . . 0.72 111.252 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.7 mmtt -99.47 124.75 44.91 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 109.301 -0.629 . . . . 1.48 109.301 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.5 m -78.9 34.42 0.23 Allowed 'General case' 0 C--N 1.254 -3.578 0 C-N-CA 126.356 1.862 . . . . 1.25 114.377 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.797 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 79.9 m-85 43.04 -93.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.499 1.519 . . . . 0.4 114.913 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -67.35 -24.37 65.71 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.993 -0.442 . . . . 1.06 111.98 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -89.45 -52.99 4.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.935 0.398 . . . . 1.74 110.952 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.55 -41.31 19.78 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 116.155 -0.475 . . . . 1.29 112.221 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.585 HD13 HG22 ' A' ' 26' ' ' VAL . 16.1 mt -83.4 -76.32 0.29 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 119.097 -0.478 . . . . 0.81 110.525 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 34.2 t70 159.82 -16.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 O-C-N 124.411 1.069 . . . . 1.12 110.608 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 36' ' ' LEU . 3.0 t -47.13 135.37 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.037 1.335 . . . . 0.79 113.276 -171.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 43' ' ' MET . 11.3 t70 -59.49 112.8 1.91 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.516 -0.766 . . . . 2.0 111.805 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.565 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 17.3 t -40.82 -43.31 2.0 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 116.069 1.877 . . . . 0.78 116.069 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 4.2 pp -80.22 -30.69 38.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.254 -1.378 . . . . 1.18 110.66 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 46' ' ' VAL . 20.1 m -76.14 -13.92 60.18 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.601 -0.727 . . . . 0.6 110.165 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.797 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.13 -36.09 76.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 123.44 0.696 . . . . 0.86 110.301 177.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.97 -44.68 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 123.959 0.787 . . . . 0.31 109.36 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.65 -43.09 94.03 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.181 -0.674 . . . . 0.68 109.181 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.553 HG22 HG13 ' A' ' 18' ' ' ILE . 57.6 t -59.26 -24.98 29.15 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.015 -0.993 . . . . 0.63 111.455 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.978 HG21 HG13 ' A' ' 63' ' ' VAL . 42.3 t -80.18 -54.32 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 N-CA-C 106.933 -1.506 . . . . 0.55 106.933 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HA ' ' OE2' ' A' ' 51' ' ' GLU . 74.2 t -53.85 -40.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.372 -1.74 . . . . 0.42 110.07 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.91 -37.08 64.76 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-O 121.233 0.54 . . . . 0.21 110.27 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.507 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -62.19 -59.97 4.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.059 -0.973 . . . . 0.21 109.905 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.296 0.9 OUTLIER -62.8 -35.53 80.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 114.377 1.251 . . . . 0.64 114.377 -176.1 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.67 -30.46 71.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.356 0.502 . . . . 2.07 112.356 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -82.82 -36.72 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.777 -0.369 . . . . 2.48 110.979 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 7.7 m-85 -87.58 -19.43 27.83 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.766 1.024 . . . . 0.81 113.766 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.0 t70 103.76 -5.35 0.02 OUTLIER 'General case' 0 N--CA 1.532 3.641 0 O-C-N 125.29 1.619 . . . . 1.99 114.227 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 76' ' ' ILE . 8.1 p -87.17 172.96 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 O-C-N 121.141 -0.974 . . . . 0.37 109.513 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.88 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -126.6 118.79 25.54 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.208 -1.405 . . . . 2.12 107.208 174.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.585 HG12 ' HE2' ' A' ' 75' ' ' TYR . 57.5 mt -111.64 114.03 52.69 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 120.88 -0.328 . . . . 0.25 110.929 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HG23 ' A' ' 63' ' ' VAL . 83.2 Cg_endo -72.82 164.6 35.11 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.524 2.816 . . . . 0.33 110.913 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.45 -38.71 74.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.905 0.482 . . . . 1.98 111.058 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.577 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.0 m-20 -61.82 -34.71 76.42 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-N 115.816 -0.629 . . . . 2.06 111.592 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.575 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.0 m-20 -87.36 -23.98 24.4 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.659 -0.816 . . . . 0.52 113.177 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.978 HG13 HG21 ' A' ' 47' ' ' VAL . 79.4 t -55.96 -45.68 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.093 -1.077 . . . . 0.38 108.093 172.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 17.4 ptmt -74.78 -10.27 59.35 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.202 -0.908 . . . . 2.16 111.84 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -91.56 -13.52 31.87 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.264 0.554 . . . . 1.59 110.168 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.821 HD13 ' HA ' ' A' ' 72' ' ' ALA . 24.9 mt -95.96 109.54 21.9 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 107.101 -1.444 . . . . 0.31 107.101 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.514 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -105.72 -45.22 4.46 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.742 -1.206 . . . . 2.55 107.742 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 62.8 p -102.86 170.44 7.99 Favored 'General case' 0 N--CA 1.383 -3.808 0 CA-C-N 114.937 -1.028 . . . . 0.23 108.821 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -79.31 -12.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.464 -0.939 . . . . 1.21 108.464 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.66 -46.98 64.36 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 108.597 -1.801 . . . . 0.33 108.597 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.92 -52.42 65.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 109.026 -0.731 . . . . 1.39 109.026 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.821 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.25 -61.26 2.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 O-C-N 124.635 1.209 . . . . 0.15 111.365 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' HG21 ' A' ' 7' ' ' ILE . 52.5 m -55.7 -50.87 69.15 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 124.211 0.945 . . . . 0.24 113.471 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.5 mptm? -60.52 -34.14 73.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 123.3 0.64 . . . . 3.63 110.185 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.585 ' HE2' HG12 ' A' ' 58' ' ' ILE . 77.1 t80 -70.37 -55.89 8.0 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.771 -0.455 . . . . 0.4 109.771 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.608 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 63.8 mt -50.31 -66.44 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 124.662 1.185 . . . . 0.21 110.909 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.41 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.5 tt -52.88 -54.32 36.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.781 1.232 . . . . 1.44 110.047 -175.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 11.9 t70 -70.57 -24.4 62.77 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.542 -1.208 . . . . 0.63 112.02 -169.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.27 -4.87 48.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.416 0.895 . . . . 1.25 113.416 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.671 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 2.0 pt20 -103.24 -55.48 2.4 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-O 122.391 1.091 . . . . 0.87 110.898 173.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 1 C--N 1.243 -4.033 0 CA-C-N 112.944 -1.934 . . . . 1.97 110.681 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.839 ' H28' HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.693 0 CA-C-O 121.072 0.463 . . . . 1.42 109.793 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -95.67 128.94 42.96 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 109.009 -0.737 . . . . 1.85 109.009 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 7' ' ' ILE . 2.5 t -85.93 176.21 8.19 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 119.114 -0.469 . . . . 0.66 109.93 -176.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.451 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -48.32 -40.32 24.86 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.398 0.888 . . . . 0.74 113.398 -176.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.27 -33.74 65.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.046 0.841 . . . . 2.66 110.411 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 15.4 tp10 -87.15 -37.74 17.07 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.403 -0.817 . . . . 2.73 109.837 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.667 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 86.1 mt -65.67 -65.75 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 116.392 -0.367 . . . . 0.23 111.711 -172.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.756 HG21 HD11 ' A' ' 28' ' ' LEU . 59.1 t -56.91 -42.31 78.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 122.126 0.17 . . . . 0.27 111.394 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -38.74 78.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.813 0.696 . . . . 0.27 111.278 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.66 -38.45 10.63 Favored Glycine 0 N--CA 1.419 -2.47 0 CA-C-N 116.183 -0.462 . . . . 0.18 113.117 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -63.97 -40.48 96.49 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.978 -0.749 . . . . 0.2 108.978 -178.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.641 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.34 -50.77 64.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.127 0.892 . . . . 0.14 109.685 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.614 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 55.6 mt-10 -61.54 -38.91 89.14 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 124.0 0.813 . . . . 0.68 111.927 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.7 mt -59.85 -45.01 95.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.843 -0.617 . . . . 0.28 109.548 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 11' ' ' LEU . 62.0 t -67.6 -24.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-O 121.747 0.784 . . . . 0.27 110.131 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.614 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.9 m120 -72.09 -38.49 69.37 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.281 -0.872 . . . . 0.34 109.322 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -82.13 -48.87 10.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.659 -0.7 . . . . 2.07 111.349 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.64 HG22 ' HB3' ' A' ' 42' ' ' SER . 33.4 mm -62.77 -53.14 50.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.902 -0.59 . . . . 0.65 110.545 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -104.5 -78.27 0.57 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.421 -0.585 . . . . 0.54 109.421 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.27 45.96 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 120.747 -0.74 . . . . 0.43 112.031 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.583 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -80.69 152.47 72.42 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 109.037 -0.727 . . . . 0.31 109.037 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.8 Cg_exo -84.83 23.34 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.104 2.536 . . . . 1.08 115.089 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.8 p 58.88 -9.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.69 1.996 . . . . 0.81 115.489 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.8 pt-20 -103.79 -7.02 20.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.365 0.602 . . . . 2.31 111.176 -174.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -99.66 -16.49 18.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.775 0.798 . . . . 1.59 110.676 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 12' ' ' ALA . 12.8 t -78.11 86.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 114.385 -1.28 . . . . 0.3 110.468 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -114.52 148.94 37.19 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.186 -1.042 . . . . 1.58 108.186 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.756 HD11 HG21 ' A' ' 8' ' ' VAL . 6.0 mp -59.89 140.27 56.78 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.578 -0.527 . . . . 1.05 109.578 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 87.26 7.21 0.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.545 1.538 . . . . 0.72 109.642 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -104.03 128.44 51.61 Favored 'General case' 0 CA--C 1.465 -2.316 0 CA-C-N 115.269 -0.878 . . . . 1.48 109.214 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 3.0 m -80.65 105.8 12.17 Favored 'General case' 1 C--N 1.238 -4.269 0 CA-C-N 114.188 -1.369 . . . . 1.25 108.316 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.765 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.4 m-85 -43.51 -55.26 4.33 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.596 0.758 . . . . 0.4 112.081 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 t -78.23 6.3 8.48 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 113.431 0.9 . . . . 1.06 113.431 -173.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -139.92 -62.18 0.52 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.318 -0.553 . . . . 1.74 110.037 -174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.05 -44.91 75.3 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.096 -0.957 . . . . 1.29 110.146 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.596 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 16.9 mt -81.38 -44.6 17.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.137 -0.938 . . . . 0.81 109.279 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 93.84 65.32 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 126.632 1.973 . . . . 1.12 111.908 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 43' ' ' MET . 48.8 t -96.04 149.47 4.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 113.485 -1.689 . . . . 0.79 107.587 171.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.475 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.3 m-20 -73.96 17.82 0.16 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 115.99 1.848 . . . . 2.0 115.99 -174.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 43' ' ' MET . 28.7 t 68.0 -53.65 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.271 1.952 . . . . 0.78 116.271 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 39' ' ' ASP . 1.7 pt? -71.36 -34.15 70.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.257 1.027 . . . . 1.18 108.491 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.64 ' HB3' HG22 ' A' ' 18' ' ' ILE . 2.1 m -65.81 -22.84 66.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.968 -1.469 . . . . 0.6 110.045 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.752 ' HB3' ' H2A' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -61.99 -43.44 98.83 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 115.375 -0.829 . . . . 0.86 112.021 -176.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.35 -43.83 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 O-C-N 124.398 1.061 . . . . 0.31 110.034 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.41 -46.82 85.69 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.917 -0.771 . . . . 0.68 108.917 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 42' ' ' SER . 61.9 t -58.54 -27.0 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.731 -1.122 . . . . 0.63 111.484 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.978 HG21 HG13 ' A' ' 63' ' ' VAL . 44.5 t -80.15 -52.53 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 107.658 -1.238 . . . . 0.55 107.658 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.28 -44.51 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 124.728 1.268 . . . . 0.42 108.919 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.69 88.33 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 121.244 0.545 . . . . 0.21 110.811 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -64.68 -55.9 17.19 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.472 -0.785 . . . . 0.21 110.239 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.262 0.0 OUTLIER -62.81 -34.03 76.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.754 1.02 . . . . 0.64 113.754 -178.188 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -67.84 -28.66 67.75 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.77 0.285 . . . . 2.07 111.77 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -87.52 -38.16 16.27 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.775 0.321 . . . . 2.48 111.52 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.667 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 10.0 m-85 -94.46 -3.91 49.18 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.106 0.78 . . . . 0.81 113.106 -172.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 87.66 -2.5 0.55 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 125.16 1.384 . . . . 1.99 114.719 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.781 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 13.9 p -81.2 173.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.363 -0.935 . . . . 0.37 108.772 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 22.2 tptp -127.58 124.91 39.26 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 107.462 -1.31 . . . . 2.12 107.462 171.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.538 HG12 ' HE2' ' A' ' 75' ' ' TYR . 59.7 mt -114.43 113.21 45.71 Favored Pre-proline 0 N--CA 1.429 -1.496 0 C-N-CA 120.599 -0.441 . . . . 0.25 111.106 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 63' ' ' VAL . 30.9 Cg_endo -66.87 152.53 80.26 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 122.642 2.228 . . . . 0.33 109.845 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 3.9 p-10 -59.1 -27.87 65.98 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.307 0.379 . . . . 1.98 111.123 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.76 -46.04 87.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 2.06 110.379 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.409 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.5 m-20 -74.76 -26.91 60.1 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 112.01 0.374 . . . . 0.52 112.01 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.978 HG13 HG21 ' A' ' 47' ' ' VAL . 86.8 t -55.57 -41.44 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.86 -1.163 . . . . 0.38 107.86 172.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HA ' H42A ' A' ' 101' ' ' SYO . 57.8 mttp -73.94 -7.83 53.81 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.067 -0.97 . . . . 2.16 112.564 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.06 -24.47 15.32 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.233 0.539 . . . . 1.59 110.316 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.852 HD13 ' HA ' ' A' ' 72' ' ' ALA . 39.1 mt -85.48 118.44 25.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.889 -1.152 . . . . 0.31 107.889 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.488 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -112.17 -29.16 7.68 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.918 -1.113 . . . . 2.55 110.591 175.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 13.6 p -116.55 179.5 3.99 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 109.477 -0.564 . . . . 0.23 109.477 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.765 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -87.23 -12.89 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 122.062 0.934 . . . . 1.21 109.787 176.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -76.6 -30.99 55.56 Favored Glycine 0 C--O 1.207 -1.542 0 N-CA-C 108.305 -1.918 . . . . 0.33 108.305 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.27 -60.35 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.21 -0.995 . . . . 1.39 109.144 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.852 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.03 -60.95 2.34 Favored 'General case' 0 CA--C 1.479 -1.771 0 O-C-N 124.569 1.168 . . . . 0.15 112.361 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.458 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.3 m -57.45 -47.99 80.36 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.894 -1.048 . . . . 0.24 113.006 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 5.7 mptp? -55.83 -50.52 70.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 124.213 0.945 . . . . 3.63 109.815 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.538 ' HE2' HG12 ' A' ' 58' ' ' ILE . 82.8 t80 -56.23 -51.51 67.82 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.364 1.04 . . . . 0.4 111.43 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.578 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 69.8 mt -54.27 -65.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.424 -1.262 . . . . 0.21 110.432 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tt -54.33 -42.8 70.6 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.11 0.964 . . . . 1.44 109.589 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 36.9 t70 -62.4 -26.81 68.68 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.41 1.084 . . . . 0.63 111.561 -172.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -102.13 -8.04 21.72 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.836 1.05 . . . . 1.25 113.836 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.781 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -120.89 -45.67 2.37 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 115.191 1.552 . . . . 0.87 115.191 -178.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 1 C--N 1.237 -4.307 0 CA-C-N 113.877 -1.51 . . . . 1.97 111.159 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.752 ' H2A' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.379 0 CA-C-O 120.892 0.377 . . . . 1.42 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -147.06 131.85 17.99 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 107.069 -1.456 . . . . 1.85 107.069 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.44 ' O ' HG13 ' A' ' 7' ' ' ILE . 15.2 t -81.77 -179.73 7.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.147 0.28 . . . . 0.66 111.162 -173.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.661 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -49.85 -46.97 51.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.157 0.983 . . . . 0.74 113.363 -178.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.64 -24.79 66.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.873 0.368 . . . . 2.66 111.624 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 7.8 tp10 -87.7 -31.08 19.9 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.152 -0.684 . . . . 2.73 109.152 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.583 HG23 ' CE2' ' A' ' 54' ' ' PHE . 97.4 mt -74.39 -65.98 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.141 0 CA-C-N 116.145 -0.48 . . . . 0.23 110.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.49 -40.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 112.365 0.506 . . . . 0.27 112.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -62.48 -40.91 98.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.37 -0.532 . . . . 0.27 110.632 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.48 -35.07 33.96 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 115.783 -0.644 . . . . 0.18 112.235 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.738 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -67.44 -39.37 85.4 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.16 -1.052 . . . . 0.2 108.16 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.628 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.36 -50.32 69.98 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.832 -0.803 . . . . 0.14 108.832 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 46.6 mt-10 -59.24 -42.48 91.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.113 0.883 . . . . 0.68 112.704 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' A' ' 11' ' ' LEU . 65.6 mt -56.07 -43.06 74.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.315 0.579 . . . . 0.28 109.923 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.716 HG12 ' HB ' ' A' ' 21' ' ' ILE . 97.8 t -68.86 -25.34 30.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.755 0.788 . . . . 0.27 110.168 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.592 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 3.6 m120 -74.07 -42.18 60.58 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.923 -1.139 . . . . 0.34 107.923 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.56 -47.95 51.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.311 -0.858 . . . . 2.07 111.445 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.4 HG13 HG22 ' A' ' 46' ' ' VAL . 28.4 mm -67.14 -53.16 35.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.896 -0.593 . . . . 0.65 111.317 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.73 -78.42 0.58 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.559 -0.456 . . . . 0.54 111.695 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.02 43.17 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.094 -1.051 . . . . 0.43 112.916 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.863 HG21 HG23 ' A' ' 26' ' ' VAL . 1.4 mp -79.41 151.25 74.75 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.033 -0.729 . . . . 0.31 109.033 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 4.6 Cg_exo -89.74 37.5 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.613 2.876 . . . . 1.08 113.276 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 9.2 p 56.11 -22.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 C-N-CA 126.982 2.113 . . . . 0.81 116.021 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 22' ' ' PRO . 29.8 mm-40 -88.73 -22.8 23.16 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.603 0.761 . . . . 2.31 111.873 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.602 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 6.6 t70 -74.57 -32.71 62.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.583 0.706 . . . . 1.59 110.494 -171.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 21' ' ' ILE . 22.0 t -78.96 94.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.908 -1.042 . . . . 0.3 111.104 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -124.3 158.55 32.32 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.315 -0.995 . . . . 1.58 108.315 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 69' ' ' VAL . 90.6 mt -54.97 141.22 34.66 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 122.934 0.494 . . . . 1.05 110.288 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.599 ' H ' ' N ' ' A' ' 70' ' ' GLY . 27.1 t70 77.22 10.55 2.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.36 1.464 . . . . 0.72 111.009 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 69' ' ' VAL . 72.1 mmtt -100.36 129.06 46.29 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 115.374 -0.83 . . . . 1.48 109.226 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 30.6 t -74.85 119.89 19.65 Favored 'General case' 1 C--N 1.244 -4.011 0 CA-C-N 115.078 -0.965 . . . . 1.25 109.901 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.617 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 74.0 m-85 -51.49 -55.87 16.5 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 123.975 0.91 . . . . 0.4 111.892 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 3.5 p -66.47 -57.45 7.33 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 122.11 0.957 . . . . 1.06 111.942 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' HB2' ' OG ' ' A' ' 31' ' ' SER . 8.0 m-20 -82.64 -41.17 19.77 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 115.202 1.556 . . . . 1.74 115.202 -166.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HB2' ' N ' ' A' ' 31' ' ' SER . 5.3 m-20 -91.66 -43.81 9.39 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.719 0.295 . . . . 1.29 111.113 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.744 HD13 HG22 ' A' ' 26' ' ' VAL . 17.8 mt -76.09 -90.11 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.758 -0.656 . . . . 0.81 110.418 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 38.9 t70 163.56 10.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.364 1.066 . . . . 1.12 109.047 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 15' ' ' VAL . 12.4 t -77.57 119.14 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 108.764 -0.828 . . . . 0.79 108.764 -172.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.714 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 13.2 t70 -58.44 120.99 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 124.106 0.879 . . . . 2.0 111.456 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.8 t -41.78 -30.91 0.27 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 127.455 2.302 . . . . 0.78 116.128 175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.714 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 4.3 pp -86.32 -31.96 21.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 120.4 1.455 . . . . 1.18 111.023 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -80.15 -13.76 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.46 1.124 . . . . 0.6 109.401 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.759 ' HG3' ' H1 ' ' A' ' 101' ' ' SYO . 3.8 tpt -60.03 -36.09 76.51 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 127.334 2.253 . . . . 0.86 110.403 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 47' ' ' VAL . 58.1 t -66.68 -25.15 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 CA-C-N 115.213 -0.903 . . . . 0.31 110.943 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -77.02 -41.02 44.36 Favored 'General case' 0 C--O 1.215 -0.739 0 O-C-N 121.515 -0.741 . . . . 0.68 109.6 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.4 HG22 HG13 ' A' ' 18' ' ' ILE . 31.5 t -59.57 -25.83 32.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.177 -0.919 . . . . 0.63 111.66 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.769 HG23 ' H6 ' ' A' ' 101' ' ' SYO . 10.7 p -81.48 -47.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 CA-C-O 122.201 1.0 . . . . 0.55 110.145 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.02 -39.5 85.9 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 CA-C-N 112.869 -1.969 . . . . 0.42 108.749 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 -32.04 72.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.856 -0.611 . . . . 0.21 110.004 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.79 -59.16 4.17 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.952 -1.022 . . . . 0.21 110.122 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.288 0.0 OUTLIER -62.44 -34.69 77.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 114.014 1.116 . . . . 0.64 114.014 -175.635 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.29 -41.82 80.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.449 0.642 . . . . 2.07 111.321 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -81.68 -41.14 21.79 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.259 -0.882 . . . . 2.48 110.812 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 7' ' ' ILE . 10.4 m-85 -83.65 -44.38 14.6 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 117.735 -1.126 . . . . 0.81 113.454 -172.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 15.8 t70 155.91 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 124.616 1.198 . . . . 1.99 112.55 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.641 HG11 ' HA ' ' A' ' 76' ' ' ILE . 8.6 p -75.29 174.56 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.301 -0.863 . . . . 0.37 112.924 -164.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.3 127.04 52.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.207 -1.775 . . . . 2.12 106.207 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 76' ' ' ILE . 59.8 mt -118.87 112.42 36.62 Favored Pre-proline 0 C--N 1.293 -1.871 0 C-N-CA 120.216 -0.594 . . . . 0.25 110.09 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.5 Cg_endo -69.27 155.95 66.05 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.361 2.707 . . . . 0.33 110.554 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.5 p-10 -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.183 0.593 . . . . 1.98 112.128 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 7.7 m-20 -65.44 -54.24 31.28 Favored 'General case' 0 C--O 1.209 -1.044 0 O-C-N 123.22 0.325 . . . . 2.06 110.538 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.53 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 11.6 m-20 -66.92 -31.85 72.72 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.509 0.559 . . . . 0.52 112.509 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.725 HG13 HG11 ' A' ' 47' ' ' VAL . 41.3 t -50.22 -59.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.281 0.988 . . . . 0.38 109.015 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 14.6 ptmm? -72.61 -1.86 17.75 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.574 -0.739 . . . . 2.16 112.916 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.68 -18.17 21.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.733 0.777 . . . . 1.59 109.418 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' HA ' ' A' ' 72' ' ' ALA . 40.1 mt -84.9 116.09 23.14 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.579 -2.008 . . . . 0.31 105.579 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.634 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -111.68 -30.05 7.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 117.982 -1.487 . . . . 2.55 109.65 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 67' ' ' LYS . 31.1 p -119.14 173.46 6.91 Favored 'General case' 0 N--CA 1.395 -3.204 0 N-CA-C 109.183 -0.673 . . . . 0.23 109.183 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 30' ' ' LYS . 23.7 t -72.01 -18.98 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 108.492 -0.929 . . . . 1.21 108.492 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.599 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -70.13 -40.96 71.36 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 110.142 -1.183 . . . . 0.33 110.142 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.575 ' OD1' ' HD2' ' A' ' 67' ' ' LYS . 6.2 m-20 -67.89 -55.04 14.35 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.547 -0.908 . . . . 1.39 108.547 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.46 -61.33 2.31 Favored 'General case' 0 CA--C 1.471 -2.058 0 O-C-N 124.875 1.359 . . . . 0.15 111.97 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.661 HG21 ' HG2' ' A' ' 4' ' ' GLN . 50.0 m -57.64 -51.19 70.51 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.591 -1.186 . . . . 0.24 112.682 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.4 OUTLIER -53.49 -49.53 67.3 Favored 'General case' 0 N--CA 1.422 -1.827 0 O-C-N 124.325 1.016 . . . . 3.63 109.601 177.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 87.1 t80 -56.96 -52.01 66.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.747 0.819 . . . . 0.4 111.208 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.641 ' HA ' HG11 ' A' ' 56' ' ' VAL . 69.9 mt -52.01 -65.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 124.812 1.32 . . . . 0.21 109.79 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.76 -45.01 70.48 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.144 1.378 . . . . 1.44 110.346 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.59 -30.32 71.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.916 -1.038 . . . . 0.63 111.105 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -100.32 -11.62 20.15 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 113.82 1.044 . . . . 1.25 113.82 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 14.8 mt-30 -80.59 -51.93 8.17 Favored 'General case' 0 CA--C 1.476 -1.898 0 CA-C-O 122.798 1.285 . . . . 0.87 107.641 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.271 -2.846 0 CA-C-N 112.417 -2.174 . . . . 1.97 110.275 -175.569 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.769 ' H6 ' HG23 ' A' ' 47' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.504 -0.822 0 N-CA-C 108.423 -0.954 . . . . 1.42 108.423 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.93 -70.23 0.15 Allowed 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.882 -0.327 . . . . 1.85 111.291 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -159.7 171.2 19.98 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.609 -0.436 . . . . 0.66 111.231 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.635 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.8 OUTLIER -51.85 -37.08 50.57 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.138 1.775 . . . . 0.74 112.423 177.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.4 -35.33 65.23 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 123.735 0.647 . . . . 2.66 111.869 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.48 -31.18 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.358 0.599 . . . . 2.73 109.504 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.636 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 80.4 mt -73.27 -66.44 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 115.775 -0.648 . . . . 0.23 109.985 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 28' ' ' LEU . 96.7 t -52.62 -38.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.067 0.765 . . . . 0.27 113.067 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.27 98.69 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.419 -0.512 . . . . 0.27 109.86 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' HA2' ' NH1' ' A' ' 53' ' ' ARG . . . -76.34 -39.93 29.8 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.366 -0.834 . . . . 0.18 112.313 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -67.04 -39.04 86.88 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 123.745 0.818 . . . . 0.2 109.377 -176.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.47 -43.68 89.0 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.687 -0.486 . . . . 0.14 109.687 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.57 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 44.4 mt-10 -61.31 -42.78 99.24 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.889 0.743 . . . . 0.68 111.46 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 11' ' ' LEU . 48.5 mt -60.7 -40.76 85.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.342 0.591 . . . . 0.28 110.046 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.732 HG12 ' HB ' ' A' ' 21' ' ' ILE . 23.9 t -73.65 -22.61 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.472 0.654 . . . . 0.27 110.162 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.57 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 14.1 m120 -72.59 -54.04 10.25 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.205 -1.035 . . . . 0.34 108.205 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.14 -44.8 62.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.342 -1.299 . . . . 2.07 113.602 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.588 HG22 ' HB3' ' A' ' 42' ' ' SER . 14.5 mt -76.27 -53.33 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.985 -0.686 . . . . 0.65 111.106 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.662 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -91.91 -80.14 0.36 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 0.54 110.809 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.93 40.04 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.16 0 C-N-CA 121.076 -0.583 . . . . 0.43 111.755 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.732 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -82.55 161.14 60.03 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 109.473 -0.566 . . . . 0.31 109.473 178.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.0 Cg_endo -90.62 141.64 3.26 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.895 2.396 . . . . 1.08 108.415 171.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -72.61 45.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.086 0 N-CA-C 113.98 1.104 . . . . 0.81 113.98 -171.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.51 -20.96 0.43 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.31 1.044 . . . . 2.31 110.548 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.65 -36.44 65.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.122 -0.49 . . . . 1.59 112.105 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.649 HG22 HD13 ' A' ' 36' ' ' LEU . 41.1 t -75.91 93.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.998 -0.546 . . . . 0.3 109.582 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 69' ' ' VAL . 30.8 mmtp -133.17 168.55 18.32 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.821 -1.178 . . . . 1.58 107.821 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.487 HD23 ' HE2' ' A' ' 74' ' ' LYS . 6.3 mp -63.67 146.92 52.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.845 -0.798 . . . . 1.05 108.845 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 t70 78.3 8.39 2.28 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.702 1.251 . . . . 0.72 110.241 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 71.4 mmtt -106.08 125.57 51.16 Favored 'General case' 0 CA--C 1.473 -1.993 0 CA-C-N 115.709 -0.678 . . . . 1.48 109.679 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 4.2 m -81.85 108.78 15.65 Favored 'General case' 0 C--N 1.245 -3.96 0 CA-C-N 114.248 -1.342 . . . . 1.25 108.763 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.879 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.4 m-85 -37.27 -66.69 0.22 Allowed 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.547 1.539 . . . . 0.4 114.197 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.54 ' CG2' ' H37' ' A' ' 101' ' ' SYO . 4.3 t -85.87 15.5 4.84 Favored 'General case' 0 C--N 1.275 -2.67 0 O-C-N 121.1 -1.0 . . . . 1.06 112.742 -174.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 1.9 m-20 -134.25 -65.72 0.64 Allowed 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.627 -0.671 . . . . 1.74 111.364 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 21.5 m-20 -68.94 -41.4 78.12 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.311 -0.858 . . . . 1.29 109.962 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.678 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 27.0 mt -79.38 -50.1 11.36 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.618 -0.719 . . . . 0.81 111.024 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 11.2 t70 94.5 68.89 0.0 OUTLIER 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.278 1.611 . . . . 1.12 110.557 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 19' ' ' ALA . 40.5 t -105.81 162.69 4.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.277 -1.783 . . . . 0.79 110.156 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.25 3.6 5.55 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.49 1.116 . . . . 2.0 113.028 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.1 p 67.41 -47.58 0.49 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.328 1.851 . . . . 0.78 113.081 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.68 -49.15 77.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.997 0.919 . . . . 1.18 108.783 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.588 ' HB3' HG22 ' A' ' 18' ' ' ILE . 2.2 m -63.75 -16.26 60.71 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.987 -1.461 . . . . 0.6 112.314 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.879 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -66.22 -34.48 78.11 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 123.406 0.682 . . . . 0.86 111.393 -176.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.59 -38.33 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 109.125 -0.694 . . . . 0.31 109.125 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.87 -44.94 91.58 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.943 -1.132 . . . . 0.68 107.943 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 42' ' ' SER . 97.8 t -57.25 -24.72 21.77 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.354 -1.294 . . . . 0.63 112.091 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.991 HG11 HG22 ' A' ' 63' ' ' VAL . 23.2 t -78.69 -53.66 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.957 -1.127 . . . . 0.55 107.957 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.73 -31.9 50.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.573 -1.194 . . . . 0.42 109.413 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -76.35 -32.01 58.41 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.158 0.504 . . . . 0.21 110.285 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -67.11 -62.86 1.22 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.486 -0.779 . . . . 0.21 109.973 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.264 0.0 OUTLIER -60.69 -37.23 80.95 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 114.411 1.263 . . . . 0.64 114.411 -174.594 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.87 -30.7 67.94 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.4 0.519 . . . . 2.07 112.4 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' NH1' ' HA2' ' A' ' 10' ' ' GLY . 64.0 ttt180 -88.05 -32.92 18.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.78 0.324 . . . . 2.48 110.96 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.6 m-85 -95.54 -1.9 49.63 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.066 0.765 . . . . 0.81 113.066 -171.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.555 ' HB2' ' HB2' ' A' ' 1' ' ' ALA . 7.8 m-20 79.75 -2.91 2.06 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.447 1.099 . . . . 1.99 113.328 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.565 ' CG1' HG23 ' A' ' 76' ' ' ILE . 10.0 p -83.92 178.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 N-CA-C 107.985 -1.117 . . . . 0.37 107.985 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 21.3 tptm -136.27 130.76 33.51 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.197 -1.038 . . . . 2.12 108.197 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.511 HG12 ' HE2' ' A' ' 75' ' ' TYR . 37.2 mt -128.96 110.21 18.41 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 123.1 0.25 . . . . 0.25 110.612 -175.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.544 ' O ' HG23 ' A' ' 63' ' ' VAL . 70.1 Cg_endo -74.47 166.84 28.51 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.581 2.187 . . . . 0.33 109.811 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -59.93 -29.24 68.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.149 0.5 . . . . 1.98 110.124 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 25.6 t70 -62.81 -38.92 92.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.288 -0.869 . . . . 2.06 111.307 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 29.5 m-20 -87.14 -28.33 22.53 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.485 -0.486 . . . . 0.52 111.455 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.991 HG22 HG11 ' A' ' 47' ' ' VAL . 54.1 t -52.1 -46.71 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.16 -0.682 . . . . 0.38 109.16 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 45.7 pttt -70.9 -2.16 14.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.064 -0.971 . . . . 2.16 113.086 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 95.4 m-20 -96.06 -34.93 11.55 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.828 0.347 . . . . 1.59 110.399 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -76.32 112.68 13.06 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.913 -0.773 . . . . 0.31 108.913 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -33.52 7.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.551 0.691 . . . . 2.55 110.361 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.0 p -116.02 169.36 9.32 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.795 -1.187 . . . . 0.23 107.795 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.47 HG11 HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -78.65 -13.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 119.831 -0.747 . . . . 1.21 109.293 175.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -67.14 -44.63 86.63 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.953 -1.659 . . . . 0.33 108.953 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.34 -48.99 71.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.498 -0.926 . . . . 1.39 108.498 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.686 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -57.26 -61.65 2.32 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 114.851 -1.068 . . . . 0.15 111.424 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.635 HG21 ' HG2' ' A' ' 4' ' ' GLN . 28.1 m -58.64 -39.67 81.2 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 113.997 1.11 . . . . 0.24 113.997 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.487 ' HE2' HD23 ' A' ' 28' ' ' LEU . 5.3 mptp? -60.91 -51.08 70.8 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.2 -1.037 . . . . 3.63 108.2 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.511 ' HE2' HG12 ' A' ' 58' ' ' ILE . 89.6 t80 -55.88 -49.13 74.23 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.29 0.994 . . . . 0.4 110.687 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.662 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 78.1 mt -57.67 -66.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.022 -0.99 . . . . 0.21 111.109 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -52.46 -47.1 66.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.532 1.533 . . . . 1.44 109.799 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.72 -28.17 68.21 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.238 -1.346 . . . . 0.63 110.931 -172.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -103.47 -2.4 26.92 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 113.403 0.89 . . . . 1.25 113.403 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 59.8 mt-30 -78.78 -63.58 1.38 Allowed 'General case' 0 CA--C 1.468 -2.201 0 N-CA-C 106.699 -1.593 . . . . 0.87 106.699 175.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.277 -2.565 0 CA-C-N 111.5 -2.591 . . . . 1.97 109.805 -178.738 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.68 ' H8B' ' HB1' ' A' ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.504 -0.815 0 N-CA-C 108.285 -1.006 . . . . 1.42 108.285 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.68 -72.48 0.4 Allowed 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.089 -0.645 . . . . 1.85 111.876 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 t -171.08 -179.11 2.63 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 120.569 -0.452 . . . . 0.66 111.02 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.482 ' HG2' HG23 ' A' ' 8' ' ' VAL . 6.1 tm0? -57.43 -35.04 69.58 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 125.679 1.591 . . . . 0.74 112.469 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.76 -24.36 67.67 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.632 0.583 . . . . 2.66 111.335 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 -44.02 11.46 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.854 -0.795 . . . . 2.73 108.854 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.617 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 79.3 mt -64.31 -64.99 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.72 0 CA-C-N 116.158 -0.474 . . . . 0.23 112.012 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG23 ' HG2' ' A' ' 4' ' ' GLN . 55.2 t -56.97 -39.26 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 112.026 0.38 . . . . 0.27 112.026 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.74 -36.49 84.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.231 0.539 . . . . 0.27 110.576 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.55 -40.87 8.67 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 115.779 -0.646 . . . . 0.18 112.92 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.651 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -64.84 -36.07 83.15 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.491 -0.929 . . . . 0.2 108.491 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.52 -51.67 67.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.771 -0.65 . . . . 0.14 109.39 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.652 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.6 mt-10 -58.12 -41.9 84.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 124.204 0.94 . . . . 0.68 112.499 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 11' ' ' LEU . 76.7 mt -58.11 -43.42 85.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.503 -0.771 . . . . 0.28 109.701 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 21' ' ' ILE . 86.1 t -68.82 -23.89 28.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.872 0.844 . . . . 0.27 110.679 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.652 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.2 m120 -75.06 -42.62 56.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.335 -0.987 . . . . 0.34 108.335 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.31 -41.19 57.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.845 -1.07 . . . . 2.07 111.636 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.731 HG13 HG22 ' A' ' 46' ' ' VAL . 30.8 mm -70.45 -53.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 116.701 -0.227 . . . . 0.65 111.007 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.594 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -106.31 -82.45 0.54 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.013 0.435 . . . . 0.54 110.607 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.34 43.96 0.02 OUTLIER Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.561 -0.828 . . . . 0.43 112.419 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.654 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -80.52 151.06 71.33 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.859 -0.423 . . . . 0.31 109.859 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.9 Cg_exo -86.17 33.3 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.155 2.57 . . . . 1.08 114.056 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.445 ' H ' HG22 ' A' ' 21' ' ' ILE 0.265 9.8 p 56.61 -20.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 C-N-CA 127.052 2.141 . . . . 0.81 116.433 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -95.51 -13.94 24.08 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.554 -0.716 . . . . 2.31 112.54 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 29.8 t0 -84.45 -28.2 26.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.728 0.775 . . . . 1.59 110.023 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 12' ' ' ALA . 25.5 t -73.6 93.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.577 -1.192 . . . . 0.3 109.072 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 69' ' ' VAL . 33.3 mmtp -131.09 151.88 50.97 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 106.954 -1.498 . . . . 1.58 106.954 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.44 HD22 ' HA2' ' A' ' 70' ' ' GLY . 50.7 mt -50.09 143.53 8.07 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.763 0.665 . . . . 1.05 109.531 177.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 82.8 4.81 0.97 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.9 1.28 . . . . 0.72 111.129 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -103.6 132.83 49.5 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 108.936 -0.764 . . . . 1.48 108.936 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 57.9 m -86.53 116.96 25.0 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 124.047 0.842 . . . . 1.25 109.666 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.734 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 94.6 m-85 -45.65 -67.46 0.28 Allowed 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 125.17 1.388 . . . . 0.4 114.178 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.467 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 14.7 t -71.79 -25.85 62.19 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.685 -1.259 . . . . 1.06 111.843 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.593 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 7.3 m-20 -87.62 -64.18 1.19 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.406 0.622 . . . . 1.74 110.972 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' SER . 4.5 m-20 -74.29 -57.6 3.84 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 115.282 -0.872 . . . . 1.29 110.439 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 26' ' ' VAL . 16.8 mt -68.17 -38.24 81.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.015 -0.993 . . . . 0.81 111.122 -172.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.2 t70 82.84 64.98 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.459 1.6 . . . . 1.12 109.558 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 19' ' ' ALA . 21.8 t -108.78 159.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 112.463 -2.153 . . . . 0.79 106.548 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.63 120.23 19.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.361 -0.977 . . . . 2.0 108.361 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.531 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 5.0 p -49.11 -38.15 23.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.078 0.951 . . . . 0.78 112.306 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 42' ' ' SER . 3.9 pp -70.63 -28.42 64.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.16 0.43 . . . . 1.18 112.16 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 46' ' ' VAL . 50.0 m -82.04 -15.7 52.72 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.425 0.631 . . . . 0.6 110.266 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -58.92 -37.35 76.48 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-N 115.445 -0.798 . . . . 0.86 111.715 -179.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.29 -45.72 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 124.087 0.867 . . . . 0.31 109.421 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.31 -49.79 74.99 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 108.615 -0.883 . . . . 0.68 108.615 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.731 HG22 HG13 ' A' ' 18' ' ' ILE . 54.2 t -57.34 -29.98 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.971 1.308 . . . . 0.63 111.672 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.86 HG21 HG13 ' A' ' 63' ' ' VAL . 38.3 t -76.96 -49.68 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.336 0 N-CA-C 108.294 -1.002 . . . . 0.55 108.294 -176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.27 -35.5 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-N 114.692 -1.14 . . . . 0.42 108.777 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.29 76.25 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.538 0.685 . . . . 0.21 109.915 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.71 -58.35 7.77 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 114.932 -1.031 . . . . 0.21 109.843 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.631 ' HB3' HG13 ' A' ' 56' ' ' VAL 0.257 0.0 OUTLIER -61.15 -37.03 81.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.056 1.132 . . . . 0.64 114.056 -177.375 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.69 -37.58 76.39 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.296 0.373 . . . . 2.07 111.401 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -84.73 -37.84 20.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.052 0.389 . . . . 2.48 112.052 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.0 m-85 -92.68 -11.03 35.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.352 1.242 . . . . 0.81 114.352 -170.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 1' ' ' ALA . 25.2 m-20 87.51 4.22 0.33 Allowed 'General case' 0 N--CA 1.519 2.995 0 N-CA-C 114.448 1.277 . . . . 1.99 114.448 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.75 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.1 p -84.12 175.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.183 -1.414 . . . . 0.37 107.183 175.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 20.5 tptp -131.75 122.35 25.7 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.887 -1.894 . . . . 2.12 105.887 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.564 HG13 ' HB3' ' A' ' 51' ' ' GLU . 52.4 mt -113.72 107.05 53.25 Favored Pre-proline 0 C--N 1.291 -1.969 0 C-N-CA 119.754 -0.778 . . . . 0.25 110.618 -174.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 63' ' ' VAL . 36.3 Cg_endo -64.8 152.38 82.3 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 C-N-CA 122.948 2.432 . . . . 0.33 109.739 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.2 -33.57 53.34 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.561 0.744 . . . . 1.98 111.153 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 21.5 t70 -62.43 -43.51 98.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.546 -0.752 . . . . 2.06 111.679 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.452 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 40.9 m-20 -86.46 -21.83 26.82 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.403 0.52 . . . . 0.52 112.403 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.86 HG13 HG21 ' A' ' 47' ' ' VAL . 51.1 t -53.68 -50.43 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.246 -1.02 . . . . 0.38 108.246 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.1 pttp -79.55 -1.47 37.96 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.523 -1.217 . . . . 2.16 111.332 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.25 -18.84 24.93 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.295 -1.002 . . . . 1.59 108.295 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.824 HD13 ' HA ' ' A' ' 72' ' ' ALA . 27.6 mt -90.38 117.82 29.39 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 106.783 -1.562 . . . . 0.31 106.783 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.82 -37.63 6.96 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.695 -0.802 . . . . 2.55 110.769 175.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 41.1 p -109.73 178.87 4.29 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 109.486 -0.561 . . . . 0.23 109.486 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.734 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -85.08 -13.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.365 -0.976 . . . . 1.21 108.365 173.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -67.5 -49.07 53.52 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 107.165 -2.374 . . . . 0.33 107.165 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 68' ' ' THR . 8.6 m-20 -56.43 -57.09 13.81 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 124.95 1.3 . . . . 1.39 110.411 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.824 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.34 -60.99 2.56 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.442 1.089 . . . . 0.15 111.667 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 7' ' ' ILE . 34.4 m -60.39 -45.33 93.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 113.26 0.837 . . . . 0.24 113.26 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.6 mptm? -63.52 -22.72 67.05 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 122.651 0.38 . . . . 3.63 110.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -82.2 -52.92 6.49 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 116.041 -0.527 . . . . 0.4 109.599 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.75 ' HA ' HG21 ' A' ' 56' ' ' VAL . 71.6 mt -52.74 -66.93 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 C-N-CA 124.827 1.251 . . . . 0.21 111.351 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -52.95 -39.91 63.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.552 1.541 . . . . 1.44 111.9 -177.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -72.69 -26.29 61.56 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 113.261 -1.791 . . . . 0.63 111.481 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -103.08 -8.59 20.42 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.994 0.739 . . . . 1.25 112.994 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.709 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 60.7 mt-30 -76.79 -65.8 0.9 Allowed 'General case' 0 CA--C 1.476 -1.88 0 CA-C-O 123.104 1.43 . . . . 0.87 108.225 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.268 -2.966 0 CA-C-N 111.821 -2.445 . . . . 1.97 109.694 -176.71 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.672 ' H2A' ' N41' ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 109.354 -0.61 . . . . 1.42 109.354 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.49 -71.56 0.1 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.994 -0.548 . . . . 1.85 109.571 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.479 ' HA ' HD13 ' A' ' 77' ' ' LEU . 15.1 t -166.43 175.13 8.37 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 116.241 -0.436 . . . . 0.66 109.869 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.601 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.8 OUTLIER -47.71 -39.92 18.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.163 1.385 . . . . 0.74 113.238 174.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -59.2 -22.56 61.2 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.519 0.933 . . . . 2.66 113.519 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 3' ' ' THR . 29.9 tt0 -79.15 -39.82 32.5 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.806 -0.812 . . . . 2.73 108.806 174.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 77' ' ' LEU . 63.9 mt -76.7 -66.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.643 -1.162 . . . . 0.23 111.526 -169.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 28' ' ' LEU . 48.1 t -56.51 -47.08 82.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 111.554 0.205 . . . . 0.27 111.554 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.35 -36.2 66.04 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.75 0.656 . . . . 0.27 112.212 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.4 -43.87 6.79 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 120.907 -0.663 . . . . 0.18 112.21 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -61.09 -39.9 91.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 124.402 1.081 . . . . 0.2 109.216 -177.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.31 -48.2 77.17 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 115.897 -0.592 . . . . 0.14 109.905 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.705 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 97.3 mt-10 -63.59 -34.09 77.04 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 123.983 0.802 . . . . 0.68 112.278 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 11' ' ' LEU . 58.9 mt -68.26 -38.8 80.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.829 -0.623 . . . . 0.28 109.495 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 11' ' ' LEU . 59.7 t -72.26 -23.6 21.61 Favored 'Isoleucine or valine' 0 C--O 1.253 1.279 0 CA-C-O 121.427 0.632 . . . . 0.27 110.206 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.705 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 7.0 m120 -62.5 -37.83 87.54 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.776 -0.824 . . . . 0.34 108.776 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -84.08 -47.64 10.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 2.07 112.309 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.835 HG13 ' HB ' ' A' ' 46' ' ' VAL . 25.0 mm -54.2 -52.38 38.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.654 0.782 . . . . 0.65 111.427 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -118.51 -56.66 2.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.118 0.485 . . . . 0.54 110.832 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 16' ' ' ASN . . . 135.95 40.6 0.14 Allowed Glycine 0 CA--C 1.49 -1.529 0 C-N-CA 120.292 -0.956 . . . . 0.43 112.29 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.816 HG21 HG23 ' A' ' 26' ' ' VAL . 1.4 mp -75.64 147.31 81.45 Favored Pre-proline 0 C--O 1.202 -1.413 0 N-CA-C 109.06 -0.719 . . . . 0.31 109.06 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.3 Cg_exo -85.44 34.5 0.49 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 123.232 2.621 . . . . 1.08 113.992 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 21' ' ' ILE 0.274 9.8 p 56.9 -15.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 C-N-CA 127.326 2.251 . . . . 0.81 116.513 177.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.24 -18.6 19.92 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.638 -0.664 . . . . 2.31 111.615 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 25.5 t0 -85.42 -24.7 27.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 120.29 -0.564 . . . . 1.59 110.609 -170.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.816 HG23 HG21 ' A' ' 21' ' ' ILE . 42.6 t -72.54 92.58 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.852 -1.166 . . . . 0.3 107.852 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 69' ' ' VAL . 9.4 tppt? -125.16 160.37 29.3 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.801 -2.296 . . . . 1.58 104.801 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.517 ' HA ' HG22 ' A' ' 69' ' ' VAL . 6.4 mp -64.22 148.72 49.46 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 118.624 0.647 . . . . 1.05 109.651 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.408 ' H ' ' N ' ' A' ' 70' ' ' GLY . 31.2 t70 76.98 11.58 2.4 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.506 -1.225 . . . . 0.72 110.665 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 35.8 mmtp -99.04 122.95 42.96 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 108.927 -0.768 . . . . 1.48 108.927 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 39.2 m -76.82 28.04 0.13 Allowed 'General case' 1 C--N 1.242 -4.071 0 C-N-CA 126.643 1.977 . . . . 1.25 114.854 -172.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.704 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 91.0 m-85 44.62 -93.0 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.4 113.698 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.3 t -77.27 44.02 0.4 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.399 1.095 . . . . 1.06 111.229 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.9 t70 -159.46 -55.47 0.06 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 108.858 -0.793 . . . . 1.74 108.858 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.557 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 33.4 m-20 -84.2 -34.95 23.83 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.134 -0.939 . . . . 1.29 111.955 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 33.3 mt -85.11 -88.94 0.11 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.31 -0.626 . . . . 0.81 109.31 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.449 ' H ' ' HB2' ' A' ' 36' ' ' LEU . 21.6 t70 157.11 64.67 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.609 -1.997 . . . . 1.12 105.609 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.54 HG11 ' HE3' ' A' ' 43' ' ' MET . 4.9 t -118.81 150.77 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.635 -0.712 . . . . 0.79 110.142 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.16 110.12 9.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.752 . . . . 2.0 108.968 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.568 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 29.5 t -41.06 -47.45 3.13 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.735 1.614 . . . . 0.78 114.071 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.9 pt? -64.67 -34.49 78.41 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.063 -0.398 . . . . 1.18 111.45 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 18' ' ' ILE . 14.7 m -82.2 -13.12 57.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.195 0.522 . . . . 0.6 111.002 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.704 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.26 -36.97 79.02 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 123.361 0.665 . . . . 0.86 110.289 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.11 -47.13 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 O-C-N 123.836 0.71 . . . . 0.31 110.31 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -56.69 -53.64 55.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.216 0.607 . . . . 0.68 110.358 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.835 ' HB ' HG13 ' A' ' 18' ' ' ILE 0.34 1.7 p -61.92 -22.59 29.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 N-CA-C 114.228 1.195 . . . . 0.63 114.228 -178.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.972 HG22 ' H6A' ' A' ' 101' ' ' SYO . 44.5 t -71.23 -50.38 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.746 -1.205 . . . . 0.55 107.746 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.28 -35.24 73.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 108.397 -0.964 . . . . 0.42 108.397 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 46' ' ' VAL . . . -68.06 -35.25 77.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.308 -0.86 . . . . 0.21 109.947 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.73 -59.08 4.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.508 -1.224 . . . . 0.21 109.102 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.273 0.0 OUTLIER -59.96 -39.31 85.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 114.461 1.282 . . . . 0.64 114.461 -175.135 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -58.92 -40.58 85.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.92 0.391 . . . . 2.07 111.835 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.9 -27.14 43.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.109 -0.496 . . . . 2.48 111.059 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.502 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 7.1 m-85 -104.27 3.06 32.25 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.675 -0.81 . . . . 0.81 112.322 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 28.0 t70 80.46 -5.68 1.75 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.821 1.248 . . . . 1.99 112.851 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 76' ' ' ILE . 10.6 p -82.02 173.43 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 121.29 -0.881 . . . . 0.37 109.205 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 18.4 tptm -128.62 127.28 41.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.552 -1.647 . . . . 2.12 106.552 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.509 HG13 ' HB3' ' A' ' 51' ' ' GLU . 64.0 mt -119.42 111.99 36.09 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.736 -0.386 . . . . 0.25 110.921 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.522 ' O ' HG23 ' A' ' 63' ' ' VAL . 58.7 Cg_endo -69.25 159.83 52.23 Favored 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 123.047 2.498 . . . . 0.33 110.808 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 22.1 t70 -52.78 -41.45 64.11 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.73 0.812 . . . . 1.98 112.116 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.5 -32.12 72.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.933 -0.576 . . . . 2.06 110.938 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 20.0 m-20 -86.3 -24.96 25.72 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.342 -0.543 . . . . 0.52 111.839 177.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.935 HG13 HG21 ' A' ' 47' ' ' VAL . 52.7 t -54.38 -51.58 47.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.588 -1.264 . . . . 0.38 107.588 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 13.8 ptmm? -78.51 -2.66 39.74 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.944 -1.026 . . . . 2.16 111.609 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -88.26 -29.67 20.24 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.935 -1.135 . . . . 1.59 107.935 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.693 HD13 ' HA ' ' A' ' 72' ' ' ALA . 29.4 mt -82.56 113.41 20.26 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 107.583 -1.265 . . . . 0.31 107.583 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -106.77 -40.2 5.58 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 119.866 -0.734 . . . . 2.55 109.129 176.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 p -108.26 178.29 4.54 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 119.715 -0.794 . . . . 0.23 109.307 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -86.63 -13.06 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.296 -1.002 . . . . 1.21 108.296 175.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.408 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -72.17 -37.63 59.59 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 108.114 -1.994 . . . . 0.33 108.114 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.1 -60.56 2.52 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.069 1.348 . . . . 1.39 109.492 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.693 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.49 -60.47 3.1 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 114.473 -1.239 . . . . 0.15 111.961 -176.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.601 HG21 ' HG2' ' A' ' 4' ' ' GLN . 61.6 m -59.39 -39.93 84.93 Favored 'General case' 0 N--CA 1.419 -2.0 0 O-C-N 124.102 0.877 . . . . 0.24 112.611 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 75' ' ' TYR . 9.7 tmtt? -61.37 -50.76 71.6 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.456 -0.942 . . . . 3.63 108.456 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' HE2' HG12 ' A' ' 58' ' ' ILE . 85.2 t80 -56.51 -50.71 71.0 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.321 1.013 . . . . 0.4 110.814 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.648 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -55.2 -66.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 114.009 -1.45 . . . . 0.21 110.223 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.646 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 64.5 tp -55.45 -38.4 68.98 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 123.968 0.907 . . . . 1.44 112.349 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.49 -28.75 67.3 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.363 -0.835 . . . . 0.63 111.194 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -102.03 -14.8 17.0 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.417 0.895 . . . . 1.25 113.417 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 66.7 mt-30 -66.43 -59.44 3.67 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 123.219 1.485 . . . . 0.87 107.753 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.259 -3.337 0 CA-C-N 111.092 -2.776 . . . . 1.97 108.823 -179.263 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.972 ' H6A' HG22 ' A' ' 47' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 109.546 -0.539 . . . . 1.42 109.546 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.06 -155.64 0.23 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.457 -1.312 . . . . 1.85 107.457 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t -131.96 -170.99 2.51 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.954 -0.387 . . . . 0.66 109.954 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.402 ' HG2' HG23 ' A' ' 8' ' ' VAL . 10.5 tm0? -49.12 -41.44 36.04 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.817 1.247 . . . . 0.74 113.552 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.59 -25.51 67.38 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.452 0.538 . . . . 2.66 112.452 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -87.19 -30.77 20.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.751 0.786 . . . . 2.73 109.108 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.419 HG23 ' CE2' ' A' ' 54' ' ' PHE . 96.1 mt -79.7 -65.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 CA-C-N 115.26 -0.882 . . . . 0.23 110.987 -172.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 4' ' ' GLN . 82.3 t -54.18 -46.71 67.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 122.568 0.347 . . . . 0.27 111.925 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.12 73.93 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.496 0.497 . . . . 0.27 111.546 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.77 -33.24 19.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.941 -0.572 . . . . 0.18 112.906 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -69.55 -34.66 74.53 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.044 -1.095 . . . . 0.2 108.044 -178.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.05 -46.47 75.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.28 -0.873 . . . . 0.14 108.826 173.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.667 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 41.9 mt-10 -61.61 -43.02 99.64 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 124.276 0.985 . . . . 0.68 111.86 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 11' ' ' LEU . 66.5 mt -58.71 -39.72 77.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.591 0.71 . . . . 0.28 109.644 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.743 HG12 ' HB ' ' A' ' 21' ' ' ILE . 62.7 t -70.74 -21.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.897 0.856 . . . . 0.27 110.015 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.667 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.0 m120 -80.47 -50.34 10.19 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.628 -1.249 . . . . 0.34 107.628 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.53 -50.25 59.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 2.07 112.279 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.01 -53.32 21.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.244 0.545 . . . . 0.65 109.86 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.56 -90.24 0.29 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.175 -0.466 . . . . 0.54 111.242 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.94 38.75 0.02 OUTLIER Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.599 -0.81 . . . . 0.43 113.104 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.743 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -80.99 155.1 72.87 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 109.417 -0.586 . . . . 0.31 109.417 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 4.8 Cg_exo -88.46 32.66 0.39 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.938 3.092 . . . . 1.08 114.768 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 5.2 p 60.05 -21.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.07 0 C-N-CA 127.147 2.179 . . . . 0.81 116.063 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -93.23 -20.32 20.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 112.691 0.626 . . . . 2.31 112.691 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.83 -30.77 51.25 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 120.74 -0.384 . . . . 1.59 111.258 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' A' ' 12' ' ' ALA . 34.7 t -72.89 97.88 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.28 -0.873 . . . . 0.3 109.672 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -135.69 151.03 49.78 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 104.413 -2.439 . . . . 1.58 104.413 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.548 HD22 ' HA2' ' A' ' 70' ' ' GLY . 49.3 mt -50.96 148.49 4.2 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.59 0.632 . . . . 1.05 109.574 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.7 t70 76.98 18.88 1.45 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.976 1.37 . . . . 0.72 109.94 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -119.21 128.46 54.23 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 114.703 -1.135 . . . . 1.48 108.442 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 5.7 m -87.36 112.1 21.77 Favored 'General case' 0 C--N 1.244 -3.983 0 N-CA-C 107.417 -1.327 . . . . 1.25 107.417 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.792 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 87.1 m-85 -46.63 -47.23 20.09 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.436 1.095 . . . . 0.4 112.708 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.426 HG21 ' C37' ' A' ' 101' ' ' SYO . 15.3 t -98.86 21.75 11.1 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 112.574 0.583 . . . . 1.06 112.574 -174.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 13.6 t70 -146.48 -56.89 0.28 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 1.74 109.792 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.22 -39.27 55.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.881 -1.054 . . . . 1.29 110.402 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' HA ' ' A' ' 32' ' ' PHE . 35.6 mt -83.61 -93.17 0.07 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.513 -0.767 . . . . 0.81 110.365 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 32.6 t70 168.09 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 121.349 0.595 . . . . 1.12 111.127 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.541 HG11 ' HE3' ' A' ' 43' ' ' MET . 41.5 t -77.29 134.82 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 O-C-N 121.178 -0.951 . . . . 0.79 112.039 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 5.3 t70 -47.37 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 129.218 3.007 . . . . 2.0 117.297 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 43' ' ' MET . 30.5 t 75.03 -54.96 0.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.455 1.279 . . . . 0.78 114.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.488 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -74.58 -29.28 61.27 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.085 -1.446 . . . . 1.18 109.37 178.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 46' ' ' VAL . 67.3 m -70.6 -16.09 62.81 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.157 -0.929 . . . . 0.6 111.412 173.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.629 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -62.24 -41.35 98.34 Favored 'General case' 0 CA--C 1.473 -1.993 0 C-N-CA 123.101 0.56 . . . . 0.86 111.851 -178.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -57.29 -43.13 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 124.302 1.001 . . . . 0.31 109.734 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -56.5 -47.51 79.16 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.855 -0.611 . . . . 0.68 109.782 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 42' ' ' SER . 40.3 t -60.91 -24.59 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.32 -0.855 . . . . 0.63 111.107 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.028 HG22 ' H6A' ' A' ' 101' ' ' SYO . 29.2 t -81.11 -53.07 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 108.182 -1.044 . . . . 0.55 108.182 -177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 -29.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.739 -1.119 . . . . 0.42 109.762 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.57 58.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.282 -0.636 . . . . 0.21 109.282 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.58 -53.63 44.73 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.103 -0.953 . . . . 0.21 109.272 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.258 0.0 OUTLIER -63.97 -34.93 79.09 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.663 0.986 . . . . 0.64 113.663 -177.716 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -64.28 -36.89 85.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.117 0.484 . . . . 2.07 111.375 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.61 -35.91 20.69 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.451 -0.795 . . . . 2.48 111.891 -172.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 11.4 m-85 -89.76 -45.1 9.54 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 118.926 -1.11 . . . . 0.81 113.185 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 13.5 t70 154.11 -33.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 124.618 1.199 . . . . 1.99 111.781 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' A' ' 79' ' ' HIS . 9.3 p -76.85 -177.0 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.449 0.537 . . . . 0.37 112.449 -165.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' H ' HG22 ' A' ' 56' ' ' VAL . 7.4 ttmm -135.98 131.37 34.97 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.721 -1.585 . . . . 2.12 106.721 169.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.621 HG23 ' HE2' ' A' ' 75' ' ' TYR . 45.4 mt -122.03 111.64 32.26 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 123.425 0.453 . . . . 0.25 110.347 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.602 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.9 Cg_endo -72.31 160.34 47.28 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.982 2.455 . . . . 0.33 110.634 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.11 -43.32 41.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.751 . . . . 1.98 111.74 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 35.0 t70 -63.64 -34.22 77.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 2.06 112.68 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.589 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 67.0 m-20 -86.15 -28.22 24.1 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.113 -0.635 . . . . 0.52 110.993 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.928 HG13 HG21 ' A' ' 47' ' ' VAL . 76.8 t -55.61 -55.46 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.363 -0.977 . . . . 0.38 108.363 174.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 61' ' ' ASP . 17.1 pttp -69.62 -1.19 8.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.927 -1.033 . . . . 2.16 112.891 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.86 -23.5 16.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.86 -1.163 . . . . 1.59 107.86 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.03 ' HB2' ' H4A' ' A' ' 101' ' ' SYO . 21.6 mt -91.59 125.17 36.23 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 106.726 -1.583 . . . . 0.31 106.726 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -113.24 -39.63 4.11 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.336 -0.987 . . . . 2.55 108.336 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.702 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 71.8 p -104.53 179.58 4.23 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-N 115.463 -0.79 . . . . 0.23 109.887 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.792 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -87.08 -13.95 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 108.237 -1.024 . . . . 1.21 108.237 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.548 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -69.03 -47.59 53.12 Favored Glycine 0 CA--C 1.492 -1.39 0 N-CA-C 107.437 -2.265 . . . . 0.33 107.437 172.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 23.7 m-20 -56.6 -55.91 28.04 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 125.271 1.429 . . . . 1.39 110.925 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.894 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -54.56 -60.49 3.28 Favored 'General case' 0 CA--C 1.479 -1.763 0 O-C-N 124.472 1.107 . . . . 0.15 112.166 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.8 HG22 HD23 ' A' ' 77' ' ' LEU . 33.7 m -54.55 -51.48 65.09 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.013 -0.994 . . . . 0.24 112.949 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -51.07 -29.25 12.41 Favored 'General case' 0 C--O 1.197 -1.675 0 C-N-CA 126.749 2.019 . . . . 3.63 111.444 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.621 ' HE2' HG23 ' A' ' 58' ' ' ILE . 73.1 t80 -85.21 -48.89 8.67 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.61 -0.723 . . . . 0.4 109.333 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.666 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.9 mt -56.51 -63.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 114.697 -1.138 . . . . 0.21 109.372 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.8 HD23 HG22 ' A' ' 73' ' ' THR . 4.5 pp -56.97 -36.58 70.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.734 0.778 . . . . 1.44 112.622 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.47 ' N ' HD12 ' A' ' 77' ' ' LEU . 5.5 t70 -76.5 -26.74 55.59 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.472 -1.24 . . . . 0.63 111.276 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.617 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 20.5 t-80 -94.98 -16.38 22.81 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.003 -0.544 . . . . 1.25 109.983 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 32.7 mt-30 -76.07 -56.67 4.44 Favored 'General case' 0 CA--C 1.478 -1.789 0 CA-C-O 122.729 1.252 . . . . 0.87 108.187 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.735 0 CA-C-N 112.328 -2.215 . . . . 1.97 110.821 -173.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 1.03 ' H4A' ' HB2' ' A' ' 66' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.965 0 N-CA-C 106.945 -1.502 . . . . 1.42 106.945 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.59 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -146.57 132.69 19.33 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 116.405 -0.361 . . . . 1.85 111.169 -169.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.44 ' O ' HG13 ' A' ' 7' ' ' ILE . 10.7 t -89.34 176.1 7.07 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 105.874 -1.898 . . . . 0.66 105.874 171.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.419 ' HG2' HG23 ' A' ' 8' ' ' VAL . 11.5 tm0? -46.62 -46.76 19.94 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.823 1.416 . . . . 0.74 114.823 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.36 -23.54 65.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.966 1.099 . . . . 2.66 113.966 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.59 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 8.8 tp10 -87.95 -33.99 18.25 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.426 -0.953 . . . . 2.73 108.426 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.621 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.3 mt -72.0 -65.35 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.515 0 CA-C-N 115.955 -0.566 . . . . 0.23 110.61 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.518 HG13 HG21 ' A' ' 69' ' ' VAL . 26.4 t -59.85 -26.7 36.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 111.934 0.346 . . . . 0.27 111.934 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.42 -37.91 68.52 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.942 -0.703 . . . . 0.27 110.124 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.68 -36.44 11.85 Favored Glycine 0 N--CA 1.419 -2.456 0 CA-C-N 116.186 -0.461 . . . . 0.18 113.068 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.07 -35.36 80.32 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.571 -0.899 . . . . 0.2 108.571 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.792 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -57.08 -44.3 82.99 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.87 -0.605 . . . . 0.14 109.74 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.689 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 46.4 mt-10 -62.69 -42.55 99.69 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.175 -0.92 . . . . 0.68 111.834 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 11' ' ' LEU . 50.2 mt -61.14 -36.63 73.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.923 0.868 . . . . 0.28 109.848 177.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.677 HG12 ' HB ' ' A' ' 21' ' ' ILE . 60.5 t -74.97 -23.27 17.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.224 -0.898 . . . . 0.27 110.325 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.689 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 9.0 m120 -70.25 -46.35 64.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.631 -0.877 . . . . 0.34 108.631 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.06 -49.38 17.66 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.997 -1.001 . . . . 2.07 113.482 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.652 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.9 mt -75.64 -51.1 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 112.327 0.492 . . . . 0.65 112.327 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.717 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -91.68 -75.28 0.48 Allowed 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.273 -0.571 . . . . 0.54 110.384 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.54 41.0 0.04 OUTLIER Glycine 0 C--N 1.3 -1.442 0 CA-C-N 115.564 -0.744 . . . . 0.43 112.572 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.833 HG21 HG23 ' A' ' 26' ' ' VAL . 1.5 mp -81.98 150.66 65.66 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 109.055 -0.72 . . . . 0.31 109.055 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 8.2 Cg_exo -87.02 33.46 0.43 Allowed 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 124.348 3.365 . . . . 1.08 114.27 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 21' ' ' ILE 0.324 9.2 p 60.81 -18.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.091 2.157 . . . . 0.81 116.597 175.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -96.79 -11.34 25.07 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.391 -0.818 . . . . 2.31 111.79 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.494 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.4 m-20 -79.73 -33.2 41.02 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.094 0.474 . . . . 1.59 110.495 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.833 HG23 HG21 ' A' ' 21' ' ' ILE . 40.9 t -72.83 93.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.969 -1.014 . . . . 0.3 110.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -124.7 168.23 13.46 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.69 -1.596 . . . . 1.58 106.69 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.573 ' HA ' HG22 ' A' ' 69' ' ' VAL . 5.8 mp -68.05 151.19 47.44 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.905 -1.146 . . . . 1.05 107.905 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 t70 76.68 12.84 2.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.282 1.039 . . . . 0.72 109.548 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -111.65 125.21 53.71 Favored 'General case' 0 CA--C 1.458 -2.576 0 O-C-N 121.7 -0.625 . . . . 1.48 110.442 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 12.2 m -80.26 111.89 17.07 Favored 'General case' 0 C--N 1.247 -3.854 0 CA-C-N 114.428 -1.26 . . . . 1.25 108.213 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 36' ' ' LEU . 90.8 m-85 -48.41 -55.48 10.73 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.445 0.698 . . . . 0.4 110.548 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.704 HG21 ' H37' ' A' ' 101' ' ' SYO . 12.3 t -84.08 25.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.595 0.591 . . . . 1.06 112.595 -175.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.7 t70 -156.11 -62.14 0.11 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.535 0.684 . . . . 1.74 111.237 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -70.79 -39.52 73.08 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 124.368 1.067 . . . . 1.29 110.466 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.608 HD13 HG22 ' A' ' 26' ' ' VAL . 16.4 mt -88.11 -50.44 6.39 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.202 -0.908 . . . . 0.81 110.802 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 95.03 68.66 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.852 2.061 . . . . 1.12 110.723 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 19' ' ' ALA . 47.4 t -101.42 132.45 47.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 CA-C-N 113.366 -1.743 . . . . 0.79 106.577 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -62.68 20.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.545 2.054 . . . . 2.0 116.545 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.484 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 28.6 t 61.99 -57.89 0.12 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 116.139 1.903 . . . . 0.78 116.139 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.57 -29.58 70.82 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.953 0.882 . . . . 1.18 109.987 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.652 ' HB3' HG22 ' A' ' 18' ' ' ILE . 1.6 m -75.05 -22.52 58.34 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.277 -1.329 . . . . 0.6 110.656 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.751 ' HB3' ' H2A' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -60.27 -43.75 95.9 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 123.743 0.817 . . . . 0.86 112.341 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.63 -36.95 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 O-C-N 123.946 0.779 . . . . 0.31 110.605 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.28 -43.94 93.23 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 108.768 -0.827 . . . . 0.68 108.768 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 42' ' ' SER . 58.3 t -61.96 -25.05 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.469 1.107 . . . . 0.63 111.11 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.884 HG11 HG22 ' A' ' 63' ' ' VAL . 55.3 t -77.25 -55.71 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 107.422 -1.325 . . . . 0.55 107.422 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 58.6 t -57.3 -40.79 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 O-C-N 124.806 1.316 . . . . 0.42 108.94 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -65.6 -35.24 80.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.373 0.606 . . . . 0.21 110.685 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -68.57 -57.13 6.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.351 -0.841 . . . . 0.21 109.783 178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.69 -33.95 76.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.634 0.976 . . . . 0.64 113.634 -177.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 51.8 mt-10 -59.32 -53.17 61.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.643 0.259 . . . . 2.07 110.368 173.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -66.18 -47.12 74.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.513 0.56 . . . . 2.48 112.513 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.621 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 12.3 m-85 -84.37 -9.41 58.45 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.648 0.61 . . . . 0.81 112.648 -172.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 85.05 3.59 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 116.385 1.994 . . . . 1.99 116.385 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 13.9 p -82.91 171.72 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.129 -1.028 . . . . 0.37 108.863 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -120.17 128.02 53.01 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.815 -1.55 . . . . 2.12 106.815 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.506 HG13 ' HB3' ' A' ' 51' ' ' GLU . 60.3 mt -116.79 108.97 43.81 Favored Pre-proline 0 C--N 1.308 -1.198 0 C-N-CA 119.964 -0.694 . . . . 0.25 111.52 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 63' ' ' VAL . 51.7 Cg_endo -69.02 159.13 55.19 Favored 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 123.184 2.59 . . . . 0.33 110.928 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.22 -33.62 67.71 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.681 0.792 . . . . 1.98 110.21 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.81 -38.07 89.26 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.067 -0.97 . . . . 2.06 110.835 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.544 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 41.1 m-20 -87.04 -25.17 24.34 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.187 -0.605 . . . . 0.52 112.464 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.884 HG22 HG11 ' A' ' 47' ' ' VAL . 94.7 t -55.88 -42.09 69.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.441 -0.948 . . . . 0.38 108.441 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -78.18 -5.32 51.42 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.669 -0.696 . . . . 2.16 112.304 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.43 -25.58 16.85 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 109.822 -0.436 . . . . 1.59 109.822 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.866 HD13 ' HA ' ' A' ' 72' ' ' ALA . 22.0 mt -89.12 122.04 32.04 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 107.095 -1.446 . . . . 0.31 107.095 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' SER . 8.3 mptt -120.21 -34.88 3.57 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.505 -0.924 . . . . 2.55 108.505 174.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 39.4 p -106.41 173.47 6.3 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 108.894 -0.78 . . . . 0.23 108.894 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 28' ' ' LEU . 1.4 m -81.92 -13.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 C-N-CA 119.35 -0.94 . . . . 1.21 108.535 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.46 -43.53 92.24 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 108.632 -1.787 . . . . 0.33 108.632 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.73 -56.84 13.98 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.866 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -52.12 -61.02 2.53 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 114.087 -1.415 . . . . 0.15 112.506 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.492 ' HA ' HG21 ' A' ' 7' ' ' ILE . 49.9 m -56.62 -46.3 81.02 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.492 1.12 . . . . 0.24 112.451 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -56.51 -52.34 65.1 Favored 'General case' 0 N--CA 1.41 -2.469 0 O-C-N 124.453 1.095 . . . . 3.63 108.765 177.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.545 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 74.4 t80 -55.18 -50.51 69.18 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 124.057 0.848 . . . . 0.4 111.515 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.631 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.8 mt -54.4 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-N 114.151 -1.386 . . . . 0.21 110.207 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.494 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 4.2 tt -57.95 -45.51 86.53 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.615 0.766 . . . . 1.44 110.182 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.85 -24.07 66.67 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.049 0.94 . . . . 0.63 111.384 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -98.8 -26.42 14.32 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 113.011 0.745 . . . . 1.25 113.011 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.45 2.7 pp0? -99.99 -99.02 0.24 Allowed 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 116.405 2.002 . . . . 0.87 116.405 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.426 ' H ' ' CD ' ' A' ' 80' ' ' GLN . . . . . . . . 0 C--N 1.258 -3.375 0 CA-C-N 116.098 -0.501 . . . . 1.97 111.271 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.851 ' H4A' ' HB2' ' A' ' 66' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.408 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 0 CA--C 1.508 -0.654 0 N-CA-C 108.629 -0.878 . . . . 1.42 108.629 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -157.4 133.83 9.77 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.306 -1.368 . . . . 1.85 107.306 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 7' ' ' ILE . 6.6 t -89.06 -178.05 5.59 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.736 -0.786 . . . . 0.66 110.751 -174.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.1 tm0? -47.79 -43.21 27.39 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.015 0.926 . . . . 0.74 113.357 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.48 -34.73 62.12 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.594 0.559 . . . . 2.66 111.709 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 19.3 tp10 -87.31 -34.88 18.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.884 -0.598 . . . . 2.73 109.941 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.538 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 92.7 mt -68.54 -65.72 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 CA-C-N 116.497 -0.319 . . . . 0.23 110.528 -174.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -41.52 67.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 112.386 0.513 . . . . 0.27 112.386 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -61.54 -42.28 98.59 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.033 0.444 . . . . 0.27 110.348 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.0 -40.91 28.93 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 121.028 -0.606 . . . . 0.18 113.081 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.16 -38.53 91.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.775 -0.824 . . . . 0.2 108.775 -178.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.619 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.13 -48.24 80.84 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.792 -0.64 . . . . 0.14 109.573 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.69 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 52.5 mt-10 -60.21 -39.37 86.33 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.895 0.747 . . . . 0.68 111.998 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 11' ' ' LEU . 62.9 mt -61.24 -41.88 91.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.009 -0.541 . . . . 0.28 109.754 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 11' ' ' LEU . 46.7 t -71.42 -23.55 22.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.357 0.599 . . . . 0.27 109.945 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.69 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.5 m120 -68.2 -48.81 64.21 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.905 -1.146 . . . . 0.34 107.905 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -69.88 -42.98 72.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.895 -1.048 . . . . 2.07 111.821 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.747 HG13 HG22 ' A' ' 46' ' ' VAL . 19.2 mm -73.85 -53.71 16.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 116.01 -0.541 . . . . 0.65 111.707 -177.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.52 -62.99 1.38 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.171 0.51 . . . . 0.54 111.403 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.33 39.13 0.07 OUTLIER Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.414 -0.898 . . . . 0.43 112.964 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.721 HG21 HG23 ' A' ' 26' ' ' VAL . 1.2 mp -78.03 152.35 79.54 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.459 -0.571 . . . . 0.31 109.459 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.6 Cg_endo -89.85 25.37 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.984 2.456 . . . . 1.08 115.052 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.477 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 5.0 p 53.62 15.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 125.447 1.499 . . . . 0.81 113.857 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 12.0 pt-20 -123.13 -16.07 7.08 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.888 -0.596 . . . . 2.31 110.338 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.441 ' OD2' ' HA ' ' A' ' 36' ' ' LEU . 22.0 t70 -92.41 -25.64 18.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.675 0.75 . . . . 1.59 110.108 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.721 HG23 HG21 ' A' ' 21' ' ' ILE . 43.0 t -76.09 92.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.444 -1.253 . . . . 0.3 108.863 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -125.87 166.78 16.25 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.576 -1.268 . . . . 1.58 107.576 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.403 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 9.5 mp -63.53 146.0 54.54 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.45 -0.574 . . . . 1.05 109.45 176.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.48 12.47 3.87 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.119 1.367 . . . . 0.72 110.431 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 68' ' ' THR . 73.7 mmtt -103.57 124.79 49.45 Favored 'General case' 0 CA--C 1.47 -2.11 0 O-C-N 121.791 -0.568 . . . . 1.48 109.777 176.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 6.3 m -83.23 110.86 18.43 Favored 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 114.488 -1.233 . . . . 1.25 108.427 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.662 ' HA ' HD12 ' A' ' 36' ' ' LEU . 98.2 m-85 -42.02 -67.23 0.28 Allowed 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 125.725 1.61 . . . . 0.4 112.426 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.505 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 14.8 t -101.56 49.35 0.87 Allowed 'General case' 0 C--N 1.275 -2.658 0 C-N-CA 118.776 -1.17 . . . . 1.06 111.134 -177.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 29.4 t70 -154.62 -53.72 0.1 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.73 -1.123 . . . . 1.74 109.773 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -86.23 -44.5 12.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.207 1.003 . . . . 1.29 110.771 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 32' ' ' PHE . 32.7 mt -71.75 -91.24 0.02 OUTLIER 'General case' 0 C--O 1.249 1.036 0 O-C-N 123.715 0.634 . . . . 0.81 111.4 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 25.4 t70 158.25 61.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 126.099 1.76 . . . . 1.12 108.459 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 33' ' ' THR . 26.8 t -101.72 165.81 2.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.694 -0.684 . . . . 0.79 110.022 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 38' ' ' VAL . 10.0 m-20 -83.26 6.15 20.62 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.681 0.793 . . . . 2.0 112.879 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 43' ' ' MET . 20.5 t 66.66 -66.5 0.18 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.579 1.152 . . . . 0.78 113.245 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.02 -26.52 65.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.583 0.706 . . . . 1.18 110.802 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 15.7 m -80.54 -13.46 59.06 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.548 -0.751 . . . . 0.6 110.569 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.694 ' SD ' ' H5A' ' A' ' 101' ' ' SYO . 18.0 tpp -73.04 -31.65 64.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.002 -0.544 . . . . 0.86 110.978 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.644 HG22 ' S1 ' ' A' ' 101' ' ' SYO . 24.8 t -55.15 -42.59 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 N-CA-C 108.784 -0.821 . . . . 0.31 108.784 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' SER . 26.0 mm-40 -54.53 -53.14 58.38 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 123.781 0.832 . . . . 0.68 110.282 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.747 HG22 HG13 ' A' ' 18' ' ' ILE . 51.6 t -54.16 -32.14 22.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 124.374 1.07 . . . . 0.63 112.048 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.83 HG21 HG13 ' A' ' 63' ' ' VAL . 27.9 t -73.32 -48.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.567 -0.901 . . . . 0.55 108.567 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.415 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 43.8 t -68.3 -31.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.272 -1.01 . . . . 0.42 108.272 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -69.66 -34.17 73.62 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.41 0.624 . . . . 0.21 109.738 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.48 42.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.974 -1.012 . . . . 0.21 108.994 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.261 0.0 OUTLIER -66.77 -29.63 69.64 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.714 1.005 . . . . 0.64 113.714 -177.727 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 41.4 mt-10 -63.34 -38.16 90.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.274 0.559 . . . . 2.07 110.627 174.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -86.86 -35.37 19.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.272 0.471 . . . . 2.48 112.272 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 8.1 m-85 -97.72 -0.03 46.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 120.025 -0.67 . . . . 0.81 112.186 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 78.44 -2.77 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.584 1.327 . . . . 1.99 114.584 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.671 ' HB ' ' HG2' ' A' ' 80' ' ' GLN . 14.8 p -75.73 175.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 O-C-N 121.098 -1.001 . . . . 0.37 108.947 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 36.5 tptt -124.61 128.96 49.68 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.82 -1.178 . . . . 2.12 107.82 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 51' ' ' GLU . 27.1 mt -123.09 110.98 30.8 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 120.165 -0.614 . . . . 0.25 110.825 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.581 ' HD2' ' OH ' ' A' ' 75' ' ' TYR . 67.8 Cg_endo -73.89 158.4 46.39 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.591 2.194 . . . . 0.33 109.582 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.69 -36.57 62.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.194 0.597 . . . . 1.98 110.806 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.44 -42.69 87.89 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.575 0.75 . . . . 2.06 111.63 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.5 m-20 -86.32 -24.92 25.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 121.017 -0.273 . . . . 0.52 111.581 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.83 HG13 HG21 ' A' ' 47' ' ' VAL . 55.8 t -53.06 -58.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.138 -1.06 . . . . 0.38 108.138 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -72.87 -1.49 17.01 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.213 -0.903 . . . . 2.16 111.705 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 38.3 t30 -87.61 -34.41 18.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.847 -1.168 . . . . 1.59 107.847 -177.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 72' ' ' ALA . 12.8 mt -79.42 131.38 36.07 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 106.459 -1.682 . . . . 0.31 106.459 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.741 ' HG3' ' H38' ' A' ' 101' ' ' SYO . 12.7 mptt -116.77 -42.34 2.98 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.997 -1.112 . . . . 2.55 107.997 171.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 81.9 p -101.88 170.38 8.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.901 -1.045 . . . . 0.23 110.224 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.5 -13.6 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.104 -1.073 . . . . 1.21 108.104 174.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.403 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -70.58 -30.47 68.72 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.244 -1.143 . . . . 0.33 110.244 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -81.97 -51.28 8.21 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.066 -1.087 . . . . 1.39 108.066 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.773 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.79 -60.42 2.91 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 114.323 -1.308 . . . . 0.15 111.967 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 4' ' ' GLN . 45.8 m -57.24 -42.27 81.14 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.671 -1.149 . . . . 0.24 112.508 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.54 ' HD2' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -57.29 -53.25 60.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.974 -1.121 . . . . 3.63 107.974 176.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.581 ' OH ' ' HD2' ' A' ' 59' ' ' PRO . 82.1 t80 -56.48 -50.54 71.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 124.19 0.931 . . . . 0.4 111.148 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.634 ' HA ' HG21 ' A' ' 56' ' ' VAL . 70.8 mt -55.73 -66.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.278 -1.328 . . . . 0.21 109.98 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.46 -47.18 66.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.8 0.84 . . . . 1.44 110.538 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.09 -22.97 65.8 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.221 -0.899 . . . . 0.63 112.285 -172.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -102.79 4.27 37.7 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.303 0.853 . . . . 1.25 113.303 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.671 ' HG2' ' HB ' ' A' ' 56' ' ' VAL 0.309 0.7 OUTLIER -124.01 -84.61 0.65 Allowed 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 113.832 1.049 . . . . 0.87 113.832 175.573 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.253 -3.627 0 CA-C-O 118.496 -0.764 . . . . 1.97 112.106 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.771 ' H28' HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.689 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 108.534 -0.913 . . . . 1.42 108.534 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . . . -165.59 -73.18 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.709 0.29 . . . . 1.85 111.696 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 6.4 t -171.71 -170.96 0.84 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.814 -0.81 . . . . 0.66 108.814 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.653 ' HA ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -48.71 -42.2 34.26 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.941 1.296 . . . . 0.74 112.653 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.35 -22.56 63.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.821 0.674 . . . . 2.66 112.821 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 3' ' ' THR . 4.1 tp10 -81.34 -36.77 29.29 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.412 -0.959 . . . . 2.73 108.412 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 4' ' ' GLN . 71.2 mt -79.03 -67.91 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.117 0 CA-C-N 115.294 -0.866 . . . . 0.23 110.844 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 t -59.09 -41.88 84.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 112.568 0.581 . . . . 0.27 112.568 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.38 82.72 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.317 0.386 . . . . 0.27 111.288 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.38 -40.53 8.39 Favored Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 120.393 -0.908 . . . . 0.18 112.2 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.72 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -59.46 -42.72 92.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.277 1.031 . . . . 0.2 108.278 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -54.43 -48.12 72.04 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.664 0.603 . . . . 0.14 110.615 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.724 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 54.4 mt-10 -65.71 -35.71 81.53 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 123.709 0.631 . . . . 0.68 111.746 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 11' ' ' LEU . 64.4 mt -60.73 -42.47 92.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.618 -0.719 . . . . 0.28 109.595 174.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 11' ' ' LEU . 41.3 t -68.47 -23.94 28.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 121.845 0.831 . . . . 0.27 109.864 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.724 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.9 m120 -75.57 -52.35 10.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.176 -1.046 . . . . 0.34 108.176 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -66.66 -46.42 75.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.615 -1.175 . . . . 2.07 112.476 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.62 HG22 ' HB3' ' A' ' 42' ' ' SER . 21.2 mm -70.79 -53.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.878 0.371 . . . . 0.65 110.27 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.74 -74.31 0.65 Allowed 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.664 -0.414 . . . . 0.54 111.519 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.18 54.45 0.02 OUTLIER Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 120.291 -0.957 . . . . 0.43 112.045 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.615 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -95.62 154.57 39.17 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.493 -0.558 . . . . 0.31 109.493 175.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.533 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 6.2 Cg_exo -88.02 29.45 0.47 Allowed 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 124.224 3.283 . . . . 1.08 115.673 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.483 ' H ' HG22 ' A' ' 21' ' ' ILE . 6.5 p 57.87 -0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 117.838 2.533 . . . . 0.81 117.838 171.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.479 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 43.7 mt-10 -117.93 -13.39 10.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.34 -1.475 . . . . 2.31 111.225 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 2.0 m-20 -87.03 -29.28 22.06 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.005 -1.452 . . . . 1.59 110.127 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 12' ' ' ALA . 41.9 t -69.35 97.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 0.3 108.79 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.1 mttt -138.35 170.04 16.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 109.069 -0.715 . . . . 1.58 109.069 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 7.8 mp -61.13 143.03 56.23 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.174 -0.676 . . . . 1.05 109.174 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t70 81.99 1.04 1.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.029 1.332 . . . . 0.72 110.898 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.596 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 44.2 mmtm -92.8 120.35 33.08 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 119.589 -0.844 . . . . 1.48 109.644 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.529 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 15.9 m -79.12 27.09 0.25 Allowed 'General case' 1 C--N 1.244 -4.019 0 C-N-CA 125.968 1.707 . . . . 1.25 113.876 -172.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.59 ' CZ ' HG22 ' A' ' 69' ' ' VAL . 96.7 m-85 46.13 -88.58 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.495 1.518 . . . . 0.4 113.989 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.431 ' CG2' ' H37' ' A' ' 101' ' ' SYO . 8.6 t -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.133 0.573 . . . . 1.06 111.374 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 32.3 t70 -88.17 -39.72 14.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.978 0.418 . . . . 1.74 111.298 -175.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.596 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -93.21 -41.31 9.97 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.514 0.931 . . . . 1.29 113.514 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 38' ' ' VAL . 22.6 mt -88.19 -72.42 0.53 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.388 -0.525 . . . . 0.81 110.68 -173.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.0 t70 163.83 -22.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 124.321 1.013 . . . . 1.12 109.612 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 36' ' ' LEU . 3.0 t -45.99 105.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.77 1.628 . . . . 0.79 112.939 -170.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.523 ' OD2' ' HG ' ' A' ' 41' ' ' LEU . 24.9 t70 -54.04 124.15 14.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 124.04 0.838 . . . . 2.0 112.589 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.588 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 29.9 t -37.51 -45.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.612 2.078 . . . . 0.78 116.612 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.523 ' HG ' ' OD2' ' A' ' 39' ' ' ASP . 3.9 pp -75.92 -23.15 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 117.607 -1.637 . . . . 1.18 112.26 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.62 ' HB3' HG22 ' A' ' 18' ' ' ILE . 42.9 m -84.2 -18.91 35.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.735 -0.666 . . . . 0.6 109.665 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.879 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -56.95 -43.55 81.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.19 0.996 . . . . 0.86 112.715 -178.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.25 -40.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 123.845 0.716 . . . . 0.31 110.171 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -63.36 -44.45 94.77 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.969 -0.56 . . . . 0.68 109.722 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.589 HG11 HG22 ' A' ' 15' ' ' VAL . 42.0 t -60.0 -25.13 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.425 -0.807 . . . . 0.63 110.903 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.926 HG21 HG13 ' A' ' 63' ' ' VAL . 21.5 t -82.27 -53.75 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 108.79 -0.818 . . . . 0.55 108.79 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.14 -36.73 74.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.72 -1.127 . . . . 0.42 109.171 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -31.61 67.37 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.824 -0.435 . . . . 0.21 109.824 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -61.55 -58.21 9.04 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.285 -0.87 . . . . 0.21 109.094 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -64.47 -36.06 82.95 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.906 1.076 . . . . 0.64 113.906 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.99 -29.74 69.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 2.07 111.512 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -88.41 -32.34 18.38 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.227 -0.442 . . . . 2.48 111.559 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CE2' ' HB1' ' A' ' 50' ' ' ALA . 4.6 m-30 -93.13 -11.14 33.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 120.386 -0.526 . . . . 0.81 111.938 -173.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.689 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 25.7 t70 81.38 6.77 1.2 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.493 1.517 . . . . 1.99 111.987 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' A' ' 76' ' ' ILE . 14.5 p -84.7 171.15 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 107.584 -1.265 . . . . 0.37 107.584 174.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 19.5 tptt -124.6 123.06 39.24 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.654 -0.869 . . . . 2.12 108.654 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.542 HG12 ' HE2' ' A' ' 75' ' ' TYR . 62.8 mt -118.9 112.73 36.32 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 109.835 -0.432 . . . . 0.25 109.835 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 63' ' ' VAL . 37.7 Cg_endo -67.43 158.2 58.18 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.747 2.298 . . . . 0.33 110.282 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 6.2 p-10 -58.55 -30.43 67.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.399 -0.364 . . . . 1.98 111.422 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.74 -34.03 69.2 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 112.428 0.529 . . . . 2.06 112.428 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.497 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 52.5 m-20 -78.73 -25.07 44.57 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 119.524 -0.87 . . . . 0.52 110.985 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.926 HG13 HG21 ' A' ' 47' ' ' VAL . 70.0 t -54.27 -39.7 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.229 -1.026 . . . . 0.38 108.229 170.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 60' ' ' ASP . 81.9 mttt -73.98 -14.63 61.06 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.0 -1.0 . . . . 2.16 112.22 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -96.49 -36.17 10.88 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.594 0.358 . . . . 1.59 111.511 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.9 mt -68.71 113.05 5.84 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 105.678 -1.971 . . . . 0.31 105.678 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -108.21 -31.3 7.95 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 119.762 -0.775 . . . . 2.55 109.807 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 67.9 p -121.01 178.42 4.74 Favored 'General case' 0 N--CA 1.392 -3.338 0 N-CA-C 108.557 -0.905 . . . . 0.23 108.557 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.59 HG22 ' CZ ' ' A' ' 32' ' ' PHE . 6.4 t -77.45 -13.56 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 107.683 -1.228 . . . . 1.21 107.683 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.84 -49.04 37.93 Favored Glycine 0 CA--C 1.489 -1.583 0 N-CA-C 109.871 -1.292 . . . . 0.33 109.871 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.77 -44.36 77.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.963 -0.618 . . . . 1.39 109.373 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -56.61 -61.64 2.28 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.019 -0.992 . . . . 0.15 111.266 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.613 ' HA ' HG21 ' A' ' 7' ' ' ILE . 60.7 m -54.36 -43.71 71.54 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.696 -1.138 . . . . 0.24 113.804 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.1 mptp? -61.03 -50.9 71.48 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.99 -0.744 . . . . 3.63 108.99 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.542 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.8 t80 -54.47 -51.82 63.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.643 -1.162 . . . . 0.4 110.225 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.655 ' HA ' HG21 ' A' ' 56' ' ' VAL . 78.3 mt -55.37 -65.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 114.19 -1.368 . . . . 0.21 110.716 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . 5.2 tt -51.73 -43.61 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.9 0.88 . . . . 1.44 110.57 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.07 -25.53 64.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.875 -1.057 . . . . 0.63 111.823 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -101.51 -5.83 24.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.794 -0.639 . . . . 1.25 112.344 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.582 HE21 HG22 ' A' ' 76' ' ' ILE 0.302 1.0 OUTLIER -106.18 -92.55 0.39 Allowed 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 113.636 0.976 . . . . 0.87 113.636 175.911 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.266 -3.044 0 CA-C-N 115.264 -0.88 . . . . 1.97 111.027 -175.288 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.879 ' H1 ' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.811 ' HB1' ' HB2' ' A' ' 81' ' ' ALA . . . . . . . . 0 CA--C 1.503 -0.849 0 N-CA-C 109.247 -0.649 . . . . 1.42 109.247 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -127.93 136.03 50.78 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.713 -0.676 . . . . 1.85 109.801 -174.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.596 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 13.1 t -94.89 -178.75 4.61 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.673 -0.862 . . . . 0.66 108.673 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' HG2' HG21 ' A' ' 73' ' ' THR . 16.0 tm0? -46.9 -48.25 21.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.141 1.163 . . . . 0.74 114.141 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.478 ' HG3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -51.98 -32.33 33.17 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.567 0.951 . . . . 2.66 113.567 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.589 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 11.1 tp10 -87.45 -40.45 14.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.292 0.637 . . . . 2.73 109.87 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.635 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 99.5 mt -63.56 -58.74 6.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 116.139 -0.482 . . . . 0.23 110.016 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.547 HG21 HD11 ' A' ' 28' ' ' LEU . 46.0 t -66.29 -22.91 30.86 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.871 -0.604 . . . . 0.27 111.695 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.92 55.78 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.759 -0.776 . . . . 0.27 109.177 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.15 -44.09 24.12 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 115.008 -0.996 . . . . 0.18 113.225 -176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -63.13 -33.08 74.68 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 123.448 0.699 . . . . 0.2 109.376 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -60.75 -51.14 70.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.659 -0.701 . . . . 0.14 109.263 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 51.2 mt-10 -59.44 -41.83 90.53 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 124.183 0.927 . . . . 0.68 111.809 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 11' ' ' LEU . 71.4 mt -56.79 -42.17 77.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.461 -0.79 . . . . 0.28 109.85 175.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.613 HG12 ' HB ' ' A' ' 21' ' ' ILE . 88.0 t -70.92 -23.73 23.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.703 0.764 . . . . 0.27 110.306 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.645 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -72.79 -43.32 62.91 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.177 -1.046 . . . . 0.34 108.177 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -71.39 -50.33 33.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.214 -0.903 . . . . 2.07 110.926 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.653 HG13 HG22 ' A' ' 46' ' ' VAL . 20.9 mm -66.76 -54.24 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.1 -0.5 . . . . 0.65 111.667 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -102.96 -66.07 0.96 Allowed 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.389 0.614 . . . . 0.54 111.036 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.7 50.87 0.06 OUTLIER Glycine 0 C--N 1.29 -1.999 0 CA-C-N 115.142 -0.936 . . . . 0.43 111.714 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.613 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -91.33 155.66 44.17 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.408 -0.396 . . . . 0.31 109.983 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 21' ' ' ILE . 6.0 Cg_exo -86.62 23.02 0.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.343 2.695 . . . . 1.08 115.698 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.633 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.9 p 48.1 26.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 C-N-CA 124.694 1.198 . . . . 0.81 113.154 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -138.9 4.72 2.31 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.345 -0.843 . . . . 2.31 110.685 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.35 -27.91 9.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.075 -0.966 . . . . 1.59 110.065 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.744 HG22 HD13 ' A' ' 36' ' ' LEU . 23.7 t -79.6 99.1 3.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.33 -1.304 . . . . 0.3 108.972 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -127.98 170.57 12.72 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.164 -1.421 . . . . 1.58 107.164 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 8' ' ' VAL . 7.9 mp -66.41 148.55 51.7 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.287 -1.005 . . . . 1.05 108.287 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 81.51 4.22 1.39 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 124.451 1.101 . . . . 0.72 110.533 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.518 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 73.6 mmtt -96.61 118.99 34.26 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 119.831 -0.748 . . . . 1.48 110.636 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 71.4 m -75.53 32.88 0.11 Allowed 'General case' 0 C--N 1.248 -3.833 0 C-N-CA 127.189 2.195 . . . . 1.25 114.039 -175.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.648 ' CE2' ' H5 ' ' A' ' 101' ' ' SYO . 86.8 m-85 41.23 -89.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.454 1.501 . . . . 0.4 115.025 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.645 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.9 t -63.15 -29.17 70.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.468 0.707 . . . . 1.06 111.05 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -96.45 -31.21 12.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.826 0.676 . . . . 1.74 112.826 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 7.2 m-20 -99.29 -36.79 9.51 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.777 1.029 . . . . 1.29 113.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.744 HD13 HG22 ' A' ' 26' ' ' VAL . 16.0 mt -94.91 -39.7 10.08 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.245 -0.434 . . . . 0.81 109.998 -174.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 t70 93.33 69.53 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.579 0 C-N-CA 126.531 1.933 . . . . 1.12 108.934 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.645 ' H ' ' HA ' ' A' ' 33' ' ' THR . 13.3 t -108.09 143.4 18.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 105.002 -2.222 . . . . 0.79 105.002 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.37 117.73 15.48 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.374 -0.93 . . . . 2.0 109.63 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.593 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.0 t -38.67 -47.37 1.34 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.573 1.694 . . . . 0.78 115.573 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -70.58 -26.37 63.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.368 -0.933 . . . . 1.18 111.628 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.2 m -84.94 -16.96 39.25 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.474 0.709 . . . . 0.6 110.507 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.723 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -56.01 -38.65 70.79 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 124.084 0.953 . . . . 0.86 111.598 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.21 -47.1 77.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 O-C-N 124.451 1.095 . . . . 0.31 109.984 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.03 -45.12 83.35 Favored 'General case' 0 C--O 1.21 -1.026 0 C-N-CA 122.873 0.469 . . . . 0.68 109.796 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.653 HG22 HG13 ' A' ' 18' ' ' ILE . 44.2 t -59.01 -28.86 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.783 0.833 . . . . 0.63 110.958 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.849 HG21 HG13 ' A' ' 63' ' ' VAL . 54.0 t -78.6 -51.43 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.766 -1.198 . . . . 0.55 107.766 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -56.0 -42.42 71.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.419 -1.264 . . . . 0.42 109.447 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -63.85 -39.07 93.34 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-O 121.499 0.666 . . . . 0.21 110.454 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.537 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -64.28 -52.57 57.95 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.87 -1.059 . . . . 0.21 109.886 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.325 0.0 OUTLIER -62.54 -35.89 80.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.708 1.003 . . . . 0.64 113.708 -179.242 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.4 -44.03 95.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.221 0.326 . . . . 2.07 111.581 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -76.66 -44.54 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.534 0.568 . . . . 2.48 112.534 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.635 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 11.8 m-85 -89.27 -5.22 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.301 -0.56 . . . . 0.81 112.434 -172.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 83.17 10.73 0.52 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 115.389 1.625 . . . . 1.99 115.389 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.6 p -87.19 179.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.273 -1.01 . . . . 0.37 108.273 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.498 ' H ' HG22 ' A' ' 56' ' ' VAL . 46.7 tptt -132.89 128.55 36.84 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 106.434 -1.691 . . . . 2.12 106.434 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.604 HG13 ' HB3' ' A' ' 51' ' ' GLU . 42.0 mt -124.11 111.57 28.66 Favored Pre-proline 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.787 . . . . 0.25 111.054 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.628 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.5 Cg_endo -73.29 162.18 41.03 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.158 2.572 . . . . 0.33 110.793 176.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.39 -41.98 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.942 0.897 . . . . 1.98 110.616 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 30.2 t70 -60.72 -37.56 82.13 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 114.685 -1.143 . . . . 2.06 111.549 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' OD2' ' OH ' ' A' ' 75' ' ' TYR . 20.4 m-20 -86.89 -28.01 23.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 113.414 0.894 . . . . 0.52 113.414 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.849 HG13 HG21 ' A' ' 47' ' ' VAL . 95.8 t -53.62 -48.72 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.767 -0.827 . . . . 0.38 108.767 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 48.3 pttt -69.73 -13.59 62.37 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.886 -1.052 . . . . 2.16 112.45 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.79 -13.08 46.18 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.405 0.621 . . . . 1.59 109.716 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.771 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.5 mt -97.52 110.37 22.95 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 106.49 -1.67 . . . . 0.31 106.49 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.7 mptp? -100.64 -44.65 5.76 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.311 -0.996 . . . . 2.55 108.311 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 20.1 p -110.25 -177.9 3.37 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.697 -0.853 . . . . 0.23 108.697 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -87.05 -13.43 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 108.344 -0.984 . . . . 1.21 108.344 176.018 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.554 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -72.33 -24.78 75.79 Favored Glycine 0 C--O 1.2 -2.014 0 N-CA-C 108.683 -1.767 . . . . 0.33 108.683 174.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' THR . 8.7 m-20 -82.66 -57.13 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.781 -1.21 . . . . 1.39 108.542 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.771 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -47.8 -60.32 2.66 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 114.881 -1.054 . . . . 0.15 112.155 -178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.467 ' HA ' HG21 ' A' ' 7' ' ' ILE . 44.9 m -56.79 -48.09 78.71 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.354 -1.294 . . . . 0.24 113.451 -174.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 6.0 mptp? -56.57 -47.08 80.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.069 0.856 . . . . 3.63 109.58 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.538 ' OH ' ' OD2' ' A' ' 62' ' ' ASP . 85.1 t80 -60.44 -51.8 67.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.081 -0.963 . . . . 0.4 111.544 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.592 ' HA ' HG21 ' A' ' 56' ' ' VAL . 69.9 mt -54.57 -65.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.584 -1.189 . . . . 0.21 110.542 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.596 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.1 tt -51.79 -46.55 64.23 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.356 1.062 . . . . 1.44 109.511 -175.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.99 -30.56 70.35 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.55 -1.205 . . . . 0.63 111.502 -172.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -100.13 0.0 39.77 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 113.923 1.083 . . . . 1.25 113.923 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -116.27 -51.44 2.62 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 113.768 1.025 . . . . 0.87 113.768 176.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.811 ' HB2' ' HB1' ' A' ' 1' ' ' ALA . . . . . . . . 1 C--N 1.243 -4.049 0 CA-C-N 114.728 -1.123 . . . . 1.97 110.31 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.791 ' H28' HN36 ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 109.832 -0.432 . . . . 1.42 109.832 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.51 -74.26 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.822 -0.807 . . . . 1.85 108.822 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t -174.6 -171.69 0.59 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.11 -0.7 . . . . 0.66 109.11 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' HG2' HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -50.66 -41.49 55.55 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.331 1.452 . . . . 0.74 114.518 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -52.51 -52.03 56.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.206 0.316 . . . . 2.66 110.581 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.03 -48.67 64.43 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 124.848 1.259 . . . . 2.73 111.184 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 73' ' ' THR . 81.4 mt -70.21 -64.13 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.275 -1.33 . . . . 0.23 110.255 -170.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.401 HG23 ' HG2' ' A' ' 4' ' ' GLN . 76.0 t -58.07 -40.42 76.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 N-CA-C 112.738 0.644 . . . . 0.27 112.738 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -62.12 -44.37 96.79 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.736 -0.468 . . . . 0.27 109.736 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -76.01 -38.24 35.97 Favored Glycine 0 N--CA 1.415 -2.742 0 CA-C-N 115.572 -0.74 . . . . 0.18 113.446 -175.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.614 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -66.49 -39.16 88.59 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.609 -0.885 . . . . 0.2 108.609 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.596 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.97 -47.49 84.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.207 -0.664 . . . . 0.14 109.207 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.646 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 44.6 mt-10 -54.89 -45.8 74.72 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 124.368 1.042 . . . . 0.68 111.806 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 11' ' ' LEU . 56.9 mt -59.55 -42.68 88.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.467 -0.788 . . . . 0.28 110.058 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 21' ' ' ILE . 48.4 t -71.86 -22.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.409 0.623 . . . . 0.27 109.931 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.646 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 7.0 m120 -66.19 -43.19 87.53 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.039 -0.726 . . . . 0.34 109.039 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -80.42 -49.3 11.63 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.518 -0.765 . . . . 2.07 111.259 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.699 HG13 HG22 ' A' ' 46' ' ' VAL . 16.8 mm -62.35 -53.56 45.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.822 -0.626 . . . . 0.65 111.374 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.409 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -104.55 -72.64 0.7 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.509 0.671 . . . . 0.54 109.857 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.31 34.65 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.563 0 CA-C-N 114.993 -1.003 . . . . 0.43 111.973 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.603 HG21 HG23 ' A' ' 26' ' ' VAL . 1.3 mp -72.96 150.43 90.33 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 109.557 -0.534 . . . . 0.31 109.557 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.7 Cg_exo -88.89 31.23 0.4 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.732 2.954 . . . . 1.08 114.758 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HA ' ' HB1' ' A' ' 12' ' ' ALA 0.25 5.6 p 58.4 -6.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 126.984 2.114 . . . . 0.81 116.393 175.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -114.85 -6.33 12.63 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.937 -1.102 . . . . 2.31 111.064 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -83.28 -30.88 27.25 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.4 1.095 . . . . 1.59 108.917 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.678 HG22 HD13 ' A' ' 36' ' ' LEU . 22.8 t -76.3 96.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 113.35 -1.75 . . . . 0.3 109.935 -176.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 69' ' ' VAL . 12.5 mptt -127.83 158.37 37.92 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.355 -1.35 . . . . 1.58 107.355 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD22 ' HA2' ' A' ' 70' ' ' GLY . 54.8 mt -52.83 144.83 13.64 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.9 -0.778 . . . . 1.05 108.9 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 78.67 10.55 1.76 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.938 1.295 . . . . 0.72 110.824 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.632 ' HD2' ' CG ' ' A' ' 35' ' ' ASP . 31.3 mmtp -96.91 122.63 40.1 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 108.617 -0.882 . . . . 1.48 108.617 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 30.3 m -76.29 36.18 0.15 Allowed 'General case' 0 C--N 1.252 -3.662 0 C-N-CA 125.279 1.432 . . . . 1.25 113.519 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.686 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 76.0 m-85 42.75 -94.12 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 125.673 1.589 . . . . 0.4 114.697 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.525 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 5.4 t -68.57 -24.66 64.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.081 0.467 . . . . 1.06 110.059 -174.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 11.0 t70 -81.32 -53.03 6.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.298 -0.864 . . . . 1.74 111.772 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.632 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t70 -84.22 -56.59 3.57 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 119.585 -0.846 . . . . 1.29 110.267 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.678 HD13 HG22 ' A' ' 26' ' ' VAL . 22.4 mt -65.91 -38.12 87.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.12 -1.4 . . . . 0.81 111.286 -170.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t70 88.22 70.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 124.919 1.387 . . . . 1.12 109.186 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.525 ' H ' ' HA ' ' A' ' 33' ' ' THR . 18.4 t -102.58 170.88 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.374 -2.194 . . . . 0.79 108.741 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 42' ' ' SER . 2.2 m-20 -78.01 -3.42 41.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.094 1.146 . . . . 2.0 114.094 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 43' ' ' MET . 29.0 t 65.87 -65.4 0.18 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.136 0.975 . . . . 0.78 113.053 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 42' ' ' SER . 0.7 OUTLIER -62.67 -36.41 82.77 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.305 0.574 . . . . 1.18 111.572 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.54 ' O ' HG23 ' A' ' 46' ' ' VAL . 12.6 m -78.23 -13.73 59.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.499 -0.773 . . . . 0.6 110.065 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 1.049 ' HG3' ' H1 ' ' A' ' 101' ' ' SYO . 12.2 tpp -73.69 -35.61 65.19 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 116.254 -0.43 . . . . 0.86 110.127 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.8 t -55.72 -37.72 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 109.487 -0.56 . . . . 0.31 109.487 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -61.89 -47.89 82.93 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.275 -0.639 . . . . 0.68 109.275 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.699 HG22 HG13 ' A' ' 18' ' ' ILE . 61.1 t -57.73 -28.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 CA-C-N 114.834 -1.075 . . . . 0.63 111.475 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.87 HG21 HG13 ' A' ' 63' ' ' VAL . 27.6 t -71.69 -52.68 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.377 0 N-CA-C 107.764 -1.199 . . . . 0.55 107.764 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.08 -38.63 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.23 -1.35 . . . . 0.42 108.55 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.74 -38.99 90.65 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.862 -0.608 . . . . 0.21 109.932 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -61.53 -58.37 8.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.731 -1.122 . . . . 0.21 109.779 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.481 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.26 0.0 OUTLIER -59.36 -39.76 84.26 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.233 1.197 . . . . 0.64 114.233 -176.384 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -59.92 -35.7 75.45 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.39 0.431 . . . . 2.07 111.846 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -86.42 -30.36 22.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.116 -0.493 . . . . 2.48 110.143 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.47 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 7.0 m-85 -100.03 1.47 42.47 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.208 0.447 . . . . 0.81 112.208 -173.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 33.7 t70 79.5 4.1 2.17 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 124.344 1.058 . . . . 1.99 112.98 174.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 76' ' ' ILE . 7.8 p -90.93 -179.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 O-C-N 121.256 -0.902 . . . . 0.37 108.703 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' H ' HG22 ' A' ' 56' ' ' VAL . 21.4 tptm -135.62 128.69 31.61 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.748 -1.575 . . . . 2.12 106.748 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.481 HG13 ' HB3' ' A' ' 51' ' ' GLU . 59.5 mt -122.07 110.47 32.89 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.128 -0.629 . . . . 0.25 111.109 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.571 ' O ' HG23 ' A' ' 63' ' ' VAL . 91.1 Cg_endo -74.94 164.94 32.41 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.125 2.55 . . . . 0.33 110.961 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 20.2 t70 -51.57 -44.12 62.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 1.98 112.101 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -58.78 -40.59 84.43 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.612 0.57 . . . . 2.06 111.301 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 24.7 m-20 -81.52 -31.11 32.94 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.777 -0.769 . . . . 0.52 112.005 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.87 HG13 HG21 ' A' ' 47' ' ' VAL . 82.7 t -53.83 -50.72 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.056 -1.09 . . . . 0.38 108.056 172.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 13.8 ptmm? -73.17 -2.7 22.67 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.372 0.878 . . . . 2.16 113.372 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -105.79 -16.81 14.57 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.993 -0.442 . . . . 1.59 111.76 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.762 HD13 ' HA ' ' A' ' 72' ' ' ALA . 44.2 mt -82.14 107.44 14.84 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 105.711 -1.959 . . . . 0.31 105.711 176.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -97.13 -39.29 9.37 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.181 -1.008 . . . . 2.55 109.744 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 27.7 p -114.97 179.64 3.89 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.46 0.648 . . . . 0.23 109.587 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.686 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -87.09 -13.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.797 -0.816 . . . . 1.21 108.797 175.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.53 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -68.12 -43.56 80.47 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 107.032 -2.427 . . . . 0.33 107.032 172.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -65.25 -56.06 14.87 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.888 -1.656 . . . . 1.39 110.895 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.762 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -49.9 -60.95 2.43 Favored 'General case' 0 CA--C 1.482 -1.665 0 O-C-N 124.304 1.002 . . . . 0.15 111.42 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.646 ' HA ' HG21 ' A' ' 7' ' ' ILE . 56.8 m -53.31 -54.59 34.26 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.589 -1.187 . . . . 0.24 113.303 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.9 mptm? -56.08 -37.5 69.42 Favored 'General case' 0 C--O 1.198 -1.658 0 C-N-CA 124.158 0.983 . . . . 3.63 110.78 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' HE2' HG12 ' A' ' 58' ' ' ILE . 90.7 t80 -66.93 -47.59 71.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.535 0.683 . . . . 0.4 109.377 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.656 ' HA ' HG21 ' A' ' 56' ' ' VAL . 72.7 mt -59.09 -65.87 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-N 114.2 -1.364 . . . . 0.21 109.441 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.626 HD23 HG22 ' A' ' 73' ' ' THR . 4.4 pp -53.41 -38.41 63.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 113.475 0.917 . . . . 1.44 113.475 -176.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.512 ' N ' HD12 ' A' ' 77' ' ' LEU . 7.7 t70 -72.03 -25.75 61.93 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.92 -1.036 . . . . 0.63 110.777 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -102.56 -6.03 23.28 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.649 -0.705 . . . . 1.25 112.083 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 85.0 mt-30 -74.49 -65.17 0.89 Allowed 'General case' 0 CA--C 1.455 -2.676 0 CA-C-O 122.866 1.317 . . . . 0.87 107.933 176.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.259 -3.359 0 CA-C-N 111.982 -2.372 . . . . 1.97 109.492 -178.645 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 1.049 ' H1 ' ' HG3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.489 -1.399 0 N-CA-C 109.478 -0.564 . . . . 1.42 109.478 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB1' ' HB3' ' A' ' 6' ' ' GLU . . . -154.4 129.77 9.78 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.914 -0.772 . . . . 1.85 108.914 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 7' ' ' ILE . 11.3 t -92.42 175.65 6.76 Favored 'General case' 0 C--N 1.264 -3.128 0 N-CA-C 107.047 -1.464 . . . . 0.66 107.047 175.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -45.86 -40.27 9.69 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.749 1.018 . . . . 0.74 113.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.49 -28.19 69.12 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.489 0.493 . . . . 2.66 111.949 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.567 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 7.8 tp10 -88.83 -35.91 16.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.368 -0.605 . . . . 2.73 109.368 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.694 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 93.9 mt -72.53 -66.37 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.059 0 CA-C-N 116.126 -0.488 . . . . 0.23 111.846 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.05 -40.39 76.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 122.081 0.153 . . . . 0.27 111.169 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.39 81.46 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.01 -0.541 . . . . 0.27 111.25 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.48 -39.42 8.99 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 116.232 -0.44 . . . . 0.18 112.399 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.709 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.79 -37.4 87.47 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.577 -0.897 . . . . 0.2 108.577 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.865 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -55.21 -47.13 75.73 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.748 -0.66 . . . . 0.14 109.847 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.688 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 41.1 mt-10 -60.94 -41.47 96.31 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 124.135 0.897 . . . . 0.68 111.658 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 11' ' ' LEU . 71.2 mt -60.74 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.277 -0.874 . . . . 0.28 109.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.834 HG12 ' HB ' ' A' ' 21' ' ' ILE . 73.9 t -67.99 -23.76 29.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 123.872 0.869 . . . . 0.27 111.038 -176.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.688 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 8.0 m120 -71.62 -45.16 62.9 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.107 -0.952 . . . . 0.34 109.142 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -83.77 -36.73 23.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.286 -0.87 . . . . 2.07 112.945 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.626 HG13 HG22 ' A' ' 46' ' ' VAL . 28.1 mm -70.2 -53.19 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.044 -0.724 . . . . 0.65 109.044 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -103.16 -88.9 0.4 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.836 -0.62 . . . . 0.54 109.556 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.03 39.53 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 120.338 -0.934 . . . . 0.43 112.88 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.834 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.4 mp -75.12 151.83 86.11 Favored Pre-proline 0 C--O 1.205 -1.257 0 N-CA-C 109.618 -0.512 . . . . 0.31 109.618 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 5.2 Cg_exo -87.36 31.88 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.53 2.82 . . . . 1.08 114.771 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' H ' HG22 ' A' ' 21' ' ' ILE 0.287 9.8 p 60.45 -22.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 C-N-CA 127.057 2.143 . . . . 0.81 116.416 175.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -93.12 -15.16 26.34 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.281 0.562 . . . . 2.31 111.021 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.28 -26.63 30.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.385 -0.825 . . . . 1.59 111.454 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.865 HG21 ' HA ' ' A' ' 12' ' ' ALA . 43.1 t -71.84 98.41 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.133 -0.939 . . . . 0.3 108.811 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -130.12 161.92 29.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.845 -1.539 . . . . 1.58 106.845 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.508 ' HA ' HG22 ' A' ' 69' ' ' VAL . 91.1 mt -61.73 145.4 52.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.164 -0.68 . . . . 1.05 109.164 177.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 74.49 9.72 4.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.503 1.121 . . . . 0.72 110.586 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.44 127.26 50.85 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 109.512 -0.551 . . . . 1.48 109.512 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.668 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 7.1 m -84.63 108.68 17.5 Favored 'General case' 1 C--N 1.239 -4.203 0 CA-C-N 114.736 -1.12 . . . . 1.25 108.34 178.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.699 ' HB2' ' SD ' ' A' ' 43' ' ' MET . 34.4 m-85 -46.51 -54.28 9.61 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 124.534 1.133 . . . . 0.4 110.207 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 1.0 HG21 ' H37' ' A' ' 101' ' ' SYO . 12.1 t -77.61 19.82 0.35 Allowed 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 125.681 1.592 . . . . 1.06 113.771 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 15.2 t70 -158.76 -62.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.276 -0.89 . . . . 1.74 110.886 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -69.31 -40.13 77.85 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.634 -1.166 . . . . 1.29 109.849 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 32' ' ' PHE . 19.0 mt -80.78 -91.23 0.06 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 114.915 -1.039 . . . . 0.81 110.907 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 31.0 t70 168.01 20.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 121.966 0.889 . . . . 1.12 109.685 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.601 HG13 ' HB2' ' A' ' 19' ' ' ALA . 13.5 t -87.67 144.98 8.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.364 -0.835 . . . . 0.79 108.986 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.11 124.28 29.71 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.694 -0.684 . . . . 2.0 109.81 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.546 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 11.3 t -36.27 -46.05 0.5 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.412 1.485 . . . . 0.78 114.421 172.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.95 -30.8 70.18 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.31 -0.556 . . . . 1.18 111.689 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 m -83.76 -18.27 38.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.388 0.613 . . . . 0.6 109.782 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.699 ' SD ' ' HB2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -57.4 -38.27 74.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.229 1.012 . . . . 0.86 112.134 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.1 t -51.46 -51.14 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.109 0.881 . . . . 0.31 109.723 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -53.89 -48.73 69.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.68 109.949 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.626 HG22 HG13 ' A' ' 18' ' ' ILE . 46.2 t -58.71 -31.6 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.839 1.256 . . . . 0.63 111.481 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.718 HG21 HG13 ' A' ' 63' ' ' VAL . 34.2 t -76.96 -47.24 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 N-CA-C 108.491 -0.929 . . . . 0.55 108.491 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.97 -36.3 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 114.787 -1.097 . . . . 0.42 108.462 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.32 -36.16 82.23 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.844 -0.616 . . . . 0.21 109.935 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -56.53 19.13 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.797 -1.092 . . . . 0.21 110.015 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.645 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -63.19 -33.11 74.77 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.724 -0.79 . . . . 0.64 113.069 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.98 -40.45 95.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.078 0.399 . . . . 2.07 112.078 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -84.56 -38.07 20.42 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.494 -0.482 . . . . 2.48 111.933 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.694 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 9.0 m-85 -97.41 20.12 12.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.053 0.76 . . . . 0.81 113.053 -170.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 32.9 t70 69.5 -2.07 2.03 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 114.675 1.361 . . . . 1.99 114.675 171.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.53 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 8.5 p -89.51 178.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 O-C-N 120.476 -1.39 . . . . 0.37 108.907 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.472 ' H ' HG22 ' A' ' 56' ' ' VAL . 19.4 ttpt -131.96 131.51 42.68 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 106.022 -1.844 . . . . 2.12 106.022 170.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.645 HG13 ' HB3' ' A' ' 51' ' ' GLU . 65.3 mt -120.62 114.99 32.55 Favored Pre-proline 0 C--N 1.293 -1.854 0 C-N-CA 120.532 -0.467 . . . . 0.25 110.205 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.558 ' O ' HG23 ' A' ' 63' ' ' VAL . 28.9 Cg_endo -62.4 155.2 59.02 Favored 'Trans proline' 0 CA--C 1.509 -0.774 0 C-N-CA 123.124 2.549 . . . . 0.33 110.883 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -54.8 -28.82 52.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.499 0.499 . . . . 1.98 111.895 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.682 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 29.8 t70 -73.88 -39.51 63.86 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 120.384 -0.526 . . . . 2.06 111.317 176.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 11.5 m-20 -77.37 -24.4 50.63 Favored 'General case' 0 CA--C 1.482 -1.663 0 C-N-CA 119.231 -0.987 . . . . 0.52 112.644 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 47' ' ' VAL . 68.8 t -51.85 -49.85 35.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 107.958 -1.126 . . . . 0.38 107.958 171.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.682 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 5.1 ptmm? -77.76 -2.01 34.18 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.431 0.9 . . . . 2.16 113.431 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 62' ' ' ASP . 91.7 m-20 -98.08 -16.97 19.35 Favored 'General case' 0 CA--C 1.485 -1.539 0 O-C-N 121.72 -0.612 . . . . 1.59 110.368 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.0 mt -87.32 128.72 35.18 Favored 'General case' 0 N--CA 1.391 -3.407 0 N-CA-C 103.788 -2.671 . . . . 0.31 103.788 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -119.85 -42.02 2.64 Favored 'General case' 0 C--N 1.268 -2.956 0 N-CA-C 108.149 -1.056 . . . . 2.55 108.149 174.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 61.6 p -102.7 174.97 5.65 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 0.23 108.894 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.508 HG22 ' HA ' ' A' ' 28' ' ' LEU . 1.5 m -81.64 -13.51 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 107.798 -1.186 . . . . 1.21 107.798 174.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.426 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -74.23 -27.16 66.62 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.193 -1.003 . . . . 0.33 110.661 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.498 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 5.9 t70 -83.64 -48.34 10.29 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.525 -0.917 . . . . 1.39 108.525 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.7 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.33 -59.98 3.62 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-N 114.028 -1.442 . . . . 0.15 111.833 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.5 ' HA ' HG21 ' A' ' 7' ' ' ILE . 60.0 m -56.91 -61.6 2.33 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.081 -0.963 . . . . 0.24 111.507 -173.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 0.3 OUTLIER -41.16 -46.75 3.13 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.86 2.064 . . . . 3.63 111.438 171.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -63.22 -47.09 83.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.292 0.568 . . . . 0.4 110.336 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.632 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 64.0 mt -60.77 -66.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.32 -1.309 . . . . 0.21 109.259 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.5 HD23 HG22 ' A' ' 73' ' ' THR . 4.5 pp -58.58 -36.66 74.32 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.369 1.248 . . . . 1.44 114.369 -174.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.473 ' N ' HD12 ' A' ' 77' ' ' LEU . 12.6 t70 -75.28 -22.63 57.62 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.952 -0.567 . . . . 0.63 111.666 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.38 -24.6 18.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.896 0.702 . . . . 1.25 112.896 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.632 ' HG3' ' O ' ' A' ' 76' ' ' ILE 0.36 0.0 OUTLIER -90.73 -56.35 3.22 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 116.101 1.889 . . . . 0.87 116.101 -179.029 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 1 C--N 1.235 -4.411 0 CA-C-N 115.545 -0.752 . . . . 1.97 110.456 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 1.0 ' H37' HG21 ' A' ' 33' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . . . . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 108.844 -0.799 . . . . 1.42 108.844 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.61 -74.08 0.52 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.145 -0.479 . . . . 1.85 111.175 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.685 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 15.2 t -175.03 -171.09 0.49 Allowed 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 116.289 -0.414 . . . . 0.66 109.907 -175.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -52.84 -41.87 64.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.85 1.26 . . . . 0.74 113.09 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.93 -32.49 33.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.003 0.521 . . . . 2.66 112.299 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.21 -36.25 27.44 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.969 -0.56 . . . . 2.73 110.336 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.471 ' HA ' ' CE1' ' A' ' 54' ' ' PHE . 74.9 mt -77.56 -66.49 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.218 0 CA-C-N 115.645 -0.707 . . . . 0.23 111.723 -171.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.2 t -55.91 -42.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 112.178 0.436 . . . . 0.27 112.178 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.96 89.49 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 123.713 0.633 . . . . 0.27 110.446 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.99 -39.0 13.78 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.895 -0.593 . . . . 0.18 113.08 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.714 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.21 -35.48 80.54 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.863 -1.162 . . . . 0.2 107.863 -177.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -57.02 -51.17 70.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.458 -0.571 . . . . 0.14 109.458 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.578 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 40.4 mt-10 -56.02 -44.32 78.61 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.417 1.073 . . . . 0.68 111.29 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 11' ' ' LEU . 72.2 mt -56.96 -45.4 83.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.263 -0.881 . . . . 0.28 110.37 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 11' ' ' LEU . 58.5 t -66.78 -23.98 31.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.848 0.832 . . . . 0.27 110.138 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.578 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 2.6 m120 -75.48 -53.11 9.19 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.321 -0.992 . . . . 0.34 108.321 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 7.3 mm-40 -67.23 -39.98 86.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.964 -1.016 . . . . 2.07 111.374 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.6 mm -74.98 -53.73 15.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.667 -0.494 . . . . 0.65 109.667 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -100.55 -86.76 0.39 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.979 -0.555 . . . . 0.54 111.566 -173.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.98 50.25 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.684 0 CA-C-N 115.817 -0.629 . . . . 0.43 112.302 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.802 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -93.74 152.89 41.07 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 110.107 -0.331 . . . . 0.31 110.107 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 3.0 Cg_exo -84.87 30.88 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.671 2.914 . . . . 1.08 114.453 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 21' ' ' ILE . 5.8 p 54.84 2.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 115.81 1.782 . . . . 0.81 115.81 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 22' ' ' PRO . 10.0 pt-20 -127.6 0.5 6.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.063 -1.023 . . . . 2.31 111.374 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 22.6 t0 -89.33 -24.06 22.1 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.589 -1.187 . . . . 1.59 109.072 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.802 HG23 HG21 ' A' ' 21' ' ' ILE . 42.1 t -81.07 93.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.107 -1.406 . . . . 0.3 109.527 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -121.55 166.12 14.66 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.504 -0.924 . . . . 1.58 108.504 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.447 HD22 ' HA2' ' A' ' 70' ' ' GLY . 67.6 mt -67.31 143.26 56.51 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.138 -1.43 . . . . 1.05 107.138 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 33.1 t70 85.64 1.43 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 124.343 1.057 . . . . 0.72 110.565 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 69' ' ' VAL . 45.4 mmtm -95.42 120.29 35.41 Favored 'General case' 0 CA--C 1.474 -1.972 0 O-C-N 121.502 -0.749 . . . . 1.48 109.879 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 10.4 t -83.02 35.22 0.47 Allowed 'General case' 1 C--N 1.24 -4.174 0 C-N-CA 126.483 1.913 . . . . 1.25 112.388 -171.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CZ ' HG22 ' A' ' 69' ' ' VAL . 96.6 m-85 41.64 -90.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.363 1.865 . . . . 0.4 115.293 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.412 ' HB ' ' SD ' ' A' ' 43' ' ' MET . 12.4 t -62.73 -27.69 69.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.281 0.633 . . . . 1.06 111.398 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 11.3 t70 -87.16 -56.35 3.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.524 -0.307 . . . . 1.74 110.564 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.08 -38.29 27.56 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 113.466 0.913 . . . . 1.29 113.466 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 32' ' ' PHE . 25.3 mt -82.62 -76.24 0.28 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.482 -0.487 . . . . 0.81 112.117 -171.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 170.9 -20.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 122.961 0.504 . . . . 1.12 110.349 -174.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 19' ' ' ALA . 10.6 t -47.84 139.96 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.362 1.065 . . . . 0.79 111.978 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -81.27 126.17 31.22 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.895 -1.15 . . . . 2.0 107.895 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 43' ' ' MET . 15.4 t -42.53 -35.63 1.12 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 114.452 1.279 . . . . 0.78 114.452 173.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 42' ' ' SER . 3.6 pp -73.18 -33.28 65.34 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 119.067 -1.053 . . . . 1.18 111.976 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 46' ' ' VAL . 19.8 m -84.66 -13.36 51.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.965 0.888 . . . . 0.6 109.674 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.921 ' HG3' ' H1 ' ' A' ' 101' ' ' SYO . 3.6 tpt -61.9 -38.42 88.3 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 125.707 1.603 . . . . 0.86 110.568 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.65 -27.16 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.023 -0.535 . . . . 0.31 110.553 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.6 -45.59 68.21 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.384 -0.969 . . . . 0.68 108.384 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 42' ' ' SER . 41.8 t -58.07 -25.69 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.486 -1.233 . . . . 0.63 110.819 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.742 HG11 HG22 ' A' ' 63' ' ' VAL . 29.6 t -81.03 -54.3 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 N-CA-C 108.968 -0.753 . . . . 0.55 108.968 -176.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.14 -33.38 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.214 -0.903 . . . . 0.42 109.33 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.62 70.89 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.268 0.556 . . . . 0.21 109.991 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.49 -56.17 20.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.18 -0.918 . . . . 0.21 109.717 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HB3' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -67.87 -31.11 70.69 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.127 1.158 . . . . 0.64 114.127 -176.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -60.53 -34.45 74.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.824 0.345 . . . . 2.07 110.306 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -86.83 -46.0 10.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.324 -0.398 . . . . 2.48 111.993 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 7' ' ' ILE . 8.5 m-85 -84.67 -2.27 57.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.997 1.11 . . . . 0.81 113.997 -169.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 22.3 t70 80.76 -0.07 1.84 Allowed 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 124.401 1.08 . . . . 1.99 112.406 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 76' ' ' ILE . 12.9 p -81.56 176.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.41 -1.33 . . . . 0.37 107.41 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 33.7 tptt -134.02 123.94 25.4 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.836 -1.172 . . . . 2.12 107.836 173.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.555 HG12 ' HE2' ' A' ' 75' ' ' TYR . 41.3 mt -120.13 102.76 45.85 Favored Pre-proline 0 C--N 1.312 -1.026 0 C-N-CA 120.92 -0.312 . . . . 0.25 110.34 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.577 ' O ' HG23 ' A' ' 63' ' ' VAL . 64.4 Cg_endo -70.08 158.69 55.74 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 123.056 2.504 . . . . 0.33 110.44 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 9.8 t70 -46.24 -42.49 14.4 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.049 0.94 . . . . 1.98 110.525 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -53.85 -44.69 70.55 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 125.155 1.382 . . . . 2.06 112.716 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -86.68 -29.95 22.08 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.522 -0.471 . . . . 0.52 111.617 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.742 HG22 HG11 ' A' ' 47' ' ' VAL . 79.5 t -50.94 -51.42 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.886 -0.783 . . . . 0.38 108.886 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' ASP . 21.3 ptmt -69.65 -4.18 18.33 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 114.152 1.167 . . . . 2.16 114.152 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.83 -23.8 14.87 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.696 0.76 . . . . 1.59 109.112 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.91 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.0 mt -82.46 133.83 35.21 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 105.965 -1.865 . . . . 0.31 105.965 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -126.11 -38.1 2.19 Favored 'General case' 0 C--N 1.259 -3.335 0 C-N-CA 119.919 -0.712 . . . . 2.55 109.995 174.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 26.9 p -107.46 -179.32 3.88 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 119.568 -0.853 . . . . 0.23 110.385 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.602 HG22 ' CZ ' ' A' ' 32' ' ' PHE . 13.0 t -83.12 -19.53 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 106.793 -1.558 . . . . 1.21 106.793 177.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.532 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -68.5 -47.2 58.55 Favored Glycine 0 CA--C 1.489 -1.545 0 N-CA-C 107.791 -2.124 . . . . 0.33 107.791 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.19 -55.85 29.63 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.638 -1.281 . . . . 1.39 110.471 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.91 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -53.69 -60.92 2.7 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.562 1.164 . . . . 0.15 111.732 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.459 ' HA ' HG21 ' A' ' 7' ' ' ILE . 35.2 m -58.77 -41.97 87.83 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 113.663 0.986 . . . . 0.24 113.663 -174.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 1.9 mptm? -61.28 -48.52 81.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 108.678 -0.86 . . . . 3.63 108.678 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.555 ' HE2' HG12 ' A' ' 58' ' ' ILE . 86.8 t80 -57.81 -51.53 69.21 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 124.536 1.148 . . . . 0.4 110.74 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 56' ' ' VAL . 72.5 mt -54.94 -66.75 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.718 0 CA-C-N 114.545 -1.207 . . . . 0.21 111.019 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 2.8 tt -52.17 -45.36 65.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.574 1.55 . . . . 1.44 109.359 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -71.15 -24.74 62.32 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.165 -1.38 . . . . 0.63 111.501 -172.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -103.7 -9.0 19.47 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 113.759 1.022 . . . . 1.25 113.759 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 92.3 mt-30 -68.77 -65.57 0.69 Allowed 'General case' 0 CA--C 1.449 -2.925 0 CA-C-O 122.909 1.338 . . . . 0.87 108.841 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.257 -3.438 0 CA-C-N 111.549 -2.569 . . . . 1.97 110.274 -175.283 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.921 ' H1 ' ' HG3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 81' ' ' ALA . . . . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 109.89 -0.411 . . . . 1.42 109.89 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.62 -96.36 0.11 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 111.958 0.355 . . . . 1.85 111.958 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.466 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.8 t -176.57 -177.88 0.86 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.556 -0.535 . . . . 0.66 109.556 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.647 ' HG2' HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -54.54 -35.84 63.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.41 1.484 . . . . 0.74 111.67 179.014 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -52.79 -47.99 67.17 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 124.12 0.887 . . . . 2.66 110.395 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.52 -30.73 64.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.804 -0.634 . . . . 2.73 110.347 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.619 HG23 ' CE2' ' A' ' 54' ' ' PHE . 97.9 mt -76.61 -66.56 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 CA-C-N 116.086 -0.506 . . . . 0.23 111.307 -172.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 28' ' ' LEU . 91.1 t -58.36 -36.07 56.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.714 0.635 . . . . 0.27 112.714 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 13' ' ' GLU . . . -66.03 -37.55 86.17 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.549 -0.46 . . . . 0.27 111.0 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 14' ' ' ILE . . . -84.18 -36.95 11.76 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 111.842 -0.503 . . . . 0.18 111.842 -176.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.746 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.82 -40.68 95.59 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.611 -0.885 . . . . 0.2 108.611 -178.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.764 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.21 -47.57 78.13 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.556 -0.747 . . . . 0.14 109.691 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.521 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 50.1 mt-10 -60.74 -39.68 89.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 123.99 0.806 . . . . 0.68 112.548 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.746 HD12 ' HA ' ' A' ' 11' ' ' LEU . 63.4 mt -59.97 -44.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.688 0.756 . . . . 0.28 109.0 176.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.707 HG12 ' HB ' ' A' ' 21' ' ' ILE . 64.7 t -67.78 -25.87 33.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.019 -0.991 . . . . 0.27 110.788 -175.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.521 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 5.6 m120 -70.5 -38.6 74.35 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.396 -0.82 . . . . 0.34 109.311 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.23 -43.62 15.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.6 -0.727 . . . . 2.07 111.58 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.695 HG13 HG22 ' A' ' 46' ' ' VAL . 17.3 mm -62.12 -52.71 57.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.988 0.515 . . . . 0.65 110.885 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -109.84 -85.56 0.54 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.435 -0.506 . . . . 0.54 110.858 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.84 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 110.931 -0.868 . . . . 0.43 110.931 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.707 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.6 mp -87.2 149.82 48.09 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 109.405 -0.591 . . . . 0.31 109.405 178.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 25' ' ' ASP . 5.0 Cg_exo -88.25 37.87 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.757 2.971 . . . . 1.08 113.723 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.425 ' HA ' HD21 ' A' ' 16' ' ' ASN 0.259 3.7 p 57.74 -14.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 117.006 2.225 . . . . 0.81 117.006 176.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.09 2.9 12.71 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 120.641 -1.287 . . . . 2.31 110.708 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.596 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 7.3 t70 -78.78 -31.72 46.19 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.119 -1.067 . . . . 1.59 108.119 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.764 HG21 ' HA ' ' A' ' 12' ' ' ALA . 24.8 t -74.46 92.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 113.129 -1.851 . . . . 0.3 110.498 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 69' ' ' VAL . 95.6 mttt -118.03 163.37 16.7 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.043 0.449 . . . . 1.58 110.152 177.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 8' ' ' VAL . 5.6 mp -70.98 136.24 48.32 Favored 'General case' 0 N--CA 1.406 -2.675 0 N-CA-C 108.822 -0.807 . . . . 1.05 108.822 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' H ' ' N ' ' A' ' 70' ' ' GLY . 22.4 t70 84.62 9.89 0.4 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.297 1.439 . . . . 0.72 109.701 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -102.08 128.4 48.56 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 115.648 -0.705 . . . . 1.48 109.22 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 14.4 m -79.92 114.12 18.6 Favored 'General case' 0 C--N 1.244 -3.987 0 CA-C-N 114.779 -1.101 . . . . 1.25 108.491 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.595 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 94.1 m-85 -45.41 -64.53 0.7 Allowed 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 124.253 1.021 . . . . 0.4 112.057 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.793 HG21 ' H37' ' A' ' 101' ' ' SYO . 10.1 t -59.01 -46.02 89.24 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 113.131 0.789 . . . . 1.06 113.131 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 12.6 t70 -86.55 -55.91 3.66 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.57 0.581 . . . . 1.74 112.57 -172.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.62 -49.14 15.19 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.659 0.783 . . . . 1.29 111.628 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.73 HD13 HG22 ' A' ' 26' ' ' VAL . 14.0 mt -77.32 -51.41 10.92 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.754 -0.657 . . . . 0.81 111.539 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 101.99 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.219 2.208 . . . . 1.12 111.275 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' THR . 22.0 t -110.09 118.84 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.607 -1.627 . . . . 0.79 106.607 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.15 113.52 0.82 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.228 0.955 . . . . 2.0 109.741 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 43' ' ' MET . 39.3 p -49.7 -21.45 1.06 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.279 1.431 . . . . 0.78 114.359 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 42' ' ' SER . 3.3 pp -81.84 -36.89 27.79 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.887 0.699 . . . . 1.18 112.887 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.447 ' N ' HD12 ' A' ' 41' ' ' LEU . 3.3 m -81.71 -13.39 57.89 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.461 1.124 . . . . 0.6 108.546 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.455 ' HE3' ' HA ' ' A' ' 43' ' ' MET . 3.7 tpt -55.49 -36.72 66.96 Favored 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 126.804 2.042 . . . . 0.86 111.061 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.74 -45.91 96.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 115.809 -0.632 . . . . 0.31 109.776 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -57.39 -41.37 80.12 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 115.906 -0.588 . . . . 0.68 109.903 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.695 HG22 HG13 ' A' ' 18' ' ' ILE . 40.1 t -59.53 -28.8 40.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-N 115.496 -0.774 . . . . 0.63 111.16 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.778 HG21 HG13 ' A' ' 63' ' ' VAL . 20.8 t -78.98 -54.94 10.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.151 -1.055 . . . . 0.55 108.151 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.4 -19.65 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.85 -1.523 . . . . 0.42 110.904 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.84 -38.91 16.36 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 121.226 0.536 . . . . 0.21 109.633 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -61.17 -64.19 1.04 Allowed 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.99 -1.005 . . . . 0.21 111.567 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 47' ' ' VAL 0.341 0.0 OUTLIER -59.43 -44.12 92.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 114.882 1.438 . . . . 0.64 114.882 -173.822 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -54.12 -39.2 66.22 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.206 1.003 . . . . 2.07 112.244 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.914 -0.585 . . . . 2.48 110.781 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CE2' HG23 ' A' ' 7' ' ' ILE . 8.2 m-85 -86.66 -44.89 11.49 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.467 -0.893 . . . . 0.81 111.839 -173.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 22.9 t70 155.14 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.751 1.282 . . . . 1.99 112.682 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.7 HG11 ' HA ' ' A' ' 76' ' ' ILE . 3.8 p -79.96 178.37 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 112.072 0.397 . . . . 0.37 112.072 -168.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' H ' HG22 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -133.31 125.56 29.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.355 -1.35 . . . . 2.12 107.355 174.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.596 HG12 ' HE2' ' A' ' 75' ' ' TYR . 64.8 mt -113.36 118.9 43.05 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.348 -0.387 . . . . 0.25 110.683 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.552 ' O ' HG23 ' A' ' 63' ' ' VAL . 56.6 Cg_endo -66.78 154.18 75.39 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.482 2.788 . . . . 0.33 110.588 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -51.66 -37.42 50.41 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.591 0.557 . . . . 1.98 111.673 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -59.56 -44.43 93.26 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.202 -0.454 . . . . 2.06 110.682 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.468 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 21.7 m-20 -82.68 -28.89 30.3 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 112.662 0.615 . . . . 0.52 112.662 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.778 HG13 HG21 ' A' ' 47' ' ' VAL . 53.0 t -52.01 -53.45 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 108.183 -1.043 . . . . 0.38 108.183 174.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -74.98 -1.91 24.77 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.975 -1.011 . . . . 2.16 113.549 -177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.92 -33.56 14.84 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.576 -0.898 . . . . 1.59 108.576 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.893 HD13 ' HA ' ' A' ' 72' ' ' ALA . 32.5 mt -69.25 133.34 47.8 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 106.267 -1.753 . . . . 0.31 106.267 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.579 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -128.39 -32.29 2.22 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-O 121.252 0.548 . . . . 2.55 110.126 175.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.628 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 28.5 p -112.07 172.81 6.69 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.683 -0.858 . . . . 0.23 108.683 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -80.4 -12.93 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.782 0.801 . . . . 1.21 109.478 175.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' H ' ' A' ' 29' ' ' ASP . . . -69.74 -37.92 76.6 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.368 -1.493 . . . . 0.33 109.368 176.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.579 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 24.3 m-20 -69.44 -54.33 14.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 108.772 -0.825 . . . . 1.39 108.772 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.893 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.19 -60.67 2.86 Favored 'General case' 0 CA--C 1.469 -2.168 0 O-C-N 124.676 1.235 . . . . 0.15 111.043 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.647 HG21 ' HG2' ' A' ' 4' ' ' GLN . 35.9 m -54.97 -49.28 71.83 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.459 1.099 . . . . 0.24 113.585 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 1.7 mptm? -67.17 -28.64 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.222 0.534 . . . . 3.63 111.051 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.596 ' HE2' HG12 ' A' ' 58' ' ' ILE . 84.9 t80 -71.52 -51.9 21.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.966 -0.753 . . . . 0.4 108.966 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.7 ' HA ' HG11 ' A' ' 56' ' ' VAL . 60.3 mt -57.41 -66.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.521 -1.218 . . . . 0.21 111.134 -177.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.466 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 4.5 tt -50.19 -50.34 49.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.211 1.404 . . . . 1.44 110.972 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.9 t70 -69.5 -25.72 64.19 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.995 -1.457 . . . . 0.63 111.417 -170.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -91.26 -22.67 20.46 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.674 -0.694 . . . . 1.25 111.682 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 76' ' ' ILE . 2.4 pt20 -90.62 -54.95 3.77 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.482 1.134 . . . . 0.87 113.385 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.528 ' HB2' ' HB1' ' A' ' 1' ' ' ALA . . . . . . . . 0 C--N 1.249 -3.766 0 CA-C-N 113.459 -1.7 . . . . 1.97 110.331 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.793 ' H37' HG21 ' A' ' 33' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 109.557 -0.534 . . . . 1.42 109.557 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.59 -74.87 0.6 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.263 -0.426 . . . . 1.85 110.611 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.3 t -174.46 -169.68 0.46 Allowed 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.996 -0.742 . . . . 0.66 108.996 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -40.19 60.56 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.593 1.157 . . . . 0.74 113.202 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.54 -23.73 64.83 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.865 0.691 . . . . 2.66 112.865 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.52 -39.9 21.76 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.018 -0.734 . . . . 2.73 109.018 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.446 HG21 ' HA ' ' A' ' 73' ' ' THR . 76.3 mt -76.66 -66.48 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 CA-C-N 114.719 -1.128 . . . . 0.23 111.692 -170.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -56.72 -42.41 77.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.376 0.51 . . . . 0.27 112.376 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.82 72.84 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.589 0.556 . . . . 0.27 111.362 176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.91 -40.09 8.3 Favored Glycine 0 N--CA 1.405 -3.418 0 C-N-CA 120.596 -0.811 . . . . 0.18 113.059 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -63.12 -41.04 99.25 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.613 0.765 . . . . 0.2 109.079 -177.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.09 -48.17 67.99 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 123.747 0.654 . . . . 0.14 109.588 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.664 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 48.3 mt-10 -62.36 -42.34 99.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 124.266 0.979 . . . . 0.68 112.05 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 11' ' ' LEU . 54.7 mt -59.49 -39.43 79.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.332 0.587 . . . . 0.28 110.179 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 11' ' ' LEU . 46.4 t -69.48 -23.52 26.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 CA-C-O 122.082 0.944 . . . . 0.27 109.722 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 4.4 m120 -77.98 -37.78 46.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.25 -1.018 . . . . 0.34 108.25 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 20.7 mm-40 -74.23 -55.52 5.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.853 -1.067 . . . . 2.07 111.296 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 46' ' ' VAL . 21.3 mm -63.87 -53.1 48.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.448 -0.796 . . . . 0.65 110.811 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -103.12 -83.1 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.438 -0.505 . . . . 0.54 110.436 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.03 44.93 0.02 OUTLIER Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 120.061 -1.066 . . . . 0.43 112.199 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 26' ' ' VAL . 1.6 mp -78.05 149.79 77.03 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 110.05 -0.352 . . . . 0.31 110.05 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' HD2' ' OD1' ' A' ' 25' ' ' ASP . 8.9 Cg_exo -82.86 24.54 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 124.526 3.484 . . . . 1.08 115.429 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.505 ' H ' HG22 ' A' ' 21' ' ' ILE . 6.9 p 52.55 22.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 125.55 1.54 . . . . 0.81 114.909 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -130.16 -13.14 4.02 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 120.909 -1.119 . . . . 2.31 111.399 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.522 ' OD1' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -93.38 -26.25 17.34 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 115.324 -0.853 . . . . 1.59 110.251 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.601 HG23 HG21 ' A' ' 21' ' ' ILE . 39.5 t -71.24 91.23 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.201 -0.908 . . . . 0.3 109.357 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 34.4 mmtp -130.74 169.98 14.96 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.294 -1.373 . . . . 1.58 107.294 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 8.3 mp -64.74 148.38 51.25 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.819 -0.808 . . . . 1.05 108.819 177.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 t70 81.76 -3.52 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.766 1.226 . . . . 0.72 110.766 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.775 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 10.4 mmpt? -98.13 124.05 42.48 Favored 'General case' 0 CA--C 1.454 -2.744 0 C-N-CA 119.713 -0.795 . . . . 1.48 110.856 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 19.2 m -79.78 115.5 19.41 Favored 'General case' 1 C--N 1.237 -4.316 0 N-CA-C 108.02 -1.104 . . . . 1.25 108.02 178.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' LEU . 83.3 m-85 -51.78 -49.35 62.84 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.566 0.698 . . . . 0.4 112.228 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.523 ' HA ' ' H ' ' A' ' 38' ' ' VAL . 9.0 t -81.36 -44.46 17.56 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.291 -0.88 . . . . 1.06 111.305 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 25.0 t70 -74.15 -50.92 17.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.032 0.753 . . . . 1.74 113.032 -175.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.442 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 12.7 t70 -83.78 -58.03 2.97 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 122.049 0.928 . . . . 1.29 109.393 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.758 HD12 ' HA ' ' A' ' 32' ' ' PHE . 25.4 mt -72.88 -32.65 65.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.48 -1.691 . . . . 0.81 112.363 -169.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 20.1 t70 83.1 66.48 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 123.193 1.473 . . . . 1.12 110.803 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 19' ' ' ALA . 49.4 t -105.62 141.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 112.767 -2.015 . . . . 0.79 107.94 170.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.456 ' HB2' ' OG ' ' A' ' 42' ' ' SER . 4.8 m-20 -56.08 7.93 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 116.618 2.081 . . . . 2.0 116.618 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.517 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 30.5 t 66.6 -57.44 0.39 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 114.383 1.253 . . . . 0.78 114.383 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 pp -63.31 -30.72 71.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.949 0.88 . . . . 1.18 109.749 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.56 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.5 m -77.94 -15.55 58.89 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.751 -1.113 . . . . 0.6 110.506 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.822 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -67.08 -40.62 87.04 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-N 116.306 -0.407 . . . . 0.86 111.967 -174.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.19 -40.84 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 124.246 0.966 . . . . 0.31 109.767 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.88 -48.02 83.72 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.578 -0.737 . . . . 0.68 109.526 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.63 HG22 HG13 ' A' ' 18' ' ' ILE . 11.9 t -60.78 -23.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.988 0.915 . . . . 0.63 110.918 -177.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.904 HG21 HG13 ' A' ' 63' ' ' VAL . 36.8 t -78.99 -54.74 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 N-CA-C 107.885 -1.154 . . . . 0.55 107.885 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -60.65 -37.06 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.882 -1.054 . . . . 0.42 108.89 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -70.01 -31.51 69.21 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 116.167 -0.47 . . . . 0.21 110.061 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -65.67 -58.16 6.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.363 -0.835 . . . . 0.21 109.266 176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.631 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.269 0.0 OUTLIER -66.42 -31.83 72.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 114.914 1.45 . . . . 0.64 114.914 -175.59 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -59.24 -33.32 70.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.908 0.861 . . . . 2.07 109.881 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -88.59 -32.33 18.17 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.11 -0.95 . . . . 2.48 111.968 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.23 18.42 21.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.397 0.518 . . . . 0.81 112.397 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 75.37 -26.02 0.2 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 114.438 1.273 . . . . 1.99 114.438 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.631 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 7.2 p -72.26 170.81 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 122.324 -0.235 . . . . 0.37 110.379 -173.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.625 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 2.8 tppp? -124.13 126.67 46.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.31 -0.996 . . . . 2.12 108.31 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.64 HG12 ' HE2' ' A' ' 75' ' ' TYR . 36.0 mt -119.99 105.02 43.26 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 120.592 -0.443 . . . . 0.25 110.457 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 63' ' ' VAL . 79.9 Cg_endo -73.8 166.6 29.31 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.106 2.537 . . . . 0.33 111.004 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.33 -46.97 37.16 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 1.98 111.487 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.16 -35.44 77.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.876 -0.602 . . . . 2.06 112.02 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.566 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 10.9 m-20 -86.03 -31.63 21.9 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.275 -0.57 . . . . 0.52 111.222 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.904 HG13 HG21 ' A' ' 47' ' ' VAL . 75.1 t -52.84 -50.52 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.843 -0.799 . . . . 0.38 108.843 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -72.41 -9.15 58.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.199 -0.909 . . . . 2.16 113.195 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.42 -25.91 21.28 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.478 0.656 . . . . 1.59 110.071 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.802 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.7 mt -82.18 110.92 17.82 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.077 -1.823 . . . . 0.31 106.077 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 47.5 mtpt -112.25 -43.88 3.48 Favored 'General case' 0 C--N 1.271 -2.834 0 N-CA-C 107.718 -1.216 . . . . 2.55 107.718 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 67.4 p -102.54 174.73 5.77 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 114.917 -1.038 . . . . 0.23 109.039 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.491 HG22 ' CE2' ' A' ' 32' ' ' PHE . 10.1 t -77.3 -14.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 107.781 -1.192 . . . . 1.21 107.781 175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.478 ' HA2' ' HG ' ' A' ' 28' ' ' LEU . . . -69.01 -51.09 30.41 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 109.39 -1.484 . . . . 0.33 109.39 175.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -60.38 -51.24 70.32 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 114.269 -0.966 . . . . 1.39 109.371 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.802 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -54.29 -61.57 2.22 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 124.494 1.122 . . . . 0.15 111.528 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.446 ' HA ' HG21 ' A' ' 7' ' ' ILE . 34.3 m -58.1 -45.83 86.56 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.437 -1.256 . . . . 0.24 113.861 -174.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -57.64 -50.8 71.98 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 123.851 0.72 . . . . 3.63 109.194 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.64 ' HE2' HG12 ' A' ' 58' ' ' ILE . 49.4 t80 -54.55 -51.22 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.124 0.89 . . . . 0.4 111.283 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 73.1 mt -55.09 -66.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.66 0 CA-C-N 114.671 -1.149 . . . . 0.21 110.611 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 tt -52.54 -43.66 65.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.796 1.638 . . . . 1.44 110.678 -177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -71.07 -26.3 63.01 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.218 -1.355 . . . . 0.63 110.96 -173.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -103.24 -7.73 20.93 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.389 0.885 . . . . 1.25 113.389 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.69 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 84.0 mt-30 -71.9 -61.08 1.91 Allowed 'General case' 0 CA--C 1.448 -2.967 0 CA-C-O 122.974 1.369 . . . . 0.87 107.623 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.257 -3.421 0 CA-C-N 112.203 -2.272 . . . . 1.97 110.198 -178.893 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.822 ' H1 ' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 109.44 -0.578 . . . . 1.42 109.44 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.04 -155.27 0.65 Allowed 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.098 -1.075 . . . . 1.85 108.098 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -134.65 174.79 10.17 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.309 -0.626 . . . . 0.66 109.309 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.554 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.9 OUTLIER -48.39 -36.91 15.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.016 1.327 . . . . 0.74 112.973 178.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -52.19 -54.49 30.23 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.787 0.68 . . . . 2.66 110.512 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.16 -37.07 71.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.728 0.811 . . . . 2.73 110.092 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' A' ' 73' ' ' THR . 82.3 mt -74.37 -66.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 115.099 -0.955 . . . . 0.23 111.149 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.26 -46.71 92.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 112.347 0.499 . . . . 0.27 112.347 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.654 -0.419 . . . . 0.27 110.808 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.55 -38.22 9.93 Favored Glycine 0 N--CA 1.415 -2.756 0 CA-C-N 116.099 -0.501 . . . . 0.18 113.362 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.667 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.47 -38.61 91.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.033 -1.099 . . . . 0.2 108.033 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -56.96 -44.73 82.89 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.14 109.966 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.665 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 42.8 mt-10 -64.09 -35.24 80.12 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.872 0.732 . . . . 0.68 111.843 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 11' ' ' LEU . 51.7 mt -67.54 -43.2 87.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.85 -0.614 . . . . 0.28 109.589 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.688 HG22 HG11 ' A' ' 46' ' ' VAL . 21.3 t -67.72 -24.65 31.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 121.885 0.85 . . . . 0.27 109.221 -177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.665 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 13.7 m120 -64.58 -43.29 94.31 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 114.776 -1.102 . . . . 0.34 109.26 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -80.44 -49.15 11.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.189 -0.914 . . . . 2.07 111.591 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.735 HG13 HG22 ' A' ' 46' ' ' VAL . 22.1 mm -61.2 -53.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.057 -0.52 . . . . 0.65 111.283 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.8 -76.59 0.6 Allowed 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.226 -0.59 . . . . 0.54 110.384 -176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.84 50.33 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 110.146 -1.182 . . . . 0.43 110.146 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.449 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.2 mp -88.46 159.77 46.4 Favored Pre-proline 0 C--N 1.278 -2.508 0 CA-C-N 114.395 -0.902 . . . . 0.31 108.577 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -92.53 141.13 2.14 Favored 'Trans proline' 0 N--CA 1.414 -3.154 0 C-N-CA 122.108 1.872 . . . . 1.08 108.954 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.5 p -73.41 54.2 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-O 122.779 1.276 . . . . 0.81 113.111 -173.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 25' ' ' ASP . 12.2 pt-20 -163.74 -9.39 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.109 -1.405 . . . . 2.31 111.087 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.42 ' H ' ' H ' ' A' ' 24' ' ' GLU . 27.6 t0 -83.71 -28.45 28.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.763 0.792 . . . . 1.59 109.394 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' A' ' 12' ' ' ALA . 43.3 t -77.46 92.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.525 -1.216 . . . . 0.3 109.304 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 99.6 mttt -121.14 172.81 7.7 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.895 -1.15 . . . . 1.58 107.895 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HG ' ' HA2' ' A' ' 70' ' ' GLY . 8.6 mp -65.81 145.48 55.91 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.822 -1.177 . . . . 1.05 107.822 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 77.0 8.7 2.88 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.246 0.966 . . . . 0.72 110.804 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 68' ' ' THR . 74.1 mmtt -92.3 119.78 32.21 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 108.387 -0.968 . . . . 1.48 108.387 174.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 17.4 m -78.58 36.69 0.26 Allowed 'General case' 1 C--N 1.243 -4.058 0 C-N-CA 125.688 1.595 . . . . 1.25 113.515 -172.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.663 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 97.4 m-85 39.96 -95.78 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 125.328 1.451 . . . . 0.4 114.622 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 15.0 t -84.72 37.57 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.546 1.165 . . . . 1.06 111.342 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 32.5 t70 -145.41 -48.5 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.23 -1.35 . . . . 1.74 107.76 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 30' ' ' LYS . 3.2 m-20 -87.35 -38.05 16.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 1.29 112.914 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 26' ' ' VAL . 59.7 mt -85.35 -48.84 8.66 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.186 0.81 . . . . 0.81 113.186 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.0 t70 102.59 69.48 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.323 1.849 . . . . 1.12 109.696 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 39' ' ' ASP . 11.5 t -105.14 175.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 113.803 -1.544 . . . . 0.79 109.733 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 38' ' ' VAL . 17.2 t70 -79.04 -18.29 53.78 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.261 0.837 . . . . 2.0 113.261 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' MET . 3.3 t 74.5 -41.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.686 1.194 . . . . 0.78 113.154 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.45 -49.59 10.44 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 106.879 -1.526 . . . . 1.18 106.879 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 19.5 m -67.08 -11.96 58.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.045 -1.434 . . . . 0.6 111.023 176.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.663 ' SD ' ' HB3' ' A' ' 32' ' ' PHE . 4.0 tpt -60.23 -33.3 72.07 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 125.073 1.349 . . . . 0.86 109.324 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.544 HG22 ' S1 ' ' A' ' 101' ' ' SYO . 60.7 t -64.74 -40.02 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.602 -0.726 . . . . 0.31 109.53 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.23 -43.18 82.64 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.374 -0.375 . . . . 0.68 110.53 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 HG13 ' A' ' 18' ' ' ILE . 6.5 t -60.97 -24.43 32.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 C-N-CA 123.526 0.73 . . . . 0.63 110.845 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.685 HG21 HG13 ' A' ' 63' ' ' VAL . 22.0 t -80.4 -53.77 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 107.78 -1.193 . . . . 0.55 107.78 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.65 -32.91 52.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 113.895 -1.502 . . . . 0.42 110.03 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 14' ' ' ILE . . . -77.67 -31.31 52.46 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.207 0.527 . . . . 0.21 109.73 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' HB1' ' CE2' ' A' ' 54' ' ' PHE . . . -62.58 -57.09 12.35 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.398 -0.819 . . . . 0.21 109.131 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.536 ' OE2' ' HD3' ' A' ' 57' ' ' LYS 0.279 0.0 OUTLIER -61.88 -38.67 89.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 114.161 1.171 . . . . 0.64 114.161 -176.274 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.19 -34.47 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.527 0.517 . . . . 2.07 112.128 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -82.88 -36.08 25.66 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.064 -0.516 . . . . 2.48 110.205 -175.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.516 ' CE2' HG23 ' A' ' 7' ' ' ILE . 7.1 m-85 -86.85 -45.08 11.2 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.2 -1.0 . . . . 0.81 112.435 -172.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 152.29 -35.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 O-C-N 124.891 1.37 . . . . 1.99 112.169 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.604 ' CG1' HG23 ' A' ' 76' ' ' ILE . 14.5 p -75.92 172.37 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 112.726 0.639 . . . . 0.37 112.726 -165.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 3.1 tppp? -125.04 119.71 29.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.368 -1.715 . . . . 2.12 106.368 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.535 HG12 ' HE2' ' A' ' 75' ' ' TYR . 58.5 mt -111.85 113.22 52.74 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 120.693 -0.403 . . . . 0.25 110.226 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 63' ' ' VAL . 93.8 Cg_endo -73.15 157.62 50.25 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.822 2.348 . . . . 0.33 110.668 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.16 -41.17 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.523 1.129 . . . . 1.98 111.617 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 2.3 m-20 -61.81 -51.02 69.96 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 115.573 -0.74 . . . . 2.06 111.247 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 m-20 -71.46 -30.32 65.88 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.971 0.36 . . . . 0.52 111.971 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 47' ' ' VAL . 53.0 t -51.43 -55.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.941 -0.763 . . . . 0.38 108.941 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 16.5 pttp -75.64 -1.92 26.9 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 115.401 -0.818 . . . . 2.16 112.674 -175.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.38 -19.57 22.76 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.656 0.741 . . . . 1.59 109.383 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 72' ' ' ALA . 33.2 mt -86.11 118.33 25.51 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 104.728 -2.323 . . . . 0.31 104.728 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -110.95 -46.69 3.3 Favored 'General case' 0 C--N 1.259 -3.341 0 N-CA-C 108.289 -1.004 . . . . 2.55 108.289 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 42.5 p -105.07 173.57 6.25 Favored 'General case' 1 N--CA 1.379 -4.004 0 CA-C-N 115.052 -0.977 . . . . 0.23 109.321 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 27' ' ' LYS . 5.5 t -77.49 -13.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 107.454 -1.313 . . . . 1.21 107.454 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.548 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -69.46 -45.69 58.97 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.201 -1.56 . . . . 0.33 109.201 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -68.17 -48.21 65.9 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.122 -1.039 . . . . 1.39 109.59 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -53.62 -61.13 2.5 Favored 'General case' 0 CA--C 1.482 -1.655 0 O-C-N 124.56 1.162 . . . . 0.15 111.124 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.568 ' HA ' HG21 ' A' ' 7' ' ' ILE . 58.5 m -54.89 -51.54 65.66 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.615 -1.175 . . . . 0.24 113.838 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HD3' ' O ' ' A' ' 70' ' ' GLY . 2.1 mptm? -54.75 -47.85 73.33 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.867 0.729 . . . . 3.63 109.456 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.535 ' HE2' HG12 ' A' ' 58' ' ' ILE . 78.0 t80 -58.19 -52.55 65.11 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 124.204 0.94 . . . . 0.4 111.412 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.604 HG23 ' CG1' ' A' ' 56' ' ' VAL . 75.8 mt -51.41 -65.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.789 -1.096 . . . . 0.21 110.298 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 tt -54.52 -42.21 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.077 1.351 . . . . 1.44 109.855 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 26.6 t70 -59.62 -41.04 89.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.163 0.985 . . . . 0.63 110.285 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.595 ' HB3' ' CG2' ' A' ' 56' ' ' VAL . 1.9 t-80 -90.07 -12.4 38.58 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.141 -1.39 . . . . 1.25 111.222 -173.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 34.0 mt-30 -81.53 -49.49 10.51 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-O 122.722 1.248 . . . . 0.87 108.351 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -2.859 0 CA-C-N 112.381 -2.19 . . . . 1.97 110.458 -175.342 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.696 ' H2A' ' N41' ' A' ' 101' ' ' SYO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 N-CA-C 108.248 -1.019 . . . . 1.42 108.248 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.06 -89.47 0.47 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 112.445 0.535 . . . . 1.85 112.445 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.513 ' HA ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 t -169.64 -172.47 1.43 Allowed 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.908 -0.405 . . . . 0.66 109.908 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HG2' HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -50.26 -41.9 51.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.855 1.662 . . . . 0.74 113.534 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -62.42 -23.69 66.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.78 0.659 . . . . 2.66 112.78 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -87.56 -35.7 17.97 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.108 -0.701 . . . . 2.73 109.108 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' A' ' 73' ' ' THR . 92.9 mt -75.73 -65.48 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-N 115.523 -0.762 . . . . 0.23 110.996 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.427 HG23 ' HG2' ' A' ' 4' ' ' GLN . 67.6 t -52.16 -45.04 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 122.869 0.468 . . . . 0.27 111.523 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.1 76.64 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 123.64 0.588 . . . . 0.27 111.604 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.58 9.94 Favored Glycine 0 N--CA 1.412 -2.949 0 CA-C-N 116.419 -0.355 . . . . 0.18 112.493 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.728 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -66.61 -36.55 82.86 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.243 -1.021 . . . . 0.2 108.243 -178.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -58.68 -44.41 90.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.482 -0.781 . . . . 0.14 110.022 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.676 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 47.0 mt-10 -62.39 -38.6 90.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 123.935 0.772 . . . . 0.68 111.746 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 11' ' ' LEU . 61.1 mt -61.53 -42.33 93.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.749 0.785 . . . . 0.28 109.161 176.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.813 HG12 ' HB ' ' A' ' 21' ' ' ILE . 86.4 t -71.16 -23.72 23.56 Favored 'Isoleucine or valine' 0 C--O 1.255 1.39 0 CA-C-N 115.182 -0.917 . . . . 0.27 111.08 -175.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.676 ' OD1' ' HA ' ' A' ' 13' ' ' GLU . 8.9 m120 -67.02 -46.31 74.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.1 -1.074 . . . . 0.34 108.1 177.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -74.97 -50.03 18.0 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.924 -1.035 . . . . 2.07 111.859 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.737 HG13 HG22 ' A' ' 46' ' ' VAL . 24.4 mm -59.71 -52.53 59.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.983 0.513 . . . . 0.65 111.403 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 38' ' ' VAL . . . -110.28 -60.0 1.86 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.077 0.465 . . . . 0.54 111.552 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.07 28.63 0.31 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 120.559 -0.829 . . . . 0.43 112.638 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.813 ' HB ' HG12 ' A' ' 15' ' ' VAL . 1.5 mp -70.41 151.73 95.62 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 109.569 -0.53 . . . . 0.31 109.569 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 21' ' ' ILE . 3.7 Cg_exo -89.8 33.97 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.993 3.128 . . . . 1.08 115.222 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.496 ' CA ' HD21 ' A' ' 16' ' ' ASN . 3.3 p 61.41 -11.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 116.444 2.016 . . . . 0.81 116.444 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -115.16 -3.42 12.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.416 -0.803 . . . . 2.31 112.231 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.31 -29.54 28.24 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-O 121.638 0.733 . . . . 1.59 109.19 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.749 HG23 HG21 ' A' ' 21' ' ' ILE . 47.4 t -71.72 90.44 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.149 -1.387 . . . . 0.3 108.126 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 69' ' ' VAL . 1.5 tppp? -124.11 158.81 31.41 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.384 -1.71 . . . . 1.58 106.384 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.455 HD22 ' HA2' ' A' ' 70' ' ' GLY . 88.4 mt -57.54 140.29 51.2 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.001 0.429 . . . . 1.05 110.531 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t70 74.75 13.97 3.43 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.467 1.507 . . . . 0.72 110.911 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -100.91 125.99 47.5 Favored 'General case' 0 CA--C 1.467 -2.238 0 CA-C-O 121.474 0.655 . . . . 1.48 109.308 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 9.3 m -80.2 111.38 16.52 Favored 'General case' 1 C--N 1.239 -4.234 0 CA-C-N 114.071 -1.422 . . . . 1.25 109.129 -177.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.583 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 93.7 m-85 -45.74 -64.92 0.62 Allowed 'General case' 0 C--N 1.271 -2.808 0 C-N-CA 124.367 1.067 . . . . 0.4 112.374 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -90.25 32.97 0.9 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.204 -0.935 . . . . 1.06 112.783 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 31' ' ' SER . 22.8 t70 -147.71 -55.83 0.23 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.671 0.748 . . . . 1.74 110.741 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.59 -50.6 8.61 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.189 -0.914 . . . . 1.29 110.394 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.634 HD13 HG22 ' A' ' 26' ' ' VAL . 17.3 mt -76.36 -45.5 31.67 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.682 -0.69 . . . . 0.81 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.6 t70 88.66 61.73 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.844 1.658 . . . . 1.12 109.921 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 19' ' ' ALA . 18.6 t -104.21 143.55 15.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 113.591 -1.64 . . . . 0.79 106.766 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 43' ' ' MET . 36.9 m-20 -60.53 109.67 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 111.876 0.325 . . . . 2.0 111.876 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.602 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 28.6 t -34.84 -50.43 0.47 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 126.527 1.931 . . . . 0.78 114.429 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 42' ' ' SER . 3.3 pp -71.12 -27.83 63.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.438 0.637 . . . . 1.18 111.918 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 46' ' ' VAL . 18.5 m -85.11 -13.38 50.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.386 0.675 . . . . 0.6 110.425 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.911 ' HB3' ' H1 ' ' A' ' 101' ' ' SYO . 0.0 OUTLIER -61.58 -38.15 86.48 Favored 'General case' 0 CA--C 1.47 -2.103 0 C-N-CA 123.289 0.636 . . . . 0.86 111.576 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.6 -42.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 124.341 1.025 . . . . 0.31 109.413 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -57.01 -50.32 73.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.374 0.606 . . . . 0.68 109.387 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.737 HG22 HG13 ' A' ' 18' ' ' ILE . 40.8 t -55.83 -28.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 124.92 1.288 . . . . 0.63 111.67 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.934 HG21 HG13 ' A' ' 63' ' ' VAL . 21.2 t -78.17 -49.25 21.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.02 -1.104 . . . . 0.55 108.02 -176.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.39 -38.6 78.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.291 -1.322 . . . . 0.42 108.517 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -38.03 77.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.703 -0.68 . . . . 0.21 110.003 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' CB ' ' H8 ' ' A' ' 101' ' ' SYO . . . -61.42 -55.22 33.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.108 -0.951 . . . . 0.21 110.008 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 56' ' ' VAL 0.324 1.9 pp20? -62.22 -38.49 89.4 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 113.996 1.11 . . . . 0.64 113.996 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.32 -25.86 66.22 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.649 0.593 . . . . 2.07 112.505 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -83.93 -52.17 6.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.644 -0.423 . . . . 2.48 110.583 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 14.2 m-85 -73.94 -44.17 55.87 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 114.629 1.344 . . . . 0.81 114.629 -169.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 54' ' ' PHE . 17.3 t70 146.52 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 O-C-N 124.732 1.27 . . . . 1.99 110.636 176.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 76' ' ' ILE . 11.8 p -73.18 173.53 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.004 -0.998 . . . . 0.37 112.303 -166.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 56' ' ' VAL . 20.9 tptm -120.69 123.3 42.41 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.449 -1.315 . . . . 2.12 107.449 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.565 HG13 ' HB3' ' A' ' 51' ' ' GLU . 55.3 mt -120.31 106.96 39.83 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.478 -0.934 . . . . 0.25 108.478 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 63' ' ' VAL . 45.7 Cg_endo -70.29 166.84 26.91 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.013 2.476 . . . . 0.33 111.517 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -50.43 -43.2 54.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.144 0.978 . . . . 1.98 109.339 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -49.6 -59.17 4.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.539 -1.21 . . . . 2.06 111.642 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.565 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 27.6 m-20 -74.19 -26.28 60.18 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.84 0.681 . . . . 0.52 112.84 -176.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.934 HG13 HG21 ' A' ' 47' ' ' VAL . 62.0 t -53.26 -41.93 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 108.919 -0.771 . . . . 0.38 108.919 174.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -80.24 -7.18 58.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.665 -1.152 . . . . 2.16 112.185 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.67 -36.91 11.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 108.862 -0.792 . . . . 1.59 108.862 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.859 HD13 ' HA ' ' A' ' 72' ' ' ALA . 19.6 mt -73.2 125.1 26.95 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 106.596 -1.631 . . . . 0.31 106.596 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.55 ' HD2' ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -130.15 -24.24 2.62 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 120.312 -0.555 . . . . 2.55 111.474 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 43.0 p -116.5 171.83 7.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 107.721 -1.214 . . . . 0.23 107.721 173.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -78.75 -13.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 C-N-CA 120.087 -0.645 . . . . 1.21 109.599 176.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.455 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . -67.32 -46.78 67.91 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 109.713 -1.355 . . . . 0.33 109.713 175.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.55 ' OD2' ' HD2' ' A' ' 67' ' ' LYS . 15.0 m-20 -61.33 -55.42 31.92 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.378 -0.971 . . . . 1.39 108.378 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.859 ' HA ' HD13 ' A' ' 66' ' ' LEU . . . -51.62 -61.19 2.4 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.0 -1.454 . . . . 0.15 111.769 -175.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.44 ' HA ' HG21 ' A' ' 7' ' ' ILE . 37.6 m -57.96 -46.33 85.28 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.96 -1.018 . . . . 0.24 113.472 -174.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 14.1 mptt -56.88 -44.75 82.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 123.771 0.669 . . . . 3.63 109.45 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.464 ' CE2' HG12 ' A' ' 58' ' ' ILE . 85.6 t80 -65.31 -48.19 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.37 1.043 . . . . 0.4 111.65 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.657 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 74.0 mt -54.94 -65.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.71 -1.132 . . . . 0.21 110.239 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 3' ' ' THR . 3.0 tt -51.7 -41.78 61.71 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.775 1.23 . . . . 1.44 109.358 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 11.5 t70 -58.28 -41.11 83.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.917 1.287 . . . . 0.63 109.549 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -102.1 3.78 38.96 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.979 1.103 . . . . 1.25 113.979 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 76' ' ' ILE . 46.3 mt-30 -87.14 -60.53 1.95 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.552 -1.277 . . . . 0.87 107.552 175.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.417 0 CA-C-N 111.736 -2.484 . . . . 1.97 112.158 -174.135 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SYO . . . . . 0.911 ' H1 ' ' HB3' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_